<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2003-11-21" modified="2021-02-10" version="120">
<accession>P60029</accession>
<name>IRPL1_PANTR</name>
<protein>
<recommendedName>
<fullName>Interleukin-1 receptor accessory protein-like 1</fullName>
<shortName>IL-1-RAPL-1</shortName>
<shortName>IL-1RAPL-1</shortName>
<shortName>IL1RAPL-1</shortName>
<ecNumber evidence="7">3.2.2.6</ecNumber>
</recommendedName>
<alternativeName>
<fullName>Oligophrenin-4</fullName>
</alternativeName>
<alternativeName>
<fullName>X-linked interleukin-1 receptor accessory protein-like 1</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">IL1RAPL1</name>
<name type="synonym">OPHN4</name>
</gene>
<organism>
<name type="scientific">Pan troglodytes</name>
<name type="common">Chimpanzee</name>
<dbReference type="NCBI Taxonomy" id="9598"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Pan</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="2003" name="Mol. Biol. Evol." volume="20" first="1281" last="1289">
<title>Gene diversity patterns at 10 X-chromosomal loci in humans and chimpanzees.</title>
<authorList>
<person name="Kitano T."/>
<person name="Schwarz C."/>
<person name="Nickel B."/>
<person name="Paeaebo S."/>
</authorList>
<dbReference type="PubMed" id="12777533"/>
<dbReference type="DOI" id="10.1093/molbev/msg134"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
</reference>
<comment type="function">
<text evidence="2 3 4">May regulate secretion and presynaptic differentiation through inhibition of the activity of N-type voltage-gated calcium channel. May activate the MAP kinase JNK (By similarity). Plays a role in neurite outgrowth (By similarity). During dendritic spine formation can bidirectionally induce pre- and post-synaptic differentiation of neurons by trans-synaptically binding to PTPRD (By similarity).</text>
</comment>
<comment type="catalytic activity">
<reaction evidence="7">
<text>H2O + NAD(+) = ADP-D-ribose + H(+) + nicotinamide</text>
<dbReference type="Rhea" id="RHEA:16301"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:17154"/>
<dbReference type="ChEBI" id="CHEBI:57540"/>
<dbReference type="ChEBI" id="CHEBI:57967"/>
<dbReference type="EC" id="3.2.2.6"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="7">
<dbReference type="Rhea" id="RHEA:16302"/>
</physiologicalReaction>
</comment>
<comment type="subunit">
<text evidence="2 4">Homodimer (By similarity). Interacts (calcium-independent) with NCS1/FREQ (By similarity). Interacts (via the first immunoglobilin domain) with PTPRD (via the second immunoglobilin domain); this interaction is PTPRD-splicing-dependent and induces pre- and post-synaptic differentiation of neurons and is required for IL1RAPL1-mediated synapse formation (By similarity).</text>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="1">Cell membrane</location>
<topology evidence="1">Single-pass type I membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="1">Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="1">Cell projection</location>
<location evidence="1">Axon</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="1">Cell projection</location>
<location evidence="1">Dendrite</location>
</subcellularLocation>
<text evidence="1">May localize to the cell body and growth cones of dendrite-like processes.</text>
</comment>
<comment type="domain">
<text evidence="7">The TIR domain mediates NAD(+) hydrolase (NADase) activity. Self-association of TIR domains is required for NADase activity.</text>
</comment>
<comment type="similarity">
<text evidence="8">Belongs to the interleukin-1 receptor family.</text>
</comment>
<dbReference type="EC" id="3.2.2.6" evidence="7"/>
<dbReference type="EMBL" id="AB102651">
<property type="protein sequence ID" value="BAC81120.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001009038.1">
<property type="nucleotide sequence ID" value="NM_001009038.1"/>
</dbReference>
<dbReference type="RefSeq" id="XP_009437156.1">
<property type="nucleotide sequence ID" value="XM_009438881.2"/>
</dbReference>
<dbReference type="SMR" id="P60029"/>
<dbReference type="STRING" id="9598.ENSPTRP00000037316"/>
<dbReference type="PaxDb" id="P60029"/>
<dbReference type="Ensembl" id="ENSPTRT00000040384">
<property type="protein sequence ID" value="ENSPTRP00000037316"/>
<property type="gene ID" value="ENSPTRG00000021762"/>
</dbReference>
<dbReference type="GeneID" id="450116"/>
<dbReference type="KEGG" id="ptr:450116"/>
<dbReference type="CTD" id="11141"/>
<dbReference type="VGNC" id="VGNC:55718">
<property type="gene designation" value="IL1RAPL1"/>
</dbReference>
<dbReference type="eggNOG" id="KOG3971">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT01010000222456"/>
<dbReference type="InParanoid" id="P60029"/>
<dbReference type="OMA" id="WRSSIVF"/>
<dbReference type="OrthoDB" id="651291at2759"/>
<dbReference type="Proteomes" id="UP000002277">
<property type="component" value="Chromosome X"/>
</dbReference>
<dbReference type="GO" id="GO:0030424">
<property type="term" value="C:axon"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0030425">
<property type="term" value="C:dendrite"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0098978">
<property type="term" value="C:glutamatergic synapse"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0016021">
<property type="term" value="C:integral component of membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050135">
<property type="term" value="F:NAD(P)+ nucleosidase activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0061809">
<property type="term" value="F:NAD+ nucleotidase, cyclic ADP-ribose generating"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0045920">
<property type="term" value="P:negative regulation of exocytosis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051965">
<property type="term" value="P:positive regulation of synapse assembly"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010975">
<property type="term" value="P:regulation of neuron projection development"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0099175">
<property type="term" value="P:regulation of postsynapse organization"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:1905606">
<property type="term" value="P:regulation of presynapse assembly"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007165">
<property type="term" value="P:signal transduction"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0099545">
<property type="term" value="P:trans-synaptic signaling by trans-synaptic complex"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="Gene3D" id="2.60.40.10">
<property type="match status" value="3"/>
</dbReference>
<dbReference type="Gene3D" id="3.40.50.10140">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR007110">
<property type="entry name" value="Ig-like_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR036179">
<property type="entry name" value="Ig-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR013783">
<property type="entry name" value="Ig-like_fold"/>
</dbReference>
<dbReference type="InterPro" id="IPR003599">
<property type="entry name" value="Ig_sub"/>
</dbReference>
<dbReference type="InterPro" id="IPR003598">
<property type="entry name" value="Ig_sub2"/>
</dbReference>
<dbReference type="InterPro" id="IPR015621">
<property type="entry name" value="IL-1_rcpt_fam"/>
</dbReference>
<dbReference type="InterPro" id="IPR041416">
<property type="entry name" value="IL-1RAcP-like_ig"/>
</dbReference>
<dbReference type="InterPro" id="IPR013151">
<property type="entry name" value="Immunoglobulin"/>
</dbReference>
<dbReference type="InterPro" id="IPR000157">
<property type="entry name" value="TIR_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR035897">
<property type="entry name" value="Toll_tir_struct_dom_sf"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR11890">
<property type="entry name" value="PTHR11890"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00047">
<property type="entry name" value="ig"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF18452">
<property type="entry name" value="Ig_6"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF01582">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00409">
<property type="entry name" value="IG"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="SMART" id="SM00408">
<property type="entry name" value="IGc2"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="SMART" id="SM00255">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF48726">
<property type="entry name" value="SSF48726"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF52200">
<property type="entry name" value="SSF52200"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50835">
<property type="entry name" value="IG_LIKE"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="PROSITE" id="PS50104">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at transcript level"/>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-0966">Cell projection</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0378">Hydrolase</keyword>
<keyword id="KW-0393">Immunoglobulin domain</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0520">NAD</keyword>
<keyword id="KW-0675">Receptor</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0732">Signal</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<feature type="signal peptide" evidence="5">
<location>
<begin position="1"/>
<end position="18"/>
</location>
</feature>
<feature type="chain" description="Interleukin-1 receptor accessory protein-like 1" id="PRO_0000015456">
<location>
<begin position="19"/>
<end position="696"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="5">
<location>
<begin position="19"/>
<end position="357"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="5">
<location>
<begin position="358"/>
<end position="378"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="5">
<location>
<begin position="379"/>
<end position="696"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 1">
<location>
<begin position="19"/>
<end position="134"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 2">
<location>
<begin position="143"/>
<end position="232"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 3">
<location>
<begin position="242"/>
<end position="350"/>
</location>
</feature>
<feature type="domain" description="TIR" evidence="7">
<location>
<begin position="403"/>
<end position="559"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with NCS1" evidence="1">
<location>
<begin position="549"/>
<end position="644"/>
</location>
</feature>
<feature type="active site" evidence="7">
<location>
<position position="491"/>
</location>
</feature>
<feature type="site" description="Essential for interaction with PTPRD" evidence="2">
<location>
<position position="34"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="5">
<location>
<position position="63"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="5">
<location>
<position position="122"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="5">
<location>
<position position="138"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="5">
<location>
<position position="213"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="5">
<location>
<position position="264"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="5">
<location>
<position position="331"/>
</location>
</feature>
<feature type="disulfide bond" evidence="2">
<location>
<begin position="31"/>
<end position="126"/>
</location>
</feature>
<feature type="disulfide bond" evidence="6">
<location>
<begin position="53"/>
<end position="118"/>
</location>
</feature>
<feature type="disulfide bond" evidence="2">
<location>
<begin position="143"/>
<end position="185"/>
</location>
</feature>
<feature type="disulfide bond" evidence="6">
<location>
<begin position="164"/>
<end position="216"/>
</location>
</feature>
<feature type="disulfide bond" evidence="6">
<location>
<begin position="267"/>
<end position="334"/>
</location>
</feature>
<evidence key="1" type="ECO:0000250"/>
<evidence key="2" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P59823"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P59824"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q9NZN1"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000255"/>
<evidence key="6" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00114"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00204"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000305"/>
<sequence length="696" mass="79969" checksum="9B7A0B503D73CCA9" modified="2003-11-21" version="1" precursor="true">MKAPIPHLILLYATFTQSLKVVTKRGSADGCTDWSIDIKKYQVLVGEPVRIKCALFYGYIRTNYSLAQSAGLSLMWYKSSGPGDFEEPIAFDGSRMSKEEDSIWFRPTLLQDSGLYACVIRNSTYCMKVSISLTVGENDTGLCYNSKMKYFEKAELSKSKEISCRDIEDFLLPTREPEILWYKECRTKTWRPSIVFKRDTLLIREVREDDIGNYTCELKYGGFVVRRTTELTVTAPLTDKPPKLLYPMESKLTIQETQLGDSANLTCRAFFGYSGDVSPLIYWMKGEKFIEDLDENRVWESDIRILKEHLGEQEVSISLIVDSVEEGDLGNYSCYVENGNGRRHASVLLHKRELMYTVELAGGLGAILLLLVCLVTIYKCYKIEIMLFYRNHFGAEELDGDNKDYDAYLSYTKVDPDQWNQETGEEERFALEILPDMLEKHYGYKLFIPDRDLIPTGTYIEDVARCVDQSKRLIIVMTPNYVVRRGWSIFELETRLRNMLVTGEIKVILIECSELRGIMNYQEVEALKHTIKLLTVIKWHGPKCNKLNSKFWKRLQYEMPFKRIEPITHEQALDVSEQGPFGELQTVSAISMAAATSTALATAHPDLRSTFHNTYHSQMRQKHYYRSYEYDVPPTGTLPLTSIGNQHTYCNIPMTLINGQRPQTKSSREQNPDEAHTNSAILPLLPRETSISSVIW</sequence>
</entry>
<entry dataset="Swiss-Prot" created="2003-08-22" modified="2021-02-10" version="180">
<accession>Q9NZN1</accession>
<accession>A0AVG4</accession>
<accession>Q9UJ53</accession>
<name>IRPL1_HUMAN</name>
<protein>
<recommendedName>
<fullName>Interleukin-1 receptor accessory protein-like 1</fullName>
<shortName>IL-1-RAPL-1</shortName>
<shortName>IL-1RAPL-1</shortName>
<shortName>IL1RAPL-1</shortName>
<ecNumber evidence="8">3.2.2.6</ecNumber>
</recommendedName>
<alternativeName>
<fullName>Oligophrenin-4</fullName>
</alternativeName>
<alternativeName>
<fullName>Three immunoglobulin domain-containing IL-1 receptor-related 2</fullName>
<shortName>TIGIRR-2</shortName>
</alternativeName>
<alternativeName>
<fullName>X-linked interleukin-1 receptor accessory protein-like 1</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">IL1RAPL1</name>
<name type="synonym">OPHN4</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1999" name="Nat. Genet." volume="23" first="25" last="31">
<title>A new member of the IL-1 receptor family highly expressed in hippocampus and involved in X-linked mental retardation.</title>
<authorList>
<person name="Carrie A."/>
<person name="Jun L."/>
<person name="Bienvenu T."/>
<person name="Vinet M.-C."/>
<person name="McDonell N."/>
<person name="Couvert P."/>
<person name="Zemni R."/>
<person name="Cardona A."/>
<person name="Van Buggenhout G."/>
<person name="Frints S."/>
<person name="Hamel B.C.J."/>
<person name="Moraine C."/>
<person name="Ropers H.-H."/>
<person name="Strom T."/>
<person name="Howell G.R."/>
<person name="Whittaker A."/>
<person name="Ross M.T."/>
<person name="Kahn A."/>
<person name="Fryns J.-P."/>
<person name="Beldjord C."/>
<person name="Marynen P."/>
<person name="Chelly J."/>
</authorList>
<dbReference type="PubMed" id="10471494"/>
<dbReference type="DOI" id="10.1038/12623"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>INVOLVEMENT IN NONSPECIFIC XLMR</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>ALTERNATIVE SPLICING</scope>
<source>
<tissue>Fetal brain</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="2000" name="Eur. J. Hum. Genet." volume="8" first="87" last="94">
<title>Two novel members of the interleukin-1 receptor gene family, one deleted in Xp22.3-Xp21.3 mental retardation.</title>
<authorList>
<person name="Jin H."/>
<person name="Gardner R.J."/>
<person name="Viswesvaraiah R."/>
<person name="Muntoni F."/>
<person name="Roberts R.G."/>
</authorList>
<dbReference type="PubMed" id="10757639"/>
<dbReference type="DOI" id="10.1038/sj.ejhg.5200415"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>INVOLVEMENT IN MRX21</scope>
</reference>
<reference key="3">
<citation type="journal article" date="2000" name="J. Biol. Chem." volume="275" first="29946" last="29954">
<title>Identification and characterization of two members of a novel class of the interleukin-1 receptor (IL-1R) family. Delineation of a new class of IL-1R-related proteins based on signaling.</title>
<authorList>
<person name="Born T.L."/>
<person name="Smith D.E."/>
<person name="Garka K.E."/>
<person name="Renshaw B.R."/>
<person name="Bertles J.S."/>
<person name="Sims J.E."/>
</authorList>
<dbReference type="PubMed" id="10882729"/>
<dbReference type="DOI" id="10.1074/jbc.m004077200"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>TISSUE SPECIFICITY</scope>
<source>
<tissue>Brain</tissue>
<tissue>Testis</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="2003" name="Mol. Biol. Evol." volume="20" first="1281" last="1289">
<title>Gene diversity patterns at 10 X-chromosomal loci in humans and chimpanzees.</title>
<authorList>
<person name="Kitano T."/>
<person name="Schwarz C."/>
<person name="Nickel B."/>
<person name="Paeaebo S."/>
</authorList>
<dbReference type="PubMed" id="12777533"/>
<dbReference type="DOI" id="10.1093/molbev/msg134"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2005" name="Nature" volume="434" first="325" last="337">
<title>The DNA sequence of the human X chromosome.</title>
<authorList>
<person name="Ross M.T."/>
<person name="Grafham D.V."/>
<person name="Coffey A.J."/>
<person name="Scherer S."/>
<person name="McLay K."/>
<person name="Muzny D."/>
<person name="Platzer M."/>
<person name="Howell G.R."/>
<person name="Burrows C."/>
<person name="Bird C.P."/>
<person name="Frankish A."/>
<person name="Lovell F.L."/>
<person name="Howe K.L."/>
<person name="Ashurst J.L."/>
<person name="Fulton R.S."/>
<person name="Sudbrak R."/>
<person name="Wen G."/>
<person name="Jones M.C."/>
<person name="Hurles M.E."/>
<person name="Andrews T.D."/>
<person name="Scott C.E."/>
<person name="Searle S."/>
<person name="Ramser J."/>
<person name="Whittaker A."/>
<person name="Deadman R."/>
<person name="Carter N.P."/>
<person name="Hunt S.E."/>
<person name="Chen R."/>
<person name="Cree A."/>
<person name="Gunaratne P."/>
<person name="Havlak P."/>
<person name="Hodgson A."/>
<person name="Metzker M.L."/>
<person name="Richards S."/>
<person name="Scott G."/>
<person name="Steffen D."/>
<person name="Sodergren E."/>
<person name="Wheeler D.A."/>
<person name="Worley K.C."/>
<person name="Ainscough R."/>
<person name="Ambrose K.D."/>
<person name="Ansari-Lari M.A."/>
<person name="Aradhya S."/>
<person name="Ashwell R.I."/>
<person name="Babbage A.K."/>
<person name="Bagguley C.L."/>
<person name="Ballabio A."/>
<person name="Banerjee R."/>
<person name="Barker G.E."/>
<person name="Barlow K.F."/>
<person name="Barrett I.P."/>
<person name="Bates K.N."/>
<person name="Beare D.M."/>
<person name="Beasley H."/>
<person name="Beasley O."/>
<person name="Beck A."/>
<person name="Bethel G."/>
<person name="Blechschmidt K."/>
<person name="Brady N."/>
<person name="Bray-Allen S."/>
<person name="Bridgeman A.M."/>
<person name="Brown A.J."/>
<person name="Brown M.J."/>
<person name="Bonnin D."/>
<person name="Bruford E.A."/>
<person name="Buhay C."/>
<person name="Burch P."/>
<person name="Burford D."/>
<person name="Burgess J."/>
<person name="Burrill W."/>
<person name="Burton J."/>
<person name="Bye J.M."/>
<person name="Carder C."/>
<person name="Carrel L."/>
<person name="Chako J."/>
<person name="Chapman J.C."/>
<person name="Chavez D."/>
<person name="Chen E."/>
<person name="Chen G."/>
<person name="Chen Y."/>
<person name="Chen Z."/>
<person name="Chinault C."/>
<person name="Ciccodicola A."/>
<person name="Clark S.Y."/>
<person name="Clarke G."/>
<person name="Clee C.M."/>
<person name="Clegg S."/>
<person name="Clerc-Blankenburg K."/>
<person name="Clifford K."/>
<person name="Cobley V."/>
<person name="Cole C.G."/>
<person name="Conquer J.S."/>
<person name="Corby N."/>
<person name="Connor R.E."/>
<person name="David R."/>
<person name="Davies J."/>
<person name="Davis C."/>
<person name="Davis J."/>
<person name="Delgado O."/>
<person name="Deshazo D."/>
<person name="Dhami P."/>
<person name="Ding Y."/>
<person name="Dinh H."/>
<person name="Dodsworth S."/>
<person name="Draper H."/>
<person name="Dugan-Rocha S."/>
<person name="Dunham A."/>
<person name="Dunn M."/>
<person name="Durbin K.J."/>
<person name="Dutta I."/>
<person name="Eades T."/>
<person name="Ellwood M."/>
<person name="Emery-Cohen A."/>
<person name="Errington H."/>
<person name="Evans K.L."/>
<person name="Faulkner L."/>
<person name="Francis F."/>
<person name="Frankland J."/>
<person name="Fraser A.E."/>
<person name="Galgoczy P."/>
<person name="Gilbert J."/>
<person name="Gill R."/>
<person name="Gloeckner G."/>
<person name="Gregory S.G."/>
<person name="Gribble S."/>
<person name="Griffiths C."/>
<person name="Grocock R."/>
<person name="Gu Y."/>
<person name="Gwilliam R."/>
<person name="Hamilton C."/>
<person name="Hart E.A."/>
<person name="Hawes A."/>
<person name="Heath P.D."/>
<person name="Heitmann K."/>
<person name="Hennig S."/>
<person name="Hernandez J."/>
<person name="Hinzmann B."/>
<person name="Ho S."/>
<person name="Hoffs M."/>
<person name="Howden P.J."/>
<person name="Huckle E.J."/>
<person name="Hume J."/>
<person name="Hunt P.J."/>
<person name="Hunt A.R."/>
<person name="Isherwood J."/>
<person name="Jacob L."/>
<person name="Johnson D."/>
<person name="Jones S."/>
<person name="de Jong P.J."/>
<person name="Joseph S.S."/>
<person name="Keenan S."/>
<person name="Kelly S."/>
<person name="Kershaw J.K."/>
<person name="Khan Z."/>
<person name="Kioschis P."/>
<person name="Klages S."/>
<person name="Knights A.J."/>
<person name="Kosiura A."/>
<person name="Kovar-Smith C."/>
<person name="Laird G.K."/>
<person name="Langford C."/>
<person name="Lawlor S."/>
<person name="Leversha M."/>
<person name="Lewis L."/>
<person name="Liu W."/>
<person name="Lloyd C."/>
<person name="Lloyd D.M."/>
<person name="Loulseged H."/>
<person name="Loveland J.E."/>
<person name="Lovell J.D."/>
<person name="Lozado R."/>
<person name="Lu J."/>
<person name="Lyne R."/>
<person name="Ma J."/>
<person name="Maheshwari M."/>
<person name="Matthews L.H."/>
<person name="McDowall J."/>
<person name="McLaren S."/>
<person name="McMurray A."/>
<person name="Meidl P."/>
<person name="Meitinger T."/>
<person name="Milne S."/>
<person name="Miner G."/>
<person name="Mistry S.L."/>
<person name="Morgan M."/>
<person name="Morris S."/>
<person name="Mueller I."/>
<person name="Mullikin J.C."/>
<person name="Nguyen N."/>
<person name="Nordsiek G."/>
<person name="Nyakatura G."/>
<person name="O'dell C.N."/>
<person name="Okwuonu G."/>
<person name="Palmer S."/>
<person name="Pandian R."/>
<person name="Parker D."/>
<person name="Parrish J."/>
<person name="Pasternak S."/>
<person name="Patel D."/>
<person name="Pearce A.V."/>
<person name="Pearson D.M."/>
<person name="Pelan S.E."/>
<person name="Perez L."/>
<person name="Porter K.M."/>
<person name="Ramsey Y."/>
<person name="Reichwald K."/>
<person name="Rhodes S."/>
<person name="Ridler K.A."/>
<person name="Schlessinger D."/>
<person name="Schueler M.G."/>
<person name="Sehra H.K."/>
<person name="Shaw-Smith C."/>
<person name="Shen H."/>
<person name="Sheridan E.M."/>
<person name="Shownkeen R."/>
<person name="Skuce C.D."/>
<person name="Smith M.L."/>
<person name="Sotheran E.C."/>
<person name="Steingruber H.E."/>
<person name="Steward C.A."/>
<person name="Storey R."/>
<person name="Swann R.M."/>
<person name="Swarbreck D."/>
<person name="Tabor P.E."/>
<person name="Taudien S."/>
<person name="Taylor T."/>
<person name="Teague B."/>
<person name="Thomas K."/>
<person name="Thorpe A."/>
<person name="Timms K."/>
<person name="Tracey A."/>
<person name="Trevanion S."/>
<person name="Tromans A.C."/>
<person name="d'Urso M."/>
<person name="Verduzco D."/>
<person name="Villasana D."/>
<person name="Waldron L."/>
<person name="Wall M."/>
<person name="Wang Q."/>
<person name="Warren J."/>
<person name="Warry G.L."/>
<person name="Wei X."/>
<person name="West A."/>
<person name="Whitehead S.L."/>
<person name="Whiteley M.N."/>
<person name="Wilkinson J.E."/>
<person name="Willey D.L."/>
<person name="Williams G."/>
<person name="Williams L."/>
<person name="Williamson A."/>
<person name="Williamson H."/>
<person name="Wilming L."/>
<person name="Woodmansey R.L."/>
<person name="Wray P.W."/>
<person name="Yen J."/>
<person name="Zhang J."/>
<person name="Zhou J."/>
<person name="Zoghbi H."/>
<person name="Zorilla S."/>
<person name="Buck D."/>
<person name="Reinhardt R."/>
<person name="Poustka A."/>
<person name="Rosenthal A."/>
<person name="Lehrach H."/>
<person name="Meindl A."/>
<person name="Minx P.J."/>
<person name="Hillier L.W."/>
<person name="Willard H.F."/>
<person name="Wilson R.K."/>
<person name="Waterston R.H."/>
<person name="Rice C.M."/>
<person name="Vaudin M."/>
<person name="Coulson A."/>
<person name="Nelson D.L."/>
<person name="Weinstock G."/>
<person name="Sulston J.E."/>
<person name="Durbin R.M."/>
<person name="Hubbard T."/>
<person name="Gibbs R.A."/>
<person name="Beck S."/>
<person name="Rogers J."/>
<person name="Bentley D.R."/>
</authorList>
<dbReference type="PubMed" id="15772651"/>
<dbReference type="DOI" id="10.1038/nature03440"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="6">
<citation type="submission" date="2005-07" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="8">
<citation type="journal article" date="2003" name="Hum. Mol. Genet." volume="12" first="1415" last="1425">
<title>IL1 receptor accessory protein like, a protein involved in X-linked mental retardation, interacts with Neuronal Calcium Sensor-1 and regulates exocytosis.</title>
<authorList>
<person name="Bahi N."/>
<person name="Friocourt G."/>
<person name="Carrie A."/>
<person name="Graham M.E."/>
<person name="Weiss J.L."/>
<person name="Chafey P."/>
<person name="Fauchereau F."/>
<person name="Burgoyne R.D."/>
<person name="Chelly J."/>
</authorList>
<dbReference type="PubMed" id="12783849"/>
<dbReference type="DOI" id="10.1093/hmg/ddg147"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH NCS1</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2006" name="Am. J. Med. Genet. A" volume="140" first="482" last="487">
<title>A truncating mutation in the IL1RAPL1 gene is responsible for X-linked mental retardation in the MRX21 family.</title>
<authorList>
<person name="Tabolacci E."/>
<person name="Pomponi M.G."/>
<person name="Pietrobono R."/>
<person name="Terracciano A."/>
<person name="Chiurazzi P."/>
<person name="Neri G."/>
</authorList>
<dbReference type="PubMed" id="16470793"/>
<dbReference type="DOI" id="10.1002/ajmg.a.31107"/>
</citation>
<scope>INVOLVEMENT IN MRX21</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2008" name="Hum. Mol. Genet." volume="17" first="3965" last="3974">
<title>Mutations in the calcium-related gene IL1RAPL1 are associated with autism.</title>
<authorList>
<person name="Piton A."/>
<person name="Michaud J.L."/>
<person name="Peng H."/>
<person name="Aradhya S."/>
<person name="Gauthier J."/>
<person name="Mottron L."/>
<person name="Champagne N."/>
<person name="Lafreniere R.G."/>
<person name="Hamdan F.F."/>
<person name="Joober R."/>
<person name="Fombonne E."/>
<person name="Marineau C."/>
<person name="Cossette P."/>
<person name="Dube M.P."/>
<person name="Haghighi P."/>
<person name="Drapeau P."/>
<person name="Barker P.A."/>
<person name="Carbonetto S."/>
<person name="Rouleau G.A."/>
</authorList>
<dbReference type="PubMed" id="18801879"/>
<dbReference type="DOI" id="10.1093/hmg/ddn300"/>
</citation>
<scope>VARIANTS ARG-379; HIS-618; SER-637 AND VAL-643</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="31664" last="31670">
<title>Crystal structure of the Toll/interleukin-1 receptor domain of human IL-1RAPL.</title>
<authorList>
<person name="Khan J.A."/>
<person name="Brint E.K."/>
<person name="O'Neill L.A.J."/>
<person name="Tong L."/>
</authorList>
<dbReference type="PubMed" id="15123616"/>
<dbReference type="DOI" id="10.1074/jbc.m403434200"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.30 ANGSTROMS) OF 403-561</scope>
<scope>FUNCTION</scope>
<scope>DIMERIZATION</scope>
</reference>
<comment type="function">
<text evidence="4 5 12 13">May regulate secretion and presynaptic differentiation through inhibition of the activity of N-type voltage-gated calcium channel (PubMed:12783849). May activate the MAP kinase JNK (PubMed:15123616). Plays a role in neurite outgrowth (By similarity). During dendritic spine formation can bidirectionally induce pre- and post-synaptic differentiation of neurons by trans-synaptically binding to PTPRD (By similarity).</text>
</comment>
<comment type="catalytic activity">
<reaction evidence="8">
<text>H2O + NAD(+) = ADP-D-ribose + H(+) + nicotinamide</text>
<dbReference type="Rhea" id="RHEA:16301"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:17154"/>
<dbReference type="ChEBI" id="CHEBI:57540"/>
<dbReference type="ChEBI" id="CHEBI:57967"/>
<dbReference type="EC" id="3.2.2.6"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="8">
<dbReference type="Rhea" id="RHEA:16302"/>
</physiologicalReaction>
</comment>
<comment type="subunit">
<text evidence="4 12 13">Homodimer (PubMed:15123616). Interacts (calcium-independent) with NCS1 (PubMed:12783849). Interacts (via the first immunoglobilin domain) with PTPRD (via the second immunoglobilin domain); this interaction is PTPRD-splicing-dependent and induces pre- and post-synaptic differentiation of neurons and is required for IL1RAPL1-mediated synapse formation (By similarity).</text>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="12">Cell membrane</location>
<topology evidence="12">Single-pass type I membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="12">Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="3">Cell projection</location>
<location evidence="3">Axon</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="3">Cell projection</location>
<location evidence="3">Dendrite</location>
</subcellularLocation>
<text evidence="3">May localize to the cell body and growth cones of dendrite-like processes.</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>Q9NZN1-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<text>A number of isoforms are produced.</text>
</comment>
<comment type="tissue specificity">
<text evidence="9 11">Detected at low levels in heart, skeletal muscle, ovary, skin, amygdala, caudate nucleus, corpus callosum, hippocampus, substantia nigra and thalamus. Detected at very low levels in tonsil, prostate, testis, small intestine, placenta, colon and fetal liver.</text>
</comment>
<comment type="domain">
<text evidence="8">The TIR domain mediates NAD(+) hydrolase (NADase) activity. Self-association of TIR domains is required for NADase activity.</text>
</comment>
<comment type="disease" evidence="10 14">
<disease id="DI-00726">
<name>Mental retardation, X-linked 21</name>
<acronym>MRX21</acronym>
<description>A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. Intellectual deficiency is the only primary symptom of non-syndromic X-linked mental retardation, while syndromic mental retardation presents with associated physical, neurological and/or psychiatric manifestations.</description>
<dbReference type="MIM" id="300143"/>
</disease>
<text>The disease is caused by variants affecting the gene represented in this entry.</text>
</comment>
<comment type="similarity">
<text evidence="16">Belongs to the interleukin-1 receptor family.</text>
</comment>
<dbReference type="EC" id="3.2.2.6" evidence="8"/>
<dbReference type="EMBL" id="AJ243874">
<property type="protein sequence ID" value="CAB56046.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF181284">
<property type="protein sequence ID" value="AAF59411.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF284435">
<property type="protein sequence ID" value="AAG21369.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB102650">
<property type="protein sequence ID" value="BAC81119.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AC005748">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC121343">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC129852">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL031466">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL031575">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471074">
<property type="protein sequence ID" value="EAW99046.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC126345">
<property type="protein sequence ID" value="AAI26346.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC126347">
<property type="protein sequence ID" value="AAI26348.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS14218.1">
<molecule id="Q9NZN1-1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_055086.1">
<molecule id="Q9NZN1-1"/>
<property type="nucleotide sequence ID" value="NM_014271.3"/>
</dbReference>
<dbReference type="RefSeq" id="XP_016884729.1">
<molecule id="Q9NZN1-1"/>
<property type="nucleotide sequence ID" value="XM_017029240.1"/>
</dbReference>
<dbReference type="PDB" id="1T3G">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="A/B=403-561"/>
</dbReference>
<dbReference type="PDB" id="4M92">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.60"/>
<property type="chains" value="B=207-222"/>
</dbReference>
<dbReference type="PDB" id="5WY8">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.07"/>
<property type="chains" value="B=27-349"/>
</dbReference>
<dbReference type="PDBsum" id="1T3G"/>
<dbReference type="PDBsum" id="4M92"/>
<dbReference type="PDBsum" id="5WY8"/>
<dbReference type="SMR" id="Q9NZN1"/>
<dbReference type="BioGRID" id="116313">
<property type="interactions" value="5"/>
</dbReference>
<dbReference type="IntAct" id="Q9NZN1">
<property type="interactions" value="1"/>
</dbReference>
<dbReference type="STRING" id="9606.ENSP00000368278"/>
<dbReference type="GlyGen" id="Q9NZN1">
<property type="glycosylation" value="6 sites"/>
</dbReference>
<dbReference type="iPTMnet" id="Q9NZN1"/>
<dbReference type="PhosphoSitePlus" id="Q9NZN1"/>
<dbReference type="BioMuta" id="IL1RAPL1"/>
<dbReference type="DMDM" id="34222654"/>
<dbReference type="EPD" id="Q9NZN1"/>
<dbReference type="MassIVE" id="Q9NZN1"/>
<dbReference type="PaxDb" id="Q9NZN1"/>
<dbReference type="PeptideAtlas" id="Q9NZN1"/>
<dbReference type="PRIDE" id="Q9NZN1"/>
<dbReference type="ProteomicsDB" id="83457">
<molecule id="Q9NZN1-1"/>
</dbReference>
<dbReference type="Antibodypedia" id="433">
<property type="antibodies" value="224 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="11141"/>
<dbReference type="Ensembl" id="ENST00000378993">
<molecule id="Q9NZN1-1"/>
<property type="protein sequence ID" value="ENSP00000368278"/>
<property type="gene ID" value="ENSG00000169306"/>
</dbReference>
<dbReference type="GeneID" id="11141"/>
<dbReference type="KEGG" id="hsa:11141"/>
<dbReference type="CTD" id="11141"/>
<dbReference type="DisGeNET" id="11141"/>
<dbReference type="GeneCards" id="IL1RAPL1"/>
<dbReference type="GeneReviews" id="IL1RAPL1"/>
<dbReference type="HGNC" id="HGNC:5996">
<property type="gene designation" value="IL1RAPL1"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000169306">
<property type="expression patterns" value="Tissue enriched (brain)"/>
</dbReference>
<dbReference type="MalaCards" id="IL1RAPL1"/>
<dbReference type="MIM" id="300143">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="300206">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q9NZN1"/>
<dbReference type="OpenTargets" id="ENSG00000169306"/>
<dbReference type="Orphanet" id="777">
<property type="disease" value="X-linked non-syndromic intellectual disability"/>
</dbReference>
<dbReference type="PharmGKB" id="PA29812"/>
<dbReference type="VEuPathDB" id="HostDB:ENSG00000169306.9"/>
<dbReference type="eggNOG" id="KOG3971">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT01010000222456"/>
<dbReference type="HOGENOM" id="CLU_025552_0_1_1"/>
<dbReference type="InParanoid" id="Q9NZN1"/>
<dbReference type="OMA" id="WRSSIVF"/>
<dbReference type="OrthoDB" id="172471at2759"/>
<dbReference type="PhylomeDB" id="Q9NZN1"/>
<dbReference type="TreeFam" id="TF333913"/>
<dbReference type="PathwayCommons" id="Q9NZN1"/>
<dbReference type="Reactome" id="R-HSA-388844">
<property type="pathway name" value="Receptor-type tyrosine-protein phosphatases"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9007892">
<property type="pathway name" value="Interleukin-38 signaling"/>
</dbReference>
<dbReference type="BioGRID-ORCS" id="11141">
<property type="hits" value="6 hits in 505 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="IL1RAPL1">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="Q9NZN1"/>
<dbReference type="GeneWiki" id="IL1RAPL1"/>
<dbReference type="GenomeRNAi" id="11141"/>
<dbReference type="Pharos" id="Q9NZN1">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:Q9NZN1"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome X"/>
</dbReference>
<dbReference type="RNAct" id="Q9NZN1">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000169306">
<property type="expression patterns" value="Expressed in corpus callosum and 104 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="Q9NZN1">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q9NZN1">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0030424">
<property type="term" value="C:axon"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0009986">
<property type="term" value="C:cell surface"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0030425">
<property type="term" value="C:dendrite"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0098978">
<property type="term" value="C:glutamatergic synapse"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="SynGO"/>
</dbReference>
<dbReference type="GO" id="GO:0016021">
<property type="term" value="C:integral component of membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045211">
<property type="term" value="C:postsynaptic membrane"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0050135">
<property type="term" value="F:NAD(P)+ nucleosidase activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0061809">
<property type="term" value="F:NAD+ nucleotidase, cyclic ADP-ribose generating"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0005102">
<property type="term" value="F:signaling receptor binding"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0071345">
<property type="term" value="P:cellular response to cytokine stimulus"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0007157">
<property type="term" value="P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045920">
<property type="term" value="P:negative regulation of exocytosis"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030182">
<property type="term" value="P:neuron differentiation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0050775">
<property type="term" value="P:positive regulation of dendrite morphogenesis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0051965">
<property type="term" value="P:positive regulation of synapse assembly"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0097105">
<property type="term" value="P:presynaptic membrane assembly"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0010975">
<property type="term" value="P:regulation of neuron projection development"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0099175">
<property type="term" value="P:regulation of postsynapse organization"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="SynGO"/>
</dbReference>
<dbReference type="GO" id="GO:1905606">
<property type="term" value="P:regulation of presynapse assembly"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="SynGO"/>
</dbReference>
<dbReference type="GO" id="GO:0007165">
<property type="term" value="P:signal transduction"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0099545">
<property type="term" value="P:trans-synaptic signaling by trans-synaptic complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="SynGO"/>
</dbReference>
<dbReference type="Gene3D" id="2.60.40.10">
<property type="match status" value="3"/>
</dbReference>
<dbReference type="Gene3D" id="3.40.50.10140">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR007110">
<property type="entry name" value="Ig-like_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR036179">
<property type="entry name" value="Ig-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR013783">
<property type="entry name" value="Ig-like_fold"/>
</dbReference>
<dbReference type="InterPro" id="IPR003599">
<property type="entry name" value="Ig_sub"/>
</dbReference>
<dbReference type="InterPro" id="IPR003598">
<property type="entry name" value="Ig_sub2"/>
</dbReference>
<dbReference type="InterPro" id="IPR015621">
<property type="entry name" value="IL-1_rcpt_fam"/>
</dbReference>
<dbReference type="InterPro" id="IPR041416">
<property type="entry name" value="IL-1RAcP-like_ig"/>
</dbReference>
<dbReference type="InterPro" id="IPR013151">
<property type="entry name" value="Immunoglobulin"/>
</dbReference>
<dbReference type="InterPro" id="IPR000157">
<property type="entry name" value="TIR_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR035897">
<property type="entry name" value="Toll_tir_struct_dom_sf"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR11890">
<property type="entry name" value="PTHR11890"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00047">
<property type="entry name" value="ig"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF18452">
<property type="entry name" value="Ig_6"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF01582">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00409">
<property type="entry name" value="IG"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="SMART" id="SM00408">
<property type="entry name" value="IGc2"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="SMART" id="SM00255">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF48726">
<property type="entry name" value="SSF48726"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF52200">
<property type="entry name" value="SSF52200"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50835">
<property type="entry name" value="IG_LIKE"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="PROSITE" id="PS50104">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-0966">Cell projection</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0378">Hydrolase</keyword>
<keyword id="KW-0393">Immunoglobulin domain</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0991">Mental retardation</keyword>
<keyword id="KW-0520">NAD</keyword>
<keyword id="KW-0675">Receptor</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0732">Signal</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<feature type="signal peptide" evidence="6">
<location>
<begin position="1"/>
<end position="18"/>
</location>
</feature>
<feature type="chain" description="Interleukin-1 receptor accessory protein-like 1" id="PRO_0000015454">
<location>
<begin position="19"/>
<end position="696"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="6">
<location>
<begin position="19"/>
<end position="357"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="6">
<location>
<begin position="358"/>
<end position="378"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="6">
<location>
<begin position="379"/>
<end position="696"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 1">
<location>
<begin position="19"/>
<end position="134"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 2">
<location>
<begin position="143"/>
<end position="232"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 3">
<location>
<begin position="242"/>
<end position="350"/>
</location>
</feature>
<feature type="domain" description="TIR" evidence="8">
<location>
<begin position="403"/>
<end position="559"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with NCS1" evidence="12">
<location>
<begin position="549"/>
<end position="644"/>
</location>
</feature>
<feature type="active site" evidence="8">
<location>
<position position="491"/>
</location>
</feature>
<feature type="site" description="Essential for interaction with PTPRD" evidence="4">
<location>
<position position="34"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="6">
<location>
<position position="63"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="6">
<location>
<position position="122"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="6">
<location>
<position position="138"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="6">
<location>
<position position="213"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="6">
<location>
<position position="264"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="6">
<location>
<position position="331"/>
</location>
</feature>
<feature type="disulfide bond" evidence="4">
<location>
<begin position="31"/>
<end position="126"/>
</location>
</feature>
<feature type="disulfide bond" evidence="7">
<location>
<begin position="53"/>
<end position="118"/>
</location>
</feature>
<feature type="disulfide bond" evidence="4">
<location>
<begin position="143"/>
<end position="185"/>
</location>
</feature>
<feature type="disulfide bond" evidence="7">
<location>
<begin position="164"/>
<end position="216"/>
</location>
</feature>
<feature type="disulfide bond" evidence="7">
<location>
<begin position="267"/>
<end position="334"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs138267399." id="VAR_062263" evidence="15">
<original>K</original>
<variation>R</variation>
<location>
<position position="379"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs890627874." id="VAR_062264" evidence="15">
<original>Q</original>
<variation>H</variation>
<location>
<position position="618"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs756672167." id="VAR_062265" evidence="15">
<original>T</original>
<variation>S</variation>
<location>
<position position="637"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs746481663." id="VAR_062266" evidence="15">
<original>I</original>
<variation>V</variation>
<location>
<position position="643"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="32"/>
<end position="34"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="40"/>
<end position="44"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="49"/>
<end position="52"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="54"/>
<end position="58"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="64"/>
<end position="69"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="73"/>
<end position="84"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="93"/>
<end position="99"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="102"/>
<end position="107"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="110"/>
<end position="112"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="114"/>
<end position="121"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="126"/>
<end position="136"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="142"/>
<end position="144"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="150"/>
<end position="155"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="160"/>
<end position="163"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="168"/>
<end position="170"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="180"/>
<end position="183"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="200"/>
<end position="205"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="208"/>
<end position="210"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="212"/>
<end position="220"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="223"/>
<end position="234"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="243"/>
<end position="247"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="259"/>
<end position="261"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="263"/>
<end position="271"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="274"/>
<end position="277"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="280"/>
<end position="285"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="295"/>
<end position="297"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="298"/>
<end position="300"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="304"/>
<end position="309"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="312"/>
<end position="323"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="326"/>
<end position="328"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="330"/>
<end position="338"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="341"/>
<end position="348"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="405"/>
<end position="410"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="426"/>
<end position="431"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="433"/>
<end position="440"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="449"/>
<end position="452"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="459"/>
<end position="468"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="470"/>
<end position="477"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="479"/>
<end position="483"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="484"/>
<end position="487"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="488"/>
<end position="492"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="494"/>
<end position="501"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="504"/>
<end position="511"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="518"/>
<end position="529"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="532"/>
<end position="538"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="542"/>
<end position="545"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="546"/>
<end position="548"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="550"/>
<end position="558"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1T3G"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5WY8"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000250"/>
<evidence key="4" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P59823"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P59824"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000255"/>
<evidence key="7" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00114"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00204"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10471494"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10757639"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10882729"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12783849"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15123616"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16470793"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18801879"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000305"/>
<sequence length="696" mass="79969" checksum="9B7A0B503D73CCA9" modified="2003-08-22" version="2" precursor="true">MKAPIPHLILLYATFTQSLKVVTKRGSADGCTDWSIDIKKYQVLVGEPVRIKCALFYGYIRTNYSLAQSAGLSLMWYKSSGPGDFEEPIAFDGSRMSKEEDSIWFRPTLLQDSGLYACVIRNSTYCMKVSISLTVGENDTGLCYNSKMKYFEKAELSKSKEISCRDIEDFLLPTREPEILWYKECRTKTWRPSIVFKRDTLLIREVREDDIGNYTCELKYGGFVVRRTTELTVTAPLTDKPPKLLYPMESKLTIQETQLGDSANLTCRAFFGYSGDVSPLIYWMKGEKFIEDLDENRVWESDIRILKEHLGEQEVSISLIVDSVEEGDLGNYSCYVENGNGRRHASVLLHKRELMYTVELAGGLGAILLLLVCLVTIYKCYKIEIMLFYRNHFGAEELDGDNKDYDAYLSYTKVDPDQWNQETGEEERFALEILPDMLEKHYGYKLFIPDRDLIPTGTYIEDVARCVDQSKRLIIVMTPNYVVRRGWSIFELETRLRNMLVTGEIKVILIECSELRGIMNYQEVEALKHTIKLLTVIKWHGPKCNKLNSKFWKRLQYEMPFKRIEPITHEQALDVSEQGPFGELQTVSAISMAAATSTALATAHPDLRSTFHNTYHSQMRQKHYYRSYEYDVPPTGTLPLTSIGNQHTYCNIPMTLINGQRPQTKSSREQNPDEAHTNSAILPLLPRETSISSVIW</sequence>
</entry>
<entry dataset="Swiss-Prot" created="2004-06-07" modified="2020-10-07" version="95">
<accession>Q7YQL9</accession>
<name>IRPL1_PONPY</name>
<protein>
<recommendedName>
<fullName>Interleukin-1 receptor accessory protein-like 1</fullName>
<shortName>IL-1-RAPL-1</shortName>
<shortName>IL-1RAPL-1</shortName>
<shortName>IL1RAPL-1</shortName>
<ecNumber evidence="7">3.2.2.6</ecNumber>
</recommendedName>
<alternativeName>
<fullName>X-linked interleukin-1 receptor accessory protein-like 1</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">IL1RAPL1</name>
<name type="synonym">OPHN4</name>
</gene>
<organism>
<name type="scientific">Pongo pygmaeus</name>
<name type="common">Bornean orangutan</name>
<dbReference type="NCBI Taxonomy" id="9600"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Pongo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="2003" name="Mol. Biol. Evol." volume="20" first="1281" last="1289">
<title>Gene diversity patterns at 10 X-chromosomal loci in humans and chimpanzees.</title>
<authorList>
<person name="Kitano T."/>
<person name="Schwarz C."/>
<person name="Nickel B."/>
<person name="Paeaebo S."/>
</authorList>
<dbReference type="PubMed" id="12777533"/>
<dbReference type="DOI" id="10.1093/molbev/msg134"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
</reference>
<comment type="function">
<text evidence="2 3 4">May regulate secretion and presynaptic differentiation through inhibition of the activity of N-type voltage-gated calcium channel. May activate the MAP kinase JNK (By similarity). Plays a role in neurite outgrowth (By similarity). During dendritic spine formation can bidirectionally induce pre- and post-synaptic differentiation of neurons by trans-synaptically binding to PTPRD (By similarity).</text>
</comment>
<comment type="catalytic activity">
<reaction evidence="7">
<text>H2O + NAD(+) = ADP-D-ribose + H(+) + nicotinamide</text>
<dbReference type="Rhea" id="RHEA:16301"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:17154"/>
<dbReference type="ChEBI" id="CHEBI:57540"/>
<dbReference type="ChEBI" id="CHEBI:57967"/>
<dbReference type="EC" id="3.2.2.6"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="7">
<dbReference type="Rhea" id="RHEA:16302"/>
</physiologicalReaction>
</comment>
<comment type="subunit">
<text evidence="2 4">Homodimer (By similarity). Interacts (calcium-independent) with NCS1/FREQ (By similarity). Interacts (via the first immunoglobilin domain) with PTPRD (via the second immunoglobilin domain); this interaction is PTPRD-splicing-dependent and induces pre- and post-synaptic differentiation of neurons and is required for IL1RAPL1-mediated synapse formation (By similarity).</text>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="1">Cell membrane</location>
<topology evidence="1">Single-pass type I membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="1">Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="1">Cell projection</location>
<location evidence="1">Axon</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="1">Cell projection</location>
<location evidence="1">Dendrite</location>
</subcellularLocation>
<text evidence="1">May localize to the cell body and growth cones of dendrite-like processes.</text>
</comment>
<comment type="domain">
<text evidence="7">The TIR domain mediates NAD(+) hydrolase (NADase) activity. Self-association of TIR domains is required for NADase activity.</text>
</comment>
<comment type="similarity">
<text evidence="8">Belongs to the interleukin-1 receptor family.</text>
</comment>
<dbReference type="EC" id="3.2.2.6" evidence="7"/>
<dbReference type="EMBL" id="AB102652">
<property type="protein sequence ID" value="BAC81121.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="SMR" id="Q7YQL9"/>
<dbReference type="PRIDE" id="Q7YQL9"/>
<dbReference type="GO" id="GO:0030424">
<property type="term" value="C:axon"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0030425">
<property type="term" value="C:dendrite"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0016021">
<property type="term" value="C:integral component of membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050135">
<property type="term" value="F:NAD(P)+ nucleosidase activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0061809">
<property type="term" value="F:NAD+ nucleotidase, cyclic ADP-ribose generating"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0045920">
<property type="term" value="P:negative regulation of exocytosis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051965">
<property type="term" value="P:positive regulation of synapse assembly"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010975">
<property type="term" value="P:regulation of neuron projection development"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007165">
<property type="term" value="P:signal transduction"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="Gene3D" id="2.60.40.10">
<property type="match status" value="3"/>
</dbReference>
<dbReference type="Gene3D" id="3.40.50.10140">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR007110">
<property type="entry name" value="Ig-like_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR036179">
<property type="entry name" value="Ig-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR013783">
<property type="entry name" value="Ig-like_fold"/>
</dbReference>
<dbReference type="InterPro" id="IPR003599">
<property type="entry name" value="Ig_sub"/>
</dbReference>
<dbReference type="InterPro" id="IPR003598">
<property type="entry name" value="Ig_sub2"/>
</dbReference>
<dbReference type="InterPro" id="IPR015621">
<property type="entry name" value="IL-1_rcpt_fam"/>
</dbReference>
<dbReference type="InterPro" id="IPR041416">
<property type="entry name" value="IL-1RAcP-like_ig"/>
</dbReference>
<dbReference type="InterPro" id="IPR013151">
<property type="entry name" value="Immunoglobulin"/>
</dbReference>
<dbReference type="InterPro" id="IPR000157">
<property type="entry name" value="TIR_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR035897">
<property type="entry name" value="Toll_tir_struct_dom_sf"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR11890">
<property type="entry name" value="PTHR11890"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00047">
<property type="entry name" value="ig"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF18452">
<property type="entry name" value="Ig_6"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF01582">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00409">
<property type="entry name" value="IG"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="SMART" id="SM00408">
<property type="entry name" value="IGc2"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="SMART" id="SM00255">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF48726">
<property type="entry name" value="SSF48726"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF52200">
<property type="entry name" value="SSF52200"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50835">
<property type="entry name" value="IG_LIKE"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="PROSITE" id="PS50104">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at transcript level"/>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-0966">Cell projection</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0378">Hydrolase</keyword>
<keyword id="KW-0393">Immunoglobulin domain</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0520">NAD</keyword>
<keyword id="KW-0675">Receptor</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0732">Signal</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<feature type="signal peptide" evidence="5">
<location>
<begin position="1"/>
<end position="18"/>
</location>
</feature>
<feature type="chain" description="Interleukin-1 receptor accessory protein-like 1" id="PRO_0000015457">
<location>
<begin position="19"/>
<end position="696"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="5">
<location>
<begin position="19"/>
<end position="357"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="5">
<location>
<begin position="358"/>
<end position="378"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="5">
<location>
<begin position="379"/>
<end position="696"/>
</location>
</feature>
<feature type="domain" description="Ig-like 1">
<location>
<begin position="19"/>
<end position="134"/>
</location>
</feature>
<feature type="domain" description="Ig-like 2">
<location>
<begin position="143"/>
<end position="232"/>
</location>
</feature>
<feature type="domain" description="Ig-like 3">
<location>
<begin position="242"/>
<end position="350"/>
</location>
</feature>
<feature type="domain" description="TIR" evidence="7">
<location>
<begin position="403"/>
<end position="559"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with NCS1" evidence="1">
<location>
<begin position="549"/>
<end position="644"/>
</location>
</feature>
<feature type="active site" evidence="7">
<location>
<position position="491"/>
</location>
</feature>
<feature type="site" description="Essential for interaction with PTPRD" evidence="2">
<location>
<position position="34"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="5">
<location>
<position position="63"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="5">
<location>
<position position="122"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="5">
<location>
<position position="138"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="5">
<location>
<position position="213"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="5">
<location>
<position position="264"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="5">
<location>
<position position="331"/>
</location>
</feature>
<feature type="disulfide bond" evidence="2">
<location>
<begin position="31"/>
<end position="126"/>
</location>
</feature>
<feature type="disulfide bond" evidence="6">
<location>
<begin position="53"/>
<end position="118"/>
</location>
</feature>
<feature type="disulfide bond" evidence="2">
<location>
<begin position="143"/>
<end position="185"/>
</location>
</feature>
<feature type="disulfide bond" evidence="6">
<location>
<begin position="164"/>
<end position="216"/>
</location>
</feature>
<feature type="disulfide bond" evidence="6">
<location>
<begin position="267"/>
<end position="334"/>
</location>
</feature>
<evidence key="1" type="ECO:0000250"/>
<evidence key="2" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P59823"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P59824"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q9NZN1"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000255"/>
<evidence key="6" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00114"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00204"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000305"/>
<sequence length="696" mass="79937" checksum="0332FE0C31C2D4E1" modified="2003-10-01" version="1" precursor="true">MKAPIPHLILLYATFTQSLKVVTKRGSADGCTDWSIDIKKYQVLVGEPVRIKCALFYGYIRTNYSLAQSAGLSLMWYKSSGPGDFEEPIAFDGSRMSKEEDSIWFRPTLLQDSGLYACVIRNSTYCMKVSISLTVGENDTGLCYNSKMKYFEKAELSKSKEISCRDIEDFLLPTREPEILWYKECRTKTWRPSIVFKRDTLLIREVREDDIGNYTCELKYGGFVVRRTTELTVTAPLTDKPPKLLYPVESKLTIQETQLGDSANLTCRAFFGYSGDVSPLIYWMKGEKFIEDLDENRVWESDIRILKEHLGEQEVSISLIVDSVEEGDLGNYSCYVENGNGRRHASVLLHKRELMYTVELAGGLGAILLLLVCLVTIYKCYKIEIMLFYRNHFGAEELDGDNKDYDAYLSYTKVDPDQWNQETGEEERFALEILPDMLEKHYGYKLFIPDRDLIPTGTYIEDVARCVDQSKRLIIVMTPNYVVRRGWSIFELETRLRNMLVTGEIKVILIECSELRGIMNYQEVEALKHTIKLLTVIKWHGPKCNKLNSKFWKRLQYEMPFKRIEPITHEQALDVSEQGPFGELQTVSAISMAAATSTALATAHPDLRSTFHNTYHSQMRQKHYYRSYEYDVPPTGTLPLTSIGNQHTYCNIPMTLINGQRPQTKSSREQNPDEAHTNSAILPLLPRETSISSVIW</sequence>
</entry>
<entry dataset="Swiss-Prot" created="2003-08-22" modified="2021-02-10" version="118">
<accession>P59824</accession>
<name>IRPL1_RAT</name>
<protein>
<recommendedName>
<fullName>Interleukin-1 receptor accessory protein-like 1</fullName>
<shortName>IL-1-RAPL-1</shortName>
<shortName>IL-1RAPL-1</shortName>
<shortName>IL1RAPL-1</shortName>
<ecNumber evidence="6">3.2.2.6</ecNumber>
</recommendedName>
<alternativeName>
<fullName>X-linked interleukin-1 receptor accessory protein-like 1</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">Il1rapl1</name>
</gene>
<organism>
<name type="scientific">Rattus norvegicus</name>
<name type="common">Rat</name>
<dbReference type="NCBI Taxonomy" id="10116"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Glires</taxon>
<taxon>Rodentia</taxon>
<taxon>Myomorpha</taxon>
<taxon>Muroidea</taxon>
<taxon>Muridae</taxon>
<taxon>Murinae</taxon>
<taxon>Rattus</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="submission" date="2003-01" db="EMBL/GenBank/DDBJ databases">
<title>Full length cloning of rat IL1RAPL in the hippocampus.</title>
<authorList>
<person name="Boda B."/>
<person name="Parisi L."/>
<person name="Muller D."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<source>
<strain>Wistar</strain>
<tissue>Hippocampus</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="2007" name="Proc. Natl. Acad. Sci. U.S.A." volume="104" first="9063" last="9068">
<title>IL1-receptor accessory protein-like 1 (IL1RAPL1), a protein involved in cognitive functions, regulates N-type Ca2+-channel and neurite elongation.</title>
<authorList>
<person name="Gambino F."/>
<person name="Pavlowsky A."/>
<person name="Begle A."/>
<person name="Dupont J.-L."/>
<person name="Bahi N."/>
<person name="Courjaret R."/>
<person name="Gardette R."/>
<person name="Hadjkacem H."/>
<person name="Skala H."/>
<person name="Poulain B."/>
<person name="Chelly J."/>
<person name="Vitale N."/>
<person name="Humeau Y."/>
</authorList>
<dbReference type="PubMed" id="17502602"/>
<dbReference type="DOI" id="10.1073/pnas.0701133104"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="3">
<citation type="journal article" date="2008" name="Hum. Mol. Genet." volume="17" first="3965" last="3974">
<title>Mutations in the calcium-related gene IL1RAPL1 are associated with autism.</title>
<authorList>
<person name="Piton A."/>
<person name="Michaud J.L."/>
<person name="Peng H."/>
<person name="Aradhya S."/>
<person name="Gauthier J."/>
<person name="Mottron L."/>
<person name="Champagne N."/>
<person name="Lafreniere R.G."/>
<person name="Hamdan F.F."/>
<person name="Joober R."/>
<person name="Fombonne E."/>
<person name="Marineau C."/>
<person name="Cossette P."/>
<person name="Dube M.P."/>
<person name="Haghighi P."/>
<person name="Drapeau P."/>
<person name="Barker P.A."/>
<person name="Carbonetto S."/>
<person name="Rouleau G.A."/>
</authorList>
<dbReference type="PubMed" id="18801879"/>
<dbReference type="DOI" id="10.1093/hmg/ddn300"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<comment type="function">
<text evidence="2 3 7 8">May regulate secretion and presynaptic differentiation through inhibition of the activity of N-type voltage-gated calcium channel (PubMed:17502602). May activate the MAP kinase JNK (By similarity). Plays a role in neurite outgrowth (PubMed:18801879). During dendritic spine formation can bidirectionally induce pre- and post-synaptic differentiation of neurons by trans-synaptically binding to PTPRD (By similarity).</text>
</comment>
<comment type="catalytic activity">
<reaction evidence="6">
<text>H2O + NAD(+) = ADP-D-ribose + H(+) + nicotinamide</text>
<dbReference type="Rhea" id="RHEA:16301"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:17154"/>
<dbReference type="ChEBI" id="CHEBI:57540"/>
<dbReference type="ChEBI" id="CHEBI:57967"/>
<dbReference type="EC" id="3.2.2.6"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="6">
<dbReference type="Rhea" id="RHEA:16302"/>
</physiologicalReaction>
</comment>
<comment type="subunit">
<text evidence="2 3">Homodimer (By similarity). Interacts (calcium-independent) with NCS1/FREQ (By similarity). Interacts (via the first immunoglobilin domain) with PTPRD (via the second immunoglobilin domain); this interaction is PTPRD-splicing-dependent and induces pre- and post-synaptic differentiation of neurons and is required for IL1RAPL1-mediated synapse formation (By similarity).</text>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="8">Cell membrane</location>
<topology evidence="8">Single-pass type I membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="8">Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="1">Cell projection</location>
<location evidence="1">Axon</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="1">Cell projection</location>
<location evidence="1">Dendrite</location>
</subcellularLocation>
<text>May localize to the cell body and growth cones of dendrite-like processes.</text>
</comment>
<comment type="domain">
<text evidence="6">The TIR domain mediates NAD(+) hydrolase (NADase) activity. Self-association of TIR domains is required for NADase activity.</text>
</comment>
<comment type="similarity">
<text evidence="9">Belongs to the interleukin-1 receptor family.</text>
</comment>
<dbReference type="EC" id="3.2.2.6" evidence="6"/>
<dbReference type="EMBL" id="AY216593">
<property type="protein sequence ID" value="AAO62634.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="RefSeq" id="NP_808796.1">
<property type="nucleotide sequence ID" value="NM_177935.2"/>
</dbReference>
<dbReference type="SMR" id="P59824"/>
<dbReference type="STRING" id="10116.ENSRNOP00000068289"/>
<dbReference type="CarbonylDB" id="P59824"/>
<dbReference type="GlyGen" id="P59824">
<property type="glycosylation" value="6 sites"/>
</dbReference>
<dbReference type="iPTMnet" id="P59824"/>
<dbReference type="PhosphoSitePlus" id="P59824"/>
<dbReference type="SwissPalm" id="P59824"/>
<dbReference type="PaxDb" id="P59824"/>
<dbReference type="PRIDE" id="P59824"/>
<dbReference type="GeneID" id="317553"/>
<dbReference type="KEGG" id="rno:317553"/>
<dbReference type="CTD" id="11141"/>
<dbReference type="RGD" id="727891">
<property type="gene designation" value="Il1rapl1"/>
</dbReference>
<dbReference type="eggNOG" id="KOG3971">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="InParanoid" id="P59824"/>
<dbReference type="PhylomeDB" id="P59824"/>
<dbReference type="Reactome" id="R-RNO-388844">
<property type="pathway name" value="Receptor-type tyrosine-protein phosphatases"/>
</dbReference>
<dbReference type="Reactome" id="R-RNO-9007892">
<property type="pathway name" value="Interleukin-38 signaling"/>
</dbReference>
<dbReference type="PRO" id="PR:P59824"/>
<dbReference type="Proteomes" id="UP000002494">
<property type="component" value="Unplaced"/>
</dbReference>
<dbReference type="GO" id="GO:0030424">
<property type="term" value="C:axon"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0009986">
<property type="term" value="C:cell surface"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0030425">
<property type="term" value="C:dendrite"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0098978">
<property type="term" value="C:glutamatergic synapse"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="SynGO"/>
</dbReference>
<dbReference type="GO" id="GO:0099061">
<property type="term" value="C:integral component of postsynaptic density membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="SynGO"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050135">
<property type="term" value="F:NAD(P)+ nucleosidase activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0061809">
<property type="term" value="F:NAD+ nucleotidase, cyclic ADP-ribose generating"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0005102">
<property type="term" value="F:signaling receptor binding"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0007157">
<property type="term" value="P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0045920">
<property type="term" value="P:negative regulation of exocytosis"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030182">
<property type="term" value="P:neuron differentiation"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0050775">
<property type="term" value="P:positive regulation of dendrite morphogenesis"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0051965">
<property type="term" value="P:positive regulation of synapse assembly"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0097105">
<property type="term" value="P:presynaptic membrane assembly"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0010975">
<property type="term" value="P:regulation of neuron projection development"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0099175">
<property type="term" value="P:regulation of postsynapse organization"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:1905606">
<property type="term" value="P:regulation of presynapse assembly"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0007165">
<property type="term" value="P:signal transduction"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0099545">
<property type="term" value="P:trans-synaptic signaling by trans-synaptic complex"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="Gene3D" id="2.60.40.10">
<property type="match status" value="3"/>
</dbReference>
<dbReference type="Gene3D" id="3.40.50.10140">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR007110">
<property type="entry name" value="Ig-like_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR036179">
<property type="entry name" value="Ig-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR013783">
<property type="entry name" value="Ig-like_fold"/>
</dbReference>
<dbReference type="InterPro" id="IPR003599">
<property type="entry name" value="Ig_sub"/>
</dbReference>
<dbReference type="InterPro" id="IPR003598">
<property type="entry name" value="Ig_sub2"/>
</dbReference>
<dbReference type="InterPro" id="IPR015621">
<property type="entry name" value="IL-1_rcpt_fam"/>
</dbReference>
<dbReference type="InterPro" id="IPR041416">
<property type="entry name" value="IL-1RAcP-like_ig"/>
</dbReference>
<dbReference type="InterPro" id="IPR013151">
<property type="entry name" value="Immunoglobulin"/>
</dbReference>
<dbReference type="InterPro" id="IPR000157">
<property type="entry name" value="TIR_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR035897">
<property type="entry name" value="Toll_tir_struct_dom_sf"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR11890">
<property type="entry name" value="PTHR11890"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00047">
<property type="entry name" value="ig"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF18452">
<property type="entry name" value="Ig_6"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF01582">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00409">
<property type="entry name" value="IG"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="SMART" id="SM00408">
<property type="entry name" value="IGc2"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="SMART" id="SM00255">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF48726">
<property type="entry name" value="SSF48726"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF52200">
<property type="entry name" value="SSF52200"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50835">
<property type="entry name" value="IG_LIKE"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="PROSITE" id="PS50104">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at transcript level"/>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-0966">Cell projection</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0378">Hydrolase</keyword>
<keyword id="KW-0393">Immunoglobulin domain</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0520">NAD</keyword>
<keyword id="KW-0675">Receptor</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0732">Signal</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<feature type="signal peptide" evidence="4">
<location>
<begin position="1"/>
<end position="24"/>
</location>
</feature>
<feature type="chain" description="Interleukin-1 receptor accessory protein-like 1" id="PRO_0000015458">
<location>
<begin position="25"/>
<end position="696"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="4">
<location>
<begin position="25"/>
<end position="357"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="4">
<location>
<begin position="358"/>
<end position="378"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="4">
<location>
<begin position="379"/>
<end position="696"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 1">
<location>
<begin position="25"/>
<end position="134"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 2">
<location>
<begin position="143"/>
<end position="232"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 3">
<location>
<begin position="242"/>
<end position="350"/>
</location>
</feature>
<feature type="domain" description="TIR" evidence="6">
<location>
<begin position="403"/>
<end position="559"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with NCS1" evidence="1">
<location>
<begin position="549"/>
<end position="644"/>
</location>
</feature>
<feature type="active site" evidence="6">
<location>
<position position="491"/>
</location>
</feature>
<feature type="site" description="Essential for interaction with PTPRD" evidence="2">
<location>
<position position="34"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="63"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="122"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="138"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="213"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="264"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="331"/>
</location>
</feature>
<feature type="disulfide bond" evidence="2">
<location>
<begin position="31"/>
<end position="126"/>
</location>
</feature>
<feature type="disulfide bond" evidence="5">
<location>
<begin position="53"/>
<end position="118"/>
</location>
</feature>
<feature type="disulfide bond" evidence="2">
<location>
<begin position="143"/>
<end position="185"/>
</location>
</feature>
<feature type="disulfide bond" evidence="5">
<location>
<begin position="164"/>
<end position="216"/>
</location>
</feature>
<feature type="disulfide bond" evidence="5">
<location>
<begin position="267"/>
<end position="334"/>
</location>
</feature>
<evidence key="1" type="ECO:0000250"/>
<evidence key="2" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P59823"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q9NZN1"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000255"/>
<evidence key="5" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00114"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00204"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17502602"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18801879"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000305"/>
<sequence length="696" mass="79771" checksum="3684FCCD0A0B3FD9" modified="2003-08-22" version="1" precursor="true">MKAPIPHLILLYATFTQSLKVVTKRGSADGCTDWSVDIKKYQVLVGEPVRIKCALFYGYIRTNYTLAQSAGLSLMWYKSSGPGDFEEPIAFDGSRMSKEEDSIWFRPTLLQDSGLYACVIRNSTYCMKVSISLTVGENDTGLCYNSKMKYFEKAELSKSKEISCRDIEDFLLPTREPEILWYKECRTKTWRPSIVFKRDTLLIKEVKEDDIGNYTCELKYGGFVVRRTTELTVTAPLTDKPPKLLYPMESKLTIQETQLGGSANLTCRAFFGYSGDVSPLIYWMKGEKFIEDLDENRVWESDIRILKEHLGEQEVSISLIVDSVEEGDLGNYSCYVENGNGRRHASVLLHKRELMYTVELAGGLGAILLLLVCSVTIYKCYKIEIMLFYRNHFGAEELDGDNKDYDAYLSYTKVDPDQWNQETGEEERFALEILPDMLEKHYGYKLFIPDRDLIPTGTYIEDVARCVDQSKRLIIVMTPNYVVRRGWSIFELETRLRNMLVTGEIKVILIECSELRGIMNYQEVEALKHTIKLLTVIKWHGPKCNKLNSKFWKRLQYEMPFKRIEPITHEQALDVSEQGPFGELQTVSAISMAAATSTALATAHPDLRSTFHNTYHSQMRQKHYYRSYEYDVPPTGTLPLTSIGNQHTYCNIPMTLINGQRPQTKSSREPNPDEAHTNSAILPLLARETSISSVIW</sequence>
</entry>
<entry dataset="Swiss-Prot" created="2003-08-22" modified="2021-02-10" version="124">
<accession>P59823</accession>
<name>IRPL1_MOUSE</name>
<protein>
<recommendedName>
<fullName>Interleukin-1 receptor accessory protein-like 1</fullName>
<shortName>IL-1-RAPL-1</shortName>
<shortName>IL-1RAPL-1</shortName>
<shortName>IL1RAPL-1</shortName>
<ecNumber evidence="9">3.2.2.6</ecNumber>
</recommendedName>
<alternativeName>
<fullName>X-linked interleukin-1 receptor accessory protein-like 1</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">Il1rapl1</name>
</gene>
<organism>
<name type="scientific">Mus musculus</name>
<name type="common">Mouse</name>
<dbReference type="NCBI Taxonomy" id="10090"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Glires</taxon>
<taxon>Rodentia</taxon>
<taxon>Myomorpha</taxon>
<taxon>Muroidea</taxon>
<taxon>Muridae</taxon>
<taxon>Murinae</taxon>
<taxon>Mus</taxon>
<taxon>Mus</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="2009" name="PLoS Biol." volume="7" first="E1000112" last="E1000112">
<title>Lineage-specific biology revealed by a finished genome assembly of the mouse.</title>
<authorList>
<person name="Church D.M."/>
<person name="Goodstadt L."/>
<person name="Hillier L.W."/>
<person name="Zody M.C."/>
<person name="Goldstein S."/>
<person name="She X."/>
<person name="Bult C.J."/>
<person name="Agarwala R."/>
<person name="Cherry J.L."/>
<person name="DiCuccio M."/>
<person name="Hlavina W."/>
<person name="Kapustin Y."/>
<person name="Meric P."/>
<person name="Maglott D."/>
<person name="Birtle Z."/>
<person name="Marques A.C."/>
<person name="Graves T."/>
<person name="Zhou S."/>
<person name="Teague B."/>
<person name="Potamousis K."/>
<person name="Churas C."/>
<person name="Place M."/>
<person name="Herschleb J."/>
<person name="Runnheim R."/>
<person name="Forrest D."/>
<person name="Amos-Landgraf J."/>
<person name="Schwartz D.C."/>
<person name="Cheng Z."/>
<person name="Lindblad-Toh K."/>
<person name="Eichler E.E."/>
<person name="Ponting C.P."/>
</authorList>
<dbReference type="PubMed" id="19468303"/>
<dbReference type="DOI" id="10.1371/journal.pbio.1000112"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
<source>
<strain>C57BL/6J</strain>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="2010" name="Cell" volume="143" first="1174" last="1189">
<title>A tissue-specific atlas of mouse protein phosphorylation and expression.</title>
<authorList>
<person name="Huttlin E.L."/>
<person name="Jedrychowski M.P."/>
<person name="Elias J.E."/>
<person name="Goswami T."/>
<person name="Rad R."/>
<person name="Beausoleil S.A."/>
<person name="Villen J."/>
<person name="Haas W."/>
<person name="Sowa M.E."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="21183079"/>
<dbReference type="DOI" id="10.1016/j.cell.2010.12.001"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="2011" name="J. Neurosci." volume="31" first="13485" last="13499">
<title>IL-1 receptor accessory protein-like 1 associated with mental retardation and autism mediates synapse formation by trans-synaptic interaction with protein tyrosine phosphatase delta.</title>
<authorList>
<person name="Yoshida T."/>
<person name="Yasumura M."/>
<person name="Uemura T."/>
<person name="Lee S.J."/>
<person name="Ra M."/>
<person name="Taguchi R."/>
<person name="Iwakura Y."/>
<person name="Mishina M."/>
</authorList>
<dbReference type="PubMed" id="21940441"/>
<dbReference type="DOI" id="10.1523/jneurosci.2136-11.2011"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH PTPRD</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2003" name="Hum. Mol. Genet." volume="12" first="1415" last="1425">
<title>IL1 receptor accessory protein like, a protein involved in X-linked mental retardation, interacts with Neuronal Calcium Sensor-1 and regulates exocytosis.</title>
<authorList>
<person name="Bahi N."/>
<person name="Friocourt G."/>
<person name="Carrie A."/>
<person name="Graham M.E."/>
<person name="Weiss J.L."/>
<person name="Chafey P."/>
<person name="Fauchereau F."/>
<person name="Burgoyne R.D."/>
<person name="Chelly J."/>
</authorList>
<dbReference type="PubMed" id="12783849"/>
<dbReference type="DOI" id="10.1093/hmg/ddg147"/>
</citation>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="5" evidence="1 2 3">
<citation type="journal article" date="2015" name="Nat. Commun." volume="6" first="6926" last="6926">
<title>Mechanisms of splicing-dependent trans-synaptic adhesion by PTPdelta-IL1RAPL1/IL-1RAcP for synaptic differentiation.</title>
<authorList>
<person name="Yamagata A."/>
<person name="Yoshida T."/>
<person name="Sato Y."/>
<person name="Goto-Ito S."/>
<person name="Uemura T."/>
<person name="Maeda A."/>
<person name="Shiroshima T."/>
<person name="Iwasawa-Okamoto S."/>
<person name="Mori H."/>
<person name="Mishina M."/>
<person name="Fukai S."/>
</authorList>
<dbReference type="PubMed" id="25908590"/>
<dbReference type="DOI" id="10.1038/ncomms7926"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.70 ANGSTROMS) OF 19-352 IN COMPLEX WITH PTPRD</scope>
<scope>GLYCOSYLATION AT ASN-63; ASN-122; ASN-138; ASN-213 AND ASN-264</scope>
<scope>DISULFIDE BONDS</scope>
<scope>SUBUNIT</scope>
<scope>INTERACTION WITH PTPRD</scope>
<scope>MUTAGENESIS OF TRP-34; ASP-37; 75-MET--TYR-77; 88-PRO--PHE-91 AND ASP-292</scope>
<scope>SITE</scope>
<scope>FUNCTION</scope>
</reference>
<comment type="function">
<text evidence="5 6 11 12">May regulate secretion and presynaptic differentiation through inhibition of the activity of N-type voltage-gated calcium channel. May activate the MAP kinase JNK (By similarity). Plays a role in neurite outgrowth (By similarity). During dendritic spine formation can bidirectionally induce pre- and post-synaptic differentiation of neurons by trans-synaptically binding to PTPRD (PubMed:25908590, PubMed:21940441).</text>
</comment>
<comment type="catalytic activity">
<reaction evidence="9">
<text>H2O + NAD(+) = ADP-D-ribose + H(+) + nicotinamide</text>
<dbReference type="Rhea" id="RHEA:16301"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:17154"/>
<dbReference type="ChEBI" id="CHEBI:57540"/>
<dbReference type="ChEBI" id="CHEBI:57967"/>
<dbReference type="EC" id="3.2.2.6"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="9">
<dbReference type="Rhea" id="RHEA:16302"/>
</physiologicalReaction>
</comment>
<comment type="subunit">
<text evidence="6 11 12">Homodimer (PubMed:25908590). Interacts (calcium-independent) with NCS1/FREQ (By similarity). Interacts (via the first immunoglobilin domain) with PTPRD (via the second immunoglobilin domain); this interaction is PTPRD-splicing-dependent and induces pre- and post-synaptic differentiation of neurons and is required for IL1RAPL1-mediated synapse formation (PubMed:25908590, PubMed:21940441).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-5452114">
<id>P59823</id>
</interactant>
<interactant intactId="EBI-771834">
<id>Q64487</id>
<label>Ptprd</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="4">Cell membrane</location>
<topology evidence="4">Single-pass type I membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="4">Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="11">Cell projection</location>
<location evidence="11">Axon</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="11">Cell projection</location>
<location evidence="11">Dendrite</location>
</subcellularLocation>
<text>May localize to the cell body and growth cones of dendrite-like processes.</text>
</comment>
<comment type="tissue specificity">
<text evidence="10">Detected in total brain extracts, olfactory bulb, hippocampus and striatum (at protein level).</text>
</comment>
<comment type="domain">
<text evidence="9">The TIR domain mediates NAD(+) hydrolase (NADase) activity. Self-association of TIR domains is required for NADase activity.</text>
</comment>
<comment type="similarity">
<text evidence="13">Belongs to the interleukin-1 receptor family.</text>
</comment>
<dbReference type="EC" id="3.2.2.6" evidence="9"/>
<dbReference type="EMBL" id="AL844900">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL672059">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AK081272">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="PDB" id="4YH6">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.00"/>
<property type="chains" value="A/B=19-352"/>
</dbReference>
<dbReference type="PDB" id="4YH7">
<property type="method" value="X-ray"/>
<property type="resolution" value="4.40"/>
<property type="chains" value="B=19-352"/>
</dbReference>
<dbReference type="PDB" id="5Y32">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.70"/>
<property type="chains" value="B=19-352"/>
</dbReference>
<dbReference type="PDBsum" id="4YH6"/>
<dbReference type="PDBsum" id="4YH7"/>
<dbReference type="PDBsum" id="5Y32"/>
<dbReference type="SMR" id="P59823"/>
<dbReference type="IntAct" id="P59823">
<property type="interactions" value="1"/>
</dbReference>
<dbReference type="STRING" id="10090.ENSMUSP00000109599"/>
<dbReference type="GlyConnect" id="2411">
<property type="glycosylation" value="4 N-Linked glycans (2 sites)"/>
</dbReference>
<dbReference type="GlyGen" id="P59823">
<property type="glycosylation" value="6 sites"/>
</dbReference>
<dbReference type="iPTMnet" id="P59823"/>
<dbReference type="PhosphoSitePlus" id="P59823"/>
<dbReference type="PaxDb" id="P59823"/>
<dbReference type="PRIDE" id="P59823"/>
<dbReference type="MGI" id="MGI:2687319">
<property type="gene designation" value="Il1rapl1"/>
</dbReference>
<dbReference type="eggNOG" id="KOG3971">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="InParanoid" id="P59823"/>
<dbReference type="Reactome" id="R-MMU-388844">
<property type="pathway name" value="Receptor-type tyrosine-protein phosphatases"/>
</dbReference>
<dbReference type="Reactome" id="R-MMU-9007892">
<property type="pathway name" value="Interleukin-38 signaling"/>
</dbReference>
<dbReference type="ChiTaRS" id="Il1rapl1">
<property type="organism name" value="mouse"/>
</dbReference>
<dbReference type="PRO" id="PR:P59823"/>
<dbReference type="Proteomes" id="UP000000589">
<property type="component" value="Unplaced"/>
</dbReference>
<dbReference type="RNAct" id="P59823">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="GO" id="GO:0030424">
<property type="term" value="C:axon"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0009986">
<property type="term" value="C:cell surface"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0030425">
<property type="term" value="C:dendrite"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0098978">
<property type="term" value="C:glutamatergic synapse"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0016021">
<property type="term" value="C:integral component of membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045211">
<property type="term" value="C:postsynaptic membrane"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0050135">
<property type="term" value="F:NAD(P)+ nucleosidase activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0061809">
<property type="term" value="F:NAD+ nucleotidase, cyclic ADP-ribose generating"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0005102">
<property type="term" value="F:signaling receptor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0007157">
<property type="term" value="P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045920">
<property type="term" value="P:negative regulation of exocytosis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030182">
<property type="term" value="P:neuron differentiation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0050775">
<property type="term" value="P:positive regulation of dendrite morphogenesis"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0051965">
<property type="term" value="P:positive regulation of synapse assembly"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0097105">
<property type="term" value="P:presynaptic membrane assembly"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0010975">
<property type="term" value="P:regulation of neuron projection development"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0099175">
<property type="term" value="P:regulation of postsynapse organization"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:1905606">
<property type="term" value="P:regulation of presynapse assembly"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0007165">
<property type="term" value="P:signal transduction"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0099545">
<property type="term" value="P:trans-synaptic signaling by trans-synaptic complex"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="Gene3D" id="2.60.40.10">
<property type="match status" value="3"/>
</dbReference>
<dbReference type="Gene3D" id="3.40.50.10140">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR007110">
<property type="entry name" value="Ig-like_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR036179">
<property type="entry name" value="Ig-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR013783">
<property type="entry name" value="Ig-like_fold"/>
</dbReference>
<dbReference type="InterPro" id="IPR003599">
<property type="entry name" value="Ig_sub"/>
</dbReference>
<dbReference type="InterPro" id="IPR003598">
<property type="entry name" value="Ig_sub2"/>
</dbReference>
<dbReference type="InterPro" id="IPR015621">
<property type="entry name" value="IL-1_rcpt_fam"/>
</dbReference>
<dbReference type="InterPro" id="IPR041416">
<property type="entry name" value="IL-1RAcP-like_ig"/>
</dbReference>
<dbReference type="InterPro" id="IPR013151">
<property type="entry name" value="Immunoglobulin"/>
</dbReference>
<dbReference type="InterPro" id="IPR000157">
<property type="entry name" value="TIR_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR035897">
<property type="entry name" value="Toll_tir_struct_dom_sf"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR11890">
<property type="entry name" value="PTHR11890"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00047">
<property type="entry name" value="ig"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF18452">
<property type="entry name" value="Ig_6"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF01582">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00409">
<property type="entry name" value="IG"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="SMART" id="SM00408">
<property type="entry name" value="IGc2"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="SMART" id="SM00255">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF48726">
<property type="entry name" value="SSF48726"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF52200">
<property type="entry name" value="SSF52200"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50835">
<property type="entry name" value="IG_LIKE"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="PROSITE" id="PS50104">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-0966">Cell projection</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0378">Hydrolase</keyword>
<keyword id="KW-0393">Immunoglobulin domain</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0520">NAD</keyword>
<keyword id="KW-0675">Receptor</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0732">Signal</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<feature type="signal peptide" evidence="7">
<location>
<begin position="1"/>
<end position="24"/>
</location>
</feature>
<feature type="chain" description="Interleukin-1 receptor accessory protein-like 1" id="PRO_0000015455">
<location>
<begin position="25"/>
<end position="695"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="7">
<location>
<begin position="25"/>
<end position="357"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="7">
<location>
<begin position="358"/>
<end position="378"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="7">
<location>
<begin position="379"/>
<end position="695"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 1">
<location>
<begin position="25"/>
<end position="134"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 2">
<location>
<begin position="143"/>
<end position="232"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 3">
<location>
<begin position="242"/>
<end position="350"/>
</location>
</feature>
<feature type="domain" description="TIR" evidence="9">
<location>
<begin position="403"/>
<end position="558"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with NCS1" evidence="4">
<location>
<begin position="548"/>
<end position="643"/>
</location>
</feature>
<feature type="active site" evidence="9">
<location>
<position position="490"/>
</location>
</feature>
<feature type="site" description="Essential for interaction with PTPRD" evidence="12">
<location>
<position position="34"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="3 12">
<location>
<position position="63"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="1 2 3 12">
<location>
<position position="122"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="1 2 3 12">
<location>
<position position="138"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="1 2 3 12">
<location>
<position position="213"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="1 2 3 12">
<location>
<position position="264"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="7">
<location>
<position position="331"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1 2 3 12">
<location>
<begin position="31"/>
<end position="126"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1 2 3 8 12">
<location>
<begin position="53"/>
<end position="118"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1 2 3 12">
<location>
<begin position="143"/>
<end position="185"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1 2 3 8 12">
<location>
<begin position="164"/>
<end position="216"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1 2 3 8 12">
<location>
<begin position="267"/>
<end position="334"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes Interaction with PTPRD. Abolishes synaptogenesis." evidence="12">
<original>W</original>
<variation>A</variation>
<location>
<position position="34"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreases affinity for PTPRD. Significantly decreases synaptogenesis." evidence="12">
<original>D</original>
<variation>A</variation>
<location>
<position position="37"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreases affinity for PTPRD; when associated with 88-A--A-91. Significantly decreases synaptogenesis; when associated with 88-A--A-91." evidence="12">
<original>MWY</original>
<variation>AWA</variation>
<location>
<begin position="75"/>
<end position="77"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreases affinity for PTPRD; when associated with 75-A--A-77. Significantly decreases synaptogenesis; when associated with 88-A--A-91." evidence="12">
<original>PIAF</original>
<variation>AIAA</variation>
<location>
<begin position="88"/>
<end position="91"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreases affinity for PTPRD. Significantly decreases synaptogenesis." evidence="12">
<original>D</original>
<variation>A</variation>
<location>
<position position="292"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="32"/>
<end position="36"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="41"/>
<end position="44"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="49"/>
<end position="52"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="54"/>
<end position="57"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="60"/>
<end position="62"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="64"/>
<end position="69"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="73"/>
<end position="81"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="93"/>
<end position="97"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="102"/>
<end position="107"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="110"/>
<end position="112"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="114"/>
<end position="121"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="126"/>
<end position="136"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="142"/>
<end position="145"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="146"/>
<end position="148"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="150"/>
<end position="155"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="160"/>
<end position="163"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="168"/>
<end position="170"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="173"/>
<end position="175"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="180"/>
<end position="183"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="194"/>
<end position="196"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="198"/>
<end position="205"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="208"/>
<end position="210"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="212"/>
<end position="220"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="223"/>
<end position="234"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="243"/>
<end position="247"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="249"/>
<end position="251"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="253"/>
<end position="257"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="263"/>
<end position="271"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="280"/>
<end position="285"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="288"/>
<end position="290"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="296"/>
<end position="300"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="304"/>
<end position="308"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="313"/>
<end position="323"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="326"/>
<end position="328"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="330"/>
<end position="338"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="341"/>
<end position="351"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4YH6"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4YH7"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5Y32"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000250"/>
<evidence key="5" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P59824"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q9NZN1"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000255"/>
<evidence key="8" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00114"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00204"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12783849"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21940441"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25908590"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000305"/>
<sequence length="695" mass="79630" checksum="5FE34F204E5908B7" modified="2003-08-22" version="1" precursor="true">MKAPIPHLILLYATFTQSLKVVTKRGSADGCTDWSVDIKKYQVLVGEPVRIKCALFYGYIRTNYSLAQSAGLSLMWYKSSGPGDFEEPIAFDGSRMSKEEDSIWFRPTLLQDSGLYACVIRNSTYCMKVSISLTVGENDTGLCYNSKMKYFEKAELSKSKEISCRDIEDFLLPTREPEILWYKECRTKAWRPSIVFKRDTLLIKEVKEDDIGNYTCELKYGGFVVRRTTELTVTAPLTDKPPKLLYPMESKLTVQETQLGGSANLTCRAFFGYSGDVSPLIYWMKGEKFIEDLDENRVWESDIRILKEHLGEQEVSISLIVDSVEEGDLGNYSCYVENGNGRRHASVLLHKRELMYTVELAGGLGAILLLLICSVTIYKCYKIEIMLFYRNHFGAEELDGDNKDYDAYLSYTKVDPDQWNQETGEEERFALEILPDMLEKHYGYKLFIPDRDLIPTGNIEDVARCVDQSKRLIIVMTPNYVVRRGWSIFELETRLRNMLVTGEIKVILIECSELRGIMNYQEVEALKHTIKLLTVIKWHGPKCNKLNSKFWKRLQYEMPFKRIEPITHEQALDVSEQGPFGELQTVSAISMAAATSTALATAHPDLRSTFHNTYHSQMRQKHYYRSYEYDVPPTGTLPLTSIGNQHTYCNIPMTLINGQRPQTKSNREPNPDEAHTNSAILPLLPRETSISSVIW</sequence>
</entry>
<entry dataset="Swiss-Prot" created="2003-08-22" modified="2020-12-02" version="129">
<accession>P59822</accession>
<name>IL1AP_MACMU</name>
<protein>
<recommendedName>
<fullName>Interleukin-1 receptor accessory protein</fullName>
<shortName>IL-1 receptor accessory protein</shortName>
<shortName>IL-1RAcP</shortName>
<ecNumber evidence="5">3.2.2.6</ecNumber>
</recommendedName>
</protein>
<gene>
<name type="primary">IL1RAP</name>
</gene>
<organism>
<name type="scientific">Macaca mulatta</name>
<name type="common">Rhesus macaque</name>
<dbReference type="NCBI Taxonomy" id="9544"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Cercopithecidae</taxon>
<taxon>Cercopithecinae</taxon>
<taxon>Macaca</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="2003" name="Immunity" volume="18" first="87" last="96">
<title>The soluble form of IL-1 receptor accessory protein enhances the ability of soluble type II IL-1 receptor to inhibit IL-1 action.</title>
<authorList>
<person name="Smith D.E."/>
<person name="Hanna R."/>
<person name="Friend D."/>
<person name="Moore H."/>
<person name="Chen H."/>
<person name="Farese A.M."/>
<person name="MacVittie T.J."/>
<person name="Virca G.D."/>
<person name="Sims J.E."/>
</authorList>
<dbReference type="PubMed" id="12530978"/>
<dbReference type="DOI" id="10.1016/s1074-7613(02)00514-9"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>FUNCTION</scope>
<scope>ALTERNATIVE SPLICING</scope>
<scope>CHARACTERIZATION OF ISOFORM 2</scope>
</reference>
<comment type="function">
<text evidence="1 2 6">Coreceptor for IL1RL2 in the IL-36 signaling system (By similarity). Coreceptor with IL1R1 in the IL-1 signaling system. Associates with IL1R1 bound to IL1B to form the high affinity interleukin-1 receptor complex which mediates interleukin-1-dependent activation of NF-kappa-B and other pathways. Signaling involves the recruitment of adapter molecules such as TOLLIP, MYD88, and IRAK1 or IRAK2 via the respective TIR domains of the receptor/coreceptor subunits. Recruits TOLLIP to the signaling complex. Does not bind to interleukin-1 alone; binding of IL1RN to IL1R1, prevents its association with IL1R1 to form a signaling complex. The cellular response is modulated through a non-signaling association with the membrane IL1R2 decoy receptor. Coreceptor for IL1RL1 in the IL-33 signaling system (By similarity). Can bidirectionally induce pre- and postsynaptic differentiation of neurons by trans-synaptically binding to PTPRD (By similarity). May play a role in IL1B-mediated costimulation of IFNG production from T-helper 1 (Th1) cells (By similarity).</text>
</comment>
<comment type="function">
<molecule>Isoform 2</molecule>
<text evidence="1 6">Associates with secreted ligand-bound IL1R2 and increases the affinity of secreted IL1R2 for IL1B; this complex formation may be the dominant mechanism for neutralization of IL1B by secreted/soluble receptors (PubMed:12530978). Enhances the ability of secreted IL1R1 to inhibit IL-33 signaling (By similarity).</text>
</comment>
<comment type="catalytic activity">
<reaction evidence="5">
<text>H2O + NAD(+) = ADP-D-ribose + H(+) + nicotinamide</text>
<dbReference type="Rhea" id="RHEA:16301"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:17154"/>
<dbReference type="ChEBI" id="CHEBI:57540"/>
<dbReference type="ChEBI" id="CHEBI:57967"/>
<dbReference type="EC" id="3.2.2.6"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="5">
<dbReference type="Rhea" id="RHEA:16302"/>
</physiologicalReaction>
</comment>
<comment type="subunit">
<text evidence="1 2">The interleukin-36 receptor complex is a heterodimer of IL1RL2 and IL1RAP; the association is inhibited by IL36RN (By similarity). The interleukin-1 receptor complex is a heterodimer of IL1R1 and IL1RAP. Associates with IL1R2 to form a non-signaling interleukin-1 receptor complex. Interacts with IL-33-bound IL1RL1 to form the minimal interleukin-33 signaling complex with a 1:1:1 stoichiometry. Interacts with KIT (independently of stimulation with KITLG/SCF). A mast cell-specific KITLG/SCF-induced interleukin-33 signaling complex contains IL1RL1, IL1RAP, KIT and MYD88 (By similarity). Interacts (via the first immunoglobilin domain) with PTPRD (via the third immunoglobilin domain); induces pre- and postsynaptic differentiation of neurons (By similarity).</text>
</comment>
<comment type="subcellular location">
<molecule>Isoform 1</molecule>
<subcellularLocation>
<location>Cell membrane</location>
<topology>Single-pass type I membrane protein</topology>
</subcellularLocation>
</comment>
<comment type="subcellular location">
<molecule>Isoform 2</molecule>
<subcellularLocation>
<location>Secreted</location>
</subcellularLocation>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>P59822-1</id>
<name>1</name>
<name>Membrane-bound IL-1R AcP</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>P59822-2</id>
<name>2</name>
<name>Soluble IL-1R AcP</name>
<sequence type="not described"/>
</isoform>
</comment>
<comment type="domain">
<text evidence="5">The TIR domain mediates NAD(+) hydrolase (NADase) activity. Self-association of TIR domains is required for NADase activity.</text>
</comment>
<comment type="similarity">
<text evidence="7">Belongs to the interleukin-1 receptor family.</text>
</comment>
<dbReference type="EC" id="3.2.2.6" evidence="5"/>
<dbReference type="EMBL" id="AY182233">
<property type="protein sequence ID" value="AAO24704.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY182234">
<property type="protein sequence ID" value="AAO24705.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001028132.1">
<molecule id="P59822-1"/>
<property type="nucleotide sequence ID" value="NM_001032960.1"/>
</dbReference>
<dbReference type="STRING" id="9544.ENSMMUP00000029702"/>
<dbReference type="Ensembl" id="ENSMMUT00000107688">
<molecule id="P59822-1"/>
<property type="protein sequence ID" value="ENSMMUP00000068286"/>
<property type="gene ID" value="ENSMMUG00000022562"/>
</dbReference>
<dbReference type="GeneID" id="574387"/>
<dbReference type="KEGG" id="mcc:574387"/>
<dbReference type="CTD" id="3556"/>
<dbReference type="VGNC" id="VGNC:73718">
<property type="gene designation" value="IL1RAP"/>
</dbReference>
<dbReference type="eggNOG" id="ENOG502QRDG">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT01010000222421"/>
<dbReference type="HOGENOM" id="CLU_025552_1_0_1"/>
<dbReference type="InParanoid" id="P59822"/>
<dbReference type="OMA" id="KSPRWSS"/>
<dbReference type="OrthoDB" id="985064at2759"/>
<dbReference type="TreeFam" id="TF325519"/>
<dbReference type="Proteomes" id="UP000006718">
<property type="component" value="Chromosome 2"/>
</dbReference>
<dbReference type="Bgee" id="ENSMMUG00000022562">
<property type="expression patterns" value="Expressed in liver and 21 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="P59822">
<property type="expression patterns" value="baseline"/>
</dbReference>
<dbReference type="GO" id="GO:0005576">
<property type="term" value="C:extracellular region"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0016021">
<property type="term" value="C:integral component of membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0004908">
<property type="term" value="F:interleukin-1 receptor activity"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0005149">
<property type="term" value="F:interleukin-1 receptor binding"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0050135">
<property type="term" value="F:NAD(P)+ nucleosidase activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0061809">
<property type="term" value="F:NAD+ nucleotidase, cyclic ADP-ribose generating"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0006954">
<property type="term" value="P:inflammatory response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0051092">
<property type="term" value="P:positive regulation of NF-kappaB transcription factor activity"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0051965">
<property type="term" value="P:positive regulation of synapse assembly"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="Gene3D" id="2.60.40.10">
<property type="match status" value="3"/>
</dbReference>
<dbReference type="Gene3D" id="3.40.50.10140">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR007110">
<property type="entry name" value="Ig-like_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR036179">
<property type="entry name" value="Ig-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR013783">
<property type="entry name" value="Ig-like_fold"/>
</dbReference>
<dbReference type="InterPro" id="IPR003599">
<property type="entry name" value="Ig_sub"/>
</dbReference>
<dbReference type="InterPro" id="IPR015621">
<property type="entry name" value="IL-1_rcpt_fam"/>
</dbReference>
<dbReference type="InterPro" id="IPR004074">
<property type="entry name" value="IL-1_rcpt_I/II-typ"/>
</dbReference>
<dbReference type="InterPro" id="IPR041416">
<property type="entry name" value="IL-1RAcP-like_ig"/>
</dbReference>
<dbReference type="InterPro" id="IPR000157">
<property type="entry name" value="TIR_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR035897">
<property type="entry name" value="Toll_tir_struct_dom_sf"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR11890">
<property type="entry name" value="PTHR11890"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF18452">
<property type="entry name" value="Ig_6"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF01582">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR01536">
<property type="entry name" value="INTRLKN1R12F"/>
</dbReference>
<dbReference type="SMART" id="SM00409">
<property type="entry name" value="IG"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="SMART" id="SM00255">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF48726">
<property type="entry name" value="SSF48726"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF52200">
<property type="entry name" value="SSF52200"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50835">
<property type="entry name" value="IG_LIKE"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="PROSITE" id="PS50104">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0378">Hydrolase</keyword>
<keyword id="KW-0393">Immunoglobulin domain</keyword>
<keyword id="KW-0395">Inflammatory response</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0520">NAD</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0675">Receptor</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0964">Secreted</keyword>
<keyword id="KW-0732">Signal</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<feature type="signal peptide" evidence="3">
<location>
<begin position="1"/>
<end position="20"/>
</location>
</feature>
<feature type="chain" description="Interleukin-1 receptor accessory protein" id="PRO_0000015451">
<location>
<begin position="21"/>
<end position="570"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="3">
<location>
<begin position="21"/>
<end position="367"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="3">
<location>
<begin position="368"/>
<end position="388"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="3">
<location>
<begin position="389"/>
<end position="570"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 1">
<location>
<begin position="21"/>
<end position="128"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 2">
<location>
<begin position="136"/>
<end position="226"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 3">
<location>
<begin position="242"/>
<end position="350"/>
</location>
</feature>
<feature type="domain" description="TIR" evidence="5">
<location>
<begin position="403"/>
<end position="546"/>
</location>
</feature>
<feature type="region of interest" description="Essential for interaction with PTPRD" evidence="1">
<location>
<begin position="69"/>
<end position="85"/>
</location>
</feature>
<feature type="active site" evidence="5">
<location>
<position position="482"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="2">
<location>
<position position="557"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="3">
<location>
<position position="57"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="3">
<location>
<position position="107"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="3">
<location>
<position position="111"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="3">
<location>
<position position="118"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="3">
<location>
<position position="196"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="3">
<location>
<position position="209"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="3">
<location>
<position position="299"/>
</location>
</feature>
<feature type="disulfide bond" evidence="4">
<location>
<begin position="24"/>
<end position="122"/>
</location>
</feature>
<feature type="disulfide bond" evidence="4">
<location>
<begin position="47"/>
<end position="114"/>
</location>
</feature>
<feature type="disulfide bond" evidence="4">
<location>
<begin position="137"/>
<end position="181"/>
</location>
</feature>
<feature type="disulfide bond" evidence="4">
<location>
<begin position="160"/>
<end position="212"/>
</location>
</feature>
<feature type="disulfide bond" evidence="4">
<location>
<begin position="266"/>
<end position="332"/>
</location>
</feature>
<evidence key="1" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q61730"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q9NPH3"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000255"/>
<evidence key="4" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00114"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00204"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12530978"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000305"/>
<sequence length="570" mass="65393" checksum="9CD78AB1E78DD4C5" modified="2003-08-22" version="1" precursor="true">MTLLWCVVSLYFYGILQSDASERCDDWGLDTMRQIQVFEDEPARIKCPLFEHFLKFNYSTAHSAGLTLIWYWTRQDRDLEEPINFRLPENRISKEKDVLWFRPTLLNDTGNYTCMLRNTTYCSKVAFPLEVVQKDSCFNSPMKLPVHKLYIEYGIQRITCPNVDGYFPSSVKPTITWYMGCYKIQNFNNVIPEGMNLSFLIAFISNNGNYTCVVTYPENGRTFHLTRTLTVKVVGSPKNAVPPVIHSPNDHVVYEKEPGEELLIPCTVYFSFLMDSRNEVWWTIDGKKPDDIPIDVTINESISHSRTEDETRTQILSIKKVTSEDLKRSYVCHARSAKGEVAKAATVKQKVPAPRYTVELACGFGATVLLVVILIVVYHVYWLEMVLFYRAHFGTDETILDGKEYDIYVSYARNAEEEEFVLLTLRGVLENEFGYKLCIFDRDSLPGGIVTDETLSFIQKSRRLLVVLSPNYVLQGTQALLELKAGLENMASQGNINVILVQYKAVKETKVKELKRAKTVLTVIKWKGEKSKYPQGRFWKQLQVAMPVKKSPRRSSSDEQGLSYSSLKNV</sequence>
</entry>
<entry dataset="Swiss-Prot" created="2003-08-22" modified="2021-02-10" version="176">
<accession>Q9NPH3</accession>
<accession>B1NLD0</accession>
<accession>D3DNW0</accession>
<accession>O14915</accession>
<accession>Q86WJ7</accession>
<name>IL1AP_HUMAN</name>
<protein>
<recommendedName>
<fullName>Interleukin-1 receptor accessory protein</fullName>
<shortName>IL-1 receptor accessory protein</shortName>
<shortName>IL-1RAcP</shortName>
<ecNumber evidence="8">3.2.2.6</ecNumber>
</recommendedName>
<alternativeName>
<fullName>Interleukin-1 receptor 3</fullName>
<shortName>IL-1R-3</shortName>
<shortName>IL-1R3</shortName>
</alternativeName>
</protein>
<gene>
<name type="primary">IL1RAP</name>
<name type="synonym">C3orf13</name>
<name type="synonym">IL1R3</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1997" name="Proc. Natl. Acad. Sci. U.S.A." volume="94" first="12829" last="12832">
<title>Recruitment of IRAK to the interleukin 1 receptor complex requires interleukin 1 receptor accessory protein.</title>
<authorList>
<person name="Huang J."/>
<person name="Gao X."/>
<person name="Li S."/>
<person name="Cao Z."/>
</authorList>
<dbReference type="PubMed" id="9371760"/>
<dbReference type="DOI" id="10.1073/pnas.94.24.12829"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH IL1R1 AND IRAK1</scope>
<source>
<tissue>Placenta</tissue>
</source>
</reference>
<reference key="2">
<citation type="submission" date="1997-08" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Saito T."/>
<person name="Seki N."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="2000" name="J. Immunol." volume="164" first="5277" last="5286">
<title>IL-1 signaling cascade in liver cells and the involvement of a soluble form of the IL-1 receptor accessory protein.</title>
<authorList>
<person name="Jensen L.E."/>
<person name="Muzio M."/>
<person name="Mantovani A."/>
<person name="Whitehead A.S."/>
</authorList>
<dbReference type="PubMed" id="10799889"/>
<dbReference type="DOI" id="10.4049/jimmunol.164.10.5277"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORMS 1 AND 2)</scope>
<scope>FUNCTION</scope>
<scope>INDUCTION BY PHORBOL ESTERS</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="2003" name="Cell. Signal." volume="15" first="793" last="802">
<title>Expression of alternatively spliced interleukin-1 receptor accessory protein mRNAs is differentially regulated during inflammation and apoptosis.</title>
<authorList>
<person name="Jensen L.E."/>
<person name="Whitehead A.S."/>
</authorList>
<dbReference type="PubMed" id="12781872"/>
<dbReference type="DOI" id="10.1016/s0898-6568(03)00039-1"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2 AND 3)</scope>
<scope>INDUCTION BY PHORBOL ESTERS</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="5">
<citation type="journal article" date="2008" name="Mol. Immunol." volume="45" first="1374" last="1384">
<title>A novel alternatively spliced interleukin-1 receptor accessory protein mIL-1RAcP687.</title>
<authorList>
<person name="Lu H.L."/>
<person name="Yang C.Y."/>
<person name="Chen H.C."/>
<person name="Hung C.S."/>
<person name="Chiang Y.C."/>
<person name="Ting L.P."/>
</authorList>
<dbReference type="PubMed" id="17949817"/>
<dbReference type="DOI" id="10.1016/j.molimm.2007.09.002"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 4)</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2009" name="Immunity" volume="30" first="817" last="831">
<title>A central nervous system-restricted isoform of the interleukin-1 receptor accessory protein modulates neuronal responses to interleukin-1.</title>
<authorList>
<person name="Smith D.E."/>
<person name="Lipsky B.P."/>
<person name="Russell C."/>
<person name="Ketchem R.R."/>
<person name="Kirchner J."/>
<person name="Hensley K."/>
<person name="Huang Y."/>
<person name="Friedman W.J."/>
<person name="Boissonneault V."/>
<person name="Plante M.M."/>
<person name="Rivest S."/>
<person name="Sims J.E."/>
</authorList>
<dbReference type="PubMed" id="19481478"/>
<dbReference type="DOI" id="10.1016/j.immuni.2009.03.020"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 4)</scope>
<scope>FUNCTION (ISOFORM 4)</scope>
<scope>TISSUE SPECIFICITY (ISOFORM 4)</scope>
<scope>INTERACTION WITH IL1R1</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2006" name="Nature" volume="440" first="1194" last="1198">
<title>The DNA sequence, annotation and analysis of human chromosome 3.</title>
<authorList>
<person name="Muzny D.M."/>
<person name="Scherer S.E."/>
<person name="Kaul R."/>
<person name="Wang J."/>
<person name="Yu J."/>
<person name="Sudbrak R."/>
<person name="Buhay C.J."/>
<person name="Chen R."/>
<person name="Cree A."/>
<person name="Ding Y."/>
<person name="Dugan-Rocha S."/>
<person name="Gill R."/>
<person name="Gunaratne P."/>
<person name="Harris R.A."/>
<person name="Hawes A.C."/>
<person name="Hernandez J."/>
<person name="Hodgson A.V."/>
<person name="Hume J."/>
<person name="Jackson A."/>
<person name="Khan Z.M."/>
<person name="Kovar-Smith C."/>
<person name="Lewis L.R."/>
<person name="Lozado R.J."/>
<person name="Metzker M.L."/>
<person name="Milosavljevic A."/>
<person name="Miner G.R."/>
<person name="Morgan M.B."/>
<person name="Nazareth L.V."/>
<person name="Scott G."/>
<person name="Sodergren E."/>
<person name="Song X.-Z."/>
<person name="Steffen D."/>
<person name="Wei S."/>
<person name="Wheeler D.A."/>
<person name="Wright M.W."/>
<person name="Worley K.C."/>
<person name="Yuan Y."/>
<person name="Zhang Z."/>
<person name="Adams C.Q."/>
<person name="Ansari-Lari M.A."/>
<person name="Ayele M."/>
<person name="Brown M.J."/>
<person name="Chen G."/>
<person name="Chen Z."/>
<person name="Clendenning J."/>
<person name="Clerc-Blankenburg K.P."/>
<person name="Chen R."/>
<person name="Chen Z."/>
<person name="Davis C."/>
<person name="Delgado O."/>
<person name="Dinh H.H."/>
<person name="Dong W."/>
<person name="Draper H."/>
<person name="Ernst S."/>
<person name="Fu G."/>
<person name="Gonzalez-Garay M.L."/>
<person name="Garcia D.K."/>
<person name="Gillett W."/>
<person name="Gu J."/>
<person name="Hao B."/>
<person name="Haugen E."/>
<person name="Havlak P."/>
<person name="He X."/>
<person name="Hennig S."/>
<person name="Hu S."/>
<person name="Huang W."/>
<person name="Jackson L.R."/>
<person name="Jacob L.S."/>
<person name="Kelly S.H."/>
<person name="Kube M."/>
<person name="Levy R."/>
<person name="Li Z."/>
<person name="Liu B."/>
<person name="Liu J."/>
<person name="Liu W."/>
<person name="Lu J."/>
<person name="Maheshwari M."/>
<person name="Nguyen B.-V."/>
<person name="Okwuonu G.O."/>
<person name="Palmeiri A."/>
<person name="Pasternak S."/>
<person name="Perez L.M."/>
<person name="Phelps K.A."/>
<person name="Plopper F.J."/>
<person name="Qiang B."/>
<person name="Raymond C."/>
<person name="Rodriguez R."/>
<person name="Saenphimmachak C."/>
<person name="Santibanez J."/>
<person name="Shen H."/>
<person name="Shen Y."/>
<person name="Subramanian S."/>
<person name="Tabor P.E."/>
<person name="Verduzco D."/>
<person name="Waldron L."/>
<person name="Wang J."/>
<person name="Wang J."/>
<person name="Wang Q."/>
<person name="Williams G.A."/>
<person name="Wong G.K.-S."/>
<person name="Yao Z."/>
<person name="Zhang J."/>
<person name="Zhang X."/>
<person name="Zhao G."/>
<person name="Zhou J."/>
<person name="Zhou Y."/>
<person name="Nelson D."/>
<person name="Lehrach H."/>
<person name="Reinhardt R."/>
<person name="Naylor S.L."/>
<person name="Yang H."/>
<person name="Olson M."/>
<person name="Weinstock G."/>
<person name="Gibbs R.A."/>
</authorList>
<dbReference type="PubMed" id="16641997"/>
<dbReference type="DOI" id="10.1038/nature04728"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="8">
<citation type="submission" date="2005-09" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2)</scope>
<source>
<tissue>Skin</tissue>
</source>
</reference>
<reference key="10">
<citation type="journal article" date="1998" name="Genomics" volume="47" first="325" last="326">
<title>The human gene encoding the interleukin-1 receptor accessory protein (IL1RAP) maps to chromosome 3q28 by fluorescence in situ hybridization and radiation hybrid mapping.</title>
<authorList>
<person name="Dale M."/>
<person name="Hammond D.W."/>
<person name="Cox A."/>
<person name="Nicklin M.J.H."/>
</authorList>
<dbReference type="PubMed" id="9479509"/>
<dbReference type="DOI" id="10.1006/geno.1997.5113"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 118-179</scope>
</reference>
<reference key="11">
<citation type="journal article" date="1998" name="J. Immunol." volume="161" first="6871" last="6877">
<title>The type II IL-1 receptor interacts with the IL-1 receptor accessory protein: a novel mechanism of regulation of IL-1 responsiveness.</title>
<authorList>
<person name="Lang D."/>
<person name="Knop J."/>
<person name="Wesche H."/>
<person name="Raffetseder U."/>
<person name="Kurrle R."/>
<person name="Boraschi D."/>
<person name="Martin M.U."/>
</authorList>
<dbReference type="PubMed" id="9862719"/>
</citation>
<scope>INTERACTION WITH IL1R2</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2000" name="Int. Immunol." volume="12" first="151" last="160">
<title>IL-12 synergizes with IL-18 or IL-1beta for IFN-gamma production from human T cells.</title>
<authorList>
<person name="Tominaga K."/>
<person name="Yoshimoto T."/>
<person name="Torigoe K."/>
<person name="Kurimoto M."/>
<person name="Matsui K."/>
<person name="Hada T."/>
<person name="Okamura H."/>
<person name="Nakanishi K."/>
</authorList>
<dbReference type="PubMed" id="10653850"/>
<dbReference type="DOI" id="10.1093/intimm/12.2.151"/>
</citation>
<scope>TISSUE SPECIFICITY</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2003" name="Biochem. Biophys. Res. Commun." volume="303" first="525" last="531">
<title>Characterization of a cascade of protein interactions initiated at the IL-1 receptor.</title>
<authorList>
<person name="Boch J.A."/>
<person name="Yoshida Y."/>
<person name="Koyama Y."/>
<person name="Wara-Aswapati N."/>
<person name="Peng H."/>
<person name="Unlu S."/>
<person name="Auron P.E."/>
</authorList>
<dbReference type="PubMed" id="12659850"/>
<dbReference type="DOI" id="10.1016/s0006-291x(03)00385-1"/>
</citation>
<scope>INTERACTION WITH IRAK2</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2003" name="Immunity" volume="18" first="87" last="96">
<title>The soluble form of IL-1 receptor accessory protein enhances the ability of soluble type II IL-1 receptor to inhibit IL-1 action.</title>
<authorList>
<person name="Smith D.E."/>
<person name="Hanna R."/>
<person name="Friend D."/>
<person name="Moore H."/>
<person name="Chen H."/>
<person name="Farese A.M."/>
<person name="MacVittie T.J."/>
<person name="Virca G.D."/>
<person name="Sims J.E."/>
</authorList>
<dbReference type="PubMed" id="12530978"/>
<dbReference type="DOI" id="10.1016/s1074-7613(02)00514-9"/>
</citation>
<scope>FUNCTION (SECRETED FORMS)</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="16">
<citation type="journal article" date="2009" name="Mol. Cell. Proteomics" volume="8" first="1751" last="1764">
<title>Large-scale proteomics analysis of the human kinome.</title>
<authorList>
<person name="Oppermann F.S."/>
<person name="Gnad F."/>
<person name="Olsen J.V."/>
<person name="Hornberger R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Mann M."/>
<person name="Daub H."/>
</authorList>
<dbReference type="PubMed" id="19369195"/>
<dbReference type="DOI" id="10.1074/mcp.m800588-mcp200"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
<title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
<authorList>
<person name="Mayya V."/>
<person name="Lundgren D.H."/>
<person name="Hwang S.-I."/>
<person name="Rezaul K."/>
<person name="Wu L."/>
<person name="Eng J.K."/>
<person name="Rodionov V."/>
<person name="Han D.K."/>
</authorList>
<dbReference type="PubMed" id="19690332"/>
<dbReference type="DOI" id="10.1126/scisignal.2000007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-557</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="18">
<citation type="journal article" date="2009" name="Structure" volume="17" first="1398" last="1410">
<title>Structure of IL-33 and its interaction with the ST2 and IL-1RAcP receptors--insight into heterotrimeric IL-1 signaling complexes.</title>
<authorList>
<person name="Lingel A."/>
<person name="Weiss T.M."/>
<person name="Niebuhr M."/>
<person name="Pan B."/>
<person name="Appleton B.A."/>
<person name="Wiesmann C."/>
<person name="Bazan J.F."/>
<person name="Fairbrother W.J."/>
</authorList>
<dbReference type="PubMed" id="19836339"/>
<dbReference type="DOI" id="10.1016/j.str.2009.08.009"/>
</citation>
<scope>FUNCTION</scope>
<scope>MODEL OF THE IL-33 SIGNALING COMPLEX</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2010" name="Proc. Natl. Acad. Sci. U.S.A." volume="107" first="16280" last="16285">
<title>Isolation and killing of candidate chronic myeloid leukemia stem cells by antibody targeting of IL-1 receptor accessory protein.</title>
<authorList>
<person name="Jaeraas M."/>
<person name="Johnels P."/>
<person name="Hansen N."/>
<person name="Agerstam H."/>
<person name="Tsapogas P."/>
<person name="Rissler M."/>
<person name="Lassen C."/>
<person name="Olofsson T."/>
<person name="Bjerrum O.W."/>
<person name="Richter J."/>
<person name="Fioretos T."/>
</authorList>
<dbReference type="PubMed" id="20805474"/>
<dbReference type="DOI" id="10.1073/pnas.1004408107"/>
</citation>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="21">
<citation type="journal article" date="2012" name="Blood" volume="120" first="1290" last="1298">
<title>Overexpression of IL-1 receptor accessory protein in stem and progenitor cells and outcome correlation in AML and MDS.</title>
<authorList>
<person name="Barreyro L."/>
<person name="Will B."/>
<person name="Bartholdy B."/>
<person name="Zhou L."/>
<person name="Todorova T.I."/>
<person name="Stanley R.F."/>
<person name="Ben-Neriah S."/>
<person name="Montagna C."/>
<person name="Parekh S."/>
<person name="Pellagatti A."/>
<person name="Boultwood J."/>
<person name="Paietta E."/>
<person name="Ketterling R.P."/>
<person name="Cripe L."/>
<person name="Fernandez H.F."/>
<person name="Greenberg P.L."/>
<person name="Tallman M.S."/>
<person name="Steidl C."/>
<person name="Mitsiades C.S."/>
<person name="Verma A."/>
<person name="Steidl U."/>
</authorList>
<dbReference type="PubMed" id="22723552"/>
<dbReference type="DOI" id="10.1182/blood-2012-01-404699"/>
</citation>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2013" name="Blood" volume="121" first="3709" last="3713">
<title>Selective killing of candidate AML stem cells by antibody targeting of IL1RAP.</title>
<authorList>
<person name="Askmyr M."/>
<person name="Aagerstam H."/>
<person name="Hansen N."/>
<person name="Gordon S."/>
<person name="Arvanitakis A."/>
<person name="Rissler M."/>
<person name="Juliusson G."/>
<person name="Richter J."/>
<person name="Jaeraas M."/>
<person name="Fioretos T."/>
</authorList>
<dbReference type="PubMed" id="23479569"/>
<dbReference type="DOI" id="10.1182/blood-2012-09-458935"/>
</citation>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-557</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="24">
<citation type="journal article" date="2015" name="Am. J. Physiol." volume="308" first="L27" last="L27">
<title>Increased IL-33 expression in chronic obstructive pulmonary disease.</title>
<authorList>
<person name="Xia J."/>
<person name="Zhao J."/>
<person name="Shang J."/>
<person name="Li M."/>
<person name="Zeng Z."/>
<person name="Zhao J."/>
<person name="Wang J."/>
<person name="Xu Y."/>
<person name="Xie J."/>
</authorList>
<dbReference type="PubMed" id="25595648"/>
<dbReference type="DOI" id="10.1152/ajplung.00305.2014"/>
</citation>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2010" name="Nat. Immunol." volume="11" first="905" last="911">
<title>Structural insights into the assembly and activation of IL-1beta with its receptors.</title>
<authorList>
<person name="Wang D."/>
<person name="Zhang S."/>
<person name="Li L."/>
<person name="Liu X."/>
<person name="Mei K."/>
<person name="Wang X."/>
</authorList>
<dbReference type="PubMed" id="20802483"/>
<dbReference type="DOI" id="10.1038/ni.1925"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (3.3 ANGSTROMS) OF 21-350 IN COMPLEX WITH IL1R2 AND IL1B</scope>
<scope>SUBUNIT</scope>
<scope>DISULFIDE BONDS</scope>
<scope>GLYCOSYLATION AT ASN-107; ASN-111; ASN-118 AND ASN-209</scope>
</reference>
<comment type="function">
<text evidence="5 10 19 27 28">Coreceptor for IL1RL2 in the IL-36 signaling system (By similarity). Coreceptor with IL1R1 in the IL-1 signaling system. Associates with IL1R1 bound to IL1B to form the high affinity interleukin-1 receptor complex which mediates interleukin-1-dependent activation of NF-kappa-B and other pathways. Signaling involves the recruitment of adapter molecules such as TOLLIP, MYD88, and IRAK1 or IRAK2 via the respective TIR domains of the receptor/coreceptor subunits. Recruits TOLLIP to the signaling complex. Does not bind to interleukin-1 alone; binding of IL1RN to IL1R1, prevents its association with IL1R1 to form a signaling complex. The cellular response is modulated through a non-signaling association with the membrane IL1R2 decoy receptor. Coreceptor for IL1RL1 in the IL-33 signaling system. Can bidirectionally induce pre- and postsynaptic differentiation of neurons by trans-synaptically binding to PTPRD (By similarity). May play a role in IL1B-mediated costimulation of IFNG production from T-helper 1 (Th1) cells (Probable).</text>
</comment>
<comment type="function">
<molecule>Isoform 2</molecule>
<text evidence="5 11">Associates with secreted ligand-bound IL1R2 and increases the affinity of secreted IL1R2 for IL1B; this complex formation may be the dominant mechanism for neutralization of IL1B by secreted/soluble receptors (PubMed:12530978). Enhances the ability of secreted IL1R1 to inhibit IL-33 signaling (By similarity).</text>
</comment>
<comment type="function">
<molecule>Isoform 4</molecule>
<text evidence="5 13">Unable to mediate canonical IL-1 signaling (PubMed:19481478). Required for Src phosphorylation by IL1B. May be involved in IL1B-potentiated NMDA-induced calcium influx in neurons (By similarity).</text>
</comment>
<comment type="catalytic activity">
<reaction evidence="8">
<text>H2O + NAD(+) = ADP-D-ribose + H(+) + nicotinamide</text>
<dbReference type="Rhea" id="RHEA:16301"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:17154"/>
<dbReference type="ChEBI" id="CHEBI:57540"/>
<dbReference type="ChEBI" id="CHEBI:57967"/>
<dbReference type="EC" id="3.2.2.6"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="8">
<dbReference type="Rhea" id="RHEA:16302"/>
</physiologicalReaction>
</comment>
<comment type="subunit">
<text evidence="5 13 14 19 20 28">The interleukin-36 receptor complex is a heterodimer of IL1RL2 and IL1RAP; the association is inhibited by IL36RN (By similarity). The interleukin-1 receptor complex is a heterodimer of IL1R1 and IL1RAP. Associates with IL1R2 to form a non-signaling interleukin-1 receptor complex. Isoform 4 interacts with IL1R1 in an interleukin-1-dependent manner. Interacts with IL-33-bound IL1RL1 to form the minimal interleukin-33 signaling complex with a 1:1:1 stoichiometry. Interacts with KIT (independently of stimulation with KITLG/SCF). A mast cell-specific KITLG/SCF-induced interleukin-33 signaling complex contains IL1RL1, IL1RAP, KIT and MYD88 (By similarity). Interacts (via the first immunoglobilin domain) with PTPRD (via the third immunoglobilin domain); induces pre- and postsynaptic differentiation of neurons (By similarity).</text>
</comment>
<comment type="subcellular location">
<molecule>Isoform 1</molecule>
<subcellularLocation>
<location>Cell membrane</location>
<topology>Single-pass type I membrane protein</topology>
</subcellularLocation>
</comment>
<comment type="subcellular location">
<molecule>Isoform 2</molecule>
<subcellularLocation>
<location>Secreted</location>
</subcellularLocation>
</comment>
<comment type="subcellular location">
<molecule>Isoform 3</molecule>
<subcellularLocation>
<location>Secreted</location>
</subcellularLocation>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>Q9NPH3-1</id>
<name>1</name>
<name>Membrane-bound IL-1RAcP</name>
<name>mIL-1RAcP</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>Q9NPH3-2</id>
<name>2</name>
<name>Soluble IL-1RAcP</name>
<name>sIL-1RAcP</name>
<sequence type="described" ref="VSP_008050 VSP_008051"/>
</isoform>
<isoform>
<id>Q9NPH3-3</id>
<name>3</name>
<name>Soluble IL-1RAcP-beta</name>
<name>sIL-1RAcP-beta</name>
<sequence type="described" ref="VSP_008052"/>
</isoform>
<isoform>
<id>Q9NPH3-5</id>
<name>4</name>
<name>AcPb</name>
<name>mIL-1RAcP687</name>
<sequence type="described" ref="VSP_041256"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="9 11 13 15 16 17 18">Detected in liver, skin, placenta, thymus and lung. Isoform 4 is predominantly expressed in brain. Overexpressed on candidate chronic myeloid leukemia (CML) stem cells, hematopoietic stem cells and mononuclear cells of patients with acute myeloid leukemia (AML). Overexpressed in patients with chronic obstructive pulmonary disease (COPD). Expressed in T-helper 1 (Th1) and T-helper 2 (Th2) cell subsets (PubMed:10653850).</text>
</comment>
<comment type="induction">
<text evidence="10 12">Isoform 1 is down-regulated by phorbol ester treatment. Isoform 2 is induced by phorbol ester treatment.</text>
</comment>
<comment type="domain">
<text evidence="8">The TIR domain mediates NAD(+) hydrolase (NADase) activity. Self-association of TIR domains is required for NADase activity.</text>
</comment>
<comment type="miscellaneous">
<molecule>Isoform 3</molecule>
<text evidence="26">May be produced at very low levels due to a premature stop codon in the mRNA, leading to nonsense-mediated mRNA decay.</text>
</comment>
<comment type="similarity">
<text evidence="26">Belongs to the interleukin-1 receptor family.</text>
</comment>
<dbReference type="EC" id="3.2.2.6" evidence="8"/>
<dbReference type="EMBL" id="AF029213">
<property type="protein sequence ID" value="AAB84059.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB006537">
<property type="protein sequence ID" value="BAA25421.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF167343">
<property type="protein sequence ID" value="AAF71687.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF167340">
<property type="protein sequence ID" value="AAF71688.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF167335">
<property type="protein sequence ID" value="AAF71688.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF167336">
<property type="protein sequence ID" value="AAF71688.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF167337">
<property type="protein sequence ID" value="AAF71688.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF167338">
<property type="protein sequence ID" value="AAF71688.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF167339">
<property type="protein sequence ID" value="AAF71688.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF167342">
<property type="protein sequence ID" value="AAF71689.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF167335">
<property type="protein sequence ID" value="AAF71689.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF167336">
<property type="protein sequence ID" value="AAF71689.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF167337">
<property type="protein sequence ID" value="AAF71689.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF167338">
<property type="protein sequence ID" value="AAF71689.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF167339">
<property type="protein sequence ID" value="AAF71689.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF167340">
<property type="protein sequence ID" value="AAF71689.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF167341">
<property type="protein sequence ID" value="AAF71689.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF538730">
<property type="protein sequence ID" value="AAQ01755.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF538731">
<property type="protein sequence ID" value="AAQ01756.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF538732">
<property type="protein sequence ID" value="AAQ01757.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF538733">
<property type="protein sequence ID" value="AAQ01758.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF538734">
<property type="protein sequence ID" value="AAQ01759.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF487335">
<property type="protein sequence ID" value="AAO49451.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="EF591790">
<property type="protein sequence ID" value="ABU90811.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="FJ998418">
<property type="protein sequence ID" value="ACR82488.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AC008249">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC108747">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471052">
<property type="protein sequence ID" value="EAW78100.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471052">
<property type="protein sequence ID" value="EAW78102.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC053621">
<property type="protein sequence ID" value="AAH53621.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF016261">
<property type="protein sequence ID" value="AAC39609.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS3298.1">
<molecule id="Q9NPH3-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS46982.1">
<molecule id="Q9NPH3-2"/>
</dbReference>
<dbReference type="CCDS" id="CCDS54696.1">
<molecule id="Q9NPH3-5"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001161400.1">
<molecule id="Q9NPH3-1"/>
<property type="nucleotide sequence ID" value="NM_001167928.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001161401.1">
<molecule id="Q9NPH3-1"/>
<property type="nucleotide sequence ID" value="NM_001167929.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001161402.1">
<molecule id="Q9NPH3-2"/>
<property type="nucleotide sequence ID" value="NM_001167930.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001161403.1">
<molecule id="Q9NPH3-5"/>
<property type="nucleotide sequence ID" value="NM_001167931.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_002173.1">
<molecule id="Q9NPH3-1"/>
<property type="nucleotide sequence ID" value="NM_002182.3"/>
</dbReference>
<dbReference type="RefSeq" id="NP_608273.1">
<molecule id="Q9NPH3-2"/>
<property type="nucleotide sequence ID" value="NM_134470.3"/>
</dbReference>
<dbReference type="PDB" id="3O4O">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.30"/>
<property type="chains" value="B=21-350"/>
</dbReference>
<dbReference type="PDB" id="4DEP">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.10"/>
<property type="chains" value="C/F=21-367"/>
</dbReference>
<dbReference type="PDBsum" id="3O4O"/>
<dbReference type="PDBsum" id="4DEP"/>
<dbReference type="SASBDB" id="Q9NPH3"/>
<dbReference type="SMR" id="Q9NPH3"/>
<dbReference type="BioGRID" id="109771">
<property type="interactions" value="26"/>
</dbReference>
<dbReference type="CORUM" id="Q9NPH3"/>
<dbReference type="DIP" id="DIP-33487N"/>
<dbReference type="IntAct" id="Q9NPH3">
<property type="interactions" value="17"/>
</dbReference>
<dbReference type="MINT" id="Q9NPH3"/>
<dbReference type="DrugCentral" id="Q9NPH3"/>
<dbReference type="GuidetoPHARMACOLOGY" id="1897"/>
<dbReference type="GlyConnect" id="1425">
<property type="glycosylation" value="13 N-Linked glycans (3 sites)"/>
</dbReference>
<dbReference type="GlyGen" id="Q9NPH3">
<property type="glycosylation" value="9 sites"/>
</dbReference>
<dbReference type="iPTMnet" id="Q9NPH3"/>
<dbReference type="PhosphoSitePlus" id="Q9NPH3"/>
<dbReference type="BioMuta" id="IL1RAP"/>
<dbReference type="DMDM" id="34222652"/>
<dbReference type="CPTAC" id="CPTAC-2221"/>
<dbReference type="EPD" id="Q9NPH3"/>
<dbReference type="jPOST" id="Q9NPH3"/>
<dbReference type="MassIVE" id="Q9NPH3"/>
<dbReference type="MaxQB" id="Q9NPH3"/>
<dbReference type="PeptideAtlas" id="Q9NPH3"/>
<dbReference type="PRIDE" id="Q9NPH3"/>
<dbReference type="ProteomicsDB" id="81999">
<molecule id="Q9NPH3-1"/>
</dbReference>
<dbReference type="ProteomicsDB" id="82000">
<molecule id="Q9NPH3-2"/>
</dbReference>
<dbReference type="ProteomicsDB" id="82001">
<molecule id="Q9NPH3-3"/>
</dbReference>
<dbReference type="ProteomicsDB" id="82002">
<molecule id="Q9NPH3-5"/>
</dbReference>
<dbReference type="ABCD" id="Q9NPH3">
<property type="antibodies" value="13 sequenced antibodies"/>
</dbReference>
<dbReference type="Antibodypedia" id="19361">
<property type="antibodies" value="371 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="3556"/>
<dbReference type="Ensembl" id="ENST00000072516">
<molecule id="Q9NPH3-1"/>
<property type="protein sequence ID" value="ENSP00000072516"/>
<property type="gene ID" value="ENSG00000196083"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000317757">
<molecule id="Q9NPH3-5"/>
<property type="protein sequence ID" value="ENSP00000314807"/>
<property type="gene ID" value="ENSG00000196083"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000342550">
<molecule id="Q9NPH3-3"/>
<property type="protein sequence ID" value="ENSP00000345829"/>
<property type="gene ID" value="ENSG00000196083"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000412504">
<molecule id="Q9NPH3-1"/>
<property type="protein sequence ID" value="ENSP00000412053"/>
<property type="gene ID" value="ENSG00000196083"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000413869">
<molecule id="Q9NPH3-3"/>
<property type="protein sequence ID" value="ENSP00000416296"/>
<property type="gene ID" value="ENSG00000196083"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000422485">
<molecule id="Q9NPH3-2"/>
<property type="protein sequence ID" value="ENSP00000409352"/>
<property type="gene ID" value="ENSG00000196083"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000422940">
<molecule id="Q9NPH3-2"/>
<property type="protein sequence ID" value="ENSP00000387371"/>
<property type="gene ID" value="ENSG00000196083"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000439062">
<molecule id="Q9NPH3-1"/>
<property type="protein sequence ID" value="ENSP00000401132"/>
<property type="gene ID" value="ENSG00000196083"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000443369">
<molecule id="Q9NPH3-5"/>
<property type="protein sequence ID" value="ENSP00000408893"/>
<property type="gene ID" value="ENSG00000196083"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000447382">
<molecule id="Q9NPH3-1"/>
<property type="protein sequence ID" value="ENSP00000390541"/>
<property type="gene ID" value="ENSG00000196083"/>
</dbReference>
<dbReference type="GeneID" id="3556"/>
<dbReference type="KEGG" id="hsa:3556"/>
<dbReference type="UCSC" id="uc003fsk.4">
<molecule id="Q9NPH3-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="3556"/>
<dbReference type="DisGeNET" id="3556"/>
<dbReference type="GeneCards" id="IL1RAP"/>
<dbReference type="HGNC" id="HGNC:5995">
<property type="gene designation" value="IL1RAP"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000196083">
<property type="expression patterns" value="Group enriched (blood, liver, placenta)"/>
</dbReference>
<dbReference type="MIM" id="602626">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q9NPH3"/>
<dbReference type="OpenTargets" id="ENSG00000196083"/>
<dbReference type="PharmGKB" id="PA29811"/>
<dbReference type="VEuPathDB" id="HostDB:ENSG00000196083.9"/>
<dbReference type="GeneTree" id="ENSGT01010000222421"/>
<dbReference type="HOGENOM" id="CLU_025552_1_0_1"/>
<dbReference type="InParanoid" id="Q9NPH3"/>
<dbReference type="OMA" id="KSPRWSS"/>
<dbReference type="OrthoDB" id="985064at2759"/>
<dbReference type="PhylomeDB" id="Q9NPH3"/>
<dbReference type="TreeFam" id="TF325519"/>
<dbReference type="PathwayCommons" id="Q9NPH3"/>
<dbReference type="Reactome" id="R-HSA-1257604">
<molecule id="Q9NPH3-1"/>
<property type="pathway name" value="PIP3 activates AKT signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-388844">
<molecule id="Q9NPH3-1"/>
<property type="pathway name" value="Receptor-type tyrosine-protein phosphatases"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6811558">
<molecule id="Q9NPH3-1"/>
<property type="pathway name" value="PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9014826">
<molecule id="Q9NPH3-1"/>
<property type="pathway name" value="Interleukin-36 pathway"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9014843">
<molecule id="Q9NPH3-1"/>
<property type="pathway name" value="Interleukin-33 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9020702">
<molecule id="Q9NPH3-1"/>
<property type="pathway name" value="Interleukin-1 signaling"/>
</dbReference>
<dbReference type="SignaLink" id="Q9NPH3"/>
<dbReference type="SIGNOR" id="Q9NPH3"/>
<dbReference type="BioGRID-ORCS" id="3556">
<property type="hits" value="10 hits in 874 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="IL1RAP">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="Q9NPH3"/>
<dbReference type="GeneWiki" id="IL1RAP"/>
<dbReference type="GenomeRNAi" id="3556"/>
<dbReference type="Pharos" id="Q9NPH3">
<property type="development level" value="Tclin"/>
</dbReference>
<dbReference type="PRO" id="PR:Q9NPH3"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 3"/>
</dbReference>
<dbReference type="RNAct" id="Q9NPH3">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000196083">
<property type="expression patterns" value="Expressed in liver and 191 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="Q9NPH3">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q9NPH3">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005576">
<property type="term" value="C:extracellular region"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0098978">
<property type="term" value="C:glutamatergic synapse"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005887">
<property type="term" value="C:integral component of plasma membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0016020">
<property type="term" value="C:membrane"/>
<property type="evidence" value="ECO:0007005"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0004908">
<property type="term" value="F:interleukin-1 receptor activity"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0005149">
<property type="term" value="F:interleukin-1 receptor binding"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0002114">
<property type="term" value="F:interleukin-33 receptor activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0050135">
<property type="term" value="F:NAD(P)+ nucleosidase activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0061809">
<property type="term" value="F:NAD+ nucleotidase, cyclic ADP-ribose generating"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0019221">
<property type="term" value="P:cytokine-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0006955">
<property type="term" value="P:immune response"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0006954">
<property type="term" value="P:inflammatory response"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0045087">
<property type="term" value="P:innate immune response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0070498">
<property type="term" value="P:interleukin-1-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0032623">
<property type="term" value="P:interleukin-2 production"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0038172">
<property type="term" value="P:interleukin-33-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0032633">
<property type="term" value="P:interleukin-4 production"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0032736">
<property type="term" value="P:positive regulation of interleukin-13 production"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0032754">
<property type="term" value="P:positive regulation of interleukin-5 production"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0032755">
<property type="term" value="P:positive regulation of interleukin-6 production"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0051092">
<property type="term" value="P:positive regulation of NF-kappaB transcription factor activity"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0051965">
<property type="term" value="P:positive regulation of synapse assembly"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0065003">
<property type="term" value="P:protein-containing complex assembly"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0099151">
<property type="term" value="P:regulation of postsynaptic density assembly"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:1905606">
<property type="term" value="P:regulation of presynapse assembly"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0099560">
<property type="term" value="P:synaptic membrane adhesion"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0099545">
<property type="term" value="P:trans-synaptic signaling by trans-synaptic complex"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="Gene3D" id="2.60.40.10">
<property type="match status" value="3"/>
</dbReference>
<dbReference type="Gene3D" id="3.40.50.10140">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR007110">
<property type="entry name" value="Ig-like_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR036179">
<property type="entry name" value="Ig-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR013783">
<property type="entry name" value="Ig-like_fold"/>
</dbReference>
<dbReference type="InterPro" id="IPR003599">
<property type="entry name" value="Ig_sub"/>
</dbReference>
<dbReference type="InterPro" id="IPR015621">
<property type="entry name" value="IL-1_rcpt_fam"/>
</dbReference>
<dbReference type="InterPro" id="IPR004074">
<property type="entry name" value="IL-1_rcpt_I/II-typ"/>
</dbReference>
<dbReference type="InterPro" id="IPR041416">
<property type="entry name" value="IL-1RAcP-like_ig"/>
</dbReference>
<dbReference type="InterPro" id="IPR000157">
<property type="entry name" value="TIR_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR035897">
<property type="entry name" value="Toll_tir_struct_dom_sf"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR11890">
<property type="entry name" value="PTHR11890"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF18452">
<property type="entry name" value="Ig_6"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF01582">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR01536">
<property type="entry name" value="INTRLKN1R12F"/>
</dbReference>
<dbReference type="SMART" id="SM00409">
<property type="entry name" value="IG"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="SMART" id="SM00255">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF48726">
<property type="entry name" value="SSF48726"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF52200">
<property type="entry name" value="SSF52200"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50835">
<property type="entry name" value="IG_LIKE"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="PROSITE" id="PS50104">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0378">Hydrolase</keyword>
<keyword id="KW-0391">Immunity</keyword>
<keyword id="KW-0393">Immunoglobulin domain</keyword>
<keyword id="KW-0395">Inflammatory response</keyword>
<keyword id="KW-0399">Innate immunity</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0520">NAD</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0675">Receptor</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0964">Secreted</keyword>
<keyword id="KW-0732">Signal</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<feature type="signal peptide" evidence="6">
<location>
<begin position="1"/>
<end position="20"/>
</location>
</feature>
<feature type="chain" description="Interleukin-1 receptor accessory protein" id="PRO_0000015450">
<location>
<begin position="21"/>
<end position="570"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="6">
<location>
<begin position="21"/>
<end position="367"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="6">
<location>
<begin position="368"/>
<end position="388"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="6">
<location>
<begin position="389"/>
<end position="570"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 1">
<location>
<begin position="21"/>
<end position="128"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 2">
<location>
<begin position="141"/>
<end position="230"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 3">
<location>
<begin position="242"/>
<end position="348"/>
</location>
</feature>
<feature type="domain" description="TIR" evidence="8">
<location>
<begin position="403"/>
<end position="546"/>
</location>
</feature>
<feature type="region of interest" description="Essential for interaction with PTPRD" evidence="5">
<location>
<begin position="69"/>
<end position="85"/>
</location>
</feature>
<feature type="active site" evidence="8">
<location>
<position position="482"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="3 4">
<location>
<position position="557"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="6">
<location>
<position position="57"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="14">
<location>
<position position="107"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="14">
<location>
<position position="111"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="14">
<location>
<position position="118"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="6">
<location>
<position position="196"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="14">
<location>
<position position="209"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="6">
<location>
<position position="299"/>
</location>
</feature>
<feature type="disulfide bond" evidence="7 14">
<location>
<begin position="24"/>
<end position="122"/>
</location>
</feature>
<feature type="disulfide bond" evidence="7 14">
<location>
<begin position="47"/>
<end position="114"/>
</location>
</feature>
<feature type="disulfide bond" evidence="7 14">
<location>
<begin position="137"/>
<end position="181"/>
</location>
</feature>
<feature type="disulfide bond" evidence="7 14">
<location>
<begin position="160"/>
<end position="212"/>
</location>
</feature>
<feature type="disulfide bond" evidence="7 14">
<location>
<begin position="266"/>
<end position="332"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_008052" evidence="22">
<original>ISHSRTEDETRTQILSIKKVTSEDLKRSYVCHARSAKGEVAKAAKVKQKVPAPRYTVELACGFGATVLLVVILIVVYHVYWLEMVLFYRAHFGTDETILDGKEYDIYVSYARNAEEEEFVLLTLRGVLENEFGYKLCIFDRDSLPGGIVTDETLSFIQKSRRLLVVLSPNYVLQGTQALLELKAGLENMASRGNINVILVQYKAVKETKVKELKRAKTVLTVIKWKGEKSKYPQGRFWKQLQVAMPVKKSPRRSSSDEQGLSYSSLKNV</original>
<variation>ASSKIHSGTGLWFWSHSPASGDSHCCLPCLLARDGPILPGSFWNR</variation>
<location>
<begin position="302"/>
<end position="570"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_008050" evidence="21 22 23">
<original>VPAPRY</original>
<variation>GNRCGQ</variation>
<location>
<begin position="351"/>
<end position="356"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_008051" evidence="21 22 23">
<location>
<begin position="357"/>
<end position="570"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 4." id="VSP_041256" evidence="24 25">
<original>IVTDETLSFIQKSRRLLVVLSPNYVLQGTQALLELKAGLENMASRGNINVILVQYKAVKETKVKELKRAKTVLTVIKWKGEKSKYPQGRFWKQLQVAMPVKKSPRRSSSDEQGLSYSSLKNV</original>
<variation>NTVEAVFDFIQRSRRMIVVLSPDYVTEKSISMLEFKLGVMCQNSIATKLIVVEYRPLEHPHPGILQLKESVSFVSWKGEKSKHSGSKFWKALRLALPLRSLSASSGWNESCSSQSDISLDHVQRRRSRLKEPPELQSSERAAGSPPAPGTMSKHRGKSSATCRCCVTYCEGENHLRNKSRAEIHNQPQWETHLCKPVPQESETQWIQNGTRLEPPAPQISALALHHFTDLSNNNDFYIL</variation>
<location>
<begin position="449"/>
<end position="570"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs34661910." id="VAR_053383">
<original>V</original>
<variation>M</variation>
<location>
<position position="473"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="25"/>
<end position="29"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="31"/>
<end position="33"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="36"/>
<end position="38"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="43"/>
<end position="46"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="49"/>
<end position="53"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="54"/>
<end position="56"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="58"/>
<end position="63"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="67"/>
<end position="76"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="80"/>
<end position="82"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="88"/>
<end position="90"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="92"/>
<end position="95"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="98"/>
<end position="103"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="106"/>
<end position="108"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="110"/>
<end position="117"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="122"/>
<end position="132"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="146"/>
<end position="150"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="154"/>
<end position="159"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="174"/>
<end position="179"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="188"/>
<end position="193"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="196"/>
<end position="201"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="204"/>
<end position="206"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="208"/>
<end position="218"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="221"/>
<end position="234"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="237"/>
<end position="239"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="244"/>
<end position="248"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="250"/>
<end position="252"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="266"/>
<end position="270"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="279"/>
<end position="285"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="300"/>
<end position="303"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="310"/>
<end position="314"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="323"/>
<end position="327"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="331"/>
<end position="335"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="340"/>
<end position="344"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3O4O"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4DEP"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19690332"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q61730"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000255"/>
<evidence key="7" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00114"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00204"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10653850"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10799889"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12530978"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12781872"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19481478"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20802483"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20805474"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22723552"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23479569"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25595648"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9371760"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9862719"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="10799889"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="12781872"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="17949817"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="19481478"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000305"/>
<evidence key="27" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="10653850"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="19836339"/>
</source>
</evidence>
<sequence length="570" mass="65418" checksum="5F47F8D0ECA98B8A" modified="2003-08-22" version="2" precursor="true">MTLLWCVVSLYFYGILQSDASERCDDWGLDTMRQIQVFEDEPARIKCPLFEHFLKFNYSTAHSAGLTLIWYWTRQDRDLEEPINFRLPENRISKEKDVLWFRPTLLNDTGNYTCMLRNTTYCSKVAFPLEVVQKDSCFNSPMKLPVHKLYIEYGIQRITCPNVDGYFPSSVKPTITWYMGCYKIQNFNNVIPEGMNLSFLIALISNNGNYTCVVTYPENGRTFHLTRTLTVKVVGSPKNAVPPVIHSPNDHVVYEKEPGEELLIPCTVYFSFLMDSRNEVWWTIDGKKPDDITIDVTINESISHSRTEDETRTQILSIKKVTSEDLKRSYVCHARSAKGEVAKAAKVKQKVPAPRYTVELACGFGATVLLVVILIVVYHVYWLEMVLFYRAHFGTDETILDGKEYDIYVSYARNAEEEEFVLLTLRGVLENEFGYKLCIFDRDSLPGGIVTDETLSFIQKSRRLLVVLSPNYVLQGTQALLELKAGLENMASRGNINVILVQYKAVKETKVKELKRAKTVLTVIKWKGEKSKYPQGRFWKQLQVAMPVKKSPRRSSSDEQGLSYSSLKNV</sequence>
</entry>
<entry dataset="Swiss-Prot" created="2003-08-22" modified="2020-12-02" version="142">
<accession>Q63621</accession>
<name>IL1AP_RAT</name>
<protein>
<recommendedName>
<fullName>Interleukin-1 receptor accessory protein</fullName>
<shortName>IL-1 receptor accessory protein</shortName>
<shortName>IL-1RAcP</shortName>
<ecNumber evidence="5">3.2.2.6</ecNumber>
</recommendedName>
</protein>
<gene>
<name type="primary">Il1rap</name>
</gene>
<organism>
<name type="scientific">Rattus norvegicus</name>
<name type="common">Rat</name>
<dbReference type="NCBI Taxonomy" id="10116"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Glires</taxon>
<taxon>Rodentia</taxon>
<taxon>Myomorpha</taxon>
<taxon>Muroidea</taxon>
<taxon>Muridae</taxon>
<taxon>Murinae</taxon>
<taxon>Rattus</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1996" name="J. Neuroimmunol." volume="66" first="41" last="48">
<title>Rat homolog of mouse interleukin-1 receptor accessory protein: cloning, localization and modulation studies.</title>
<authorList>
<person name="Liu C."/>
<person name="Chalmers D."/>
<person name="Maki R."/>
<person name="De Souza E.B."/>
</authorList>
<dbReference type="PubMed" id="8964912"/>
<dbReference type="DOI" id="10.1016/0165-5728(96)00016-1"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>TISSUE SPECIFICITY</scope>
<source>
<tissue>Cervical ganglion</tissue>
</source>
</reference>
<comment type="function">
<text evidence="1 2">Coreceptor for IL1RL2 in the IL-36 signaling system (By similarity). Coreceptor with IL1R1 in the IL-1 signaling system. Associates with IL1R1 bound to IL1B to form the high affinity interleukin-1 receptor complex which mediates interleukin-1-dependent activation of NF-kappa-B and other pathways. Signaling involves the recruitment of adapter molecules such as TOLLIP, MYD88, and IRAK1 or IRAK2 via the respective TIR domains of the receptor/coreceptor subunits. Recruits TOLLIP to the signaling complex. Does not bind to interleukin-1 alone; binding of IL1RN to IL1R1, prevents its association with IL1R1 to form a signaling complex. The cellular response is modulated through a non-signaling association with the membrane IL1R2 decoy receptor. Coreceptor for IL1RL1 in the IL-33 signaling system (By similarity). Can bidirectionally induce pre- and postsynaptic differentiation of neurons by trans-synaptically binding to PTPRD (By similarity). May play a role in IL1B-mediated costimulation of IFNG production from T-helper 1 (Th1) cells (By similarity).</text>
</comment>
<comment type="catalytic activity">
<reaction evidence="5">
<text>H2O + NAD(+) = ADP-D-ribose + H(+) + nicotinamide</text>
<dbReference type="Rhea" id="RHEA:16301"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:17154"/>
<dbReference type="ChEBI" id="CHEBI:57540"/>
<dbReference type="ChEBI" id="CHEBI:57967"/>
<dbReference type="EC" id="3.2.2.6"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="5">
<dbReference type="Rhea" id="RHEA:16302"/>
</physiologicalReaction>
</comment>
<comment type="subunit">
<text evidence="1 2">The interleukin-36 receptor complex is a heterodimer of IL1RL2 and IL1RAP; the association is inhibited by IL36RN (By similarity). The interleukin-1 receptor complex is a heterodimer of IL1R1 and IL1RAP. Associates with IL1R2 to form a non-signaling interleukin-1 receptor complex (By similarity). Interacts with IL-33-bound IL1RL1 to form the minimal interleukin-33 signaling complex with a 1:1:1 stoichiometry. Interacts with KIT (independently of stimulation with KITLG/SCF). A mast cell-specific KITLG/SCF-induced interleukin-33 signaling complex contains IL1RL1, IL1RAP, KIT and MYD88 (By similarity). Interacts (via the first immunoglobilin domain) with PTPRD (via the third immunoglobilin domain); induces pre- and postsynaptic differentiation of neurons (By similarity).</text>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location>Membrane</location>
<topology>Single-pass type I membrane protein</topology>
</subcellularLocation>
</comment>
<comment type="tissue specificity">
<text evidence="6">Highly expressed in hypothalamus, in the dentate gyrus of hippocampus, cerebral cortex, cerebellum, liver and lung.</text>
</comment>
<comment type="domain">
<text evidence="5">The TIR domain mediates NAD(+) hydrolase (NADase) activity. Self-association of TIR domains is required for NADase activity.</text>
</comment>
<comment type="similarity">
<text evidence="7">Belongs to the interleukin-1 receptor family.</text>
</comment>
<dbReference type="EC" id="3.2.2.6" evidence="5"/>
<dbReference type="EMBL" id="U48592">
<property type="protein sequence ID" value="AAB03502.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="RefSeq" id="NP_037100.1">
<property type="nucleotide sequence ID" value="NM_012968.1"/>
</dbReference>
<dbReference type="SMR" id="Q63621"/>
<dbReference type="BioGRID" id="247499">
<property type="interactions" value="2"/>
</dbReference>
<dbReference type="IntAct" id="Q63621">
<property type="interactions" value="1"/>
</dbReference>
<dbReference type="MINT" id="Q63621"/>
<dbReference type="GlyGen" id="Q63621">
<property type="glycosylation" value="7 sites"/>
</dbReference>
<dbReference type="PRIDE" id="Q63621"/>
<dbReference type="GeneID" id="25466"/>
<dbReference type="KEGG" id="rno:25466"/>
<dbReference type="UCSC" id="RGD:2893">
<property type="organism name" value="rat"/>
</dbReference>
<dbReference type="CTD" id="3556"/>
<dbReference type="RGD" id="2893">
<property type="gene designation" value="Il1rap"/>
</dbReference>
<dbReference type="InParanoid" id="Q63621"/>
<dbReference type="PhylomeDB" id="Q63621"/>
<dbReference type="Reactome" id="R-RNO-1257604">
<property type="pathway name" value="PIP3 activates AKT signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-RNO-388844">
<property type="pathway name" value="Receptor-type tyrosine-protein phosphatases"/>
</dbReference>
<dbReference type="Reactome" id="R-RNO-6811558">
<property type="pathway name" value="PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-RNO-9014826">
<property type="pathway name" value="Interleukin-36 pathway"/>
</dbReference>
<dbReference type="Reactome" id="R-RNO-9014843">
<property type="pathway name" value="Interleukin-33 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-RNO-9020702">
<property type="pathway name" value="Interleukin-1 signaling"/>
</dbReference>
<dbReference type="PRO" id="PR:Q63621"/>
<dbReference type="Proteomes" id="UP000002494">
<property type="component" value="Unplaced"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0098978">
<property type="term" value="C:glutamatergic synapse"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0016021">
<property type="term" value="C:integral component of membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0032991">
<property type="term" value="C:protein-containing complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0019966">
<property type="term" value="F:interleukin-1 binding"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0004908">
<property type="term" value="F:interleukin-1 receptor activity"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0005149">
<property type="term" value="F:interleukin-1 receptor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0002114">
<property type="term" value="F:interleukin-33 receptor activity"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0050135">
<property type="term" value="F:NAD(P)+ nucleosidase activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0061809">
<property type="term" value="F:NAD+ nucleotidase, cyclic ADP-ribose generating"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:1990782">
<property type="term" value="F:protein tyrosine kinase binding"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0030674">
<property type="term" value="F:protein-macromolecule adaptor activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0019221">
<property type="term" value="P:cytokine-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0006954">
<property type="term" value="P:inflammatory response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0032623">
<property type="term" value="P:interleukin-2 production"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0038172">
<property type="term" value="P:interleukin-33-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0032633">
<property type="term" value="P:interleukin-4 production"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:1900006">
<property type="term" value="P:positive regulation of dendrite development"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0032736">
<property type="term" value="P:positive regulation of interleukin-13 production"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0032754">
<property type="term" value="P:positive regulation of interleukin-5 production"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0032755">
<property type="term" value="P:positive regulation of interleukin-6 production"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0051092">
<property type="term" value="P:positive regulation of NF-kappaB transcription factor activity"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0051965">
<property type="term" value="P:positive regulation of synapse assembly"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0099151">
<property type="term" value="P:regulation of postsynaptic density assembly"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:1905606">
<property type="term" value="P:regulation of presynapse assembly"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0099560">
<property type="term" value="P:synaptic membrane adhesion"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0099545">
<property type="term" value="P:trans-synaptic signaling by trans-synaptic complex"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="Gene3D" id="2.60.40.10">
<property type="match status" value="3"/>
</dbReference>
<dbReference type="Gene3D" id="3.40.50.10140">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR007110">
<property type="entry name" value="Ig-like_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR036179">
<property type="entry name" value="Ig-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR013783">
<property type="entry name" value="Ig-like_fold"/>
</dbReference>
<dbReference type="InterPro" id="IPR003599">
<property type="entry name" value="Ig_sub"/>
</dbReference>
<dbReference type="InterPro" id="IPR015621">
<property type="entry name" value="IL-1_rcpt_fam"/>
</dbReference>
<dbReference type="InterPro" id="IPR004074">
<property type="entry name" value="IL-1_rcpt_I/II-typ"/>
</dbReference>
<dbReference type="InterPro" id="IPR041416">
<property type="entry name" value="IL-1RAcP-like_ig"/>
</dbReference>
<dbReference type="InterPro" id="IPR000157">
<property type="entry name" value="TIR_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR035897">
<property type="entry name" value="Toll_tir_struct_dom_sf"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR11890">
<property type="entry name" value="PTHR11890"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF13895">
<property type="entry name" value="Ig_2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF18452">
<property type="entry name" value="Ig_6"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF01582">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR01536">
<property type="entry name" value="INTRLKN1R12F"/>
</dbReference>
<dbReference type="SMART" id="SM00409">
<property type="entry name" value="IG"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="SMART" id="SM00255">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF48726">
<property type="entry name" value="SSF48726"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF52200">
<property type="entry name" value="SSF52200"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50835">
<property type="entry name" value="IG_LIKE"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="PROSITE" id="PS50104">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at transcript level"/>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0378">Hydrolase</keyword>
<keyword id="KW-0393">Immunoglobulin domain</keyword>
<keyword id="KW-0395">Inflammatory response</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0520">NAD</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0675">Receptor</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0732">Signal</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<feature type="signal peptide" evidence="3">
<location>
<begin position="1"/>
<end position="20"/>
</location>
</feature>
<feature type="chain" description="Interleukin-1 receptor accessory protein" id="PRO_0000015453">
<location>
<begin position="21"/>
<end position="570"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="3">
<location>
<begin position="21"/>
<end position="367"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="3">
<location>
<begin position="368"/>
<end position="388"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="3">
<location>
<begin position="389"/>
<end position="570"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 1">
<location>
<begin position="21"/>
<end position="128"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 2">
<location>
<begin position="141"/>
<end position="230"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 3">
<location>
<begin position="243"/>
<end position="348"/>
</location>
</feature>
<feature type="domain" description="TIR" evidence="5">
<location>
<begin position="403"/>
<end position="546"/>
</location>
</feature>
<feature type="region of interest" description="Essential for interaction with PTPRD" evidence="1">
<location>
<begin position="69"/>
<end position="85"/>
</location>
</feature>
<feature type="active site" evidence="5">
<location>
<position position="482"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="2">
<location>
<position position="557"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="3">
<location>
<position position="57"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="3">
<location>
<position position="107"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="3">
<location>
<position position="111"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="3">
<location>
<position position="118"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="3">
<location>
<position position="157"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="3">
<location>
<position position="196"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="3">
<location>
<position position="209"/>
</location>
</feature>
<feature type="disulfide bond" evidence="4">
<location>
<begin position="24"/>
<end position="122"/>
</location>
</feature>
<feature type="disulfide bond" evidence="4">
<location>
<begin position="47"/>
<end position="114"/>
</location>
</feature>
<feature type="disulfide bond" evidence="4">
<location>
<begin position="137"/>
<end position="181"/>
</location>
</feature>
<feature type="disulfide bond" evidence="4">
<location>
<begin position="160"/>
<end position="212"/>
</location>
</feature>
<feature type="disulfide bond" evidence="4">
<location>
<begin position="266"/>
<end position="332"/>
</location>
</feature>
<evidence key="1" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q61730"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q9NPH3"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000255"/>
<evidence key="4" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00114"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00204"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8964912"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000305"/>
<sequence length="570" mass="65599" checksum="20C3A5478127AABE" modified="1996-11-01" version="1" precursor="true">MGLPWCLMSLFFCGILQSHASERCDDWGLDTMRQIQVFEDEPARIKCPLFEHFLKYNYSTAHSSGLTLIWYWTRQDRDLEEPINFRLPENRISKEKDVLWFRPTLLNDTGNYTCMLRNTTYCSKVAFPLEVVQKDSCFNSPMRLPVHRLYIEQGIHNITCPNVDGYFPSSVKPSVTWYKGCTEIVNFHNVQPKGMNLSFFIPLVSNNGNYTCVVTYLENGRLFHLTRTMTVKVVGSPKDAVPPHIYSPNDRVVYEKEPGEELVIPCKVYFSFIMDSHNEIWWTIDGKKPDDVPVDITIIESVSYSSTEDETRTQILSIKKVTPEDLKRNYVCHARNAEGEAEQAAKVKQKVIPPRYTVELACGFGATVFLVVVLIVVYHVYWLEMVLFYRAHFGTDETILDGKEYDIYVSYARNAEEEEFVLLTLRGVLENEFGYKLCIFDRDSFPGGIVTDETLSFIQKSRRLLVVLSPNYVLQGTQALLELKAGLENMASRGNINVILVQYKAVKDLKVKELKRAKSVLTVIKWKGEKSKYPQGRFWKQLQVAMPVKKSPRWSSSDKQGLSYSSLKNV</sequence>
</entry>
<entry dataset="Swiss-Prot" created="2003-08-22" modified="2020-12-02" version="185">
<accession>Q61730</accession>
<accession>Q3UVZ1</accession>
<accession>Q8VCB9</accession>
<name>IL1AP_MOUSE</name>
<protein>
<recommendedName>
<fullName>Interleukin-1 receptor accessory protein</fullName>
<shortName>IL-1 receptor accessory protein</shortName>
<shortName>IL-1RAcP</shortName>
<ecNumber evidence="6">3.2.2.6</ecNumber>
</recommendedName>
<alternativeName>
<fullName evidence="23">Interleukin-33 receptot beta chain</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">Il1rap</name>
</gene>
<organism>
<name type="scientific">Mus musculus</name>
<name type="common">Mouse</name>
<dbReference type="NCBI Taxonomy" id="10090"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Glires</taxon>
<taxon>Rodentia</taxon>
<taxon>Myomorpha</taxon>
<taxon>Muroidea</taxon>
<taxon>Muridae</taxon>
<taxon>Murinae</taxon>
<taxon>Mus</taxon>
<taxon>Mus</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1995" name="J. Biol. Chem." volume="270" first="13757" last="13765">
<title>Molecular cloning and characterization of a second subunit of the interleukin 1 receptor complex.</title>
<authorList>
<person name="Greenfeder S.A."/>
<person name="Nunes P."/>
<person name="Kwee L."/>
<person name="Labow M."/>
<person name="Chizzonite R.A."/>
<person name="Ju G."/>
</authorList>
<dbReference type="PubMed" id="7775431"/>
<dbReference type="DOI" id="10.1074/jbc.270.23.13757"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2)</scope>
<scope>INTERACTION WITH IL1R1</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>SUBCELLULAR LOCATION</scope>
<source>
<tissue>Fibroblast</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="2005" name="Science" volume="309" first="1559" last="1563">
<title>The transcriptional landscape of the mammalian genome.</title>
<authorList>
<person name="Carninci P."/>
<person name="Kasukawa T."/>
<person name="Katayama S."/>
<person name="Gough J."/>
<person name="Frith M.C."/>
<person name="Maeda N."/>
<person name="Oyama R."/>
<person name="Ravasi T."/>
<person name="Lenhard B."/>
<person name="Wells C."/>
<person name="Kodzius R."/>
<person name="Shimokawa K."/>
<person name="Bajic V.B."/>
<person name="Brenner S.E."/>
<person name="Batalov S."/>
<person name="Forrest A.R."/>
<person name="Zavolan M."/>
<person name="Davis M.J."/>
<person name="Wilming L.G."/>
<person name="Aidinis V."/>
<person name="Allen J.E."/>
<person name="Ambesi-Impiombato A."/>
<person name="Apweiler R."/>
<person name="Aturaliya R.N."/>
<person name="Bailey T.L."/>
<person name="Bansal M."/>
<person name="Baxter L."/>
<person name="Beisel K.W."/>
<person name="Bersano T."/>
<person name="Bono H."/>
<person name="Chalk A.M."/>
<person name="Chiu K.P."/>
<person name="Choudhary V."/>
<person name="Christoffels A."/>
<person name="Clutterbuck D.R."/>
<person name="Crowe M.L."/>
<person name="Dalla E."/>
<person name="Dalrymple B.P."/>
<person name="de Bono B."/>
<person name="Della Gatta G."/>
<person name="di Bernardo D."/>
<person name="Down T."/>
<person name="Engstrom P."/>
<person name="Fagiolini M."/>
<person name="Faulkner G."/>
<person name="Fletcher C.F."/>
<person name="Fukushima T."/>
<person name="Furuno M."/>
<person name="Futaki S."/>
<person name="Gariboldi M."/>
<person name="Georgii-Hemming P."/>
<person name="Gingeras T.R."/>
<person name="Gojobori T."/>
<person name="Green R.E."/>
<person name="Gustincich S."/>
<person name="Harbers M."/>
<person name="Hayashi Y."/>
<person name="Hensch T.K."/>
<person name="Hirokawa N."/>
<person name="Hill D."/>
<person name="Huminiecki L."/>
<person name="Iacono M."/>
<person name="Ikeo K."/>
<person name="Iwama A."/>
<person name="Ishikawa T."/>
<person name="Jakt M."/>
<person name="Kanapin A."/>
<person name="Katoh M."/>
<person name="Kawasawa Y."/>
<person name="Kelso J."/>
<person name="Kitamura H."/>
<person name="Kitano H."/>
<person name="Kollias G."/>
<person name="Krishnan S.P."/>
<person name="Kruger A."/>
<person name="Kummerfeld S.K."/>
<person name="Kurochkin I.V."/>
<person name="Lareau L.F."/>
<person name="Lazarevic D."/>
<person name="Lipovich L."/>
<person name="Liu J."/>
<person name="Liuni S."/>
<person name="McWilliam S."/>
<person name="Madan Babu M."/>
<person name="Madera M."/>
<person name="Marchionni L."/>
<person name="Matsuda H."/>
<person name="Matsuzawa S."/>
<person name="Miki H."/>
<person name="Mignone F."/>
<person name="Miyake S."/>
<person name="Morris K."/>
<person name="Mottagui-Tabar S."/>
<person name="Mulder N."/>
<person name="Nakano N."/>
<person name="Nakauchi H."/>
<person name="Ng P."/>
<person name="Nilsson R."/>
<person name="Nishiguchi S."/>
<person name="Nishikawa S."/>
<person name="Nori F."/>
<person name="Ohara O."/>
<person name="Okazaki Y."/>
<person name="Orlando V."/>
<person name="Pang K.C."/>
<person name="Pavan W.J."/>
<person name="Pavesi G."/>
<person name="Pesole G."/>
<person name="Petrovsky N."/>
<person name="Piazza S."/>
<person name="Reed J."/>
<person name="Reid J.F."/>
<person name="Ring B.Z."/>
<person name="Ringwald M."/>
<person name="Rost B."/>
<person name="Ruan Y."/>
<person name="Salzberg S.L."/>
<person name="Sandelin A."/>
<person name="Schneider C."/>
<person name="Schoenbach C."/>
<person name="Sekiguchi K."/>
<person name="Semple C.A."/>
<person name="Seno S."/>
<person name="Sessa L."/>
<person name="Sheng Y."/>
<person name="Shibata Y."/>
<person name="Shimada H."/>
<person name="Shimada K."/>
<person name="Silva D."/>
<person name="Sinclair B."/>
<person name="Sperling S."/>
<person name="Stupka E."/>
<person name="Sugiura K."/>
<person name="Sultana R."/>
<person name="Takenaka Y."/>
<person name="Taki K."/>
<person name="Tammoja K."/>
<person name="Tan S.L."/>
<person name="Tang S."/>
<person name="Taylor M.S."/>
<person name="Tegner J."/>
<person name="Teichmann S.A."/>
<person name="Ueda H.R."/>
<person name="van Nimwegen E."/>
<person name="Verardo R."/>
<person name="Wei C.L."/>
<person name="Yagi K."/>
<person name="Yamanishi H."/>
<person name="Zabarovsky E."/>
<person name="Zhu S."/>
<person name="Zimmer A."/>
<person name="Hide W."/>
<person name="Bult C."/>
<person name="Grimmond S.M."/>
<person name="Teasdale R.D."/>
<person name="Liu E.T."/>
<person name="Brusic V."/>
<person name="Quackenbush J."/>
<person name="Wahlestedt C."/>
<person name="Mattick J.S."/>
<person name="Hume D.A."/>
<person name="Kai C."/>
<person name="Sasaki D."/>
<person name="Tomaru Y."/>
<person name="Fukuda S."/>
<person name="Kanamori-Katayama M."/>
<person name="Suzuki M."/>
<person name="Aoki J."/>
<person name="Arakawa T."/>
<person name="Iida J."/>
<person name="Imamura K."/>
<person name="Itoh M."/>
<person name="Kato T."/>
<person name="Kawaji H."/>
<person name="Kawagashira N."/>
<person name="Kawashima T."/>
<person name="Kojima M."/>
<person name="Kondo S."/>
<person name="Konno H."/>
<person name="Nakano K."/>
<person name="Ninomiya N."/>
<person name="Nishio T."/>
<person name="Okada M."/>
<person name="Plessy C."/>
<person name="Shibata K."/>
<person name="Shiraki T."/>
<person name="Suzuki S."/>
<person name="Tagami M."/>
<person name="Waki K."/>
<person name="Watahiki A."/>
<person name="Okamura-Oho Y."/>
<person name="Suzuki H."/>
<person name="Kawai J."/>
<person name="Hayashizaki Y."/>
</authorList>
<dbReference type="PubMed" id="16141072"/>
<dbReference type="DOI" id="10.1126/science.1112014"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 2 AND 3)</scope>
<source>
<strain>C57BL/6J</strain>
<tissue>Brain</tissue>
<tissue>Diencephalon</tissue>
<tissue>Spinal cord</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="2009" name="PLoS Biol." volume="7" first="E1000112" last="E1000112">
<title>Lineage-specific biology revealed by a finished genome assembly of the mouse.</title>
<authorList>
<person name="Church D.M."/>
<person name="Goodstadt L."/>
<person name="Hillier L.W."/>
<person name="Zody M.C."/>
<person name="Goldstein S."/>
<person name="She X."/>
<person name="Bult C.J."/>
<person name="Agarwala R."/>
<person name="Cherry J.L."/>
<person name="DiCuccio M."/>
<person name="Hlavina W."/>
<person name="Kapustin Y."/>
<person name="Meric P."/>
<person name="Maglott D."/>
<person name="Birtle Z."/>
<person name="Marques A.C."/>
<person name="Graves T."/>
<person name="Zhou S."/>
<person name="Teague B."/>
<person name="Potamousis K."/>
<person name="Churas C."/>
<person name="Place M."/>
<person name="Herschleb J."/>
<person name="Runnheim R."/>
<person name="Forrest D."/>
<person name="Amos-Landgraf J."/>
<person name="Schwartz D.C."/>
<person name="Cheng Z."/>
<person name="Lindblad-Toh K."/>
<person name="Eichler E.E."/>
<person name="Ponting C.P."/>
</authorList>
<dbReference type="PubMed" id="19468303"/>
<dbReference type="DOI" id="10.1371/journal.pbio.1000112"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
<source>
<strain>C57BL/6J</strain>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2)</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="5">
<citation type="journal article" date="1998" name="J. Immunol." volume="161" first="6871" last="6877">
<title>The type II IL-1 receptor interacts with the IL-1 receptor accessory protein: a novel mechanism of regulation of IL-1 responsiveness.</title>
<authorList>
<person name="Lang D."/>
<person name="Knop J."/>
<person name="Wesche H."/>
<person name="Raffetseder U."/>
<person name="Kurrle R."/>
<person name="Boraschi D."/>
<person name="Martin M.U."/>
</authorList>
<dbReference type="PubMed" id="9862719"/>
</citation>
<scope>INTERACTION WITH IL1R2</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2000" name="Nat. Cell Biol." volume="2" first="346" last="351">
<title>Tollip, a new component of the IL-1R1 pathway, links IRAK to the IL-1 receptor.</title>
<authorList>
<person name="Burns K."/>
<person name="Clatworthy J."/>
<person name="Martin L."/>
<person name="Martinon F."/>
<person name="Plumpton C."/>
<person name="Maschera B."/>
<person name="Lewis A."/>
<person name="Ray K."/>
<person name="Tschopp J."/>
<person name="Volpe F."/>
</authorList>
<dbReference type="PubMed" id="10854325"/>
<dbReference type="DOI" id="10.1038/35014038"/>
</citation>
<scope>INTERACTION WITH TOLLIP</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2002" name="J. Biol. Chem." volume="277" first="16456" last="16463">
<title>Identification of essential regions in the cytoplasmic tail of interleukin-1 receptor accessory protein critical for interleukin-1 signaling.</title>
<authorList>
<person name="Radons J."/>
<person name="Gabler S."/>
<person name="Wesche H."/>
<person name="Korherr C."/>
<person name="Hofmeister R."/>
<person name="Falk W."/>
</authorList>
<dbReference type="PubMed" id="11880380"/>
<dbReference type="DOI" id="10.1074/jbc.m201000200"/>
</citation>
<scope>MUTAGENESIS OF 527-LYS--PRO-534</scope>
<scope>INTERACTION WITH MYD88</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2003" name="Biochem. Biophys. Res. Commun." volume="303" first="525" last="531">
<title>Characterization of a cascade of protein interactions initiated at the IL-1 receptor.</title>
<authorList>
<person name="Boch J.A."/>
<person name="Yoshida Y."/>
<person name="Koyama Y."/>
<person name="Wara-Aswapati N."/>
<person name="Peng H."/>
<person name="Unlu S."/>
<person name="Auron P.E."/>
</authorList>
<dbReference type="PubMed" id="12659850"/>
<dbReference type="DOI" id="10.1016/s0006-291x(03)00385-1"/>
</citation>
<scope>INTERACTION WITH IRAK2</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2005" name="Arthritis Rheum." volume="52" first="2202" last="2211">
<title>Soluble interleukin-1 receptor accessory protein ameliorates collagen-induced arthritis by a different mode of action from that of interleukin-1 receptor antagonist.</title>
<authorList>
<person name="Smeets R.L."/>
<person name="Joosten L.A."/>
<person name="Arntz O.J."/>
<person name="Bennink M.B."/>
<person name="Takahashi N."/>
<person name="Carlsen H."/>
<person name="Martin M.U."/>
<person name="van den Berg W.B."/>
<person name="van de Loo F.A."/>
</authorList>
<dbReference type="PubMed" id="15986350"/>
<dbReference type="DOI" id="10.1002/art.21108"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2007" name="J. Immunol." volume="179" first="2551" last="2555">
<title>IL-1 receptor accessory protein and ST2 comprise the IL-33 receptor complex.</title>
<authorList>
<person name="Chackerian A.A."/>
<person name="Oldham E.R."/>
<person name="Murphy E.E."/>
<person name="Schmitz J."/>
<person name="Pflanz S."/>
<person name="Kastelein R.A."/>
</authorList>
<dbReference type="PubMed" id="17675517"/>
<dbReference type="DOI" id="10.4049/jimmunol.179.4.2551"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBUNIT</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2007" name="Proc. Natl. Acad. Sci. U.S.A." volume="104" first="18660" last="18665">
<title>IL-1 receptor accessory protein is essential for IL-33-induced activation of T lymphocytes and mast cells.</title>
<authorList>
<person name="Ali S."/>
<person name="Huber M."/>
<person name="Kollewe C."/>
<person name="Bischoff S.C."/>
<person name="Falk W."/>
<person name="Martin M.U."/>
</authorList>
<dbReference type="PubMed" id="18003919"/>
<dbReference type="DOI" id="10.1073/pnas.0705939104"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH IL1RL1</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2008" name="Cytokine" volume="42" first="358" last="364">
<title>The IL-1 receptor accessory protein (AcP) is required for IL-33 signaling and soluble AcP enhances the ability of soluble ST2 to inhibit IL-33.</title>
<authorList>
<person name="Palmer G."/>
<person name="Lipsky B.P."/>
<person name="Smithgall M.D."/>
<person name="Meininger D."/>
<person name="Siu S."/>
<person name="Talabot-Ayer D."/>
<person name="Gabay C."/>
<person name="Smith D.E."/>
</authorList>
<dbReference type="PubMed" id="18450470"/>
<dbReference type="DOI" id="10.1016/j.cyto.2008.03.008"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH IL1RL1</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2009" name="Immunity" volume="30" first="817" last="831">
<title>A central nervous system-restricted isoform of the interleukin-1 receptor accessory protein modulates neuronal responses to interleukin-1.</title>
<authorList>
<person name="Smith D.E."/>
<person name="Lipsky B.P."/>
<person name="Russell C."/>
<person name="Ketchem R.R."/>
<person name="Kirchner J."/>
<person name="Hensley K."/>
<person name="Huang Y."/>
<person name="Friedman W.J."/>
<person name="Boissonneault V."/>
<person name="Plante M.M."/>
<person name="Rivest S."/>
<person name="Sims J.E."/>
</authorList>
<dbReference type="PubMed" id="19481478"/>
<dbReference type="DOI" id="10.1016/j.immuni.2009.03.020"/>
</citation>
<scope>ALTERNATIVE SPLICING (ISOFORM 3)</scope>
<scope>TISSUE SPECIFICITY (ISOFORM 3)</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2010" name="Blood" volume="115" first="3899" last="3906">
<title>The receptor tyrosine kinase c-Kit controls IL-33 receptor signaling in mast cells.</title>
<authorList>
<person name="Drube S."/>
<person name="Heink S."/>
<person name="Walter S."/>
<person name="Loehn T."/>
<person name="Grusser M."/>
<person name="Gerbaulet A."/>
<person name="Berod L."/>
<person name="Schons J."/>
<person name="Dudeck A."/>
<person name="Freitag J."/>
<person name="Grotha S."/>
<person name="Reich D."/>
<person name="Rudeschko O."/>
<person name="Norgauer J."/>
<person name="Hartmann K."/>
<person name="Roers A."/>
<person name="Kamradt T."/>
</authorList>
<dbReference type="PubMed" id="20200353"/>
<dbReference type="DOI" id="10.1182/blood-2009-10-247411"/>
</citation>
<scope>INTERACTION WITH KIT</scope>
<scope>SUBUNIT</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2011" name="Brain Res." volume="1385" first="8" last="17">
<title>Production and functions of IL-33 in the central nervous system.</title>
<authorList>
<person name="Yasuoka S."/>
<person name="Kawanokuchi J."/>
<person name="Parajuli B."/>
<person name="Jin S."/>
<person name="Doi Y."/>
<person name="Noda M."/>
<person name="Sonobe Y."/>
<person name="Takeuchi H."/>
<person name="Mizuno T."/>
<person name="Suzumura A."/>
</authorList>
<dbReference type="PubMed" id="21349253"/>
<dbReference type="DOI" id="10.1016/j.brainres.2011.02.045"/>
</citation>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2011" name="J. Biol. Chem." volume="286" first="42594" last="42602">
<title>Interleukin-36 (IL-36) ligands require processing for full agonist (IL-36alpha, IL-36beta, and IL-36gamma) or antagonist (IL-36Ra) activity.</title>
<authorList>
<person name="Towne J.E."/>
<person name="Renshaw B.R."/>
<person name="Douangpanya J."/>
<person name="Lipsky B.P."/>
<person name="Shen M."/>
<person name="Gabel C.A."/>
<person name="Sims J.E."/>
</authorList>
<dbReference type="PubMed" id="21965679"/>
<dbReference type="DOI" id="10.1074/jbc.m111.267922"/>
</citation>
<scope>INTERACTION WITH IL1RL2</scope>
<scope>SUBUNIT</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2011" name="J. Neurosci." volume="31" first="18048" last="18059">
<title>Neuron-specific effects of interleukin-1beta are mediated by a novel isoform of the IL-1 receptor accessory protein.</title>
<authorList>
<person name="Huang Y."/>
<person name="Smith D.E."/>
<person name="Ibanez-Sandoval O."/>
<person name="Sims J.E."/>
<person name="Friedman W.J."/>
</authorList>
<dbReference type="PubMed" id="22159118"/>
<dbReference type="DOI" id="10.1523/jneurosci.4067-11.2011"/>
</citation>
<scope>FUNCTION (ISOFORM 3)</scope>
<scope>TISSUE SPECIFICITY (ISOFORM 3)</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2012" name="Proc. Natl. Acad. Sci. U.S.A." volume="109" first="12189" last="12194">
<title>Interleukin-1R3 mediates interleukin-1-induced potassium current increase through fast activation of Akt kinase.</title>
<authorList>
<person name="Qian J."/>
<person name="Zhu L."/>
<person name="Li Q."/>
<person name="Belevych N."/>
<person name="Chen Q."/>
<person name="Zhao F."/>
<person name="Herness S."/>
<person name="Quan N."/>
</authorList>
<dbReference type="PubMed" id="22778412"/>
<dbReference type="DOI" id="10.1073/pnas.1205207109"/>
</citation>
<scope>FUNCTION (ISOFORM 3)</scope>
</reference>
<reference key="19" evidence="1">
<citation type="journal article" date="2015" name="Nat. Commun." volume="6" first="6926" last="6926">
<title>Mechanisms of splicing-dependent trans-synaptic adhesion by PTPdelta-IL1RAPL1/IL-1RAcP for synaptic differentiation.</title>
<authorList>
<person name="Yamagata A."/>
<person name="Yoshida T."/>
<person name="Sato Y."/>
<person name="Goto-Ito S."/>
<person name="Uemura T."/>
<person name="Maeda A."/>
<person name="Shiroshima T."/>
<person name="Iwasawa-Okamoto S."/>
<person name="Mori H."/>
<person name="Mishina M."/>
<person name="Fukai S."/>
</authorList>
<dbReference type="PubMed" id="25908590"/>
<dbReference type="DOI" id="10.1038/ncomms7926"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.97 ANGSTROMS) OF 21-351 IN COMPLEX WITH PTPRD</scope>
<scope>DISULFIDE BONDS</scope>
<scope>GLYCOSYLATION AT ASN-57; ASN-107; ASN-111; ASN-118 AND ASN-209</scope>
<scope>INTERACTION WITH PTPRD</scope>
<scope>FUNCTION</scope>
<scope>MUTAGENESIS OF TRP-27; ASP-30; 69-ILE--TYR-71; 82-PRO--PHE-85 AND LYS-94</scope>
<scope>REGION</scope>
</reference>
<comment type="function">
<text evidence="3 7 8 9 10 11 18 24">Coreceptor for IL1RL2 in the IL-36 signaling system. Coreceptor with IL1R1 in the IL-1 signaling system. Associates with IL1R1 bound to IL1B to form the high affinity interleukin-1 receptor complex which mediates interleukin-1-dependent activation of NF-kappa-B and other pathways. Signaling involves the recruitment of adapter molecules such as TOLLIP, MYD88, and IRAK1 or IRAK2 via the respective TIR domains of the receptor/coreceptor subunits. Recruits TOLLIP to the signaling complex. Does not bind to interleukin-1 alone; binding of IL1RN to IL1R1, prevents its association with IL1R1 to form a signaling complex. The cellular response is modulated through a non-signaling association with the membrane IL1R2 decoy receptor. Secreted forms (isoforms 2 and 3) associate with secreted ligand-bound IL1R2 and increase the affinity of secreted IL1R2 for IL1B; this complex formation may be the dominant mechanism for neutralization of IL1B by secreted/soluble receptors. Coreceptor for IL1RL1 in the IL-33 signaling system. Can bidirectionally induce pre- and postsynaptic differentiation of neurons by trans-synaptically binding to PTPRD (PubMed:25908590). May play a role in IL1B-mediated costimulation of IFNG production from T-helper 1 (Th1) cells (By similarity).</text>
</comment>
<comment type="function">
<molecule>Isoform 2</molecule>
<text evidence="8 11">Associates with secreted ligand-bound IL1R2 and increases the affinity of secreted IL1R2 for IL1B; this complex formation may be the dominant mechanism for neutralization of IL1B by secreted/soluble receptors. Enhances the ability of secreted IL1R1 to inhibit IL-33 signaling.</text>
</comment>
<comment type="function">
<molecule>Isoform 3</molecule>
<text evidence="16 17">Required for Src phosphorylation by IL1B. Required for IL1B-potentiated NMDA-induced calcium influx in neurons acting in cooperation with IL1R1 isoform 2 to mediate Akt kinase activation.</text>
</comment>
<comment type="catalytic activity">
<reaction evidence="6">
<text>H2O + NAD(+) = ADP-D-ribose + H(+) + nicotinamide</text>
<dbReference type="Rhea" id="RHEA:16301"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:17154"/>
<dbReference type="ChEBI" id="CHEBI:57540"/>
<dbReference type="ChEBI" id="CHEBI:57967"/>
<dbReference type="EC" id="3.2.2.6"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="6">
<dbReference type="Rhea" id="RHEA:16302"/>
</physiologicalReaction>
</comment>
<comment type="subunit">
<text evidence="9 10 13 15 18 20">The interleukin-36 receptor complex is a heterodimer of IL1RL2 and IL1RAP; the association is inhibited by IL36RN. The interleukin-1 receptor complex is a heterodimer of IL1R1 and IL1RAP. Associates with IL1R2 to form a non-signaling interleukin-1 receptor complex. Interacts with IL-33-bound IL1RL1 to form the minimal interleukin-33 signaling complex with a 1:1:1 stoichiometry. Interacts with KIT (independently of stimulation with KITLG/SCF). A mast cell-specific KITLG/SCF-induced interleukin-33 signaling complex contains IL1RL1, IL1RAP, KIT and MYD88. Interacts (via the first immunoglobilin domain) with PTPRD (via the third immunoglobilin domain); induces pre- and postsynaptic differentiation of neurons (PubMed:25908590).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-525035">
<id>Q61730</id>
</interactant>
<interactant intactId="EBI-525078">
<id>P14719</id>
<label>Il1rl1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-525035">
<id>Q61730</id>
</interactant>
<interactant intactId="EBI-74272">
<id>Q9QZ06</id>
<label>Tollip</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="subcellular location">
<molecule>Isoform 1</molecule>
<subcellularLocation>
<location>Cell membrane</location>
<topology>Single-pass type I membrane protein</topology>
</subcellularLocation>
</comment>
<comment type="subcellular location">
<molecule>Isoform 2</molecule>
<subcellularLocation>
<location>Secreted</location>
</subcellularLocation>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>Q61730-1</id>
<name>1</name>
<name>MuIL-1R AcP</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>Q61730-2</id>
<name>2</name>
<name>SmuIL-1R AcP</name>
<sequence type="described" ref="VSP_008054 VSP_008055"/>
</isoform>
<isoform>
<id>Q61730-3</id>
<name>3</name>
<name>IL-1RAcPb</name>
<sequence type="described" ref="VSP_058171"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="12 14 16 19">Detected in lung, brain, spleen, thymus and liver. Expressed in brain endothelial cells, astrocytes, microglia and neurons. Isoform 3 is predominantly expressed in brain; expressed in hippocampal neurons.</text>
</comment>
<comment type="domain">
<text evidence="6">The TIR domain mediates NAD(+) hydrolase (NADase) activity. Self-association of TIR domains is required for NADase activity.</text>
</comment>
<comment type="similarity">
<text evidence="26">Belongs to the interleukin-1 receptor family.</text>
</comment>
<dbReference type="EC" id="3.2.2.6" evidence="6"/>
<dbReference type="EMBL" id="X85999">
<property type="protein sequence ID" value="CAA59991.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK039582">
<property type="protein sequence ID" value="BAC30392.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK045686">
<property type="protein sequence ID" value="BAC32457.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK136782">
<property type="protein sequence ID" value="BAE23128.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AC154234">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC154601">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CT009561">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC021159">
<property type="protein sequence ID" value="AAH21159.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS28089.1">
<molecule id="Q61730-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS49815.1">
<molecule id="Q61730-3"/>
</dbReference>
<dbReference type="CCDS" id="CCDS57023.1">
<molecule id="Q61730-2"/>
</dbReference>
<dbReference type="PIR" id="A57535">
<property type="entry name" value="A57535"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001152790.1">
<molecule id="Q61730-3"/>
<property type="nucleotide sequence ID" value="NM_001159318.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_032390.1">
<molecule id="Q61730-1"/>
<property type="nucleotide sequence ID" value="NM_008364.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_598864.1">
<molecule id="Q61730-2"/>
<property type="nucleotide sequence ID" value="NM_134103.2"/>
</dbReference>
<dbReference type="PDB" id="4YFD">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.25"/>
<property type="chains" value="B=21-351"/>
</dbReference>
<dbReference type="PDB" id="5VI4">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.79"/>
<property type="chains" value="C/F=21-350"/>
</dbReference>
<dbReference type="PDBsum" id="4YFD"/>
<dbReference type="PDBsum" id="5VI4"/>
<dbReference type="SMR" id="Q61730"/>
<dbReference type="BioGRID" id="200628">
<property type="interactions" value="5"/>
</dbReference>
<dbReference type="CORUM" id="Q61730"/>
<dbReference type="DIP" id="DIP-296N"/>
<dbReference type="IntAct" id="Q61730">
<property type="interactions" value="3"/>
</dbReference>
<dbReference type="GlyGen" id="Q61730">
<property type="glycosylation" value="7 sites"/>
</dbReference>
<dbReference type="iPTMnet" id="Q61730"/>
<dbReference type="PhosphoSitePlus" id="Q61730"/>
<dbReference type="CPTAC" id="non-CPTAC-3320"/>
<dbReference type="EPD" id="Q61730"/>
<dbReference type="jPOST" id="Q61730"/>
<dbReference type="PeptideAtlas" id="Q61730"/>
<dbReference type="PRIDE" id="Q61730"/>
<dbReference type="ABCD" id="Q61730">
<property type="antibodies" value="22 sequenced antibodies"/>
</dbReference>
<dbReference type="Antibodypedia" id="19361">
<property type="antibodies" value="371 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="16180"/>
<dbReference type="Ensembl" id="ENSMUST00000023156">
<molecule id="Q61730-1"/>
<property type="protein sequence ID" value="ENSMUSP00000023156"/>
<property type="gene ID" value="ENSMUSG00000022514"/>
</dbReference>
<dbReference type="Ensembl" id="ENSMUST00000096129">
<molecule id="Q61730-3"/>
<property type="protein sequence ID" value="ENSMUSP00000093843"/>
<property type="gene ID" value="ENSMUSG00000022514"/>
</dbReference>
<dbReference type="Ensembl" id="ENSMUST00000174202">
<molecule id="Q61730-2"/>
<property type="protein sequence ID" value="ENSMUSP00000134202"/>
<property type="gene ID" value="ENSMUSG00000022514"/>
</dbReference>
<dbReference type="GeneID" id="16180"/>
<dbReference type="KEGG" id="mmu:16180"/>
<dbReference type="UCSC" id="uc007yve.2">
<molecule id="Q61730-1"/>
<property type="organism name" value="mouse"/>
</dbReference>
<dbReference type="UCSC" id="uc007yvg.2">
<property type="organism name" value="mouse"/>
</dbReference>
<dbReference type="CTD" id="3556"/>
<dbReference type="MGI" id="MGI:104975">
<property type="gene designation" value="Il1rap"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT01010000222421"/>
<dbReference type="HOGENOM" id="CLU_025552_3_2_1"/>
<dbReference type="InParanoid" id="Q61730"/>
<dbReference type="OMA" id="KSPRWSS"/>
<dbReference type="PhylomeDB" id="Q61730"/>
<dbReference type="TreeFam" id="TF325519"/>
<dbReference type="Reactome" id="R-MMU-1257604">
<property type="pathway name" value="PIP3 activates AKT signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-MMU-388844">
<property type="pathway name" value="Receptor-type tyrosine-protein phosphatases"/>
</dbReference>
<dbReference type="Reactome" id="R-MMU-6811558">
<property type="pathway name" value="PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-MMU-9014826">
<property type="pathway name" value="Interleukin-36 pathway"/>
</dbReference>
<dbReference type="Reactome" id="R-MMU-9014843">
<property type="pathway name" value="Interleukin-33 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-MMU-9020702">
<property type="pathway name" value="Interleukin-1 signaling"/>
</dbReference>
<dbReference type="BioGRID-ORCS" id="16180">
<property type="hits" value="0 hits in 17 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="Il1rap">
<property type="organism name" value="mouse"/>
</dbReference>
<dbReference type="PRO" id="PR:Q61730"/>
<dbReference type="Proteomes" id="UP000000589">
<property type="component" value="Chromosome 16"/>
</dbReference>
<dbReference type="RNAct" id="Q61730">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSMUSG00000022514">
<property type="expression patterns" value="Expressed in liver and 250 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="Q61730">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q61730">
<property type="organism ID" value="MM"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0005576">
<property type="term" value="C:extracellular region"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0098978">
<property type="term" value="C:glutamatergic synapse"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="SynGO"/>
</dbReference>
<dbReference type="GO" id="GO:0016021">
<property type="term" value="C:integral component of membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0032991">
<property type="term" value="C:protein-containing complex"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0004908">
<property type="term" value="F:interleukin-1 receptor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0005149">
<property type="term" value="F:interleukin-1 receptor binding"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0002114">
<property type="term" value="F:interleukin-33 receptor activity"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050135">
<property type="term" value="F:NAD(P)+ nucleosidase activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0061809">
<property type="term" value="F:NAD+ nucleotidase, cyclic ADP-ribose generating"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:1990782">
<property type="term" value="F:protein tyrosine kinase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0019221">
<property type="term" value="P:cytokine-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0006954">
<property type="term" value="P:inflammatory response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0045087">
<property type="term" value="P:innate immune response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0032623">
<property type="term" value="P:interleukin-2 production"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0038172">
<property type="term" value="P:interleukin-33-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032633">
<property type="term" value="P:interleukin-4 production"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1900006">
<property type="term" value="P:positive regulation of dendrite development"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0032736">
<property type="term" value="P:positive regulation of interleukin-13 production"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032754">
<property type="term" value="P:positive regulation of interleukin-5 production"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032755">
<property type="term" value="P:positive regulation of interleukin-6 production"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051092">
<property type="term" value="P:positive regulation of NF-kappaB transcription factor activity"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051965">
<property type="term" value="P:positive regulation of synapse assembly"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0099151">
<property type="term" value="P:regulation of postsynaptic density assembly"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="SynGO"/>
</dbReference>
<dbReference type="GO" id="GO:1905606">
<property type="term" value="P:regulation of presynapse assembly"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="SynGO"/>
</dbReference>
<dbReference type="GO" id="GO:0099560">
<property type="term" value="P:synaptic membrane adhesion"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="SynGO"/>
</dbReference>
<dbReference type="GO" id="GO:0099545">
<property type="term" value="P:trans-synaptic signaling by trans-synaptic complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="SynGO"/>
</dbReference>
<dbReference type="Gene3D" id="2.60.40.10">
<property type="match status" value="3"/>
</dbReference>
<dbReference type="Gene3D" id="3.40.50.10140">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR007110">
<property type="entry name" value="Ig-like_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR036179">
<property type="entry name" value="Ig-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR013783">
<property type="entry name" value="Ig-like_fold"/>
</dbReference>
<dbReference type="InterPro" id="IPR003599">
<property type="entry name" value="Ig_sub"/>
</dbReference>
<dbReference type="InterPro" id="IPR015621">
<property type="entry name" value="IL-1_rcpt_fam"/>
</dbReference>
<dbReference type="InterPro" id="IPR004074">
<property type="entry name" value="IL-1_rcpt_I/II-typ"/>
</dbReference>
<dbReference type="InterPro" id="IPR041416">
<property type="entry name" value="IL-1RAcP-like_ig"/>
</dbReference>
<dbReference type="InterPro" id="IPR000157">
<property type="entry name" value="TIR_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR035897">
<property type="entry name" value="Toll_tir_struct_dom_sf"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR11890">
<property type="entry name" value="PTHR11890"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF13895">
<property type="entry name" value="Ig_2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF18452">
<property type="entry name" value="Ig_6"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF01582">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR01536">
<property type="entry name" value="INTRLKN1R12F"/>
</dbReference>
<dbReference type="SMART" id="SM00409">
<property type="entry name" value="IG"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="SMART" id="SM00255">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF48726">
<property type="entry name" value="SSF48726"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF52200">
<property type="entry name" value="SSF52200"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50835">
<property type="entry name" value="IG_LIKE"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="PROSITE" id="PS50104">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0378">Hydrolase</keyword>
<keyword id="KW-0391">Immunity</keyword>
<keyword id="KW-0393">Immunoglobulin domain</keyword>
<keyword id="KW-0395">Inflammatory response</keyword>
<keyword id="KW-0399">Innate immunity</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0520">NAD</keyword>
<keyword id="KW-0675">Receptor</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0964">Secreted</keyword>
<keyword id="KW-0732">Signal</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<feature type="signal peptide" evidence="4">
<location>
<begin position="1"/>
<end position="20"/>
</location>
</feature>
<feature type="chain" description="Interleukin-1 receptor accessory protein" id="PRO_0000015452">
<location>
<begin position="21"/>
<end position="570"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="4">
<location>
<begin position="21"/>
<end position="367"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="4">
<location>
<begin position="368"/>
<end position="388"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="4">
<location>
<begin position="389"/>
<end position="570"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 1">
<location>
<begin position="21"/>
<end position="128"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 2">
<location>
<begin position="139"/>
<end position="230"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 3">
<location>
<begin position="243"/>
<end position="348"/>
</location>
</feature>
<feature type="domain" description="TIR" evidence="6">
<location>
<begin position="403"/>
<end position="546"/>
</location>
</feature>
<feature type="region of interest" description="Essential for interaction with PTPRD" evidence="18">
<location>
<begin position="69"/>
<end position="85"/>
</location>
</feature>
<feature type="active site" evidence="6">
<location>
<position position="482"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="1 18">
<location>
<position position="57"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="1 18">
<location>
<position position="107"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="1 18">
<location>
<position position="111"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="1 18">
<location>
<position position="118"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="196"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="1 18">
<location>
<position position="209"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="299"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1 5 18">
<location>
<begin position="24"/>
<end position="122"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1 5 18">
<location>
<begin position="47"/>
<end position="114"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1 5 18">
<location>
<begin position="137"/>
<end position="181"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1 5 18">
<location>
<begin position="160"/>
<end position="212"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1 5 18">
<location>
<begin position="266"/>
<end position="332"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_008054" evidence="21 22 25">
<original>VIPPRYTVE</original>
<variation>GNGCTEPMTL</variation>
<location>
<begin position="351"/>
<end position="359"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_008055" evidence="21 22 25">
<location>
<begin position="360"/>
<end position="570"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_058171">
<original>IVTDETLSFIQKSRRLLVVLSPNYVLQGTQALLELKAGLENMASRGNINVILVQYKAVKDMKVKELKRAKTVLTVIKWKGEKSKYPQGRFWKQLQVAMPVKKSPRWSSNDKQGLSYSSLKNV</original>
<variation>NTVEAVFDFIQRSRRMIVVLSPDYVTEKSISMLEFKLGVMCQNSIATKLIVVEYRPLEQPHPGIMQLKESVSFVSWKGEKSKHSGSKFWKALRLALPLRSLSASSGWNESCSSQSDISLDHVQRRSRLKEPPELRSSERVSGAEPAPGTMSKHRGKPSAACRCCVTYCEGESHLRSKSRAEMHTHPQWETHLCKPPLQESESQWIQNGTRPEPAPQISALALRHFTDLSNNNDFYIL</variation>
<location>
<begin position="449"/>
<end position="570"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces affinity for PTPRD." evidence="18">
<original>W</original>
<variation>A</variation>
<location>
<position position="27"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not affect affinity for PTPRD." evidence="18">
<original>D</original>
<variation>A</variation>
<location>
<position position="30"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes interaction with PTPRD; when associates with 82-A--A-85. Significantly reduces synaptogenesis; when associates with 82-A--A-85." evidence="18">
<original>IWY</original>
<variation>AWA</variation>
<location>
<begin position="69"/>
<end position="71"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes interaction with PTPRD; when associates with 69-A--A-71 Significantly reduces synaptogenesis; when associates with 82-A--A-85." evidence="18">
<original>PINF</original>
<variation>AINA</variation>
<location>
<begin position="82"/>
<end position="85"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces affinity for PTPRD." evidence="18">
<original>K</original>
<variation>A</variation>
<location>
<position position="94"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes interaction with MYD88 and IL-1-dependent activation of NF-kappa-B." evidence="7">
<original>KGEKSKYP</original>
<variation>AAAAAAAA</variation>
<location>
<begin position="527"/>
<end position="534"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="26"/>
<end position="30"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="35"/>
<end position="38"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="43"/>
<end position="46"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="49"/>
<end position="52"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="58"/>
<end position="63"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="67"/>
<end position="74"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="85"/>
<end position="87"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="88"/>
<end position="90"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="91"/>
<end position="95"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="98"/>
<end position="103"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="106"/>
<end position="108"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="110"/>
<end position="117"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="122"/>
<end position="132"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="146"/>
<end position="150"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="156"/>
<end position="159"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="174"/>
<end position="179"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="182"/>
<end position="185"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="188"/>
<end position="193"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="196"/>
<end position="201"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="204"/>
<end position="206"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="208"/>
<end position="218"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="221"/>
<end position="234"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="237"/>
<end position="239"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="244"/>
<end position="248"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="250"/>
<end position="252"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="264"/>
<end position="270"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="279"/>
<end position="286"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="296"/>
<end position="299"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="300"/>
<end position="304"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="310"/>
<end position="316"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="325"/>
<end position="327"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="330"/>
<end position="336"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="339"/>
<end position="345"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4YFD"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5VI4"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q9NPH3"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000255"/>
<evidence key="5" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00114"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00204"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11880380"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15986350"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17675517"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18003919"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18450470"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19481478"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20200353"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21349253"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21965679"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22159118"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22778412"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25908590"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7775431"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9862719"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="16141072"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="18003919"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="21965679"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="7775431"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000305"/>
<sequence length="570" mass="65741" checksum="4D4B07E0310AFDC5" modified="1996-11-01" version="1" precursor="true">MGLLWYLMSLSFYGILQSHASERCDDWGLDTMRQIQVFEDEPARIKCPLFEHFLKYNYSTAHSSGLTLIWYWTRQDRDLEEPINFRLPENRISKEKDVLWFRPTLLNDTGNYTCMLRNTTYCSKVAFPLEVVQKDSCFNSAMRFPVHKMYIEHGIHKITCPNVDGYFPSSVKPSVTWYKGCTEIVDFHNVLPEGMNLSFFIPLVSNNGNYTCVVTYPENGRLFHLTRTVTVKVVGSPKDALPPQIYSPNDRVVYEKEPGEELVIPCKVYFSFIMDSHNEVWWTIDGKKPDDVTVDITINESVSYSSTEDETRTQILSIKKVTPEDLRRNYVCHARNTKGEAEQAAKVKQKVIPPRYTVELACGFGATVFLVVVLIVVYHVYWLEMVLFYRAHFGTDETILDGKEYDIYVSYARNVEEEEFVLLTLRGVLENEFGYKLCIFDRDSLPGGIVTDETLSFIQKSRRLLVVLSPNYVLQGTQALLELKAGLENMASRGNINVILVQYKAVKDMKVKELKRAKTVLTVIKWKGEKSKYPQGRFWKQLQVAMPVKKSPRWSSNDKQGLSYSSLKNV</sequence>
</entry>
<entry dataset="Swiss-Prot" created="2010-01-19" modified="2020-12-02" version="67">
<accession>B6ZK77</accession>
<name>IRL1B_DANRE</name>
<protein>
<recommendedName>
<fullName>Interleukin-1 receptor accessory protein-like 1-B</fullName>
<ecNumber evidence="4">3.2.2.6</ecNumber>
</recommendedName>
</protein>
<gene>
<name type="primary">il1rapl1b</name>
</gene>
<organism>
<name type="scientific">Danio rerio</name>
<name type="common">Zebrafish</name>
<name type="synonym">Brachydanio rerio</name>
<dbReference type="NCBI Taxonomy" id="7955"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Actinopterygii</taxon>
<taxon>Neopterygii</taxon>
<taxon>Teleostei</taxon>
<taxon>Ostariophysi</taxon>
<taxon>Cypriniformes</taxon>
<taxon>Danionidae</taxon>
<taxon>Danioninae</taxon>
<taxon>Danio</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="2008" name="Mol. Cell. Neurosci." volume="39" first="218" last="228">
<title>Zebrafish orthologue of mental retardation protein IL1RAPL1 regulates presynaptic differentiation.</title>
<authorList>
<person name="Yoshida T."/>
<person name="Mishina M."/>
</authorList>
<dbReference type="PubMed" id="18657618"/>
<dbReference type="DOI" id="10.1016/j.mcn.2008.06.013"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>DEVELOPMENTAL STAGE</scope>
<scope>MUTAGENESIS OF PRO-455</scope>
</reference>
<comment type="function">
<text evidence="5">May regulate secretion and presynaptic differentiation through inhibition of the activity of N-type voltage-gated calcium channel. During presynaptic differentiation may regulate both synaptic vesicle accumulation in axon terminals and subsequent axon terminal remodeling.</text>
</comment>
<comment type="catalytic activity">
<reaction evidence="4">
<text>H2O + NAD(+) = ADP-D-ribose + H(+) + nicotinamide</text>
<dbReference type="Rhea" id="RHEA:16301"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:17154"/>
<dbReference type="ChEBI" id="CHEBI:57540"/>
<dbReference type="ChEBI" id="CHEBI:57967"/>
<dbReference type="EC" id="3.2.2.6"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="4">
<dbReference type="Rhea" id="RHEA:16302"/>
</physiologicalReaction>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="1">Cell membrane</location>
<topology evidence="1">Single-pass type I membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="1">Cytoplasm</location>
</subcellularLocation>
<text evidence="5">May localize to the cell body and growth cones of dendrite-like processes.</text>
</comment>
<comment type="developmental stage">
<text evidence="5">Detectable at 24 hpf and gradually increases through development. Detected in the nervous system in olfactory placode, olfactory bulb, telencephalon and tectum.</text>
</comment>
<comment type="domain">
<text evidence="4">The TIR domain mediates NAD(+) hydrolase (NADase) activity. Self-association of TIR domains is required for NADase activity.</text>
</comment>
<comment type="similarity">
<text evidence="6">Belongs to the interleukin-1 receptor family.</text>
</comment>
<dbReference type="EC" id="3.2.2.6" evidence="4"/>
<dbReference type="EMBL" id="AB449368">
<property type="protein sequence ID" value="BAG85347.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001136054.1">
<property type="nucleotide sequence ID" value="NM_001142582.1"/>
</dbReference>
<dbReference type="SMR" id="B6ZK77"/>
<dbReference type="STRING" id="7955.ENSDARP00000099490"/>
<dbReference type="PaxDb" id="B6ZK77"/>
<dbReference type="GeneID" id="557801"/>
<dbReference type="KEGG" id="dre:557801"/>
<dbReference type="CTD" id="557801"/>
<dbReference type="ZFIN" id="ZDB-GENE-090109-2">
<property type="gene designation" value="il1rapl1b"/>
</dbReference>
<dbReference type="eggNOG" id="KOG3971">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="InParanoid" id="B6ZK77"/>
<dbReference type="OrthoDB" id="651291at2759"/>
<dbReference type="PhylomeDB" id="B6ZK77"/>
<dbReference type="Reactome" id="R-DRE-388844">
<property type="pathway name" value="Receptor-type tyrosine-protein phosphatases"/>
</dbReference>
<dbReference type="Reactome" id="R-DRE-9007892">
<property type="pathway name" value="Interleukin-38 signaling"/>
</dbReference>
<dbReference type="PRO" id="PR:B6ZK77"/>
<dbReference type="Proteomes" id="UP000000437">
<property type="component" value="Unplaced"/>
</dbReference>
<dbReference type="GO" id="GO:0043679">
<property type="term" value="C:axon terminus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ZFIN"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0016021">
<property type="term" value="C:integral component of membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0043025">
<property type="term" value="C:neuronal cell body"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ZFIN"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0050135">
<property type="term" value="F:NAD(P)+ nucleosidase activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0061809">
<property type="term" value="F:NAD+ nucleotidase, cyclic ADP-ribose generating"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0045920">
<property type="term" value="P:negative regulation of exocytosis"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0016322">
<property type="term" value="P:neuron remodeling"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="ZFIN"/>
</dbReference>
<dbReference type="GO" id="GO:0007165">
<property type="term" value="P:signal transduction"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0050808">
<property type="term" value="P:synapse organization"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="ZFIN"/>
</dbReference>
<dbReference type="Gene3D" id="2.60.40.10">
<property type="match status" value="3"/>
</dbReference>
<dbReference type="Gene3D" id="3.40.50.10140">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR007110">
<property type="entry name" value="Ig-like_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR036179">
<property type="entry name" value="Ig-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR013783">
<property type="entry name" value="Ig-like_fold"/>
</dbReference>
<dbReference type="InterPro" id="IPR003599">
<property type="entry name" value="Ig_sub"/>
</dbReference>
<dbReference type="InterPro" id="IPR003598">
<property type="entry name" value="Ig_sub2"/>
</dbReference>
<dbReference type="InterPro" id="IPR015621">
<property type="entry name" value="IL-1_rcpt_fam"/>
</dbReference>
<dbReference type="InterPro" id="IPR041416">
<property type="entry name" value="IL-1RAcP-like_ig"/>
</dbReference>
<dbReference type="InterPro" id="IPR000157">
<property type="entry name" value="TIR_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR035897">
<property type="entry name" value="Toll_tir_struct_dom_sf"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR11890">
<property type="entry name" value="PTHR11890"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF18452">
<property type="entry name" value="Ig_6"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF01582">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00409">
<property type="entry name" value="IG"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="SMART" id="SM00408">
<property type="entry name" value="IGc2"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="SMART" id="SM00255">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF48726">
<property type="entry name" value="SSF48726"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF52200">
<property type="entry name" value="SSF52200"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50835">
<property type="entry name" value="IG_LIKE"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="PROSITE" id="PS50104">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0378">Hydrolase</keyword>
<keyword id="KW-0393">Immunoglobulin domain</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0520">NAD</keyword>
<keyword id="KW-0675">Receptor</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0732">Signal</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<feature type="signal peptide" evidence="2">
<location>
<begin position="1"/>
<end position="18"/>
</location>
</feature>
<feature type="chain" description="Interleukin-1 receptor accessory protein-like 1-B" id="PRO_0000390563">
<location>
<begin position="19"/>
<end position="700"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="2">
<location>
<begin position="19"/>
<end position="357"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="2">
<location>
<begin position="358"/>
<end position="378"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="2">
<location>
<begin position="379"/>
<end position="700"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 1">
<location>
<begin position="32"/>
<end position="134"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 2">
<location>
<begin position="143"/>
<end position="232"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 3">
<location>
<begin position="242"/>
<end position="350"/>
</location>
</feature>
<feature type="domain" description="TIR" evidence="4">
<location>
<begin position="403"/>
<end position="559"/>
</location>
</feature>
<feature type="region of interest" description="Required for synaptic vesicle accumulation during synaptogenesis">
<location>
<begin position="564"/>
<end position="700"/>
</location>
</feature>
<feature type="active site" evidence="4">
<location>
<position position="491"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="2">
<location>
<position position="63"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="2">
<location>
<position position="122"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="2">
<location>
<position position="138"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="2">
<location>
<position position="213"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="2">
<location>
<position position="264"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="2">
<location>
<position position="331"/>
</location>
</feature>
<feature type="disulfide bond" evidence="3">
<location>
<begin position="53"/>
<end position="118"/>
</location>
</feature>
<feature type="disulfide bond" evidence="3">
<location>
<begin position="164"/>
<end position="216"/>
</location>
</feature>
<feature type="disulfide bond" evidence="3">
<location>
<begin position="267"/>
<end position="334"/>
</location>
</feature>
<feature type="mutagenesis site" description="Unable to induce axon terminal remodeling." evidence="5">
<original>P</original>
<variation>H</variation>
<location>
<position position="455"/>
</location>
</feature>
<evidence key="1" type="ECO:0000250"/>
<evidence key="2" type="ECO:0000255"/>
<evidence key="3" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00114"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00204"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18657618"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000305"/>
<sequence length="700" mass="80314" checksum="4871CC6BE227C51A" modified="2009-02-10" version="1" precursor="true">MRSRVPLQILLYAAVIRSLKVVSKRGSVDGCTDWSVDYLRYRVLLGEPVRIKCALFYGYIRANYTHAQSAGLSLMWYRSATHTDHEEPITLDGTRTLKEEDALWFRPAQLQDSGHYSCVLRNSSYCMKVSMALTVAENSSGLCYNSKMRRLEKAELSKSKDILCPDIQDYTPAGSEPHVTWYKECRPKQWRSSIIRTADLLSIRDVREDDIGNYTCEIQFGRFLVRRTTELTVTAPLTDKPPKILQPPEHKLSVMELQLGGPVNLTCRAFFGYSGDVSPLIYWMKGEKFIEDLDETRIRESEIKMVREHLGEQEVSVSLTIDSLQEEDLGNYSCYVENGHGRRHAIIQLSRRELMYTVELAGGLGAILLMLIFLVSLYKCYRIELMLFYRNHFGSEDVDGENKDYDAYVSYTKVDPDQWSQETREEEHFALEILPDMLEKHYGYKLFIPDRDLIPTGTYIEDVARCVDQSKRLIIVMTPNYVVRRGWSIFELETRLRNMLVSGEIKVILIECSDLRGIMNYQEVEALKHTIKLLTVIRWPGPGSSKPNSRFWKQLQYEMPFRRPEPKLSHEQVLDASEQGPFGELQTVSALSMVSATSTAMATAHPDLRSGFHNTYNTQLRQKHYYRGYEYDIPSSGTLPPLATMGSQHTYCNIPMSLLNGQRPPGQPAHGQQQSLEEQQVNNALLPLLPRETSISSVIW</sequence>
</entry>
<entry dataset="Swiss-Prot" created="2002-12-06" modified="2020-12-02" version="153">
<accession>Q9ERS7</accession>
<name>ILRL2_MOUSE</name>
<protein>
<recommendedName>
<fullName>Interleukin-1 receptor-like 2</fullName>
<ecNumber evidence="3">3.2.2.6</ecNumber>
</recommendedName>
<alternativeName>
<fullName>IL-36 receptor</fullName>
</alternativeName>
<alternativeName>
<fullName>Interleukin-1 receptor-related protein 2</fullName>
<shortName>IL-1Rrp2</shortName>
<shortName>IL1R-rp2</shortName>
</alternativeName>
</protein>
<gene>
<name type="primary">Il1rl2</name>
</gene>
<organism>
<name type="scientific">Mus musculus</name>
<name type="common">Mouse</name>
<dbReference type="NCBI Taxonomy" id="10090"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Glires</taxon>
<taxon>Rodentia</taxon>
<taxon>Myomorpha</taxon>
<taxon>Muroidea</taxon>
<taxon>Muridae</taxon>
<taxon>Murinae</taxon>
<taxon>Mus</taxon>
<taxon>Mus</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="2000" name="J. Biol. Chem." volume="275" first="29946" last="29954">
<title>Identification and characterization of two members of a novel class of the interleukin-1 receptor (IL-1R) family. Delineation of a new class of IL-1R-related proteins based on signaling.</title>
<authorList>
<person name="Born T.L."/>
<person name="Smith D.E."/>
<person name="Garka K.E."/>
<person name="Renshaw B.R."/>
<person name="Bertles J.S."/>
<person name="Sims J.E."/>
</authorList>
<dbReference type="PubMed" id="10882729"/>
<dbReference type="DOI" id="10.1074/jbc.m004077200"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
</reference>
<reference key="2">
<citation type="journal article" date="2011" name="Blood" volume="118" first="5813" last="5823">
<title>IL-36R ligands are potent regulators of dendritic and T cells.</title>
<authorList>
<person name="Vigne S."/>
<person name="Palmer G."/>
<person name="Lamacchia C."/>
<person name="Martin P."/>
<person name="Talabot-Ayer D."/>
<person name="Rodriguez E."/>
<person name="Ronchi F."/>
<person name="Sallusto F."/>
<person name="Dinh H."/>
<person name="Sims J.E."/>
<person name="Gabay C."/>
</authorList>
<dbReference type="PubMed" id="21860022"/>
<dbReference type="DOI" id="10.1182/blood-2011-05-356873"/>
</citation>
<scope>FUNCTION</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="3">
<citation type="journal article" date="2011" name="J. Biol. Chem." volume="286" first="42594" last="42602">
<title>Interleukin-36 (IL-36) ligands require processing for full agonist (IL-36alpha, IL-36beta, and IL-36gamma) or antagonist (IL-36Ra) activity.</title>
<authorList>
<person name="Towne J.E."/>
<person name="Renshaw B.R."/>
<person name="Douangpanya J."/>
<person name="Lipsky B.P."/>
<person name="Shen M."/>
<person name="Gabel C.A."/>
<person name="Sims J.E."/>
</authorList>
<dbReference type="PubMed" id="21965679"/>
<dbReference type="DOI" id="10.1074/jbc.m111.267922"/>
</citation>
<scope>INTERACTION WITH IL1RAP</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2012" name="J. Clin. Invest." volume="122" first="3965" last="3976">
<title>Psoriasiform dermatitis is driven by IL-36-mediated DC-keratinocyte crosstalk.</title>
<authorList>
<person name="Tortola L."/>
<person name="Rosenwald E."/>
<person name="Abel B."/>
<person name="Blumberg H."/>
<person name="Schafer M."/>
<person name="Coyle A.J."/>
<person name="Renauld J.C."/>
<person name="Werner S."/>
<person name="Kisielow J."/>
<person name="Kopf M."/>
</authorList>
<dbReference type="PubMed" id="23064362"/>
<dbReference type="DOI" id="10.1172/jci63451"/>
</citation>
<scope>FUNCTION</scope>
<scope>DISRUPTION PHENOTYPE</scope>
</reference>
<comment type="function">
<text evidence="4 6">Receptor for interleukin-36 (IL36A, IL36B and IL36G). After binding to interleukin-36 associates with the coreceptor IL1RAP to form the interleukin-36 receptor complex which mediates interleukin-36-dependent activation of NF-kappa-B, MAPK and other pathways. The IL-36 signaling system is thought to be present in epithelial barriers and to take part in local inflammatory response; it is similar to the IL-1 system. Seems to be involved in skin inflammatory response by induction of the IL-23/IL-17/IL-22 pathway.</text>
</comment>
<comment type="catalytic activity">
<reaction evidence="3">
<text>H2O + NAD(+) = ADP-D-ribose + H(+) + nicotinamide</text>
<dbReference type="Rhea" id="RHEA:16301"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:17154"/>
<dbReference type="ChEBI" id="CHEBI:57540"/>
<dbReference type="ChEBI" id="CHEBI:57967"/>
<dbReference type="EC" id="3.2.2.6"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="3">
<dbReference type="Rhea" id="RHEA:16302"/>
</physiologicalReaction>
</comment>
<comment type="subunit">
<text evidence="5">Interacts with IL1RAP; the association is enhanced by IL36B indicative for an functional signaling complex and inhibited by IL36RN.</text>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location>Membrane</location>
<topology>Single-pass type I membrane protein</topology>
</subcellularLocation>
</comment>
<comment type="tissue specificity">
<text evidence="4">Expressed in bone marrow-derived dendritic cells, splenic CD4(+) T-cells, bone marrow-derived macrophages and bone marrow-derived neutrophils.</text>
</comment>
<comment type="domain">
<text evidence="3">The TIR domain mediates NAD(+) hydrolase (NADase) activity. Self-association of TIR domains is required for NADase activity.</text>
</comment>
<comment type="disruption phenotype">
<text evidence="6">Complete protection from imiquimodum (IMQ)-induced skin pathology observed in wild-type mice, including hyperkeratosis, acanthosis, neutrophil recruitment, and expansion of IL-17-producing T-cells.</text>
</comment>
<comment type="similarity">
<text evidence="7">Belongs to the interleukin-1 receptor family.</text>
</comment>
<dbReference type="EC" id="3.2.2.6" evidence="3"/>
<dbReference type="EMBL" id="AF284433">
<property type="protein sequence ID" value="AAG21367.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS14910.1"/>
<dbReference type="RefSeq" id="NP_573456.1">
<property type="nucleotide sequence ID" value="NM_133193.3"/>
</dbReference>
<dbReference type="RefSeq" id="XP_006495671.1">
<property type="nucleotide sequence ID" value="XM_006495608.3"/>
</dbReference>
<dbReference type="RefSeq" id="XP_006495672.1">
<property type="nucleotide sequence ID" value="XM_006495609.3"/>
</dbReference>
<dbReference type="RefSeq" id="XP_006495673.1">
<property type="nucleotide sequence ID" value="XM_006495610.3"/>
</dbReference>
<dbReference type="RefSeq" id="XP_006495674.1">
<property type="nucleotide sequence ID" value="XM_006495611.3"/>
</dbReference>
<dbReference type="STRING" id="10090.ENSMUSP00000092630"/>
<dbReference type="GlyGen" id="Q9ERS7">
<property type="glycosylation" value="9 sites"/>
</dbReference>
<dbReference type="iPTMnet" id="Q9ERS7"/>
<dbReference type="PhosphoSitePlus" id="Q9ERS7"/>
<dbReference type="PaxDb" id="Q9ERS7"/>
<dbReference type="PRIDE" id="Q9ERS7"/>
<dbReference type="Antibodypedia" id="2361">
<property type="antibodies" value="261 antibodies"/>
</dbReference>
<dbReference type="Ensembl" id="ENSMUST00000095020">
<property type="protein sequence ID" value="ENSMUSP00000092630"/>
<property type="gene ID" value="ENSMUSG00000070942"/>
</dbReference>
<dbReference type="Ensembl" id="ENSMUST00000194296">
<property type="protein sequence ID" value="ENSMUSP00000142248"/>
<property type="gene ID" value="ENSMUSG00000070942"/>
</dbReference>
<dbReference type="GeneID" id="107527"/>
<dbReference type="KEGG" id="mmu:107527"/>
<dbReference type="UCSC" id="uc007atx.1">
<property type="organism name" value="mouse"/>
</dbReference>
<dbReference type="CTD" id="8808"/>
<dbReference type="MGI" id="MGI:1913107">
<property type="gene designation" value="Il1rl2"/>
</dbReference>
<dbReference type="eggNOG" id="ENOG502QWEU">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT01000000214361"/>
<dbReference type="HOGENOM" id="CLU_025552_3_0_1"/>
<dbReference type="InParanoid" id="Q9ERS7"/>
<dbReference type="OMA" id="LTCHLHF"/>
<dbReference type="OrthoDB" id="1109920at2759"/>
<dbReference type="PhylomeDB" id="Q9ERS7"/>
<dbReference type="TreeFam" id="TF325519"/>
<dbReference type="Reactome" id="R-MMU-9007892">
<property type="pathway name" value="Interleukin-38 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-MMU-9014826">
<property type="pathway name" value="Interleukin-36 pathway"/>
</dbReference>
<dbReference type="BioGRID-ORCS" id="107527">
<property type="hits" value="1 hit in 17 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="Il1rl2">
<property type="organism name" value="mouse"/>
</dbReference>
<dbReference type="PRO" id="PR:Q9ERS7"/>
<dbReference type="Proteomes" id="UP000000589">
<property type="component" value="Chromosome 1"/>
</dbReference>
<dbReference type="RNAct" id="Q9ERS7">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSMUSG00000070942">
<property type="expression patterns" value="Expressed in ear and 159 other tissues"/>
</dbReference>
<dbReference type="Genevisible" id="Q9ERS7">
<property type="organism ID" value="MM"/>
</dbReference>
<dbReference type="GO" id="GO:0016021">
<property type="term" value="C:integral component of membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0004896">
<property type="term" value="F:cytokine receptor activity"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0004909">
<property type="term" value="F:interleukin-1, type I, activating receptor activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0050135">
<property type="term" value="F:NAD(P)+ nucleosidase activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0061809">
<property type="term" value="F:NAD+ nucleotidase, cyclic ADP-ribose generating"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0006954">
<property type="term" value="P:inflammatory response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0045087">
<property type="term" value="P:innate immune response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0032755">
<property type="term" value="P:positive regulation of interleukin-6 production"/>
<property type="evidence" value="ECO:0000316"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0045582">
<property type="term" value="P:positive regulation of T cell differentiation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0050727">
<property type="term" value="P:regulation of inflammatory response"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="Gene3D" id="2.60.40.10">
<property type="match status" value="3"/>
</dbReference>
<dbReference type="Gene3D" id="3.40.50.10140">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR007110">
<property type="entry name" value="Ig-like_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR036179">
<property type="entry name" value="Ig-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR013783">
<property type="entry name" value="Ig-like_fold"/>
</dbReference>
<dbReference type="InterPro" id="IPR003599">
<property type="entry name" value="Ig_sub"/>
</dbReference>
<dbReference type="InterPro" id="IPR003598">
<property type="entry name" value="Ig_sub2"/>
</dbReference>
<dbReference type="InterPro" id="IPR015621">
<property type="entry name" value="IL-1_rcpt_fam"/>
</dbReference>
<dbReference type="InterPro" id="IPR004076">
<property type="entry name" value="IL-1_rcpt_I-typ"/>
</dbReference>
<dbReference type="InterPro" id="IPR004074">
<property type="entry name" value="IL-1_rcpt_I/II-typ"/>
</dbReference>
<dbReference type="InterPro" id="IPR000157">
<property type="entry name" value="TIR_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR035897">
<property type="entry name" value="Toll_tir_struct_dom_sf"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR11890">
<property type="entry name" value="PTHR11890"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF13895">
<property type="entry name" value="Ig_2"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="Pfam" id="PF01582">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR01538">
<property type="entry name" value="INTRLEUKN1R1"/>
</dbReference>
<dbReference type="PRINTS" id="PR01536">
<property type="entry name" value="INTRLKN1R12F"/>
</dbReference>
<dbReference type="SMART" id="SM00409">
<property type="entry name" value="IG"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="SMART" id="SM00408">
<property type="entry name" value="IGc2"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="SMART" id="SM00255">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF48726">
<property type="entry name" value="SSF48726"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF52200">
<property type="entry name" value="SSF52200"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50835">
<property type="entry name" value="IG_LIKE"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="PROSITE" id="PS50104">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0378">Hydrolase</keyword>
<keyword id="KW-0391">Immunity</keyword>
<keyword id="KW-0393">Immunoglobulin domain</keyword>
<keyword id="KW-0395">Inflammatory response</keyword>
<keyword id="KW-0399">Innate immunity</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0520">NAD</keyword>
<keyword id="KW-0675">Receptor</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0732">Signal</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<feature type="signal peptide" evidence="1">
<location>
<begin position="1"/>
<end position="21"/>
</location>
</feature>
<feature type="chain" description="Interleukin-1 receptor-like 2" id="PRO_0000015446">
<location>
<begin position="22"/>
<end position="574"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="1">
<location>
<begin position="22"/>
<end position="338"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="1">
<location>
<begin position="339"/>
<end position="359"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="1">
<location>
<begin position="360"/>
<end position="574"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 1">
<location>
<begin position="25"/>
<end position="113"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 2">
<location>
<begin position="132"/>
<end position="215"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 3">
<location>
<begin position="225"/>
<end position="321"/>
</location>
</feature>
<feature type="domain" description="TIR" evidence="3">
<location>
<begin position="384"/>
<end position="539"/>
</location>
</feature>
<feature type="active site" evidence="3">
<location>
<position position="470"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="1">
<location>
<position position="43"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="1">
<location>
<position position="55"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="1">
<location>
<position position="111"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="1">
<location>
<position position="231"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="1">
<location>
<position position="237"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="1">
<location>
<position position="253"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="1">
<location>
<position position="269"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="1">
<location>
<position position="290"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="1">
<location>
<position position="302"/>
</location>
</feature>
<feature type="disulfide bond" evidence="2">
<location>
<begin position="44"/>
<end position="97"/>
</location>
</feature>
<feature type="disulfide bond" evidence="2">
<location>
<begin position="149"/>
<end position="199"/>
</location>
</feature>
<feature type="disulfide bond" evidence="2">
<location>
<begin position="252"/>
<end position="319"/>
</location>
</feature>
<evidence key="1" type="ECO:0000255"/>
<evidence key="2" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00114"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00204"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21860022"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21965679"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23064362"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000305"/>
<sequence length="574" mass="65108" checksum="A677A77BBFA50A76" modified="2001-03-01" version="1" precursor="true">MGVTSLLFCGVFFLLLLFVAADTCEDIFMHNVIISEGQPFPFNCTYPPETNGAVNLTWYKTPSKSPVSNNRHLRVHQDQTWILFLPLTLEDSGIYQCVIRNAHNCYQIAVNLTVLKNHWCDSSMEGSPVNSPDVYQQILPIGKSGSLNCHLYFPESCALDSIKWYKGCEEIKAGKKYSPSGAKLLVNNVAVEDGGSYACSARLTHLGRHFTIRNYIAVNTKEVEYGRRIPNITYPKNNSIEVPLGSTLIVNCNITDTKENTNLRCWRVNNTLVDDYYKDSKRIQEGIETNVSLRDQIRYTVNITFLKVKMEDYGRPFTCHAGVSAAYIILIYPVPDFRAYLLGGLMAFLLLVVSVLFIYNSFKIDIMLWYRSAFHTAQAPDDEKLYDAYVLYPKYPRGSQGHDVDTLVLKILPEVLEKQCGYKLFIFGRDEFPGQAVASVIDENIKLCRRLMVFVAPESSSFGFLKNLSEEQIAVYNALIQHGMKVILIELEKVKDYSTMPESIQYIRQKHGAIQWDGDFTEQSQCAKTKFWKKVRYHMPPRRYPASSPVQLLGHIPCNCKAGKCNAATGLITP</sequence>
</entry>
<entry dataset="Swiss-Prot" created="2002-12-06" modified="2020-12-02" version="135">
<accession>Q62929</accession>
<name>ILRL2_RAT</name>
<protein>
<recommendedName>
<fullName>Interleukin-1 receptor-like 2</fullName>
<ecNumber evidence="4">3.2.2.6</ecNumber>
</recommendedName>
<alternativeName>
<fullName>IL-36 receptor</fullName>
</alternativeName>
<alternativeName>
<fullName>Interleukin-1 receptor-related protein 2</fullName>
<shortName>IL-1Rrp2</shortName>
<shortName>IL1R-rp2</shortName>
</alternativeName>
</protein>
<gene>
<name type="primary">Il1rl2</name>
</gene>
<organism>
<name type="scientific">Rattus norvegicus</name>
<name type="common">Rat</name>
<dbReference type="NCBI Taxonomy" id="10116"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Glires</taxon>
<taxon>Rodentia</taxon>
<taxon>Myomorpha</taxon>
<taxon>Muroidea</taxon>
<taxon>Muridae</taxon>
<taxon>Murinae</taxon>
<taxon>Rattus</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1996" name="J. Neuroimmunol." volume="70" first="113" last="122">
<title>Cloning of a cDNA encoding a novel interleukin-1 receptor related protein (IL1R-rp2).</title>
<authorList>
<person name="Lovenberg T.W."/>
<person name="Crowe P.D."/>
<person name="Liu C."/>
<person name="Chalmers D.T."/>
<person name="Liu X.-J."/>
<person name="Liaw C."/>
<person name="Clevenger W."/>
<person name="Oltersdorf T."/>
<person name="De Souza E.B."/>
<person name="Maki R.A."/>
</authorList>
<dbReference type="PubMed" id="8898719"/>
<dbReference type="DOI" id="10.1016/s0165-5728(96)00047-1"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<comment type="function">
<text evidence="1">Receptor for interleukin-36 (IL36A, IL36B and IL36G). After binding to interleukin-36 associates with the coreceptor IL1RAP to form the interleukin-36 receptor complex which mediates interleukin-36-dependent activation of NF-kappa-B, MAPK and other pathways. The IL-36 signaling system is thought to be present in epithelial barriers and to take part in local inflammatory response; it is similar to the IL-1 system. Seems to be involved in skin inflammatory response by induction of the IL-23/IL-17/IL-22 pathway. Receptor for the interleukin IL36G. Binding to the agonist leads to the activation of NF-kappa-B (By similarity).</text>
</comment>
<comment type="catalytic activity">
<reaction evidence="4">
<text>H2O + NAD(+) = ADP-D-ribose + H(+) + nicotinamide</text>
<dbReference type="Rhea" id="RHEA:16301"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:17154"/>
<dbReference type="ChEBI" id="CHEBI:57540"/>
<dbReference type="ChEBI" id="CHEBI:57967"/>
<dbReference type="EC" id="3.2.2.6"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="4">
<dbReference type="Rhea" id="RHEA:16302"/>
</physiologicalReaction>
</comment>
<comment type="subunit">
<text evidence="1">Interacts with IL1RAP; the association is enhanced by IL36B indicative for an functional signaling complex and inhibited by IL36RN (By similarity).</text>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location>Membrane</location>
<topology>Single-pass type I membrane protein</topology>
</subcellularLocation>
</comment>
<comment type="tissue specificity">
<text>Predominant expression in the lung and epididymis, with lower expression in cerebral cortex and testis. Expression in the brain is non-neuronal and associated with the cerebral vasculature. Not detected in any cell line tested.</text>
</comment>
<comment type="domain">
<text evidence="4">The TIR domain mediates NAD(+) hydrolase (NADase) activity. Self-association of TIR domains is required for NADase activity.</text>
</comment>
<comment type="similarity">
<text evidence="5">Belongs to the interleukin-1 receptor family.</text>
</comment>
<dbReference type="EC" id="3.2.2.6" evidence="4"/>
<dbReference type="EMBL" id="U49066">
<property type="protein sequence ID" value="AAB53238.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="RefSeq" id="NP_598259.1">
<property type="nucleotide sequence ID" value="NM_133575.1"/>
</dbReference>
<dbReference type="SMR" id="Q62929"/>
<dbReference type="STRING" id="10116.ENSRNOP00000019880"/>
<dbReference type="GlyGen" id="Q62929">
<property type="glycosylation" value="11 sites"/>
</dbReference>
<dbReference type="PaxDb" id="Q62929"/>
<dbReference type="GeneID" id="171106"/>
<dbReference type="KEGG" id="rno:171106"/>
<dbReference type="UCSC" id="RGD:621782">
<property type="organism name" value="rat"/>
</dbReference>
<dbReference type="CTD" id="8808"/>
<dbReference type="RGD" id="621782">
<property type="gene designation" value="Il1rl2"/>
</dbReference>
<dbReference type="eggNOG" id="ENOG502QWEU">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="InParanoid" id="Q62929"/>
<dbReference type="OrthoDB" id="1109920at2759"/>
<dbReference type="PhylomeDB" id="Q62929"/>
<dbReference type="Reactome" id="R-RNO-9007892">
<property type="pathway name" value="Interleukin-38 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-RNO-9014826">
<property type="pathway name" value="Interleukin-36 pathway"/>
</dbReference>
<dbReference type="PRO" id="PR:Q62929"/>
<dbReference type="Proteomes" id="UP000002494">
<property type="component" value="Unplaced"/>
</dbReference>
<dbReference type="GO" id="GO:0016021">
<property type="term" value="C:integral component of membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0004908">
<property type="term" value="F:interleukin-1 receptor activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0050135">
<property type="term" value="F:NAD(P)+ nucleosidase activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0061809">
<property type="term" value="F:NAD+ nucleotidase, cyclic ADP-ribose generating"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0032755">
<property type="term" value="P:positive regulation of interleukin-6 production"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0045582">
<property type="term" value="P:positive regulation of T cell differentiation"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0050727">
<property type="term" value="P:regulation of inflammatory response"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="Gene3D" id="2.60.40.10">
<property type="match status" value="3"/>
</dbReference>
<dbReference type="Gene3D" id="3.40.50.10140">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR007110">
<property type="entry name" value="Ig-like_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR036179">
<property type="entry name" value="Ig-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR013783">
<property type="entry name" value="Ig-like_fold"/>
</dbReference>
<dbReference type="InterPro" id="IPR003599">
<property type="entry name" value="Ig_sub"/>
</dbReference>
<dbReference type="InterPro" id="IPR003598">
<property type="entry name" value="Ig_sub2"/>
</dbReference>
<dbReference type="InterPro" id="IPR015621">
<property type="entry name" value="IL-1_rcpt_fam"/>
</dbReference>
<dbReference type="InterPro" id="IPR004074">
<property type="entry name" value="IL-1_rcpt_I/II-typ"/>
</dbReference>
<dbReference type="InterPro" id="IPR041416">
<property type="entry name" value="IL-1RAcP-like_ig"/>
</dbReference>
<dbReference type="InterPro" id="IPR000157">
<property type="entry name" value="TIR_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR035897">
<property type="entry name" value="Toll_tir_struct_dom_sf"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR11890">
<property type="entry name" value="PTHR11890"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF13895">
<property type="entry name" value="Ig_2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF18452">
<property type="entry name" value="Ig_6"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF01582">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR01536">
<property type="entry name" value="INTRLKN1R12F"/>
</dbReference>
<dbReference type="SMART" id="SM00409">
<property type="entry name" value="IG"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="SMART" id="SM00408">
<property type="entry name" value="IGc2"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="SMART" id="SM00255">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF48726">
<property type="entry name" value="SSF48726"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF52200">
<property type="entry name" value="SSF52200"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50835">
<property type="entry name" value="IG_LIKE"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="PROSITE" id="PS50104">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at transcript level"/>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0378">Hydrolase</keyword>
<keyword id="KW-0393">Immunoglobulin domain</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0520">NAD</keyword>
<keyword id="KW-0675">Receptor</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0732">Signal</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<feature type="signal peptide" evidence="2">
<location>
<begin position="1"/>
<end position="21"/>
</location>
</feature>
<feature type="chain" description="Interleukin-1 receptor-like 2" id="PRO_0000015447">
<location>
<begin position="22"/>
<end position="561"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="2">
<location>
<begin position="22"/>
<end position="338"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="2">
<location>
<begin position="339"/>
<end position="358"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="2">
<location>
<begin position="359"/>
<end position="561"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 1">
<location>
<begin position="22"/>
<end position="113"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 2">
<location>
<begin position="128"/>
<end position="215"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 3">
<location>
<begin position="225"/>
<end position="321"/>
</location>
</feature>
<feature type="domain" description="TIR" evidence="4">
<location>
<begin position="384"/>
<end position="539"/>
</location>
</feature>
<feature type="active site" evidence="4">
<location>
<position position="470"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="2">
<location>
<position position="23"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="2">
<location>
<position position="43"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="2">
<location>
<position position="55"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="2">
<location>
<position position="111"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="2">
<location>
<position position="130"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="2">
<location>
<position position="231"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="2">
<location>
<position position="237"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="2">
<location>
<position position="253"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="2">
<location>
<position position="269"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="2">
<location>
<position position="290"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="2">
<location>
<position position="302"/>
</location>
</feature>
<feature type="disulfide bond" evidence="3">
<location>
<begin position="44"/>
<end position="97"/>
</location>
</feature>
<feature type="disulfide bond" evidence="3">
<location>
<begin position="149"/>
<end position="199"/>
</location>
</feature>
<feature type="disulfide bond" evidence="3">
<location>
<begin position="252"/>
<end position="319"/>
</location>
</feature>
<evidence key="1" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q9ERS7"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000255"/>
<evidence key="3" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00114"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00204"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000305"/>
<sequence length="561" mass="64142" checksum="4021C297917F0199" modified="1996-11-01" version="1" precursor="true">MGMPPLLFCWVSFVLPLFVAAGNCTDVYMHHEMISEGQPFPFNCTYPPVTNGAVNLTWHRTPSKSPISINRHVRIHQDQSWILFLPLALEDSGIYQCVIKDAHSCYRIAINLTVFRKHWCDSSNEESSINSSDEYQQWLPIGKSGSLTCHLYFPESCVLDSIKWYKGCEEIKVSKKFCPTGTKLLVNNIDVEDSGSYACSARLTHLGRIFTVRNYIAVNTKEVGSGGRIPNITYPKNNSIEVQLGSTLIVDCNITDTKENTNLRCWRVNNTLVDDYYNDFKRIQEGIETNLSLRNHILYTVNITFLEVKMEDYGHPFTCHAAVSAAYIILKRPAPDFRAYLIGGLMAFLLLAVSILYIYNTFKVDIVLWYRSTFHTAQAPDDEKLYDAYVLYPKYPRESQGHDVDTLVLKILPEVLEKQCGYKLFIFGRDEFPGQAVASVIDENIKLCRRLMVLVAPETSSFSFLKNLTEEQIAVYNALVQDGMKVILIELERVKDYSTMPESIQYIRQKHGAIQWDGDFTEQAQCAKTKFWKKVRYHMPPRRYPASPPVQLLGHTPRIPG</sequence>
</entry>
<entry dataset="Swiss-Prot" created="1993-07-01" modified="2020-10-07" version="155">
<accession>Q02955</accession>
<name>IL1R1_RAT</name>
<protein>
<recommendedName>
<fullName>Interleukin-1 receptor type 1</fullName>
<shortName>IL-1R-1</shortName>
<shortName>IL-1RT-1</shortName>
<shortName>IL-1RT1</shortName>
<ecNumber evidence="6">3.2.2.6</ecNumber>
</recommendedName>
<alternativeName>
<fullName>CD121 antigen-like family member A</fullName>
</alternativeName>
<alternativeName>
<fullName>Interleukin-1 receptor alpha</fullName>
<shortName>IL-1R-alpha</shortName>
</alternativeName>
<alternativeName>
<fullName>Interleukin-1 receptor type I</fullName>
</alternativeName>
<alternativeName>
<fullName>p80</fullName>
</alternativeName>
<cdAntigenName>CD121a</cdAntigenName>
<component>
<recommendedName>
<fullName>Interleukin-1 receptor type 1, membrane form</fullName>
<shortName>mIL-1R1</shortName>
<shortName>mIL-1RI</shortName>
</recommendedName>
</component>
<component>
<recommendedName>
<fullName>Interleukin-1 receptor type 1, soluble form</fullName>
<shortName>sIL-1R1</shortName>
<shortName>sIL-1RI</shortName>
</recommendedName>
</component>
</protein>
<gene>
<name type="primary">Il1r1</name>
<name type="synonym">Il1ra</name>
</gene>
<organism>
<name type="scientific">Rattus norvegicus</name>
<name type="common">Rat</name>
<dbReference type="NCBI Taxonomy" id="10116"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Glires</taxon>
<taxon>Rodentia</taxon>
<taxon>Myomorpha</taxon>
<taxon>Muroidea</taxon>
<taxon>Muridae</taxon>
<taxon>Murinae</taxon>
<taxon>Rattus</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1993" name="J. Neuroimmunol." volume="44" first="49" last="56">
<title>An mRNA homologous to interleukin-1 receptor type I is expressed in cultured rat sympathetic ganglia.</title>
<authorList>
<person name="Hart R.P."/>
<person name="Liu C."/>
<person name="Shadiack A.M."/>
<person name="McCormack R.J."/>
<person name="Jonakait G.M."/>
</authorList>
<dbReference type="PubMed" id="7684399"/>
<dbReference type="DOI" id="10.1016/0165-5728(93)90267-3"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<source>
<tissue>Ganglion</tissue>
</source>
</reference>
<comment type="function">
<text evidence="3">Receptor for IL1A, IL1B and IL1RN. After binding to interleukin-1 associates with the coreceptor IL1RAP to form the high affinity interleukin-1 receptor complex which mediates interleukin-1-dependent activation of NF-kappa-B, MAPK and other pathways. Signaling involves the recruitment of adapter molecules such as TOLLIP, MYD88, and IRAK1 or IRAK2 via the respective TIR domains of the receptor/coreceptor subunits. Binds ligands with comparable affinity and binding of antagonist IL1RN prevents association with IL1RAP to form a signaling complex. Involved in IL1B-mediated costimulation of IFNG production from T-helper 1 (Th1) cells (By similarity).</text>
</comment>
<comment type="catalytic activity">
<reaction evidence="6">
<text>H2O + NAD(+) = ADP-D-ribose + H(+) + nicotinamide</text>
<dbReference type="Rhea" id="RHEA:16301"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:17154"/>
<dbReference type="ChEBI" id="CHEBI:57540"/>
<dbReference type="ChEBI" id="CHEBI:57967"/>
<dbReference type="EC" id="3.2.2.6"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="6">
<dbReference type="Rhea" id="RHEA:16302"/>
</physiologicalReaction>
</comment>
<comment type="subunit">
<text evidence="1">The interleukin-1 receptor complex is a heterodimer of IL1R1 and IL1RAP. Interacts with PIK3R1 (By similarity).</text>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location>Membrane</location>
<topology>Single-pass type I membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="7">Cell membrane</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="1">Secreted</location>
</subcellularLocation>
</comment>
<comment type="domain">
<text evidence="6">The TIR domain mediates NAD(+) hydrolase (NADase) activity. Self-association of TIR domains is required for NADase activity.</text>
</comment>
<comment type="PTM">
<text evidence="1">A soluble form (sIL1R1) is probably produced by proteolytic cleavage at the cell surface (shedding).</text>
</comment>
<comment type="PTM">
<text evidence="1">Rapidly phosphorylated on Tyr-499 in response to IL-1, which creates a SH2 binding site for the PI 3-kinase regulatory subunit PIK3R1.</text>
</comment>
<comment type="similarity">
<text evidence="7">Belongs to the interleukin-1 receptor family.</text>
</comment>
<comment type="sequence caution" evidence="7">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="AAA16196" version="1"/>
</conflict>
</comment>
<dbReference type="EC" id="3.2.2.6" evidence="6"/>
<dbReference type="EMBL" id="M95578">
<property type="protein sequence ID" value="AAA16196.1"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="PIR" id="I56526">
<property type="entry name" value="I56526"/>
</dbReference>
<dbReference type="SMR" id="Q02955"/>
<dbReference type="STRING" id="10116.ENSRNOP00000019673"/>
<dbReference type="GlyGen" id="Q02955">
<property type="glycosylation" value="5 sites"/>
</dbReference>
<dbReference type="PaxDb" id="Q02955"/>
<dbReference type="PRIDE" id="Q02955"/>
<dbReference type="UCSC" id="RGD:2892">
<property type="organism name" value="rat"/>
</dbReference>
<dbReference type="RGD" id="2892">
<property type="gene designation" value="Il1r1"/>
</dbReference>
<dbReference type="eggNOG" id="ENOG502QWEU">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="InParanoid" id="Q02955"/>
<dbReference type="PhylomeDB" id="Q02955"/>
<dbReference type="Reactome" id="R-RNO-9020702">
<property type="pathway name" value="Interleukin-1 signaling"/>
</dbReference>
<dbReference type="PRO" id="PR:Q02955"/>
<dbReference type="Proteomes" id="UP000002494">
<property type="component" value="Unplaced"/>
</dbReference>
<dbReference type="GO" id="GO:0030424">
<property type="term" value="C:axon"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0009986">
<property type="term" value="C:cell surface"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0009897">
<property type="term" value="C:external side of plasma membrane"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0005615">
<property type="term" value="C:extracellular space"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0016021">
<property type="term" value="C:integral component of membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0016020">
<property type="term" value="C:membrane"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0014069">
<property type="term" value="C:postsynaptic density"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0032991">
<property type="term" value="C:protein-containing complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0019966">
<property type="term" value="F:interleukin-1 binding"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0004908">
<property type="term" value="F:interleukin-1 receptor activity"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0004909">
<property type="term" value="F:interleukin-1, type I, activating receptor activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0035255">
<property type="term" value="F:ionotropic glutamate receptor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0050135">
<property type="term" value="F:NAD(P)+ nucleosidase activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0061809">
<property type="term" value="F:NAD+ nucleotidase, cyclic ADP-ribose generating"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0005161">
<property type="term" value="F:platelet-derived growth factor receptor binding"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0002020">
<property type="term" value="F:protease binding"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0071333">
<property type="term" value="P:cellular response to glucose stimulus"/>
<property type="evidence" value="ECO:0000270"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0019221">
<property type="term" value="P:cytokine-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0010286">
<property type="term" value="P:heat acclimation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0006954">
<property type="term" value="P:inflammatory response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0070498">
<property type="term" value="P:interleukin-1-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0030728">
<property type="term" value="P:ovulation"/>
<property type="evidence" value="ECO:0000270"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0032729">
<property type="term" value="P:positive regulation of interferon-gamma production"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2000661">
<property type="term" value="P:positive regulation of interleukin-1-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:2001224">
<property type="term" value="P:positive regulation of neuron migration"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:2000391">
<property type="term" value="P:positive regulation of neutrophil extravasation"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:2000556">
<property type="term" value="P:positive regulation of T-helper 1 cell cytokine production"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050727">
<property type="term" value="P:regulation of inflammatory response"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0070849">
<property type="term" value="P:response to epidermal growth factor"/>
<property type="evidence" value="ECO:0000270"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0070555">
<property type="term" value="P:response to interleukin-1"/>
<property type="evidence" value="ECO:0000270"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0071731">
<property type="term" value="P:response to nitric oxide"/>
<property type="evidence" value="ECO:0000270"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:1990834">
<property type="term" value="P:response to odorant"/>
<property type="evidence" value="ECO:0000270"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0009314">
<property type="term" value="P:response to radiation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0071559">
<property type="term" value="P:response to transforming growth factor beta"/>
<property type="evidence" value="ECO:0000270"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="Gene3D" id="2.60.40.10">
<property type="match status" value="3"/>
</dbReference>
<dbReference type="Gene3D" id="3.40.50.10140">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR007110">
<property type="entry name" value="Ig-like_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR036179">
<property type="entry name" value="Ig-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR013783">
<property type="entry name" value="Ig-like_fold"/>
</dbReference>
<dbReference type="InterPro" id="IPR003599">
<property type="entry name" value="Ig_sub"/>
</dbReference>
<dbReference type="InterPro" id="IPR015621">
<property type="entry name" value="IL-1_rcpt_fam"/>
</dbReference>
<dbReference type="InterPro" id="IPR004076">
<property type="entry name" value="IL-1_rcpt_I-typ"/>
</dbReference>
<dbReference type="InterPro" id="IPR004074">
<property type="entry name" value="IL-1_rcpt_I/II-typ"/>
</dbReference>
<dbReference type="InterPro" id="IPR041416">
<property type="entry name" value="IL-1RAcP-like_ig"/>
</dbReference>
<dbReference type="InterPro" id="IPR000157">
<property type="entry name" value="TIR_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR035897">
<property type="entry name" value="Toll_tir_struct_dom_sf"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR11890">
<property type="entry name" value="PTHR11890"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF13895">
<property type="entry name" value="Ig_2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF18452">
<property type="entry name" value="Ig_6"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF01582">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR01538">
<property type="entry name" value="INTRLEUKN1R1"/>
</dbReference>
<dbReference type="PRINTS" id="PR01536">
<property type="entry name" value="INTRLKN1R12F"/>
</dbReference>
<dbReference type="SMART" id="SM00409">
<property type="entry name" value="IG"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="SMART" id="SM00255">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF48726">
<property type="entry name" value="SSF48726"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF52200">
<property type="entry name" value="SSF52200"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50835">
<property type="entry name" value="IG_LIKE"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="PROSITE" id="PS50104">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at transcript level"/>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0378">Hydrolase</keyword>
<keyword id="KW-0393">Immunoglobulin domain</keyword>
<keyword id="KW-0395">Inflammatory response</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0520">NAD</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0675">Receptor</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0964">Secreted</keyword>
<keyword id="KW-0732">Signal</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<feature type="signal peptide" evidence="1">
<location>
<begin position="1"/>
<end position="19"/>
</location>
</feature>
<feature type="chain" description="Interleukin-1 receptor type 1, membrane form" id="PRO_0000015437">
<location>
<begin position="20"/>
<end position="576"/>
</location>
</feature>
<feature type="chain" description="Interleukin-1 receptor type 1, soluble form" id="PRO_0000415346">
<location>
<begin position="20"/>
<end status="unknown"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="4">
<location>
<begin position="20"/>
<end position="338"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="4">
<location>
<begin position="339"/>
<end position="359"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="4">
<location>
<begin position="360"/>
<end position="576"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 1">
<location>
<begin position="20"/>
<end position="115"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 2">
<location>
<begin position="121"/>
<end position="217"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 3">
<location>
<begin position="229"/>
<end position="331"/>
</location>
</feature>
<feature type="domain" description="TIR" evidence="6">
<location>
<begin position="386"/>
<end position="541"/>
</location>
</feature>
<feature type="active site" evidence="6">
<location>
<position position="473"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="3">
<location>
<position position="499"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by PKC" evidence="2">
<location>
<position position="556"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="63"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="103"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="236"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="252"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="266"/>
</location>
</feature>
<feature type="disulfide bond" evidence="5">
<location>
<begin position="25"/>
<end position="107"/>
</location>
</feature>
<feature type="disulfide bond" evidence="5">
<location>
<begin position="46"/>
<end position="99"/>
</location>
</feature>
<feature type="disulfide bond" evidence="5">
<location>
<begin position="145"/>
<end position="199"/>
</location>
</feature>
<feature type="disulfide bond" evidence="5">
<location>
<begin position="251"/>
<end position="315"/>
</location>
</feature>
<evidence key="1" type="ECO:0000250"/>
<evidence key="2" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P13504"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P14778"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000255"/>
<evidence key="5" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00114"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00204"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000305"/>
<sequence length="576" mass="66759" checksum="55BE20C92385A34A" modified="1993-07-01" version="1" precursor="true">MENMKVLLGFICLIVPLLSLETDKCTEYPNEVISFSSVNEIDIRSCPLTPNEMHGGTIIWYKNDSKTPISADKDSRIHQQNEHLWFVPAKMEDSGYYYCIMRNSTYCLKTKITMSVLENDPGLCYNTQASFIQRLHVAGDGSLVCPYLDFFKDENNELPKVQWYKNCKPLPLDDGNFFGFKNKLMVMNVAEEHRGNYTCRTSYTYQGKQYPVTRVITFITIDDSKRDRPVIMSPRNETMEADPGSTIQLICNVTGQFTDLVYWKWNGSEIEWDDPILAEDYQFLEHPSAKRKYTLITTLNVSEVKSQFYRYPFICFVKNTHILETAHVRLVYPVPDFKNYLIGGFAIFTATAVFCACIYKVFKVDIVLWYRDSCSDFLPRKASDGRTYDAYVLYPKTYGEGSFAYLDTFVFKLLPEVLEGQFGYKLFICGRDDYVGEDTIEVTNENVKRSRRLIIILVRDMGSFSCLGQSSEEQIAIYDALIREGIKIILLELEKIQDYEKMPESIQFIKQKHGAICWSGDFKERPQSAKTRFWKNLRYQMPAQRRSPLSKHHLLTLDPVLDTKEKLQAETHLPLG</sequence>
</entry>
<entry dataset="Swiss-Prot" created="1990-01-01" modified="2021-02-10" version="197">
<accession>P13504</accession>
<name>IL1R1_MOUSE</name>
<protein>
<recommendedName>
<fullName>Interleukin-1 receptor type 1</fullName>
<shortName>IL-1R-1</shortName>
<shortName>IL-1RT-1</shortName>
<shortName>IL-1RT1</shortName>
<ecNumber evidence="5">3.2.2.6</ecNumber>
</recommendedName>
<alternativeName>
<fullName>CD121 antigen-like family member A</fullName>
</alternativeName>
<alternativeName>
<fullName>Interleukin-1 receptor alpha</fullName>
<shortName>IL-1R-alpha</shortName>
</alternativeName>
<alternativeName>
<fullName>Interleukin-1 receptor type I</fullName>
</alternativeName>
<alternativeName>
<fullName>p80</fullName>
</alternativeName>
<cdAntigenName>CD121a</cdAntigenName>
<component>
<recommendedName>
<fullName>Interleukin-1 receptor type 1, membrane form</fullName>
<shortName>mIL-1R1</shortName>
<shortName>mIL-1RI</shortName>
</recommendedName>
</component>
<component>
<recommendedName>
<fullName>Interleukin-1 receptor type 1, soluble form</fullName>
<shortName>sIL-1R1</shortName>
<shortName>sIL-1RI</shortName>
</recommendedName>
</component>
</protein>
<gene>
<name type="primary">Il1r1</name>
<name type="synonym">Il-1r1</name>
<name type="synonym">Il1ra</name>
</gene>
<organism>
<name type="scientific">Mus musculus</name>
<name type="common">Mouse</name>
<dbReference type="NCBI Taxonomy" id="10090"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Glires</taxon>
<taxon>Rodentia</taxon>
<taxon>Myomorpha</taxon>
<taxon>Muroidea</taxon>
<taxon>Muridae</taxon>
<taxon>Murinae</taxon>
<taxon>Mus</taxon>
<taxon>Mus</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1988" name="Science" volume="241" first="585" last="589">
<title>cDNA expression cloning of the IL-1 receptor, a member of the immunoglobulin superfamily.</title>
<authorList>
<person name="Sims J.E."/>
<person name="March C.J."/>
<person name="Cosman D."/>
<person name="Widmer M.B."/>
<person name="McDonald H.R."/>
<person name="McMahan C.J."/>
<person name="Grubin C.E."/>
<person name="Wignall J.M."/>
<person name="Jackson J.L."/>
<person name="Call S.M."/>
<person name="Friend D."/>
<person name="Alpert A.R."/>
<person name="Gillis S."/>
<person name="Urdal D.L."/>
<person name="Dower S.K."/>
</authorList>
<dbReference type="PubMed" id="2969618"/>
<dbReference type="DOI" id="10.1126/science.2969618"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>PROTEIN SEQUENCE OF 20-45</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1991" name="Biochem. Biophys. Res. Commun." volume="177" first="61" last="67">
<title>Phorbol ester induces phosphorylation of the 80 kilodalton murine interleukin 1 receptor at a single threonine residue.</title>
<authorList>
<person name="Bird T.A."/>
<person name="Woodward A."/>
<person name="Jackson J.L."/>
<person name="Dower S.K."/>
<person name="Sims J.E."/>
</authorList>
<dbReference type="PubMed" id="1828344"/>
<dbReference type="DOI" id="10.1016/0006-291x(91)91948-c"/>
</citation>
<scope>PHOSPHORYLATION AT THR-556</scope>
</reference>
<reference key="3">
<citation type="journal article" date="1995" name="J. Biol. Chem." volume="270" first="13757" last="13765">
<title>Molecular cloning and characterization of a second subunit of the interleukin 1 receptor complex.</title>
<authorList>
<person name="Greenfeder S.A."/>
<person name="Nunes P."/>
<person name="Kwee L."/>
<person name="Labow M."/>
<person name="Chizzonite R.A."/>
<person name="Ju G."/>
</authorList>
<dbReference type="PubMed" id="7775431"/>
<dbReference type="DOI" id="10.1074/jbc.270.23.13757"/>
</citation>
<scope>INTERACTION WITH IL1RAP</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2000" name="Nat. Cell Biol." volume="2" first="346" last="351">
<title>Tollip, a new component of the IL-1R1 pathway, links IRAK to the IL-1 receptor.</title>
<authorList>
<person name="Burns K."/>
<person name="Clatworthy J."/>
<person name="Martin L."/>
<person name="Martinon F."/>
<person name="Plumpton C."/>
<person name="Maschera B."/>
<person name="Lewis A."/>
<person name="Ray K."/>
<person name="Tschopp J."/>
<person name="Volpe F."/>
</authorList>
<dbReference type="PubMed" id="10854325"/>
<dbReference type="DOI" id="10.1038/35014038"/>
</citation>
<scope>INTERACTION WITH TOLLIP; MYD88 AND IRAK1</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2012" name="Proc. Natl. Acad. Sci. U.S.A." volume="109" first="12189" last="12194">
<title>Interleukin-1R3 mediates interleukin-1-induced potassium current increase through fast activation of Akt kinase.</title>
<authorList>
<person name="Qian J."/>
<person name="Zhu L."/>
<person name="Li Q."/>
<person name="Belevych N."/>
<person name="Chen Q."/>
<person name="Zhao F."/>
<person name="Herness S."/>
<person name="Quan N."/>
</authorList>
<dbReference type="PubMed" id="22778412"/>
<dbReference type="DOI" id="10.1073/pnas.1205207109"/>
</citation>
<scope>FUNCTION (ISOFORM 2)</scope>
<scope>ALTERNATIVE SPLICING (ISOFORM 2)</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2004" name="Dev. Comp. Immunol." volume="28" first="429" last="441">
<title>Modelling of fish interleukin-1 and its receptor.</title>
<authorList>
<person name="Scapigliati G."/>
<person name="Costantini S."/>
<person name="Colonna G."/>
<person name="Facchiano A."/>
<person name="Buonocore F."/>
<person name="Bossu P."/>
<person name="Cunningham C."/>
<person name="Holland J.W."/>
<person name="Secombes C.J."/>
</authorList>
<dbReference type="PubMed" id="15062642"/>
<dbReference type="DOI" id="10.1016/j.dci.2003.09.014"/>
</citation>
<scope>3D-STRUCTURE MODELING OF 25-334</scope>
</reference>
<comment type="function">
<text evidence="2">Receptor for IL1A, IL1B and IL1RN. After binding to interleukin-1 associates with the coreceptor IL1RAP to form the high affinity interleukin-1 receptor complex which mediates interleukin-1-dependent activation of NF-kappa-B, MAPK and other pathways. Signaling involves the recruitment of adapter molecules such as TOLLIP, MYD88, and IRAK1 or IRAK2 via the respective TIR domains of the receptor/coreceptor subunits. Binds ligands with comparable affinity and binding of antagonist IL1RN prevents association with IL1RAP to form a signaling complex. Involved in IL1B-mediated costimulation of IFNG production from T-helper 1 (Th1) cells (By similarity).</text>
</comment>
<comment type="function">
<molecule>Isoform 2</molecule>
<text evidence="7">Unable to mediate canonical IL-1 signaling. Cooperates with IL1RAP isoform 3 to mediate IL1B-induced neuronal activity including IL1B-potentiated NMDA-induced calcium influx mediated by Akt kinase activation.</text>
</comment>
<comment type="catalytic activity">
<reaction evidence="5">
<text>H2O + NAD(+) = ADP-D-ribose + H(+) + nicotinamide</text>
<dbReference type="Rhea" id="RHEA:16301"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:17154"/>
<dbReference type="ChEBI" id="CHEBI:57540"/>
<dbReference type="ChEBI" id="CHEBI:57967"/>
<dbReference type="EC" id="3.2.2.6"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="5">
<dbReference type="Rhea" id="RHEA:16302"/>
</physiologicalReaction>
</comment>
<comment type="subunit">
<text evidence="1">The interleukin-1 receptor complex is a heterodimer of IL1R1 and IL1RAP. Interacts with PIK3R1 (By similarity).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1782675">
<id>P13504</id>
</interactant>
<interactant intactId="EBI-525108">
<id>P22366</id>
<label>Myd88</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location>Membrane</location>
<topology>Single-pass type I membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="9">Cell membrane</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="1">Secreted</location>
</subcellularLocation>
</comment>
<comment type="alternative products">
<event type="alternative promoter"/>
<isoform>
<id>P13504-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>P13504-2</id>
<name>2</name>
<name>IL-1R3</name>
<sequence type="described" ref="VSP_058170"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="7">Isoform 2 is expressed in various brain tissues.</text>
</comment>
<comment type="domain">
<text evidence="5">The TIR domain mediates NAD(+) hydrolase (NADase) activity. Self-association of TIR domains is required for NADase activity.</text>
</comment>
<comment type="PTM">
<text evidence="1">A soluble form (sIL1R1) is probably produced by proteolytic cleavage at the cell surface (shedding).</text>
</comment>
<comment type="PTM">
<text evidence="1">Rapidly phosphorylated on Tyr-499 in response to IL-1, which creates a SH2 binding site for the PI 3-kinase regulatory subunit PIK3R1.</text>
</comment>
<comment type="similarity">
<text evidence="9">Belongs to the interleukin-1 receptor family.</text>
</comment>
<dbReference type="EC" id="3.2.2.6" evidence="5"/>
<dbReference type="EMBL" id="M20658">
<property type="protein sequence ID" value="AAA39279.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS35547.1">
<molecule id="P13504-1"/>
</dbReference>
<dbReference type="PIR" id="A32604">
<property type="entry name" value="A32604"/>
</dbReference>
<dbReference type="RefSeq" id="NP_032388.1">
<molecule id="P13504-1"/>
<property type="nucleotide sequence ID" value="NM_008362.2"/>
</dbReference>
<dbReference type="RefSeq" id="XP_006495776.1">
<molecule id="P13504-1"/>
<property type="nucleotide sequence ID" value="XM_006495713.2"/>
</dbReference>
<dbReference type="PDB" id="1OU3">
<property type="method" value="Model"/>
<property type="chains" value="A=25-334"/>
</dbReference>
<dbReference type="PDBsum" id="1OU3"/>
<dbReference type="SMR" id="P13504"/>
<dbReference type="BioGRID" id="200625">
<property type="interactions" value="6"/>
</dbReference>
<dbReference type="DIP" id="DIP-40669N"/>
<dbReference type="IntAct" id="P13504">
<property type="interactions" value="5"/>
</dbReference>
<dbReference type="STRING" id="10090.ENSMUSP00000027241"/>
<dbReference type="ChEMBL" id="CHEMBL2189148"/>
<dbReference type="GlyGen" id="P13504">
<property type="glycosylation" value="7 sites"/>
</dbReference>
<dbReference type="iPTMnet" id="P13504"/>
<dbReference type="PhosphoSitePlus" id="P13504"/>
<dbReference type="PaxDb" id="P13504"/>
<dbReference type="PRIDE" id="P13504"/>
<dbReference type="Antibodypedia" id="3576">
<property type="antibodies" value="960 antibodies"/>
</dbReference>
<dbReference type="Ensembl" id="ENSMUST00000027241">
<molecule id="P13504-1"/>
<property type="protein sequence ID" value="ENSMUSP00000027241"/>
<property type="gene ID" value="ENSMUSG00000026072"/>
</dbReference>
<dbReference type="GeneID" id="16177"/>
<dbReference type="KEGG" id="mmu:16177"/>
<dbReference type="UCSC" id="uc007atv.1">
<molecule id="P13504-1"/>
<property type="organism name" value="mouse"/>
</dbReference>
<dbReference type="CTD" id="3554"/>
<dbReference type="MGI" id="MGI:96545">
<property type="gene designation" value="Il1r1"/>
</dbReference>
<dbReference type="eggNOG" id="ENOG502QWEU">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT01000000214361"/>
<dbReference type="InParanoid" id="P13504"/>
<dbReference type="OMA" id="EISGFSW"/>
<dbReference type="PhylomeDB" id="P13504"/>
<dbReference type="TreeFam" id="TF325519"/>
<dbReference type="Reactome" id="R-MMU-9020702">
<property type="pathway name" value="Interleukin-1 signaling"/>
</dbReference>
<dbReference type="BioGRID-ORCS" id="16177">
<property type="hits" value="1 hit in 18 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="Il1r1">
<property type="organism name" value="mouse"/>
</dbReference>
<dbReference type="PRO" id="PR:P13504"/>
<dbReference type="Proteomes" id="UP000000589">
<property type="component" value="Chromosome 1"/>
</dbReference>
<dbReference type="RNAct" id="P13504">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSMUSG00000026072">
<property type="expression patterns" value="Expressed in islet of Langerhans and 215 other tissues"/>
</dbReference>
<dbReference type="Genevisible" id="P13504">
<property type="organism ID" value="MM"/>
</dbReference>
<dbReference type="GO" id="GO:0030424">
<property type="term" value="C:axon"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0009986">
<property type="term" value="C:cell surface"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0009897">
<property type="term" value="C:external side of plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0005615">
<property type="term" value="C:extracellular space"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0016021">
<property type="term" value="C:integral component of membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0016020">
<property type="term" value="C:membrane"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0014069">
<property type="term" value="C:postsynaptic density"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0032991">
<property type="term" value="C:protein-containing complex"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0019966">
<property type="term" value="F:interleukin-1 binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0004908">
<property type="term" value="F:interleukin-1 receptor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004909">
<property type="term" value="F:interleukin-1, type I, activating receptor activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0035255">
<property type="term" value="F:ionotropic glutamate receptor binding"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0050135">
<property type="term" value="F:NAD(P)+ nucleosidase activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0061809">
<property type="term" value="F:NAD+ nucleotidase, cyclic ADP-ribose generating"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0005161">
<property type="term" value="F:platelet-derived growth factor receptor binding"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0002020">
<property type="term" value="F:protease binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0019221">
<property type="term" value="P:cytokine-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0010286">
<property type="term" value="P:heat acclimation"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0006954">
<property type="term" value="P:inflammatory response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0070498">
<property type="term" value="P:interleukin-1-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032729">
<property type="term" value="P:positive regulation of interferon-gamma production"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2000661">
<property type="term" value="P:positive regulation of interleukin-1-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:2001224">
<property type="term" value="P:positive regulation of neuron migration"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:2000391">
<property type="term" value="P:positive regulation of neutrophil extravasation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:2000556">
<property type="term" value="P:positive regulation of T-helper 1 cell cytokine production"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050727">
<property type="term" value="P:regulation of inflammatory response"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0070555">
<property type="term" value="P:response to interleukin-1"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0009314">
<property type="term" value="P:response to radiation"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="Gene3D" id="2.60.40.10">
<property type="match status" value="3"/>
</dbReference>
<dbReference type="Gene3D" id="3.40.50.10140">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR007110">
<property type="entry name" value="Ig-like_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR036179">
<property type="entry name" value="Ig-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR013783">
<property type="entry name" value="Ig-like_fold"/>
</dbReference>
<dbReference type="InterPro" id="IPR003599">
<property type="entry name" value="Ig_sub"/>
</dbReference>
<dbReference type="InterPro" id="IPR015621">
<property type="entry name" value="IL-1_rcpt_fam"/>
</dbReference>
<dbReference type="InterPro" id="IPR004076">
<property type="entry name" value="IL-1_rcpt_I-typ"/>
</dbReference>
<dbReference type="InterPro" id="IPR004074">
<property type="entry name" value="IL-1_rcpt_I/II-typ"/>
</dbReference>
<dbReference type="InterPro" id="IPR041416">
<property type="entry name" value="IL-1RAcP-like_ig"/>
</dbReference>
<dbReference type="InterPro" id="IPR000157">
<property type="entry name" value="TIR_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR035897">
<property type="entry name" value="Toll_tir_struct_dom_sf"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR11890">
<property type="entry name" value="PTHR11890"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF13895">
<property type="entry name" value="Ig_2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF18452">
<property type="entry name" value="Ig_6"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF01582">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR01538">
<property type="entry name" value="INTRLEUKN1R1"/>
</dbReference>
<dbReference type="PRINTS" id="PR01536">
<property type="entry name" value="INTRLKN1R12F"/>
</dbReference>
<dbReference type="SMART" id="SM00409">
<property type="entry name" value="IG"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="SMART" id="SM00255">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF48726">
<property type="entry name" value="SSF48726"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF52200">
<property type="entry name" value="SSF52200"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50835">
<property type="entry name" value="IG_LIKE"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="PROSITE" id="PS50104">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0877">Alternative promoter usage</keyword>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0378">Hydrolase</keyword>
<keyword id="KW-0393">Immunoglobulin domain</keyword>
<keyword id="KW-0395">Inflammatory response</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0520">NAD</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0675">Receptor</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0964">Secreted</keyword>
<keyword id="KW-0732">Signal</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<feature type="signal peptide" evidence="8">
<location>
<begin position="1"/>
<end position="19"/>
</location>
</feature>
<feature type="chain" description="Interleukin-1 receptor type 1, membrane form" id="PRO_0000015436">
<location>
<begin position="20"/>
<end position="576"/>
</location>
</feature>
<feature type="chain" description="Interleukin-1 receptor type 1, soluble form" id="PRO_0000415345">
<location>
<begin position="20"/>
<end status="unknown"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="3">
<location>
<begin position="20"/>
<end position="338"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="3">
<location>
<begin position="339"/>
<end position="359"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="3">
<location>
<begin position="360"/>
<end position="576"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 1">
<location>
<begin position="25"/>
<end position="115"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 2">
<location>
<begin position="121"/>
<end position="213"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 3">
<location>
<begin position="229"/>
<end position="329"/>
</location>
</feature>
<feature type="domain" description="TIR" evidence="5">
<location>
<begin position="386"/>
<end position="541"/>
</location>
</feature>
<feature type="active site" evidence="5">
<location>
<position position="473"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="2">
<location>
<position position="499"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by PKC" evidence="6">
<location>
<position position="556"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="3">
<location>
<position position="63"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="3">
<location>
<position position="103"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="3">
<location>
<position position="174"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="3">
<location>
<position position="236"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="3">
<location>
<position position="252"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="3">
<location>
<position position="266"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="3">
<location>
<position position="300"/>
</location>
</feature>
<feature type="disulfide bond" evidence="4">
<location>
<begin position="25"/>
<end position="107"/>
</location>
</feature>
<feature type="disulfide bond" evidence="4">
<location>
<begin position="46"/>
<end position="99"/>
</location>
</feature>
<feature type="disulfide bond" evidence="4">
<location>
<begin position="145"/>
<end position="199"/>
</location>
</feature>
<feature type="disulfide bond" evidence="4">
<location>
<begin position="251"/>
<end position="315"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_058170">
<location>
<begin position="1"/>
<end position="200"/>
</location>
</feature>
<evidence key="1" type="ECO:0000250"/>
<evidence key="2" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P14778"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000255"/>
<evidence key="4" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00114"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00204"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1828344"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22778412"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2969618"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000305"/>
<sequence length="576" mass="66698" checksum="7AA8304C86412A16" modified="1990-01-01" version="1" precursor="true">MENMKVLLGLICLMVPLLSLEIDVCTEYPNQIVLFLSVNEIDIRKCPLTPNKMHGDTIIWYKNDSKTPISADRDSRIHQQNEHLWFVPAKVEDSGYYYCIVRNSTYCLKTKVTVTVLENDPGLCYSTQATFPQRLHIAGDGSLVCPYVSYFKDENNELPEVQWYKNCKPLLLDNVSFFGVKDKLLVRNVAEEHRGDYICRMSYTFRGKQYPVTRVIQFITIDENKRDRPVILSPRNETIEADPGSMIQLICNVTGQFSDLVYWKWNGSEIEWNDPFLAEDYQFVEHPSTKRKYTLITTLNISEVKSQFYRYPFICVVKNTNIFESAHVQLIYPVPDFKNYLIGGFIILTATIVCCVCIYKVFKVDIVLWYRDSCSGFLPSKASDGKTYDAYILYPKTLGEGSFSDLDTFVFKLLPEVLEGQFGYKLFIYGRDDYVGEDTIEVTNENVKKSRRLIIILVRDMGGFSWLGQSSEEQIAIYNALIQEGIKIVLLELEKIQDYEKMPDSIQFIKQKHGVICWSGDFQERPQSAKTRFWKNLRYQMPAQRRSPLSKHRLLTLDPVRDTKEKLPAATHLPLG</sequence>
</entry>
<entry dataset="Swiss-Prot" created="2002-12-06" modified="2021-02-10" version="146">
<accession>Q62611</accession>
<accession>Q62612</accession>
<name>ILRL1_RAT</name>
<protein>
<recommendedName>
<fullName>Interleukin-1 receptor-like 1</fullName>
<ecNumber evidence="6">3.2.2.6</ecNumber>
</recommendedName>
<alternativeName>
<fullName>Fit-1</fullName>
</alternativeName>
<alternativeName>
<fullName>Fos-responsive gene 1 protein</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">Il1rl1</name>
<name type="synonym">Fit1</name>
</gene>
<organism>
<name type="scientific">Rattus norvegicus</name>
<name type="common">Rat</name>
<dbReference type="NCBI Taxonomy" id="10116"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Glires</taxon>
<taxon>Rodentia</taxon>
<taxon>Myomorpha</taxon>
<taxon>Muroidea</taxon>
<taxon>Muridae</taxon>
<taxon>Murinae</taxon>
<taxon>Rattus</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1994" name="EMBO J." volume="13" first="1176" last="1188">
<title>Alternative promoter usage of the Fos-responsive gene Fit-1 generates mRNA isoforms coding for either secreted or membrane-bound proteins related to the IL-1 receptor.</title>
<authorList>
<person name="Bergers G."/>
<person name="Reikersdorfer A."/>
<person name="Braselmann S."/>
<person name="Graninger P."/>
<person name="Busslinger M."/>
</authorList>
<dbReference type="PubMed" id="8131748"/>
<dbReference type="DOI" id="10.1002/j.1460-2075.1994.tb06367.x"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS A AND B)</scope>
</reference>
<comment type="function">
<text evidence="3">Receptor for interleukin-33 (IL-33), its stimulation recruits MYD88, IRAK1, IRAK4, and TRAF6, followed by phosphorylation of MAPK3/ERK1 and/or MAPK1/ERK2, MAPK14, and MAPK8. Possibly involved in helper T-cell function (By similarity).</text>
</comment>
<comment type="function">
<molecule>Isoform B</molecule>
<text evidence="2">Inhibits IL-33 signaling.</text>
</comment>
<comment type="catalytic activity">
<reaction evidence="6">
<text>H2O + NAD(+) = ADP-D-ribose + H(+) + nicotinamide</text>
<dbReference type="Rhea" id="RHEA:16301"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:17154"/>
<dbReference type="ChEBI" id="CHEBI:57540"/>
<dbReference type="ChEBI" id="CHEBI:57967"/>
<dbReference type="EC" id="3.2.2.6"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="6">
<dbReference type="Rhea" id="RHEA:16302"/>
</physiologicalReaction>
</comment>
<comment type="subunit">
<text evidence="2 3">Interacts with MYD88, IRAK1, IRAK4, and TRAF6 (By similarity). Bound to its ligand IL-33, interacts with IL1RAP to form the minimal interleukin-33 signaling complex with a 1:1:1 stoichiometry. Interacts with KIT (bound to KITLG/SCF). A mast cell-specific KITLG/SCF-induced interleukin-33 signaling complex contains IL1RL1, IL1RAP, KIT and MYD88 (By similarity).</text>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location>Cell membrane</location>
<topology>Single-pass type I membrane protein</topology>
</subcellularLocation>
</comment>
<comment type="subcellular location">
<molecule>Isoform B</molecule>
<subcellularLocation>
<location>Secreted</location>
</subcellularLocation>
</comment>
<comment type="alternative products">
<event type="alternative promoter"/>
<event type="alternative splicing"/>
<isoform>
<id>Q62611-1</id>
<name>A</name>
<name>Membrane-bound</name>
<name>Fit-1M</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>Q62611-2</id>
<name>B</name>
<name>Soluble</name>
<name>Fit-1S</name>
<sequence type="described" ref="VSP_002670 VSP_002671"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text>Isoform A is detected in spleen, lung, bone marrow and lymh node. Isoform B is predominant in fibroblasts.</text>
</comment>
<comment type="induction">
<text>By FOS.</text>
</comment>
<comment type="domain">
<text evidence="6">The TIR domain mediates NAD(+) hydrolase (NADase) activity. Self-association of TIR domains is required for NADase activity.</text>
</comment>
<comment type="similarity">
<text evidence="8">Belongs to the interleukin-1 receptor family.</text>
</comment>
<dbReference type="EC" id="3.2.2.6" evidence="6"/>
<dbReference type="EMBL" id="U04317">
<property type="protein sequence ID" value="AAA18480.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U04319">
<property type="protein sequence ID" value="AAA67172.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="PIR" id="S42632">
<property type="entry name" value="S42632"/>
</dbReference>
<dbReference type="PIR" id="S42633">
<property type="entry name" value="S42633"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001121161.1">
<molecule id="Q62611-1"/>
<property type="nucleotide sequence ID" value="NM_001127689.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_037169.1">
<molecule id="Q62611-2"/>
<property type="nucleotide sequence ID" value="NM_013037.1"/>
</dbReference>
<dbReference type="SMR" id="Q62611"/>
<dbReference type="STRING" id="10116.ENSRNOP00000020144"/>
<dbReference type="GlyGen" id="Q62611">
<property type="glycosylation" value="6 sites"/>
</dbReference>
<dbReference type="PhosphoSitePlus" id="Q62611"/>
<dbReference type="PaxDb" id="Q62611"/>
<dbReference type="PRIDE" id="Q62611"/>
<dbReference type="GeneID" id="25556"/>
<dbReference type="KEGG" id="rno:25556"/>
<dbReference type="UCSC" id="RGD:2894">
<molecule id="Q62611-1"/>
<property type="organism name" value="rat"/>
</dbReference>
<dbReference type="CTD" id="9173"/>
<dbReference type="RGD" id="2894">
<property type="gene designation" value="Il1rl1"/>
</dbReference>
<dbReference type="eggNOG" id="ENOG502RU6H">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="InParanoid" id="Q62611"/>
<dbReference type="PhylomeDB" id="Q62611"/>
<dbReference type="Reactome" id="R-RNO-1257604">
<property type="pathway name" value="PIP3 activates AKT signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-RNO-6811558">
<property type="pathway name" value="PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-RNO-9014843">
<property type="pathway name" value="Interleukin-33 signaling"/>
</dbReference>
<dbReference type="PRO" id="PR:Q62611"/>
<dbReference type="Proteomes" id="UP000002494">
<property type="component" value="Unplaced"/>
</dbReference>
<dbReference type="GO" id="GO:0009986">
<property type="term" value="C:cell surface"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0009897">
<property type="term" value="C:external side of plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0031012">
<property type="term" value="C:extracellular matrix"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0005615">
<property type="term" value="C:extracellular space"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0016021">
<property type="term" value="C:integral component of membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0016020">
<property type="term" value="C:membrane"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0004908">
<property type="term" value="F:interleukin-1 receptor activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0002113">
<property type="term" value="F:interleukin-33 binding"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0002114">
<property type="term" value="F:interleukin-33 receptor activity"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0050135">
<property type="term" value="F:NAD(P)+ nucleosidase activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0061809">
<property type="term" value="F:NAD+ nucleotidase, cyclic ADP-ribose generating"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:1901653">
<property type="term" value="P:cellular response to peptide"/>
<property type="evidence" value="ECO:0000270"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0008285">
<property type="term" value="P:negative regulation of cell population proliferation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0043124">
<property type="term" value="P:negative regulation of I-kappaB kinase/NF-kappaB signaling"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0032689">
<property type="term" value="P:negative regulation of interferon-gamma production"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0002826">
<property type="term" value="P:negative regulation of T-helper 1 type immune response"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0050729">
<property type="term" value="P:positive regulation of inflammatory response"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0032754">
<property type="term" value="P:positive regulation of interleukin-5 production"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0043032">
<property type="term" value="P:positive regulation of macrophage activation"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="Gene3D" id="2.60.40.10">
<property type="match status" value="3"/>
</dbReference>
<dbReference type="Gene3D" id="3.40.50.10140">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR007110">
<property type="entry name" value="Ig-like_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR036179">
<property type="entry name" value="Ig-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR013783">
<property type="entry name" value="Ig-like_fold"/>
</dbReference>
<dbReference type="InterPro" id="IPR003599">
<property type="entry name" value="Ig_sub"/>
</dbReference>
<dbReference type="InterPro" id="IPR003598">
<property type="entry name" value="Ig_sub2"/>
</dbReference>
<dbReference type="InterPro" id="IPR015621">
<property type="entry name" value="IL-1_rcpt_fam"/>
</dbReference>
<dbReference type="InterPro" id="IPR004074">
<property type="entry name" value="IL-1_rcpt_I/II-typ"/>
</dbReference>
<dbReference type="InterPro" id="IPR041416">
<property type="entry name" value="IL-1RAcP-like_ig"/>
</dbReference>
<dbReference type="InterPro" id="IPR000157">
<property type="entry name" value="TIR_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR035897">
<property type="entry name" value="Toll_tir_struct_dom_sf"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR11890">
<property type="entry name" value="PTHR11890"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF18452">
<property type="entry name" value="Ig_6"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF01582">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR01536">
<property type="entry name" value="INTRLKN1R12F"/>
</dbReference>
<dbReference type="SMART" id="SM00409">
<property type="entry name" value="IG"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="SMART" id="SM00408">
<property type="entry name" value="IGc2"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="SMART" id="SM00255">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF48726">
<property type="entry name" value="SSF48726"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF52200">
<property type="entry name" value="SSF52200"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50835">
<property type="entry name" value="IG_LIKE"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="PROSITE" id="PS50104">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at transcript level"/>
<keyword id="KW-0877">Alternative promoter usage</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0378">Hydrolase</keyword>
<keyword id="KW-0393">Immunoglobulin domain</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0520">NAD</keyword>
<keyword id="KW-0675">Receptor</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0964">Secreted</keyword>
<keyword id="KW-0732">Signal</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<feature type="signal peptide" evidence="4">
<location>
<begin position="1"/>
<end position="26"/>
</location>
</feature>
<feature type="chain" description="Interleukin-1 receptor-like 1" id="PRO_0000015444">
<location>
<begin position="27"/>
<end position="566"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="4">
<location>
<begin position="27"/>
<end position="331"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="4">
<location>
<begin position="332"/>
<end position="354"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="4">
<location>
<begin position="355"/>
<end position="566"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 1">
<location>
<begin position="27"/>
<end position="109"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 2">
<location>
<begin position="120"/>
<end position="207"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 3">
<location>
<begin position="217"/>
<end position="323"/>
</location>
</feature>
<feature type="domain" description="TIR" evidence="6">
<location>
<begin position="379"/>
<end position="539"/>
</location>
</feature>
<feature type="region of interest" description="Flexible linker" evidence="1">
<location>
<begin position="204"/>
<end position="216"/>
</location>
</feature>
<feature type="active site" evidence="6">
<location>
<position position="465"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="107"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="146"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="194"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="225"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="258"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="277"/>
</location>
</feature>
<feature type="disulfide bond" evidence="5">
<location>
<begin position="42"/>
<end position="93"/>
</location>
</feature>
<feature type="disulfide bond" evidence="5">
<location>
<begin position="117"/>
<end position="157"/>
</location>
</feature>
<feature type="disulfide bond" evidence="5">
<location>
<begin position="139"/>
<end position="187"/>
</location>
</feature>
<feature type="disulfide bond" evidence="5">
<location>
<begin position="240"/>
<end position="307"/>
</location>
</feature>
<feature type="disulfide bond" evidence="5">
<location>
<begin position="243"/>
<end position="286"/>
</location>
</feature>
<feature type="splice variant" description="In isoform B." id="VSP_002670" evidence="7">
<original>IDHQSTYYI</original>
<variation>SKECLSQIA</variation>
<location>
<begin position="328"/>
<end position="336"/>
</location>
</feature>
<feature type="splice variant" description="In isoform B." id="VSP_002671" evidence="7">
<location>
<begin position="337"/>
<end position="566"/>
</location>
</feature>
<evidence key="1" type="ECO:0000250"/>
<evidence key="2" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P14719"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q01638"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000255"/>
<evidence key="5" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00114"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00204"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="8131748"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000305"/>
<sequence length="566" mass="64406" checksum="50554A29437A0C31" modified="1996-11-01" version="1" precursor="true">MIGKWRMGLWALAILTVPMYFIVTEGRKTSWGLENEALIVRCPQRGGAINPVEWYYSNTNERIPTQKRNRIFVSRDRLKFLPAKVEDSGIYTCVIRSPESIKTGSLNVTIYKRPPNCKIPDYMMYSTVDGSDKNSKITCPTIALYNWTAPVQWFKNCKALQGPRFRAHMSYLFIDKVSHVDEGDYTCRFTHTENGTNYIVTATRSFTVEEKGFSTFPVITNPPHNYTVEVEIGKTANIACSACFGTASQFVAVLWQINKTRIGSFGKARIQEEKGPNKSSSNGMICLTSLLRITGVTDKDFSLKYDCVAMNHHGVIRHPVRLRRKQPIDHQSTYYIVAGCSLLLMFINVLVIVLKVFWIEVALFWRDIMAPYKTQNDGKLYDAYIIYPRVFRGSAAGTGSVEYFVHYTLPDVLENKCGYKLCIYGRDLLPGQDAATVVESSIQNSRRQVFVLAPHMMHSKEFAYEQEIALHSALIQNNSKVILIEMEPMGEASRLQLGDLQDSLQHLVKMQGTIKWREDHVADKQSLSSKFWKHVRYQMPVPKRPPKMASVAAPLSGKVCLDLKHF</sequence>
</entry>
<entry dataset="Swiss-Prot" created="1990-04-01" modified="2021-02-10" version="196">
<accession>P14719</accession>
<accession>Q05208</accession>
<name>ILRL1_MOUSE</name>
<protein>
<recommendedName>
<fullName>Interleukin-1 receptor-like 1</fullName>
<ecNumber evidence="6">3.2.2.6</ecNumber>
</recommendedName>
<alternativeName>
<fullName evidence="14">Interleukin-33 receptor alpha chain</fullName>
</alternativeName>
<alternativeName>
<fullName>Lymphocyte antigen 84</fullName>
</alternativeName>
<alternativeName>
<fullName>Protein ST2</fullName>
</alternativeName>
<alternativeName>
<fullName>Protein T1</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">Il1rl1</name>
<name type="synonym">Ly84</name>
<name type="synonym">St2</name>
<name type="synonym">Ste2</name>
</gene>
<organism>
<name type="scientific">Mus musculus</name>
<name type="common">Mouse</name>
<dbReference type="NCBI Taxonomy" id="10090"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Glires</taxon>
<taxon>Rodentia</taxon>
<taxon>Myomorpha</taxon>
<taxon>Muroidea</taxon>
<taxon>Muridae</taxon>
<taxon>Murinae</taxon>
<taxon>Mus</taxon>
<taxon>Mus</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1989" name="FEBS Lett." volume="258" first="301" last="304">
<title>A putative protein of a growth specific cDNA from BALB/c-3T3 cells is highly similar to the extracellular portion of mouse interleukin 1 receptor.</title>
<authorList>
<person name="Tominaga S."/>
</authorList>
<dbReference type="PubMed" id="2532153"/>
<dbReference type="DOI" id="10.1016/0014-5793(89)81679-5"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM B)</scope>
<source>
<strain>BALB/cJ</strain>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="1991" name="Biochim. Biophys. Acta" volume="1090" first="1" last="8">
<title>Molecular cloning of the murine ST2 gene. Characterization and chromosomal mapping.</title>
<authorList>
<person name="Tominaga S."/>
<person name="Jenkins N.A."/>
<person name="Gilbert D.J."/>
<person name="Copeland N.G."/>
<person name="Tetsuka T."/>
</authorList>
<dbReference type="PubMed" id="1832015"/>
<dbReference type="DOI" id="10.1016/0167-4781(91)90029-l"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM B)</scope>
<source>
<strain>C3H/He</strain>
<tissue>Spleen</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="1989" name="Proc. Natl. Acad. Sci. U.S.A." volume="86" first="5708" last="5712">
<title>Serum- and oncoprotein-mediated induction of a gene with sequence similarity to the gene encoding carcinoembryonic antigen.</title>
<authorList>
<person name="Klemenz R."/>
<person name="Hoffmann S."/>
<person name="Werenskiold A.K."/>
</authorList>
<dbReference type="PubMed" id="2527364"/>
<dbReference type="DOI" id="10.1073/pnas.86.15.5708"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM B)</scope>
</reference>
<reference key="4">
<citation type="journal article" date="1993" name="FEBS Lett." volume="318" first="83" last="87">
<title>Presence of a novel primary response gene ST2L, encoding a product highly similar to the interleukin 1 receptor type 1.</title>
<authorList>
<person name="Yanagisawa K."/>
<person name="Takagi T."/>
<person name="Tsukamoto T."/>
<person name="Tetsuka T."/>
<person name="Tominaga S."/>
</authorList>
<dbReference type="PubMed" id="7916701"/>
<dbReference type="DOI" id="10.1016/0014-5793(93)81333-u"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM A)</scope>
</reference>
<reference key="5">
<citation type="journal article" date="1994" name="EMBO J." volume="13" first="1176" last="1188">
<title>Alternative promoter usage of the Fos-responsive gene Fit-1 generates mRNA isoforms coding for either secreted or membrane-bound proteins related to the IL-1 receptor.</title>
<authorList>
<person name="Bergers G."/>
<person name="Reikersdorfer A."/>
<person name="Braselmann S."/>
<person name="Graninger P."/>
<person name="Busslinger M."/>
</authorList>
<dbReference type="PubMed" id="8131748"/>
<dbReference type="DOI" id="10.1002/j.1460-2075.1994.tb06367.x"/>
</citation>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2007" name="J. Immunol." volume="179" first="2551" last="2555">
<title>IL-1 receptor accessory protein and ST2 comprise the IL-33 receptor complex.</title>
<authorList>
<person name="Chackerian A.A."/>
<person name="Oldham E.R."/>
<person name="Murphy E.E."/>
<person name="Schmitz J."/>
<person name="Pflanz S."/>
<person name="Kastelein R.A."/>
</authorList>
<dbReference type="PubMed" id="17675517"/>
<dbReference type="DOI" id="10.4049/jimmunol.179.4.2551"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBUNIT</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2007" name="Proc. Natl. Acad. Sci. U.S.A." volume="104" first="18660" last="18665">
<title>IL-1 receptor accessory protein is essential for IL-33-induced activation of T lymphocytes and mast cells.</title>
<authorList>
<person name="Ali S."/>
<person name="Huber M."/>
<person name="Kollewe C."/>
<person name="Bischoff S.C."/>
<person name="Falk W."/>
<person name="Martin M.U."/>
</authorList>
<dbReference type="PubMed" id="18003919"/>
<dbReference type="DOI" id="10.1073/pnas.0705939104"/>
</citation>
<scope>INTERACTION WITH IL1RAP</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2008" name="Cytokine" volume="42" first="358" last="364">
<title>The IL-1 receptor accessory protein (AcP) is required for IL-33 signaling and soluble AcP enhances the ability of soluble ST2 to inhibit IL-33.</title>
<authorList>
<person name="Palmer G."/>
<person name="Lipsky B.P."/>
<person name="Smithgall M.D."/>
<person name="Meininger D."/>
<person name="Siu S."/>
<person name="Talabot-Ayer D."/>
<person name="Gabay C."/>
<person name="Smith D.E."/>
</authorList>
<dbReference type="PubMed" id="18450470"/>
<dbReference type="DOI" id="10.1016/j.cyto.2008.03.008"/>
</citation>
<scope>FUNCTION (ISOFORM B)</scope>
<scope>INTERACTION WITH IL1RAP</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2010" name="Blood" volume="115" first="3899" last="3906">
<title>The receptor tyrosine kinase c-Kit controls IL-33 receptor signaling in mast cells.</title>
<authorList>
<person name="Drube S."/>
<person name="Heink S."/>
<person name="Walter S."/>
<person name="Loehn T."/>
<person name="Grusser M."/>
<person name="Gerbaulet A."/>
<person name="Berod L."/>
<person name="Schons J."/>
<person name="Dudeck A."/>
<person name="Freitag J."/>
<person name="Grotha S."/>
<person name="Reich D."/>
<person name="Rudeschko O."/>
<person name="Norgauer J."/>
<person name="Hartmann K."/>
<person name="Roers A."/>
<person name="Kamradt T."/>
</authorList>
<dbReference type="PubMed" id="20200353"/>
<dbReference type="DOI" id="10.1182/blood-2009-10-247411"/>
</citation>
<scope>INTERACTION WITH KIT</scope>
<scope>SUBUNIT</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2011" name="Brain Res." volume="1385" first="8" last="17">
<title>Production and functions of IL-33 in the central nervous system.</title>
<authorList>
<person name="Yasuoka S."/>
<person name="Kawanokuchi J."/>
<person name="Parajuli B."/>
<person name="Jin S."/>
<person name="Doi Y."/>
<person name="Noda M."/>
<person name="Sonobe Y."/>
<person name="Takeuchi H."/>
<person name="Mizuno T."/>
<person name="Suzumura A."/>
</authorList>
<dbReference type="PubMed" id="21349253"/>
<dbReference type="DOI" id="10.1016/j.brainres.2011.02.045"/>
</citation>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2017" name="Immunity" volume="47" first="739" last="751">
<title>HpARI Protein Secreted by a Helminth Parasite Suppresses Interleukin-33.</title>
<authorList>
<person name="Osbourn M."/>
<person name="Soares D.C."/>
<person name="Vacca F."/>
<person name="Cohen E.S."/>
<person name="Scott I.C."/>
<person name="Gregory W.F."/>
<person name="Smyth D.J."/>
<person name="Toivakka M."/>
<person name="Kemter A.M."/>
<person name="le Bihan T."/>
<person name="Wear M."/>
<person name="Hoving D."/>
<person name="Filbey K.J."/>
<person name="Hewitson J.P."/>
<person name="Henderson H."/>
<person name="Gonzalez-Ciscar A."/>
<person name="Errington C."/>
<person name="Vermeren S."/>
<person name="Astier A.L."/>
<person name="Wallace W.A."/>
<person name="Schwarze J."/>
<person name="Ivens A.C."/>
<person name="Maizels R.M."/>
<person name="McSorley H.J."/>
</authorList>
<dbReference type="PubMed" id="29045903"/>
<dbReference type="DOI" id="10.1016/j.immuni.2017.09.015"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<comment type="function">
<text evidence="3 7 9 12">Receptor for interleukin-33 (IL-33); signaling requires association of the coreceptor IL1RAP (PubMed:18450470, PubMed:17675517, PubMed:29045903). Its stimulation recruits MYD88, IRAK1, IRAK4, and TRAF6, followed by phosphorylation of MAPK3/ERK1 and/or MAPK1/ERK2, MAPK14, and MAPK8 (By similarity). Possibly involved in helper T-cell function.</text>
</comment>
<comment type="function">
<molecule>Isoform B</molecule>
<text evidence="9">Inhibits IL-33 signaling.</text>
</comment>
<comment type="catalytic activity">
<reaction evidence="6">
<text>H2O + NAD(+) = ADP-D-ribose + H(+) + nicotinamide</text>
<dbReference type="Rhea" id="RHEA:16301"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:17154"/>
<dbReference type="ChEBI" id="CHEBI:57540"/>
<dbReference type="ChEBI" id="CHEBI:57967"/>
<dbReference type="EC" id="3.2.2.6"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="6">
<dbReference type="Rhea" id="RHEA:16302"/>
</physiologicalReaction>
</comment>
<comment type="subunit">
<text evidence="3 7 8 9 10">Interacts with MYD88, IRAK1, IRAK4, and TRAF6 (By similarity). Bound to its ligand IL33, interacts with IL1RAP to form the minimal interleukin-33 signaling complex with a 1:1:1 stoichiometry. Interacts with KIT (bound to KITLG/SCF). A mast cell-specific KITLG/SCF-induced interleukin-33 signaling complex contains IL1RL1, IL1RAP, KIT and MYD88.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-525078">
<id>P14719</id>
</interactant>
<interactant intactId="EBI-525035">
<id>Q61730</id>
<label>Il1rap</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-525078">
<id>P14719</id>
</interactant>
<interactant intactId="EBI-6664563">
<id>Q6PCT2</id>
<label>FBXL19</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location>Cell membrane</location>
<topology>Single-pass type I membrane protein</topology>
</subcellularLocation>
</comment>
<comment type="subcellular location">
<molecule>Isoform B</molecule>
<subcellularLocation>
<location>Secreted</location>
</subcellularLocation>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>P14719-1</id>
<name>A</name>
<name>Membrane-bound</name>
<name>ST2L</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>P14719-2</id>
<name>B</name>
<name>Soluble</name>
<name>ST2</name>
<sequence type="described" ref="VSP_002668 VSP_002669"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="11 13">Predominantly expressed in hematopoietic tissues, and in macrophage, erythroid, epithelial and fibroblast cell lines. Isoform A is expressed in brain astrocytes and microglia. Isoform B is expressed in brain endothelial cells.</text>
</comment>
<comment type="developmental stage">
<text>Expressed first in the fetal liver and then in lung and hematopoietic tissues.</text>
</comment>
<comment type="domain">
<text evidence="6">The TIR domain mediates NAD(+) hydrolase (NADase) activity. Self-association of TIR domains is required for NADase activity.</text>
</comment>
<comment type="similarity">
<text evidence="17">Belongs to the interleukin-1 receptor family.</text>
</comment>
<dbReference type="EC" id="3.2.2.6" evidence="6"/>
<dbReference type="EMBL" id="Y07519">
<property type="protein sequence ID" value="CAA68812.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="X60184">
<property type="protein sequence ID" value="CAA42742.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M24843">
<property type="protein sequence ID" value="AAA40160.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="D13695">
<property type="protein sequence ID" value="BAA02854.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS35548.1">
<molecule id="P14719-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS56626.1">
<molecule id="P14719-2"/>
</dbReference>
<dbReference type="PIR" id="S29498">
<property type="entry name" value="S29498"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001020773.1">
<molecule id="P14719-1"/>
<property type="nucleotide sequence ID" value="NM_001025602.3"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001281100.1">
<molecule id="P14719-2"/>
<property type="nucleotide sequence ID" value="NM_001294171.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_034873.2">
<molecule id="P14719-2"/>
<property type="nucleotide sequence ID" value="NM_010743.3"/>
</dbReference>
<dbReference type="RefSeq" id="XP_006495804.1">
<molecule id="P14719-1"/>
<property type="nucleotide sequence ID" value="XM_006495741.1"/>
</dbReference>
<dbReference type="RefSeq" id="XP_006495807.1">
<molecule id="P14719-1"/>
<property type="nucleotide sequence ID" value="XM_006495744.2"/>
</dbReference>
<dbReference type="RefSeq" id="XP_017174571.1">
<molecule id="P14719-1"/>
<property type="nucleotide sequence ID" value="XM_017319082.1"/>
</dbReference>
<dbReference type="PDB" id="5VI4">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.79"/>
<property type="chains" value="B/E=26-326"/>
</dbReference>
<dbReference type="PDBsum" id="5VI4"/>
<dbReference type="SMR" id="P14719"/>
<dbReference type="BioGRID" id="201248">
<property type="interactions" value="2"/>
</dbReference>
<dbReference type="CORUM" id="P14719"/>
<dbReference type="DIP" id="DIP-34958N"/>
<dbReference type="IntAct" id="P14719">
<property type="interactions" value="4"/>
</dbReference>
<dbReference type="STRING" id="10090.ENSMUSP00000095379"/>
<dbReference type="GlyGen" id="P14719">
<property type="glycosylation" value="9 sites"/>
</dbReference>
<dbReference type="iPTMnet" id="P14719"/>
<dbReference type="PhosphoSitePlus" id="P14719"/>
<dbReference type="EPD" id="P14719"/>
<dbReference type="MaxQB" id="P14719"/>
<dbReference type="PaxDb" id="P14719"/>
<dbReference type="PRIDE" id="P14719"/>
<dbReference type="ABCD" id="P14719">
<property type="antibodies" value="2 sequenced antibodies"/>
</dbReference>
<dbReference type="Antibodypedia" id="2362">
<property type="antibodies" value="580 antibodies"/>
</dbReference>
<dbReference type="Ensembl" id="ENSMUST00000053043">
<molecule id="P14719-1"/>
<property type="protein sequence ID" value="ENSMUSP00000054914"/>
<property type="gene ID" value="ENSMUSG00000026069"/>
</dbReference>
<dbReference type="Ensembl" id="ENSMUST00000097772">
<molecule id="P14719-1"/>
<property type="protein sequence ID" value="ENSMUSP00000095379"/>
<property type="gene ID" value="ENSMUSG00000026069"/>
</dbReference>
<dbReference type="Ensembl" id="ENSMUST00000173514">
<molecule id="P14719-2"/>
<property type="protein sequence ID" value="ENSMUSP00000133784"/>
<property type="gene ID" value="ENSMUSG00000026069"/>
</dbReference>
<dbReference type="Ensembl" id="ENSMUST00000174335">
<molecule id="P14719-2"/>
<property type="protein sequence ID" value="ENSMUSP00000134351"/>
<property type="gene ID" value="ENSMUSG00000026069"/>
</dbReference>
<dbReference type="GeneID" id="17082"/>
<dbReference type="KEGG" id="mmu:17082"/>
<dbReference type="UCSC" id="uc007aub.3">
<molecule id="P14719-1"/>
<property type="organism name" value="mouse"/>
</dbReference>
<dbReference type="CTD" id="9173"/>
<dbReference type="MGI" id="MGI:98427">
<property type="gene designation" value="Il1rl1"/>
</dbReference>
<dbReference type="eggNOG" id="ENOG502RU6H">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT01000000214361"/>
<dbReference type="HOGENOM" id="CLU_025552_3_2_1"/>
<dbReference type="InParanoid" id="P14719"/>
<dbReference type="OMA" id="HVRYHMP"/>
<dbReference type="OrthoDB" id="1109920at2759"/>
<dbReference type="PhylomeDB" id="P14719"/>
<dbReference type="TreeFam" id="TF325519"/>
<dbReference type="Reactome" id="R-MMU-1257604">
<property type="pathway name" value="PIP3 activates AKT signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-MMU-6811558">
<property type="pathway name" value="PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-MMU-9014843">
<property type="pathway name" value="Interleukin-33 signaling"/>
</dbReference>
<dbReference type="BioGRID-ORCS" id="17082">
<property type="hits" value="0 hits in 17 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="Il1rl1">
<property type="organism name" value="mouse"/>
</dbReference>
<dbReference type="PRO" id="PR:P14719"/>
<dbReference type="Proteomes" id="UP000000589">
<property type="component" value="Chromosome 1"/>
</dbReference>
<dbReference type="RNAct" id="P14719">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSMUSG00000026069">
<property type="expression patterns" value="Expressed in fibroblast and 76 other tissues"/>
</dbReference>
<dbReference type="Genevisible" id="P14719">
<property type="organism ID" value="MM"/>
</dbReference>
<dbReference type="GO" id="GO:0009986">
<property type="term" value="C:cell surface"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0009897">
<property type="term" value="C:external side of plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0031012">
<property type="term" value="C:extracellular matrix"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0005615">
<property type="term" value="C:extracellular space"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0005925">
<property type="term" value="C:focal adhesion"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0016021">
<property type="term" value="C:integral component of membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0016020">
<property type="term" value="C:membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0004908">
<property type="term" value="F:interleukin-1 receptor activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0002113">
<property type="term" value="F:interleukin-33 binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0002114">
<property type="term" value="F:interleukin-33 receptor activity"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0050135">
<property type="term" value="F:NAD(P)+ nucleosidase activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0061809">
<property type="term" value="F:NAD+ nucleotidase, cyclic ADP-ribose generating"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0008285">
<property type="term" value="P:negative regulation of cell population proliferation"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0043124">
<property type="term" value="P:negative regulation of I-kappaB kinase/NF-kappaB signaling"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0032689">
<property type="term" value="P:negative regulation of interferon-gamma production"/>
<property type="evidence" value="ECO:0000316"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0002826">
<property type="term" value="P:negative regulation of T-helper 1 type immune response"/>
<property type="evidence" value="ECO:0000316"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032722">
<property type="term" value="P:positive regulation of chemokine production"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0050729">
<property type="term" value="P:positive regulation of inflammatory response"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032754">
<property type="term" value="P:positive regulation of interleukin-5 production"/>
<property type="evidence" value="ECO:0000316"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0043032">
<property type="term" value="P:positive regulation of macrophage activation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="Gene3D" id="2.60.40.10">
<property type="match status" value="3"/>
</dbReference>
<dbReference type="Gene3D" id="3.40.50.10140">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR007110">
<property type="entry name" value="Ig-like_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR036179">
<property type="entry name" value="Ig-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR013783">
<property type="entry name" value="Ig-like_fold"/>
</dbReference>
<dbReference type="InterPro" id="IPR003599">
<property type="entry name" value="Ig_sub"/>
</dbReference>
<dbReference type="InterPro" id="IPR003598">
<property type="entry name" value="Ig_sub2"/>
</dbReference>
<dbReference type="InterPro" id="IPR015621">
<property type="entry name" value="IL-1_rcpt_fam"/>
</dbReference>
<dbReference type="InterPro" id="IPR004074">
<property type="entry name" value="IL-1_rcpt_I/II-typ"/>
</dbReference>
<dbReference type="InterPro" id="IPR000157">
<property type="entry name" value="TIR_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR035897">
<property type="entry name" value="Toll_tir_struct_dom_sf"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR11890">
<property type="entry name" value="PTHR11890"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF13895">
<property type="entry name" value="Ig_2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF01582">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR01536">
<property type="entry name" value="INTRLKN1R12F"/>
</dbReference>
<dbReference type="SMART" id="SM00409">
<property type="entry name" value="IG"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="SMART" id="SM00408">
<property type="entry name" value="IGc2"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="SMART" id="SM00255">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF48726">
<property type="entry name" value="SSF48726"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF52200">
<property type="entry name" value="SSF52200"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50835">
<property type="entry name" value="IG_LIKE"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="PROSITE" id="PS50104">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0378">Hydrolase</keyword>
<keyword id="KW-0393">Immunoglobulin domain</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0520">NAD</keyword>
<keyword id="KW-0675">Receptor</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0964">Secreted</keyword>
<keyword id="KW-0732">Signal</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<feature type="signal peptide" evidence="4">
<location>
<begin position="1"/>
<end position="26"/>
</location>
</feature>
<feature type="chain" description="Interleukin-1 receptor-like 1" id="PRO_0000015443">
<location>
<begin position="27"/>
<end position="567"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="4">
<location>
<begin position="27"/>
<end position="332"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="4">
<location>
<begin position="333"/>
<end position="355"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="4">
<location>
<begin position="356"/>
<end position="567"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 1">
<location>
<begin position="27"/>
<end position="109"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 2">
<location>
<begin position="120"/>
<end position="203"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 3">
<location>
<begin position="217"/>
<end position="324"/>
</location>
</feature>
<feature type="domain" description="TIR" evidence="6">
<location>
<begin position="380"/>
<end position="540"/>
</location>
</feature>
<feature type="region of interest" description="Flexible linker" evidence="2">
<location>
<begin position="204"/>
<end position="216"/>
</location>
</feature>
<feature type="active site" evidence="6">
<location>
<position position="466"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="60"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="101"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="107"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="146"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="176"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="194"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="225"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="259"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="278"/>
</location>
</feature>
<feature type="disulfide bond" evidence="5">
<location>
<begin position="42"/>
<end position="93"/>
</location>
</feature>
<feature type="disulfide bond" evidence="5">
<location>
<begin position="117"/>
<end position="157"/>
</location>
</feature>
<feature type="disulfide bond" evidence="5">
<location>
<begin position="139"/>
<end position="187"/>
</location>
</feature>
<feature type="disulfide bond" evidence="5">
<location>
<begin position="240"/>
<end position="308"/>
</location>
</feature>
<feature type="disulfide bond" evidence="5">
<location>
<begin position="243"/>
<end position="287"/>
</location>
</feature>
<feature type="splice variant" description="In isoform B." id="VSP_002668" evidence="15 16">
<original>IDHRSIYYI</original>
<variation>SKECPSHIA</variation>
<location>
<begin position="329"/>
<end position="337"/>
</location>
</feature>
<feature type="splice variant" description="In isoform B." id="VSP_002669" evidence="15 16">
<location>
<begin position="338"/>
<end position="567"/>
</location>
</feature>
<feature type="sequence variant" description="In strain: C3H/He.">
<original>A</original>
<variation>V</variation>
<location>
<position position="192"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="30"/>
<end position="33"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="36"/>
<end position="41"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="55"/>
<end position="57"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="72"/>
<end position="74"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="77"/>
<end position="83"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="85"/>
<end position="87"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="89"/>
<end position="95"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="103"/>
<end position="111"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="115"/>
<end position="118"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="121"/>
<end position="123"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="124"/>
<end position="131"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="136"/>
<end position="138"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="142"/>
<end position="144"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="152"/>
<end position="155"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="162"/>
<end position="168"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="171"/>
<end position="174"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="179"/>
<end position="181"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="183"/>
<end position="193"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="196"/>
<end position="209"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="218"/>
<end position="222"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="224"/>
<end position="227"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="237"/>
<end position="243"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="252"/>
<end position="262"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="271"/>
<end position="274"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="287"/>
<end position="293"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="301"/>
<end position="303"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="306"/>
<end position="312"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="315"/>
<end position="322"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5VI4"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000250"/>
<evidence key="3" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q01638"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000255"/>
<evidence key="5" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00114"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00204"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17675517"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18003919"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18450470"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20200353"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21349253"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="29045903"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8131748"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="18003919"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="2527364"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="2532153"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000305"/>
<sequence length="567" mass="64801" checksum="9228CE227D95B0BC" modified="2002-12-06" version="2" precursor="true">MIDRQRMGLWALAILTLPMYLTVTEGSKSSWGLENEALIVRCPQRGRSTYPVEWYYSDTNESIPTQKRNRIFVSRDRLKFLPARVEDSGIYACVIRSPNLNKTGYLNVTIHKKPPSCNIPDYLMYSTVRGSDKNFKITCPTIDLYNWTAPVQWFKNCKALQEPRFRAHRSYLFIDNVTHDDEGDYTCQFTHAENGTNYIVTATRSFTVEEKGFSMFPVITNPPYNHTMEVEIGKPASIACSACFGKGSHFLADVLWQINKTVVGNFGEARIQEEEGRNESSSNDMDCLTSVLRITGVTEKDLSLEYDCLALNLHGMIRHTIRLRRKQPIDHRSIYYIVAGCSLLLMFINVLVIVLKVFWIEVALFWRDIVTPYKTRNDGKLYDAYIIYPRVFRGSAAGTHSVEYFVHHTLPDVLENKCGYKLCIYGRDLLPGQDAATVVESSIQNSRRQVFVLAPHMMHSKEFAYEQEIALHSALIQNNSKVILIEMEPLGEASRLQVGDLQDSLQHLVKIQGTIKWREDHVADKQSLSSKFWKHVRYQMPVPERASKTASVAAPLSGKACLDLKHF</sequence>
</entry>
<entry dataset="Swiss-Prot" created="2009-02-10" modified="2021-02-10" version="61">
<accession>B2LT65</accession>
<accession>B5DC87</accession>
<name>TLR2_SHEEP</name>
<protein>
<recommendedName>
<fullName>Toll-like receptor 2</fullName>
<ecNumber evidence="5">3.2.2.6</ecNumber>
</recommendedName>
<cdAntigenName>CD282</cdAntigenName>
</protein>
<gene>
<name type="primary">TLR2</name>
</gene>
<organism>
<name type="scientific">Ovis aries</name>
<name type="common">Sheep</name>
<dbReference type="NCBI Taxonomy" id="9940"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Laurasiatheria</taxon>
<taxon>Artiodactyla</taxon>
<taxon>Ruminantia</taxon>
<taxon>Pecora</taxon>
<taxon>Bovidae</taxon>
<taxon>Caprinae</taxon>
<taxon>Ovis</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="2008" name="BMC Evol. Biol." volume="8" first="288" last="288">
<title>Molecular evolution of bovine Toll-like receptor 2 suggests substitutions of functional relevance.</title>
<authorList>
<person name="Jann O.C."/>
<person name="Werling D."/>
<person name="Chang J.S."/>
<person name="Haig D."/>
<person name="Glass E.J."/>
</authorList>
<dbReference type="PubMed" id="18937834"/>
<dbReference type="DOI" id="10.1186/1471-2148-8-288"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<reference key="2">
<citation type="journal article" date="2009" name="Vet. Immunol. Immunopathol." volume="127" first="94" last="105">
<title>Molecular cloning and characterization of Toll-like receptors 1-10 in sheep.</title>
<authorList>
<person name="Chang J.S."/>
<person name="Russell G.C."/>
<person name="Jann O."/>
<person name="Glass E.J."/>
<person name="Werling D."/>
<person name="Haig D.M."/>
</authorList>
<dbReference type="PubMed" id="19004506"/>
<dbReference type="DOI" id="10.1016/j.vetimm.2008.09.026"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<source>
<tissue>Peripheral blood</tissue>
</source>
</reference>
<comment type="function">
<text evidence="2 3">Cooperates with LY96 to mediate the innate immune response to bacterial lipoproteins and other microbial cell wall components. Cooperates with TLR1 or TLR6 to mediate the innate immune response to bacterial lipoproteins or lipopeptides. Acts via MYD88 and TRAF6, leading to NF-kappa-B activation, cytokine secretion and the inflammatory response (By similarity). May also promote apoptosis in response to lipoproteins. Forms activation clusters composed of several receptors depending on the ligand, these clusters trigger signaling from the cell surface and subsequently are targeted to the Golgi in a lipid-raft dependent pathway. Forms the cluster TLR2:TLR6:CD14:CD36 in response to diacylated lipopeptides and TLR2:TLR1:CD14 in response to triacylated lipopeptides (By similarity).</text>
</comment>
<comment type="catalytic activity">
<reaction evidence="5">
<text>H2O + NAD(+) = ADP-D-ribose + H(+) + nicotinamide</text>
<dbReference type="Rhea" id="RHEA:16301"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:17154"/>
<dbReference type="ChEBI" id="CHEBI:57540"/>
<dbReference type="ChEBI" id="CHEBI:57967"/>
<dbReference type="EC" id="3.2.2.6"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="5">
<dbReference type="Rhea" id="RHEA:16302"/>
</physiologicalReaction>
</comment>
<comment type="subunit">
<text evidence="2 3">Interacts with LY96, TLR1 and TLR6 (via extracellular domain). TLR2 seems to exist in heterodimers with either TLR1 or TLR6 before stimulation by the ligand. The heterodimers form bigger oligomers in response to their corresponding ligands as well as further heterotypic associations with other receptors such as CD14 and/or CD36. Binds MYD88 (via TIR domain). Interacts with TICAM1. Interacts with CNPY3. Interacts with ATG16L1. Interacts with PPP1R11. Interacts with TICAM2.</text>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="3">Membrane</location>
<topology evidence="4">Single-pass type I membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="3">Cytoplasmic vesicle</location>
<location evidence="3">Phagosome membrane</location>
<topology evidence="4">Single-pass type I membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="2">Membrane raft</location>
</subcellularLocation>
<text evidence="2">Does not reside in lipid rafts before stimulation but accumulates increasingly in the raft upon the presence of the microbial ligand. In response to diacylated lipoproteins, TLR2:TLR6 heterodimers are recruited in lipid rafts, this recruitment determine the intracellular targeting to the Golgi apparatus. Triacylated lipoproteins induce the same mechanism for TLR2:TLR1 heterodimers.</text>
</comment>
<comment type="domain">
<text evidence="1">Ester-bound lipid substrates are bound through a crevice formed between the LRR 11 and LRR 12.</text>
</comment>
<comment type="domain">
<text evidence="1">The ATG16L1-binding motif mediates interaction with ATG16L1.</text>
</comment>
<comment type="domain">
<text evidence="5">The TIR domain mediates NAD(+) hydrolase (NADase) activity. Self-association of TIR domains is required for NADase activity.</text>
</comment>
<comment type="PTM">
<text evidence="3">Ubiquitinated at Lys-754 by PPP1R11, leading to its degradation. Deubiquitinated by USP2.</text>
</comment>
<comment type="PTM">
<text evidence="2">Glycosylation of Asn-442 is critical for secretion of the N-terminal ectodomain of TLR2.</text>
</comment>
<comment type="similarity">
<text evidence="6">Belongs to the Toll-like receptor family.</text>
</comment>
<dbReference type="EC" id="3.2.2.6" evidence="5"/>
<dbReference type="EMBL" id="EU580543">
<property type="protein sequence ID" value="ACB72732.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AM981300">
<property type="protein sequence ID" value="CAQ37821.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="SMR" id="B2LT65"/>
<dbReference type="STRING" id="9940.ENSOARP00000016139"/>
<dbReference type="eggNOG" id="KOG4641">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="Proteomes" id="UP000002356">
<property type="component" value="Unplaced"/>
</dbReference>
<dbReference type="GO" id="GO:0005794">
<property type="term" value="C:Golgi apparatus"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016021">
<property type="term" value="C:integral component of membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0045121">
<property type="term" value="C:membrane raft"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030670">
<property type="term" value="C:phagocytic vesicle membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0050135">
<property type="term" value="F:NAD(P)+ nucleosidase activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0061809">
<property type="term" value="F:NAD+ nucleotidase, cyclic ADP-ribose generating"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0004888">
<property type="term" value="F:transmembrane signaling receptor activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0071726">
<property type="term" value="P:cellular response to diacyl bacterial lipopeptide"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071727">
<property type="term" value="P:cellular response to triacyl bacterial lipopeptide"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006954">
<property type="term" value="P:inflammatory response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0045087">
<property type="term" value="P:innate immune response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0002755">
<property type="term" value="P:MyD88-dependent toll-like receptor signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0050729">
<property type="term" value="P:positive regulation of inflammatory response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0034134">
<property type="term" value="P:toll-like receptor 2 signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="Gene3D" id="3.40.50.10140">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="3.80.10.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR000483">
<property type="entry name" value="Cys-rich_flank_reg_C"/>
</dbReference>
<dbReference type="InterPro" id="IPR001611">
<property type="entry name" value="Leu-rich_rpt"/>
</dbReference>
<dbReference type="InterPro" id="IPR003591">
<property type="entry name" value="Leu-rich_rpt_typical-subtyp"/>
</dbReference>
<dbReference type="InterPro" id="IPR032675">
<property type="entry name" value="LRR_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR000157">
<property type="entry name" value="TIR_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR027185">
<property type="entry name" value="TLR2"/>
</dbReference>
<dbReference type="InterPro" id="IPR017241">
<property type="entry name" value="Toll-like_receptor"/>
</dbReference>
<dbReference type="InterPro" id="IPR035897">
<property type="entry name" value="Toll_tir_struct_dom_sf"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR24365">
<property type="entry name" value="PTHR24365"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR24365:SF17">
<property type="entry name" value="PTHR24365:SF17"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF13855">
<property type="entry name" value="LRR_8"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="Pfam" id="PF01582">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PIRSF" id="PIRSF037595">
<property type="entry name" value="Toll-like_receptor"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00369">
<property type="entry name" value="LRR_TYP"/>
<property type="match status" value="6"/>
</dbReference>
<dbReference type="SMART" id="SM00082">
<property type="entry name" value="LRRCT"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00255">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF52200">
<property type="entry name" value="SSF52200"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51450">
<property type="entry name" value="LRR"/>
<property type="match status" value="10"/>
</dbReference>
<dbReference type="PROSITE" id="PS50104">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at transcript level"/>
<keyword id="KW-0968">Cytoplasmic vesicle</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0378">Hydrolase</keyword>
<keyword id="KW-0391">Immunity</keyword>
<keyword id="KW-0395">Inflammatory response</keyword>
<keyword id="KW-0399">Innate immunity</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0433">Leucine-rich repeat</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0520">NAD</keyword>
<keyword id="KW-0675">Receptor</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0732">Signal</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="signal peptide" evidence="4">
<location>
<begin position="1"/>
<end position="20"/>
</location>
</feature>
<feature type="chain" description="Toll-like receptor 2" id="PRO_0000363771">
<location>
<begin position="21"/>
<end position="784"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="4">
<location>
<begin position="21"/>
<end position="587"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="4">
<location>
<begin position="588"/>
<end position="608"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="4">
<location>
<begin position="609"/>
<end position="784"/>
</location>
</feature>
<feature type="repeat" description="LRR 1">
<location>
<begin position="54"/>
<end position="77"/>
</location>
</feature>
<feature type="repeat" description="LRR 2">
<location>
<begin position="78"/>
<end position="101"/>
</location>
</feature>
<feature type="repeat" description="LRR 3">
<location>
<begin position="102"/>
<end position="125"/>
</location>
</feature>
<feature type="repeat" description="LRR 4">
<location>
<begin position="126"/>
<end position="150"/>
</location>
</feature>
<feature type="repeat" description="LRR 5">
<location>
<begin position="151"/>
<end position="175"/>
</location>
</feature>
<feature type="repeat" description="LRR 6">
<location>
<begin position="176"/>
<end position="199"/>
</location>
</feature>
<feature type="repeat" description="LRR 7">
<location>
<begin position="200"/>
<end position="223"/>
</location>
</feature>
<feature type="repeat" description="LRR 8">
<location>
<begin position="224"/>
<end position="250"/>
</location>
</feature>
<feature type="repeat" description="LRR 9">
<location>
<begin position="251"/>
<end position="278"/>
</location>
</feature>
<feature type="repeat" description="LRR 10">
<location>
<begin position="279"/>
<end position="308"/>
</location>
</feature>
<feature type="repeat" description="LRR 11">
<location>
<begin position="309"/>
<end position="337"/>
</location>
</feature>
<feature type="repeat" description="LRR 12">
<location>
<begin position="338"/>
<end position="361"/>
</location>
</feature>
<feature type="repeat" description="LRR 13">
<location>
<begin position="362"/>
<end position="388"/>
</location>
</feature>
<feature type="repeat" description="LRR 14">
<location>
<begin position="389"/>
<end position="414"/>
</location>
</feature>
<feature type="repeat" description="LRR 15">
<location>
<begin position="415"/>
<end position="437"/>
</location>
</feature>
<feature type="repeat" description="LRR 16">
<location>
<begin position="438"/>
<end position="457"/>
</location>
</feature>
<feature type="repeat" description="LRR 17">
<location>
<begin position="458"/>
<end position="478"/>
</location>
</feature>
<feature type="repeat" description="LRR 18">
<location>
<begin position="479"/>
<end position="500"/>
</location>
</feature>
<feature type="repeat" description="LRR 19">
<location>
<begin position="501"/>
<end position="524"/>
</location>
</feature>
<feature type="domain" description="LRRCT">
<location>
<begin position="525"/>
<end position="579"/>
</location>
</feature>
<feature type="domain" description="TIR" evidence="5">
<location>
<begin position="639"/>
<end position="782"/>
</location>
</feature>
<feature type="short sequence motif" description="ATG16L1-binding motif">
<location>
<begin position="761"/>
<end position="778"/>
</location>
</feature>
<feature type="active site" evidence="5">
<location>
<position position="716"/>
</location>
</feature>
<feature type="site" description="Interaction with bacterial lipopeptide" evidence="1">
<location>
<position position="349"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="114"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="199"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="248"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="442"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1">
<location>
<begin position="30"/>
<end position="36"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1">
<location>
<begin position="353"/>
<end position="382"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1">
<location>
<begin position="432"/>
<end position="454"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="2">
<location>
<position position="754"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; CAQ37821." ref="2" evidence="6">
<original>G</original>
<variation>E</variation>
<location>
<position position="140"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; CAQ37821." ref="2" evidence="6">
<original>HR</original>
<variation>QQ</variation>
<location>
<begin position="770"/>
<end position="771"/>
</location>
</feature>
<evidence key="1" type="ECO:0000250"/>
<evidence key="2" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="O60603"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q9QUN7"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000255"/>
<evidence key="5" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00204"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000305"/>
<sequence length="784" mass="90139" checksum="035E64D860325BEF" modified="2008-06-10" version="1" precursor="true">MPRALWTAWVWAVISVFTEGASDQASSLSCDPTGVCDGHSRSLNSIPSGLTASVKSLDLSDNEITYVGNRDLQRCVNLKTLRLGANEIHTVEEDSFFHLRNLEYLDLSYNRLSNLSSSWFRSLYVLKFLNLLGNLYKTLGETSLFSHLPNLRTLKVGNSNSFTQIHEKDFTGLTFLEELEISAQNLQLYVPKSLKSIQNISHLILHLRQPVLLLDILIDIVSSLDYLELRDTNLHTFYFSEASISEINTSVKKLTFRNVQFTDDSFVEVVKLFNYVSGILEVEFDDCTHDGVGDFTALTLNRIRYLGNVETLTIRKLHIPQFFLFYDLSSIYPLTGKVKRVTIENSKVFLVPCLLSQHLKSLEYLDLSENLMSEETLKNSACEHAWPVLQTLVLRQNRLKSLEKTGELLLTLKNLNNLDISKNNFLSMPETCQWPGKMKQLNLSSTRIHSLTQCLPQTLEILDVSNNNLDSFSLILPQLKELYISRNKLKTLPDASFLPVLSVMRISGNIINTFSKEQLDSFPQLKALEAGGNNFICSCDFLSFAQGQQALARVLVDWPDGYRCDAPSHVRGQRVQDARLSLSECHRAAVVSAVCCALFLLLLLTGVLCHRFHGLWYMKMMWAWLQAKRKPRKAPRRDLCYDAFVSYSERDSYWVENLMVQELEHFNPPFKLCLHKRDFVPGKWIIDNIIDSIEKSRKTIFVLSESFVRSEWCKYELDFSHFRLFDENNDAAILILLEPIDKKAVPQRFCKLRKIMNTRTYLEWPTDETHREAFWLNLRAAIRS</sequence>
</entry>
<entry dataset="Swiss-Prot" created="2009-02-10" modified="2021-02-10" version="83">
<accession>Q0GC71</accession>
<name>TLR2_CAPHI</name>
<protein>
<recommendedName>
<fullName>Toll-like receptor 2</fullName>
<ecNumber evidence="5">3.2.2.6</ecNumber>
</recommendedName>
<cdAntigenName>CD282</cdAntigenName>
</protein>
<gene>
<name type="primary">TLR2</name>
</gene>
<organism>
<name type="scientific">Capra hircus</name>
<name type="common">Goat</name>
<dbReference type="NCBI Taxonomy" id="9925"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Laurasiatheria</taxon>
<taxon>Artiodactyla</taxon>
<taxon>Ruminantia</taxon>
<taxon>Pecora</taxon>
<taxon>Bovidae</taxon>
<taxon>Caprinae</taxon>
<taxon>Capra</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="submission" date="2006-07" db="EMBL/GenBank/DDBJ databases">
<title>Full-length cDNA cloning and characterization of Toll-like receptor 2 (TLR2) from goat (Capra hiscus).</title>
<authorList>
<person name="Das D.K."/>
<person name="Saini M."/>
<person name="Dhara A."/>
<person name="Swarup D."/>
<person name="Sharma B."/>
<person name="Gupta P.K."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
</reference>
<comment type="function">
<text evidence="2 3">Cooperates with LY96 to mediate the innate immune response to bacterial lipoproteins and other microbial cell wall components. Cooperates with TLR1 or TLR6 to mediate the innate immune response to bacterial lipoproteins or lipopeptides. Acts via MYD88 and TRAF6, leading to NF-kappa-B activation, cytokine secretion and the inflammatory response (By similarity). May also promote apoptosis in response to lipoproteins. Forms activation clusters composed of several receptors depending on the ligand, these clusters trigger signaling from the cell surface and subsequently are targeted to the Golgi in a lipid-raft dependent pathway. Forms the cluster TLR2:TLR6:CD14:CD36 in response to diacylated lipopeptides and TLR2:TLR1:CD14 in response to triacylated lipopeptides (By similarity).</text>
</comment>
<comment type="catalytic activity">
<reaction evidence="5">
<text>H2O + NAD(+) = ADP-D-ribose + H(+) + nicotinamide</text>
<dbReference type="Rhea" id="RHEA:16301"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:17154"/>
<dbReference type="ChEBI" id="CHEBI:57540"/>
<dbReference type="ChEBI" id="CHEBI:57967"/>
<dbReference type="EC" id="3.2.2.6"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="5">
<dbReference type="Rhea" id="RHEA:16302"/>
</physiologicalReaction>
</comment>
<comment type="subunit">
<text evidence="2 3">Interacts with LY96, TLR1 and TLR6 (via extracellular domain). TLR2 seems to exist in heterodimers with either TLR1 or TLR6 before stimulation by the ligand. The heterodimers form bigger oligomers in response to their corresponding ligands as well as further heterotypic associations with other receptors such as CD14 and/or CD36. Binds MYD88 (via TIR domain). Interacts with TICAM1. Interacts with CNPY3. Interacts with ATG16L1. Interacts with PPP1R11. Interacts with TICAM2.</text>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="3">Membrane</location>
<topology evidence="4">Single-pass type I membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="3">Cytoplasmic vesicle</location>
<location evidence="3">Phagosome membrane</location>
<topology evidence="4">Single-pass type I membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="2">Membrane raft</location>
</subcellularLocation>
<text evidence="2">Does not reside in lipid rafts before stimulation but accumulates increasingly in the raft upon the presence of the microbial ligand. In response to diacylated lipoproteins, TLR2:TLR6 heterodimers are recruited in lipid rafts, this recruitment determine the intracellular targeting to the Golgi apparatus. Triacylated lipoproteins induce the same mechanism for TLR2:TLR1 heterodimers.</text>
</comment>
<comment type="domain">
<text evidence="1">Ester-bound lipid substrates are bound through a crevice formed between the LRR 11 and LRR 12.</text>
</comment>
<comment type="domain">
<text evidence="1">The ATG16L1-binding motif mediates interaction with ATG16L1.</text>
</comment>
<comment type="domain">
<text evidence="5">The TIR domain mediates NAD(+) hydrolase (NADase) activity. Self-association of TIR domains is required for NADase activity.</text>
</comment>
<comment type="PTM">
<text evidence="3">Ubiquitinated at Lys-754 by PPP1R11, leading to its degradation. Deubiquitinated by USP2.</text>
</comment>
<comment type="PTM">
<text evidence="2">Glycosylation of Asn-442 is critical for secretion of the N-terminal ectodomain of TLR2.</text>
</comment>
<comment type="similarity">
<text evidence="6">Belongs to the Toll-like receptor family.</text>
</comment>
<dbReference type="EC" id="3.2.2.6" evidence="5"/>
<dbReference type="EMBL" id="DQ872435">
<property type="protein sequence ID" value="ABI31733.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001272532.1">
<property type="nucleotide sequence ID" value="NM_001285603.1"/>
</dbReference>
<dbReference type="SMR" id="Q0GC71"/>
<dbReference type="GeneID" id="100860747"/>
<dbReference type="KEGG" id="chx:100860747"/>
<dbReference type="CTD" id="7097"/>
<dbReference type="Proteomes" id="UP000291000">
<property type="component" value="Unassembled WGS sequence"/>
</dbReference>
<dbReference type="GO" id="GO:0005794">
<property type="term" value="C:Golgi apparatus"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016021">
<property type="term" value="C:integral component of membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0045121">
<property type="term" value="C:membrane raft"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030670">
<property type="term" value="C:phagocytic vesicle membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0050135">
<property type="term" value="F:NAD(P)+ nucleosidase activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0061809">
<property type="term" value="F:NAD+ nucleotidase, cyclic ADP-ribose generating"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0004888">
<property type="term" value="F:transmembrane signaling receptor activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0071726">
<property type="term" value="P:cellular response to diacyl bacterial lipopeptide"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071727">
<property type="term" value="P:cellular response to triacyl bacterial lipopeptide"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006954">
<property type="term" value="P:inflammatory response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0045087">
<property type="term" value="P:innate immune response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0002755">
<property type="term" value="P:MyD88-dependent toll-like receptor signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0050729">
<property type="term" value="P:positive regulation of inflammatory response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0034134">
<property type="term" value="P:toll-like receptor 2 signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="Gene3D" id="3.40.50.10140">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="3.80.10.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR000483">
<property type="entry name" value="Cys-rich_flank_reg_C"/>
</dbReference>
<dbReference type="InterPro" id="IPR001611">
<property type="entry name" value="Leu-rich_rpt"/>
</dbReference>
<dbReference type="InterPro" id="IPR003591">
<property type="entry name" value="Leu-rich_rpt_typical-subtyp"/>
</dbReference>
<dbReference type="InterPro" id="IPR032675">
<property type="entry name" value="LRR_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR000157">
<property type="entry name" value="TIR_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR027185">
<property type="entry name" value="TLR2"/>
</dbReference>
<dbReference type="InterPro" id="IPR017241">
<property type="entry name" value="Toll-like_receptor"/>
</dbReference>
<dbReference type="InterPro" id="IPR035897">
<property type="entry name" value="Toll_tir_struct_dom_sf"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR24365">
<property type="entry name" value="PTHR24365"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR24365:SF17">
<property type="entry name" value="PTHR24365:SF17"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF13855">
<property type="entry name" value="LRR_8"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="Pfam" id="PF01582">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PIRSF" id="PIRSF037595">
<property type="entry name" value="Toll-like_receptor"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00369">
<property type="entry name" value="LRR_TYP"/>
<property type="match status" value="6"/>
</dbReference>
<dbReference type="SMART" id="SM00082">
<property type="entry name" value="LRRCT"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00255">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF52200">
<property type="entry name" value="SSF52200"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51450">
<property type="entry name" value="LRR"/>
<property type="match status" value="10"/>
</dbReference>
<dbReference type="PROSITE" id="PS50104">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at transcript level"/>
<keyword id="KW-0968">Cytoplasmic vesicle</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0378">Hydrolase</keyword>
<keyword id="KW-0391">Immunity</keyword>
<keyword id="KW-0395">Inflammatory response</keyword>
<keyword id="KW-0399">Innate immunity</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0433">Leucine-rich repeat</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0520">NAD</keyword>
<keyword id="KW-0675">Receptor</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0732">Signal</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="signal peptide" evidence="4">
<location>
<begin position="1"/>
<end position="20"/>
</location>
</feature>
<feature type="chain" description="Toll-like receptor 2" id="PRO_0000363775">
<location>
<begin position="21"/>
<end position="784"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="4">
<location>
<begin position="21"/>
<end position="587"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="4">
<location>
<begin position="588"/>
<end position="608"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="4">
<location>
<begin position="609"/>
<end position="784"/>
</location>
</feature>
<feature type="repeat" description="LRR 1">
<location>
<begin position="54"/>
<end position="77"/>
</location>
</feature>
<feature type="repeat" description="LRR 2">
<location>
<begin position="78"/>
<end position="101"/>
</location>
</feature>
<feature type="repeat" description="LRR 3">
<location>
<begin position="102"/>
<end position="125"/>
</location>
</feature>
<feature type="repeat" description="LRR 4">
<location>
<begin position="126"/>
<end position="150"/>
</location>
</feature>
<feature type="repeat" description="LRR 5">
<location>
<begin position="151"/>
<end position="175"/>
</location>
</feature>
<feature type="repeat" description="LRR 6">
<location>
<begin position="176"/>
<end position="199"/>
</location>
</feature>
<feature type="repeat" description="LRR 7">
<location>
<begin position="200"/>
<end position="223"/>
</location>
</feature>
<feature type="repeat" description="LRR 8">
<location>
<begin position="224"/>
<end position="250"/>
</location>
</feature>
<feature type="repeat" description="LRR 9">
<location>
<begin position="251"/>
<end position="278"/>
</location>
</feature>
<feature type="repeat" description="LRR 10">
<location>
<begin position="279"/>
<end position="308"/>
</location>
</feature>
<feature type="repeat" description="LRR 11">
<location>
<begin position="309"/>
<end position="337"/>
</location>
</feature>
<feature type="repeat" description="LRR 12">
<location>
<begin position="338"/>
<end position="361"/>
</location>
</feature>
<feature type="repeat" description="LRR 13">
<location>
<begin position="362"/>
<end position="388"/>
</location>
</feature>
<feature type="repeat" description="LRR 14">
<location>
<begin position="389"/>
<end position="414"/>
</location>
</feature>
<feature type="repeat" description="LRR 15">
<location>
<begin position="415"/>
<end position="437"/>
</location>
</feature>
<feature type="repeat" description="LRR 16">
<location>
<begin position="438"/>
<end position="457"/>
</location>
</feature>
<feature type="repeat" description="LRR 17">
<location>
<begin position="458"/>
<end position="478"/>
</location>
</feature>
<feature type="repeat" description="LRR 18">
<location>
<begin position="479"/>
<end position="500"/>
</location>
</feature>
<feature type="repeat" description="LRR 19">
<location>
<begin position="501"/>
<end position="524"/>
</location>
</feature>
<feature type="domain" description="LRRCT">
<location>
<begin position="525"/>
<end position="579"/>
</location>
</feature>
<feature type="domain" description="TIR" evidence="5">
<location>
<begin position="639"/>
<end position="782"/>
</location>
</feature>
<feature type="short sequence motif" description="ATG16L1-binding motif">
<location>
<begin position="761"/>
<end position="778"/>
</location>
</feature>
<feature type="active site" evidence="5">
<location>
<position position="716"/>
</location>
</feature>
<feature type="site" description="Interaction with bacterial lipopeptide" evidence="1">
<location>
<position position="349"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="114"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="199"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="248"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="442"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1">
<location>
<begin position="30"/>
<end position="36"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1">
<location>
<begin position="353"/>
<end position="382"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1">
<location>
<begin position="432"/>
<end position="454"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="2">
<location>
<position position="754"/>
</location>
</feature>
<evidence key="1" type="ECO:0000250"/>
<evidence key="2" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="O60603"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q9QUN7"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000255"/>
<evidence key="5" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00204"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000305"/>
<sequence length="784" mass="90067" checksum="C3434B760BB92E6A" modified="2006-10-03" version="1" precursor="true">MPRALWTAWVWAVIILSMEGASHQASSLSCDPTGVCDGHSRSLNSIPSGLTDGVKSLDLSNNEITYVSNRDLQRCVNLKTLRLGANEIHTVEEDSFFHLRNLEYLDLSYNRLSNLSSSWFRSLYALKFLNLLGNVYKTLGETSLFSHLPNLRTLKVGNSNSFTEIHEKDFTGLIFLEELEISAQNLQIYVPKSLKSIQNISHLILHLKQPVLLVDILVDIVSSLDCLELRDTNLHTFHFSEASISEMNTSVKKLIFRNVQFTDESFVEVVKLFNYVSGILEVEFDDCTHDGIGDFRALSLDRIRHLGNVETLTIRKLHIPQFFLFHDLSSIYPLTGKVKRVTIESSKVFLVPCLLSQHLKSLEYLDLSENLMSEETLKNSACKDAWPFLQTLVLRQNRLKSLEKTGELLLTLKNLNNLDISKNNFLSMPETCQWPGKMKQLNLSSTRIHSLTQCLPQTLEILDVSNNNLDSFSLILPQLKELYISRNKLKTLPDASFLPVLSVMRISGNIINTFSKEQLDSFPQLKALEAGGNNFICSCDFLSFTQGQQALARVLVDWPDGYRCDAPSHVRGQRVQDARLSLSECHRAAVVSAVCCALFLLLLLTGVLCHRFHGLWYMKMMWAWLQAKRKPRKAPRRDLCYDAFVSYSEQDSYWVENLMVQELEHFNPPFKLCLHKRDFVPGKWIIDNIIDSIEKSRKTIFVLSENFVRSEWCKYELDFSHFRLFDENNDAAILILLEPIDKKAIPQRFCKLRKIMNTKTYLEWPTDETQQEAFWLNLRAAIRS</sequence>
</entry>
<entry dataset="Swiss-Prot" created="2003-08-22" modified="2021-02-10" version="158">
<accession>Q9NP60</accession>
<accession>Q2M3U3</accession>
<accession>Q9NZN0</accession>
<name>IRPL2_HUMAN</name>
<protein>
<recommendedName>
<fullName>X-linked interleukin-1 receptor accessory protein-like 2</fullName>
<shortName>IL-1 receptor accessory protein-like 2</shortName>
<shortName>IL-1-RAPL-2</shortName>
<shortName>IL-1RAPL-2</shortName>
<shortName>IL1RAPL-2</shortName>
<ecNumber evidence="3">3.2.2.6</ecNumber>
</recommendedName>
<alternativeName>
<fullName>IL1RAPL-2-related protein</fullName>
</alternativeName>
<alternativeName>
<fullName>Interleukin-1 receptor 9</fullName>
<shortName>IL-1R-9</shortName>
<shortName>IL-1R9</shortName>
</alternativeName>
<alternativeName>
<fullName>Three immunoglobulin domain-containing IL-1 receptor-related 1</fullName>
<shortName>TIGIRR-1</shortName>
</alternativeName>
</protein>
<gene>
<name type="primary">IL1RAPL2</name>
<name type="synonym">IL1R9</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="2000" name="Genomics" volume="69" first="252" last="262">
<title>Computational identification, cloning, and characterization of IL-1R9, a novel interleukin-1 receptor-like gene encoded over an unusually large interval of human chromosome Xq22.2-q22.3.</title>
<authorList>
<person name="Sana T.R."/>
<person name="Debets R."/>
<person name="Timans J.C."/>
<person name="Bazan J.F."/>
<person name="Kastelein R.A."/>
</authorList>
<dbReference type="PubMed" id="11031108"/>
<dbReference type="DOI" id="10.1006/geno.2000.6328"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>TISSUE SPECIFICITY</scope>
<source>
<tissue>Fetal brain</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="2000" name="J. Biol. Chem." volume="275" first="29946" last="29954">
<title>Identification and characterization of two members of a novel class of the interleukin-1 receptor (IL-1R) family. Delineation of a new class of IL-1R-related proteins based on signaling.</title>
<authorList>
<person name="Born T.L."/>
<person name="Smith D.E."/>
<person name="Garka K.E."/>
<person name="Renshaw B.R."/>
<person name="Bertles J.S."/>
<person name="Sims J.E."/>
</authorList>
<dbReference type="PubMed" id="10882729"/>
<dbReference type="DOI" id="10.1074/jbc.m004077200"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>TISSUE SPECIFICITY</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="3">
<citation type="submission" date="2000-02" db="EMBL/GenBank/DDBJ databases">
<title>A gene (IL1RAPL-2) with 61% identity to IL1RAPL maps to Xq22.2.</title>
<authorList>
<person name="Grabowski M."/>
<person name="Lorenz B."/>
<person name="Hubel R."/>
<person name="Strom T.M."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="2001" name="Gene" volume="275" first="217" last="221">
<title>IL1RAPL2 maps to Xq22 and is specifically expressed in the central nervous system.</title>
<authorList>
<person name="Ferrante M.I."/>
<person name="Ghiani M."/>
<person name="Bulfone A."/>
<person name="Franco B."/>
</authorList>
<dbReference type="PubMed" id="11587848"/>
<dbReference type="DOI" id="10.1016/s0378-1119(01)00659-x"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>TISSUE SPECIFICITY</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="5">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Thalamus</tissue>
</source>
</reference>
<reference key="6">
<citation type="journal article" date="2005" name="Nature" volume="434" first="325" last="337">
<title>The DNA sequence of the human X chromosome.</title>
<authorList>
<person name="Ross M.T."/>
<person name="Grafham D.V."/>
<person name="Coffey A.J."/>
<person name="Scherer S."/>
<person name="McLay K."/>
<person name="Muzny D."/>
<person name="Platzer M."/>
<person name="Howell G.R."/>
<person name="Burrows C."/>
<person name="Bird C.P."/>
<person name="Frankish A."/>
<person name="Lovell F.L."/>
<person name="Howe K.L."/>
<person name="Ashurst J.L."/>
<person name="Fulton R.S."/>
<person name="Sudbrak R."/>
<person name="Wen G."/>
<person name="Jones M.C."/>
<person name="Hurles M.E."/>
<person name="Andrews T.D."/>
<person name="Scott C.E."/>
<person name="Searle S."/>
<person name="Ramser J."/>
<person name="Whittaker A."/>
<person name="Deadman R."/>
<person name="Carter N.P."/>
<person name="Hunt S.E."/>
<person name="Chen R."/>
<person name="Cree A."/>
<person name="Gunaratne P."/>
<person name="Havlak P."/>
<person name="Hodgson A."/>
<person name="Metzker M.L."/>
<person name="Richards S."/>
<person name="Scott G."/>
<person name="Steffen D."/>
<person name="Sodergren E."/>
<person name="Wheeler D.A."/>
<person name="Worley K.C."/>
<person name="Ainscough R."/>
<person name="Ambrose K.D."/>
<person name="Ansari-Lari M.A."/>
<person name="Aradhya S."/>
<person name="Ashwell R.I."/>
<person name="Babbage A.K."/>
<person name="Bagguley C.L."/>
<person name="Ballabio A."/>
<person name="Banerjee R."/>
<person name="Barker G.E."/>
<person name="Barlow K.F."/>
<person name="Barrett I.P."/>
<person name="Bates K.N."/>
<person name="Beare D.M."/>
<person name="Beasley H."/>
<person name="Beasley O."/>
<person name="Beck A."/>
<person name="Bethel G."/>
<person name="Blechschmidt K."/>
<person name="Brady N."/>
<person name="Bray-Allen S."/>
<person name="Bridgeman A.M."/>
<person name="Brown A.J."/>
<person name="Brown M.J."/>
<person name="Bonnin D."/>
<person name="Bruford E.A."/>
<person name="Buhay C."/>
<person name="Burch P."/>
<person name="Burford D."/>
<person name="Burgess J."/>
<person name="Burrill W."/>
<person name="Burton J."/>
<person name="Bye J.M."/>
<person name="Carder C."/>
<person name="Carrel L."/>
<person name="Chako J."/>
<person name="Chapman J.C."/>
<person name="Chavez D."/>
<person name="Chen E."/>
<person name="Chen G."/>
<person name="Chen Y."/>
<person name="Chen Z."/>
<person name="Chinault C."/>
<person name="Ciccodicola A."/>
<person name="Clark S.Y."/>
<person name="Clarke G."/>
<person name="Clee C.M."/>
<person name="Clegg S."/>
<person name="Clerc-Blankenburg K."/>
<person name="Clifford K."/>
<person name="Cobley V."/>
<person name="Cole C.G."/>
<person name="Conquer J.S."/>
<person name="Corby N."/>
<person name="Connor R.E."/>
<person name="David R."/>
<person name="Davies J."/>
<person name="Davis C."/>
<person name="Davis J."/>
<person name="Delgado O."/>
<person name="Deshazo D."/>
<person name="Dhami P."/>
<person name="Ding Y."/>
<person name="Dinh H."/>
<person name="Dodsworth S."/>
<person name="Draper H."/>
<person name="Dugan-Rocha S."/>
<person name="Dunham A."/>
<person name="Dunn M."/>
<person name="Durbin K.J."/>
<person name="Dutta I."/>
<person name="Eades T."/>
<person name="Ellwood M."/>
<person name="Emery-Cohen A."/>
<person name="Errington H."/>
<person name="Evans K.L."/>
<person name="Faulkner L."/>
<person name="Francis F."/>
<person name="Frankland J."/>
<person name="Fraser A.E."/>
<person name="Galgoczy P."/>
<person name="Gilbert J."/>
<person name="Gill R."/>
<person name="Gloeckner G."/>
<person name="Gregory S.G."/>
<person name="Gribble S."/>
<person name="Griffiths C."/>
<person name="Grocock R."/>
<person name="Gu Y."/>
<person name="Gwilliam R."/>
<person name="Hamilton C."/>
<person name="Hart E.A."/>
<person name="Hawes A."/>
<person name="Heath P.D."/>
<person name="Heitmann K."/>
<person name="Hennig S."/>
<person name="Hernandez J."/>
<person name="Hinzmann B."/>
<person name="Ho S."/>
<person name="Hoffs M."/>
<person name="Howden P.J."/>
<person name="Huckle E.J."/>
<person name="Hume J."/>
<person name="Hunt P.J."/>
<person name="Hunt A.R."/>
<person name="Isherwood J."/>
<person name="Jacob L."/>
<person name="Johnson D."/>
<person name="Jones S."/>
<person name="de Jong P.J."/>
<person name="Joseph S.S."/>
<person name="Keenan S."/>
<person name="Kelly S."/>
<person name="Kershaw J.K."/>
<person name="Khan Z."/>
<person name="Kioschis P."/>
<person name="Klages S."/>
<person name="Knights A.J."/>
<person name="Kosiura A."/>
<person name="Kovar-Smith C."/>
<person name="Laird G.K."/>
<person name="Langford C."/>
<person name="Lawlor S."/>
<person name="Leversha M."/>
<person name="Lewis L."/>
<person name="Liu W."/>
<person name="Lloyd C."/>
<person name="Lloyd D.M."/>
<person name="Loulseged H."/>
<person name="Loveland J.E."/>
<person name="Lovell J.D."/>
<person name="Lozado R."/>
<person name="Lu J."/>
<person name="Lyne R."/>
<person name="Ma J."/>
<person name="Maheshwari M."/>
<person name="Matthews L.H."/>
<person name="McDowall J."/>
<person name="McLaren S."/>
<person name="McMurray A."/>
<person name="Meidl P."/>
<person name="Meitinger T."/>
<person name="Milne S."/>
<person name="Miner G."/>
<person name="Mistry S.L."/>
<person name="Morgan M."/>
<person name="Morris S."/>
<person name="Mueller I."/>
<person name="Mullikin J.C."/>
<person name="Nguyen N."/>
<person name="Nordsiek G."/>
<person name="Nyakatura G."/>
<person name="O'dell C.N."/>
<person name="Okwuonu G."/>
<person name="Palmer S."/>
<person name="Pandian R."/>
<person name="Parker D."/>
<person name="Parrish J."/>
<person name="Pasternak S."/>
<person name="Patel D."/>
<person name="Pearce A.V."/>
<person name="Pearson D.M."/>
<person name="Pelan S.E."/>
<person name="Perez L."/>
<person name="Porter K.M."/>
<person name="Ramsey Y."/>
<person name="Reichwald K."/>
<person name="Rhodes S."/>
<person name="Ridler K.A."/>
<person name="Schlessinger D."/>
<person name="Schueler M.G."/>
<person name="Sehra H.K."/>
<person name="Shaw-Smith C."/>
<person name="Shen H."/>
<person name="Sheridan E.M."/>
<person name="Shownkeen R."/>
<person name="Skuce C.D."/>
<person name="Smith M.L."/>
<person name="Sotheran E.C."/>
<person name="Steingruber H.E."/>
<person name="Steward C.A."/>
<person name="Storey R."/>
<person name="Swann R.M."/>
<person name="Swarbreck D."/>
<person name="Tabor P.E."/>
<person name="Taudien S."/>
<person name="Taylor T."/>
<person name="Teague B."/>
<person name="Thomas K."/>
<person name="Thorpe A."/>
<person name="Timms K."/>
<person name="Tracey A."/>
<person name="Trevanion S."/>
<person name="Tromans A.C."/>
<person name="d'Urso M."/>
<person name="Verduzco D."/>
<person name="Villasana D."/>
<person name="Waldron L."/>
<person name="Wall M."/>
<person name="Wang Q."/>
<person name="Warren J."/>
<person name="Warry G.L."/>
<person name="Wei X."/>
<person name="West A."/>
<person name="Whitehead S.L."/>
<person name="Whiteley M.N."/>
<person name="Wilkinson J.E."/>
<person name="Willey D.L."/>
<person name="Williams G."/>
<person name="Williams L."/>
<person name="Williamson A."/>
<person name="Williamson H."/>
<person name="Wilming L."/>
<person name="Woodmansey R.L."/>
<person name="Wray P.W."/>
<person name="Yen J."/>
<person name="Zhang J."/>
<person name="Zhou J."/>
<person name="Zoghbi H."/>
<person name="Zorilla S."/>
<person name="Buck D."/>
<person name="Reinhardt R."/>
<person name="Poustka A."/>
<person name="Rosenthal A."/>
<person name="Lehrach H."/>
<person name="Meindl A."/>
<person name="Minx P.J."/>
<person name="Hillier L.W."/>
<person name="Willard H.F."/>
<person name="Wilson R.K."/>
<person name="Waterston R.H."/>
<person name="Rice C.M."/>
<person name="Vaudin M."/>
<person name="Coulson A."/>
<person name="Nelson D.L."/>
<person name="Weinstock G."/>
<person name="Sulston J.E."/>
<person name="Durbin R.M."/>
<person name="Hubbard T."/>
<person name="Gibbs R.A."/>
<person name="Beck S."/>
<person name="Rogers J."/>
<person name="Bentley D.R."/>
</authorList>
<dbReference type="PubMed" id="15772651"/>
<dbReference type="DOI" id="10.1038/nature03440"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="8">
<citation type="journal article" date="2000" name="Eur. J. Hum. Genet." volume="8" first="87" last="94">
<title>Two novel members of the interleukin-1 receptor gene family, one deleted in Xp22.3-Xp21.3 mental retardation.</title>
<authorList>
<person name="Jin H."/>
<person name="Gardner R.J."/>
<person name="Viswesvaraiah R."/>
<person name="Muntoni F."/>
<person name="Roberts R.G."/>
</authorList>
<dbReference type="PubMed" id="10757639"/>
<dbReference type="DOI" id="10.1038/sj.ejhg.5200415"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 29-686</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2006" name="Science" volume="314" first="268" last="274">
<title>The consensus coding sequences of human breast and colorectal cancers.</title>
<authorList>
<person name="Sjoeblom T."/>
<person name="Jones S."/>
<person name="Wood L.D."/>
<person name="Parsons D.W."/>
<person name="Lin J."/>
<person name="Barber T.D."/>
<person name="Mandelker D."/>
<person name="Leary R.J."/>
<person name="Ptak J."/>
<person name="Silliman N."/>
<person name="Szabo S."/>
<person name="Buckhaults P."/>
<person name="Farrell C."/>
<person name="Meeh P."/>
<person name="Markowitz S.D."/>
<person name="Willis J."/>
<person name="Dawson D."/>
<person name="Willson J.K.V."/>
<person name="Gazdar A.F."/>
<person name="Hartigan J."/>
<person name="Wu L."/>
<person name="Liu C."/>
<person name="Parmigiani G."/>
<person name="Park B.H."/>
<person name="Bachman K.E."/>
<person name="Papadopoulos N."/>
<person name="Vogelstein B."/>
<person name="Kinzler K.W."/>
<person name="Velculescu V.E."/>
</authorList>
<dbReference type="PubMed" id="16959974"/>
<dbReference type="DOI" id="10.1126/science.1133427"/>
</citation>
<scope>VARIANT [LARGE SCALE ANALYSIS] LEU-606</scope>
</reference>
<comment type="catalytic activity">
<reaction evidence="3">
<text>H2O + NAD(+) = ADP-D-ribose + H(+) + nicotinamide</text>
<dbReference type="Rhea" id="RHEA:16301"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:17154"/>
<dbReference type="ChEBI" id="CHEBI:57540"/>
<dbReference type="ChEBI" id="CHEBI:57967"/>
<dbReference type="EC" id="3.2.2.6"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="3">
<dbReference type="Rhea" id="RHEA:16302"/>
</physiologicalReaction>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location>Membrane</location>
<topology>Single-pass type I membrane protein</topology>
</subcellularLocation>
</comment>
<comment type="tissue specificity">
<text evidence="4 5 6">Detected at low levels in fetal and adult brain, in particular in the frontal lobe, temporal lobe and cerebellum. Detected at very low levels in skin, liver, fetal ovary and in placenta.</text>
</comment>
<comment type="domain">
<text evidence="3">The TIR domain mediates NAD(+) hydrolase (NADase) activity. Self-association of TIR domains is required for NADase activity.</text>
</comment>
<comment type="similarity">
<text evidence="8">Belongs to the interleukin-1 receptor family.</text>
</comment>
<dbReference type="EC" id="3.2.2.6" evidence="3"/>
<dbReference type="EMBL" id="AF212016">
<property type="protein sequence ID" value="AAF61307.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF284436">
<property type="protein sequence ID" value="AAG21370.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AJ272208">
<property type="protein sequence ID" value="CAB86868.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AJ290436">
<property type="protein sequence ID" value="CAB89867.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK290196">
<property type="protein sequence ID" value="BAF82885.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AL050401">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="Z68328">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="Z68330">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="Z68908">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="Z69721">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="Z74477">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="Z74619">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="Z81144">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF181285">
<property type="protein sequence ID" value="AAF59412.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC104784">
<property type="protein sequence ID" value="AAI04785.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC104786">
<property type="protein sequence ID" value="AAI04787.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS14517.1"/>
<dbReference type="RefSeq" id="NP_059112.1">
<property type="nucleotide sequence ID" value="NM_017416.1"/>
</dbReference>
<dbReference type="RefSeq" id="XP_016884892.1">
<property type="nucleotide sequence ID" value="XM_017029403.1"/>
</dbReference>
<dbReference type="SMR" id="Q9NP60"/>
<dbReference type="BioGRID" id="117663">
<property type="interactions" value="4"/>
</dbReference>
<dbReference type="IntAct" id="Q9NP60">
<property type="interactions" value="1"/>
</dbReference>
<dbReference type="STRING" id="9606.ENSP00000361663"/>
<dbReference type="GlyGen" id="Q9NP60">
<property type="glycosylation" value="5 sites"/>
</dbReference>
<dbReference type="iPTMnet" id="Q9NP60"/>
<dbReference type="PhosphoSitePlus" id="Q9NP60"/>
<dbReference type="BioMuta" id="IL1RAPL2"/>
<dbReference type="DMDM" id="34222651"/>
<dbReference type="PaxDb" id="Q9NP60"/>
<dbReference type="PeptideAtlas" id="Q9NP60"/>
<dbReference type="PRIDE" id="Q9NP60"/>
<dbReference type="ProteomicsDB" id="81891"/>
<dbReference type="Antibodypedia" id="35255">
<property type="antibodies" value="272 antibodies"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000372582">
<property type="protein sequence ID" value="ENSP00000361663"/>
<property type="gene ID" value="ENSG00000189108"/>
</dbReference>
<dbReference type="GeneID" id="26280"/>
<dbReference type="KEGG" id="hsa:26280"/>
<dbReference type="UCSC" id="uc004elz.1">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="26280"/>
<dbReference type="DisGeNET" id="26280"/>
<dbReference type="GeneCards" id="IL1RAPL2"/>
<dbReference type="HGNC" id="HGNC:5997">
<property type="gene designation" value="IL1RAPL2"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000189108">
<property type="expression patterns" value="Tissue enhanced (brain, parathyroid gland)"/>
</dbReference>
<dbReference type="MIM" id="300277">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q9NP60"/>
<dbReference type="OpenTargets" id="ENSG00000189108"/>
<dbReference type="PharmGKB" id="PA29813"/>
<dbReference type="VEuPathDB" id="HostDB:ENSG00000189108.12"/>
<dbReference type="eggNOG" id="KOG3971">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT01010000222456"/>
<dbReference type="HOGENOM" id="CLU_025552_0_1_1"/>
<dbReference type="InParanoid" id="Q9NP60"/>
<dbReference type="OMA" id="QMRHYCR"/>
<dbReference type="OrthoDB" id="651291at2759"/>
<dbReference type="PhylomeDB" id="Q9NP60"/>
<dbReference type="TreeFam" id="TF333913"/>
<dbReference type="PathwayCommons" id="Q9NP60"/>
<dbReference type="Reactome" id="R-HSA-388844">
<property type="pathway name" value="Receptor-type tyrosine-protein phosphatases"/>
</dbReference>
<dbReference type="BioGRID-ORCS" id="26280">
<property type="hits" value="6 hits in 496 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="IL1RAPL2">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="GeneWiki" id="IL1RAPL2"/>
<dbReference type="GenomeRNAi" id="26280"/>
<dbReference type="Pharos" id="Q9NP60">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:Q9NP60"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome X"/>
</dbReference>
<dbReference type="RNAct" id="Q9NP60">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000189108">
<property type="expression patterns" value="Expressed in cortical plate and 88 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="Q9NP60">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q9NP60">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0098978">
<property type="term" value="C:glutamatergic synapse"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="SynGO"/>
</dbReference>
<dbReference type="GO" id="GO:0016021">
<property type="term" value="C:integral component of membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0004908">
<property type="term" value="F:interleukin-1 receptor activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0004910">
<property type="term" value="F:interleukin-1, type II, blocking receptor activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0050135">
<property type="term" value="F:NAD(P)+ nucleosidase activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0061809">
<property type="term" value="F:NAD+ nucleotidase, cyclic ADP-ribose generating"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0007417">
<property type="term" value="P:central nervous system development"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:1905606">
<property type="term" value="P:regulation of presynapse assembly"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="SynGO"/>
</dbReference>
<dbReference type="Gene3D" id="2.60.40.10">
<property type="match status" value="3"/>
</dbReference>
<dbReference type="Gene3D" id="3.40.50.10140">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR007110">
<property type="entry name" value="Ig-like_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR036179">
<property type="entry name" value="Ig-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR013783">
<property type="entry name" value="Ig-like_fold"/>
</dbReference>
<dbReference type="InterPro" id="IPR003599">
<property type="entry name" value="Ig_sub"/>
</dbReference>
<dbReference type="InterPro" id="IPR015621">
<property type="entry name" value="IL-1_rcpt_fam"/>
</dbReference>
<dbReference type="InterPro" id="IPR004077">
<property type="entry name" value="IL-1_rcpt_II-typ"/>
</dbReference>
<dbReference type="InterPro" id="IPR041416">
<property type="entry name" value="IL-1RAcP-like_ig"/>
</dbReference>
<dbReference type="InterPro" id="IPR013151">
<property type="entry name" value="Immunoglobulin"/>
</dbReference>
<dbReference type="InterPro" id="IPR000157">
<property type="entry name" value="TIR_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR035897">
<property type="entry name" value="Toll_tir_struct_dom_sf"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR11890">
<property type="entry name" value="PTHR11890"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00047">
<property type="entry name" value="ig"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF13895">
<property type="entry name" value="Ig_2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF18452">
<property type="entry name" value="Ig_6"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF01582">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR01539">
<property type="entry name" value="INTRLEUKN1R2"/>
</dbReference>
<dbReference type="SMART" id="SM00409">
<property type="entry name" value="IG"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="SMART" id="SM00255">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF48726">
<property type="entry name" value="SSF48726"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF52200">
<property type="entry name" value="SSF52200"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50835">
<property type="entry name" value="IG_LIKE"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="PROSITE" id="PS50104">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at transcript level"/>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0378">Hydrolase</keyword>
<keyword id="KW-0393">Immunoglobulin domain</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0520">NAD</keyword>
<keyword id="KW-0675">Receptor</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0732">Signal</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<feature type="signal peptide" evidence="1">
<location>
<begin position="1"/>
<end position="16"/>
</location>
</feature>
<feature type="chain" description="X-linked interleukin-1 receptor accessory protein-like 2" id="PRO_0000015459">
<location>
<begin position="17"/>
<end position="686"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="1">
<location>
<begin position="17"/>
<end position="354"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="1">
<location>
<begin position="355"/>
<end position="375"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="1">
<location>
<begin position="376"/>
<end position="686"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 1">
<location>
<begin position="18"/>
<end position="132"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 2">
<location>
<begin position="141"/>
<end position="232"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 3">
<location>
<begin position="239"/>
<end position="347"/>
</location>
</feature>
<feature type="domain" description="TIR" evidence="3">
<location>
<begin position="400"/>
<end position="556"/>
</location>
</feature>
<feature type="active site" evidence="3">
<location>
<position position="488"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="1">
<location>
<position position="63"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="1">
<location>
<position position="120"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="1">
<location>
<position position="136"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="1">
<location>
<position position="211"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="1">
<location>
<position position="328"/>
</location>
</feature>
<feature type="disulfide bond" evidence="2">
<location>
<begin position="53"/>
<end position="116"/>
</location>
</feature>
<feature type="disulfide bond" evidence="2">
<location>
<begin position="162"/>
<end position="214"/>
</location>
</feature>
<feature type="disulfide bond" evidence="2">
<location>
<begin position="265"/>
<end position="331"/>
</location>
</feature>
<feature type="sequence variant" description="In a breast cancer sample; somatic mutation." id="VAR_036592" evidence="7">
<original>F</original>
<variation>L</variation>
<location>
<position position="606"/>
</location>
</feature>
<evidence key="1" type="ECO:0000255"/>
<evidence key="2" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00114"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00204"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10882729"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11031108"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11587848"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16959974"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000305"/>
<sequence length="686" mass="78670" checksum="E400F7ECD186957C" modified="2000-10-01" version="1" precursor="true">MKPPFLLALVVCSVVSTNLKMVSKRNSVDGCIDWSVDLKTYMALAGEPVRVKCALFYSYIRTNYSTAQSTGLRLMWYKNKGDLEEPIIFSEVRMSKEEDSIWFHSAEAQDSGFYTCVLRNSTYCMKVSMSLTVAENESGLCYNSRIRYLEKSEVTKRKEISCPDMDDFKKSDQEPDVVWYKECKPKMWRSIIIQKGNALLIQEVQEEDGGNYTCELKYEGKLVRRTTELKVTALLTDKPPKPLFPMENQPSVIDVQLGKPLNIPCKAFFGFSGESGPMIYWMKGEKFIEELAGHIREGEIRLLKEHLGEKEVELALIFDSVVEADLANYTCHVENRNGRKHASVLLRKKDLIYKIELAGGLGAIFLLLVLLVVIYKCYNIELMLFYRQHFGADETNDDNKEYDAYLSYTKVDQDTLDCDNPEEEQFALEVLPDVLEKHYGYKLFIPERDLIPSGTYMEDLTRYVEQSRRLIIVLTPDYILRRGWSIFELESRLHNMLVSGEIKVILIECTELKGKVNCQEVESLKRSIKLLSLIKWKGSKSSKLNSKFWKHLVYEMPIKKKEMLPRCHVLDSAEQGLFGELQPIPSIAMTSTSATLVSSQADLPEFHPSDSMQIRHCCRGYKHEIPATTLPVPSLGNHHTYCNLPLTLLNGQLPLNNTLKDTQEFHRNSSLLPLSSKELSFTSDIW</sequence>
</entry>
<entry dataset="Swiss-Prot" created="2009-02-10" modified="2021-02-10" version="56">
<accession>B2LT62</accession>
<name>TLR2_CAPIB</name>
<protein>
<recommendedName>
<fullName>Toll-like receptor 2</fullName>
<ecNumber evidence="5">3.2.2.6</ecNumber>
</recommendedName>
<cdAntigenName>CD282</cdAntigenName>
</protein>
<gene>
<name type="primary">TLR2</name>
</gene>
<organism>
<name type="scientific">Capra ibex</name>
<name type="common">Ibex</name>
<dbReference type="NCBI Taxonomy" id="72542"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Laurasiatheria</taxon>
<taxon>Artiodactyla</taxon>
<taxon>Ruminantia</taxon>
<taxon>Pecora</taxon>
<taxon>Bovidae</taxon>
<taxon>Caprinae</taxon>
<taxon>Capra</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="2008" name="BMC Evol. Biol." volume="8" first="288" last="288">
<title>Molecular evolution of bovine Toll-like receptor 2 suggests substitutions of functional relevance.</title>
<authorList>
<person name="Jann O.C."/>
<person name="Werling D."/>
<person name="Chang J.S."/>
<person name="Haig D."/>
<person name="Glass E.J."/>
</authorList>
<dbReference type="PubMed" id="18937834"/>
<dbReference type="DOI" id="10.1186/1471-2148-8-288"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<comment type="function">
<text evidence="2 3">Cooperates with LY96 to mediate the innate immune response to bacterial lipoproteins and other microbial cell wall components. Cooperates with TLR1 or TLR6 to mediate the innate immune response to bacterial lipoproteins or lipopeptides. Acts via MYD88 and TRAF6, leading to NF-kappa-B activation, cytokine secretion and the inflammatory response (By similarity). May also promote apoptosis in response to lipoproteins. Forms activation clusters composed of several receptors depending on the ligand, these clusters trigger signaling from the cell surface and subsequently are targeted to the Golgi in a lipid-raft dependent pathway. Forms the cluster TLR2:TLR6:CD14:CD36 in response to diacylated lipopeptides and TLR2:TLR1:CD14 in response to triacylated lipopeptides (By similarity).</text>
</comment>
<comment type="catalytic activity">
<reaction evidence="5">
<text>H2O + NAD(+) = ADP-D-ribose + H(+) + nicotinamide</text>
<dbReference type="Rhea" id="RHEA:16301"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:17154"/>
<dbReference type="ChEBI" id="CHEBI:57540"/>
<dbReference type="ChEBI" id="CHEBI:57967"/>
<dbReference type="EC" id="3.2.2.6"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="5">
<dbReference type="Rhea" id="RHEA:16302"/>
</physiologicalReaction>
</comment>
<comment type="subunit">
<text evidence="2 3">Interacts with LY96, TLR1 and TLR6 (via extracellular domain). TLR2 seems to exist in heterodimers with either TLR1 or TLR6 before stimulation by the ligand. The heterodimers form bigger oligomers in response to their corresponding ligands as well as further heterotypic associations with other receptors such as CD14 and/or CD36. Binds MYD88 (via TIR domain). Interacts with TICAM1. Interacts with CNPY3. Interacts with ATG16L1. Interacts with PPP1R11.</text>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="3">Membrane</location>
<topology evidence="4">Single-pass type I membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="3">Cytoplasmic vesicle</location>
<location evidence="3">Phagosome membrane</location>
<topology evidence="4">Single-pass type I membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="2">Membrane raft</location>
</subcellularLocation>
<text evidence="2">Does not reside in lipid rafts before stimulation but accumulates increasingly in the raft upon the presence of the microbial ligand. In response to diacylated lipoproteins, TLR2:TLR6 heterodimers are recruited in lipid rafts, this recruitment determine the intracellular targeting to the Golgi apparatus. Triacylated lipoproteins induce the same mechanism for TLR2:TLR1 heterodimers.</text>
</comment>
<comment type="domain">
<text evidence="1">Ester-bound lipid substrates are bound through a crevice formed between the LRR 11 and LRR 12.</text>
</comment>
<comment type="domain">
<text evidence="1">The ATG16L1-binding motif mediates interaction with ATG16L1.</text>
</comment>
<comment type="domain">
<text evidence="5">The TIR domain mediates NAD(+) hydrolase (NADase) activity. Self-association of TIR domains is required for NADase activity.</text>
</comment>
<comment type="PTM">
<text evidence="3">Ubiquitinated at Lys-754 by PPP1R11, leading to its degradation. Deubiquitinated by USP2.</text>
</comment>
<comment type="PTM">
<text evidence="2">Glycosylation of Asn-442 is critical for secretion of the N-terminal ectodomain of TLR2.</text>
</comment>
<comment type="similarity">
<text evidence="6">Belongs to the Toll-like receptor family.</text>
</comment>
<dbReference type="EC" id="3.2.2.6" evidence="5"/>
<dbReference type="EMBL" id="EU580540">
<property type="protein sequence ID" value="ACB72729.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="SMR" id="B2LT62"/>
<dbReference type="GO" id="GO:0005794">
<property type="term" value="C:Golgi apparatus"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016021">
<property type="term" value="C:integral component of membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0045121">
<property type="term" value="C:membrane raft"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030670">
<property type="term" value="C:phagocytic vesicle membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0050135">
<property type="term" value="F:NAD(P)+ nucleosidase activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0061809">
<property type="term" value="F:NAD+ nucleotidase, cyclic ADP-ribose generating"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0004888">
<property type="term" value="F:transmembrane signaling receptor activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0071726">
<property type="term" value="P:cellular response to diacyl bacterial lipopeptide"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071727">
<property type="term" value="P:cellular response to triacyl bacterial lipopeptide"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006954">
<property type="term" value="P:inflammatory response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0045087">
<property type="term" value="P:innate immune response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0002755">
<property type="term" value="P:MyD88-dependent toll-like receptor signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0050729">
<property type="term" value="P:positive regulation of inflammatory response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0034134">
<property type="term" value="P:toll-like receptor 2 signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="Gene3D" id="3.40.50.10140">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="3.80.10.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR000483">
<property type="entry name" value="Cys-rich_flank_reg_C"/>
</dbReference>
<dbReference type="InterPro" id="IPR001611">
<property type="entry name" value="Leu-rich_rpt"/>
</dbReference>
<dbReference type="InterPro" id="IPR003591">
<property type="entry name" value="Leu-rich_rpt_typical-subtyp"/>
</dbReference>
<dbReference type="InterPro" id="IPR032675">
<property type="entry name" value="LRR_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR000157">
<property type="entry name" value="TIR_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR027185">
<property type="entry name" value="TLR2"/>
</dbReference>
<dbReference type="InterPro" id="IPR017241">
<property type="entry name" value="Toll-like_receptor"/>
</dbReference>
<dbReference type="InterPro" id="IPR035897">
<property type="entry name" value="Toll_tir_struct_dom_sf"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR24365">
<property type="entry name" value="PTHR24365"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR24365:SF17">
<property type="entry name" value="PTHR24365:SF17"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF13855">
<property type="entry name" value="LRR_8"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="Pfam" id="PF01582">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PIRSF" id="PIRSF037595">
<property type="entry name" value="Toll-like_receptor"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00369">
<property type="entry name" value="LRR_TYP"/>
<property type="match status" value="6"/>
</dbReference>
<dbReference type="SMART" id="SM00082">
<property type="entry name" value="LRRCT"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00255">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF52200">
<property type="entry name" value="SSF52200"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51450">
<property type="entry name" value="LRR"/>
<property type="match status" value="10"/>
</dbReference>
<dbReference type="PROSITE" id="PS50104">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="inferred from homology"/>
<keyword id="KW-0968">Cytoplasmic vesicle</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0378">Hydrolase</keyword>
<keyword id="KW-0391">Immunity</keyword>
<keyword id="KW-0395">Inflammatory response</keyword>
<keyword id="KW-0399">Innate immunity</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0433">Leucine-rich repeat</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0520">NAD</keyword>
<keyword id="KW-0675">Receptor</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0732">Signal</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="signal peptide" evidence="4">
<location>
<begin position="1"/>
<end position="20"/>
</location>
</feature>
<feature type="chain" description="Toll-like receptor 2" id="PRO_0000363772">
<location>
<begin position="21"/>
<end position="784"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="4">
<location>
<begin position="21"/>
<end position="587"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="4">
<location>
<begin position="588"/>
<end position="608"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="4">
<location>
<begin position="609"/>
<end position="784"/>
</location>
</feature>
<feature type="repeat" description="LRR 1">
<location>
<begin position="54"/>
<end position="77"/>
</location>
</feature>
<feature type="repeat" description="LRR 2">
<location>
<begin position="78"/>
<end position="101"/>
</location>
</feature>
<feature type="repeat" description="LRR 3">
<location>
<begin position="102"/>
<end position="125"/>
</location>
</feature>
<feature type="repeat" description="LRR 4">
<location>
<begin position="126"/>
<end position="150"/>
</location>
</feature>
<feature type="repeat" description="LRR 5">
<location>
<begin position="151"/>
<end position="175"/>
</location>
</feature>
<feature type="repeat" description="LRR 6">
<location>
<begin position="176"/>
<end position="199"/>
</location>
</feature>
<feature type="repeat" description="LRR 7">
<location>
<begin position="200"/>
<end position="223"/>
</location>
</feature>
<feature type="repeat" description="LRR 8">
<location>
<begin position="224"/>
<end position="250"/>
</location>
</feature>
<feature type="repeat" description="LRR 9">
<location>
<begin position="251"/>
<end position="278"/>
</location>
</feature>
<feature type="repeat" description="LRR 10">
<location>
<begin position="279"/>
<end position="308"/>
</location>
</feature>
<feature type="repeat" description="LRR 11">
<location>
<begin position="309"/>
<end position="337"/>
</location>
</feature>
<feature type="repeat" description="LRR 12">
<location>
<begin position="338"/>
<end position="361"/>
</location>
</feature>
<feature type="repeat" description="LRR 13">
<location>
<begin position="362"/>
<end position="388"/>
</location>
</feature>
<feature type="repeat" description="LRR 14">
<location>
<begin position="389"/>
<end position="414"/>
</location>
</feature>
<feature type="repeat" description="LRR 15">
<location>
<begin position="415"/>
<end position="437"/>
</location>
</feature>
<feature type="repeat" description="LRR 16">
<location>
<begin position="438"/>
<end position="457"/>
</location>
</feature>
<feature type="repeat" description="LRR 17">
<location>
<begin position="458"/>
<end position="478"/>
</location>
</feature>
<feature type="repeat" description="LRR 18">
<location>
<begin position="479"/>
<end position="500"/>
</location>
</feature>
<feature type="repeat" description="LRR 19">
<location>
<begin position="501"/>
<end position="524"/>
</location>
</feature>
<feature type="domain" description="LRRCT">
<location>
<begin position="525"/>
<end position="579"/>
</location>
</feature>
<feature type="domain" description="TIR" evidence="5">
<location>
<begin position="639"/>
<end position="782"/>
</location>
</feature>
<feature type="short sequence motif" description="ATG16L1-binding motif">
<location>
<begin position="761"/>
<end position="778"/>
</location>
</feature>
<feature type="active site" evidence="5">
<location>
<position position="716"/>
</location>
</feature>
<feature type="site" description="Interaction with bacterial lipopeptide" evidence="1">
<location>
<position position="349"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="114"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="199"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="248"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="442"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1">
<location>
<begin position="30"/>
<end position="36"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1">
<location>
<begin position="353"/>
<end position="382"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1">
<location>
<begin position="432"/>
<end position="454"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="2">
<location>
<position position="754"/>
</location>
</feature>
<evidence key="1" type="ECO:0000250"/>
<evidence key="2" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="O60603"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q9QUN7"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000255"/>
<evidence key="5" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00204"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000305"/>
<sequence length="784" mass="90147" checksum="B618180B2C5DB02F" modified="2008-06-10" version="1" precursor="true">MPRALWTAWVWAVISAFTEGASDQASSLSCDPTGVCDGHSRSLNSIPSGLTAGVKSLDLSDNEITYVGNRDLQRCVNLKTLRLGANEIHTVEEDSFFHLRNLEYLDLSYNRLSNLSSSWFRSLYVLKFLNLLGNLYKTLGETSLFSHLPNLRTLKVGNSNSFTQIHEKDFTGLTFLEELEISAQNLQLYVPKSLKSIQNISHLILHLKQPVLLLDILIDIVSSLDYLELRDTNLHTFYFSEASISEINTSVKKLIFRNVQFTDESFVEVVKLFNYVSGILEVEFDDCTHDGIGDFTALTLNRIRYLGNVETLTIRKLHIPQFFLFYDLSSIYPLTGKVKRVTIENSKVFLVPCLLSQHLKSLEYLDLSENLMSEETLRNSACEHAWPFLQTLVLRQNRLKSLEKTGELLLTLKNLNNLDISKNNFLSMPETCQWPGKMKQLNLSSTRIHSLTQCLPQTLEILDVSNNNLDSFSLILPQLKELYISRNKLKTLPDASFLPVLSVMRISGNIINTFSKEQLDSFPQLKALEAGGNNFICSCDFLSFTQGQQALARVLVDWPDGYRCDAPSHVRGQRVQDARLSLSECHRAAVVSAVCCALFLLLLLTGVLCHRFHGLWYMKMMWAWLQAKRKPRKAPRRDLCYDAFVSYSEQDSYWVENLMVQELEHFNPPFKLCLHKRDFVPGKWIIDNIIDSIEKSRKTIFVLSENFVRSEWCKYELDFSHFRLFDENNDAAILILLEPIDKKAIPQRFCKLRKIMNTKTYLEWPTDETQQEAFWLNLRAAIRS</sequence>
</entry>
<entry dataset="Swiss-Prot" created="2009-02-10" modified="2021-02-10" version="54">
<accession>B5T267</accession>
<accession>B1A0T3</accession>
<accession>B5T264</accession>
<name>TLR2_BOSIN</name>
<protein>
<recommendedName>
<fullName>Toll-like receptor 2</fullName>
<ecNumber evidence="5">3.2.2.6</ecNumber>
</recommendedName>
<cdAntigenName>CD282</cdAntigenName>
</protein>
<gene>
<name type="primary">TLR2</name>
</gene>
<organism>
<name type="scientific">Bos indicus</name>
<name type="common">Zebu</name>
<dbReference type="NCBI Taxonomy" id="9915"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Laurasiatheria</taxon>
<taxon>Artiodactyla</taxon>
<taxon>Ruminantia</taxon>
<taxon>Pecora</taxon>
<taxon>Bovidae</taxon>
<taxon>Bovinae</taxon>
<taxon>Bos</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="2008" name="Genomics" volume="92" first="235" last="245">
<title>Analysis of sequence variability and protein domain architectures for bovine peptidoglycan recognition protein 1 and Toll-like receptors 2 and 6.</title>
<authorList>
<person name="Seabury C.M."/>
<person name="Womack J.E."/>
</authorList>
<dbReference type="PubMed" id="18639626"/>
<dbReference type="DOI" id="10.1016/j.ygeno.2008.06.005"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>VARIANTS GLY-68; PHE-227 AND THR-605</scope>
<source>
<strain>Isolate 23</strain>
<strain>Isolate 86</strain>
</source>
</reference>
<reference key="2">
<citation type="submission" date="2008-01" db="EMBL/GenBank/DDBJ databases">
<title>Bos indicus Toll-like receptor 2.</title>
<authorList>
<person name="Tantia M.S."/>
<person name="Mishra B."/>
<person name="Bharani Kumar S.T."/>
<person name="Vijh R.K."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<comment type="function">
<text evidence="2 3">Cooperates with LY96 to mediate the innate immune response to bacterial lipoproteins and other microbial cell wall components. Cooperates with TLR1 or TLR6 to mediate the innate immune response to bacterial lipoproteins or lipopeptides. Acts via MYD88 and TRAF6, leading to NF-kappa-B activation, cytokine secretion and the inflammatory response (By similarity). May also promote apoptosis in response to lipoproteins. Forms activation clusters composed of several receptors depending on the ligand, these clusters trigger signaling from the cell surface and subsequently are targeted to the Golgi in a lipid-raft dependent pathway. Forms the cluster TLR2:TLR6:CD14:CD36 in response to diacylated lipopeptides and TLR2:TLR1:CD14 in response to triacylated lipopeptides (By similarity).</text>
</comment>
<comment type="catalytic activity">
<reaction evidence="5">
<text>H2O + NAD(+) = ADP-D-ribose + H(+) + nicotinamide</text>
<dbReference type="Rhea" id="RHEA:16301"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:17154"/>
<dbReference type="ChEBI" id="CHEBI:57540"/>
<dbReference type="ChEBI" id="CHEBI:57967"/>
<dbReference type="EC" id="3.2.2.6"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="5">
<dbReference type="Rhea" id="RHEA:16302"/>
</physiologicalReaction>
</comment>
<comment type="subunit">
<text evidence="2 3">Interacts with LY96, TLR1 and TLR6 (via extracellular domain). TLR2 seems to exist in heterodimers with either TLR1 or TLR6 before stimulation by the ligand. The heterodimers form bigger oligomers in response to their corresponding ligands as well as further heterotypic associations with other receptors such as CD14 and/or CD36. Binds MYD88 (via TIR domain). Interacts with TICAM1. Interacts with CNPY3. Interacts with ATG16L1. Interacts with PPP1R11. Interacts with TICAM2.</text>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="3">Membrane</location>
<topology evidence="4">Single-pass type I membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="3">Cytoplasmic vesicle</location>
<location evidence="3">Phagosome membrane</location>
<topology evidence="4">Single-pass type I membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="2">Membrane raft</location>
</subcellularLocation>
<text evidence="2">Does not reside in lipid rafts before stimulation but accumulates increasingly in the raft upon the presence of the microbial ligand. In response to diacylated lipoproteins, TLR2:TLR6 heterodimers are recruited in lipid rafts, this recruitment determine the intracellular targeting to the Golgi apparatus. Triacylated lipoproteins induce the same mechanism for TLR2:TLR1 heterodimers.</text>
</comment>
<comment type="domain">
<text evidence="1">Ester-bound lipid substrates are bound through a crevice formed between the LRR 11 and LRR 12.</text>
</comment>
<comment type="domain">
<text evidence="1">The ATG16L1-binding motif mediates interaction with ATG16L1.</text>
</comment>
<comment type="domain">
<text evidence="5">The TIR domain mediates NAD(+) hydrolase (NADase) activity. Self-association of TIR domains is required for NADase activity.</text>
</comment>
<comment type="PTM">
<text evidence="3">Ubiquitinated at Lys-754 by PPP1R11, leading to its degradation. Deubiquitinated by USP2.</text>
</comment>
<comment type="PTM">
<text evidence="2">Glycosylation of Asn-442 is critical for secretion of the N-terminal ectodomain of TLR2.</text>
</comment>
<comment type="similarity">
<text evidence="7">Belongs to the Toll-like receptor family.</text>
</comment>
<dbReference type="EC" id="3.2.2.6" evidence="5"/>
<dbReference type="EMBL" id="EU746458">
<property type="protein sequence ID" value="ACH92787.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="EU746461">
<property type="protein sequence ID" value="ACH92790.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="EU413951">
<property type="protein sequence ID" value="ABY90177.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="GO" id="GO:0005794">
<property type="term" value="C:Golgi apparatus"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016021">
<property type="term" value="C:integral component of membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0045121">
<property type="term" value="C:membrane raft"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030670">
<property type="term" value="C:phagocytic vesicle membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0050135">
<property type="term" value="F:NAD(P)+ nucleosidase activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0061809">
<property type="term" value="F:NAD+ nucleotidase, cyclic ADP-ribose generating"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0004888">
<property type="term" value="F:transmembrane signaling receptor activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0071726">
<property type="term" value="P:cellular response to diacyl bacterial lipopeptide"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071727">
<property type="term" value="P:cellular response to triacyl bacterial lipopeptide"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006954">
<property type="term" value="P:inflammatory response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0045087">
<property type="term" value="P:innate immune response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0002755">
<property type="term" value="P:MyD88-dependent toll-like receptor signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0050729">
<property type="term" value="P:positive regulation of inflammatory response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0034134">
<property type="term" value="P:toll-like receptor 2 signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="Gene3D" id="3.40.50.10140">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="3.80.10.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR000483">
<property type="entry name" value="Cys-rich_flank_reg_C"/>
</dbReference>
<dbReference type="InterPro" id="IPR001611">
<property type="entry name" value="Leu-rich_rpt"/>
</dbReference>
<dbReference type="InterPro" id="IPR003591">
<property type="entry name" value="Leu-rich_rpt_typical-subtyp"/>
</dbReference>
<dbReference type="InterPro" id="IPR032675">
<property type="entry name" value="LRR_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR000157">
<property type="entry name" value="TIR_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR027185">
<property type="entry name" value="TLR2"/>
</dbReference>
<dbReference type="InterPro" id="IPR017241">
<property type="entry name" value="Toll-like_receptor"/>
</dbReference>
<dbReference type="InterPro" id="IPR035897">
<property type="entry name" value="Toll_tir_struct_dom_sf"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR24365">
<property type="entry name" value="PTHR24365"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR24365:SF17">
<property type="entry name" value="PTHR24365:SF17"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF13855">
<property type="entry name" value="LRR_8"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="Pfam" id="PF01582">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PIRSF" id="PIRSF037595">
<property type="entry name" value="Toll-like_receptor"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00369">
<property type="entry name" value="LRR_TYP"/>
<property type="match status" value="7"/>
</dbReference>
<dbReference type="SMART" id="SM00082">
<property type="entry name" value="LRRCT"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00255">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF52200">
<property type="entry name" value="SSF52200"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51450">
<property type="entry name" value="LRR"/>
<property type="match status" value="11"/>
</dbReference>
<dbReference type="PROSITE" id="PS50104">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="inferred from homology"/>
<keyword id="KW-0968">Cytoplasmic vesicle</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0378">Hydrolase</keyword>
<keyword id="KW-0391">Immunity</keyword>
<keyword id="KW-0395">Inflammatory response</keyword>
<keyword id="KW-0399">Innate immunity</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0433">Leucine-rich repeat</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0520">NAD</keyword>
<keyword id="KW-0675">Receptor</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0732">Signal</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="signal peptide" evidence="4">
<location>
<begin position="1"/>
<end position="20"/>
</location>
</feature>
<feature type="chain" description="Toll-like receptor 2" id="PRO_0000363767">
<location>
<begin position="21"/>
<end position="784"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="4">
<location>
<begin position="21"/>
<end position="587"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="4">
<location>
<begin position="588"/>
<end position="608"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="4">
<location>
<begin position="609"/>
<end position="784"/>
</location>
</feature>
<feature type="repeat" description="LRR 1">
<location>
<begin position="54"/>
<end position="77"/>
</location>
</feature>
<feature type="repeat" description="LRR 2">
<location>
<begin position="78"/>
<end position="101"/>
</location>
</feature>
<feature type="repeat" description="LRR 3">
<location>
<begin position="102"/>
<end position="125"/>
</location>
</feature>
<feature type="repeat" description="LRR 4">
<location>
<begin position="126"/>
<end position="150"/>
</location>
</feature>
<feature type="repeat" description="LRR 5">
<location>
<begin position="151"/>
<end position="175"/>
</location>
</feature>
<feature type="repeat" description="LRR 6">
<location>
<begin position="176"/>
<end position="199"/>
</location>
</feature>
<feature type="repeat" description="LRR 7">
<location>
<begin position="200"/>
<end position="223"/>
</location>
</feature>
<feature type="repeat" description="LRR 8">
<location>
<begin position="224"/>
<end position="250"/>
</location>
</feature>
<feature type="repeat" description="LRR 9">
<location>
<begin position="251"/>
<end position="278"/>
</location>
</feature>
<feature type="repeat" description="LRR 10">
<location>
<begin position="279"/>
<end position="308"/>
</location>
</feature>
<feature type="repeat" description="LRR 11">
<location>
<begin position="309"/>
<end position="337"/>
</location>
</feature>
<feature type="repeat" description="LRR 12">
<location>
<begin position="338"/>
<end position="361"/>
</location>
</feature>
<feature type="repeat" description="LRR 13">
<location>
<begin position="362"/>
<end position="388"/>
</location>
</feature>
<feature type="repeat" description="LRR 14">
<location>
<begin position="389"/>
<end position="414"/>
</location>
</feature>
<feature type="repeat" description="LRR 15">
<location>
<begin position="415"/>
<end position="437"/>
</location>
</feature>
<feature type="repeat" description="LRR 16">
<location>
<begin position="438"/>
<end position="457"/>
</location>
</feature>
<feature type="repeat" description="LRR 17">
<location>
<begin position="458"/>
<end position="478"/>
</location>
</feature>
<feature type="repeat" description="LRR 18">
<location>
<begin position="479"/>
<end position="500"/>
</location>
</feature>
<feature type="repeat" description="LRR 19">
<location>
<begin position="501"/>
<end position="524"/>
</location>
</feature>
<feature type="domain" description="LRRCT">
<location>
<begin position="525"/>
<end position="579"/>
</location>
</feature>
<feature type="domain" description="TIR" evidence="5">
<location>
<begin position="639"/>
<end position="782"/>
</location>
</feature>
<feature type="short sequence motif" description="ATG16L1-binding motif">
<location>
<begin position="761"/>
<end position="778"/>
</location>
</feature>
<feature type="active site" evidence="5">
<location>
<position position="716"/>
</location>
</feature>
<feature type="site" description="Interaction with bacterial lipopeptide" evidence="1">
<location>
<position position="349"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="114"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="199"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="442"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1">
<location>
<begin position="30"/>
<end position="36"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1">
<location>
<begin position="353"/>
<end position="382"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1">
<location>
<begin position="432"/>
<end position="454"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="2">
<location>
<position position="754"/>
</location>
</feature>
<feature type="sequence variant" evidence="6">
<original>S</original>
<variation>G</variation>
<location>
<position position="68"/>
</location>
</feature>
<feature type="sequence variant" evidence="6">
<original>L</original>
<variation>F</variation>
<location>
<position position="227"/>
</location>
</feature>
<feature type="sequence variant" evidence="6">
<original>M</original>
<variation>T</variation>
<location>
<position position="605"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; ABY90177." ref="2" evidence="7">
<original>P</original>
<variation>Q</variation>
<location>
<position position="149"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; ABY90177." ref="2" evidence="7">
<original>T</original>
<variation>I</variation>
<location>
<position position="335"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; ABY90177." ref="2" evidence="7">
<original>N</original>
<variation>S</variation>
<location>
<position position="345"/>
</location>
</feature>
<evidence key="1" type="ECO:0000250"/>
<evidence key="2" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="O60603"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q9QUN7"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000255"/>
<evidence key="5" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00204"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18639626"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000305"/>
<sequence length="784" mass="90173" checksum="560D12665561A689" modified="2008-11-04" version="1" precursor="true">MPRALWTAWVWAVIILSTEGASDQASSLSCDPTGVCDGHSRSLNSIPSGLTAGVKSLDLSNNEITYVSNRDLQRCVNLKTLRLGANEIHTVEEDSFFHLRNLEYLDLSYNRLSNLSSSWFRSLYVLKFLNLLGNLYKTLGETSLFSHLPNLRTLKVGNSNSFTEIHEKDFTGLTFLEELEISAQNLQIYVPKSLKSIQNISHLILHLKQPVLLVDILVDIVSSLDCLELRDTNLHTFHFSEASISEMSTSVKKLIFRNVQFTDESFVEVVKLFNYVSGILEVEFDDCTHDGIGDFRALSLDRIRHLGNVETLTIRKLHIPQFFLFQDLSSIYPLTGKVKRVTIENSKVFLVPCLLSQHLKSLEYLDLSENLMSEETLKNSACKDAWPFLQTLVLRQNRLKSLEKXGELLLTLENLNSLDISKNNFLSMPETCQWPGKMKQLNLSSTRIHSLTQCLPQTLEILDVSNNNLDSFSLILPQLKELYISRNKLKTLPDASFLPVLXVMRISRNIINTFSKEQLDSFQQLKTLEAGGNNFICSCDFLSFTQGQQALGRVLVDWPDDYHCDSPSHVRGQRVQDARLSLSECHRAAVVSAACCALFLLLLLMGVLCHRFHGLWYMKMMWAWLQAKRKPRKAPRRDICYDAFVSYSERDSYWVENLMVQELEQFNPPFKLCLHKRDFIPGKWIIDNIIDSIEKSHKTIFVLSENFVKSEWCKYELDFSHFRLFDENNDAAILILLEPIDKKAIPQRFCKLRKIMNTKTYLEWPVDETQQEGFWLNLRAAIRS</sequence>
</entry>
<entry dataset="Swiss-Prot" created="2003-08-22" modified="2020-12-02" version="144">
<accession>Q9ERS6</accession>
<accession>Q9ER66</accession>
<name>IRPL2_MOUSE</name>
<protein>
<recommendedName>
<fullName>X-linked interleukin-1 receptor accessory protein-like 2</fullName>
<shortName>IL-1 receptor accessory protein-like 2</shortName>
<shortName>IL-1-RAPL-2</shortName>
<shortName>IL-1RAPL-2</shortName>
<shortName>IL1RAPL-2</shortName>
<ecNumber evidence="3">3.2.2.6</ecNumber>
</recommendedName>
<alternativeName>
<fullName>IL1RAPL-2-related protein</fullName>
</alternativeName>
<alternativeName>
<fullName>Three immunoglobulin domain-containing IL-1 receptor-related 1</fullName>
<shortName>TIGIRR-1</shortName>
</alternativeName>
</protein>
<gene>
<name type="primary">Il1rapl2</name>
</gene>
<organism>
<name type="scientific">Mus musculus</name>
<name type="common">Mouse</name>
<dbReference type="NCBI Taxonomy" id="10090"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Glires</taxon>
<taxon>Rodentia</taxon>
<taxon>Myomorpha</taxon>
<taxon>Muroidea</taxon>
<taxon>Muridae</taxon>
<taxon>Murinae</taxon>
<taxon>Mus</taxon>
<taxon>Mus</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="2000" name="J. Biol. Chem." volume="275" first="29946" last="29954">
<title>Identification and characterization of two members of a novel class of the interleukin-1 receptor (IL-1R) family. Delineation of a new class of IL-1R-related proteins based on signaling.</title>
<authorList>
<person name="Born T.L."/>
<person name="Smith D.E."/>
<person name="Garka K.E."/>
<person name="Renshaw B.R."/>
<person name="Bertles J.S."/>
<person name="Sims J.E."/>
</authorList>
<dbReference type="PubMed" id="10882729"/>
<dbReference type="DOI" id="10.1074/jbc.m004077200"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Brain</tissue>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="2001" name="Gene" volume="275" first="217" last="221">
<title>IL1RAPL2 maps to Xq22 and is specifically expressed in the central nervous system.</title>
<authorList>
<person name="Ferrante M.I."/>
<person name="Ghiani M."/>
<person name="Bulfone A."/>
<person name="Franco B."/>
</authorList>
<dbReference type="PubMed" id="11587848"/>
<dbReference type="DOI" id="10.1016/s0378-1119(01)00659-x"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2)</scope>
<scope>TISSUE SPECIFICITY</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<comment type="catalytic activity">
<reaction evidence="3">
<text>H2O + NAD(+) = ADP-D-ribose + H(+) + nicotinamide</text>
<dbReference type="Rhea" id="RHEA:16301"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:17154"/>
<dbReference type="ChEBI" id="CHEBI:57540"/>
<dbReference type="ChEBI" id="CHEBI:57967"/>
<dbReference type="EC" id="3.2.2.6"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="3">
<dbReference type="Rhea" id="RHEA:16302"/>
</physiologicalReaction>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location>Membrane</location>
<topology>Single-pass type I membrane protein</topology>
</subcellularLocation>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>Q9ERS6-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>Q9ERS6-2</id>
<name>2</name>
<sequence type="described" ref="VSP_008056 VSP_008057"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="4">Detected in fetal brain after day 12.5, in particular in parts of the diencephalon and in the basal plate of the spinal cord. In postnatal brain detected in cerebral cortex, olfactory bulb, in the CA1 region of the hippocampus and in Purkinje cells of the Xth cerebellar lobule.</text>
</comment>
<comment type="domain">
<text evidence="3">The TIR domain mediates NAD(+) hydrolase (NADase) activity. Self-association of TIR domains is required for NADase activity.</text>
</comment>
<comment type="miscellaneous">
<molecule>Isoform 2</molecule>
<text evidence="6">may be due to an intron retention.</text>
</comment>
<comment type="similarity">
<text evidence="6">Belongs to the interleukin-1 receptor family.</text>
</comment>
<dbReference type="EC" id="3.2.2.6" evidence="3"/>
<dbReference type="EMBL" id="AF284437">
<property type="protein sequence ID" value="AAG21371.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AJ277831">
<property type="protein sequence ID" value="CAC10559.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS30429.1">
<molecule id="Q9ERS6-1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_109613.1">
<molecule id="Q9ERS6-1"/>
<property type="nucleotide sequence ID" value="NM_030688.2"/>
</dbReference>
<dbReference type="SMR" id="Q9ERS6"/>
<dbReference type="STRING" id="10090.ENSMUSP00000108686"/>
<dbReference type="GlyGen" id="Q9ERS6">
<property type="glycosylation" value="5 sites"/>
</dbReference>
<dbReference type="iPTMnet" id="Q9ERS6"/>
<dbReference type="PhosphoSitePlus" id="Q9ERS6"/>
<dbReference type="PaxDb" id="Q9ERS6"/>
<dbReference type="PRIDE" id="Q9ERS6"/>
<dbReference type="Antibodypedia" id="35255">
<property type="antibodies" value="272 antibodies"/>
</dbReference>
<dbReference type="Ensembl" id="ENSMUST00000075471">
<molecule id="Q9ERS6-1"/>
<property type="protein sequence ID" value="ENSMUSP00000074917"/>
<property type="gene ID" value="ENSMUSG00000059203"/>
</dbReference>
<dbReference type="Ensembl" id="ENSMUST00000113063">
<molecule id="Q9ERS6-1"/>
<property type="protein sequence ID" value="ENSMUSP00000108686"/>
<property type="gene ID" value="ENSMUSG00000059203"/>
</dbReference>
<dbReference type="GeneID" id="60367"/>
<dbReference type="KEGG" id="mmu:60367"/>
<dbReference type="UCSC" id="uc009ujt.1">
<molecule id="Q9ERS6-2"/>
<property type="organism name" value="mouse"/>
</dbReference>
<dbReference type="UCSC" id="uc009ujv.1">
<molecule id="Q9ERS6-1"/>
<property type="organism name" value="mouse"/>
</dbReference>
<dbReference type="CTD" id="26280"/>
<dbReference type="MGI" id="MGI:1913106">
<property type="gene designation" value="Il1rapl2"/>
</dbReference>
<dbReference type="eggNOG" id="KOG3971">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT01010000222456"/>
<dbReference type="HOGENOM" id="CLU_025552_0_1_1"/>
<dbReference type="InParanoid" id="Q9ERS6"/>
<dbReference type="OMA" id="QMRHYCR"/>
<dbReference type="PhylomeDB" id="Q9ERS6"/>
<dbReference type="TreeFam" id="TF333913"/>
<dbReference type="Reactome" id="R-MMU-388844">
<property type="pathway name" value="Receptor-type tyrosine-protein phosphatases"/>
</dbReference>
<dbReference type="BioGRID-ORCS" id="60367">
<property type="hits" value="0 hits in 12 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="Il1rapl2">
<property type="organism name" value="mouse"/>
</dbReference>
<dbReference type="PRO" id="PR:Q9ERS6"/>
<dbReference type="Proteomes" id="UP000000589">
<property type="component" value="Chromosome X"/>
</dbReference>
<dbReference type="RNAct" id="Q9ERS6">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSMUSG00000059203">
<property type="expression patterns" value="Expressed in brain and 68 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="Q9ERS6">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q9ERS6">
<property type="organism ID" value="MM"/>
</dbReference>
<dbReference type="GO" id="GO:0098978">
<property type="term" value="C:glutamatergic synapse"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0016021">
<property type="term" value="C:integral component of membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0004910">
<property type="term" value="F:interleukin-1, type II, blocking receptor activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0050135">
<property type="term" value="F:NAD(P)+ nucleosidase activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0061809">
<property type="term" value="F:NAD+ nucleotidase, cyclic ADP-ribose generating"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:1905606">
<property type="term" value="P:regulation of presynapse assembly"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="Gene3D" id="2.60.40.10">
<property type="match status" value="3"/>
</dbReference>
<dbReference type="Gene3D" id="3.40.50.10140">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR007110">
<property type="entry name" value="Ig-like_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR036179">
<property type="entry name" value="Ig-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR013783">
<property type="entry name" value="Ig-like_fold"/>
</dbReference>
<dbReference type="InterPro" id="IPR013098">
<property type="entry name" value="Ig_I-set"/>
</dbReference>
<dbReference type="InterPro" id="IPR003599">
<property type="entry name" value="Ig_sub"/>
</dbReference>
<dbReference type="InterPro" id="IPR003598">
<property type="entry name" value="Ig_sub2"/>
</dbReference>
<dbReference type="InterPro" id="IPR015621">
<property type="entry name" value="IL-1_rcpt_fam"/>
</dbReference>
<dbReference type="InterPro" id="IPR004077">
<property type="entry name" value="IL-1_rcpt_II-typ"/>
</dbReference>
<dbReference type="InterPro" id="IPR041416">
<property type="entry name" value="IL-1RAcP-like_ig"/>
</dbReference>
<dbReference type="InterPro" id="IPR000157">
<property type="entry name" value="TIR_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR035897">
<property type="entry name" value="Toll_tir_struct_dom_sf"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR11890">
<property type="entry name" value="PTHR11890"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF07679">
<property type="entry name" value="I-set"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF13895">
<property type="entry name" value="Ig_2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF18452">
<property type="entry name" value="Ig_6"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF01582">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR01539">
<property type="entry name" value="INTRLEUKN1R2"/>
</dbReference>
<dbReference type="SMART" id="SM00409">
<property type="entry name" value="IG"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="SMART" id="SM00408">
<property type="entry name" value="IGc2"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="SMART" id="SM00255">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF48726">
<property type="entry name" value="SSF48726"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF52200">
<property type="entry name" value="SSF52200"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50835">
<property type="entry name" value="IG_LIKE"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="PROSITE" id="PS50104">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at transcript level"/>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0378">Hydrolase</keyword>
<keyword id="KW-0393">Immunoglobulin domain</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0520">NAD</keyword>
<keyword id="KW-0675">Receptor</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0732">Signal</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<feature type="signal peptide" evidence="1">
<location>
<begin position="1"/>
<end position="16"/>
</location>
</feature>
<feature type="chain" description="X-linked interleukin-1 receptor accessory protein-like 2" id="PRO_0000015460">
<location>
<begin position="17"/>
<end position="686"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="1">
<location>
<begin position="17"/>
<end position="354"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="1">
<location>
<begin position="355"/>
<end position="375"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="1">
<location>
<begin position="376"/>
<end position="686"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 1">
<location>
<begin position="32"/>
<end position="132"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 2">
<location>
<begin position="141"/>
<end position="232"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 3">
<location>
<begin position="239"/>
<end position="347"/>
</location>
</feature>
<feature type="domain" description="TIR" evidence="3">
<location>
<begin position="400"/>
<end position="556"/>
</location>
</feature>
<feature type="active site" evidence="3">
<location>
<position position="488"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="1">
<location>
<position position="63"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="1">
<location>
<position position="120"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="1">
<location>
<position position="136"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="1">
<location>
<position position="211"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="1">
<location>
<position position="328"/>
</location>
</feature>
<feature type="disulfide bond" evidence="2">
<location>
<begin position="53"/>
<end position="116"/>
</location>
</feature>
<feature type="disulfide bond" evidence="2">
<location>
<begin position="162"/>
<end position="214"/>
</location>
</feature>
<feature type="disulfide bond" evidence="2">
<location>
<begin position="265"/>
<end position="331"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_008056" evidence="5">
<original>DLIYK</original>
<variation>GILFS</variation>
<location>
<begin position="350"/>
<end position="354"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_008057" evidence="5">
<location>
<begin position="355"/>
<end position="686"/>
</location>
</feature>
<evidence key="1" type="ECO:0000255"/>
<evidence key="2" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00114"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00204"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11587848"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="11587848"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000305"/>
<sequence length="686" mass="78798" checksum="36160D1CDE9B8264" modified="2001-03-01" version="1" precursor="true">MKLPLLLALVVCSAVSTNLKMVSKRNSVDGCIDWSVDLKTYMALAGEPVRVKCALFYSYIRTNYSMAQSTGLRLMWYRNKGDLEEPIIFSEVRMSKEEDAIWFHSAEEQDSGFYTCVLRNSTYCMKVSMSLTVAENESGLCYNSRIRYLEKSEVTKRKEISCPDMDDFKKSDQEPDVVWYKECKPKMWRSIIIQKGNALLIQEVQEEDGGNYTCELKYEGKLVRRTTELKVTALLTDKPPKPLFPMENQPSVIDVQLGKPLNIPCKAFFGFSGESGPMIYWMKGEKFIEELAGHIREGEIRLLKEHLGEKEVELTLIFDSVVEADLANYTCHVENRNGRKHASVLLRKKDLIYKIELAGGLGAIFLLLILLLVVYKCYNIELMLFYRQRFGGDETTDDNKEYDAYLSYTKVDQDTLDCDNTEEEQFALEILPDVLEKHYGYKLFIPERDLIPSGTYIEDLTRCVEQSRRLIIVLTPDYILRRGWSIFELESRLHNMLVSGEIKVILIECTELKGKVNCQEVESLKHNIKLLSLIKWKGPKSSKLNSKFWKHLVYEMPIKKKEMLSHCHVLDSAEQGLFGELQPIPSIAMTSTSATMVPSQADLPEFHHSDSMQMRHCCRGYQHEMPANTLSVPSLGNHHTYCNLPLTLLNGQLPLNNSLKETEEFSRNNPLLPLTSKELSFTSDIW</sequence>
</entry>
<entry dataset="Swiss-Prot" created="2009-02-10" modified="2021-02-10" version="56">
<accession>B2LT61</accession>
<name>TLR2_BISBI</name>
<protein>
<recommendedName>
<fullName>Toll-like receptor 2</fullName>
<ecNumber evidence="5">3.2.2.6</ecNumber>
</recommendedName>
<cdAntigenName>CD282</cdAntigenName>
</protein>
<gene>
<name type="primary">TLR2</name>
</gene>
<organism>
<name type="scientific">Bison bison</name>
<name type="common">American bison</name>
<name type="synonym">Bos bison</name>
<dbReference type="NCBI Taxonomy" id="9901"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Laurasiatheria</taxon>
<taxon>Artiodactyla</taxon>
<taxon>Ruminantia</taxon>
<taxon>Pecora</taxon>
<taxon>Bovidae</taxon>
<taxon>Bovinae</taxon>
<taxon>Bison</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="2008" name="BMC Evol. Biol." volume="8" first="288" last="288">
<title>Molecular evolution of bovine Toll-like receptor 2 suggests substitutions of functional relevance.</title>
<authorList>
<person name="Jann O.C."/>
<person name="Werling D."/>
<person name="Chang J.S."/>
<person name="Haig D."/>
<person name="Glass E.J."/>
</authorList>
<dbReference type="PubMed" id="18937834"/>
<dbReference type="DOI" id="10.1186/1471-2148-8-288"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<comment type="function">
<text evidence="2 3">Cooperates with LY96 to mediate the innate immune response to bacterial lipoproteins and other microbial cell wall components. Cooperates with TLR1 or TLR6 to mediate the innate immune response to bacterial lipoproteins or lipopeptides. Acts via MYD88 and TRAF6, leading to NF-kappa-B activation, cytokine secretion and the inflammatory response (By similarity). May also promote apoptosis in response to lipoproteins. Forms activation clusters composed of several receptors depending on the ligand, these clusters trigger signaling from the cell surface and subsequently are targeted to the Golgi in a lipid-raft dependent pathway. Forms the cluster TLR2:TLR6:CD14:CD36 in response to diacylated lipopeptides and TLR2:TLR1:CD14 in response to triacylated lipopeptides (By similarity).</text>
</comment>
<comment type="catalytic activity">
<reaction evidence="5">
<text>H2O + NAD(+) = ADP-D-ribose + H(+) + nicotinamide</text>
<dbReference type="Rhea" id="RHEA:16301"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:17154"/>
<dbReference type="ChEBI" id="CHEBI:57540"/>
<dbReference type="ChEBI" id="CHEBI:57967"/>
<dbReference type="EC" id="3.2.2.6"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="5">
<dbReference type="Rhea" id="RHEA:16302"/>
</physiologicalReaction>
</comment>
<comment type="subunit">
<text evidence="2 3">Interacts with LY96, TLR1 and TLR6 (via extracellular domain). TLR2 seems to exist in heterodimers with either TLR1 or TLR6 before stimulation by the ligand. The heterodimers form bigger oligomers in response to their corresponding ligands as well as further heterotypic associations with other receptors such as CD14 and/or CD36. Binds MYD88 (via TIR domain). Interacts with TICAM1. Interacts with CNPY3. Interacts with ATG16L1. Interacts with PPP1R11. Interacts with TICAM2.</text>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="3">Membrane</location>
<topology evidence="4">Single-pass type I membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="3">Cytoplasmic vesicle</location>
<location evidence="3">Phagosome membrane</location>
<topology evidence="4">Single-pass type I membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="2">Membrane raft</location>
</subcellularLocation>
<text evidence="2">Does not reside in lipid rafts before stimulation but accumulates increasingly in the raft upon the presence of the microbial ligand. In response to diacylated lipoproteins, TLR2:TLR6 heterodimers are recruited in lipid rafts, this recruitment determine the intracellular targeting to the Golgi apparatus. Triacylated lipoproteins induce the same mechanism for TLR2:TLR1 heterodimers.</text>
</comment>
<comment type="domain">
<text evidence="1">Ester-bound lipid substrates are bound through a crevice formed between the LRR 11 and LRR 12.</text>
</comment>
<comment type="domain">
<text evidence="1">The ATG16L1-binding motif mediates interaction with ATG16L1.</text>
</comment>
<comment type="domain">
<text evidence="5">The TIR domain mediates NAD(+) hydrolase (NADase) activity. Self-association of TIR domains is required for NADase activity.</text>
</comment>
<comment type="PTM">
<text evidence="3">Ubiquitinated at Lys-754 by PPP1R11, leading to its degradation. Deubiquitinated by USP2.</text>
</comment>
<comment type="PTM">
<text evidence="2">Glycosylation of Asn-442 is critical for secretion of the N-terminal ectodomain of TLR2.</text>
</comment>
<comment type="similarity">
<text evidence="6">Belongs to the Toll-like receptor family.</text>
</comment>
<dbReference type="EC" id="3.2.2.6" evidence="5"/>
<dbReference type="EMBL" id="EU580539">
<property type="protein sequence ID" value="ACB72728.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="GO" id="GO:0005794">
<property type="term" value="C:Golgi apparatus"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016021">
<property type="term" value="C:integral component of membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0045121">
<property type="term" value="C:membrane raft"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030670">
<property type="term" value="C:phagocytic vesicle membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0050135">
<property type="term" value="F:NAD(P)+ nucleosidase activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0061809">
<property type="term" value="F:NAD+ nucleotidase, cyclic ADP-ribose generating"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0004888">
<property type="term" value="F:transmembrane signaling receptor activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0071726">
<property type="term" value="P:cellular response to diacyl bacterial lipopeptide"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071727">
<property type="term" value="P:cellular response to triacyl bacterial lipopeptide"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006954">
<property type="term" value="P:inflammatory response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0045087">
<property type="term" value="P:innate immune response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0002755">
<property type="term" value="P:MyD88-dependent toll-like receptor signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0050729">
<property type="term" value="P:positive regulation of inflammatory response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0034134">
<property type="term" value="P:toll-like receptor 2 signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="Gene3D" id="3.40.50.10140">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="3.80.10.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR000483">
<property type="entry name" value="Cys-rich_flank_reg_C"/>
</dbReference>
<dbReference type="InterPro" id="IPR001611">
<property type="entry name" value="Leu-rich_rpt"/>
</dbReference>
<dbReference type="InterPro" id="IPR003591">
<property type="entry name" value="Leu-rich_rpt_typical-subtyp"/>
</dbReference>
<dbReference type="InterPro" id="IPR032675">
<property type="entry name" value="LRR_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR000157">
<property type="entry name" value="TIR_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR027185">
<property type="entry name" value="TLR2"/>
</dbReference>
<dbReference type="InterPro" id="IPR017241">
<property type="entry name" value="Toll-like_receptor"/>
</dbReference>
<dbReference type="InterPro" id="IPR035897">
<property type="entry name" value="Toll_tir_struct_dom_sf"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR24365">
<property type="entry name" value="PTHR24365"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR24365:SF17">
<property type="entry name" value="PTHR24365:SF17"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF13855">
<property type="entry name" value="LRR_8"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="Pfam" id="PF01582">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PIRSF" id="PIRSF037595">
<property type="entry name" value="Toll-like_receptor"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00369">
<property type="entry name" value="LRR_TYP"/>
<property type="match status" value="6"/>
</dbReference>
<dbReference type="SMART" id="SM00082">
<property type="entry name" value="LRRCT"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00255">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF52200">
<property type="entry name" value="SSF52200"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51450">
<property type="entry name" value="LRR"/>
<property type="match status" value="10"/>
</dbReference>
<dbReference type="PROSITE" id="PS50104">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="inferred from homology"/>
<keyword id="KW-0968">Cytoplasmic vesicle</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0378">Hydrolase</keyword>
<keyword id="KW-0391">Immunity</keyword>
<keyword id="KW-0395">Inflammatory response</keyword>
<keyword id="KW-0399">Innate immunity</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0433">Leucine-rich repeat</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0520">NAD</keyword>
<keyword id="KW-0675">Receptor</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0732">Signal</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="signal peptide" evidence="4">
<location>
<begin position="1"/>
<end position="20"/>
</location>
</feature>
<feature type="chain" description="Toll-like receptor 2" id="PRO_0000363768">
<location>
<begin position="21"/>
<end position="784"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="4">
<location>
<begin position="21"/>
<end position="587"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="4">
<location>
<begin position="588"/>
<end position="608"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="4">
<location>
<begin position="609"/>
<end position="784"/>
</location>
</feature>
<feature type="repeat" description="LRR 1">
<location>
<begin position="54"/>
<end position="77"/>
</location>
</feature>
<feature type="repeat" description="LRR 2">
<location>
<begin position="78"/>
<end position="101"/>
</location>
</feature>
<feature type="repeat" description="LRR 3">
<location>
<begin position="102"/>
<end position="125"/>
</location>
</feature>
<feature type="repeat" description="LRR 4">
<location>
<begin position="126"/>
<end position="150"/>
</location>
</feature>
<feature type="repeat" description="LRR 5">
<location>
<begin position="151"/>
<end position="175"/>
</location>
</feature>
<feature type="repeat" description="LRR 6">
<location>
<begin position="176"/>
<end position="199"/>
</location>
</feature>
<feature type="repeat" description="LRR 7">
<location>
<begin position="200"/>
<end position="223"/>
</location>
</feature>
<feature type="repeat" description="LRR 8">
<location>
<begin position="224"/>
<end position="250"/>
</location>
</feature>
<feature type="repeat" description="LRR 9">
<location>
<begin position="251"/>
<end position="278"/>
</location>
</feature>
<feature type="repeat" description="LRR 10">
<location>
<begin position="279"/>
<end position="308"/>
</location>
</feature>
<feature type="repeat" description="LRR 11">
<location>
<begin position="309"/>
<end position="337"/>
</location>
</feature>
<feature type="repeat" description="LRR 12">
<location>
<begin position="338"/>
<end position="361"/>
</location>
</feature>
<feature type="repeat" description="LRR 13">
<location>
<begin position="362"/>
<end position="388"/>
</location>
</feature>
<feature type="repeat" description="LRR 14">
<location>
<begin position="389"/>
<end position="414"/>
</location>
</feature>
<feature type="repeat" description="LRR 15">
<location>
<begin position="415"/>
<end position="437"/>
</location>
</feature>
<feature type="repeat" description="LRR 16">
<location>
<begin position="438"/>
<end position="457"/>
</location>
</feature>
<feature type="repeat" description="LRR 17">
<location>
<begin position="458"/>
<end position="478"/>
</location>
</feature>
<feature type="repeat" description="LRR 18">
<location>
<begin position="479"/>
<end position="500"/>
</location>
</feature>
<feature type="repeat" description="LRR 19">
<location>
<begin position="501"/>
<end position="524"/>
</location>
</feature>
<feature type="domain" description="LRRCT">
<location>
<begin position="525"/>
<end position="579"/>
</location>
</feature>
<feature type="domain" description="TIR" evidence="5">
<location>
<begin position="639"/>
<end position="782"/>
</location>
</feature>
<feature type="short sequence motif" description="ATG16L1-binding motif">
<location>
<begin position="761"/>
<end position="778"/>
</location>
</feature>
<feature type="active site" evidence="5">
<location>
<position position="716"/>
</location>
</feature>
<feature type="site" description="Interaction with bacterial lipopeptide" evidence="1">
<location>
<position position="349"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="114"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="199"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="442"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1">
<location>
<begin position="30"/>
<end position="36"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1">
<location>
<begin position="353"/>
<end position="382"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1">
<location>
<begin position="432"/>
<end position="454"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="2">
<location>
<position position="754"/>
</location>
</feature>
<evidence key="1" type="ECO:0000250"/>
<evidence key="2" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="O60603"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q9QUN7"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000255"/>
<evidence key="5" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00204"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000305"/>
<sequence length="784" mass="90033" checksum="FD25EA04E218B0D1" modified="2008-06-10" version="1" precursor="true">MPRALWTAWVWAXIILSTEGASDQASSLSCDSTGVCDGHSRSLNSIPSGLTAGVKSLDLSNNEITYVGNRDLQRCVNLKTLRLGANEIHTVEEDSFFHLRNLEYLDLSYNRLSNLSSSWFRSLYVLKFLNLLGNLYKTLGETSLFSHLPNLXTLKVGNSNSFTEIHEKDFTGLTFLEELEISAQNLQIYVPKSLKSIQNISHLILHLKQPVLLVDILVDIVSSLDCLELRDTNLHTFHFSEASISEMSTSVKKLIFRNVQFTDESFVEVVKLFNYVSGILEVEFDDCTHDGIGDFRALSLDRIRHLGNVETLTIRKLHIPQFFLFHDLSSIYPLTGKVKRVTIENSKVFLVPCLLSQHLKSLEYLDLSENLMSEETLKNSACKDAWPFLQTLVLRQNRLKSLEKTGELLLTLENLNSLDISKNNFLSMPETCQWPGKMKQLNLSSTRIHSLTQCLPQTLEILDVSNNNLDSFSLILPQLKELYISRNKLKTLPDASFLPVLSVMRISRNIINTFSKEQLDSFQQLKTLEAGGNNFICSCDFLSFTQGQQALGRVLVDWPDDYRCDSPSHVRGQRVQDARLSLSECHRAAVVSAACCALFLVLLLTGVLCHRFHGLWYMKMMWAWLQAKRKPRKAPRRDICYDAFVSYSERDSYWVENLMVQELEQFNPPFKLCLHKRDFIPGKWIIDNIIDSIEKSHKTIFVLSENFVXSEWCKYELDFSHFRLFDENNDAAILILLEPIDKKAIPQRFCKLRKIMNTKTYLEWPVDETQQEGFWLNLRAAIRS</sequence>
</entry>
<entry dataset="Swiss-Prot" created="2002-01-31" modified="2021-02-10" version="130">
<accession>Q95LA9</accession>
<accession>B5T265</accession>
<accession>B5T266</accession>
<accession>B5T271</accession>
<accession>Q6GV20</accession>
<accession>Q9GL66</accession>
<name>TLR2_BOVIN</name>
<protein>
<recommendedName>
<fullName>Toll-like receptor 2</fullName>
<ecNumber evidence="5">3.2.2.6</ecNumber>
</recommendedName>
<cdAntigenName>CD282</cdAntigenName>
</protein>
<gene>
<name type="primary">TLR2</name>
</gene>
<organism>
<name type="scientific">Bos taurus</name>
<name type="common">Bovine</name>
<dbReference type="NCBI Taxonomy" id="9913"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Laurasiatheria</taxon>
<taxon>Artiodactyla</taxon>
<taxon>Ruminantia</taxon>
<taxon>Pecora</taxon>
<taxon>Bovidae</taxon>
<taxon>Bovinae</taxon>
<taxon>Bos</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="submission" date="2001-04" db="EMBL/GenBank/DDBJ databases">
<title>Role of bovine TLR2, TLR4 and CD14 in the recognition of bacterial constituents.</title>
<authorList>
<person name="Guionaud C.T."/>
<person name="Dubey C."/>
<person name="Zumkehr J.R."/>
<person name="Sonstegard T.S."/>
<person name="Jungi T.W."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
</reference>
<reference key="2">
<citation type="submission" date="2004-05" db="EMBL/GenBank/DDBJ databases">
<title>Role of bovine TLRs in antigen presentation.</title>
<authorList>
<person name="Werling D."/>
<person name="McGuire K."/>
<person name="Glass E."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
</reference>
<reference key="3">
<citation type="journal article" date="2008" name="Genomics" volume="92" first="235" last="245">
<title>Analysis of sequence variability and protein domain architectures for bovine peptidoglycan recognition protein 1 and Toll-like receptors 2 and 6.</title>
<authorList>
<person name="Seabury C.M."/>
<person name="Womack J.E."/>
</authorList>
<dbReference type="PubMed" id="18639626"/>
<dbReference type="DOI" id="10.1016/j.ygeno.2008.06.005"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>VARIANTS GLU-290 AND LYS-783</scope>
<source>
<strain>Isolate 44</strain>
<strain>Isolate 74</strain>
<strain>Isolate 80</strain>
<strain>Isolate JEW38</strain>
</source>
</reference>
<comment type="function">
<text evidence="2 3">Cooperates with LY96 to mediate the innate immune response to bacterial lipoproteins and other microbial cell wall components. Cooperates with TLR1 or TLR6 to mediate the innate immune response to bacterial lipoproteins or lipopeptides. Acts via MYD88 and TRAF6, leading to NF-kappa-B activation, cytokine secretion and the inflammatory response (By similarity). May also promote apoptosis in response to lipoproteins. Forms activation clusters composed of several receptors depending on the ligand, these clusters trigger signaling from the cell surface and subsequently are targeted to the Golgi in a lipid-raft dependent pathway. Forms the cluster TLR2:TLR6:CD14:CD36 in response to diacylated lipopeptides and TLR2:TLR1:CD14 in response to triacylated lipopeptides (By similarity).</text>
</comment>
<comment type="catalytic activity">
<reaction evidence="5">
<text>H2O + NAD(+) = ADP-D-ribose + H(+) + nicotinamide</text>
<dbReference type="Rhea" id="RHEA:16301"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:17154"/>
<dbReference type="ChEBI" id="CHEBI:57540"/>
<dbReference type="ChEBI" id="CHEBI:57967"/>
<dbReference type="EC" id="3.2.2.6"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="5">
<dbReference type="Rhea" id="RHEA:16302"/>
</physiologicalReaction>
</comment>
<comment type="subunit">
<text evidence="2 3">Interacts with LY96, TLR1 and TLR6 (via extracellular domain). TLR2 seems to exist in heterodimers with either TLR1 or TLR6 before stimulation by the ligand. The heterodimers form bigger oligomers in response to their corresponding ligands as well as further heterotypic associations with other receptors such as CD14 and/or CD36. Binds MYD88 (via TIR domain). Interacts with TICAM1. Interacts with CNPY3. Interacts with ATG16L1. Interacts with PPP1R11. Interacts with TICAM2.</text>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="3">Membrane</location>
<topology evidence="4">Single-pass type I membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="3">Cytoplasmic vesicle</location>
<location evidence="3">Phagosome membrane</location>
<topology evidence="4">Single-pass type I membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="2">Membrane raft</location>
</subcellularLocation>
<text evidence="2">Does not reside in lipid rafts before stimulation but accumulates increasingly in the raft upon the presence of the microbial ligand. In response to diacylated lipoproteins, TLR2:TLR6 heterodimers are recruited in lipid rafts, this recruitment determine the intracellular targeting to the Golgi apparatus. Triacylated lipoproteins induce the same mechanism for TLR2:TLR1 heterodimers.</text>
</comment>
<comment type="domain">
<text evidence="1">Ester-bound lipid substrates are bound through a crevice formed between the LRR 11 and LRR 12.</text>
</comment>
<comment type="domain">
<text evidence="1">The ATG16L1-binding motif mediates interaction with ATG16L1.</text>
</comment>
<comment type="domain">
<text evidence="5">The TIR domain mediates NAD(+) hydrolase (NADase) activity. Self-association of TIR domains is required for NADase activity.</text>
</comment>
<comment type="PTM">
<text evidence="3">Ubiquitinated at Lys-754 by PPP1R11, leading to its degradation. Deubiquitinated by USP2.</text>
</comment>
<comment type="PTM">
<text evidence="2">Glycosylation of Asn-442 is critical for secretion of the N-terminal ectodomain of TLR2.</text>
</comment>
<comment type="similarity">
<text evidence="7">Belongs to the Toll-like receptor family.</text>
</comment>
<dbReference type="EC" id="3.2.2.6" evidence="5"/>
<dbReference type="EMBL" id="AF368419">
<property type="protein sequence ID" value="AAL16722.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF310951">
<property type="protein sequence ID" value="AAG32060.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY634629">
<property type="protein sequence ID" value="AAT48487.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="EU746459">
<property type="protein sequence ID" value="ACH92788.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="EU746460">
<property type="protein sequence ID" value="ACH92789.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="EU746464">
<property type="protein sequence ID" value="ACH92793.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="EU746465">
<property type="protein sequence ID" value="ACH92794.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="RefSeq" id="NP_776622.1">
<property type="nucleotide sequence ID" value="NM_174197.2"/>
</dbReference>
<dbReference type="SMR" id="Q95LA9"/>
<dbReference type="STRING" id="9913.ENSBTAP00000010530"/>
<dbReference type="PaxDb" id="Q95LA9"/>
<dbReference type="GeneID" id="281534"/>
<dbReference type="KEGG" id="bta:281534"/>
<dbReference type="CTD" id="7097"/>
<dbReference type="eggNOG" id="KOG4641">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="InParanoid" id="Q95LA9"/>
<dbReference type="OrthoDB" id="282372at2759"/>
<dbReference type="Proteomes" id="UP000009136">
<property type="component" value="Unplaced"/>
</dbReference>
<dbReference type="GO" id="GO:0005794">
<property type="term" value="C:Golgi apparatus"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016021">
<property type="term" value="C:integral component of membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0045121">
<property type="term" value="C:membrane raft"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030670">
<property type="term" value="C:phagocytic vesicle membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0050135">
<property type="term" value="F:NAD(P)+ nucleosidase activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0061809">
<property type="term" value="F:NAD+ nucleotidase, cyclic ADP-ribose generating"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0004888">
<property type="term" value="F:transmembrane signaling receptor activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0071726">
<property type="term" value="P:cellular response to diacyl bacterial lipopeptide"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071727">
<property type="term" value="P:cellular response to triacyl bacterial lipopeptide"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006954">
<property type="term" value="P:inflammatory response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0045087">
<property type="term" value="P:innate immune response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0002755">
<property type="term" value="P:MyD88-dependent toll-like receptor signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0050729">
<property type="term" value="P:positive regulation of inflammatory response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0034134">
<property type="term" value="P:toll-like receptor 2 signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="Gene3D" id="3.40.50.10140">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="3.80.10.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR000483">
<property type="entry name" value="Cys-rich_flank_reg_C"/>
</dbReference>
<dbReference type="InterPro" id="IPR001611">
<property type="entry name" value="Leu-rich_rpt"/>
</dbReference>
<dbReference type="InterPro" id="IPR003591">
<property type="entry name" value="Leu-rich_rpt_typical-subtyp"/>
</dbReference>
<dbReference type="InterPro" id="IPR032675">
<property type="entry name" value="LRR_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR000157">
<property type="entry name" value="TIR_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR027185">
<property type="entry name" value="TLR2"/>
</dbReference>
<dbReference type="InterPro" id="IPR017241">
<property type="entry name" value="Toll-like_receptor"/>
</dbReference>
<dbReference type="InterPro" id="IPR035897">
<property type="entry name" value="Toll_tir_struct_dom_sf"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR24365">
<property type="entry name" value="PTHR24365"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR24365:SF17">
<property type="entry name" value="PTHR24365:SF17"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF13855">
<property type="entry name" value="LRR_8"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="Pfam" id="PF01582">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PIRSF" id="PIRSF037595">
<property type="entry name" value="Toll-like_receptor"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00369">
<property type="entry name" value="LRR_TYP"/>
<property type="match status" value="6"/>
</dbReference>
<dbReference type="SMART" id="SM00082">
<property type="entry name" value="LRRCT"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00255">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF52200">
<property type="entry name" value="SSF52200"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51450">
<property type="entry name" value="LRR"/>
<property type="match status" value="11"/>
</dbReference>
<dbReference type="PROSITE" id="PS50104">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at transcript level"/>
<keyword id="KW-0968">Cytoplasmic vesicle</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0378">Hydrolase</keyword>
<keyword id="KW-0391">Immunity</keyword>
<keyword id="KW-0395">Inflammatory response</keyword>
<keyword id="KW-0399">Innate immunity</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0433">Leucine-rich repeat</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0520">NAD</keyword>
<keyword id="KW-0675">Receptor</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0732">Signal</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="signal peptide" evidence="4">
<location>
<begin position="1"/>
<end position="20"/>
</location>
</feature>
<feature type="chain" description="Toll-like receptor 2" id="PRO_0000034707">
<location>
<begin position="21"/>
<end position="784"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="4">
<location>
<begin position="21"/>
<end position="587"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="4">
<location>
<begin position="588"/>
<end position="608"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="4">
<location>
<begin position="609"/>
<end position="784"/>
</location>
</feature>
<feature type="repeat" description="LRR 1">
<location>
<begin position="54"/>
<end position="77"/>
</location>
</feature>
<feature type="repeat" description="LRR 2">
<location>
<begin position="78"/>
<end position="101"/>
</location>
</feature>
<feature type="repeat" description="LRR 3">
<location>
<begin position="102"/>
<end position="125"/>
</location>
</feature>
<feature type="repeat" description="LRR 4">
<location>
<begin position="126"/>
<end position="150"/>
</location>
</feature>
<feature type="repeat" description="LRR 5">
<location>
<begin position="151"/>
<end position="175"/>
</location>
</feature>
<feature type="repeat" description="LRR 6">
<location>
<begin position="176"/>
<end position="199"/>
</location>
</feature>
<feature type="repeat" description="LRR 7">
<location>
<begin position="200"/>
<end position="223"/>
</location>
</feature>
<feature type="repeat" description="LRR 8">
<location>
<begin position="224"/>
<end position="250"/>
</location>
</feature>
<feature type="repeat" description="LRR 9">
<location>
<begin position="251"/>
<end position="278"/>
</location>
</feature>
<feature type="repeat" description="LRR 10">
<location>
<begin position="279"/>
<end position="308"/>
</location>
</feature>
<feature type="repeat" description="LRR 11">
<location>
<begin position="309"/>
<end position="337"/>
</location>
</feature>
<feature type="repeat" description="LRR 12">
<location>
<begin position="338"/>
<end position="361"/>
</location>
</feature>
<feature type="repeat" description="LRR 13">
<location>
<begin position="362"/>
<end position="388"/>
</location>
</feature>
<feature type="repeat" description="LRR 14">
<location>
<begin position="389"/>
<end position="414"/>
</location>
</feature>
<feature type="repeat" description="LRR 15">
<location>
<begin position="415"/>
<end position="437"/>
</location>
</feature>
<feature type="repeat" description="LRR 16">
<location>
<begin position="438"/>
<end position="457"/>
</location>
</feature>
<feature type="repeat" description="LRR 17">
<location>
<begin position="458"/>
<end position="478"/>
</location>
</feature>
<feature type="repeat" description="LRR 18">
<location>
<begin position="479"/>
<end position="500"/>
</location>
</feature>
<feature type="repeat" description="LRR 19">
<location>
<begin position="501"/>
<end position="524"/>
</location>
</feature>
<feature type="domain" description="LRRCT">
<location>
<begin position="525"/>
<end position="579"/>
</location>
</feature>
<feature type="domain" description="TIR" evidence="5">
<location>
<begin position="639"/>
<end position="782"/>
</location>
</feature>
<feature type="short sequence motif" description="ATG16L1-binding motif">
<location>
<begin position="761"/>
<end position="778"/>
</location>
</feature>
<feature type="active site" evidence="5">
<location>
<position position="716"/>
</location>
</feature>
<feature type="site" description="Interaction with bacterial lipopeptide" evidence="1">
<location>
<position position="349"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="114"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="199"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="442"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1">
<location>
<begin position="30"/>
<end position="36"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1">
<location>
<begin position="353"/>
<end position="382"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1">
<location>
<begin position="432"/>
<end position="454"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="2">
<location>
<position position="754"/>
</location>
</feature>
<feature type="sequence variant" evidence="6">
<original>D</original>
<variation>E</variation>
<location>
<position position="290"/>
</location>
</feature>
<feature type="sequence variant" evidence="6">
<original>R</original>
<variation>K</variation>
<location>
<position position="783"/>
</location>
</feature>
<evidence key="1" type="ECO:0000250"/>
<evidence key="2" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="O60603"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q9QUN7"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000255"/>
<evidence key="5" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00204"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18639626"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000305"/>
<sequence length="784" mass="90205" checksum="59FDB9DFA7984C18" modified="2001-12-01" version="1" precursor="true">MPRALWTAWVWAVIILSTEGASDQASSLSCDPTGVCDGHSRSLNSIPSGLTAGVKSLDLSNNDITYVGNRDLQRCVNLKTLRLGANEIHTVEEDSFFHLRNLEYLDLSYNRLSNLSSSWFRSLYVLKFLNLLGNLYKTLGETSLFSHLPNLRTLKVGNSNSFTEIHEKDFTGLTFLEELEISAQNLQIYVPKSLKSIQNISHLILHLKQPILLVDILVDIVSSLDCFELRDTNLHTFHFSEASISEMSTSVKKLIFRNVQFTDESFVEVVKLFNYVSGILEVEFDDCTHDGIGDFRALSLDRIRHLGNVETLTIRKLHIPQFFLFHDLSSIYPLTGRVKRVTIENSKVFLVPCLLSQHLKSLEYLDLSENLMSEETLKNSACKDAWPFLQTLVLRQNRLKSLEKTGELLLTLENLNNLDISKNNFLSMPETCQWPGKMKQLNLSSTRIHSLTQCLPQTLEILDVSNNNLDSFSLILPQLKELYISRNKLKTLPDASFLPVLSVMRISRNIINTFSKEQLDSFQQLKTLEAGGNNFICSCDFLSFTQGQQALGRVLVDWPDDYRCDSPSHVRGQRVQDARLSLSECHRAAVVSAACCALFLLLLLTGVLCHRFHGLWYMKMMWAWLQAKRKPRKAPRRDICYDAFVSYSERDSYWVENLMVQELEHFNPPFKLCLHKRDFIPGKWIIDNIIDSIEKSHKTIFVLSENFVKSEWCKYELDFSHFRLFDENNDAAILILLEPIDKKAIPQRFCKLRKIMNTKTYLEWPVDETQQEGFWLNLRAAIRS</sequence>
</entry>
<entry dataset="Swiss-Prot" created="2009-02-10" modified="2021-02-10" version="83">
<accession>Q2PZH4</accession>
<name>TLR2_BUBBU</name>
<protein>
<recommendedName>
<fullName>Toll-like receptor 2</fullName>
<ecNumber evidence="5">3.2.2.6</ecNumber>
</recommendedName>
<cdAntigenName>CD282</cdAntigenName>
</protein>
<gene>
<name type="primary">TLR2</name>
</gene>
<organism>
<name type="scientific">Bubalus bubalis</name>
<name type="common">Domestic water buffalo</name>
<dbReference type="NCBI Taxonomy" id="89462"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Laurasiatheria</taxon>
<taxon>Artiodactyla</taxon>
<taxon>Ruminantia</taxon>
<taxon>Pecora</taxon>
<taxon>Bovidae</taxon>
<taxon>Bovinae</taxon>
<taxon>Bubalus</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="submission" date="2005-11" db="EMBL/GenBank/DDBJ databases">
<title>Full-length cDNA cloning of toll-like receptor 2 in Bubalus bubalis.</title>
<authorList>
<person name="Das D.K."/>
<person name="Saini M."/>
<person name="Swarup D."/>
<person name="Sharma B."/>
<person name="Yadav M.P."/>
<person name="Gupta P.K."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
</reference>
<reference key="2">
<citation type="submission" date="2007-09" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Vijh R.K."/>
<person name="Bharani Kumar S.T."/>
<person name="Mishra B."/>
<person name="Tantia M.S."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<comment type="function">
<text evidence="2 3">Cooperates with LY96 to mediate the innate immune response to bacterial lipoproteins and other microbial cell wall components. Cooperates with TLR1 or TLR6 to mediate the innate immune response to bacterial lipoproteins or lipopeptides. Acts via MYD88 and TRAF6, leading to NF-kappa-B activation, cytokine secretion and the inflammatory response (By similarity). May also promote apoptosis in response to lipoproteins. Forms activation clusters composed of several receptors depending on the ligand, these clusters trigger signaling from the cell surface and subsequently are targeted to the Golgi in a lipid-raft dependent pathway. Forms the cluster TLR2:TLR6:CD14:CD36 in response to diacylated lipopeptides and TLR2:TLR1:CD14 in response to triacylated lipopeptides (By similarity).</text>
</comment>
<comment type="catalytic activity">
<reaction evidence="5">
<text>H2O + NAD(+) = ADP-D-ribose + H(+) + nicotinamide</text>
<dbReference type="Rhea" id="RHEA:16301"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:17154"/>
<dbReference type="ChEBI" id="CHEBI:57540"/>
<dbReference type="ChEBI" id="CHEBI:57967"/>
<dbReference type="EC" id="3.2.2.6"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="5">
<dbReference type="Rhea" id="RHEA:16302"/>
</physiologicalReaction>
</comment>
<comment type="subunit">
<text evidence="2 3">Interacts with LY96, TLR1 and TLR6 (via extracellular domain). TLR2 seems to exist in heterodimers with either TLR1 or TLR6 before stimulation by the ligand. The heterodimers form bigger oligomers in response to their corresponding ligands as well as further heterotypic associations with other receptors such as CD14 and/or CD36. Binds MYD88 (via TIR domain). Interacts with TICAM1. Interacts with CNPY3. Interacts with ATG16L1. Interacts with PPP1R11. Interacts with TICAM2.</text>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="3">Membrane</location>
<topology evidence="4">Single-pass type I membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="3">Cytoplasmic vesicle</location>
<location evidence="3">Phagosome membrane</location>
<topology evidence="4">Single-pass type I membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="2">Membrane raft</location>
</subcellularLocation>
<text evidence="2">Does not reside in lipid rafts before stimulation but accumulates increasingly in the raft upon the presence of the microbial ligand. In response to diacylated lipoproteins, TLR2:TLR6 heterodimers are recruited in lipid rafts, this recruitment determine the intracellular targeting to the Golgi apparatus. Triacylated lipoproteins induce the same mechanism for TLR2:TLR1 heterodimers.</text>
</comment>
<comment type="domain">
<text evidence="1">Ester-bound lipid substrates are bound through a crevice formed between the LRR 11 and LRR 12.</text>
</comment>
<comment type="domain">
<text evidence="1">The ATG16L1-binding motif mediates interaction with ATG16L1.</text>
</comment>
<comment type="domain">
<text evidence="5">The TIR domain mediates NAD(+) hydrolase (NADase) activity. Self-association of TIR domains is required for NADase activity.</text>
</comment>
<comment type="PTM">
<text evidence="3">Ubiquitinated at Lys-754 by PPP1R11, leading to its degradation. Deubiquitinated by USP2.</text>
</comment>
<comment type="PTM">
<text evidence="2">Glycosylation of Asn-442 is critical for secretion of the N-terminal ectodomain of TLR2.</text>
</comment>
<comment type="similarity">
<text evidence="6">Belongs to the Toll-like receptor family.</text>
</comment>
<dbReference type="EC" id="3.2.2.6" evidence="5"/>
<dbReference type="EMBL" id="DQ288130">
<property type="protein sequence ID" value="ABC00775.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="EU178742">
<property type="protein sequence ID" value="ABW79911.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001277820.1">
<property type="nucleotide sequence ID" value="NM_001290891.1"/>
</dbReference>
<dbReference type="RefSeq" id="XP_006070178.1">
<property type="nucleotide sequence ID" value="XM_006070116.1"/>
</dbReference>
<dbReference type="RefSeq" id="XP_006070179.1">
<property type="nucleotide sequence ID" value="XM_006070117.1"/>
</dbReference>
<dbReference type="SMR" id="Q2PZH4"/>
<dbReference type="GeneID" id="102397791"/>
<dbReference type="KEGG" id="bbub:102397791"/>
<dbReference type="CTD" id="7097"/>
<dbReference type="GO" id="GO:0005794">
<property type="term" value="C:Golgi apparatus"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016021">
<property type="term" value="C:integral component of membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0045121">
<property type="term" value="C:membrane raft"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030670">
<property type="term" value="C:phagocytic vesicle membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0050135">
<property type="term" value="F:NAD(P)+ nucleosidase activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0061809">
<property type="term" value="F:NAD+ nucleotidase, cyclic ADP-ribose generating"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0004888">
<property type="term" value="F:transmembrane signaling receptor activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0071726">
<property type="term" value="P:cellular response to diacyl bacterial lipopeptide"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071727">
<property type="term" value="P:cellular response to triacyl bacterial lipopeptide"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006954">
<property type="term" value="P:inflammatory response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0045087">
<property type="term" value="P:innate immune response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0002755">
<property type="term" value="P:MyD88-dependent toll-like receptor signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0050729">
<property type="term" value="P:positive regulation of inflammatory response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0034134">
<property type="term" value="P:toll-like receptor 2 signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="Gene3D" id="3.40.50.10140">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="3.80.10.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR000483">
<property type="entry name" value="Cys-rich_flank_reg_C"/>
</dbReference>
<dbReference type="InterPro" id="IPR001611">
<property type="entry name" value="Leu-rich_rpt"/>
</dbReference>
<dbReference type="InterPro" id="IPR003591">
<property type="entry name" value="Leu-rich_rpt_typical-subtyp"/>
</dbReference>
<dbReference type="InterPro" id="IPR032675">
<property type="entry name" value="LRR_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR000157">
<property type="entry name" value="TIR_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR027185">
<property type="entry name" value="TLR2"/>
</dbReference>
<dbReference type="InterPro" id="IPR017241">
<property type="entry name" value="Toll-like_receptor"/>
</dbReference>
<dbReference type="InterPro" id="IPR035897">
<property type="entry name" value="Toll_tir_struct_dom_sf"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR24365">
<property type="entry name" value="PTHR24365"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR24365:SF17">
<property type="entry name" value="PTHR24365:SF17"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF13855">
<property type="entry name" value="LRR_8"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="Pfam" id="PF01582">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PIRSF" id="PIRSF037595">
<property type="entry name" value="Toll-like_receptor"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00369">
<property type="entry name" value="LRR_TYP"/>
<property type="match status" value="6"/>
</dbReference>
<dbReference type="SMART" id="SM00082">
<property type="entry name" value="LRRCT"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00255">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF52200">
<property type="entry name" value="SSF52200"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51450">
<property type="entry name" value="LRR"/>
<property type="match status" value="9"/>
</dbReference>
<dbReference type="PROSITE" id="PS50104">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at transcript level"/>
<keyword id="KW-0968">Cytoplasmic vesicle</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0378">Hydrolase</keyword>
<keyword id="KW-0391">Immunity</keyword>
<keyword id="KW-0395">Inflammatory response</keyword>
<keyword id="KW-0399">Innate immunity</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0433">Leucine-rich repeat</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0520">NAD</keyword>
<keyword id="KW-0675">Receptor</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0732">Signal</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="signal peptide" evidence="4">
<location>
<begin position="1"/>
<end position="20"/>
</location>
</feature>
<feature type="chain" description="Toll-like receptor 2" id="PRO_0000363769">
<location>
<begin position="21"/>
<end position="784"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="4">
<location>
<begin position="21"/>
<end position="587"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="4">
<location>
<begin position="588"/>
<end position="608"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="4">
<location>
<begin position="609"/>
<end position="784"/>
</location>
</feature>
<feature type="repeat" description="LRR 1">
<location>
<begin position="54"/>
<end position="77"/>
</location>
</feature>
<feature type="repeat" description="LRR 2">
<location>
<begin position="78"/>
<end position="101"/>
</location>
</feature>
<feature type="repeat" description="LRR 3">
<location>
<begin position="102"/>
<end position="125"/>
</location>
</feature>
<feature type="repeat" description="LRR 4">
<location>
<begin position="126"/>
<end position="150"/>
</location>
</feature>
<feature type="repeat" description="LRR 5">
<location>
<begin position="151"/>
<end position="175"/>
</location>
</feature>
<feature type="repeat" description="LRR 6">
<location>
<begin position="176"/>
<end position="199"/>
</location>
</feature>
<feature type="repeat" description="LRR 7">
<location>
<begin position="200"/>
<end position="223"/>
</location>
</feature>
<feature type="repeat" description="LRR 8">
<location>
<begin position="224"/>
<end position="250"/>
</location>
</feature>
<feature type="repeat" description="LRR 9">
<location>
<begin position="251"/>
<end position="278"/>
</location>
</feature>
<feature type="repeat" description="LRR 10">
<location>
<begin position="279"/>
<end position="308"/>
</location>
</feature>
<feature type="repeat" description="LRR 11">
<location>
<begin position="309"/>
<end position="337"/>
</location>
</feature>
<feature type="repeat" description="LRR 12">
<location>
<begin position="338"/>
<end position="361"/>
</location>
</feature>
<feature type="repeat" description="LRR 13">
<location>
<begin position="362"/>
<end position="388"/>
</location>
</feature>
<feature type="repeat" description="LRR 14">
<location>
<begin position="389"/>
<end position="414"/>
</location>
</feature>
<feature type="repeat" description="LRR 15">
<location>
<begin position="415"/>
<end position="437"/>
</location>
</feature>
<feature type="repeat" description="LRR 16">
<location>
<begin position="438"/>
<end position="457"/>
</location>
</feature>
<feature type="repeat" description="LRR 17">
<location>
<begin position="458"/>
<end position="478"/>
</location>
</feature>
<feature type="repeat" description="LRR 18">
<location>
<begin position="479"/>
<end position="500"/>
</location>
</feature>
<feature type="repeat" description="LRR 19">
<location>
<begin position="501"/>
<end position="524"/>
</location>
</feature>
<feature type="domain" description="LRRCT">
<location>
<begin position="525"/>
<end position="579"/>
</location>
</feature>
<feature type="domain" description="TIR" evidence="5">
<location>
<begin position="639"/>
<end position="782"/>
</location>
</feature>
<feature type="short sequence motif" description="ATG16L1-binding motif">
<location>
<begin position="761"/>
<end position="778"/>
</location>
</feature>
<feature type="active site" evidence="5">
<location>
<position position="716"/>
</location>
</feature>
<feature type="site" description="Interaction with bacterial lipopeptide" evidence="1">
<location>
<position position="349"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="114"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="199"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="248"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="442"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1">
<location>
<begin position="30"/>
<end position="36"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1">
<location>
<begin position="353"/>
<end position="382"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1">
<location>
<begin position="432"/>
<end position="454"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="2">
<location>
<position position="754"/>
</location>
</feature>
<evidence key="1" type="ECO:0000250"/>
<evidence key="2" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="O60603"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q9QUN7"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000255"/>
<evidence key="5" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00204"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000305"/>
<sequence length="784" mass="90195" checksum="C1A50A1C48ECFBEB" modified="2006-01-24" version="1" precursor="true">MPRALWTAWVWAVIILSMEGASHQASSLSCDPTGVCDGHSRSLNSIPSGLTDGVKSLDLSNNEITYVSNRDLQRCVNLKTLRLGANEIHTVEEDSFFHLRNLEYLDLSYNRLSNLSSSWFRSLYALKFLNLLGNVYKTLGETSLFSHLPNLRTLKVGNSNSFTEIHEKDFTGLIFLEELEISAQNLQIYVPKSLKSIQNISHLILHLKQPVLLVDILVDIVSSLDCLELRDTNLHTFHFSEASISEMNTSVKKLIFRNVQFTDESFVEVVKLFNYVSGILEVEFDDCTHDGIGDFRALSLDRIRHLGNVETLTIRKLHIPQFFLFHDLSSIYPLTGKVKRVTIESSKVFLVPCLLSQHLKSLEYLDLSENLMSEETLKNSACKDAWPFLQTLVLRQNRLKSLEKTGELLLTLENLNNLDISKNNFLSMPETCRWPGKMKQLNLSSTRVHSLTQCLPQTLEILDVSNNNLDSFSLILPQLKELYISRNKLKTLPDASFLPVLSVMRISRNIINTFSKEQLDSFQQLKTLEAGGNNFICSCDFLSFTQGQQALGRVLVDWPAEYRCDSPSHVRGQRVQDARLSLSECHRAAVVSAACCALFLLLLLTGVLCHRFHGLWYMKMMWAWLQAKRKPRKAPRRDICYDAFVSYSEQDSYWVENLMVQELEHFNPPFKLCLHKRDFIPGKWIIDNIIDSIEKSHKTIFVLSENFVKSEWCKYELDFSHFRLFDENNDAAILILLEPIDKKAIPQRFCKLRKIMNTKTYLEWPVDETQQEGFWLNLRAAIRS</sequence>
</entry>
<entry dataset="Swiss-Prot" created="2006-10-17" modified="2021-02-10" version="73">
<accession>Q2V897</accession>
<name>TLR2_BOSTR</name>
<protein>
<recommendedName>
<fullName>Toll-like receptor 2</fullName>
<ecNumber evidence="5">3.2.2.6</ecNumber>
</recommendedName>
<cdAntigenName>CD282</cdAntigenName>
</protein>
<gene>
<name type="primary">TLR2</name>
</gene>
<organism>
<name type="scientific">Boselaphus tragocamelus</name>
<name type="common">Nilgai</name>
<dbReference type="NCBI Taxonomy" id="9917"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Laurasiatheria</taxon>
<taxon>Artiodactyla</taxon>
<taxon>Ruminantia</taxon>
<taxon>Pecora</taxon>
<taxon>Bovidae</taxon>
<taxon>Bovinae</taxon>
<taxon>Boselaphus</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="submission" date="2005-11" db="EMBL/GenBank/DDBJ databases">
<title>Full-length cDNA cloning of toll-like receptor 2 in Boselaphus tragocamelus.</title>
<authorList>
<person name="Das D.K."/>
<person name="Saini M."/>
<person name="Swarup D."/>
<person name="Yadav M.P."/>
<person name="Sharma B."/>
<person name="Gupta P.K."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
</reference>
<comment type="function">
<text evidence="2 3">Cooperates with LY96 to mediate the innate immune response to bacterial lipoproteins and other microbial cell wall components. Cooperates with TLR1 or TLR6 to mediate the innate immune response to bacterial lipoproteins or lipopeptides. Acts via MYD88 and TRAF6, leading to NF-kappa-B activation, cytokine secretion and the inflammatory response (By similarity). May also promote apoptosis in response to lipoproteins. Forms activation clusters composed of several receptors depending on the ligand, these clusters trigger signaling from the cell surface and subsequently are targeted to the Golgi in a lipid-raft dependent pathway. Forms the cluster TLR2:TLR6:CD14:CD36 in response to diacylated lipopeptides and TLR2:TLR1:CD14 in response to triacylated lipopeptides (By similarity).</text>
</comment>
<comment type="catalytic activity">
<reaction evidence="5">
<text>H2O + NAD(+) = ADP-D-ribose + H(+) + nicotinamide</text>
<dbReference type="Rhea" id="RHEA:16301"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:17154"/>
<dbReference type="ChEBI" id="CHEBI:57540"/>
<dbReference type="ChEBI" id="CHEBI:57967"/>
<dbReference type="EC" id="3.2.2.6"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="5">
<dbReference type="Rhea" id="RHEA:16302"/>
</physiologicalReaction>
</comment>
<comment type="subunit">
<text evidence="2 3">Interacts with LY96, TLR1 and TLR6 (via extracellular domain). TLR2 seems to exist in heterodimers with either TLR1 or TLR6 before stimulation by the ligand. The heterodimers form bigger oligomers in response to their corresponding ligands as well as further heterotypic associations with other receptors such as CD14 and/or CD36. Binds MYD88 (via TIR domain). Interacts with TICAM1. Interacts with CNPY3. Interacts with ATG16L1. Interacts with PPP1R11. Interacts with TICAM2.</text>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="3">Membrane</location>
<topology evidence="4">Single-pass type I membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="3">Cytoplasmic vesicle</location>
<location evidence="3">Phagosome membrane</location>
<topology evidence="4">Single-pass type I membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="2">Membrane raft</location>
</subcellularLocation>
<text evidence="2">Does not reside in lipid rafts before stimulation but accumulates increasingly in the raft upon the presence of the microbial ligand. In response to diacylated lipoproteins, TLR2:TLR6 heterodimers are recruited in lipid rafts, this recruitment determine the intracellular targeting to the Golgi apparatus. Triacylated lipoproteins induce the same mechanism for TLR2:TLR1 heterodimers.</text>
</comment>
<comment type="domain">
<text evidence="1">Ester-bound lipid substrates are bound through a crevice formed between the LRR 11 and LRR 12.</text>
</comment>
<comment type="domain">
<text evidence="1">The ATG16L1-binding motif mediates interaction with ATG16L1.</text>
</comment>
<comment type="domain">
<text evidence="5">The TIR domain mediates NAD(+) hydrolase (NADase) activity. Self-association of TIR domains is required for NADase activity.</text>
</comment>
<comment type="PTM">
<text evidence="3">Ubiquitinated at Lys-754 by PPP1R11, leading to its degradation. Deubiquitinated by USP2.</text>
</comment>
<comment type="PTM">
<text evidence="2">Glycosylation of Asn-442 is critical for secretion of the N-terminal ectodomain of TLR2.</text>
</comment>
<comment type="similarity">
<text evidence="6">Belongs to the Toll-like receptor family.</text>
</comment>
<dbReference type="EC" id="3.2.2.6" evidence="5"/>
<dbReference type="EMBL" id="DQ286731">
<property type="protein sequence ID" value="ABB97025.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="SMR" id="Q2V897"/>
<dbReference type="GO" id="GO:0005794">
<property type="term" value="C:Golgi apparatus"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016021">
<property type="term" value="C:integral component of membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0045121">
<property type="term" value="C:membrane raft"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030670">
<property type="term" value="C:phagocytic vesicle membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0050135">
<property type="term" value="F:NAD(P)+ nucleosidase activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0061809">
<property type="term" value="F:NAD+ nucleotidase, cyclic ADP-ribose generating"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0004888">
<property type="term" value="F:transmembrane signaling receptor activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0071726">
<property type="term" value="P:cellular response to diacyl bacterial lipopeptide"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071727">
<property type="term" value="P:cellular response to triacyl bacterial lipopeptide"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006954">
<property type="term" value="P:inflammatory response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0045087">
<property type="term" value="P:innate immune response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0002755">
<property type="term" value="P:MyD88-dependent toll-like receptor signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0050729">
<property type="term" value="P:positive regulation of inflammatory response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0034134">
<property type="term" value="P:toll-like receptor 2 signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="Gene3D" id="3.40.50.10140">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="3.80.10.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR000483">
<property type="entry name" value="Cys-rich_flank_reg_C"/>
</dbReference>
<dbReference type="InterPro" id="IPR001611">
<property type="entry name" value="Leu-rich_rpt"/>
</dbReference>
<dbReference type="InterPro" id="IPR003591">
<property type="entry name" value="Leu-rich_rpt_typical-subtyp"/>
</dbReference>
<dbReference type="InterPro" id="IPR032675">
<property type="entry name" value="LRR_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR000157">
<property type="entry name" value="TIR_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR027185">
<property type="entry name" value="TLR2"/>
</dbReference>
<dbReference type="InterPro" id="IPR017241">
<property type="entry name" value="Toll-like_receptor"/>
</dbReference>
<dbReference type="InterPro" id="IPR035897">
<property type="entry name" value="Toll_tir_struct_dom_sf"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR24365">
<property type="entry name" value="PTHR24365"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR24365:SF17">
<property type="entry name" value="PTHR24365:SF17"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF13855">
<property type="entry name" value="LRR_8"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="Pfam" id="PF01582">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PIRSF" id="PIRSF037595">
<property type="entry name" value="Toll-like_receptor"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00369">
<property type="entry name" value="LRR_TYP"/>
<property type="match status" value="6"/>
</dbReference>
<dbReference type="SMART" id="SM00082">
<property type="entry name" value="LRRCT"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00255">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF52200">
<property type="entry name" value="SSF52200"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51450">
<property type="entry name" value="LRR"/>
<property type="match status" value="10"/>
</dbReference>
<dbReference type="PROSITE" id="PS50104">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at transcript level"/>
<keyword id="KW-0968">Cytoplasmic vesicle</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0378">Hydrolase</keyword>
<keyword id="KW-0391">Immunity</keyword>
<keyword id="KW-0395">Inflammatory response</keyword>
<keyword id="KW-0399">Innate immunity</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0433">Leucine-rich repeat</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0520">NAD</keyword>
<keyword id="KW-0675">Receptor</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0732">Signal</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="signal peptide" evidence="4">
<location>
<begin position="1"/>
<end position="20"/>
</location>
</feature>
<feature type="chain" description="Toll-like receptor 2" id="PRO_0000253494">
<location>
<begin position="21"/>
<end position="784"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="4">
<location>
<begin position="21"/>
<end position="587"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="4">
<location>
<begin position="588"/>
<end position="608"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="4">
<location>
<begin position="609"/>
<end position="784"/>
</location>
</feature>
<feature type="repeat" description="LRR 1">
<location>
<begin position="54"/>
<end position="77"/>
</location>
</feature>
<feature type="repeat" description="LRR 2">
<location>
<begin position="78"/>
<end position="101"/>
</location>
</feature>
<feature type="repeat" description="LRR 3">
<location>
<begin position="102"/>
<end position="125"/>
</location>
</feature>
<feature type="repeat" description="LRR 4">
<location>
<begin position="126"/>
<end position="150"/>
</location>
</feature>
<feature type="repeat" description="LRR 5">
<location>
<begin position="151"/>
<end position="175"/>
</location>
</feature>
<feature type="repeat" description="LRR 6">
<location>
<begin position="176"/>
<end position="199"/>
</location>
</feature>
<feature type="repeat" description="LRR 7">
<location>
<begin position="200"/>
<end position="223"/>
</location>
</feature>
<feature type="repeat" description="LRR 8">
<location>
<begin position="224"/>
<end position="250"/>
</location>
</feature>
<feature type="repeat" description="LRR 9">
<location>
<begin position="251"/>
<end position="278"/>
</location>
</feature>
<feature type="repeat" description="LRR 10">
<location>
<begin position="279"/>
<end position="308"/>
</location>
</feature>
<feature type="repeat" description="LRR 11">
<location>
<begin position="309"/>
<end position="337"/>
</location>
</feature>
<feature type="repeat" description="LRR 12">
<location>
<begin position="338"/>
<end position="361"/>
</location>
</feature>
<feature type="repeat" description="LRR 13">
<location>
<begin position="362"/>
<end position="388"/>
</location>
</feature>
<feature type="repeat" description="LRR 14">
<location>
<begin position="389"/>
<end position="414"/>
</location>
</feature>
<feature type="repeat" description="LRR 15">
<location>
<begin position="415"/>
<end position="437"/>
</location>
</feature>
<feature type="repeat" description="LRR 16">
<location>
<begin position="438"/>
<end position="457"/>
</location>
</feature>
<feature type="repeat" description="LRR 17">
<location>
<begin position="458"/>
<end position="478"/>
</location>
</feature>
<feature type="repeat" description="LRR 18">
<location>
<begin position="479"/>
<end position="500"/>
</location>
</feature>
<feature type="repeat" description="LRR 19">
<location>
<begin position="501"/>
<end position="524"/>
</location>
</feature>
<feature type="domain" description="LRRCT">
<location>
<begin position="525"/>
<end position="579"/>
</location>
</feature>
<feature type="domain" description="TIR" evidence="5">
<location>
<begin position="639"/>
<end position="782"/>
</location>
</feature>
<feature type="short sequence motif" description="ATG16L1-binding motif">
<location>
<begin position="761"/>
<end position="778"/>
</location>
</feature>
<feature type="active site" evidence="5">
<location>
<position position="716"/>
</location>
</feature>
<feature type="site" description="Interaction with bacterial lipopeptide" evidence="1">
<location>
<position position="349"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="114"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="199"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="442"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1">
<location>
<begin position="30"/>
<end position="36"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1">
<location>
<begin position="353"/>
<end position="382"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1">
<location>
<begin position="432"/>
<end position="454"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="2">
<location>
<position position="754"/>
</location>
</feature>
<evidence key="1" type="ECO:0000250"/>
<evidence key="2" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="O60603"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q9QUN7"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000255"/>
<evidence key="5" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00204"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000305"/>
<sequence length="784" mass="90115" checksum="C98ABDDF465E4DF0" modified="2006-01-10" version="1" precursor="true">MPRALWPAWVWAIIILSMEGASDKASSLSCDPTGVCDGRSRSLNSIPSGLTAGVKSLDLSNNEITYVGNRDLQRCVNLKTLRLGANEIHTVEEDSFFHLRNLEYLDLSYNRLSNLSSSWFRSLYVLKFLNLLGNLYKTLGETSLFSHLPDLRTLKVGNSNSFTEIHEKDFTGLTFLEELEISAQNLQIYVPKSLKSIQNISHLILHLKQPVLLVDILVDIVSSLDCLELRDTNLHTFHFSEASISEMSTSVKKLIFRNVQFTDESFVEVVKLFNYVSGIVEVEFDDCTHDGIGDFRALSLDRIRHLGNVETLTIRKLHIPQFFLFQDLSSIYPLTGKVKRVTIENSKVFLVPCLLSQHLKSLEYLDLSENLMSEETLKNSACKDAWPFLQTLVLRQNRLKSLEKTGELLLTLKNLNNLDISKNNFLSMPETCQWPGKMKQLNLSSTKIRSLTQCLPQTLEILDVSNNNLDSFSLILPQLKELYISRNKLKTLPDASFLPVLSVMGISKNIINTFSKEQLDSFQQLKTLEAGGNNFICSCDFLSFTQGQQALGRVLVDWPDDYRCDSPSHVRGQRLQDARLSLSECHRAAVVSAACCALFLFLLLTGVLCHRFHGLWYMKIMWAWLQAKRKPRKAPRRDICYDAFVSYSERDSYWVENLMVQELEHFNPPFKLCLHKRDFIPGKWIIDNIIDSIEKSHKTIFVLSENFVKSEWCKYELDFSHFRLFDENNDAVILILLEPIDKKAIPQRFCKLRKIMNTKTYLEWPLDETQQEGFWLNLRAAIRS</sequence>
</entry>
<entry dataset="Swiss-Prot" created="2009-02-10" modified="2021-02-10" version="58">
<accession>B2LT64</accession>
<name>TLR2_GIRCA</name>
<protein>
<recommendedName>
<fullName>Toll-like receptor 2</fullName>
<ecNumber evidence="5">3.2.2.6</ecNumber>
</recommendedName>
<cdAntigenName>CD282</cdAntigenName>
</protein>
<gene>
<name type="primary">TLR2</name>
</gene>
<organism>
<name type="scientific">Giraffa camelopardalis</name>
<name type="common">Giraffe</name>
<dbReference type="NCBI Taxonomy" id="9894"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Laurasiatheria</taxon>
<taxon>Artiodactyla</taxon>
<taxon>Ruminantia</taxon>
<taxon>Pecora</taxon>
<taxon>Giraffidae</taxon>
<taxon>Giraffa</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="2008" name="BMC Evol. Biol." volume="8" first="288" last="288">
<title>Molecular evolution of bovine Toll-like receptor 2 suggests substitutions of functional relevance.</title>
<authorList>
<person name="Jann O.C."/>
<person name="Werling D."/>
<person name="Chang J.S."/>
<person name="Haig D."/>
<person name="Glass E.J."/>
</authorList>
<dbReference type="PubMed" id="18937834"/>
<dbReference type="DOI" id="10.1186/1471-2148-8-288"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<comment type="function">
<text evidence="2 3">Cooperates with LY96 to mediate the innate immune response to bacterial lipoproteins and other microbial cell wall components. Cooperates with TLR1 or TLR6 to mediate the innate immune response to bacterial lipoproteins or lipopeptides. Acts via MYD88 and TRAF6, leading to NF-kappa-B activation, cytokine secretion and the inflammatory response (By similarity). May also promote apoptosis in response to lipoproteins. Forms activation clusters composed of several receptors depending on the ligand, these clusters trigger signaling from the cell surface and subsequently are targeted to the Golgi in a lipid-raft dependent pathway. Forms the cluster TLR2:TLR6:CD14:CD36 in response to diacylated lipopeptides and TLR2:TLR1:CD14 in response to triacylated lipopeptides (By similarity).</text>
</comment>
<comment type="catalytic activity">
<reaction evidence="5">
<text>H2O + NAD(+) = ADP-D-ribose + H(+) + nicotinamide</text>
<dbReference type="Rhea" id="RHEA:16301"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:17154"/>
<dbReference type="ChEBI" id="CHEBI:57540"/>
<dbReference type="ChEBI" id="CHEBI:57967"/>
<dbReference type="EC" id="3.2.2.6"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="5">
<dbReference type="Rhea" id="RHEA:16302"/>
</physiologicalReaction>
</comment>
<comment type="subunit">
<text evidence="2 3">Interacts with LY96, TLR1 and TLR6 (via extracellular domain). TLR2 seems to exist in heterodimers with either TLR1 or TLR6 before stimulation by the ligand. The heterodimers form bigger oligomers in response to their corresponding ligands as well as further heterotypic associations with other receptors such as CD14 and/or CD36. Binds MYD88 (via TIR domain). Interacts with TICAM1. Interacts with CNPY3. Interacts with ATG16L1. Interacts with PPP1R11. Interacts with TICAM2.</text>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="3">Membrane</location>
<topology evidence="4">Single-pass type I membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="3">Cytoplasmic vesicle</location>
<location evidence="3">Phagosome membrane</location>
<topology evidence="4">Single-pass type I membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="2">Membrane raft</location>
</subcellularLocation>
<text evidence="2">Does not reside in lipid rafts before stimulation but accumulates increasingly in the raft upon the presence of the microbial ligand. In response to diacylated lipoproteins, TLR2:TLR6 heterodimers are recruited in lipid rafts, this recruitment determine the intracellular targeting to the Golgi apparatus. Triacylated lipoproteins induce the same mechanism for TLR2:TLR1 heterodimers.</text>
</comment>
<comment type="domain">
<text evidence="1">Ester-bound lipid substrates are bound through a crevice formed between the LRR 11 and LRR 12.</text>
</comment>
<comment type="domain">
<text evidence="1">The ATG16L1-binding motif mediates interaction with ATG16L1.</text>
</comment>
<comment type="domain">
<text evidence="5">The TIR domain mediates NAD(+) hydrolase (NADase) activity. Self-association of TIR domains is required for NADase activity.</text>
</comment>
<comment type="PTM">
<text evidence="3">Ubiquitinated at Lys-754 by PPP1R11, leading to its degradation. Deubiquitinated by USP2.</text>
</comment>
<comment type="PTM">
<text evidence="2">Glycosylation of Asn-442 is critical for secretion of the N-terminal ectodomain of TLR2.</text>
</comment>
<comment type="similarity">
<text evidence="6">Belongs to the Toll-like receptor family.</text>
</comment>
<dbReference type="EC" id="3.2.2.6" evidence="5"/>
<dbReference type="EMBL" id="EU580542">
<property type="protein sequence ID" value="ACB72731.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="SMR" id="B2LT64"/>
<dbReference type="GO" id="GO:0005794">
<property type="term" value="C:Golgi apparatus"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016021">
<property type="term" value="C:integral component of membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0045121">
<property type="term" value="C:membrane raft"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030670">
<property type="term" value="C:phagocytic vesicle membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0050135">
<property type="term" value="F:NAD(P)+ nucleosidase activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0061809">
<property type="term" value="F:NAD+ nucleotidase, cyclic ADP-ribose generating"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0004888">
<property type="term" value="F:transmembrane signaling receptor activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0071726">
<property type="term" value="P:cellular response to diacyl bacterial lipopeptide"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071727">
<property type="term" value="P:cellular response to triacyl bacterial lipopeptide"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006954">
<property type="term" value="P:inflammatory response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0045087">
<property type="term" value="P:innate immune response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0002755">
<property type="term" value="P:MyD88-dependent toll-like receptor signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0050729">
<property type="term" value="P:positive regulation of inflammatory response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0034134">
<property type="term" value="P:toll-like receptor 2 signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="Gene3D" id="3.40.50.10140">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="3.80.10.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR000483">
<property type="entry name" value="Cys-rich_flank_reg_C"/>
</dbReference>
<dbReference type="InterPro" id="IPR001611">
<property type="entry name" value="Leu-rich_rpt"/>
</dbReference>
<dbReference type="InterPro" id="IPR003591">
<property type="entry name" value="Leu-rich_rpt_typical-subtyp"/>
</dbReference>
<dbReference type="InterPro" id="IPR032675">
<property type="entry name" value="LRR_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR000157">
<property type="entry name" value="TIR_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR027185">
<property type="entry name" value="TLR2"/>
</dbReference>
<dbReference type="InterPro" id="IPR017241">
<property type="entry name" value="Toll-like_receptor"/>
</dbReference>
<dbReference type="InterPro" id="IPR035897">
<property type="entry name" value="Toll_tir_struct_dom_sf"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR24365">
<property type="entry name" value="PTHR24365"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR24365:SF17">
<property type="entry name" value="PTHR24365:SF17"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF13855">
<property type="entry name" value="LRR_8"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="Pfam" id="PF01582">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PIRSF" id="PIRSF037595">
<property type="entry name" value="Toll-like_receptor"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00369">
<property type="entry name" value="LRR_TYP"/>
<property type="match status" value="7"/>
</dbReference>
<dbReference type="SMART" id="SM00082">
<property type="entry name" value="LRRCT"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00255">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF52200">
<property type="entry name" value="SSF52200"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51450">
<property type="entry name" value="LRR"/>
<property type="match status" value="11"/>
</dbReference>
<dbReference type="PROSITE" id="PS50104">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="inferred from homology"/>
<keyword id="KW-0968">Cytoplasmic vesicle</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0378">Hydrolase</keyword>
<keyword id="KW-0391">Immunity</keyword>
<keyword id="KW-0395">Inflammatory response</keyword>
<keyword id="KW-0399">Innate immunity</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0433">Leucine-rich repeat</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0520">NAD</keyword>
<keyword id="KW-0675">Receptor</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0732">Signal</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="signal peptide" evidence="4">
<location>
<begin position="1"/>
<end position="20"/>
</location>
</feature>
<feature type="chain" description="Toll-like receptor 2" id="PRO_0000363770">
<location>
<begin position="21"/>
<end position="784"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="4">
<location>
<begin position="21"/>
<end position="587"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="4">
<location>
<begin position="588"/>
<end position="608"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="4">
<location>
<begin position="609"/>
<end position="784"/>
</location>
</feature>
<feature type="repeat" description="LRR 1">
<location>
<begin position="54"/>
<end position="77"/>
</location>
</feature>
<feature type="repeat" description="LRR 2">
<location>
<begin position="78"/>
<end position="101"/>
</location>
</feature>
<feature type="repeat" description="LRR 3">
<location>
<begin position="102"/>
<end position="125"/>
</location>
</feature>
<feature type="repeat" description="LRR 4">
<location>
<begin position="126"/>
<end position="150"/>
</location>
</feature>
<feature type="repeat" description="LRR 5">
<location>
<begin position="151"/>
<end position="175"/>
</location>
</feature>
<feature type="repeat" description="LRR 6">
<location>
<begin position="176"/>
<end position="199"/>
</location>
</feature>
<feature type="repeat" description="LRR 7">
<location>
<begin position="200"/>
<end position="223"/>
</location>
</feature>
<feature type="repeat" description="LRR 8">
<location>
<begin position="224"/>
<end position="250"/>
</location>
</feature>
<feature type="repeat" description="LRR 9">
<location>
<begin position="251"/>
<end position="278"/>
</location>
</feature>
<feature type="repeat" description="LRR 10">
<location>
<begin position="279"/>
<end position="308"/>
</location>
</feature>
<feature type="repeat" description="LRR 11">
<location>
<begin position="309"/>
<end position="337"/>
</location>
</feature>
<feature type="repeat" description="LRR 12">
<location>
<begin position="338"/>
<end position="361"/>
</location>
</feature>
<feature type="repeat" description="LRR 13">
<location>
<begin position="362"/>
<end position="388"/>
</location>
</feature>
<feature type="repeat" description="LRR 14">
<location>
<begin position="389"/>
<end position="414"/>
</location>
</feature>
<feature type="repeat" description="LRR 15">
<location>
<begin position="415"/>
<end position="437"/>
</location>
</feature>
<feature type="repeat" description="LRR 16">
<location>
<begin position="438"/>
<end position="457"/>
</location>
</feature>
<feature type="repeat" description="LRR 17">
<location>
<begin position="458"/>
<end position="478"/>
</location>
</feature>
<feature type="repeat" description="LRR 18">
<location>
<begin position="479"/>
<end position="500"/>
</location>
</feature>
<feature type="repeat" description="LRR 19">
<location>
<begin position="501"/>
<end position="524"/>
</location>
</feature>
<feature type="domain" description="LRRCT">
<location>
<begin position="525"/>
<end position="579"/>
</location>
</feature>
<feature type="domain" description="TIR" evidence="5">
<location>
<begin position="639"/>
<end position="782"/>
</location>
</feature>
<feature type="short sequence motif" description="ATG16L1-binding motif">
<location>
<begin position="761"/>
<end position="778"/>
</location>
</feature>
<feature type="active site" evidence="5">
<location>
<position position="716"/>
</location>
</feature>
<feature type="site" description="Interaction with bacterial lipopeptide" evidence="1">
<location>
<position position="349"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="114"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="199"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="248"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="414"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="442"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1">
<location>
<begin position="30"/>
<end position="36"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1">
<location>
<begin position="353"/>
<end position="382"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1">
<location>
<begin position="432"/>
<end position="454"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="2">
<location>
<position position="754"/>
</location>
</feature>
<evidence key="1" type="ECO:0000250"/>
<evidence key="2" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="O60603"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q9QUN7"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000255"/>
<evidence key="5" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00204"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000305"/>
<sequence length="784" mass="90217" checksum="10EF98BE1F39CBD1" modified="2008-06-10" version="1" precursor="true">MPRALWTAWVWAVISLSTEGASDQASSLSCDPTGVCDGHSRSLNSIPSGLTAGVKSLDLSNNEITHVGNRDLQSCVNLKTLRLGANEIHTVEEDSFFHLRSLEYLDLSYNRLSNLSSSWFRSLYVLKFLNLLGNLYRTLGETSLFSHLSNLRTLKVGNSNSFTEIHEKDFTGLTFLEELEISARNLQIYAPKSLKSIQNISHLILHLKQPVLLLDILVDIVSSLDYLELRDTNLHTFHFSEASISEMNTSVKKLIFRNVQFTDESFVEVVKLFNYVSGISEVEFDDCTHDGIGDFRALALERTRYLGNVETLTIRKLHIPQFFLFQDLSSIYSLTGKVKRVTIENSKVFLVPCLLSQHLKSLEYLDLSENLMSEETLKNSACEHAWPFLQTLVLRQNRLKSLEKTGELLLTLKNLTNLDISKNNFLSMPETCQWPGKMKQLNLSSTRIHSLTHCLPQTLEILDVSSNNLDSFSLILPQLKELYISRNKLKTLPDASFLPVLSVMRISRNIINTFSKEQLDSFQQLKTLEAGGNNFICSCDFLSFMQGQQALARVLADWPDDYWCDSPSHVRGQRVRDARLTLSECHRTAVVSAVCCALFLLLLLTGVLCHRLHGLWYMKMMWAWLQAKRKPRKAPRRDICYDAFVSYSERDSYWVENLMVRELEHFDPPFKLCLHKRDFIPGKWIIDNIIDSIEKSHKTIFVLSENFVKSEWCKYELDFSHFRLFDENNDAAILILLEPIDKKAIPQRFCKLRKVMNTKTYLEWPMDETQQEGFWLNLRAAVRS</sequence>
</entry>
<entry dataset="Swiss-Prot" created="2002-01-31" modified="2021-02-10" version="188">
<accession>Q9Y2C9</accession>
<accession>B3Y640</accession>
<accession>B6CH35</accession>
<accession>B6RFS4</accession>
<accession>B6RFS5</accession>
<accession>Q2NKL3</accession>
<name>TLR6_HUMAN</name>
<protein>
<recommendedName>
<fullName>Toll-like receptor 6</fullName>
<ecNumber evidence="5">3.2.2.6</ecNumber>
</recommendedName>
<cdAntigenName>CD286</cdAntigenName>
</protein>
<gene>
<name type="primary">TLR6</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1999" name="Gene" volume="231" first="59" last="65">
<title>TLR6: a novel member of an expanding Toll-like receptor family.</title>
<authorList>
<person name="Takeuchi O."/>
<person name="Kawai T."/>
<person name="Sanjo H."/>
<person name="Copeland N.G."/>
<person name="Gilbert D.J."/>
<person name="Jenkins N.A."/>
<person name="Takeda K."/>
<person name="Akira S."/>
</authorList>
<dbReference type="PubMed" id="10231569"/>
<dbReference type="DOI" id="10.1016/s0378-1119(99)00098-0"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Placenta</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="2008" name="Immunogenetics" volume="60" first="727" last="735">
<title>Natural selection in the TLR-related genes in the course of primate evolution.</title>
<authorList>
<person name="Nakajima T."/>
<person name="Ohtani H."/>
<person name="Satta Y."/>
<person name="Uno Y."/>
<person name="Akari H."/>
<person name="Ishida T."/>
<person name="Kimura A."/>
</authorList>
<dbReference type="PubMed" id="18810425"/>
<dbReference type="DOI" id="10.1007/s00251-008-0332-0"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>VARIANT PRO-249</scope>
</reference>
<reference key="3">
<citation type="submission" date="2007-10" db="EMBL/GenBank/DDBJ databases">
<title>The novel allele of toll-like receptor 6 gene.</title>
<authorList>
<person name="Liu Z."/>
<person name="Xiao W."/>
<person name="Wang J."/>
<person name="Li N."/>
<person name="Tai Y."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>VARIANTS THR-120 AND PRO-249; MET-327</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2005" name="Nature" volume="434" first="724" last="731">
<title>Generation and annotation of the DNA sequences of human chromosomes 2 and 4.</title>
<authorList>
<person name="Hillier L.W."/>
<person name="Graves T.A."/>
<person name="Fulton R.S."/>
<person name="Fulton L.A."/>
<person name="Pepin K.H."/>
<person name="Minx P."/>
<person name="Wagner-McPherson C."/>
<person name="Layman D."/>
<person name="Wylie K."/>
<person name="Sekhon M."/>
<person name="Becker M.C."/>
<person name="Fewell G.A."/>
<person name="Delehaunty K.D."/>
<person name="Miner T.L."/>
<person name="Nash W.E."/>
<person name="Kremitzki C."/>
<person name="Oddy L."/>
<person name="Du H."/>
<person name="Sun H."/>
<person name="Bradshaw-Cordum H."/>
<person name="Ali J."/>
<person name="Carter J."/>
<person name="Cordes M."/>
<person name="Harris A."/>
<person name="Isak A."/>
<person name="van Brunt A."/>
<person name="Nguyen C."/>
<person name="Du F."/>
<person name="Courtney L."/>
<person name="Kalicki J."/>
<person name="Ozersky P."/>
<person name="Abbott S."/>
<person name="Armstrong J."/>
<person name="Belter E.A."/>
<person name="Caruso L."/>
<person name="Cedroni M."/>
<person name="Cotton M."/>
<person name="Davidson T."/>
<person name="Desai A."/>
<person name="Elliott G."/>
<person name="Erb T."/>
<person name="Fronick C."/>
<person name="Gaige T."/>
<person name="Haakenson W."/>
<person name="Haglund K."/>
<person name="Holmes A."/>
<person name="Harkins R."/>
<person name="Kim K."/>
<person name="Kruchowski S.S."/>
<person name="Strong C.M."/>
<person name="Grewal N."/>
<person name="Goyea E."/>
<person name="Hou S."/>
<person name="Levy A."/>
<person name="Martinka S."/>
<person name="Mead K."/>
<person name="McLellan M.D."/>
<person name="Meyer R."/>
<person name="Randall-Maher J."/>
<person name="Tomlinson C."/>
<person name="Dauphin-Kohlberg S."/>
<person name="Kozlowicz-Reilly A."/>
<person name="Shah N."/>
<person name="Swearengen-Shahid S."/>
<person name="Snider J."/>
<person name="Strong J.T."/>
<person name="Thompson J."/>
<person name="Yoakum M."/>
<person name="Leonard S."/>
<person name="Pearman C."/>
<person name="Trani L."/>
<person name="Radionenko M."/>
<person name="Waligorski J.E."/>
<person name="Wang C."/>
<person name="Rock S.M."/>
<person name="Tin-Wollam A.-M."/>
<person name="Maupin R."/>
<person name="Latreille P."/>
<person name="Wendl M.C."/>
<person name="Yang S.-P."/>
<person name="Pohl C."/>
<person name="Wallis J.W."/>
<person name="Spieth J."/>
<person name="Bieri T.A."/>
<person name="Berkowicz N."/>
<person name="Nelson J.O."/>
<person name="Osborne J."/>
<person name="Ding L."/>
<person name="Meyer R."/>
<person name="Sabo A."/>
<person name="Shotland Y."/>
<person name="Sinha P."/>
<person name="Wohldmann P.E."/>
<person name="Cook L.L."/>
<person name="Hickenbotham M.T."/>
<person name="Eldred J."/>
<person name="Williams D."/>
<person name="Jones T.A."/>
<person name="She X."/>
<person name="Ciccarelli F.D."/>
<person name="Izaurralde E."/>
<person name="Taylor J."/>
<person name="Schmutz J."/>
<person name="Myers R.M."/>
<person name="Cox D.R."/>
<person name="Huang X."/>
<person name="McPherson J.D."/>
<person name="Mardis E.R."/>
<person name="Clifton S.W."/>
<person name="Warren W.C."/>
<person name="Chinwalla A.T."/>
<person name="Eddy S.R."/>
<person name="Marra M.A."/>
<person name="Ovcharenko I."/>
<person name="Furey T.S."/>
<person name="Miller W."/>
<person name="Eichler E.E."/>
<person name="Bork P."/>
<person name="Suyama M."/>
<person name="Torrents D."/>
<person name="Waterston R.H."/>
<person name="Wilson R.K."/>
</authorList>
<dbReference type="PubMed" id="15815621"/>
<dbReference type="DOI" id="10.1038/nature03466"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
<scope>VARIANT PRO-249</scope>
</reference>
<reference key="5">
<citation type="submission" date="2005-07" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2)</scope>
<scope>VARIANT PRO-249</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2001" name="J. Immunol." volume="167" first="987" last="994">
<title>Cooperation of Toll-like receptor 2 and 6 for cellular activation by soluble tuberculosis factor and Borrelia burgdorferi outer surface protein A lipoprotein: role of Toll-interacting protein and IL-1 receptor signaling molecules in Toll-like receptor 2 signaling.</title>
<authorList>
<person name="Bulut Y."/>
<person name="Faure E."/>
<person name="Thomas L."/>
<person name="Equils O."/>
<person name="Arditi M."/>
</authorList>
<dbReference type="PubMed" id="11441107"/>
<dbReference type="DOI" id="10.4049/jimmunol.167.2.987"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2006" name="J. Biol. Chem." volume="281" first="31002" last="31011">
<title>Membrane sorting of toll-like receptor (TLR)-2/6 and TLR2/1 heterodimers at the cell surface determines heterotypic associations with CD36 and intracellular targeting.</title>
<authorList>
<person name="Triantafilou M."/>
<person name="Gamper F.G."/>
<person name="Haston R.M."/>
<person name="Mouratis M.A."/>
<person name="Morath S."/>
<person name="Hartung T."/>
<person name="Triantafilou K."/>
</authorList>
<dbReference type="PubMed" id="16880211"/>
<dbReference type="DOI" id="10.1074/jbc.m602794200"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH TLR2; CD14 AND CD36</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2010" name="Nat. Immunol." volume="11" first="155" last="161">
<title>CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer.</title>
<authorList>
<person name="Stewart C.R."/>
<person name="Stuart L.M."/>
<person name="Wilkinson K."/>
<person name="van Gils J.M."/>
<person name="Deng J."/>
<person name="Halle A."/>
<person name="Rayner K.J."/>
<person name="Boyer L."/>
<person name="Zhong R."/>
<person name="Frazier W.A."/>
<person name="Lacy-Hulbert A."/>
<person name="El Khoury J."/>
<person name="Golenbock D.T."/>
<person name="Moore K.J."/>
</authorList>
<dbReference type="PubMed" id="20037584"/>
<dbReference type="DOI" id="10.1038/ni.1836"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH CD36 AND TLR4</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2014" name="J. Mol. Biol." volume="426" first="3305" last="3313">
<title>Crystal structure of TIR domain of TLR6 reveals novel dimeric interface of TIR-TIR interaction for toll-like receptor signaling pathway.</title>
<authorList>
<person name="Jang T.H."/>
<person name="Park H.H."/>
</authorList>
<dbReference type="PubMed" id="25088687"/>
<dbReference type="DOI" id="10.1016/j.jmb.2014.07.024"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.20 ANGSTROMS) OF 640-782</scope>
<scope>SUBUNIT</scope>
<scope>MUTAGENESIS OF PHE-678; CYS-712 AND LEU-716</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2011" name="Hum. Mutat." volume="32" first="643" last="652">
<title>Functional characterization of naturally occurring genetic variants in the human TLR1-2-6 gene family.</title>
<authorList>
<person name="Ben-Ali M."/>
<person name="Corre B."/>
<person name="Manry J."/>
<person name="Barreiro L.B."/>
<person name="Quach H."/>
<person name="Boniotto M."/>
<person name="Pellegrini S."/>
<person name="Quintana-Murci L."/>
</authorList>
<dbReference type="PubMed" id="21618349"/>
<dbReference type="DOI" id="10.1002/humu.21486"/>
</citation>
<scope>VARIANTS THR-120; VAL-128; PRO-194; THR-210; GLY-210; LYS-247; PRO-249; VAL-283; MET-327; ALA-427; ALA-442; ILE-465; THR-474; VAL-474; VAL-592; THR-690 AND HIS-708</scope>
<scope>CHARACTERIZATION OF VARIANTS VAL-128; PRO-194; VAL-474; THR-690 AND HIS-708</scope>
</reference>
<comment type="function">
<text evidence="6 9 11">Participates in the innate immune response to Gram-positive bacteria and fungi. Specifically recognizes diacylated and, to a lesser extent, triacylated lipopeptides (PubMed:20037584). In response to diacylated lipopeptides, forms the activation cluster TLR2:TLR6:CD14:CD36, this cluster triggers signaling from the cell surface and subsequently is targeted to the Golgi in a lipid-raft dependent pathway (PubMed:16880211). Acts via MYD88 and TRAF6, leading to NF-kappa-B activation, cytokine secretion and the inflammatory response. Recognizes mycoplasmal macrophage-activating lipopeptide-2kD (MALP-2), soluble tuberculosis factor (STF), phenol-soluble modulin (PSM) and B.burgdorferi outer surface protein A lipoprotein (OspA-L) cooperatively with TLR2 (PubMed:11441107). In complex with TLR4, promotes sterile inflammation in monocytes/macrophages in response to oxidized low-density lipoprotein (oxLDL) or amyloid-beta 42. In this context, the initial signal is provided by oxLDL- or amyloid-beta 42-binding to CD36. This event induces the formation of a heterodimer of TLR4 and TLR6, which is rapidly internalized and triggers inflammatory response, leading to the NF-kappa-B-dependent production of CXCL1, CXCL2 and CCL9 cytokines, via MYD88 signaling pathway, and CCL5 cytokine, via TICAM1 signaling pathway, as well as IL1B secretion (PubMed:11441107, PubMed:20037584).</text>
</comment>
<comment type="catalytic activity">
<reaction evidence="5">
<text>H2O + NAD(+) = ADP-D-ribose + H(+) + nicotinamide</text>
<dbReference type="Rhea" id="RHEA:16301"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:17154"/>
<dbReference type="ChEBI" id="CHEBI:57540"/>
<dbReference type="ChEBI" id="CHEBI:57967"/>
<dbReference type="EC" id="3.2.2.6"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="5">
<dbReference type="Rhea" id="RHEA:16302"/>
</physiologicalReaction>
</comment>
<comment type="subunit">
<text evidence="9 11 13 16">Homodimer (via cytoplasmic TIR domain) (PubMed:25088687). Heterodimer with TLR2 via their respective extracellular domains (PubMed:16880211). Binds MYD88 via their respective TIR domains (Probable). Interacts with CD36, following CD36 stimulation by oxLDL or amyloid-beta 42, and forms a heterodimer with TLR4. The trimeric complex is internalized and triggers inflammatory response. LYN kinase activity facilitates TLR4:TLR6 heterodimerization and signal initiation (PubMed:20037584). The heterodimer TLR2:TLR6 interacts with CD14 and CD36 in response to triacylated lipopeptides (PubMed:16880211).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-13940779">
<id>Q9Y2C9</id>
</interactant>
<interactant intactId="EBI-973722">
<id>O60603</id>
<label>TLR2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-13940779">
<id>Q9Y2C9</id>
</interactant>
<interactant intactId="EBI-528701">
<id>O00206</id>
<label>TLR4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-13940779">
<id>Q9Y2C9</id>
</interactant>
<interactant intactId="EBI-13940779">
<id>Q9Y2C9</id>
<label>TLR6</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="11">Cell membrane</location>
<topology evidence="4">Single-pass type I membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="3">Cytoplasmic vesicle</location>
<location evidence="3">Phagosome membrane</location>
<topology evidence="4">Single-pass type I membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="9">Membrane raft</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="9">Golgi apparatus</location>
</subcellularLocation>
<text evidence="9 11">Upon complex formation with CD36 and TLR4, internalized through dynamin-dependent endocytosis. Does not reside in lipid rafts before stimulation but accumulates increasingly in the raft upon the presence of the microbial ligand. In response to diacylated lipoproteins, TLR2:TLR6 heterodimers are recruited in lipid rafts, this recruitment determine the intracellular targeting to the Golgi apparatus (PubMed:16880211).</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>Q9Y2C9-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>Q9Y2C9-2</id>
<name>2</name>
<sequence type="described" ref="VSP_056851"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text>Detected in monocytes, CD11c+ immature dendritic cells, plasmacytoid pre-dendritic cells and dermal microvessel endothelial cells.</text>
</comment>
<comment type="domain">
<text evidence="5">The TIR domain mediates NAD(+) hydrolase (NADase) activity. Self-association of TIR domains is required for NADase activity.</text>
</comment>
<comment type="similarity">
<text evidence="16">Belongs to the Toll-like receptor family.</text>
</comment>
<dbReference type="EC" id="3.2.2.6" evidence="5"/>
<dbReference type="EMBL" id="AB020807">
<property type="protein sequence ID" value="BAA78631.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB445652">
<property type="protein sequence ID" value="BAG55049.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="EU170528">
<property type="protein sequence ID" value="ABW37063.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="EU170529">
<property type="protein sequence ID" value="ABW37064.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="EU170531">
<property type="protein sequence ID" value="ABW37066.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="EU170532">
<property type="protein sequence ID" value="ABW37067.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="EU170533">
<property type="protein sequence ID" value="ABW37068.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="EU170534">
<property type="protein sequence ID" value="ABW37069.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="EU170536">
<property type="protein sequence ID" value="ABW37071.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="EU195537">
<property type="protein sequence ID" value="ABY67113.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="EU195538">
<property type="protein sequence ID" value="ABY67114.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="EU195539">
<property type="protein sequence ID" value="ABY67115.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="EU195541">
<property type="protein sequence ID" value="ABY67117.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="EU195542">
<property type="protein sequence ID" value="ABY67118.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="EU195543">
<property type="protein sequence ID" value="ABY67119.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="EU195544">
<property type="protein sequence ID" value="ABY67120.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="EU195545">
<property type="protein sequence ID" value="ABY67121.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="EU195546">
<property type="protein sequence ID" value="ABY67122.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="EU195547">
<property type="protein sequence ID" value="ABY67123.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="EU195548">
<property type="protein sequence ID" value="ABY67124.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="EU195550">
<property type="protein sequence ID" value="ABY67126.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="EU195551">
<property type="protein sequence ID" value="ABY67127.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="EU195553">
<property type="protein sequence ID" value="ABY67129.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="EU195554">
<property type="protein sequence ID" value="ABY67130.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="EU195555">
<property type="protein sequence ID" value="ABY67131.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="EU195557">
<property type="protein sequence ID" value="ABY67133.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC108044">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471069">
<property type="protein sequence ID" value="EAW92902.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC111755">
<property type="protein sequence ID" value="AAI11756.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS3446.1">
<molecule id="Q9Y2C9-1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_006059.2">
<molecule id="Q9Y2C9-1"/>
<property type="nucleotide sequence ID" value="NM_006068.4"/>
</dbReference>
<dbReference type="RefSeq" id="XP_005262694.1">
<molecule id="Q9Y2C9-1"/>
<property type="nucleotide sequence ID" value="XM_005262637.4"/>
</dbReference>
<dbReference type="RefSeq" id="XP_011511914.1">
<property type="nucleotide sequence ID" value="XM_011513612.2"/>
</dbReference>
<dbReference type="RefSeq" id="XP_011511915.1">
<molecule id="Q9Y2C9-1"/>
<property type="nucleotide sequence ID" value="XM_011513613.2"/>
</dbReference>
<dbReference type="RefSeq" id="XP_011511916.1">
<molecule id="Q9Y2C9-1"/>
<property type="nucleotide sequence ID" value="XM_011513614.2"/>
</dbReference>
<dbReference type="PDB" id="4OM7">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="A/B=640-796"/>
</dbReference>
<dbReference type="PDBsum" id="4OM7"/>
<dbReference type="SMR" id="Q9Y2C9"/>
<dbReference type="BioGRID" id="115616">
<property type="interactions" value="5"/>
</dbReference>
<dbReference type="IntAct" id="Q9Y2C9">
<property type="interactions" value="9"/>
</dbReference>
<dbReference type="STRING" id="9606.ENSP00000389600"/>
<dbReference type="ChEMBL" id="CHEMBL3301399"/>
<dbReference type="GlyGen" id="Q9Y2C9">
<property type="glycosylation" value="9 sites"/>
</dbReference>
<dbReference type="iPTMnet" id="Q9Y2C9"/>
<dbReference type="PhosphoSitePlus" id="Q9Y2C9"/>
<dbReference type="BioMuta" id="TLR6"/>
<dbReference type="DMDM" id="296452933"/>
<dbReference type="jPOST" id="Q9Y2C9"/>
<dbReference type="MassIVE" id="Q9Y2C9"/>
<dbReference type="PaxDb" id="Q9Y2C9"/>
<dbReference type="PeptideAtlas" id="Q9Y2C9"/>
<dbReference type="PRIDE" id="Q9Y2C9"/>
<dbReference type="ProteomicsDB" id="85731">
<molecule id="Q9Y2C9-1"/>
</dbReference>
<dbReference type="Antibodypedia" id="10461">
<property type="antibodies" value="850 antibodies"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000381950">
<molecule id="Q9Y2C9-1"/>
<property type="protein sequence ID" value="ENSP00000371376"/>
<property type="gene ID" value="ENSG00000174130"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000436693">
<molecule id="Q9Y2C9-1"/>
<property type="protein sequence ID" value="ENSP00000389600"/>
<property type="gene ID" value="ENSG00000174130"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000610323">
<molecule id="Q9Y2C9-2"/>
<property type="protein sequence ID" value="ENSP00000480266"/>
<property type="gene ID" value="ENSG00000174130"/>
</dbReference>
<dbReference type="GeneID" id="10333"/>
<dbReference type="KEGG" id="hsa:10333"/>
<dbReference type="UCSC" id="uc010ifg.3">
<molecule id="Q9Y2C9-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="10333"/>
<dbReference type="DisGeNET" id="10333"/>
<dbReference type="GeneCards" id="TLR6"/>
<dbReference type="HGNC" id="HGNC:16711">
<property type="gene designation" value="TLR6"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000174130">
<property type="expression patterns" value="Tissue enhanced (blood, brain, lymphoid tissue)"/>
</dbReference>
<dbReference type="MIM" id="605403">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q9Y2C9"/>
<dbReference type="OpenTargets" id="ENSG00000174130"/>
<dbReference type="PharmGKB" id="PA38183"/>
<dbReference type="VEuPathDB" id="HostDB:ENSG00000174130.12"/>
<dbReference type="eggNOG" id="KOG4641">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000162201"/>
<dbReference type="HOGENOM" id="CLU_006000_3_0_1"/>
<dbReference type="InParanoid" id="Q9Y2C9"/>
<dbReference type="OMA" id="FLWPKPV"/>
<dbReference type="OrthoDB" id="282372at2759"/>
<dbReference type="PhylomeDB" id="Q9Y2C9"/>
<dbReference type="TreeFam" id="TF351113"/>
<dbReference type="PathwayCommons" id="Q9Y2C9"/>
<dbReference type="Reactome" id="R-HSA-1236974">
<property type="pathway name" value="ER-Phagosome pathway"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-166058">
<property type="pathway name" value="MyD88:MAL(TIRAP) cascade initiated on plasma membrane"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-168188">
<property type="pathway name" value="Toll Like Receptor TLR6:TLR2 Cascade"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5602498">
<property type="pathway name" value="MyD88 deficiency (TLR2/4)"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5603041">
<property type="pathway name" value="IRAK4 deficiency (TLR2/4)"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5686938">
<property type="pathway name" value="Regulation of TLR by endogenous ligand"/>
</dbReference>
<dbReference type="BioGRID-ORCS" id="10333">
<property type="hits" value="4 hits in 877 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="TLR6">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="GeneWiki" id="TLR6"/>
<dbReference type="GenomeRNAi" id="10333"/>
<dbReference type="Pharos" id="Q9Y2C9">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:Q9Y2C9"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 4"/>
</dbReference>
<dbReference type="RNAct" id="Q9Y2C9">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000174130">
<property type="expression patterns" value="Expressed in blood and 120 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="Q9Y2C9">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q9Y2C9">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005794">
<property type="term" value="C:Golgi apparatus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005887">
<property type="term" value="C:integral component of plasma membrane"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0045121">
<property type="term" value="C:membrane raft"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030670">
<property type="term" value="C:phagocytic vesicle membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0043235">
<property type="term" value="C:receptor complex"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0035355">
<property type="term" value="C:Toll-like receptor 2-Toll-like receptor 6 protein complex"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0001540">
<property type="term" value="F:amyloid-beta binding"/>
<property type="evidence" value="ECO:0000305"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0042802">
<property type="term" value="F:identical protein binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071723">
<property type="term" value="F:lipopeptide binding"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050135">
<property type="term" value="F:NAD(P)+ nucleosidase activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0061809">
<property type="term" value="F:NAD+ nucleotidase, cyclic ADP-ribose generating"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0046982">
<property type="term" value="F:protein heterodimerization activity"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0038023">
<property type="term" value="F:signaling receptor activity"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0005102">
<property type="term" value="F:signaling receptor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0035663">
<property type="term" value="F:Toll-like receptor 2 binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004888">
<property type="term" value="F:transmembrane signaling receptor activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0007250">
<property type="term" value="P:activation of NF-kappaB-inducing kinase activity"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001775">
<property type="term" value="P:cell activation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="AgBase"/>
</dbReference>
<dbReference type="GO" id="GO:1904646">
<property type="term" value="P:cellular response to amyloid-beta"/>
<property type="evidence" value="ECO:0000316"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0071221">
<property type="term" value="P:cellular response to bacterial lipopeptide"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0071726">
<property type="term" value="P:cellular response to diacyl bacterial lipopeptide"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0140052">
<property type="term" value="P:cellular response to oxidised low-density lipoprotein particle stimulus"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0042742">
<property type="term" value="P:defense response to bacterium"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0042496">
<property type="term" value="P:detection of diacyl bacterial lipopeptide"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0006955">
<property type="term" value="P:immune response"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0006954">
<property type="term" value="P:inflammatory response"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0045087">
<property type="term" value="P:innate immune response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0032611">
<property type="term" value="P:interleukin-1 beta production"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001774">
<property type="term" value="P:microglial cell activation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0002755">
<property type="term" value="P:MyD88-dependent toll-like receptor signaling pathway"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032717">
<property type="term" value="P:negative regulation of interleukin-8 production"/>
<property type="evidence" value="ECO:0000316"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0034136">
<property type="term" value="P:negative regulation of toll-like receptor 2 signaling pathway"/>
<property type="evidence" value="ECO:0000316"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0046209">
<property type="term" value="P:nitric oxide metabolic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:1900017">
<property type="term" value="P:positive regulation of cytokine production involved in inflammatory response"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0010628">
<property type="term" value="P:positive regulation of gene expression"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0043123">
<property type="term" value="P:positive regulation of I-kappaB kinase/NF-kappaB signaling"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0032755">
<property type="term" value="P:positive regulation of interleukin-6 production"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043507">
<property type="term" value="P:positive regulation of JUN kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0043032">
<property type="term" value="P:positive regulation of macrophage activation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0051092">
<property type="term" value="P:positive regulation of NF-kappaB transcription factor activity"/>
<property type="evidence" value="ECO:0000316"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045429">
<property type="term" value="P:positive regulation of nitric oxide biosynthetic process"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1900227">
<property type="term" value="P:positive regulation of NLRP3 inflammasome complex assembly"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1903223">
<property type="term" value="P:positive regulation of oxidative stress-induced neuron death"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1903428">
<property type="term" value="P:positive regulation of reactive oxygen species biosynthetic process"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0007165">
<property type="term" value="P:signal transduction"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0034150">
<property type="term" value="P:toll-like receptor 6 signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0002224">
<property type="term" value="P:toll-like receptor signaling pathway"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0038124">
<property type="term" value="P:toll-like receptor TLR6:TLR2 signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0035666">
<property type="term" value="P:TRIF-dependent toll-like receptor signaling pathway"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="Gene3D" id="3.40.50.10140">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="3.80.10.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR000483">
<property type="entry name" value="Cys-rich_flank_reg_C"/>
</dbReference>
<dbReference type="InterPro" id="IPR001611">
<property type="entry name" value="Leu-rich_rpt"/>
</dbReference>
<dbReference type="InterPro" id="IPR003591">
<property type="entry name" value="Leu-rich_rpt_typical-subtyp"/>
</dbReference>
<dbReference type="InterPro" id="IPR032675">
<property type="entry name" value="LRR_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR000157">
<property type="entry name" value="TIR_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR027187">
<property type="entry name" value="TLR6"/>
</dbReference>
<dbReference type="InterPro" id="IPR017241">
<property type="entry name" value="Toll-like_receptor"/>
</dbReference>
<dbReference type="InterPro" id="IPR035897">
<property type="entry name" value="Toll_tir_struct_dom_sf"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR24365">
<property type="entry name" value="PTHR24365"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR24365:SF422">
<property type="entry name" value="PTHR24365:SF422"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF13855">
<property type="entry name" value="LRR_8"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="Pfam" id="PF01463">
<property type="entry name" value="LRRCT"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF01582">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PIRSF" id="PIRSF037595">
<property type="entry name" value="Toll-like_receptor"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00369">
<property type="entry name" value="LRR_TYP"/>
<property type="match status" value="5"/>
</dbReference>
<dbReference type="SMART" id="SM00082">
<property type="entry name" value="LRRCT"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00255">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF52200">
<property type="entry name" value="SSF52200"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51450">
<property type="entry name" value="LRR"/>
<property type="match status" value="9"/>
</dbReference>
<dbReference type="PROSITE" id="PS50104">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-0968">Cytoplasmic vesicle</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0333">Golgi apparatus</keyword>
<keyword id="KW-0378">Hydrolase</keyword>
<keyword id="KW-0391">Immunity</keyword>
<keyword id="KW-0395">Inflammatory response</keyword>
<keyword id="KW-0399">Innate immunity</keyword>
<keyword id="KW-0433">Leucine-rich repeat</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0520">NAD</keyword>
<keyword id="KW-0675">Receptor</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0732">Signal</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<feature type="signal peptide" evidence="4">
<location>
<begin position="1"/>
<end position="31"/>
</location>
</feature>
<feature type="chain" description="Toll-like receptor 6" id="PRO_0000034731">
<location>
<begin position="32"/>
<end position="796"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="4">
<location>
<begin position="32"/>
<end position="586"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="4">
<location>
<begin position="587"/>
<end position="607"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="4">
<location>
<begin position="608"/>
<end position="796"/>
</location>
</feature>
<feature type="repeat" description="LRR 1">
<location>
<begin position="54"/>
<end position="77"/>
</location>
</feature>
<feature type="repeat" description="LRR 2">
<location>
<begin position="78"/>
<end position="101"/>
</location>
</feature>
<feature type="repeat" description="LRR 3">
<location>
<begin position="102"/>
<end position="122"/>
</location>
</feature>
<feature type="repeat" description="LRR 4">
<location>
<begin position="123"/>
<end position="147"/>
</location>
</feature>
<feature type="repeat" description="LRR 5">
<location>
<begin position="148"/>
<end position="168"/>
</location>
</feature>
<feature type="repeat" description="LRR 6">
<location>
<begin position="169"/>
<end position="196"/>
</location>
</feature>
<feature type="repeat" description="LRR 7">
<location>
<begin position="197"/>
<end position="219"/>
</location>
</feature>
<feature type="repeat" description="LRR 8">
<location>
<begin position="220"/>
<end position="250"/>
</location>
</feature>
<feature type="repeat" description="LRR 9">
<location>
<begin position="251"/>
<end position="277"/>
</location>
</feature>
<feature type="repeat" description="LRR 10">
<location>
<begin position="278"/>
<end position="303"/>
</location>
</feature>
<feature type="repeat" description="LRR 11">
<location>
<begin position="304"/>
<end position="330"/>
</location>
</feature>
<feature type="repeat" description="LRR 12">
<location>
<begin position="331"/>
<end position="354"/>
</location>
</feature>
<feature type="repeat" description="LRR 13">
<location>
<begin position="355"/>
<end position="378"/>
</location>
</feature>
<feature type="repeat" description="LRR 14">
<location>
<begin position="379"/>
<end position="404"/>
</location>
</feature>
<feature type="repeat" description="LRR 15">
<location>
<begin position="405"/>
<end position="429"/>
</location>
</feature>
<feature type="repeat" description="LRR 16">
<location>
<begin position="430"/>
<end position="450"/>
</location>
</feature>
<feature type="repeat" description="LRR 17">
<location>
<begin position="451"/>
<end position="474"/>
</location>
</feature>
<feature type="repeat" description="LRR 18">
<location>
<begin position="475"/>
<end position="496"/>
</location>
</feature>
<feature type="repeat" description="LRR 19">
<location>
<begin position="497"/>
<end position="520"/>
</location>
</feature>
<feature type="domain" description="LRRCT">
<location>
<begin position="521"/>
<end position="575"/>
</location>
</feature>
<feature type="domain" description="TIR" evidence="5">
<location>
<begin position="640"/>
<end position="781"/>
</location>
</feature>
<feature type="active site" evidence="5">
<location>
<position position="715"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="144"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="186"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="214"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="253"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="285"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="359"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="423"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="434"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="583"/>
</location>
</feature>
<feature type="disulfide bond" evidence="2">
<location>
<begin position="117"/>
<end position="139"/>
</location>
</feature>
<feature type="disulfide bond" evidence="2">
<location>
<begin position="235"/>
<end position="265"/>
</location>
</feature>
<feature type="disulfide bond" evidence="2">
<location>
<begin position="348"/>
<end position="373"/>
</location>
</feature>
<feature type="disulfide bond" evidence="2">
<location>
<begin position="424"/>
<end position="447"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_056851" evidence="15">
<location>
<begin position="383"/>
<end position="698"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs5743808." id="VAR_057289" evidence="12 14">
<original>I</original>
<variation>T</variation>
<location>
<position position="120"/>
</location>
</feature>
<feature type="sequence variant" description="Impairs the ability to induce NF-kappa-B activation; dbSNP:rs137853178." id="VAR_066352" evidence="12">
<original>L</original>
<variation>V</variation>
<location>
<position position="128"/>
</location>
</feature>
<feature type="sequence variant" description="Impairs the ability to induce NF-kappa-B activation; dbSNP:rs5743809." id="VAR_057290" evidence="12">
<original>L</original>
<variation>P</variation>
<location>
<position position="194"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs137853180." id="VAR_066353" evidence="12">
<original>A</original>
<variation>G</variation>
<location>
<position position="210"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs137853179." id="VAR_066354" evidence="12">
<original>A</original>
<variation>T</variation>
<location>
<position position="210"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs35220466." id="VAR_057291" evidence="12">
<original>R</original>
<variation>K</variation>
<location>
<position position="247"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs5743810." id="VAR_063110" evidence="7 8 10 12 14">
<original>S</original>
<variation>P</variation>
<location>
<position position="249"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs137853181." id="VAR_066355" evidence="12">
<original>I</original>
<variation>V</variation>
<location>
<position position="283"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs3796508." id="VAR_057292" evidence="12 14">
<original>V</original>
<variation>M</variation>
<location>
<position position="327"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs5743813." id="VAR_057293">
<original>H</original>
<variation>Y</variation>
<location>
<position position="345"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs5743815." id="VAR_057294" evidence="12">
<original>V</original>
<variation>A</variation>
<location>
<position position="427"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs137853182." id="VAR_066356" evidence="12">
<original>D</original>
<variation>A</variation>
<location>
<position position="442"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs5743816." id="VAR_057295" evidence="12">
<original>V</original>
<variation>I</variation>
<location>
<position position="465"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs5743817." id="VAR_057296" evidence="12">
<original>A</original>
<variation>T</variation>
<location>
<position position="474"/>
</location>
</feature>
<feature type="sequence variant" description="Impairs the ability to induce NF-kappa-B activation; dbSNP:rs1302799168." id="VAR_066357" evidence="12">
<original>A</original>
<variation>V</variation>
<location>
<position position="474"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs75244616." id="VAR_066358" evidence="12">
<original>G</original>
<variation>V</variation>
<location>
<position position="592"/>
</location>
</feature>
<feature type="sequence variant" description="Impairs the ability to induce NF-kappa-B activation; dbSNP:rs114855575." id="VAR_066359" evidence="12">
<original>N</original>
<variation>T</variation>
<location>
<position position="690"/>
</location>
</feature>
<feature type="sequence variant" description="Impairs the ability to induce NF-kappa-B activation; dbSNP:rs137853183." id="VAR_066360" evidence="12">
<original>Q</original>
<variation>H</variation>
<location>
<position position="708"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs5743822." id="VAR_057297">
<original>M</original>
<variation>V</variation>
<location>
<position position="783"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not inhibit homodimer formation." evidence="13">
<original>F</original>
<variation>A</variation>
<location>
<position position="678"/>
</location>
</feature>
<feature type="mutagenesis site" description="Inhibits homodimer formation." evidence="13">
<original>C</original>
<variation>R</variation>
<location>
<position position="712"/>
</location>
</feature>
<feature type="mutagenesis site" description="Inhibits homodimer formation." evidence="13">
<original>L</original>
<variation>R</variation>
<location>
<position position="716"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="642"/>
<end position="647"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="650"/>
<end position="652"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="653"/>
<end position="658"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="660"/>
<end position="666"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="674"/>
<end position="677"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="684"/>
<end position="694"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="695"/>
<end position="702"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="704"/>
<end position="709"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="711"/>
<end position="717"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="722"/>
<end position="724"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="725"/>
<end position="727"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="731"/>
<end position="737"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="741"/>
<end position="743"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="749"/>
<end position="757"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="772"/>
<end position="780"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4OM7"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000250"/>
<evidence key="3" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q9EPW9"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000255"/>
<evidence key="5" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00204"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11441107"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15815621"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16880211"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18810425"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20037584"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21618349"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25088687"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source ref="3"/>
</evidence>
<evidence key="15" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000305"/>
<sequence length="796" mass="91880" checksum="9ACEAEC084CB466C" modified="2010-05-18" version="2" precursor="true">MTKDKEPIVKSFHFVCLMIIIVGTRIQFSDGNEFAVDKSKRGLIHVPKDLPLKTKVLDMSQNYIAELQVSDMSFLSELTVLRLSHNRIQLLDLSVFKFNQDLEYLDLSHNQLQKISCHPIVSFRHLDLSFNDFKALPICKEFGNLSQLNFLGLSAMKLQKLDLLPIAHLHLSYILLDLRNYYIKENETESLQILNAKTLHLVFHPTSLFAIQVNISVNTLGCLQLTNIKLNDDNCQVFIKFLSELTRGSTLLNFTLNHIETTWKCLVRVFQFLWPKPVEYLNIYNLTIIESIREEDFTYSKTTLKALTIEHITNQVFLFSQTALYTVFSEMNIMMLTISDTPFIHMLCPHAPSTFKFLNFTQNVFTDSIFEKCSTLVKLETLILQKNGLKDLFKVGLMTKDMPSLEILDVSWNSLESGRHKENCTWVESIVVLNLSSNMLTDSVFRCLPPRIKVLDLHSNKIKSVPKQVVKLEALQELNVAFNSLTDLPGCGSFSSLSVLIIDHNSVSHPSADFFQSCQKMRSIKAGDNPFQCTCELREFVKNIDQVSSEVLEGWPDSYKCDYPESYRGSPLKDFHMSELSCNITLLIVTIGATMLVLAVTVTSLCIYLDLPWYLRMVCQWTQTRRRARNIPLEELQRNLQFHAFISYSEHDSAWVKSELVPYLEKEDIQICLHERNFVPGKSIVENIINCIEKSYKSIFVLSPNFVQSEWCHYELYFAHHNLFHEGSNNLILILLEPIPQNSIPNKYHKLKALMTQRTYLQWPKEKSKRGLFWANIRAAFNMKLTLVTENNDVKS</sequence>
</entry>
<entry dataset="Swiss-Prot" created="2010-01-19" modified="2020-12-02" version="75">
<accession>B6ZK76</accession>
<accession>Q08BS0</accession>
<name>IRL1A_DANRE</name>
<protein>
<recommendedName>
<fullName>Interleukin-1 receptor accessory protein-like 1-A</fullName>
<ecNumber evidence="4">3.2.2.6</ecNumber>
</recommendedName>
</protein>
<gene>
<name type="primary">il1rapl1a</name>
<name type="ORF">zgc:152866</name>
</gene>
<organism>
<name type="scientific">Danio rerio</name>
<name type="common">Zebrafish</name>
<name type="synonym">Brachydanio rerio</name>
<dbReference type="NCBI Taxonomy" id="7955"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Actinopterygii</taxon>
<taxon>Neopterygii</taxon>
<taxon>Teleostei</taxon>
<taxon>Ostariophysi</taxon>
<taxon>Cypriniformes</taxon>
<taxon>Danionidae</taxon>
<taxon>Danioninae</taxon>
<taxon>Danio</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="2008" name="Mol. Cell. Neurosci." volume="39" first="218" last="228">
<title>Zebrafish orthologue of mental retardation protein IL1RAPL1 regulates presynaptic differentiation.</title>
<authorList>
<person name="Yoshida T."/>
<person name="Mishina M."/>
</authorList>
<dbReference type="PubMed" id="18657618"/>
<dbReference type="DOI" id="10.1016/j.mcn.2008.06.013"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>DEVELOPMENTAL STAGE</scope>
</reference>
<reference key="2">
<citation type="submission" date="2006-10" db="EMBL/GenBank/DDBJ databases">
<authorList>
<consortium name="NIH - Zebrafish Gene Collection (ZGC) project"/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2)</scope>
<source>
<strain>AB</strain>
</source>
</reference>
<comment type="function">
<text>May regulate secretion and presynaptic differentiation through inhibition of the activity of N-type voltage-gated calcium channel. During presynaptic differentiation may regulate both synaptic vesicle accumulation in axon terminals and subsequent axon terminal remodeling.</text>
</comment>
<comment type="catalytic activity">
<reaction evidence="4">
<text>H2O + NAD(+) = ADP-D-ribose + H(+) + nicotinamide</text>
<dbReference type="Rhea" id="RHEA:16301"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:17154"/>
<dbReference type="ChEBI" id="CHEBI:57540"/>
<dbReference type="ChEBI" id="CHEBI:57967"/>
<dbReference type="EC" id="3.2.2.6"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="4">
<dbReference type="Rhea" id="RHEA:16302"/>
</physiologicalReaction>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="1">Cell membrane</location>
<topology evidence="1">Single-pass type I membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="1">Cytoplasm</location>
</subcellularLocation>
<text evidence="1">May localize to the cell body and growth cones of dendrite-like processes.</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>B6ZK76-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>B6ZK76-2</id>
<name>2</name>
<sequence type="described" ref="VSP_038547"/>
</isoform>
</comment>
<comment type="developmental stage">
<text evidence="5">Maternally provided it is detected at all tested stages of development.</text>
</comment>
<comment type="domain">
<text evidence="4">The TIR domain mediates NAD(+) hydrolase (NADase) activity. Self-association of TIR domains is required for NADase activity.</text>
</comment>
<comment type="similarity">
<text evidence="7">Belongs to the interleukin-1 receptor family.</text>
</comment>
<dbReference type="EC" id="3.2.2.6" evidence="4"/>
<dbReference type="EMBL" id="AB449367">
<property type="protein sequence ID" value="BAG85346.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC124594">
<property type="protein sequence ID" value="AAI24595.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001071044.1">
<property type="nucleotide sequence ID" value="NM_001077576.1"/>
</dbReference>
<dbReference type="RefSeq" id="XP_005174755.1">
<molecule id="B6ZK76-2"/>
<property type="nucleotide sequence ID" value="XM_005174698.3"/>
</dbReference>
<dbReference type="RefSeq" id="XP_009303034.1">
<molecule id="B6ZK76-2"/>
<property type="nucleotide sequence ID" value="XM_009304759.2"/>
</dbReference>
<dbReference type="RefSeq" id="XP_009303035.1">
<molecule id="B6ZK76-2"/>
<property type="nucleotide sequence ID" value="XM_009304760.2"/>
</dbReference>
<dbReference type="RefSeq" id="XP_017213199.1">
<molecule id="B6ZK76-2"/>
<property type="nucleotide sequence ID" value="XM_017357710.1"/>
</dbReference>
<dbReference type="SMR" id="B6ZK76"/>
<dbReference type="STRING" id="7955.ENSDARP00000117551"/>
<dbReference type="PaxDb" id="B6ZK76"/>
<dbReference type="Ensembl" id="ENSDART00000089206">
<molecule id="B6ZK76-1"/>
<property type="protein sequence ID" value="ENSDARP00000083639"/>
<property type="gene ID" value="ENSDARG00000115285"/>
</dbReference>
<dbReference type="GeneID" id="568868"/>
<dbReference type="KEGG" id="dre:568868"/>
<dbReference type="CTD" id="568868"/>
<dbReference type="ZFIN" id="ZDB-GENE-061013-249">
<property type="gene designation" value="il1rapl1a"/>
</dbReference>
<dbReference type="eggNOG" id="KOG3971">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="InParanoid" id="B6ZK76"/>
<dbReference type="OrthoDB" id="651291at2759"/>
<dbReference type="PhylomeDB" id="B6ZK76"/>
<dbReference type="PRO" id="PR:B6ZK76"/>
<dbReference type="Proteomes" id="UP000000437">
<property type="component" value="Unplaced"/>
</dbReference>
<dbReference type="Bgee" id="ENSDARG00000062045">
<property type="expression patterns" value="Expressed in brain and 25 other tissues"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0016021">
<property type="term" value="C:integral component of membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0004908">
<property type="term" value="F:interleukin-1 receptor activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0050135">
<property type="term" value="F:NAD(P)+ nucleosidase activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0061809">
<property type="term" value="F:NAD+ nucleotidase, cyclic ADP-ribose generating"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0045920">
<property type="term" value="P:negative regulation of exocytosis"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="Gene3D" id="2.60.40.10">
<property type="match status" value="3"/>
</dbReference>
<dbReference type="Gene3D" id="3.40.50.10140">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR007110">
<property type="entry name" value="Ig-like_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR036179">
<property type="entry name" value="Ig-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR013783">
<property type="entry name" value="Ig-like_fold"/>
</dbReference>
<dbReference type="InterPro" id="IPR003599">
<property type="entry name" value="Ig_sub"/>
</dbReference>
<dbReference type="InterPro" id="IPR003598">
<property type="entry name" value="Ig_sub2"/>
</dbReference>
<dbReference type="InterPro" id="IPR015621">
<property type="entry name" value="IL-1_rcpt_fam"/>
</dbReference>
<dbReference type="InterPro" id="IPR004074">
<property type="entry name" value="IL-1_rcpt_I/II-typ"/>
</dbReference>
<dbReference type="InterPro" id="IPR041416">
<property type="entry name" value="IL-1RAcP-like_ig"/>
</dbReference>
<dbReference type="InterPro" id="IPR000157">
<property type="entry name" value="TIR_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR035897">
<property type="entry name" value="Toll_tir_struct_dom_sf"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR11890">
<property type="entry name" value="PTHR11890"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF18452">
<property type="entry name" value="Ig_6"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF01582">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR01536">
<property type="entry name" value="INTRLKN1R12F"/>
</dbReference>
<dbReference type="SMART" id="SM00409">
<property type="entry name" value="IG"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="SMART" id="SM00408">
<property type="entry name" value="IGc2"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="SMART" id="SM00255">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF48726">
<property type="entry name" value="SSF48726"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF52200">
<property type="entry name" value="SSF52200"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50835">
<property type="entry name" value="IG_LIKE"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="PROSITE" id="PS50104">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at transcript level"/>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0378">Hydrolase</keyword>
<keyword id="KW-0393">Immunoglobulin domain</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0520">NAD</keyword>
<keyword id="KW-0675">Receptor</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0732">Signal</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<feature type="signal peptide" evidence="2">
<location>
<begin position="1"/>
<end position="19"/>
</location>
</feature>
<feature type="chain" description="Interleukin-1 receptor accessory protein-like 1-A" id="PRO_0000390562">
<location>
<begin position="20"/>
<end position="701"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="2">
<location>
<begin position="20"/>
<end position="361"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="2">
<location>
<begin position="362"/>
<end position="382"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="2">
<location>
<begin position="383"/>
<end position="701"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 1">
<location>
<begin position="33"/>
<end position="133"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 2">
<location>
<begin position="146"/>
<end position="235"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 3">
<location>
<begin position="245"/>
<end position="353"/>
</location>
</feature>
<feature type="domain" description="TIR" evidence="4">
<location>
<begin position="407"/>
<end position="563"/>
</location>
</feature>
<feature type="region of interest" description="Required for synaptic vesicle accumulation during synaptogenesis" evidence="1">
<location>
<begin position="568"/>
<end position="701"/>
</location>
</feature>
<feature type="active site" evidence="4">
<location>
<position position="495"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="2">
<location>
<position position="64"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="2">
<location>
<position position="125"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="2">
<location>
<position position="141"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="2">
<location>
<position position="216"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="2">
<location>
<position position="267"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="2">
<location>
<position position="334"/>
</location>
</feature>
<feature type="disulfide bond" evidence="3">
<location>
<begin position="54"/>
<end position="121"/>
</location>
</feature>
<feature type="disulfide bond" evidence="3">
<location>
<begin position="167"/>
<end position="219"/>
</location>
</feature>
<feature type="disulfide bond" evidence="3">
<location>
<begin position="270"/>
<end position="337"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_038547" evidence="6">
<original>T</original>
<variation>SMSSQHYQDDTHLLRA</variation>
<location>
<position position="462"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; AAI24595." ref="2" evidence="7">
<original>Y</original>
<variation>C</variation>
<location>
<position position="42"/>
</location>
</feature>
<evidence key="1" type="ECO:0000250"/>
<evidence key="2" type="ECO:0000255"/>
<evidence key="3" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00114"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00204"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18657618"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000303">
<source ref="2"/>
</evidence>
<evidence key="7" type="ECO:0000305"/>
<sequence length="701" mass="79647" checksum="08B38920D4542584" modified="2009-02-10" version="1" precursor="true">MTALNPVLFLLCGVSVSLSLKVVSKRGSVDGCTDWSVDYLKYRVLHGEPVRIKCALFYGYIRANYTQAQSIGLSLMWYRSSGLGHGDFEEPISFDGTRMSKEEDAIWFRPAELQDAGLYSCVLRNSTFCMKVSMTLLVADNDTAGCYNSKLRYTEKGELGKSKDISCPDIQDYVQPGEKPQITWYKECNVQQWRSSVLQTADLLAIQDVREDDIGNYTCELLFGGFLVRRTTYLSVTAPLTEEPPRILFPSENKLLAMDVQLGSMLNLTCRAFFGYSGDISPLVYWMKGEKFIEDMDQSRIRESEIKTVREHLGEQEVSITLTIDSLEEVDLGNYSCYAENGNGRRQANVQIGKRVELMYTVELAGGLGAILLLLALLLSVYKCYRIELLLCYRHHFGGEDTDGDNKEYDAYLSYSKVELDQWGQELQEEERFALEILPDVLEKHYGYKLFIPDRDLIPTSTYIEDVSRCVDMSKRLIIVLTPSYVLRRGWSIFELESRLRNSLVSGDIKVILIECADLRGVINYQEVEELKQSIKCLSVVHWNGPQSNKPGSRFWKQLRYTMPYRRPQQTITNHALDTSEPGPFADLQTVSAISMATATSAALAPAHPELRPSLRSSYRSHSLARQKHSHYRSYDYELPFTAGGTLPPQHTYCNLPLTLLNGQRPVNNKTLRQHSLDEHHGNNAMLPLLPRETSISSVIW</sequence>
</entry>
<entry dataset="Swiss-Prot" created="2002-12-06" modified="2021-02-10" version="165">
<accession>Q9HB29</accession>
<accession>A4FU63</accession>
<accession>Q13525</accession>
<accession>Q45H74</accession>
<accession>Q53TU8</accession>
<accession>Q587I8</accession>
<name>ILRL2_HUMAN</name>
<protein>
<recommendedName>
<fullName>Interleukin-1 receptor-like 2</fullName>
<ecNumber evidence="5">3.2.2.6</ecNumber>
</recommendedName>
<alternativeName>
<fullName>IL-36 receptor</fullName>
<shortName>IL-36R</shortName>
</alternativeName>
<alternativeName>
<fullName>Interleukin-1 receptor-related protein 2</fullName>
<shortName>IL-1Rrp2</shortName>
<shortName>IL1R-rp2</shortName>
</alternativeName>
</protein>
<gene>
<name type="primary">IL1RL2</name>
<name type="synonym">IL1RRP2</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="2000" name="J. Biol. Chem." volume="275" first="29946" last="29954">
<title>Identification and characterization of two members of a novel class of the interleukin-1 receptor (IL-1R) family. Delineation of a new class of IL-1R-related proteins based on signaling.</title>
<authorList>
<person name="Born T.L."/>
<person name="Smith D.E."/>
<person name="Garka K.E."/>
<person name="Renshaw B.R."/>
<person name="Bertles J.S."/>
<person name="Sims J.E."/>
</authorList>
<dbReference type="PubMed" id="10882729"/>
<dbReference type="DOI" id="10.1074/jbc.m004077200"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1996" name="J. Neuroimmunol." volume="70" first="113" last="122">
<title>Cloning of a cDNA encoding a novel interleukin-1 receptor related protein (IL1R-rp2).</title>
<authorList>
<person name="Lovenberg T.W."/>
<person name="Crowe P.D."/>
<person name="Liu C."/>
<person name="Chalmers D.T."/>
<person name="Liu X.-J."/>
<person name="Liaw C."/>
<person name="Clevenger W."/>
<person name="Oltersdorf T."/>
<person name="De Souza E.B."/>
<person name="Maki R.A."/>
</authorList>
<dbReference type="PubMed" id="8898719"/>
<dbReference type="DOI" id="10.1016/s0165-5728(96)00047-1"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
</reference>
<reference key="3">
<citation type="submission" date="2005-07" db="EMBL/GenBank/DDBJ databases">
<authorList>
<consortium name="SeattleSNPs variation discovery resource"/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>VARIANTS ILE-352 AND PRO-550</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2005" name="Nature" volume="434" first="724" last="731">
<title>Generation and annotation of the DNA sequences of human chromosomes 2 and 4.</title>
<authorList>
<person name="Hillier L.W."/>
<person name="Graves T.A."/>
<person name="Fulton R.S."/>
<person name="Fulton L.A."/>
<person name="Pepin K.H."/>
<person name="Minx P."/>
<person name="Wagner-McPherson C."/>
<person name="Layman D."/>
<person name="Wylie K."/>
<person name="Sekhon M."/>
<person name="Becker M.C."/>
<person name="Fewell G.A."/>
<person name="Delehaunty K.D."/>
<person name="Miner T.L."/>
<person name="Nash W.E."/>
<person name="Kremitzki C."/>
<person name="Oddy L."/>
<person name="Du H."/>
<person name="Sun H."/>
<person name="Bradshaw-Cordum H."/>
<person name="Ali J."/>
<person name="Carter J."/>
<person name="Cordes M."/>
<person name="Harris A."/>
<person name="Isak A."/>
<person name="van Brunt A."/>
<person name="Nguyen C."/>
<person name="Du F."/>
<person name="Courtney L."/>
<person name="Kalicki J."/>
<person name="Ozersky P."/>
<person name="Abbott S."/>
<person name="Armstrong J."/>
<person name="Belter E.A."/>
<person name="Caruso L."/>
<person name="Cedroni M."/>
<person name="Cotton M."/>
<person name="Davidson T."/>
<person name="Desai A."/>
<person name="Elliott G."/>
<person name="Erb T."/>
<person name="Fronick C."/>
<person name="Gaige T."/>
<person name="Haakenson W."/>
<person name="Haglund K."/>
<person name="Holmes A."/>
<person name="Harkins R."/>
<person name="Kim K."/>
<person name="Kruchowski S.S."/>
<person name="Strong C.M."/>
<person name="Grewal N."/>
<person name="Goyea E."/>
<person name="Hou S."/>
<person name="Levy A."/>
<person name="Martinka S."/>
<person name="Mead K."/>
<person name="McLellan M.D."/>
<person name="Meyer R."/>
<person name="Randall-Maher J."/>
<person name="Tomlinson C."/>
<person name="Dauphin-Kohlberg S."/>
<person name="Kozlowicz-Reilly A."/>
<person name="Shah N."/>
<person name="Swearengen-Shahid S."/>
<person name="Snider J."/>
<person name="Strong J.T."/>
<person name="Thompson J."/>
<person name="Yoakum M."/>
<person name="Leonard S."/>
<person name="Pearman C."/>
<person name="Trani L."/>
<person name="Radionenko M."/>
<person name="Waligorski J.E."/>
<person name="Wang C."/>
<person name="Rock S.M."/>
<person name="Tin-Wollam A.-M."/>
<person name="Maupin R."/>
<person name="Latreille P."/>
<person name="Wendl M.C."/>
<person name="Yang S.-P."/>
<person name="Pohl C."/>
<person name="Wallis J.W."/>
<person name="Spieth J."/>
<person name="Bieri T.A."/>
<person name="Berkowicz N."/>
<person name="Nelson J.O."/>
<person name="Osborne J."/>
<person name="Ding L."/>
<person name="Meyer R."/>
<person name="Sabo A."/>
<person name="Shotland Y."/>
<person name="Sinha P."/>
<person name="Wohldmann P.E."/>
<person name="Cook L.L."/>
<person name="Hickenbotham M.T."/>
<person name="Eldred J."/>
<person name="Williams D."/>
<person name="Jones T.A."/>
<person name="She X."/>
<person name="Ciccarelli F.D."/>
<person name="Izaurralde E."/>
<person name="Taylor J."/>
<person name="Schmutz J."/>
<person name="Myers R.M."/>
<person name="Cox D.R."/>
<person name="Huang X."/>
<person name="McPherson J.D."/>
<person name="Mardis E.R."/>
<person name="Clifton S.W."/>
<person name="Warren W.C."/>
<person name="Chinwalla A.T."/>
<person name="Eddy S.R."/>
<person name="Marra M.A."/>
<person name="Ovcharenko I."/>
<person name="Furey T.S."/>
<person name="Miller W."/>
<person name="Eichler E.E."/>
<person name="Bork P."/>
<person name="Suyama M."/>
<person name="Torrents D."/>
<person name="Waterston R.H."/>
<person name="Wilson R.K."/>
</authorList>
<dbReference type="PubMed" id="15815621"/>
<dbReference type="DOI" id="10.1038/nature03466"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2)</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2001" name="J. Immunol." volume="167" first="1440" last="1446">
<title>Two novel IL-1 family members, IL-1 delta and IL-1 epsilon, function as an antagonist and agonist of NF-kappa B activation through the orphan IL-1 receptor-related protein 2.</title>
<authorList>
<person name="Debets R."/>
<person name="Timans J.C."/>
<person name="Homey B."/>
<person name="Zurawski S."/>
<person name="Sana T.R."/>
<person name="Lo S."/>
<person name="Wagner J."/>
<person name="Edwards G."/>
<person name="Clifford T."/>
<person name="Menon S."/>
<person name="Bazan J.F."/>
<person name="Kastelein R.A."/>
</authorList>
<dbReference type="PubMed" id="11466363"/>
<dbReference type="DOI" id="10.4049/jimmunol.167.3.1440"/>
</citation>
<scope>FUNCTION AS RECEPTOR FOR IL36G</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2006" name="Arthritis Res. Ther." volume="8" first="R80" last="R80">
<title>The new IL-1 family member IL-1F8 stimulates production of inflammatory mediators by synovial fibroblasts and articular chondrocytes.</title>
<authorList>
<person name="Magne D."/>
<person name="Palmer G."/>
<person name="Barton J.L."/>
<person name="Mezin F."/>
<person name="Talabot-Ayer D."/>
<person name="Bas S."/>
<person name="Duffy T."/>
<person name="Noger M."/>
<person name="Guerne P.A."/>
<person name="Nicklin M.J."/>
<person name="Gabay C."/>
</authorList>
<dbReference type="PubMed" id="16646978"/>
<dbReference type="DOI" id="10.1186/ar1946"/>
</citation>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2014" name="J. Immunol." volume="192" first="6053" last="6061">
<title>IL-36 promotes myeloid cell infiltration, activation, and inflammatory activity in skin.</title>
<authorList>
<person name="Foster A.M."/>
<person name="Baliwag J."/>
<person name="Chen C.S."/>
<person name="Guzman A.M."/>
<person name="Stoll S.W."/>
<person name="Gudjonsson J.E."/>
<person name="Ward N.L."/>
<person name="Johnston A."/>
</authorList>
<dbReference type="PubMed" id="24829417"/>
<dbReference type="DOI" id="10.4049/jimmunol.1301481"/>
</citation>
<scope>TISSUE SPECIFICITY</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<comment type="function">
<text evidence="2 6">Receptor for interleukin-36 (IL36A, IL36B and IL36G). After binding to interleukin-36 associates with the coreceptor IL1RAP to form the interleukin-36 receptor complex which mediates interleukin-36-dependent activation of NF-kappa-B, MAPK and other pathways (By similarity). The IL-36 signaling system is thought to be present in epithelial barriers and to take part in local inflammatory response; it is similar to the IL-1 system. Seems to be involved in skin inflammatory response by induction of the IL-23/IL-17/IL-22 pathway.</text>
</comment>
<comment type="catalytic activity">
<reaction evidence="5">
<text>H2O + NAD(+) = ADP-D-ribose + H(+) + nicotinamide</text>
<dbReference type="Rhea" id="RHEA:16301"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:17154"/>
<dbReference type="ChEBI" id="CHEBI:57540"/>
<dbReference type="ChEBI" id="CHEBI:57967"/>
<dbReference type="EC" id="3.2.2.6"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="5">
<dbReference type="Rhea" id="RHEA:16302"/>
</physiologicalReaction>
</comment>
<comment type="subunit">
<text evidence="2">Interacts with IL1RAP; the association is enhanced by IL36B indicative for an functional signaling complex and inhibited by IL36RN (By similarity).</text>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location>Membrane</location>
<topology evidence="8">Single-pass type I membrane protein</topology>
</subcellularLocation>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>Q9HB29-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>Q9HB29-2</id>
<name>2</name>
<sequence type="described" ref="VSP_056292 VSP_056293 VSP_056294"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="7 8">Expressed in synovial fibroblasts and articular chondrocytes. Expressed in keratinocytes and monocyte-derived dendritic cells. Expressed in monocytes and myeloid dendritic cells; at protein level.</text>
</comment>
<comment type="domain">
<text evidence="5">The TIR domain mediates NAD(+) hydrolase (NADase) activity. Self-association of TIR domains is required for NADase activity.</text>
</comment>
<comment type="similarity">
<text evidence="11">Belongs to the interleukin-1 receptor family.</text>
</comment>
<comment type="sequence caution" evidence="11">
<conflict type="frameshift">
<sequence resource="EMBL-CDS" id="AAB53237" version="1"/>
</conflict>
</comment>
<comment type="online information" name="SeattleSNPs">
<link uri="http://pga.gs.washington.edu/data/il1rl2/"/>
</comment>
<dbReference type="EC" id="3.2.2.6" evidence="5"/>
<dbReference type="EMBL" id="AF284434">
<property type="protein sequence ID" value="AAG21368.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U49065">
<property type="protein sequence ID" value="AAB53237.1"/>
<property type="status" value="ALT_FRAME"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="DQ131903">
<property type="protein sequence ID" value="AAZ38712.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC007271">
<property type="protein sequence ID" value="AAX81989.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC007248">
<property type="protein sequence ID" value="AAY15046.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC107064">
<property type="protein sequence ID" value="AAI07065.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS2056.1">
<molecule id="Q9HB29-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS86867.1">
<molecule id="Q9HB29-2"/>
</dbReference>
<dbReference type="PIR" id="G02426">
<property type="entry name" value="G02426"/>
</dbReference>
<dbReference type="RefSeq" id="NP_003845.2">
<molecule id="Q9HB29-1"/>
<property type="nucleotide sequence ID" value="NM_003854.2"/>
</dbReference>
<dbReference type="RefSeq" id="XP_005264093.1">
<property type="nucleotide sequence ID" value="XM_005264036.1"/>
</dbReference>
<dbReference type="PDB" id="6U6U">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.31"/>
<property type="chains" value="R=21-215"/>
</dbReference>
<dbReference type="PDBsum" id="6U6U"/>
<dbReference type="SMR" id="Q9HB29"/>
<dbReference type="BioGRID" id="114336">
<property type="interactions" value="12"/>
</dbReference>
<dbReference type="IntAct" id="Q9HB29">
<property type="interactions" value="6"/>
</dbReference>
<dbReference type="STRING" id="9606.ENSP00000264257"/>
<dbReference type="GuidetoPHARMACOLOGY" id="1736"/>
<dbReference type="GlyGen" id="Q9HB29">
<property type="glycosylation" value="9 sites"/>
</dbReference>
<dbReference type="iPTMnet" id="Q9HB29"/>
<dbReference type="PhosphoSitePlus" id="Q9HB29"/>
<dbReference type="BioMuta" id="IL1RL2"/>
<dbReference type="DMDM" id="90110768"/>
<dbReference type="PaxDb" id="Q9HB29"/>
<dbReference type="PeptideAtlas" id="Q9HB29"/>
<dbReference type="PRIDE" id="Q9HB29"/>
<dbReference type="ProteomicsDB" id="668"/>
<dbReference type="ProteomicsDB" id="81476">
<molecule id="Q9HB29-1"/>
</dbReference>
<dbReference type="ABCD" id="Q9HB29">
<property type="antibodies" value="19 sequenced antibodies"/>
</dbReference>
<dbReference type="Antibodypedia" id="2361">
<property type="antibodies" value="261 antibodies"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000264257">
<molecule id="Q9HB29-1"/>
<property type="protein sequence ID" value="ENSP00000264257"/>
<property type="gene ID" value="ENSG00000115598"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000441515">
<molecule id="Q9HB29-2"/>
<property type="protein sequence ID" value="ENSP00000413348"/>
<property type="gene ID" value="ENSG00000115598"/>
</dbReference>
<dbReference type="GeneID" id="8808"/>
<dbReference type="KEGG" id="hsa:8808"/>
<dbReference type="UCSC" id="uc002tbs.4">
<molecule id="Q9HB29-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="8808"/>
<dbReference type="DisGeNET" id="8808"/>
<dbReference type="GeneCards" id="IL1RL2"/>
<dbReference type="HGNC" id="HGNC:5999">
<property type="gene designation" value="IL1RL2"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000115598">
<property type="expression patterns" value="Tissue enhanced (skin)"/>
</dbReference>
<dbReference type="MIM" id="604512">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q9HB29"/>
<dbReference type="OpenTargets" id="ENSG00000115598"/>
<dbReference type="PharmGKB" id="PA29815"/>
<dbReference type="VEuPathDB" id="HostDB:ENSG00000115598.9"/>
<dbReference type="eggNOG" id="ENOG502QWEU">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT01000000214361"/>
<dbReference type="HOGENOM" id="CLU_025552_3_0_1"/>
<dbReference type="InParanoid" id="Q9HB29"/>
<dbReference type="OMA" id="LTCHLHF"/>
<dbReference type="OrthoDB" id="1109920at2759"/>
<dbReference type="PhylomeDB" id="Q9HB29"/>
<dbReference type="TreeFam" id="TF325519"/>
<dbReference type="PathwayCommons" id="Q9HB29"/>
<dbReference type="Reactome" id="R-HSA-9007892">
<property type="pathway name" value="Interleukin-38 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9014826">
<property type="pathway name" value="Interleukin-36 pathway"/>
</dbReference>
<dbReference type="BioGRID-ORCS" id="8808">
<property type="hits" value="10 hits in 865 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="IL1RL2">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="GeneWiki" id="IL1RL2"/>
<dbReference type="GenomeRNAi" id="8808"/>
<dbReference type="Pharos" id="Q9HB29">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:Q9HB29"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 2"/>
</dbReference>
<dbReference type="RNAct" id="Q9HB29">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000115598">
<property type="expression patterns" value="Expressed in zone of skin and 110 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="Q9HB29">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q9HB29">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005887">
<property type="term" value="C:integral component of plasma membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0004908">
<property type="term" value="F:interleukin-1 receptor activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0004909">
<property type="term" value="F:interleukin-1, type I, activating receptor activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0050135">
<property type="term" value="F:NAD(P)+ nucleosidase activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0061809">
<property type="term" value="F:NAD+ nucleotidase, cyclic ADP-ribose generating"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0006968">
<property type="term" value="P:cellular defense response"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0071345">
<property type="term" value="P:cellular response to cytokine stimulus"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0019221">
<property type="term" value="P:cytokine-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0006954">
<property type="term" value="P:inflammatory response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0045087">
<property type="term" value="P:innate immune response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0032755">
<property type="term" value="P:positive regulation of interleukin-6 production"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045582">
<property type="term" value="P:positive regulation of T cell differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0050727">
<property type="term" value="P:regulation of inflammatory response"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0007165">
<property type="term" value="P:signal transduction"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="Gene3D" id="2.60.40.10">
<property type="match status" value="3"/>
</dbReference>
<dbReference type="Gene3D" id="3.40.50.10140">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR007110">
<property type="entry name" value="Ig-like_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR036179">
<property type="entry name" value="Ig-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR013783">
<property type="entry name" value="Ig-like_fold"/>
</dbReference>
<dbReference type="InterPro" id="IPR003599">
<property type="entry name" value="Ig_sub"/>
</dbReference>
<dbReference type="InterPro" id="IPR015621">
<property type="entry name" value="IL-1_rcpt_fam"/>
</dbReference>
<dbReference type="InterPro" id="IPR004076">
<property type="entry name" value="IL-1_rcpt_I-typ"/>
</dbReference>
<dbReference type="InterPro" id="IPR004074">
<property type="entry name" value="IL-1_rcpt_I/II-typ"/>
</dbReference>
<dbReference type="InterPro" id="IPR041416">
<property type="entry name" value="IL-1RAcP-like_ig"/>
</dbReference>
<dbReference type="InterPro" id="IPR000157">
<property type="entry name" value="TIR_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR035897">
<property type="entry name" value="Toll_tir_struct_dom_sf"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR11890">
<property type="entry name" value="PTHR11890"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF13895">
<property type="entry name" value="Ig_2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF18452">
<property type="entry name" value="Ig_6"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF01582">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR01538">
<property type="entry name" value="INTRLEUKN1R1"/>
</dbReference>
<dbReference type="PRINTS" id="PR01536">
<property type="entry name" value="INTRLKN1R12F"/>
</dbReference>
<dbReference type="SMART" id="SM00409">
<property type="entry name" value="IG"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="SMART" id="SM00255">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF48726">
<property type="entry name" value="SSF48726"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF52200">
<property type="entry name" value="SSF52200"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50835">
<property type="entry name" value="IG_LIKE"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="PROSITE" id="PS50104">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0378">Hydrolase</keyword>
<keyword id="KW-0391">Immunity</keyword>
<keyword id="KW-0393">Immunoglobulin domain</keyword>
<keyword id="KW-0395">Inflammatory response</keyword>
<keyword id="KW-0399">Innate immunity</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0520">NAD</keyword>
<keyword id="KW-0675">Receptor</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0732">Signal</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<feature type="signal peptide" evidence="3">
<location>
<begin position="1"/>
<end position="19"/>
</location>
</feature>
<feature type="chain" description="Interleukin-1 receptor-like 2" id="PRO_0000015445">
<location>
<begin position="20"/>
<end position="575"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="3">
<location>
<begin position="20"/>
<end position="335"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="3">
<location>
<begin position="336"/>
<end position="356"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="3">
<location>
<begin position="357"/>
<end position="575"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 1">
<location>
<begin position="20"/>
<end position="111"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 2">
<location>
<begin position="126"/>
<end position="211"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 3">
<location>
<begin position="222"/>
<end position="318"/>
</location>
</feature>
<feature type="domain" description="TIR" evidence="5">
<location>
<begin position="381"/>
<end position="536"/>
</location>
</feature>
<feature type="active site" evidence="5">
<location>
<position position="467"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="3">
<location>
<position position="41"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="3">
<location>
<position position="59"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="3">
<location>
<position position="109"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="3">
<location>
<position position="127"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="3">
<location>
<position position="184"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="3">
<location>
<position position="234"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="3">
<location>
<position position="250"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="3">
<location>
<position position="266"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="3">
<location>
<position position="299"/>
</location>
</feature>
<feature type="disulfide bond" evidence="4">
<location>
<begin position="42"/>
<end position="95"/>
</location>
</feature>
<feature type="disulfide bond" evidence="4">
<location>
<begin position="146"/>
<end position="195"/>
</location>
</feature>
<feature type="disulfide bond" evidence="4">
<location>
<begin position="249"/>
<end position="316"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_056292" evidence="10">
<original>MWSLLLCGLSIALPLSVTADGCKDIFMKNEILSASQPFAFNCTFPP</original>
<variation>MTGLVSLSYFPLSTRSCALQSCSPVWGCGPCCSAGCPSPFHCLSQQ</variation>
<location>
<begin position="1"/>
<end position="46"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_056293" evidence="10">
<location>
<begin position="47"/>
<end position="163"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_056294" evidence="10">
<original>TE</original>
<variation>K</variation>
<location>
<begin position="217"/>
<end position="218"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs13405631." id="VAR_053378">
<original>I</original>
<variation>T</variation>
<location>
<position position="237"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs33946385." id="VAR_025259" evidence="9">
<original>V</original>
<variation>I</variation>
<location>
<position position="352"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs2302612." id="VAR_025260" evidence="9">
<original>L</original>
<variation>P</variation>
<location>
<position position="550"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAG21368." ref="1" evidence="11">
<original>I</original>
<variation>V</variation>
<location>
<position position="486"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2." ref="2" evidence="11">
<original>PPVQLLQHTPCY</original>
<variation>LRSTCRSTHLCTA</variation>
<location>
<begin position="545"/>
<end position="556"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAG21368." ref="1" evidence="11">
<original>Y</original>
<variation>C</variation>
<location>
<position position="556"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="23"/>
<end position="26"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="31"/>
<end position="36"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="38"/>
<end position="41"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="47"/>
<end position="49"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="53"/>
<end position="59"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="61"/>
<end position="63"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="71"/>
<end position="76"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="79"/>
<end position="82"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="91"/>
<end position="98"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="103"/>
<end position="113"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="117"/>
<end position="119"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="130"/>
<end position="132"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="133"/>
<end position="135"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="142"/>
<end position="145"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="154"/>
<end position="163"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="173"/>
<end position="176"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="179"/>
<end position="184"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="187"/>
<end position="189"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="191"/>
<end position="201"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="204"/>
<end position="215"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="6U6U"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q9ERS7"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000255"/>
<evidence key="4" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00114"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00204"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11466363"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16646978"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24829417"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source ref="3"/>
</evidence>
<evidence key="10" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000305"/>
<sequence length="575" mass="65405" checksum="7AC0FCAB43A2A6CD" modified="2006-02-07" version="2" precursor="true">MWSLLLCGLSIALPLSVTADGCKDIFMKNEILSASQPFAFNCTFPPITSGEVSVTWYKNSSKIPVSKIIQSRIHQDETWILFLPMEWGDSGVYQCVIKGRDSCHRIHVNLTVFEKHWCDTSIGGLPNLSDEYKQILHLGKDDSLTCHLHFPKSCVLGPIKWYKDCNEIKGERFTVLETRLLVSNVSAEDRGNYACQAILTHSGKQYEVLNGITVSITERAGYGGSVPKIIYPKNHSIEVQLGTTLIVDCNVTDTKDNTNLRCWRVNNTLVDDYYDESKRIREGVETHVSFREHNLYTVNITFLEVKMEDYGLPFMCHAGVSTAYIILQLPAPDFRAYLIGGLIALVAVAVSVVYIYNIFKIDIVLWYRSAFHSTETIVDGKLYDAYVLYPKPHKESQRHAVDALVLNILPEVLERQCGYKLFIFGRDEFPGQAVANVIDENVKLCRRLIVIVVPESLGFGLLKNLSEEQIAVYSALIQDGMKVILIELEKIEDYTVMPESIQYIKQKHGAIRWHGDFTEQSQCMKTKFWKTVRYHMPPRRCRPFPPVQLLQHTPCYRTAGPELGSRRKKCTLTTG</sequence>
</entry>
<entry dataset="Swiss-Prot" created="2006-10-17" modified="2021-02-10" version="93">
<accession>Q0ZUL9</accession>
<name>TLR6_DASNO</name>
<protein>
<recommendedName>
<fullName>Toll-like receptor 6</fullName>
<ecNumber evidence="5">3.2.2.6</ecNumber>
</recommendedName>
<cdAntigenName>CD286</cdAntigenName>
</protein>
<gene>
<name type="primary">TLR6</name>
</gene>
<organism>
<name type="scientific">Dasypus novemcinctus</name>
<name type="common">Nine-banded armadillo</name>
<dbReference type="NCBI Taxonomy" id="9361"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Xenarthra</taxon>
<taxon>Cingulata</taxon>
<taxon>Dasypodidae</taxon>
<taxon>Dasypus</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="submission" date="2005-06" db="EMBL/GenBank/DDBJ databases">
<title>TLR-6 in Dasypus novemcinctus.</title>
<authorList>
<person name="Adams J.E."/>
<person name="Pena M.T."/>
<person name="Gillis T.P."/>
<person name="Williams D.L."/>
<person name="Adams L.B."/>
<person name="Truman R.W."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
</reference>
<comment type="function">
<text evidence="3">Participates in the innate immune response to Gram-positive bacteria and fungi. Specifically recognizes diacylated and, to a lesser extent, triacylated lipopeptides. In response to diacylated lipopeptides, forms the activation cluster TLR2:TLR6:CD14:CD36, this cluster triggers signaling from the cell surface and subsequently is targeted to the Golgi in a lipid-raft dependent pathway. Acts via MYD88 and TRAF6, leading to NF-kappa-B activation, cytokine secretion and the inflammatory response. Recognizes mycoplasmal macrophage-activating lipopeptide-2kD (MALP-2), soluble tuberculosis factor (STF), phenol-soluble modulin (PSM) and B.burgdorferi outer surface protein A lipoprotein (OspA-L) cooperatively with TLR2. In complex with TLR4, promotes sterile inflammation in monocytes/macrophages in response to oxidized low-density lipoprotein (oxLDL) or amyloid-beta 42. In this context, the initial signal is provided by oxLDL- or amyloid-beta 42-binding to CD36. This event induces the formation of a heterodimer of TLR4 and TLR6, which is rapidly internalized and triggers inflammatory response, leading to the NF-kappa-B-dependent production of CXCL1, CXCL2 and CCL9 cytokines, via MYD88 signaling pathway, and CCL5 cytokine, via TICAM1 signaling pathway, as well as IL1B secretion.</text>
</comment>
<comment type="catalytic activity">
<reaction evidence="5">
<text>H2O + NAD(+) = ADP-D-ribose + H(+) + nicotinamide</text>
<dbReference type="Rhea" id="RHEA:16301"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:17154"/>
<dbReference type="ChEBI" id="CHEBI:57540"/>
<dbReference type="ChEBI" id="CHEBI:57967"/>
<dbReference type="EC" id="3.2.2.6"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="5">
<dbReference type="Rhea" id="RHEA:16302"/>
</physiologicalReaction>
</comment>
<comment type="subunit">
<text evidence="2 3">Homodimer (via cytoplasmic TIR domain) (By similarity). Heterodimer with TLR2 via their respective extracellular domains. Binds MYD88 via their respective TIR domains (By similarity). Interacts with CD36, following CD36 stimulation by oxLDL or amyloid-beta 42, and forms a heterodimer with TLR4. The trimeric complex is internalized and triggers inflammatory response. LYN kinase activity facilitates TLR4:TLR6 heterodimerization and signal initiation (By similarity). The heterodimer TLR2:TLR6 interacts with CD14 and CD36 in response to triacylated lipopeptides.</text>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="3">Cell membrane</location>
<topology evidence="4">Single-pass type I membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="2">Cytoplasmic vesicle</location>
<location evidence="2">Phagosome membrane</location>
<topology evidence="4">Single-pass type I membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="3">Membrane raft</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="3">Golgi apparatus</location>
</subcellularLocation>
<text evidence="3">Upon complex formation with CD36 and TLR4, internalized through dynamin-dependent endocytosis. Does not reside in lipid rafts before stimulation but accumulates increasingly in the raft upon the presence of the microbial ligand. In response to diacylated lipoproteins, TLR2:TLR6 heterodimers are recruited in lipid rafts, this recruitment determine the intracellular targeting to the Golgi apparatus.</text>
</comment>
<comment type="domain">
<text evidence="5">The TIR domain mediates NAD(+) hydrolase (NADase) activity. Self-association of TIR domains is required for NADase activity.</text>
</comment>
<comment type="similarity">
<text evidence="6">Belongs to the Toll-like receptor family.</text>
</comment>
<dbReference type="EC" id="3.2.2.6" evidence="5"/>
<dbReference type="EMBL" id="DQ113655">
<property type="protein sequence ID" value="AAZ52552.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001268236.1">
<property type="nucleotide sequence ID" value="NM_001281307.1"/>
</dbReference>
<dbReference type="GeneID" id="100913181"/>
<dbReference type="CTD" id="10333"/>
<dbReference type="HOGENOM" id="CLU_006000_3_0_1"/>
<dbReference type="OrthoDB" id="282372at2759"/>
<dbReference type="TreeFam" id="TF351113"/>
<dbReference type="GO" id="GO:0005794">
<property type="term" value="C:Golgi apparatus"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016021">
<property type="term" value="C:integral component of membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0045121">
<property type="term" value="C:membrane raft"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030670">
<property type="term" value="C:phagocytic vesicle membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0042802">
<property type="term" value="F:identical protein binding"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050135">
<property type="term" value="F:NAD(P)+ nucleosidase activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0061809">
<property type="term" value="F:NAD+ nucleotidase, cyclic ADP-ribose generating"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0004888">
<property type="term" value="F:transmembrane signaling receptor activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0071726">
<property type="term" value="P:cellular response to diacyl bacterial lipopeptide"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042496">
<property type="term" value="P:detection of diacyl bacterial lipopeptide"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0006954">
<property type="term" value="P:inflammatory response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0045087">
<property type="term" value="P:innate immune response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0032611">
<property type="term" value="P:interleukin-1 beta production"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0002755">
<property type="term" value="P:MyD88-dependent toll-like receptor signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:1900227">
<property type="term" value="P:positive regulation of NLRP3 inflammasome complex assembly"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0034150">
<property type="term" value="P:toll-like receptor 6 signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="Gene3D" id="3.40.50.10140">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="3.80.10.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR000483">
<property type="entry name" value="Cys-rich_flank_reg_C"/>
</dbReference>
<dbReference type="InterPro" id="IPR001611">
<property type="entry name" value="Leu-rich_rpt"/>
</dbReference>
<dbReference type="InterPro" id="IPR003591">
<property type="entry name" value="Leu-rich_rpt_typical-subtyp"/>
</dbReference>
<dbReference type="InterPro" id="IPR032675">
<property type="entry name" value="LRR_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR000157">
<property type="entry name" value="TIR_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR027187">
<property type="entry name" value="TLR6"/>
</dbReference>
<dbReference type="InterPro" id="IPR017241">
<property type="entry name" value="Toll-like_receptor"/>
</dbReference>
<dbReference type="InterPro" id="IPR035897">
<property type="entry name" value="Toll_tir_struct_dom_sf"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR24365">
<property type="entry name" value="PTHR24365"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR24365:SF422">
<property type="entry name" value="PTHR24365:SF422"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF13855">
<property type="entry name" value="LRR_8"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF01582">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PIRSF" id="PIRSF037595">
<property type="entry name" value="Toll-like_receptor"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00369">
<property type="entry name" value="LRR_TYP"/>
<property type="match status" value="5"/>
</dbReference>
<dbReference type="SMART" id="SM00082">
<property type="entry name" value="LRRCT"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00255">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF52200">
<property type="entry name" value="SSF52200"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51450">
<property type="entry name" value="LRR"/>
<property type="match status" value="10"/>
</dbReference>
<dbReference type="PROSITE" id="PS50104">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at transcript level"/>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-0968">Cytoplasmic vesicle</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0333">Golgi apparatus</keyword>
<keyword id="KW-0378">Hydrolase</keyword>
<keyword id="KW-0391">Immunity</keyword>
<keyword id="KW-0395">Inflammatory response</keyword>
<keyword id="KW-0399">Innate immunity</keyword>
<keyword id="KW-0433">Leucine-rich repeat</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0520">NAD</keyword>
<keyword id="KW-0675">Receptor</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0732">Signal</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<feature type="signal peptide" evidence="4">
<location>
<begin position="1"/>
<end position="31"/>
</location>
</feature>
<feature type="chain" description="Toll-like receptor 6" id="PRO_0000253756">
<location>
<begin position="32"/>
<end position="789"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="4">
<location>
<begin position="32"/>
<end position="587"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="4">
<location>
<begin position="588"/>
<end position="608"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="4">
<location>
<begin position="609"/>
<end position="789"/>
</location>
</feature>
<feature type="repeat" description="LRR 1">
<location>
<begin position="54"/>
<end position="77"/>
</location>
</feature>
<feature type="repeat" description="LRR 2">
<location>
<begin position="78"/>
<end position="101"/>
</location>
</feature>
<feature type="repeat" description="LRR 3">
<location>
<begin position="102"/>
<end position="122"/>
</location>
</feature>
<feature type="repeat" description="LRR 4">
<location>
<begin position="123"/>
<end position="147"/>
</location>
</feature>
<feature type="repeat" description="LRR 5">
<location>
<begin position="148"/>
<end position="168"/>
</location>
</feature>
<feature type="repeat" description="LRR 6">
<location>
<begin position="169"/>
<end position="196"/>
</location>
</feature>
<feature type="repeat" description="LRR 7">
<location>
<begin position="197"/>
<end position="219"/>
</location>
</feature>
<feature type="repeat" description="LRR 8">
<location>
<begin position="220"/>
<end position="250"/>
</location>
</feature>
<feature type="repeat" description="LRR 9">
<location>
<begin position="251"/>
<end position="277"/>
</location>
</feature>
<feature type="repeat" description="LRR 10">
<location>
<begin position="278"/>
<end position="303"/>
</location>
</feature>
<feature type="repeat" description="LRR 11">
<location>
<begin position="304"/>
<end position="330"/>
</location>
</feature>
<feature type="repeat" description="LRR 12">
<location>
<begin position="331"/>
<end position="354"/>
</location>
</feature>
<feature type="repeat" description="LRR 13">
<location>
<begin position="355"/>
<end position="378"/>
</location>
</feature>
<feature type="repeat" description="LRR 14">
<location>
<begin position="379"/>
<end position="404"/>
</location>
</feature>
<feature type="repeat" description="LRR 15">
<location>
<begin position="405"/>
<end position="428"/>
</location>
</feature>
<feature type="repeat" description="LRR 16">
<location>
<begin position="429"/>
<end position="449"/>
</location>
</feature>
<feature type="repeat" description="LRR 17">
<location>
<begin position="450"/>
<end position="473"/>
</location>
</feature>
<feature type="repeat" description="LRR 18">
<location>
<begin position="474"/>
<end position="495"/>
</location>
</feature>
<feature type="repeat" description="LRR 19">
<location>
<begin position="496"/>
<end position="519"/>
</location>
</feature>
<feature type="domain" description="LRRCT">
<location>
<begin position="520"/>
<end position="575"/>
</location>
</feature>
<feature type="domain" description="TIR" evidence="5">
<location>
<begin position="639"/>
<end position="780"/>
</location>
</feature>
<feature type="active site" evidence="5">
<location>
<position position="714"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="144"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="186"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="214"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="253"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="285"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="372"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="433"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="519"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1">
<location>
<begin position="117"/>
<end position="139"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1">
<location>
<begin position="235"/>
<end position="265"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1">
<location>
<begin position="348"/>
<end position="373"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1">
<location>
<begin position="423"/>
<end position="446"/>
</location>
</feature>
<evidence key="1" type="ECO:0000250"/>
<evidence key="2" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q9EPW9"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q9Y2C9"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000255"/>
<evidence key="5" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00204"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000305"/>
<sequence length="789" mass="91379" checksum="81CB96D6B3C5C00C" modified="2006-08-22" version="1" precursor="true">MTKDKEPIVKNFHLVCIVTLIVGTIIQFSDADEFAIDMSKTGLTHVPKDLPPKTKVLDMSQNYLSELQISDISFLSGLKILVLSHNRLQLLDLSVFKFNQDLEYLDLSHNQLKKMSCHPFVNLKHLDLSFNDFDSLPICKEFGNLTQLDFLGLSATKLQQLDLLPIAHLHLNCILLDLKGYYVKQNETESLQILNTKKLHLVFHTGSFFSVQVNMSVNTLGCLEMTNIKLNDKNCYFLMKFLLELTKGPSLLNFTLNHMETTWKCLVRVFQFLWTKPVEYLNIYNLTIVDDINKEYFIYCKTALKALKIEHITKTVFIFSWSSLYTLFSEMNIMMLSITDTPFIHMLCPKTRSTFKFLDFTQNVFTDSIFENCSTLVELETLILQKNGLKDLFKIGLMTKGMPSLEILDLSWNSLVFNRQRKCIWVGSILMLNMSSNLLTDLVFRCLPPRVTVLDLHNNRIMSIPKDVTSLETLQELNIAFNSLTDLPGCGTFSSLSVLIIDYNLISHPSTDFIQSCQNITSIKAGKNPFQCTCDLREFIKTISQMSSEVVKDWPDSYKCDYPESYKGTLLQDFHISQLSCSTSLLTVTIGATMLVLVVTVTFLCIYLDLPWYIRMVYQWTQTRRRARNIPLEELQRTLQFHAFISYSGHDSAWVKTELLPNLEKEDIQICLHERNFVPGKSIIENIINFIEKSYKSIFVLSPNFVQSEWCHYELYFAHHNLFHEAFDNLILILLEPIPQYSIPNNYHKLKSLIAQRTYLEWPKEKSKHGLFWANLRAAINIKLMEEKK</sequence>
</entry>
<entry dataset="Swiss-Prot" created="1990-04-01" modified="2021-02-10" version="227">
<accession>P14778</accession>
<accession>Q587I7</accession>
<name>IL1R1_HUMAN</name>
<protein>
<recommendedName>
<fullName>Interleukin-1 receptor type 1</fullName>
<shortName>IL-1R-1</shortName>
<shortName>IL-1RT-1</shortName>
<shortName>IL-1RT1</shortName>
<ecNumber evidence="6">3.2.2.6</ecNumber>
</recommendedName>
<alternativeName>
<fullName>CD121 antigen-like family member A</fullName>
</alternativeName>
<alternativeName>
<fullName>Interleukin-1 receptor alpha</fullName>
<shortName>IL-1R-alpha</shortName>
</alternativeName>
<alternativeName>
<fullName>Interleukin-1 receptor type I</fullName>
</alternativeName>
<alternativeName>
<fullName>p80</fullName>
</alternativeName>
<cdAntigenName>CD121a</cdAntigenName>
<component>
<recommendedName>
<fullName>Interleukin-1 receptor type 1, membrane form</fullName>
<shortName>mIL-1R1</shortName>
<shortName>mIL-1RI</shortName>
</recommendedName>
</component>
<component>
<recommendedName>
<fullName>Interleukin-1 receptor type 1, soluble form</fullName>
<shortName>sIL-1R1</shortName>
<shortName>sIL-1RI</shortName>
</recommendedName>
</component>
</protein>
<gene>
<name type="primary">IL1R1</name>
<name type="synonym">IL1R</name>
<name type="synonym">IL1RA</name>
<name type="synonym">IL1RT1</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1989" name="Nucleic Acids Res." volume="17" first="10114" last="10114">
<title>Sequence of the cDNA for the human fibroblast type interleukin-1 receptor.</title>
<authorList>
<person name="Chua A.O."/>
<person name="Gubler U."/>
</authorList>
<dbReference type="PubMed" id="2532321"/>
<dbReference type="DOI" id="10.1093/nar/17.23.10114"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="1989" name="Proc. Natl. Acad. Sci. U.S.A." volume="86" first="8946" last="8950">
<title>Cloning the interleukin 1 receptor from human T cells.</title>
<authorList>
<person name="Sims J.E."/>
<person name="Acres R.B."/>
<person name="Grubin C.E."/>
<person name="McMahan C.J."/>
<person name="Wignall J.M."/>
<person name="March C.J."/>
<person name="Dower S.K."/>
</authorList>
<dbReference type="PubMed" id="2530587"/>
<dbReference type="DOI" id="10.1073/pnas.86.22.8946"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<source>
<tissue>T-cell</tissue>
</source>
</reference>
<reference key="3">
<citation type="submission" date="2002-07" db="EMBL/GenBank/DDBJ databases">
<authorList>
<consortium name="SeattleSNPs variation discovery resource"/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>VARIANT GLY-124</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2005" name="Nature" volume="434" first="724" last="731">
<title>Generation and annotation of the DNA sequences of human chromosomes 2 and 4.</title>
<authorList>
<person name="Hillier L.W."/>
<person name="Graves T.A."/>
<person name="Fulton R.S."/>
<person name="Fulton L.A."/>
<person name="Pepin K.H."/>
<person name="Minx P."/>
<person name="Wagner-McPherson C."/>
<person name="Layman D."/>
<person name="Wylie K."/>
<person name="Sekhon M."/>
<person name="Becker M.C."/>
<person name="Fewell G.A."/>
<person name="Delehaunty K.D."/>
<person name="Miner T.L."/>
<person name="Nash W.E."/>
<person name="Kremitzki C."/>
<person name="Oddy L."/>
<person name="Du H."/>
<person name="Sun H."/>
<person name="Bradshaw-Cordum H."/>
<person name="Ali J."/>
<person name="Carter J."/>
<person name="Cordes M."/>
<person name="Harris A."/>
<person name="Isak A."/>
<person name="van Brunt A."/>
<person name="Nguyen C."/>
<person name="Du F."/>
<person name="Courtney L."/>
<person name="Kalicki J."/>
<person name="Ozersky P."/>
<person name="Abbott S."/>
<person name="Armstrong J."/>
<person name="Belter E.A."/>
<person name="Caruso L."/>
<person name="Cedroni M."/>
<person name="Cotton M."/>
<person name="Davidson T."/>
<person name="Desai A."/>
<person name="Elliott G."/>
<person name="Erb T."/>
<person name="Fronick C."/>
<person name="Gaige T."/>
<person name="Haakenson W."/>
<person name="Haglund K."/>
<person name="Holmes A."/>
<person name="Harkins R."/>
<person name="Kim K."/>
<person name="Kruchowski S.S."/>
<person name="Strong C.M."/>
<person name="Grewal N."/>
<person name="Goyea E."/>
<person name="Hou S."/>
<person name="Levy A."/>
<person name="Martinka S."/>
<person name="Mead K."/>
<person name="McLellan M.D."/>
<person name="Meyer R."/>
<person name="Randall-Maher J."/>
<person name="Tomlinson C."/>
<person name="Dauphin-Kohlberg S."/>
<person name="Kozlowicz-Reilly A."/>
<person name="Shah N."/>
<person name="Swearengen-Shahid S."/>
<person name="Snider J."/>
<person name="Strong J.T."/>
<person name="Thompson J."/>
<person name="Yoakum M."/>
<person name="Leonard S."/>
<person name="Pearman C."/>
<person name="Trani L."/>
<person name="Radionenko M."/>
<person name="Waligorski J.E."/>
<person name="Wang C."/>
<person name="Rock S.M."/>
<person name="Tin-Wollam A.-M."/>
<person name="Maupin R."/>
<person name="Latreille P."/>
<person name="Wendl M.C."/>
<person name="Yang S.-P."/>
<person name="Pohl C."/>
<person name="Wallis J.W."/>
<person name="Spieth J."/>
<person name="Bieri T.A."/>
<person name="Berkowicz N."/>
<person name="Nelson J.O."/>
<person name="Osborne J."/>
<person name="Ding L."/>
<person name="Meyer R."/>
<person name="Sabo A."/>
<person name="Shotland Y."/>
<person name="Sinha P."/>
<person name="Wohldmann P.E."/>
<person name="Cook L.L."/>
<person name="Hickenbotham M.T."/>
<person name="Eldred J."/>
<person name="Williams D."/>
<person name="Jones T.A."/>
<person name="She X."/>
<person name="Ciccarelli F.D."/>
<person name="Izaurralde E."/>
<person name="Taylor J."/>
<person name="Schmutz J."/>
<person name="Myers R.M."/>
<person name="Cox D.R."/>
<person name="Huang X."/>
<person name="McPherson J.D."/>
<person name="Mardis E.R."/>
<person name="Clifton S.W."/>
<person name="Warren W.C."/>
<person name="Chinwalla A.T."/>
<person name="Eddy S.R."/>
<person name="Marra M.A."/>
<person name="Ovcharenko I."/>
<person name="Furey T.S."/>
<person name="Miller W."/>
<person name="Eichler E.E."/>
<person name="Bork P."/>
<person name="Suyama M."/>
<person name="Torrents D."/>
<person name="Waterston R.H."/>
<person name="Wilson R.K."/>
</authorList>
<dbReference type="PubMed" id="15815621"/>
<dbReference type="DOI" id="10.1038/nature03466"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="5">
<citation type="submission" date="2005-09" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="7">
<citation type="journal article" date="1993" name="Cytokine" volume="5" first="427" last="435">
<title>Specific binding of interleukin 1 (IL-1) beta and IL-1 receptor antagonist (IL-1ra) to human serum. High-affinity binding of IL-1ra to soluble IL-1 receptor type I.</title>
<authorList>
<person name="Svenson M."/>
<person name="Hansen M.B."/>
<person name="Heegaard P."/>
<person name="Abell K."/>
<person name="Bendtzen K."/>
</authorList>
<dbReference type="PubMed" id="8142597"/>
<dbReference type="DOI" id="10.1016/1043-4666(93)90032-z"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>PROTEOLYTIC PROCESSING</scope>
</reference>
<reference key="8">
<citation type="journal article" date="1994" name="J. Immunol." volume="153" first="5802" last="5809">
<title>Elevated levels of shed type II IL-1 receptor in sepsis. Potential role for type II receptor in regulation of IL-1 responses.</title>
<authorList>
<person name="Giri J.G."/>
<person name="Wells J."/>
<person name="Dower S.K."/>
<person name="McCall C.E."/>
<person name="Guzman R.N."/>
<person name="Slack J."/>
<person name="Bird T.A."/>
<person name="Shanebeck K."/>
<person name="Grabstein K.H."/>
<person name="Sims J.E."/>
<person name="Alderson M.R."/>
</authorList>
<dbReference type="PubMed" id="7989776"/>
</citation>
<scope>LIGAND-BINDING</scope>
</reference>
<reference key="9">
<citation type="journal article" date="1997" name="Proc. Natl. Acad. Sci. U.S.A." volume="94" first="12829" last="12832">
<title>Recruitment of IRAK to the interleukin 1 receptor complex requires interleukin 1 receptor accessory protein.</title>
<authorList>
<person name="Huang J."/>
<person name="Gao X."/>
<person name="Li S."/>
<person name="Cao Z."/>
</authorList>
<dbReference type="PubMed" id="9371760"/>
<dbReference type="DOI" id="10.1073/pnas.94.24.12829"/>
</citation>
<scope>INTERACTION WITH IL1RAP AND IRAK1</scope>
<source>
<tissue>Placenta</tissue>
</source>
</reference>
<reference key="10">
<citation type="journal article" date="1998" name="FEBS Lett." volume="438" first="49" last="54">
<title>Phosphatidylinositol 3-kinase is recruited to a specific site in the activated IL-1 receptor I.</title>
<authorList>
<person name="Marmiroli S."/>
<person name="Bavelloni A."/>
<person name="Faenza I."/>
<person name="Sirri A."/>
<person name="Ognibene A."/>
<person name="Cenni V."/>
<person name="Tsukada J."/>
<person name="Koyama Y."/>
<person name="Ruzzene M."/>
<person name="Ferri A."/>
<person name="Auron P.E."/>
<person name="Toker A."/>
<person name="Maraldi N.M."/>
</authorList>
<dbReference type="PubMed" id="9821957"/>
<dbReference type="DOI" id="10.1016/s0014-5793(98)01270-8"/>
</citation>
<scope>PHOSPHORYLATION AT TYR-496</scope>
<scope>INTERACTION WITH PIK3R1</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2000" name="Int. Immunol." volume="12" first="151" last="160">
<title>IL-12 synergizes with IL-18 or IL-1beta for IFN-gamma production from human T cells.</title>
<authorList>
<person name="Tominaga K."/>
<person name="Yoshimoto T."/>
<person name="Torigoe K."/>
<person name="Kurimoto M."/>
<person name="Matsui K."/>
<person name="Hada T."/>
<person name="Okamura H."/>
<person name="Nakanishi K."/>
</authorList>
<dbReference type="PubMed" id="10653850"/>
<dbReference type="DOI" id="10.1093/intimm/12.2.151"/>
</citation>
<scope>FUNCTION</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2000" name="J. Biol. Chem." volume="275" first="4670" last="4678">
<title>Identification of two major sites in the type I interleukin-1 receptor cytoplasmic region responsible for coupling to pro-inflammatory signaling pathways.</title>
<authorList>
<person name="Slack J.L."/>
<person name="Schooley K."/>
<person name="Bonnert T.P."/>
<person name="Mitcham J.L."/>
<person name="Qwarnstrom E.E."/>
<person name="Sims J.E."/>
<person name="Dower S.K."/>
</authorList>
<dbReference type="PubMed" id="10671496"/>
<dbReference type="DOI" id="10.1074/jbc.275.7.4670"/>
</citation>
<scope>FUNCTION</scope>
<scope>MUTAGENESIS OF ASP-369 AND ARG-428</scope>
</reference>
<reference key="13">
<citation type="journal article" date="1997" name="Nature" volume="386" first="190" last="194">
<title>Crystal structure of the type-I interleukin-1 receptor complexed with interleukin-1beta.</title>
<authorList>
<person name="Vigers G.P.A."/>
<person name="Anderson L.J."/>
<person name="Caffes P."/>
<person name="Brandhuber B.J."/>
</authorList>
<dbReference type="PubMed" id="9062193"/>
<dbReference type="DOI" id="10.1038/386190a0"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 23-332 IN COMPLEX WITH IL1B</scope>
</reference>
<reference key="14">
<citation type="journal article" date="1997" name="Nature" volume="386" first="194" last="200">
<title>A new cytokine-receptor binding mode revealed by the crystal structure of the IL-1 receptor with an antagonist.</title>
<authorList>
<person name="Schreuder H."/>
<person name="Tardif C."/>
<person name="Trump-Kallmeyer S."/>
<person name="Soffientini A."/>
<person name="Sarubbi E."/>
<person name="Akeson A."/>
<person name="Bowlin T."/>
<person name="Yanofsky S."/>
<person name="Barrett R.W."/>
</authorList>
<dbReference type="PubMed" id="9062194"/>
<dbReference type="DOI" id="10.1038/386194a0"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.7 ANGSTROMS) OF 21-331 IN COMPLEX WITH IL1RA</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2000" name="J. Biol. Chem." volume="275" first="36927" last="36933">
<title>X-ray crystal structure of a small antagonist peptide bound to interleukin-1 receptor type 1.</title>
<authorList>
<person name="Vigers G.P.A."/>
<person name="Dripps D.J."/>
<person name="Edwards C.K. III"/>
<person name="Brandhuber B.J."/>
</authorList>
<dbReference type="PubMed" id="10903327"/>
<dbReference type="DOI" id="10.1074/jbc.m006071200"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (3.0 ANGSTROMS) OF 4-315 IN COMPLEX WITH THE ANTAGONIST PEPTIDE AF10847</scope>
</reference>
<comment type="function">
<text evidence="7 8">Receptor for IL1A, IL1B and IL1RN. After binding to interleukin-1 associates with the coreceptor IL1RAP to form the high affinity interleukin-1 receptor complex which mediates interleukin-1-dependent activation of NF-kappa-B, MAPK and other pathways. Signaling involves the recruitment of adapter molecules such as TOLLIP, MYD88, and IRAK1 or IRAK2 via the respective TIR domains of the receptor/coreceptor subunits. Binds ligands with comparable affinity and binding of antagonist IL1RN prevents association with IL1RAP to form a signaling complex. Involved in IL1B-mediated costimulation of IFNG production from T-helper 1 (Th1) cells (PubMed:10653850).</text>
</comment>
<comment type="catalytic activity">
<reaction evidence="6">
<text>H2O + NAD(+) = ADP-D-ribose + H(+) + nicotinamide</text>
<dbReference type="Rhea" id="RHEA:16301"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:17154"/>
<dbReference type="ChEBI" id="CHEBI:57540"/>
<dbReference type="ChEBI" id="CHEBI:57967"/>
<dbReference type="EC" id="3.2.2.6"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="6">
<dbReference type="Rhea" id="RHEA:16302"/>
</physiologicalReaction>
</comment>
<comment type="subunit">
<text evidence="9 11 12 13 14">The interleukin-1 receptor complex is a heterodimer of IL1R1 and IL1RAP. Interacts with PIK3R1.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-525905">
<id>P14778</id>
</interactant>
<interactant intactId="EBI-641237">
<id>P09619</id>
<label>PDGFRB</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-525905">
<id>P14778</id>
</interactant>
<interactant intactId="EBI-359276">
<id>Q9Y4K3</id>
<label>TRAF6</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="10">Membrane</location>
<topology evidence="10">Single-pass type I membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="17">Cell membrane</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="10">Secreted</location>
</subcellularLocation>
</comment>
<comment type="tissue specificity">
<text evidence="7">Expressed in T-helper cell subsets. Preferentially expressed in T-helper 1 (Th1) cells.</text>
</comment>
<comment type="domain">
<text evidence="6">The TIR domain mediates NAD(+) hydrolase (NADase) activity. Self-association of TIR domains is required for NADase activity.</text>
</comment>
<comment type="PTM">
<text evidence="10">A soluble form (sIL1R1) is probably produced by proteolytic cleavage at the cell surface (shedding).</text>
</comment>
<comment type="PTM">
<text evidence="14">Rapidly phosphorylated on Tyr-496 in response to IL-1, which creates a SH2 binding site for the PI 3-kinase regulatory subunit PIK3R1.</text>
</comment>
<comment type="similarity">
<text evidence="16">Belongs to the interleukin-1 receptor family.</text>
</comment>
<comment type="online information" name="SeattleSNPs">
<link uri="http://pga.gs.washington.edu/data/il1r1/"/>
</comment>
<dbReference type="EC" id="3.2.2.6" evidence="6"/>
<dbReference type="EMBL" id="X16896">
<property type="protein sequence ID" value="CAA34773.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M27492">
<property type="protein sequence ID" value="AAA59137.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF531102">
<property type="protein sequence ID" value="AAM88423.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC007271">
<property type="protein sequence ID" value="AAX81988.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471127">
<property type="protein sequence ID" value="EAX01799.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC067506">
<property type="protein sequence ID" value="AAH67506.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC075062">
<property type="protein sequence ID" value="AAH75062.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC075063">
<property type="protein sequence ID" value="AAH75063.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS2055.1"/>
<dbReference type="PIR" id="A36187">
<property type="entry name" value="A36187"/>
</dbReference>
<dbReference type="RefSeq" id="NP_000868.1">
<property type="nucleotide sequence ID" value="NM_000877.3"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001275635.1">
<property type="nucleotide sequence ID" value="NM_001288706.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001307907.1">
<property type="nucleotide sequence ID" value="NM_001320978.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001307909.1">
<property type="nucleotide sequence ID" value="NM_001320980.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001307910.1">
<property type="nucleotide sequence ID" value="NM_001320981.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001307911.1">
<property type="nucleotide sequence ID" value="NM_001320982.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001307912.1">
<property type="nucleotide sequence ID" value="NM_001320983.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001307913.1">
<property type="nucleotide sequence ID" value="NM_001320984.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001307914.1">
<property type="nucleotide sequence ID" value="NM_001320985.1"/>
</dbReference>
<dbReference type="RefSeq" id="XP_005263987.1">
<property type="nucleotide sequence ID" value="XM_005263930.4"/>
</dbReference>
<dbReference type="RefSeq" id="XP_005263991.1">
<property type="nucleotide sequence ID" value="XM_005263934.4"/>
</dbReference>
<dbReference type="RefSeq" id="XP_011509417.1">
<property type="nucleotide sequence ID" value="XM_011511115.2"/>
</dbReference>
<dbReference type="RefSeq" id="XP_011509418.1">
<property type="nucleotide sequence ID" value="XM_011511116.1"/>
</dbReference>
<dbReference type="RefSeq" id="XP_011509419.1">
<property type="nucleotide sequence ID" value="XM_011511117.1"/>
</dbReference>
<dbReference type="RefSeq" id="XP_011509420.1">
<property type="nucleotide sequence ID" value="XM_011511118.2"/>
</dbReference>
<dbReference type="RefSeq" id="XP_016859478.1">
<property type="nucleotide sequence ID" value="XM_017003989.1"/>
</dbReference>
<dbReference type="PDB" id="1G0Y">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.00"/>
<property type="chains" value="R=21-332"/>
</dbReference>
<dbReference type="PDB" id="1IRA">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.70"/>
<property type="chains" value="Y=18-336"/>
</dbReference>
<dbReference type="PDB" id="1ITB">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="B=18-332"/>
</dbReference>
<dbReference type="PDB" id="4DEP">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.10"/>
<property type="chains" value="B/E=18-336"/>
</dbReference>
<dbReference type="PDB" id="4GAF">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.15"/>
<property type="chains" value="B=18-336"/>
</dbReference>
<dbReference type="PDBsum" id="1G0Y"/>
<dbReference type="PDBsum" id="1IRA"/>
<dbReference type="PDBsum" id="1ITB"/>
<dbReference type="PDBsum" id="4DEP"/>
<dbReference type="PDBsum" id="4GAF"/>
<dbReference type="SASBDB" id="P14778"/>
<dbReference type="SMR" id="P14778"/>
<dbReference type="BioGRID" id="109770">
<property type="interactions" value="29"/>
</dbReference>
<dbReference type="DIP" id="DIP-93N"/>
<dbReference type="IntAct" id="P14778">
<property type="interactions" value="15"/>
</dbReference>
<dbReference type="STRING" id="9606.ENSP00000386380"/>
<dbReference type="BindingDB" id="P14778"/>
<dbReference type="ChEMBL" id="CHEMBL1959"/>
<dbReference type="DrugBank" id="DB00026">
<property type="generic name" value="Anakinra"/>
</dbReference>
<dbReference type="DrugBank" id="DB10770">
<property type="generic name" value="Foreskin fibroblast (neonatal)"/>
</dbReference>
<dbReference type="DrugBank" id="DB05303">
<property type="generic name" value="OMS-103HP"/>
</dbReference>
<dbReference type="DrugBank" id="DB05207">
<property type="generic name" value="SD118"/>
</dbReference>
<dbReference type="DrugCentral" id="P14778"/>
<dbReference type="GuidetoPHARMACOLOGY" id="1734"/>
<dbReference type="TCDB" id="8.A.23.1.11">
<property type="family name" value="the basigin (basigin) family"/>
</dbReference>
<dbReference type="GlyGen" id="P14778">
<property type="glycosylation" value="6 sites"/>
</dbReference>
<dbReference type="iPTMnet" id="P14778"/>
<dbReference type="PhosphoSitePlus" id="P14778"/>
<dbReference type="BioMuta" id="IL1R1"/>
<dbReference type="DMDM" id="124308"/>
<dbReference type="jPOST" id="P14778"/>
<dbReference type="MassIVE" id="P14778"/>
<dbReference type="MaxQB" id="P14778"/>
<dbReference type="PaxDb" id="P14778"/>
<dbReference type="PeptideAtlas" id="P14778"/>
<dbReference type="PRIDE" id="P14778"/>
<dbReference type="ProteomicsDB" id="53081"/>
<dbReference type="ABCD" id="P14778">
<property type="antibodies" value="16 sequenced antibodies"/>
</dbReference>
<dbReference type="Antibodypedia" id="3576">
<property type="antibodies" value="960 antibodies"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000410023">
<property type="protein sequence ID" value="ENSP00000386380"/>
<property type="gene ID" value="ENSG00000115594"/>
</dbReference>
<dbReference type="GeneID" id="3554"/>
<dbReference type="KEGG" id="hsa:3554"/>
<dbReference type="UCSC" id="uc002tbq.5">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="3554"/>
<dbReference type="DisGeNET" id="3554"/>
<dbReference type="GeneCards" id="IL1R1"/>
<dbReference type="HGNC" id="HGNC:5993">
<property type="gene designation" value="IL1R1"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000115594">
<property type="expression patterns" value="Low tissue specificity"/>
</dbReference>
<dbReference type="MIM" id="147810">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P14778"/>
<dbReference type="OpenTargets" id="ENSG00000115594"/>
<dbReference type="PharmGKB" id="PA29809"/>
<dbReference type="VEuPathDB" id="HostDB:ENSG00000115594.11"/>
<dbReference type="eggNOG" id="ENOG502QWEU">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT01000000214361"/>
<dbReference type="HOGENOM" id="CLU_025552_3_1_1"/>
<dbReference type="InParanoid" id="P14778"/>
<dbReference type="OMA" id="EISGFSW"/>
<dbReference type="OrthoDB" id="1109920at2759"/>
<dbReference type="PhylomeDB" id="P14778"/>
<dbReference type="TreeFam" id="TF325519"/>
<dbReference type="PathwayCommons" id="P14778"/>
<dbReference type="Reactome" id="R-HSA-6783783">
<property type="pathway name" value="Interleukin-10 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9020702">
<property type="pathway name" value="Interleukin-1 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9679191">
<property type="pathway name" value="Potential therapeutics for SARS"/>
</dbReference>
<dbReference type="SignaLink" id="P14778"/>
<dbReference type="SIGNOR" id="P14778"/>
<dbReference type="BioGRID-ORCS" id="3554">
<property type="hits" value="13 hits in 878 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="IL1R1">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="P14778"/>
<dbReference type="GeneWiki" id="Interleukin_1_receptor,_type_I"/>
<dbReference type="GenomeRNAi" id="3554"/>
<dbReference type="Pharos" id="P14778">
<property type="development level" value="Tclin"/>
</dbReference>
<dbReference type="PRO" id="PR:P14778"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 2"/>
</dbReference>
<dbReference type="RNAct" id="P14778">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000115594">
<property type="expression patterns" value="Expressed in palpebral conjunctiva and 237 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="P14778">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P14778">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0009897">
<property type="term" value="C:external side of plasma membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005576">
<property type="term" value="C:extracellular region"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0005887">
<property type="term" value="C:integral component of plasma membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0016020">
<property type="term" value="C:membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0019966">
<property type="term" value="F:interleukin-1 binding"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0004908">
<property type="term" value="F:interleukin-1 receptor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0004909">
<property type="term" value="F:interleukin-1, type I, activating receptor activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0050135">
<property type="term" value="F:NAD(P)+ nucleosidase activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0061809">
<property type="term" value="F:NAD+ nucleotidase, cyclic ADP-ribose generating"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0005161">
<property type="term" value="F:platelet-derived growth factor receptor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0002020">
<property type="term" value="F:protease binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0004888">
<property type="term" value="F:transmembrane signaling receptor activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0007166">
<property type="term" value="P:cell surface receptor signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0019221">
<property type="term" value="P:cytokine-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0006955">
<property type="term" value="P:immune response"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0006954">
<property type="term" value="P:inflammatory response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0070498">
<property type="term" value="P:interleukin-1-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032729">
<property type="term" value="P:positive regulation of interferon-gamma production"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2000661">
<property type="term" value="P:positive regulation of interleukin-1-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:2000391">
<property type="term" value="P:positive regulation of neutrophil extravasation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:2000556">
<property type="term" value="P:positive regulation of T-helper 1 cell cytokine production"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050727">
<property type="term" value="P:regulation of inflammatory response"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0070555">
<property type="term" value="P:response to interleukin-1"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="Gene3D" id="2.60.40.10">
<property type="match status" value="3"/>
</dbReference>
<dbReference type="Gene3D" id="3.40.50.10140">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR007110">
<property type="entry name" value="Ig-like_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR036179">
<property type="entry name" value="Ig-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR013783">
<property type="entry name" value="Ig-like_fold"/>
</dbReference>
<dbReference type="InterPro" id="IPR003599">
<property type="entry name" value="Ig_sub"/>
</dbReference>
<dbReference type="InterPro" id="IPR015621">
<property type="entry name" value="IL-1_rcpt_fam"/>
</dbReference>
<dbReference type="InterPro" id="IPR004076">
<property type="entry name" value="IL-1_rcpt_I-typ"/>
</dbReference>
<dbReference type="InterPro" id="IPR004074">
<property type="entry name" value="IL-1_rcpt_I/II-typ"/>
</dbReference>
<dbReference type="InterPro" id="IPR041416">
<property type="entry name" value="IL-1RAcP-like_ig"/>
</dbReference>
<dbReference type="InterPro" id="IPR000157">
<property type="entry name" value="TIR_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR035897">
<property type="entry name" value="Toll_tir_struct_dom_sf"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR11890">
<property type="entry name" value="PTHR11890"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF13895">
<property type="entry name" value="Ig_2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF18452">
<property type="entry name" value="Ig_6"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF01582">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR01538">
<property type="entry name" value="INTRLEUKN1R1"/>
</dbReference>
<dbReference type="PRINTS" id="PR01536">
<property type="entry name" value="INTRLKN1R12F"/>
</dbReference>
<dbReference type="SMART" id="SM00409">
<property type="entry name" value="IG"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="SMART" id="SM00255">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF48726">
<property type="entry name" value="SSF48726"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF52200">
<property type="entry name" value="SSF52200"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50835">
<property type="entry name" value="IG_LIKE"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="PROSITE" id="PS50104">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0378">Hydrolase</keyword>
<keyword id="KW-0393">Immunoglobulin domain</keyword>
<keyword id="KW-0395">Inflammatory response</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0520">NAD</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0675">Receptor</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0964">Secreted</keyword>
<keyword id="KW-0732">Signal</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<feature type="signal peptide">
<location>
<begin position="1"/>
<end position="17"/>
</location>
</feature>
<feature type="chain" description="Interleukin-1 receptor type 1, membrane form" id="PRO_0000015435">
<location>
<begin position="18"/>
<end position="569"/>
</location>
</feature>
<feature type="chain" description="Interleukin-1 receptor type 1, soluble form" id="PRO_0000415344">
<location>
<begin position="18"/>
<end status="unknown"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="5">
<location>
<begin position="18"/>
<end position="336"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="5">
<location>
<begin position="337"/>
<end position="356"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="5">
<location>
<begin position="357"/>
<end position="569"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 1">
<location>
<begin position="23"/>
<end position="110"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 2">
<location>
<begin position="118"/>
<end position="210"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 3">
<location>
<begin position="226"/>
<end position="328"/>
</location>
</feature>
<feature type="domain" description="TIR" evidence="6">
<location>
<begin position="383"/>
<end position="538"/>
</location>
</feature>
<feature type="active site" evidence="6">
<location>
<position position="470"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="14">
<location>
<position position="496"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="5">
<location>
<position position="100"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="5">
<location>
<position position="193"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="5">
<location>
<position position="233"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="5">
<location>
<position position="249"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="5">
<location>
<position position="263"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="5">
<location>
<position position="297"/>
</location>
</feature>
<feature type="disulfide bond">
<location>
<begin position="23"/>
<end position="104"/>
</location>
</feature>
<feature type="disulfide bond">
<location>
<begin position="44"/>
<end position="96"/>
</location>
</feature>
<feature type="disulfide bond">
<location>
<begin position="121"/>
<end position="164"/>
</location>
</feature>
<feature type="disulfide bond">
<location>
<begin position="142"/>
<end position="196"/>
</location>
</feature>
<feature type="disulfide bond">
<location>
<begin position="248"/>
<end position="312"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs2228139." id="VAR_019131" evidence="15">
<original>A</original>
<variation>G</variation>
<location>
<position position="124"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs28362304." id="VAR_029189">
<original>T</original>
<variation>M</variation>
<location>
<position position="344"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces NF-kappa-B activation." evidence="8">
<original>D</original>
<variation>A</variation>
<location>
<position position="369"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces NF-kappa-B activation and receptor-associated kinase activation." evidence="8">
<original>R</original>
<variation>A</variation>
<location>
<position position="428"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="24"/>
<end position="27"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="32"/>
<end position="35"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="40"/>
<end position="43"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="48"/>
<end position="50"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="56"/>
<end position="59"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="72"/>
<end position="77"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="80"/>
<end position="83"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="88"/>
<end position="90"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="92"/>
<end position="97"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="100"/>
<end position="102"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="105"/>
<end position="114"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="120"/>
<end position="122"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="124"/>
<end position="126"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="127"/>
<end position="133"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="135"/>
<end position="137"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="138"/>
<end position="141"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="146"/>
<end position="148"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="151"/>
<end position="153"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="159"/>
<end position="162"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="171"/>
<end position="177"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="180"/>
<end position="183"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="188"/>
<end position="190"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="192"/>
<end position="202"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="205"/>
<end position="218"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="227"/>
<end position="230"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="233"/>
<end position="237"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="240"/>
<end position="242"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="244"/>
<end position="252"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="256"/>
<end position="262"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="272"/>
<end position="281"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="287"/>
<end position="289"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="290"/>
<end position="300"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="303"/>
<end position="306"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="310"/>
<end position="316"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="319"/>
<end position="328"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1G0Y"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1IRA"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1ITB"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4GAF"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000255"/>
<evidence key="6" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00204"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10653850"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10671496"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10903327"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8142597"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9062193"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9062194"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9371760"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9821957"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source ref="3"/>
</evidence>
<evidence key="16" type="ECO:0000305"/>
<evidence key="17" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="8142597"/>
</source>
</evidence>
<sequence length="569" mass="65402" checksum="5BAA83F8F0225C25" modified="1990-04-01" version="1" precursor="true">MKVLLRLICFIALLISSLEADKCKEREEKIILVSSANEIDVRPCPLNPNEHKGTITWYKDDSKTPVSTEQASRIHQHKEKLWFVPAKVEDSGHYYCVVRNSSYCLRIKISAKFVENEPNLCYNAQAIFKQKLPVAGDGGLVCPYMEFFKNENNELPKLQWYKDCKPLLLDNIHFSGVKDRLIVMNVAEKHRGNYTCHASYTYLGKQYPITRVIEFITLEENKPTRPVIVSPANETMEVDLGSQIQLICNVTGQLSDIAYWKWNGSVIDEDDPVLGEDYYSVENPANKRRSTLITVLNISEIESRFYKHPFTCFAKNTHGIDAAYIQLIYPVTNFQKHMIGICVTLTVIIVCSVFIYKIFKIDIVLWYRDSCYDFLPIKASDGKTYDAYILYPKTVGEGSTSDCDIFVFKVLPEVLEKQCGYKLFIYGRDDYVGEDIVEVINENVKKSRRLIIILVRETSGFSWLGGSSEEQIAMYNALVQDGIKVVLLELEKIQDYEKMPESIKFIKQKHGAIRWSGDFTQGPQSAKTRFWKNVRYHMPVQRRSPSSKHQLLSPATKEKLQREAHVPLG</sequence>
</entry>
<entry dataset="Swiss-Prot" created="1993-04-01" modified="2021-02-10" version="202">
<accession>Q01638</accession>
<accession>A8K6B3</accession>
<accession>B4E0I3</accession>
<accession>Q53TU7</accession>
<accession>Q8NEJ3</accession>
<accession>Q9ULV7</accession>
<accession>Q9UQ44</accession>
<name>ILRL1_HUMAN</name>
<protein>
<recommendedName>
<fullName>Interleukin-1 receptor-like 1</fullName>
<ecNumber evidence="5">3.2.2.6</ecNumber>
</recommendedName>
<alternativeName>
<fullName>Protein ST2</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">IL1RL1</name>
<name type="synonym">DER4</name>
<name type="synonym">ST2</name>
<name type="synonym">T1</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1992" name="Biochim. Biophys. Acta" volume="1171" first="215" last="218">
<title>Nucleotide sequence of a complementary DNA for human ST2.</title>
<authorList>
<person name="Tominaga S."/>
<person name="Yokota T."/>
<person name="Yanagisawa K."/>
<person name="Tsukamoto T."/>
<person name="Takagi T."/>
<person name="Tetsuka T."/>
</authorList>
<dbReference type="PubMed" id="1482686"/>
<dbReference type="DOI" id="10.1016/0167-4781(92)90125-j"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORM B)</scope>
<scope>VARIANT GLU-78</scope>
<source>
<tissue>Lymphocyte</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="1999" name="Biochem. Biophys. Res. Commun." volume="264" first="14" last="18">
<title>Presence and expression of a novel variant form of ST2 gene product in human leukemic cell line UT-7/GM.</title>
<authorList>
<person name="Tominaga S."/>
<person name="Kuroiwa K."/>
<person name="Tago K."/>
<person name="Iwahana H."/>
<person name="Yanagisawa K."/>
<person name="Komatsu N."/>
</authorList>
<dbReference type="PubMed" id="10527832"/>
<dbReference type="DOI" id="10.1006/bbrc.1999.1469"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM C)</scope>
<scope>VARIANT GLU-78</scope>
</reference>
<reference key="3">
<citation type="journal article" date="2000" name="Genomics" volume="67" first="284" last="290">
<title>The cloning and nucleotide sequence of human ST2L cDNA.</title>
<authorList>
<person name="Li H."/>
<person name="Tago K."/>
<person name="Io K."/>
<person name="Kuroiwa K."/>
<person name="Arai T."/>
<person name="Iwahana H."/>
<person name="Tominaga S."/>
<person name="Yanagisawa K."/>
</authorList>
<dbReference type="PubMed" id="10936050"/>
<dbReference type="DOI" id="10.1006/geno.2000.6269"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM A)</scope>
<scope>VARIANTS GLU-78 AND THR-433</scope>
<source>
<tissue>Megakaryoblast</tissue>
</source>
</reference>
<reference key="4">
<citation type="submission" date="2001-06" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Yanagisawa K."/>
</authorList>
</citation>
<scope>SEQUENCE REVISION TO 433</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS B AND 4)</scope>
<source>
<tissue>Placenta</tissue>
<tissue>Thymus</tissue>
</source>
</reference>
<reference key="6">
<citation type="journal article" date="2005" name="Nature" volume="434" first="724" last="731">
<title>Generation and annotation of the DNA sequences of human chromosomes 2 and 4.</title>
<authorList>
<person name="Hillier L.W."/>
<person name="Graves T.A."/>
<person name="Fulton R.S."/>
<person name="Fulton L.A."/>
<person name="Pepin K.H."/>
<person name="Minx P."/>
<person name="Wagner-McPherson C."/>
<person name="Layman D."/>
<person name="Wylie K."/>
<person name="Sekhon M."/>
<person name="Becker M.C."/>
<person name="Fewell G.A."/>
<person name="Delehaunty K.D."/>
<person name="Miner T.L."/>
<person name="Nash W.E."/>
<person name="Kremitzki C."/>
<person name="Oddy L."/>
<person name="Du H."/>
<person name="Sun H."/>
<person name="Bradshaw-Cordum H."/>
<person name="Ali J."/>
<person name="Carter J."/>
<person name="Cordes M."/>
<person name="Harris A."/>
<person name="Isak A."/>
<person name="van Brunt A."/>
<person name="Nguyen C."/>
<person name="Du F."/>
<person name="Courtney L."/>
<person name="Kalicki J."/>
<person name="Ozersky P."/>
<person name="Abbott S."/>
<person name="Armstrong J."/>
<person name="Belter E.A."/>
<person name="Caruso L."/>
<person name="Cedroni M."/>
<person name="Cotton M."/>
<person name="Davidson T."/>
<person name="Desai A."/>
<person name="Elliott G."/>
<person name="Erb T."/>
<person name="Fronick C."/>
<person name="Gaige T."/>
<person name="Haakenson W."/>
<person name="Haglund K."/>
<person name="Holmes A."/>
<person name="Harkins R."/>
<person name="Kim K."/>
<person name="Kruchowski S.S."/>
<person name="Strong C.M."/>
<person name="Grewal N."/>
<person name="Goyea E."/>
<person name="Hou S."/>
<person name="Levy A."/>
<person name="Martinka S."/>
<person name="Mead K."/>
<person name="McLellan M.D."/>
<person name="Meyer R."/>
<person name="Randall-Maher J."/>
<person name="Tomlinson C."/>
<person name="Dauphin-Kohlberg S."/>
<person name="Kozlowicz-Reilly A."/>
<person name="Shah N."/>
<person name="Swearengen-Shahid S."/>
<person name="Snider J."/>
<person name="Strong J.T."/>
<person name="Thompson J."/>
<person name="Yoakum M."/>
<person name="Leonard S."/>
<person name="Pearman C."/>
<person name="Trani L."/>
<person name="Radionenko M."/>
<person name="Waligorski J.E."/>
<person name="Wang C."/>
<person name="Rock S.M."/>
<person name="Tin-Wollam A.-M."/>
<person name="Maupin R."/>
<person name="Latreille P."/>
<person name="Wendl M.C."/>
<person name="Yang S.-P."/>
<person name="Pohl C."/>
<person name="Wallis J.W."/>
<person name="Spieth J."/>
<person name="Bieri T.A."/>
<person name="Berkowicz N."/>
<person name="Nelson J.O."/>
<person name="Osborne J."/>
<person name="Ding L."/>
<person name="Meyer R."/>
<person name="Sabo A."/>
<person name="Shotland Y."/>
<person name="Sinha P."/>
<person name="Wohldmann P.E."/>
<person name="Cook L.L."/>
<person name="Hickenbotham M.T."/>
<person name="Eldred J."/>
<person name="Williams D."/>
<person name="Jones T.A."/>
<person name="She X."/>
<person name="Ciccarelli F.D."/>
<person name="Izaurralde E."/>
<person name="Taylor J."/>
<person name="Schmutz J."/>
<person name="Myers R.M."/>
<person name="Cox D.R."/>
<person name="Huang X."/>
<person name="McPherson J.D."/>
<person name="Mardis E.R."/>
<person name="Clifton S.W."/>
<person name="Warren W.C."/>
<person name="Chinwalla A.T."/>
<person name="Eddy S.R."/>
<person name="Marra M.A."/>
<person name="Ovcharenko I."/>
<person name="Furey T.S."/>
<person name="Miller W."/>
<person name="Eichler E.E."/>
<person name="Bork P."/>
<person name="Suyama M."/>
<person name="Torrents D."/>
<person name="Waterston R.H."/>
<person name="Wilson R.K."/>
</authorList>
<dbReference type="PubMed" id="15815621"/>
<dbReference type="DOI" id="10.1038/nature03466"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="7">
<citation type="submission" date="2005-09" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM B)</scope>
<source>
<tissue>Placenta</tissue>
</source>
</reference>
<reference key="9">
<citation type="journal article" date="2004" name="Protein Sci." volume="13" first="2819" last="2824">
<title>Signal peptide prediction based on analysis of experimentally verified cleavage sites.</title>
<authorList>
<person name="Zhang Z."/>
<person name="Henzel W.J."/>
</authorList>
<dbReference type="PubMed" id="15340161"/>
<dbReference type="DOI" id="10.1110/ps.04682504"/>
</citation>
<scope>PROTEIN SEQUENCE OF 19-33</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2001" name="Biochem. Biophys. Res. Commun." volume="285" first="1377" last="1383">
<title>Tissue distribution and subcellular localization of a variant form of the human ST2 gene product, ST2V.</title>
<authorList>
<person name="Tago K."/>
<person name="Noda T."/>
<person name="Hayakawa M."/>
<person name="Iwahana H."/>
<person name="Yanagisawa K."/>
<person name="Yashiro T."/>
<person name="Tominaga S."/>
</authorList>
<dbReference type="PubMed" id="11478810"/>
<dbReference type="DOI" id="10.1006/bbrc.2001.5306"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2005" name="Immunity" volume="23" first="479" last="490">
<title>IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST 2 and induces T helper type 2-associated cytokines.</title>
<authorList>
<person name="Schmitz J."/>
<person name="Owyang A."/>
<person name="Oldham E."/>
<person name="Song Y."/>
<person name="Murphy E."/>
<person name="McClanahan T.K."/>
<person name="Zurawski G."/>
<person name="Moshrefi M."/>
<person name="Qin J."/>
<person name="Li X."/>
<person name="Gorman D.M."/>
<person name="Bazan J.F."/>
<person name="Kastelein R.A."/>
</authorList>
<dbReference type="PubMed" id="16286016"/>
<dbReference type="DOI" id="10.1016/j.immuni.2005.09.015"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBUNIT</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2004" name="Genome Biol." volume="5" first="R8.1" last="R8.16">
<title>An unappreciated role for RNA surveillance.</title>
<authorList>
<person name="Hillman R.T."/>
<person name="Green R.E."/>
<person name="Brenner S.E."/>
</authorList>
<dbReference type="PubMed" id="14759258"/>
<dbReference type="DOI" id="10.1186/gb-2004-5-2-r8"/>
</citation>
<scope>SPLICE ISOFORM(S) THAT ARE POTENTIAL NMD TARGET(S)</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2009" name="Structure" volume="17" first="1398" last="1410">
<title>Structure of IL-33 and its interaction with the ST2 and IL-1RAcP receptors--insight into heterotrimeric IL-1 signaling complexes.</title>
<authorList>
<person name="Lingel A."/>
<person name="Weiss T.M."/>
<person name="Niebuhr M."/>
<person name="Pan B."/>
<person name="Appleton B.A."/>
<person name="Wiesmann C."/>
<person name="Bazan J.F."/>
<person name="Fairbrother W.J."/>
</authorList>
<dbReference type="PubMed" id="19836339"/>
<dbReference type="DOI" id="10.1016/j.str.2009.08.009"/>
</citation>
<scope>FUNCTION</scope>
<scope>MODEL OF THE IL-33 SIGNALING COMPLEX</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2010" name="J. Cell. Mol. Med." volume="14" first="1726" last="1739">
<title>Interleukin-33 overexpression is associated with liver fibrosis in mice and humans.</title>
<authorList>
<person name="Marvie P."/>
<person name="Lisbonne M."/>
<person name="L'helgoualc'h A."/>
<person name="Rauch M."/>
<person name="Turlin B."/>
<person name="Preisser L."/>
<person name="Bourd-Boittin K."/>
<person name="Theret N."/>
<person name="Gascan H."/>
<person name="Piquet-Pellorce C."/>
<person name="Samson M."/>
</authorList>
<dbReference type="PubMed" id="19508382"/>
<dbReference type="DOI" id="10.1111/j.1582-4934.2009.00801.x"/>
</citation>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2013" name="Proc. Natl. Acad. Sci. U.S.A." volume="110" first="14918" last="14923">
<title>Structural insights into the interaction of IL-33 with its receptors.</title>
<authorList>
<person name="Liu X."/>
<person name="Hammel M."/>
<person name="He Y."/>
<person name="Tainer J.A."/>
<person name="Jeng U.S."/>
<person name="Zhang L."/>
<person name="Wang S."/>
<person name="Wang X."/>
</authorList>
<dbReference type="PubMed" id="23980170"/>
<dbReference type="DOI" id="10.1073/pnas.1308651110"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (3.27 ANGSTROMS) OF 19-321 IN COMPLEX WITH IL33</scope>
<scope>GLYCOSYLATION AT ASN-95; ASN-140 AND ASN-191</scope>
<scope>DISULFIDE BONDS</scope>
</reference>
<comment type="function">
<text evidence="11 19">Receptor for interleukin-33 (IL-33); signaling requires association of the coreceptor IL1RAP. Its stimulation recruits MYD88, IRAK1, IRAK4, and TRAF6, followed by phosphorylation of MAPK3/ERK1 and/or MAPK1/ERK2, MAPK14, and MAPK8. Possibly involved in helper T-cell function.</text>
</comment>
<comment type="function">
<molecule>Isoform B</molecule>
<text evidence="2">Inhibits IL-33 signaling.</text>
</comment>
<comment type="catalytic activity">
<reaction evidence="5">
<text>H2O + NAD(+) = ADP-D-ribose + H(+) + nicotinamide</text>
<dbReference type="Rhea" id="RHEA:16301"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:17154"/>
<dbReference type="ChEBI" id="CHEBI:57540"/>
<dbReference type="ChEBI" id="CHEBI:57967"/>
<dbReference type="EC" id="3.2.2.6"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="5">
<dbReference type="Rhea" id="RHEA:16302"/>
</physiologicalReaction>
</comment>
<comment type="subunit">
<text evidence="2 11 13 19">Interacts with MYD88, IRAK1, IRAK4, and TRAF6. Bound to its ligand IL-33, interacts with IL1RAP to form the minimal interleukin-33 signaling complex with a 1:1:1 stoichiometry. Interacts with KIT (bound to KITLG/SCF). A mast cell-specific KITLG/SCF-induced interleukin-33 signaling complex contains IL1RL1, IL1RAP, KIT and MYD88.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-993762">
<id>Q01638</id>
</interactant>
<interactant intactId="EBI-3939278">
<id>Q9BXN2</id>
<label>CLEC7A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-993762">
<id>Q01638</id>
</interactant>
<interactant intactId="EBI-724057">
<id>O95760</id>
<label>IL33</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-12838366">
<id>Q01638-2</id>
</interactant>
<interactant intactId="EBI-12808270">
<id>P07307-3</id>
<label>ASGR2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-12838366">
<id>Q01638-2</id>
</interactant>
<interactant intactId="EBI-12811991">
<id>Q2HXU8-2</id>
<label>CLEC12B</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-12838366">
<id>Q01638-2</id>
</interactant>
<interactant intactId="EBI-11749983">
<id>Q9UHP7-3</id>
<label>CLEC2D</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-12838366">
<id>Q01638-2</id>
</interactant>
<interactant intactId="EBI-6942903">
<id>Q96BA8</id>
<label>CREB3L1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-12838366">
<id>Q01638-2</id>
</interactant>
<interactant intactId="EBI-13345167">
<id>Q8TDT2</id>
<label>GPR152</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-12838366">
<id>Q01638-2</id>
</interactant>
<interactant intactId="EBI-18076404">
<id>O15529</id>
<label>GPR42</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-12838366">
<id>Q01638-2</id>
</interactant>
<interactant intactId="EBI-2689785">
<id>Q8NI22</id>
<label>MCFD2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-12838366">
<id>Q01638-2</id>
</interactant>
<interactant intactId="EBI-17640454">
<id>Q96PQ1</id>
<label>SIGLEC12</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-12838366">
<id>Q01638-2</id>
</interactant>
<interactant intactId="EBI-9978441">
<id>Q9H2H9</id>
<label>SLC38A1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-12838366">
<id>Q01638-2</id>
</interactant>
<interactant intactId="EBI-17670824">
<id>Q8WUV1</id>
<label>TSPAN18</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-12838366">
<id>Q01638-2</id>
</interactant>
<interactant intactId="EBI-751210">
<id>Q96EC8</id>
<label>YIPF6</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="subcellular location">
<molecule>Isoform C</molecule>
<subcellularLocation>
<location>Cell membrane</location>
</subcellularLocation>
</comment>
<comment type="subcellular location">
<molecule>Isoform B</molecule>
<subcellularLocation>
<location>Secreted</location>
</subcellularLocation>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="8">Cell membrane</location>
<topology evidence="8">Single-pass type I membrane protein</topology>
</subcellularLocation>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>Q01638-1</id>
<name>A</name>
<name>ST2L</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>Q01638-2</id>
<name>B</name>
<name>ST2S</name>
<sequence type="described" ref="VSP_002666 VSP_002667"/>
</isoform>
<isoform>
<id>Q01638-3</id>
<name>C</name>
<name>ST2V</name>
<sequence type="described" ref="VSP_002664 VSP_002665"/>
</isoform>
<isoform>
<id>Q01638-4</id>
<name>4</name>
<sequence type="described" ref="VSP_054933 VSP_002666 VSP_002667"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="8 12">Highly expressed in kidney, lung, placenta, stomach, skeletal muscle, colon and small intestine. Isoform A is prevalently expressed in the lung, testis, placenta, stomach and colon. Isoform B is more abundant in the brain, kidney and the liver. Isoform C is not detected in brain, heart, liver, kidney and skeletal muscle. Expressed on T-cells in fibrotic liver; at protein level. Overexpressed in fibrotic and cirrhotic liver.</text>
</comment>
<comment type="domain">
<text evidence="5">The TIR domain mediates NAD(+) hydrolase (NADase) activity. Self-association of TIR domains is required for NADase activity.</text>
</comment>
<comment type="miscellaneous">
<molecule>Isoform C</molecule>
<text evidence="18">May be produced at very low levels due to a premature stop codon in the mRNA, leading to nonsense-mediated mRNA decay.</text>
</comment>
<comment type="similarity">
<text evidence="18">Belongs to the interleukin-1 receptor family.</text>
</comment>
<dbReference type="EC" id="3.2.2.6" evidence="5"/>
<dbReference type="EMBL" id="D12763">
<property type="protein sequence ID" value="BAA02233.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="D12764">
<property type="protein sequence ID" value="BAA20539.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AB029084">
<property type="protein sequence ID" value="BAA85894.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB012701">
<property type="protein sequence ID" value="BAA82405.2"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK291578">
<property type="protein sequence ID" value="BAF84267.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK303389">
<property type="protein sequence ID" value="BAG64445.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AC007248">
<property type="protein sequence ID" value="AAY15047.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471127">
<property type="protein sequence ID" value="EAX01795.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC030975">
<property type="protein sequence ID" value="AAH30975.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS2057.1">
<molecule id="Q01638-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS2058.1">
<molecule id="Q01638-2"/>
</dbReference>
<dbReference type="CCDS" id="CCDS74548.1">
<molecule id="Q01638-4"/>
</dbReference>
<dbReference type="PIR" id="JC7109">
<property type="entry name" value="JC7109"/>
</dbReference>
<dbReference type="PIR" id="S30444">
<property type="entry name" value="S30444"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001269337.1">
<molecule id="Q01638-4"/>
<property type="nucleotide sequence ID" value="NM_001282408.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_003847.2">
<molecule id="Q01638-2"/>
<property type="nucleotide sequence ID" value="NM_003856.3"/>
</dbReference>
<dbReference type="RefSeq" id="NP_057316.3">
<molecule id="Q01638-1"/>
<property type="nucleotide sequence ID" value="NM_016232.4"/>
</dbReference>
<dbReference type="RefSeq" id="XP_006712902.1">
<molecule id="Q01638-1"/>
<property type="nucleotide sequence ID" value="XM_006712839.3"/>
</dbReference>
<dbReference type="RefSeq" id="XP_011510453.1">
<molecule id="Q01638-2"/>
<property type="nucleotide sequence ID" value="XM_011512151.1"/>
</dbReference>
<dbReference type="PDB" id="4KC3">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.27"/>
<property type="chains" value="B=19-321"/>
</dbReference>
<dbReference type="PDBsum" id="4KC3"/>
<dbReference type="SMR" id="Q01638"/>
<dbReference type="BioGRID" id="114613">
<property type="interactions" value="20"/>
</dbReference>
<dbReference type="CORUM" id="Q01638"/>
<dbReference type="DIP" id="DIP-37861N"/>
<dbReference type="IntAct" id="Q01638">
<property type="interactions" value="16"/>
</dbReference>
<dbReference type="STRING" id="9606.ENSP00000233954"/>
<dbReference type="GlyConnect" id="1948">
<property type="glycosylation" value="10 N-Linked glycans (5 sites)"/>
</dbReference>
<dbReference type="GlyGen" id="Q01638">
<property type="glycosylation" value="10 sites"/>
</dbReference>
<dbReference type="iPTMnet" id="Q01638"/>
<dbReference type="PhosphoSitePlus" id="Q01638"/>
<dbReference type="BioMuta" id="IL1RL1"/>
<dbReference type="DMDM" id="116242527"/>
<dbReference type="EPD" id="Q01638"/>
<dbReference type="jPOST" id="Q01638"/>
<dbReference type="MassIVE" id="Q01638"/>
<dbReference type="PaxDb" id="Q01638"/>
<dbReference type="PeptideAtlas" id="Q01638"/>
<dbReference type="PRIDE" id="Q01638"/>
<dbReference type="ProteomicsDB" id="57975">
<molecule id="Q01638-1"/>
</dbReference>
<dbReference type="ProteomicsDB" id="57976">
<molecule id="Q01638-2"/>
</dbReference>
<dbReference type="ProteomicsDB" id="57977">
<molecule id="Q01638-3"/>
</dbReference>
<dbReference type="TopDownProteomics" id="Q01638-2">
<molecule id="Q01638-2"/>
</dbReference>
<dbReference type="ABCD" id="Q01638">
<property type="antibodies" value="14 sequenced antibodies"/>
</dbReference>
<dbReference type="Antibodypedia" id="2362">
<property type="antibodies" value="580 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="9173"/>
<dbReference type="Ensembl" id="ENST00000233954">
<molecule id="Q01638-1"/>
<property type="protein sequence ID" value="ENSP00000233954"/>
<property type="gene ID" value="ENSG00000115602"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000311734">
<molecule id="Q01638-2"/>
<property type="protein sequence ID" value="ENSP00000310371"/>
<property type="gene ID" value="ENSG00000115602"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000404917">
<molecule id="Q01638-4"/>
<property type="protein sequence ID" value="ENSP00000384822"/>
<property type="gene ID" value="ENSG00000115602"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000427077">
<molecule id="Q01638-3"/>
<property type="protein sequence ID" value="ENSP00000391120"/>
<property type="gene ID" value="ENSG00000115602"/>
</dbReference>
<dbReference type="GeneID" id="9173"/>
<dbReference type="KEGG" id="hsa:9173"/>
<dbReference type="UCSC" id="uc002tbu.1">
<molecule id="Q01638-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="9173"/>
<dbReference type="DisGeNET" id="9173"/>
<dbReference type="GeneCards" id="IL1RL1"/>
<dbReference type="HGNC" id="HGNC:5998">
<property type="gene designation" value="IL1RL1"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000115602">
<property type="expression patterns" value="Group enriched (kidney, lung, placenta)"/>
</dbReference>
<dbReference type="MIM" id="601203">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q01638"/>
<dbReference type="OpenTargets" id="ENSG00000115602"/>
<dbReference type="PharmGKB" id="PA29814"/>
<dbReference type="VEuPathDB" id="HostDB:ENSG00000115602.16"/>
<dbReference type="eggNOG" id="ENOG502RU6H">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT01000000214361"/>
<dbReference type="HOGENOM" id="CLU_025552_3_1_1"/>
<dbReference type="InParanoid" id="Q01638"/>
<dbReference type="OMA" id="HVRYHMP"/>
<dbReference type="OrthoDB" id="1109920at2759"/>
<dbReference type="PhylomeDB" id="Q01638"/>
<dbReference type="TreeFam" id="TF325519"/>
<dbReference type="PathwayCommons" id="Q01638"/>
<dbReference type="Reactome" id="R-HSA-1257604">
<property type="pathway name" value="PIP3 activates AKT signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6811558">
<property type="pathway name" value="PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9014843">
<molecule id="Q01638-2"/>
<property type="pathway name" value="Interleukin-33 signaling"/>
</dbReference>
<dbReference type="BioGRID-ORCS" id="9173">
<property type="hits" value="3 hits in 876 CRISPR screens"/>
</dbReference>
<dbReference type="GeneWiki" id="IL1RL1"/>
<dbReference type="GenomeRNAi" id="9173"/>
<dbReference type="Pharos" id="Q01638">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:Q01638"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 2"/>
</dbReference>
<dbReference type="RNAct" id="Q01638">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000115602">
<property type="expression patterns" value="Expressed in right lung and 156 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="Q01638">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q01638">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0009897">
<property type="term" value="C:external side of plasma membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005576">
<property type="term" value="C:extracellular region"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0005925">
<property type="term" value="C:focal adhesion"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0016021">
<property type="term" value="C:integral component of membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0004896">
<property type="term" value="F:cytokine receptor activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004908">
<property type="term" value="F:interleukin-1 receptor activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0002113">
<property type="term" value="F:interleukin-33 binding"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0002114">
<property type="term" value="F:interleukin-33 receptor activity"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0050135">
<property type="term" value="F:NAD(P)+ nucleosidase activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0061809">
<property type="term" value="F:NAD+ nucleotidase, cyclic ADP-ribose generating"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0006955">
<property type="term" value="P:immune response"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0038172">
<property type="term" value="P:interleukin-33-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0032689">
<property type="term" value="P:negative regulation of interferon-gamma production"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0002826">
<property type="term" value="P:negative regulation of T-helper 1 type immune response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0032722">
<property type="term" value="P:positive regulation of chemokine production"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0050729">
<property type="term" value="P:positive regulation of inflammatory response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0032754">
<property type="term" value="P:positive regulation of interleukin-5 production"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043032">
<property type="term" value="P:positive regulation of macrophage activation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007165">
<property type="term" value="P:signal transduction"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="Gene3D" id="2.60.40.10">
<property type="match status" value="3"/>
</dbReference>
<dbReference type="Gene3D" id="3.40.50.10140">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR007110">
<property type="entry name" value="Ig-like_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR036179">
<property type="entry name" value="Ig-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR013783">
<property type="entry name" value="Ig-like_fold"/>
</dbReference>
<dbReference type="InterPro" id="IPR013098">
<property type="entry name" value="Ig_I-set"/>
</dbReference>
<dbReference type="InterPro" id="IPR003599">
<property type="entry name" value="Ig_sub"/>
</dbReference>
<dbReference type="InterPro" id="IPR003598">
<property type="entry name" value="Ig_sub2"/>
</dbReference>
<dbReference type="InterPro" id="IPR015621">
<property type="entry name" value="IL-1_rcpt_fam"/>
</dbReference>
<dbReference type="InterPro" id="IPR004074">
<property type="entry name" value="IL-1_rcpt_I/II-typ"/>
</dbReference>
<dbReference type="InterPro" id="IPR000157">
<property type="entry name" value="TIR_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR035897">
<property type="entry name" value="Toll_tir_struct_dom_sf"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR11890">
<property type="entry name" value="PTHR11890"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF07679">
<property type="entry name" value="I-set"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF01582">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR01536">
<property type="entry name" value="INTRLKN1R12F"/>
</dbReference>
<dbReference type="SMART" id="SM00409">
<property type="entry name" value="IG"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="SMART" id="SM00408">
<property type="entry name" value="IGc2"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="SMART" id="SM00255">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF48726">
<property type="entry name" value="SSF48726"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF52200">
<property type="entry name" value="SSF52200"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50835">
<property type="entry name" value="IG_LIKE"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="PROSITE" id="PS50104">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0378">Hydrolase</keyword>
<keyword id="KW-0393">Immunoglobulin domain</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0520">NAD</keyword>
<keyword id="KW-0675">Receptor</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0964">Secreted</keyword>
<keyword id="KW-0732">Signal</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<feature type="signal peptide" evidence="10">
<location>
<begin position="1"/>
<end position="18"/>
</location>
</feature>
<feature type="chain" description="Interleukin-1 receptor-like 1" id="PRO_0000015442">
<location>
<begin position="19"/>
<end position="556"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="3">
<location>
<begin position="19"/>
<end position="328"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="3">
<location>
<begin position="329"/>
<end position="349"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="3">
<location>
<begin position="350"/>
<end position="556"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 1">
<location>
<begin position="19"/>
<end position="103"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 2">
<location>
<begin position="114"/>
<end position="197"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 3">
<location>
<begin position="212"/>
<end position="319"/>
</location>
</feature>
<feature type="domain" description="TIR" evidence="5">
<location>
<begin position="375"/>
<end position="535"/>
</location>
</feature>
<feature type="region of interest" description="Flexible linker">
<location>
<begin position="198"/>
<end position="211"/>
</location>
</feature>
<feature type="active site" evidence="5">
<location>
<position position="461"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="3">
<location>
<position position="54"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="13">
<location>
<position position="95"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="3">
<location>
<position position="101"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="13">
<location>
<position position="140"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="13">
<location>
<position position="191"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="3">
<location>
<position position="232"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="3">
<location>
<position position="254"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="3">
<location>
<position position="273"/>
</location>
</feature>
<feature type="disulfide bond" evidence="4 13">
<location>
<begin position="36"/>
<end position="87"/>
</location>
</feature>
<feature type="disulfide bond" evidence="4 13">
<location>
<begin position="111"/>
<end position="151"/>
</location>
</feature>
<feature type="disulfide bond" evidence="4 13">
<location>
<begin position="133"/>
<end position="181"/>
</location>
</feature>
<feature type="disulfide bond" evidence="4 13">
<location>
<begin position="235"/>
<end position="303"/>
</location>
</feature>
<feature type="disulfide bond" evidence="4 13">
<location>
<begin position="238"/>
<end position="282"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 4." id="VSP_054933" evidence="15">
<location>
<begin position="1"/>
<end position="117"/>
</location>
</feature>
<feature type="splice variant" description="In isoform C." id="VSP_002664" evidence="14">
<original>DEQGFSLFPVIGAPAQNEIKEVEIGKNANLTCSACFGKGTQFLAAVLWQLNGTKIT</original>
<variation>VWCQSFCKLKKSLIFSNTHWIQSLMRGFVMVYYGVHKCCRVVFNLCLQYFQHHQWP</variation>
<location>
<begin position="204"/>
<end position="259"/>
</location>
</feature>
<feature type="splice variant" description="In isoform C." id="VSP_002665" evidence="14">
<location>
<begin position="260"/>
<end position="556"/>
</location>
</feature>
<feature type="splice variant" description="In isoform B and isoform 4." id="VSP_002666" evidence="15 16 17">
<original>IDHHS</original>
<variation>SKECF</variation>
<location>
<begin position="324"/>
<end position="328"/>
</location>
</feature>
<feature type="splice variant" description="In isoform B and isoform 4." id="VSP_002667" evidence="15 16 17">
<location>
<begin position="329"/>
<end position="556"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1041973." id="VAR_023749" evidence="6 7 9">
<original>A</original>
<variation>E</variation>
<location>
<position position="78"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs4988956." id="VAR_053373" evidence="7">
<original>A</original>
<variation>T</variation>
<location>
<position position="433"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs10192036." id="VAR_053374">
<original>Q</original>
<variation>K</variation>
<location>
<position position="501"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs10204137." id="VAR_053375">
<original>Q</original>
<variation>R</variation>
<location>
<position position="501"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs10192157." id="VAR_053376">
<original>T</original>
<variation>I</variation>
<location>
<position position="549"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs10206753." id="VAR_053377">
<original>L</original>
<variation>S</variation>
<location>
<position position="551"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; BAA85894." ref="2" evidence="18">
<original>Q</original>
<variation>R</variation>
<location>
<position position="70"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="24"/>
<end position="27"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="32"/>
<end position="35"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="44"/>
<end position="49"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="63"/>
<end position="68"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="71"/>
<end position="76"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="79"/>
<end position="81"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="83"/>
<end position="90"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="95"/>
<end position="105"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="121"/>
<end position="123"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="125"/>
<end position="127"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="130"/>
<end position="132"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="136"/>
<end position="138"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="146"/>
<end position="149"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="156"/>
<end position="158"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="159"/>
<end position="162"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="165"/>
<end position="170"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="173"/>
<end position="175"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="177"/>
<end position="189"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="191"/>
<end position="202"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="209"/>
<end position="216"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="219"/>
<end position="221"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="234"/>
<end position="242"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="248"/>
<end position="253"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="265"/>
<end position="269"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="281"/>
<end position="288"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="295"/>
<end position="297"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="301"/>
<end position="306"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="311"/>
<end position="317"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4KC3"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P14719"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000255"/>
<evidence key="4" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00114"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00204"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10527832"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10936050"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11478810"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1482686"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15340161"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16286016"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19508382"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23980170"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="10527832"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="14702039"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="1482686"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000305"/>
<evidence key="19" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="19836339"/>
</source>
</evidence>
<sequence length="556" mass="63358" checksum="CB3E444A2DD477B5" modified="2006-10-17" version="4" precursor="true">MGFWILAILTILMYSTAAKFSKQSWGLENEALIVRCPRQGKPSYTVDWYYSQTNKSIPTQERNRVFASGQLLKFLPAAVADSGIYTCIVRSPTFNRTGYANVTIYKKQSDCNVPDYLMYSTVSGSEKNSKIYCPTIDLYNWTAPLEWFKNCQALQGSRYRAHKSFLVIDNVMTEDAGDYTCKFIHNENGANYSVTATRSFTVKDEQGFSLFPVIGAPAQNEIKEVEIGKNANLTCSACFGKGTQFLAAVLWQLNGTKITDFGEPRIQQEEGQNQSFSNGLACLDMVLRIADVKEEDLLLQYDCLALNLHGLRRHTVRLSRKNPIDHHSIYCIIAVCSVFLMLINVLVIILKMFWIEATLLWRDIAKPYKTRNDGKLYDAYVVYPRNYKSSTDGASRVEHFVHQILPDVLENKCGYTLCIYGRDMLPGEDVVTAVETNIRKSRRHIFILTPQITHNKEFAYEQEVALHCALIQNDAKVILIEMEALSELDMLQAEALQDSLQHLMKVQGTIKWREDHIANKRSLNSKFWKHVRYQMPVPSKIPRKASSLTPLAAQKQ</sequence>
</entry>
<entry dataset="Swiss-Prot" created="2005-09-27" modified="2021-02-10" version="153">
<accession>Q9Z2B1</accession>
<name>I18RA_MOUSE</name>
<protein>
<recommendedName>
<fullName>Interleukin-18 receptor accessory protein</fullName>
<shortName>IL-18 receptor accessory protein</shortName>
<shortName>IL-18RAcP</shortName>
<ecNumber evidence="4">3.2.2.6</ecNumber>
</recommendedName>
<alternativeName>
<fullName>Accessory protein-like</fullName>
<shortName>AcPL</shortName>
</alternativeName>
<alternativeName>
<fullName>CD218 antigen-like family member B</fullName>
</alternativeName>
<alternativeName>
<fullName>IL-1R accessory protein-like</fullName>
<shortName>IL-1RAcPL</shortName>
</alternativeName>
<alternativeName>
<fullName>Interleukin-18 receptor accessory protein-like</fullName>
</alternativeName>
<alternativeName>
<fullName>Interleukin-18 receptor beta</fullName>
<shortName>IL-18R-beta</shortName>
<shortName>IL-18Rbeta</shortName>
</alternativeName>
<cdAntigenName>CD218b</cdAntigenName>
</protein>
<gene>
<name type="primary" evidence="9">Il18rap</name>
</gene>
<organism>
<name type="scientific">Mus musculus</name>
<name type="common">Mouse</name>
<dbReference type="NCBI Taxonomy" id="10090"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Glires</taxon>
<taxon>Rodentia</taxon>
<taxon>Myomorpha</taxon>
<taxon>Muroidea</taxon>
<taxon>Muridae</taxon>
<taxon>Murinae</taxon>
<taxon>Mus</taxon>
<taxon>Mus</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1998" name="J. Biol. Chem." volume="273" first="29445" last="29450">
<title>Cloning of a novel receptor subunit, AcPL, required for interleukin-18 signaling.</title>
<authorList>
<person name="Born T.L."/>
<person name="Thomassen E."/>
<person name="Bird T.A."/>
<person name="Sims J.E."/>
</authorList>
<dbReference type="PubMed" id="9792649"/>
<dbReference type="DOI" id="10.1074/jbc.273.45.29445"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="2">
<citation type="journal article" date="2000" name="J. Immunol." volume="165" first="4950" last="4956">
<title>IL-18 receptors, their role in ligand binding and function: anti-IL-1RAcPL antibody, a potent antagonist of IL-18.</title>
<authorList>
<person name="Debets R."/>
<person name="Timans J.C."/>
<person name="Churakowa T."/>
<person name="Zurawski S."/>
<person name="de Waal Malefyt R."/>
<person name="Moore K.W."/>
<person name="Abrams J.S."/>
<person name="O'Garra A."/>
<person name="Bazan J.F."/>
<person name="Kastelein R.A."/>
</authorList>
<dbReference type="PubMed" id="11046021"/>
<dbReference type="DOI" id="10.4049/jimmunol.165.9.4950"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="3">
<citation type="journal article" date="2005" name="J. Immunol." volume="174" first="5351" last="5357">
<title>Accessory protein-like is essential for IL-18-mediated signaling.</title>
<authorList>
<person name="Cheung H."/>
<person name="Chen N.-J."/>
<person name="Cao Z."/>
<person name="Ono N."/>
<person name="Ohashi P.S."/>
<person name="Yeh W.-C."/>
</authorList>
<dbReference type="PubMed" id="15843532"/>
<dbReference type="DOI" id="10.4049/jimmunol.174.9.5351"/>
</citation>
<scope>FUNCTION</scope>
<scope>DISRUPTION PHENOTYPE</scope>
</reference>
<comment type="function">
<text evidence="1 5 6 7">Within the IL18 receptor complex, does not mediate IL18-binding, but involved in IL18-dependent signal transduction, leading to NF-kappa-B and JNK activation (PubMed:11046021, PubMed:15843532, PubMed:9792649). May play a role in IL18-mediated IFNG synthesis from T-helper 1 (Th1) cells (By similarity).</text>
</comment>
<comment type="catalytic activity">
<reaction evidence="4">
<text>H2O + NAD(+) = ADP-D-ribose + H(+) + nicotinamide</text>
<dbReference type="Rhea" id="RHEA:16301"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:17154"/>
<dbReference type="ChEBI" id="CHEBI:57540"/>
<dbReference type="ChEBI" id="CHEBI:57967"/>
<dbReference type="EC" id="3.2.2.6"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="4">
<dbReference type="Rhea" id="RHEA:16302"/>
</physiologicalReaction>
</comment>
<comment type="subunit">
<text evidence="1">Forms a ternary complex with IL18 and IL18R1. Within this complex, IL18R1 is involved in ligand-binding and IL18RAP in signaling leading to NF-kappa-B and JNK activation.</text>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="1">Cell membrane</location>
<topology evidence="8">Single-pass type I membrane protein</topology>
</subcellularLocation>
</comment>
<comment type="domain">
<text evidence="4">The TIR domain mediates NAD(+) hydrolase (NADase) activity. Self-association of TIR domains is required for NADase activity.</text>
</comment>
<comment type="disruption phenotype">
<text evidence="6">Impaired IL-18 signaling.</text>
</comment>
<comment type="similarity">
<text evidence="8">Belongs to the interleukin-1 receptor family.</text>
</comment>
<dbReference type="EC" id="3.2.2.6" evidence="4"/>
<dbReference type="EMBL" id="AF077347">
<property type="protein sequence ID" value="AAC72197.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS14912.1"/>
<dbReference type="RefSeq" id="NP_034683.1">
<property type="nucleotide sequence ID" value="NM_010553.4"/>
</dbReference>
<dbReference type="STRING" id="10090.ENSMUSP00000027237"/>
<dbReference type="GlyGen" id="Q9Z2B1">
<property type="glycosylation" value="4 sites"/>
</dbReference>
<dbReference type="iPTMnet" id="Q9Z2B1"/>
<dbReference type="PhosphoSitePlus" id="Q9Z2B1"/>
<dbReference type="EPD" id="Q9Z2B1"/>
<dbReference type="jPOST" id="Q9Z2B1"/>
<dbReference type="PaxDb" id="Q9Z2B1"/>
<dbReference type="PRIDE" id="Q9Z2B1"/>
<dbReference type="Antibodypedia" id="17791">
<property type="antibodies" value="380 antibodies"/>
</dbReference>
<dbReference type="Ensembl" id="ENSMUST00000027237">
<property type="protein sequence ID" value="ENSMUSP00000027237"/>
<property type="gene ID" value="ENSMUSG00000026068"/>
</dbReference>
<dbReference type="GeneID" id="16174"/>
<dbReference type="KEGG" id="mmu:16174"/>
<dbReference type="UCSC" id="uc007auk.2">
<property type="organism name" value="mouse"/>
</dbReference>
<dbReference type="CTD" id="8807"/>
<dbReference type="MGI" id="MGI:1338888">
<property type="gene designation" value="Il18rap"/>
</dbReference>
<dbReference type="eggNOG" id="ENOG502QUSU">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT01010000222421"/>
<dbReference type="HOGENOM" id="CLU_025552_2_0_1"/>
<dbReference type="InParanoid" id="Q9Z2B1"/>
<dbReference type="OMA" id="YVCDYTQ"/>
<dbReference type="OrthoDB" id="985064at2759"/>
<dbReference type="PhylomeDB" id="Q9Z2B1"/>
<dbReference type="TreeFam" id="TF325519"/>
<dbReference type="BioGRID-ORCS" id="16174">
<property type="hits" value="0 hits in 17 CRISPR screens"/>
</dbReference>
<dbReference type="PRO" id="PR:Q9Z2B1"/>
<dbReference type="Proteomes" id="UP000000589">
<property type="component" value="Chromosome 1"/>
</dbReference>
<dbReference type="RNAct" id="Q9Z2B1">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSMUSG00000026068">
<property type="expression patterns" value="Expressed in granulocyte and 71 other tissues"/>
</dbReference>
<dbReference type="Genevisible" id="Q9Z2B1">
<property type="organism ID" value="MM"/>
</dbReference>
<dbReference type="GO" id="GO:0045092">
<property type="term" value="C:interleukin-18 receptor complex"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0004908">
<property type="term" value="F:interleukin-1 receptor activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0042008">
<property type="term" value="F:interleukin-18 receptor activity"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050135">
<property type="term" value="F:NAD(P)+ nucleosidase activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0061809">
<property type="term" value="F:NAD+ nucleotidase, cyclic ADP-ribose generating"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0008283">
<property type="term" value="P:cell population proliferation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0070301">
<property type="term" value="P:cellular response to hydrogen peroxide"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0071351">
<property type="term" value="P:cellular response to interleukin-18"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0006954">
<property type="term" value="P:inflammatory response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0032609">
<property type="term" value="P:interferon-gamma production"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0035655">
<property type="term" value="P:interleukin-18-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0032635">
<property type="term" value="P:interleukin-6 production"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0042119">
<property type="term" value="P:neutrophil activation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0045954">
<property type="term" value="P:positive regulation of natural killer cell mediated cytotoxicity"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0051092">
<property type="term" value="P:positive regulation of NF-kappaB transcription factor activity"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0035744">
<property type="term" value="P:T-helper 1 cell cytokine production"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="Gene3D" id="2.60.40.10">
<property type="match status" value="2"/>
</dbReference>
<dbReference type="Gene3D" id="3.40.50.10140">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR007110">
<property type="entry name" value="Ig-like_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR036179">
<property type="entry name" value="Ig-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR013783">
<property type="entry name" value="Ig-like_fold"/>
</dbReference>
<dbReference type="InterPro" id="IPR003599">
<property type="entry name" value="Ig_sub"/>
</dbReference>
<dbReference type="InterPro" id="IPR015621">
<property type="entry name" value="IL-1_rcpt_fam"/>
</dbReference>
<dbReference type="InterPro" id="IPR004074">
<property type="entry name" value="IL-1_rcpt_I/II-typ"/>
</dbReference>
<dbReference type="InterPro" id="IPR041416">
<property type="entry name" value="IL-1RAcP-like_ig"/>
</dbReference>
<dbReference type="InterPro" id="IPR013151">
<property type="entry name" value="Immunoglobulin"/>
</dbReference>
<dbReference type="InterPro" id="IPR000157">
<property type="entry name" value="TIR_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR035897">
<property type="entry name" value="Toll_tir_struct_dom_sf"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR11890">
<property type="entry name" value="PTHR11890"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00047">
<property type="entry name" value="ig"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF18452">
<property type="entry name" value="Ig_6"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF01582">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR01536">
<property type="entry name" value="INTRLKN1R12F"/>
</dbReference>
<dbReference type="SMART" id="SM00409">
<property type="entry name" value="IG"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="SMART" id="SM00255">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF48726">
<property type="entry name" value="SSF48726"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF52200">
<property type="entry name" value="SSF52200"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50835">
<property type="entry name" value="IG_LIKE"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="PROSITE" id="PS50104">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at transcript level"/>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0378">Hydrolase</keyword>
<keyword id="KW-0393">Immunoglobulin domain</keyword>
<keyword id="KW-0395">Inflammatory response</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0520">NAD</keyword>
<keyword id="KW-0675">Receptor</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0732">Signal</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<feature type="signal peptide" evidence="2">
<location>
<begin position="1"/>
<end position="19"/>
</location>
</feature>
<feature type="chain" description="Interleukin-18 receptor accessory protein" id="PRO_0000042186">
<location>
<begin position="20"/>
<end position="614"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="2">
<location>
<begin position="20"/>
<end position="356"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="2">
<location>
<begin position="357"/>
<end position="377"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="2">
<location>
<begin position="378"/>
<end position="614"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 1">
<location>
<begin position="148"/>
<end position="234"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 2">
<location>
<begin position="250"/>
<end position="352"/>
</location>
</feature>
<feature type="domain" description="TIR" evidence="4">
<location>
<begin position="405"/>
<end position="558"/>
</location>
</feature>
<feature type="active site" evidence="4">
<location>
<position position="492"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="2">
<location>
<position position="21"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="2">
<location>
<position position="151"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="2">
<location>
<position position="227"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="2">
<location>
<position position="344"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1">
<location>
<begin position="46"/>
<end position="126"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1">
<location>
<begin position="154"/>
<end position="179"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1">
<location>
<begin position="174"/>
<end position="220"/>
</location>
</feature>
<feature type="disulfide bond" evidence="3">
<location>
<begin position="179"/>
<end position="220"/>
</location>
</feature>
<feature type="disulfide bond" evidence="3">
<location>
<begin position="272"/>
<end position="336"/>
</location>
</feature>
<evidence key="1" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="O95256"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000255"/>
<evidence key="3" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00114"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00204"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11046021"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15843532"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9792649"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000305"/>
<evidence key="9" type="ECO:0000312">
<source>
<dbReference type="MGI" id="MGI:1338888"/>
</source>
</evidence>
<sequence length="614" mass="70094" checksum="B71D005E4FA99BA1" modified="1999-05-01" version="1" precursor="true">MLCLGWVFLWFVAGEKTTGFNHSACATKKLLWTYSARGAENFVLFCDLQELQEQKFSHASQLSPTQSPAHKPCSGSQKDLSDVQWYMQPRSGSPLEEISRNSPHMQSEGMLHILAPQTNSIWSYICRPRIRSPQDMACCIKTVLEVKPQRNVSCGNTAQDEQVLLLGSTGSIHCPSLSCQSDVQSPEMTWYKDGRLLPEHKKNPIEMADIYVFNQGLYVCDYTQSDNVSSWTVRAVVKVRTIGKDINVKPEILDPITDTLDVELGKPLTLPCRVQFGFQRLSKPVIKWYVKESTQEWEMSVFEEKRIQSTFKNEVIERTIFLREVTQRDLSRKFVCFAQNSIGNTTRTIRLRKKEEVVFVYILLGTALMLVGVLVAAAFLYWYWIEVVLLCRTYKNKDETLGDKKEFDAFVSYSNWSSPETDAVGSLSEEHLALNLFPEVLEDTYGYRLCLLDRDVTPGGVYADDIVSIIKKSRRGIFILSPSYLNGPRVFELQAAVNLALVDQTLKLILIKFCSFQEPESLPYLVKKALRVLPTVTWKGLKSVHASSRFWTQIRYHMPVKNSNRFMFNGLRIFLKGFSPEKDLVTQKPLEGMPKSGNDHGAQNLLLYSDQKRC</sequence>
</entry>
<entry dataset="Swiss-Prot" created="2005-09-27" modified="2021-02-10" version="175">
<accession>O95256</accession>
<accession>B2RPJ3</accession>
<accession>Q2QDE5</accession>
<accession>Q3KPE7</accession>
<accession>Q3KPE8</accession>
<accession>Q53TT4</accession>
<accession>Q53TU5</accession>
<name>I18RA_HUMAN</name>
<protein>
<recommendedName>
<fullName>Interleukin-18 receptor accessory protein</fullName>
<shortName>IL-18 receptor accessory protein</shortName>
<shortName>IL-18RAcP</shortName>
<ecNumber evidence="5">3.2.2.6</ecNumber>
</recommendedName>
<alternativeName>
<fullName>Accessory protein-like</fullName>
<shortName>AcPL</shortName>
</alternativeName>
<alternativeName>
<fullName>CD218 antigen-like family member B</fullName>
</alternativeName>
<alternativeName>
<fullName>CDw218b</fullName>
</alternativeName>
<alternativeName>
<fullName evidence="13">IL-1R accessory protein-like</fullName>
<shortName>IL-1RAcPL</shortName>
</alternativeName>
<alternativeName>
<fullName>Interleukin-1 receptor 7</fullName>
<shortName>IL-1R-7</shortName>
<shortName>IL-1R7</shortName>
</alternativeName>
<alternativeName>
<fullName>Interleukin-18 receptor accessory protein-like</fullName>
</alternativeName>
<alternativeName>
<fullName evidence="13 14 17">Interleukin-18 receptor beta</fullName>
<shortName>IL-18R-beta</shortName>
<shortName evidence="13 14 17">IL-18Rbeta</shortName>
</alternativeName>
<cdAntigenName>CD218b</cdAntigenName>
</protein>
<gene>
<name type="primary" evidence="20">IL18RAP</name>
<name type="synonym">IL1R7</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1998" name="J. Biol. Chem." volume="273" first="29445" last="29450">
<title>Cloning of a novel receptor subunit, AcPL, required for interleukin-18 signaling.</title>
<authorList>
<person name="Born T.L."/>
<person name="Thomassen E."/>
<person name="Bird T.A."/>
<person name="Sims J.E."/>
</authorList>
<dbReference type="PubMed" id="9792649"/>
<dbReference type="DOI" id="10.1074/jbc.273.45.29445"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>FUNCTION</scope>
<scope>SUBUNIT</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="2">
<citation type="journal article" date="2007" name="Cytokine" volume="39" first="178" last="183">
<title>Identification of IL-18RAP mRNA truncated splice variants in human testis and the other human tissues.</title>
<authorList>
<person name="Fiszer D."/>
<person name="Rozwadowska N."/>
<person name="Rychlewski L."/>
<person name="Kosicki W."/>
<person name="Kurpisz M."/>
</authorList>
<dbReference type="PubMed" id="17897836"/>
<dbReference type="DOI" id="10.1016/j.cyto.2007.07.186"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 3 AND 4)</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="3">
<citation type="journal article" date="2005" name="Nature" volume="434" first="724" last="731">
<title>Generation and annotation of the DNA sequences of human chromosomes 2 and 4.</title>
<authorList>
<person name="Hillier L.W."/>
<person name="Graves T.A."/>
<person name="Fulton R.S."/>
<person name="Fulton L.A."/>
<person name="Pepin K.H."/>
<person name="Minx P."/>
<person name="Wagner-McPherson C."/>
<person name="Layman D."/>
<person name="Wylie K."/>
<person name="Sekhon M."/>
<person name="Becker M.C."/>
<person name="Fewell G.A."/>
<person name="Delehaunty K.D."/>
<person name="Miner T.L."/>
<person name="Nash W.E."/>
<person name="Kremitzki C."/>
<person name="Oddy L."/>
<person name="Du H."/>
<person name="Sun H."/>
<person name="Bradshaw-Cordum H."/>
<person name="Ali J."/>
<person name="Carter J."/>
<person name="Cordes M."/>
<person name="Harris A."/>
<person name="Isak A."/>
<person name="van Brunt A."/>
<person name="Nguyen C."/>
<person name="Du F."/>
<person name="Courtney L."/>
<person name="Kalicki J."/>
<person name="Ozersky P."/>
<person name="Abbott S."/>
<person name="Armstrong J."/>
<person name="Belter E.A."/>
<person name="Caruso L."/>
<person name="Cedroni M."/>
<person name="Cotton M."/>
<person name="Davidson T."/>
<person name="Desai A."/>
<person name="Elliott G."/>
<person name="Erb T."/>
<person name="Fronick C."/>
<person name="Gaige T."/>
<person name="Haakenson W."/>
<person name="Haglund K."/>
<person name="Holmes A."/>
<person name="Harkins R."/>
<person name="Kim K."/>
<person name="Kruchowski S.S."/>
<person name="Strong C.M."/>
<person name="Grewal N."/>
<person name="Goyea E."/>
<person name="Hou S."/>
<person name="Levy A."/>
<person name="Martinka S."/>
<person name="Mead K."/>
<person name="McLellan M.D."/>
<person name="Meyer R."/>
<person name="Randall-Maher J."/>
<person name="Tomlinson C."/>
<person name="Dauphin-Kohlberg S."/>
<person name="Kozlowicz-Reilly A."/>
<person name="Shah N."/>
<person name="Swearengen-Shahid S."/>
<person name="Snider J."/>
<person name="Strong J.T."/>
<person name="Thompson J."/>
<person name="Yoakum M."/>
<person name="Leonard S."/>
<person name="Pearman C."/>
<person name="Trani L."/>
<person name="Radionenko M."/>
<person name="Waligorski J.E."/>
<person name="Wang C."/>
<person name="Rock S.M."/>
<person name="Tin-Wollam A.-M."/>
<person name="Maupin R."/>
<person name="Latreille P."/>
<person name="Wendl M.C."/>
<person name="Yang S.-P."/>
<person name="Pohl C."/>
<person name="Wallis J.W."/>
<person name="Spieth J."/>
<person name="Bieri T.A."/>
<person name="Berkowicz N."/>
<person name="Nelson J.O."/>
<person name="Osborne J."/>
<person name="Ding L."/>
<person name="Meyer R."/>
<person name="Sabo A."/>
<person name="Shotland Y."/>
<person name="Sinha P."/>
<person name="Wohldmann P.E."/>
<person name="Cook L.L."/>
<person name="Hickenbotham M.T."/>
<person name="Eldred J."/>
<person name="Williams D."/>
<person name="Jones T.A."/>
<person name="She X."/>
<person name="Ciccarelli F.D."/>
<person name="Izaurralde E."/>
<person name="Taylor J."/>
<person name="Schmutz J."/>
<person name="Myers R.M."/>
<person name="Cox D.R."/>
<person name="Huang X."/>
<person name="McPherson J.D."/>
<person name="Mardis E.R."/>
<person name="Clifton S.W."/>
<person name="Warren W.C."/>
<person name="Chinwalla A.T."/>
<person name="Eddy S.R."/>
<person name="Marra M.A."/>
<person name="Ovcharenko I."/>
<person name="Furey T.S."/>
<person name="Miller W."/>
<person name="Eichler E.E."/>
<person name="Bork P."/>
<person name="Suyama M."/>
<person name="Torrents D."/>
<person name="Waterston R.H."/>
<person name="Wilson R.K."/>
</authorList>
<dbReference type="PubMed" id="15815621"/>
<dbReference type="DOI" id="10.1038/nature03466"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="4">
<citation type="submission" date="2005-09" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="5">
<citation type="submission" date="2007-10" db="EMBL/GenBank/DDBJ databases">
<title>NEDO human cDNA sequencing project focused on splicing variants.</title>
<authorList>
<person name="Wakamatsu A."/>
<person name="Yamamoto J."/>
<person name="Kimura K."/>
<person name="Ishii S."/>
<person name="Watanabe K."/>
<person name="Sugiyama A."/>
<person name="Murakawa K."/>
<person name="Kaida T."/>
<person name="Tsuchiya K."/>
<person name="Fukuzumi Y."/>
<person name="Kumagai A."/>
<person name="Oishi Y."/>
<person name="Yamamoto S."/>
<person name="Ono Y."/>
<person name="Komori Y."/>
<person name="Yamazaki M."/>
<person name="Kisu Y."/>
<person name="Nishikawa T."/>
<person name="Sugano S."/>
<person name="Nomura N."/>
<person name="Isogai T."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3)</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2)</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="7">
<citation type="journal article" date="2000" name="Int. Immunol." volume="12" first="151" last="160">
<title>IL-12 synergizes with IL-18 or IL-1beta for IFN-gamma production from human T cells.</title>
<authorList>
<person name="Tominaga K."/>
<person name="Yoshimoto T."/>
<person name="Torigoe K."/>
<person name="Kurimoto M."/>
<person name="Matsui K."/>
<person name="Hada T."/>
<person name="Okamura H."/>
<person name="Nakanishi K."/>
</authorList>
<dbReference type="PubMed" id="10653850"/>
<dbReference type="DOI" id="10.1093/intimm/12.2.151"/>
</citation>
<scope>FUNCTION</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2000" name="J. Immunol." volume="165" first="1933" last="1938">
<title>IFN-alpha and IL-12 induce IL-18 receptor gene expression in human NK and T cells.</title>
<authorList>
<person name="Sareneva T."/>
<person name="Julkunen I."/>
<person name="Matikainen S."/>
</authorList>
<dbReference type="PubMed" id="10925275"/>
<dbReference type="DOI" id="10.4049/jimmunol.165.4.1933"/>
</citation>
<scope>TISSUE SPECIFICITY</scope>
<scope>INDUCTION BY IFN-ALPHA AND IL12/INTERLEUKIN-12</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2000" name="J. Immunol." volume="165" first="4950" last="4956">
<title>IL-18 receptors, their role in ligand binding and function: anti-IL-1RAcPL antibody, a potent antagonist of IL-18.</title>
<authorList>
<person name="Debets R."/>
<person name="Timans J.C."/>
<person name="Churakowa T."/>
<person name="Zurawski S."/>
<person name="de Waal Malefyt R."/>
<person name="Moore K.W."/>
<person name="Abrams J.S."/>
<person name="O'Garra A."/>
<person name="Bazan J.F."/>
<person name="Kastelein R.A."/>
</authorList>
<dbReference type="PubMed" id="11046021"/>
<dbReference type="DOI" id="10.4049/jimmunol.165.9.4950"/>
</citation>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2003" name="Nat. Struct. Biol." volume="10" first="966" last="971">
<title>The structure and binding mode of interleukin-18.</title>
<authorList>
<person name="Kato Z."/>
<person name="Jee J."/>
<person name="Shikano H."/>
<person name="Mishima M."/>
<person name="Ohki I."/>
<person name="Ohnishi H."/>
<person name="Li A."/>
<person name="Hashimoto K."/>
<person name="Matsukuma E."/>
<person name="Omoya K."/>
<person name="Yamamoto Y."/>
<person name="Yoneda T."/>
<person name="Hara T."/>
<person name="Kondo N."/>
<person name="Shirakawa M."/>
</authorList>
<dbReference type="PubMed" id="14528293"/>
<dbReference type="DOI" id="10.1038/nsb993"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBUNIT</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2014" name="Nat. Commun." volume="5" first="5340" last="5340">
<title>The structural basis for receptor recognition of human interleukin-18.</title>
<authorList>
<person name="Tsutsumi N."/>
<person name="Kimura T."/>
<person name="Arita K."/>
<person name="Ariyoshi M."/>
<person name="Ohnishi H."/>
<person name="Yamamoto T."/>
<person name="Zuo X."/>
<person name="Maenaka K."/>
<person name="Park E.Y."/>
<person name="Kondo N."/>
<person name="Shirakawa M."/>
<person name="Tochio H."/>
<person name="Kato Z."/>
</authorList>
<dbReference type="PubMed" id="25500532"/>
<dbReference type="DOI" id="10.1038/ncomms6340"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (3.10 ANGSTROMS) OF 15-356</scope>
<scope>GLYCOSYLATION AT ASN-119; ASN-152 AND ASN-345</scope>
<scope>DISULFIDE BONDS</scope>
<scope>MUTAGENESIS OF LEU-167; GLU-210; TYR-212; TYR-214; LYS-313 AND 15-GLU--PRO-176</scope>
<scope>SUBUNIT</scope>
<scope>FUNCTION</scope>
</reference>
<comment type="function">
<text evidence="9 11 12 19">Within the IL18 receptor complex, does not mediate IL18-binding, but involved in IL18-dependent signal transduction, leading to NF-kappa-B and JNK activation (PubMed:9792649, PubMed:14528293, PubMed:25500532). May play a role in IL18-mediated IFNG synthesis from T-helper 1 (Th1) cells (Probable).</text>
</comment>
<comment type="catalytic activity">
<reaction evidence="5">
<text>H2O + NAD(+) = ADP-D-ribose + H(+) + nicotinamide</text>
<dbReference type="Rhea" id="RHEA:16301"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:17154"/>
<dbReference type="ChEBI" id="CHEBI:57540"/>
<dbReference type="ChEBI" id="CHEBI:57967"/>
<dbReference type="EC" id="3.2.2.6"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="5">
<dbReference type="Rhea" id="RHEA:16302"/>
</physiologicalReaction>
</comment>
<comment type="subunit">
<text evidence="9 11 18">Forms a ternary complex with IL18 and IL18R1 (PubMed:14528293, PubMed:25500532). Within this complex, IL18R1 is involved in ligand-binding and IL18RAP in signaling leading to NF-kappa-B and JNK activation (Probable).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-21018056">
<id>O95256</id>
</interactant>
<interactant intactId="EBI-720609">
<id>O76024</id>
<label>WFS1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="9">Cell membrane</location>
<topology evidence="18">Single-pass type I membrane protein</topology>
</subcellularLocation>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>O95256-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>O95256-2</id>
<name>2</name>
<sequence type="described" ref="VSP_056295"/>
</isoform>
<isoform>
<id>O95256-3</id>
<name>3</name>
<name evidence="16">IL-18RAPshort</name>
<sequence type="described" ref="VSP_059116 VSP_059117"/>
</isoform>
<isoform>
<id>O95256-4</id>
<name>4</name>
<sequence type="described" ref="VSP_059114 VSP_059115"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="6 7 8 10 12">Detected in adrenal gland, bone marrow, brain, fetal brain, fetal liver, heart, kidney, lung, liver, peripheral blood leukocytes, placenta, prostate, salivary gland, skeletal muscle, spinal cord, testis, thymus, thyroid, trachea and uterus (PubMed:17897836). Strongly expressed in peripheral blood leukocytes and spleen and, to a lesser extent, in colon (PubMed:9792649). Specifically coexpressed with IL18R1 in T-helper 1 (Th1)cells (PubMed:10925275, PubMed:11046021, PubMed:10653850).</text>
</comment>
<comment type="induction">
<text evidence="7">Induced by IFN-alpha and IL12/interleukin-12 in natural killer (NK) cells and T-cells.</text>
</comment>
<comment type="domain">
<text evidence="5">The TIR domain mediates NAD(+) hydrolase (NADase) activity. Self-association of TIR domains is required for NADase activity.</text>
</comment>
<comment type="PTM">
<text evidence="11">N-glycosylated.</text>
</comment>
<comment type="similarity">
<text evidence="18">Belongs to the interleukin-1 receptor family.</text>
</comment>
<dbReference type="EC" id="3.2.2.6" evidence="5"/>
<dbReference type="EMBL" id="AF077346">
<property type="protein sequence ID" value="AAC72196.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="DQ116957">
<property type="protein sequence ID" value="AAZ52551.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AC007278">
<property type="protein sequence ID" value="AAY15080.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC007248">
<property type="protein sequence ID" value="AAY15049.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471127">
<property type="protein sequence ID" value="EAX01791.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AK300026">
<property type="protein sequence ID" value="BAG61837.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC069630">
<property type="protein sequence ID" value="AAH69630.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC106764">
<property type="protein sequence ID" value="AAI06765.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC106765">
<property type="protein sequence ID" value="AAI06766.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC137474">
<property type="protein sequence ID" value="AAI37475.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC137475">
<property type="protein sequence ID" value="AAI37476.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS2061.1">
<molecule id="O95256-1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_003844.1">
<molecule id="O95256-1"/>
<property type="nucleotide sequence ID" value="NM_003853.3"/>
</dbReference>
<dbReference type="RefSeq" id="XP_011510389.1">
<molecule id="O95256-2"/>
<property type="nucleotide sequence ID" value="XM_011512087.2"/>
</dbReference>
<dbReference type="RefSeq" id="XP_011510390.1">
<molecule id="O95256-2"/>
<property type="nucleotide sequence ID" value="XM_011512088.2"/>
</dbReference>
<dbReference type="PDB" id="3WO4">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.10"/>
<property type="chains" value="C=15-356"/>
</dbReference>
<dbReference type="PDB" id="6KN9">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.30"/>
<property type="chains" value="A/B/C=20-356"/>
</dbReference>
<dbReference type="PDBsum" id="3WO4"/>
<dbReference type="PDBsum" id="6KN9"/>
<dbReference type="SASBDB" id="O95256"/>
<dbReference type="SMR" id="O95256"/>
<dbReference type="BioGRID" id="114335">
<property type="interactions" value="3"/>
</dbReference>
<dbReference type="IntAct" id="O95256">
<property type="interactions" value="5"/>
</dbReference>
<dbReference type="STRING" id="9606.ENSP00000264260"/>
<dbReference type="GlyGen" id="O95256">
<property type="glycosylation" value="4 sites"/>
</dbReference>
<dbReference type="iPTMnet" id="O95256"/>
<dbReference type="PhosphoSitePlus" id="O95256"/>
<dbReference type="BioMuta" id="IL18RAP"/>
<dbReference type="PaxDb" id="O95256"/>
<dbReference type="PeptideAtlas" id="O95256"/>
<dbReference type="PRIDE" id="O95256"/>
<dbReference type="ProteomicsDB" id="50750">
<molecule id="O95256-1"/>
</dbReference>
<dbReference type="ProteomicsDB" id="61717"/>
<dbReference type="ABCD" id="O95256">
<property type="antibodies" value="3 sequenced antibodies"/>
</dbReference>
<dbReference type="Antibodypedia" id="17791">
<property type="antibodies" value="380 antibodies"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000264260">
<molecule id="O95256-1"/>
<property type="protein sequence ID" value="ENSP00000264260"/>
<property type="gene ID" value="ENSG00000115607"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000409369">
<molecule id="O95256-2"/>
<property type="protein sequence ID" value="ENSP00000387201"/>
<property type="gene ID" value="ENSG00000115607"/>
</dbReference>
<dbReference type="GeneID" id="8807"/>
<dbReference type="KEGG" id="hsa:8807"/>
<dbReference type="UCSC" id="uc002tbx.4">
<molecule id="O95256-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="8807"/>
<dbReference type="DisGeNET" id="8807"/>
<dbReference type="GeneCards" id="IL18RAP"/>
<dbReference type="HGNC" id="HGNC:5989">
<property type="gene designation" value="IL18RAP"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000115607">
<property type="expression patterns" value="Tissue enhanced (blood, bone marrow, lymphoid tissue)"/>
</dbReference>
<dbReference type="MIM" id="604509">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_O95256"/>
<dbReference type="OpenTargets" id="ENSG00000115607"/>
<dbReference type="PharmGKB" id="PA29805"/>
<dbReference type="VEuPathDB" id="HostDB:ENSG00000115607.9"/>
<dbReference type="eggNOG" id="ENOG502QUSU">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT01010000222421"/>
<dbReference type="HOGENOM" id="CLU_025552_2_0_1"/>
<dbReference type="InParanoid" id="O95256"/>
<dbReference type="OMA" id="YVCDYTQ"/>
<dbReference type="OrthoDB" id="985064at2759"/>
<dbReference type="PhylomeDB" id="O95256"/>
<dbReference type="TreeFam" id="TF325519"/>
<dbReference type="PathwayCommons" id="O95256"/>
<dbReference type="Reactome" id="R-HSA-9012546">
<property type="pathway name" value="Interleukin-18 signaling"/>
</dbReference>
<dbReference type="BioGRID-ORCS" id="8807">
<property type="hits" value="3 hits in 878 CRISPR screens"/>
</dbReference>
<dbReference type="GeneWiki" id="IL18RAP"/>
<dbReference type="GenomeRNAi" id="8807"/>
<dbReference type="Pharos" id="O95256">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:O95256"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 2"/>
</dbReference>
<dbReference type="RNAct" id="O95256">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000115607">
<property type="expression patterns" value="Expressed in bone marrow and 129 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="O95256">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="O95256">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0045092">
<property type="term" value="C:interleukin-18 receptor complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0042008">
<property type="term" value="F:interleukin-18 receptor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050135">
<property type="term" value="F:NAD(P)+ nucleosidase activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0061809">
<property type="term" value="F:NAD+ nucleotidase, cyclic ADP-ribose generating"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0008283">
<property type="term" value="P:cell population proliferation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0070301">
<property type="term" value="P:cellular response to hydrogen peroxide"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0006955">
<property type="term" value="P:immune response"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0006954">
<property type="term" value="P:inflammatory response"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0032609">
<property type="term" value="P:interferon-gamma production"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0035655">
<property type="term" value="P:interleukin-18-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032635">
<property type="term" value="P:interleukin-6 production"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0042119">
<property type="term" value="P:neutrophil activation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045954">
<property type="term" value="P:positive regulation of natural killer cell mediated cytotoxicity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0051092">
<property type="term" value="P:positive regulation of NF-kappaB transcription factor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0035744">
<property type="term" value="P:T-helper 1 cell cytokine production"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="Gene3D" id="2.60.40.10">
<property type="match status" value="2"/>
</dbReference>
<dbReference type="Gene3D" id="3.40.50.10140">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR007110">
<property type="entry name" value="Ig-like_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR036179">
<property type="entry name" value="Ig-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR013783">
<property type="entry name" value="Ig-like_fold"/>
</dbReference>
<dbReference type="InterPro" id="IPR003599">
<property type="entry name" value="Ig_sub"/>
</dbReference>
<dbReference type="InterPro" id="IPR015621">
<property type="entry name" value="IL-1_rcpt_fam"/>
</dbReference>
<dbReference type="InterPro" id="IPR041416">
<property type="entry name" value="IL-1RAcP-like_ig"/>
</dbReference>
<dbReference type="InterPro" id="IPR000157">
<property type="entry name" value="TIR_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR035897">
<property type="entry name" value="Toll_tir_struct_dom_sf"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR11890">
<property type="entry name" value="PTHR11890"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF13895">
<property type="entry name" value="Ig_2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF18452">
<property type="entry name" value="Ig_6"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF01582">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00409">
<property type="entry name" value="IG"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="SMART" id="SM00255">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF48726">
<property type="entry name" value="SSF48726"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF52200">
<property type="entry name" value="SSF52200"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50835">
<property type="entry name" value="IG_LIKE"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="PROSITE" id="PS50104">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0378">Hydrolase</keyword>
<keyword id="KW-0393">Immunoglobulin domain</keyword>
<keyword id="KW-0395">Inflammatory response</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0520">NAD</keyword>
<keyword id="KW-0675">Receptor</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0732">Signal</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<feature type="signal peptide" evidence="3">
<location>
<begin position="1"/>
<end position="19"/>
</location>
</feature>
<feature type="chain" description="Interleukin-18 receptor accessory protein" id="PRO_0000042185">
<location>
<begin position="20"/>
<end position="599"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="3">
<location>
<begin position="20"/>
<end position="356"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="3">
<location>
<begin position="357"/>
<end position="377"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="3">
<location>
<begin position="378"/>
<end position="599"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 1">
<location>
<begin position="149"/>
<end position="235"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 2">
<location>
<begin position="251"/>
<end position="353"/>
</location>
</feature>
<feature type="domain" description="TIR" evidence="5">
<location>
<begin position="406"/>
<end position="559"/>
</location>
</feature>
<feature type="active site" evidence="5">
<location>
<position position="493"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="3">
<location>
<position position="21"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="1 11">
<location>
<position position="119"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="1 11">
<location>
<position position="152"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="1 11">
<location>
<position position="345"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1 11">
<location>
<begin position="46"/>
<end position="126"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1 11">
<location>
<begin position="155"/>
<end position="180"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1 11">
<location>
<begin position="175"/>
<end position="221"/>
</location>
</feature>
<feature type="disulfide bond" evidence="4">
<location>
<begin position="180"/>
<end position="221"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1 4 11">
<location>
<begin position="273"/>
<end position="337"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_056295" evidence="15">
<location>
<begin position="1"/>
<end position="142"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 4." id="VSP_059114" evidence="10">
<original>VNNSGSYIC</original>
<variation>LGHIFVDPR</variation>
<location>
<begin position="118"/>
<end position="126"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 4." id="VSP_059115" evidence="10">
<location>
<begin position="127"/>
<end position="599"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_059116" evidence="10">
<original>SPYDVACCVKMILEVKP</original>
<variation>YDPNTFLSENISKSSII</variation>
<location>
<begin position="133"/>
<end position="149"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_059117" evidence="10">
<location>
<begin position="150"/>
<end position="599"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs11465716." id="VAR_034005">
<original>V</original>
<variation>I</variation>
<location>
<position position="350"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs IL18 receptor signaling via NF-kappa-B." evidence="11">
<location>
<begin position="15"/>
<end position="176"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreases binding to the preformed binary complex of IL18 and IL18R1." evidence="11">
<original>L</original>
<variation>A</variation>
<location>
<position position="167"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreases binding to the preformed binary complex of IL18 and IL18R1. Impairs IL18 receptor signaling via NF-kappa-B; when associated with A-212 and A-214." evidence="11">
<original>E</original>
<variation>A</variation>
<location>
<position position="210"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes binding to the preformed binary complex of IL18 and IL18R1. Impairs IL18 receptor signaling via NF-kappa-B; when associated with A-210 and A-214." evidence="11">
<original>Y</original>
<variation>A</variation>
<location>
<position position="212"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreases binding to the preformed binary complex of IL18 and IL18R1. Impairs IL18 receptor signaling via NF-kappa-B; when associated with A-210 and A-212." evidence="11">
<original>Y</original>
<variation>A</variation>
<location>
<position position="214"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreases binding to the preformed binary complex of IL18 and IL18R1. Decreases IL18 receptor signaling via NF-kappa-B." evidence="11">
<original>K</original>
<variation>A</variation>
<location>
<position position="313"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="32"/>
<end position="36"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="41"/>
<end position="44"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="110"/>
<end position="115"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="117"/>
<end position="120"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="122"/>
<end position="126"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="141"/>
<end position="149"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="154"/>
<end position="157"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="161"/>
<end position="166"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="171"/>
<end position="174"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="176"/>
<end position="178"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="180"/>
<end position="183"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="189"/>
<end position="193"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="196"/>
<end position="199"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="203"/>
<end position="210"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="213"/>
<end position="215"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="217"/>
<end position="224"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="233"/>
<end position="243"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="252"/>
<end position="255"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="258"/>
<end position="263"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="269"/>
<end position="278"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="286"/>
<end position="293"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="296"/>
<end position="299"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="306"/>
<end position="310"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="312"/>
<end position="325"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="328"/>
<end position="331"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="333"/>
<end position="341"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="344"/>
<end position="354"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3WO4"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="6KN9"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000255"/>
<evidence key="4" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00114"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00204"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10653850"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10925275"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11046021"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14528293"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17897836"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25500532"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9792649"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="10653850"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="14528293"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="17897836"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="25500532"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000305"/>
<evidence key="19" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="10653850"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000312">
<source>
<dbReference type="HGNC" id="HGNC:5989"/>
</source>
</evidence>
<sequence length="599" mass="68310" checksum="54807DA3E05462F1" modified="1999-05-01" version="1" precursor="true">MLCLGWIFLWLVAGERIKGFNISGCSTKKLLWTYSTRSEEEFVLFCDLPEPQKSHFCHRNRLSPKQVPEHLPFMGSNDLSDVQWYQQPSNGDPLEDIRKSYPHIIQDKCTLHFLTPGVNNSGSYICRPKMIKSPYDVACCVKMILEVKPQTNASCEYSASHKQDLLLGSTGSISCPSLSCQSDAQSPAVTWYKNGKLLSVERSNRIVVDEVYDYHQGTYVCDYTQSDTVSSWTVRAVVQVRTIVGDTKLKPDILDPVEDTLEVELGKPLTISCKARFGFERVFNPVIKWYIKDSDLEWEVSVPEAKSIKSTLKDEIIERNIILEKVTQRDLRRKFVCFVQNSIGNTTQSVQLKEKRGVVLLYILLGTIGTLVAVLAASALLYRHWIEIVLLYRTYQSKDQTLGDKKDFDAFVSYAKWSSFPSEATSSLSEEHLALSLFPDVLENKYGYSLCLLERDVAPGGVYAEDIVSIIKRSRRGIFILSPNYVNGPSIFELQAAVNLALDDQTLKLILIKFCYFQEPESLPHLVKKALRVLPTVTWRGLKSVPPNSRFWAKMRYHMPVKNSQGFTWNQLRITSRIFQWKGLSRTETTGRSSQPKEW</sequence>
</entry>
<entry dataset="Swiss-Prot" created="2002-12-06" modified="2021-02-10" version="166">
<accession>Q61098</accession>
<name>IL18R_MOUSE</name>
<protein>
<recommendedName>
<fullName>Interleukin-18 receptor 1</fullName>
<shortName>IL-18R-1</shortName>
<shortName>IL-18R1</shortName>
<ecNumber evidence="4">3.2.2.6</ecNumber>
</recommendedName>
<alternativeName>
<fullName>CD218 antigen-like family member A</fullName>
</alternativeName>
<alternativeName>
<fullName>IL1 receptor-related protein</fullName>
<shortName>IL-1Rrp</shortName>
<shortName>IL1R-rp</shortName>
</alternativeName>
<alternativeName>
<fullName>Interleukin-18 receptor alpha</fullName>
<shortName>IL-18R-alpha</shortName>
<shortName>IL-18Ralpha</shortName>
</alternativeName>
<cdAntigenName>CD218a</cdAntigenName>
</protein>
<gene>
<name type="primary" evidence="7">Il18r1</name>
</gene>
<organism>
<name type="scientific">Mus musculus</name>
<name type="common">Mouse</name>
<dbReference type="NCBI Taxonomy" id="10090"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Glires</taxon>
<taxon>Rodentia</taxon>
<taxon>Myomorpha</taxon>
<taxon>Muroidea</taxon>
<taxon>Muridae</taxon>
<taxon>Murinae</taxon>
<taxon>Mus</taxon>
<taxon>Mus</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1996" name="J. Biol. Chem." volume="271" first="3967" last="3970">
<title>IL-1Rrp is a novel receptor-like molecule similar to the type I interleukin-1 receptor and its homologues T1/ST2 and IL-1R AcP.</title>
<authorList>
<person name="Parnet P."/>
<person name="Garka K.E."/>
<person name="Bonnert T.P."/>
<person name="Dower S.K."/>
<person name="Sims J.E."/>
</authorList>
<dbReference type="PubMed" id="8626725"/>
<dbReference type="DOI" id="10.1074/jbc.271.8.3967"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>VARIANT ALA-317 DEL</scope>
</reference>
<reference key="2">
<citation type="journal article" date="2015" name="Nat. Med." volume="21" first="820" last="826">
<title>Interleukin 18 function in atherosclerosis is mediated by the interleukin 18 receptor and the Na-Cl co-transporter.</title>
<authorList>
<person name="Wang J."/>
<person name="Sun C."/>
<person name="Gerdes N."/>
<person name="Liu C."/>
<person name="Liao M."/>
<person name="Liu J."/>
<person name="Shi M.A."/>
<person name="He A."/>
<person name="Zhou Y."/>
<person name="Sukhova G.K."/>
<person name="Chen H."/>
<person name="Cheng X.W."/>
<person name="Kuzuya M."/>
<person name="Murohara T."/>
<person name="Zhang J."/>
<person name="Cheng X."/>
<person name="Jiang M."/>
<person name="Shull G.E."/>
<person name="Rogers S."/>
<person name="Yang C.L."/>
<person name="Ke Q."/>
<person name="Jelen S."/>
<person name="Bindels R."/>
<person name="Ellison D.H."/>
<person name="Jarolim P."/>
<person name="Libby P."/>
<person name="Shi G.P."/>
</authorList>
<dbReference type="PubMed" id="26099046"/>
<dbReference type="DOI" id="10.1038/nm.3890"/>
</citation>
<scope>INTERACTION WITH SLC12A3</scope>
</reference>
<comment type="function">
<text evidence="1 5">Within the IL18 receptor complex, responsible for the binding of the proinflammatory cytokine IL18, but not IL1A nor IL1B. Involved in IL18-mediated IFNG synthesis from T-helper 1 (Th1) cells (By similarity). Contributes to IL18-induced cytokine production, either independently of SLC12A3, or as a complex with SLC12A3 (PubMed:26099046).</text>
</comment>
<comment type="catalytic activity">
<reaction evidence="4">
<text>H2O + NAD(+) = ADP-D-ribose + H(+) + nicotinamide</text>
<dbReference type="Rhea" id="RHEA:16301"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:17154"/>
<dbReference type="ChEBI" id="CHEBI:57540"/>
<dbReference type="ChEBI" id="CHEBI:57967"/>
<dbReference type="EC" id="3.2.2.6"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="4">
<dbReference type="Rhea" id="RHEA:16302"/>
</physiologicalReaction>
</comment>
<comment type="subunit">
<text evidence="1 5">Forms a ternary complex with IL18 and IL18RAP (By similarity). Within this complex, IL18R1 is involved in ligand-binding and IL18RAP in signaling leading to NF-kappa-B and JNK activation (By similarity). Interacts with SLC12A3 in peritoneal macrophages; this interaction is increased by IL18 treatment (PubMed:26099046).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-13612516">
<id>Q61098</id>
</interactant>
<interactant intactId="EBI-8366645">
<id>P59158</id>
<label>Slc12a3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="1">Membrane</location>
<topology evidence="6">Single-pass type I membrane protein</topology>
</subcellularLocation>
</comment>
<comment type="domain">
<text evidence="4">The TIR domain mediates NAD(+) hydrolase (NADase) activity. Self-association of TIR domains is required for NADase activity.</text>
</comment>
<comment type="similarity">
<text evidence="6">Belongs to the interleukin-1 receptor family.</text>
</comment>
<dbReference type="EC" id="3.2.2.6" evidence="4"/>
<dbReference type="EMBL" id="U43673">
<property type="protein sequence ID" value="AAC52437.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS35549.1"/>
<dbReference type="RefSeq" id="NP_032391.1">
<property type="nucleotide sequence ID" value="NM_008365.2"/>
</dbReference>
<dbReference type="RefSeq" id="XP_006495790.1">
<property type="nucleotide sequence ID" value="XM_006495727.3"/>
</dbReference>
<dbReference type="RefSeq" id="XP_006495791.1">
<property type="nucleotide sequence ID" value="XM_006495728.3"/>
</dbReference>
<dbReference type="RefSeq" id="XP_006495792.1">
<property type="nucleotide sequence ID" value="XM_006495729.3"/>
</dbReference>
<dbReference type="RefSeq" id="XP_006495793.1">
<property type="nucleotide sequence ID" value="XM_006495730.3"/>
</dbReference>
<dbReference type="RefSeq" id="XP_006495795.1">
<property type="nucleotide sequence ID" value="XM_006495732.3"/>
</dbReference>
<dbReference type="RefSeq" id="XP_006495797.1">
<property type="nucleotide sequence ID" value="XM_006495734.3"/>
</dbReference>
<dbReference type="SMR" id="Q61098"/>
<dbReference type="IntAct" id="Q61098">
<property type="interactions" value="1"/>
</dbReference>
<dbReference type="STRING" id="10090.ENSMUSP00000103679"/>
<dbReference type="GlyGen" id="Q61098">
<property type="glycosylation" value="10 sites"/>
</dbReference>
<dbReference type="PhosphoSitePlus" id="Q61098"/>
<dbReference type="EPD" id="Q61098"/>
<dbReference type="MaxQB" id="Q61098"/>
<dbReference type="PaxDb" id="Q61098"/>
<dbReference type="PRIDE" id="Q61098"/>
<dbReference type="Antibodypedia" id="2363">
<property type="antibodies" value="819 antibodies"/>
</dbReference>
<dbReference type="Ensembl" id="ENSMUST00000087983">
<property type="protein sequence ID" value="ENSMUSP00000085298"/>
<property type="gene ID" value="ENSMUSG00000026070"/>
</dbReference>
<dbReference type="Ensembl" id="ENSMUST00000108044">
<property type="protein sequence ID" value="ENSMUSP00000103679"/>
<property type="gene ID" value="ENSMUSG00000026070"/>
</dbReference>
<dbReference type="Ensembl" id="ENSMUST00000195684">
<property type="protein sequence ID" value="ENSMUSP00000142070"/>
<property type="gene ID" value="ENSMUSG00000026070"/>
</dbReference>
<dbReference type="GeneID" id="16182"/>
<dbReference type="KEGG" id="mmu:16182"/>
<dbReference type="UCSC" id="uc011wjz.1">
<property type="organism name" value="mouse"/>
</dbReference>
<dbReference type="CTD" id="8809"/>
<dbReference type="MGI" id="MGI:105383">
<property type="gene designation" value="Il18r1"/>
</dbReference>
<dbReference type="eggNOG" id="ENOG502QUAC">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT01000000214361"/>
<dbReference type="HOGENOM" id="CLU_025552_3_1_1"/>
<dbReference type="InParanoid" id="Q61098"/>
<dbReference type="OMA" id="NFLEFWP"/>
<dbReference type="OrthoDB" id="985064at2759"/>
<dbReference type="PhylomeDB" id="Q61098"/>
<dbReference type="TreeFam" id="TF325519"/>
<dbReference type="BioGRID-ORCS" id="16182">
<property type="hits" value="0 hits in 17 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="Il18r1">
<property type="organism name" value="mouse"/>
</dbReference>
<dbReference type="PRO" id="PR:Q61098"/>
<dbReference type="Proteomes" id="UP000000589">
<property type="component" value="Chromosome 1"/>
</dbReference>
<dbReference type="RNAct" id="Q61098">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSMUSG00000026070">
<property type="expression patterns" value="Expressed in right lung and 85 other tissues"/>
</dbReference>
<dbReference type="Genevisible" id="Q61098">
<property type="organism ID" value="MM"/>
</dbReference>
<dbReference type="GO" id="GO:0045092">
<property type="term" value="C:interleukin-18 receptor complex"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0042007">
<property type="term" value="F:interleukin-18 binding"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042008">
<property type="term" value="F:interleukin-18 receptor activity"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0050135">
<property type="term" value="F:NAD(P)+ nucleosidase activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0061809">
<property type="term" value="F:NAD+ nucleotidase, cyclic ADP-ribose generating"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0006954">
<property type="term" value="P:inflammatory response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0035655">
<property type="term" value="P:interleukin-18-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0030101">
<property type="term" value="P:natural killer cell activation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0120163">
<property type="term" value="P:negative regulation of cold-induced thermogenesis"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="YuBioLab"/>
</dbReference>
<dbReference type="GO" id="GO:0032729">
<property type="term" value="P:positive regulation of interferon-gamma production"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0051092">
<property type="term" value="P:positive regulation of NF-kappaB transcription factor activity"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1901224">
<property type="term" value="P:positive regulation of NIK/NF-kappaB signaling"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:2000556">
<property type="term" value="P:positive regulation of T-helper 1 cell cytokine production"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045063">
<property type="term" value="P:T-helper 1 cell differentiation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="Gene3D" id="2.60.40.10">
<property type="match status" value="3"/>
</dbReference>
<dbReference type="Gene3D" id="3.40.50.10140">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR007110">
<property type="entry name" value="Ig-like_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR036179">
<property type="entry name" value="Ig-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR013783">
<property type="entry name" value="Ig-like_fold"/>
</dbReference>
<dbReference type="InterPro" id="IPR003599">
<property type="entry name" value="Ig_sub"/>
</dbReference>
<dbReference type="InterPro" id="IPR015621">
<property type="entry name" value="IL-1_rcpt_fam"/>
</dbReference>
<dbReference type="InterPro" id="IPR000157">
<property type="entry name" value="TIR_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR035897">
<property type="entry name" value="Toll_tir_struct_dom_sf"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR11890">
<property type="entry name" value="PTHR11890"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF13895">
<property type="entry name" value="Ig_2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF01582">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00409">
<property type="entry name" value="IG"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="SMART" id="SM00255">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF48726">
<property type="entry name" value="SSF48726"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF52200">
<property type="entry name" value="SSF52200"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50835">
<property type="entry name" value="IG_LIKE"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50104">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0378">Hydrolase</keyword>
<keyword id="KW-0393">Immunoglobulin domain</keyword>
<keyword id="KW-0395">Inflammatory response</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0520">NAD</keyword>
<keyword id="KW-0675">Receptor</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0732">Signal</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<feature type="signal peptide" evidence="2">
<location>
<begin position="1"/>
<end position="19"/>
</location>
</feature>
<feature type="chain" description="Interleukin-18 receptor 1" id="PRO_0000015449">
<location>
<begin position="20"/>
<end position="537"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="2">
<location>
<begin position="20"/>
<end position="326"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="2">
<location>
<begin position="327"/>
<end position="347"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="2">
<location>
<begin position="348"/>
<end position="537"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 1">
<location>
<begin position="33"/>
<end position="102"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 2">
<location>
<begin position="134"/>
<end position="189"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 3">
<location>
<begin position="212"/>
<end position="312"/>
</location>
</feature>
<feature type="domain" description="TIR" evidence="4">
<location>
<begin position="370"/>
<end position="516"/>
</location>
</feature>
<feature type="active site" evidence="4">
<location>
<position position="452"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="2">
<location>
<position position="50"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="2">
<location>
<position position="71"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="2">
<location>
<position position="107"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="2">
<location>
<position position="111"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="2">
<location>
<position position="134"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="2">
<location>
<position position="189"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="2">
<location>
<position position="194"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="2">
<location>
<position position="200"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="2">
<location>
<position position="233"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="2">
<location>
<position position="295"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1">
<location>
<begin position="22"/>
<end position="41"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1">
<location>
<begin position="120"/>
<end position="159"/>
</location>
</feature>
<feature type="disulfide bond" evidence="3">
<location>
<begin position="141"/>
<end position="182"/>
</location>
</feature>
<feature type="disulfide bond" evidence="3">
<location>
<begin position="234"/>
<end position="296"/>
</location>
</feature>
<feature type="sequence variant">
<location>
<position position="317"/>
</location>
</feature>
<evidence key="1" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q13478"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000255"/>
<evidence key="3" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00114"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00204"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26099046"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000305"/>
<evidence key="7" type="ECO:0000312">
<source>
<dbReference type="MGI" id="MGI:105383"/>
</source>
</evidence>
<sequence length="537" mass="61601" checksum="B119FEA403355458" modified="1996-11-01" version="1" precursor="true">MHHEELILTLCILIVKSASKSCIHRSQIHVVEGEPFYLKPCGISAPVHRNETATMRWFKGSASHEYRELNNRSSPRVTFHDHTLEFWPVEMEDEGTYISQVGNDRRNWTLNVTKRNKHSCFSDKLVTSRDVEVNKSLHITCKNPNYEELIQDTWLYKNCKEISKTPRILKDAEFGDEGYYSCVFSVHHNGTRYNITKTVNITVIEGRSKVTPAILGPKCEKVGVELGKDVELNCSASLNKDDLFYWSIRKEDSSDPNVQEDRKETTTWISEGKLHASKILRFQKITENYLNVLYNCTVANEEAIDTKSFVLVRKEIPDIPGHVFTGGVTVLVLASVAAVCIVILCVIYKVDLVLFYRRIAERDETLTDGKTYDAFVSYLKECHPENKEEYTFAVETLPRVLEKQFGYKLCIFERDVVPGGAVVEEIHSLIEKSRRLIIVLSQSYLTNGARRELESGLHEALVERKIKIILIEFTPASNITFLPPSLKLLKSYRVLKWRADSPSMNSRFWKNLVYLMPAKAVKPWREESEARSVLSAP</sequence>
</entry>
<entry dataset="Swiss-Prot" created="2002-12-06" modified="2021-02-10" version="178">
<accession>Q13478</accession>
<accession>B2R9Y5</accession>
<accession>Q52LC9</accession>
<name>IL18R_HUMAN</name>
<protein>
<recommendedName>
<fullName>Interleukin-18 receptor 1</fullName>
<shortName>IL-18R-1</shortName>
<shortName>IL-18R1</shortName>
<ecNumber evidence="7">3.2.2.6</ecNumber>
</recommendedName>
<alternativeName>
<fullName>CD218 antigen-like family member A</fullName>
</alternativeName>
<alternativeName>
<fullName>CDw218a</fullName>
</alternativeName>
<alternativeName>
<fullName>IL1 receptor-related protein</fullName>
<shortName>IL-1Rrp</shortName>
<shortName>IL1R-rp</shortName>
</alternativeName>
<alternativeName>
<fullName evidence="16 17 18 19">Interleukin-18 receptor alpha</fullName>
<shortName>IL-18R-alpha</shortName>
<shortName evidence="16 17 18 19">IL-18Ralpha</shortName>
</alternativeName>
<cdAntigenName>CD218a</cdAntigenName>
</protein>
<gene>
<name type="primary" evidence="21">IL18R1</name>
<name type="synonym">IL1RRP</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1996" name="J. Biol. Chem." volume="271" first="3967" last="3970">
<title>IL-1Rrp is a novel receptor-like molecule similar to the type I interleukin-1 receptor and its homologues T1/ST2 and IL-1R AcP.</title>
<authorList>
<person name="Parnet P."/>
<person name="Garka K.E."/>
<person name="Bonnert T.P."/>
<person name="Dower S.K."/>
<person name="Sims J.E."/>
</authorList>
<dbReference type="PubMed" id="8626725"/>
<dbReference type="DOI" id="10.1074/jbc.271.8.3967"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>VARIANT ALA-317 DEL</scope>
<scope>LACK OF BINDING TO IL1A AND IL1B</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="2">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Thymus</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="2005" name="Nature" volume="434" first="724" last="731">
<title>Generation and annotation of the DNA sequences of human chromosomes 2 and 4.</title>
<authorList>
<person name="Hillier L.W."/>
<person name="Graves T.A."/>
<person name="Fulton R.S."/>
<person name="Fulton L.A."/>
<person name="Pepin K.H."/>
<person name="Minx P."/>
<person name="Wagner-McPherson C."/>
<person name="Layman D."/>
<person name="Wylie K."/>
<person name="Sekhon M."/>
<person name="Becker M.C."/>
<person name="Fewell G.A."/>
<person name="Delehaunty K.D."/>
<person name="Miner T.L."/>
<person name="Nash W.E."/>
<person name="Kremitzki C."/>
<person name="Oddy L."/>
<person name="Du H."/>
<person name="Sun H."/>
<person name="Bradshaw-Cordum H."/>
<person name="Ali J."/>
<person name="Carter J."/>
<person name="Cordes M."/>
<person name="Harris A."/>
<person name="Isak A."/>
<person name="van Brunt A."/>
<person name="Nguyen C."/>
<person name="Du F."/>
<person name="Courtney L."/>
<person name="Kalicki J."/>
<person name="Ozersky P."/>
<person name="Abbott S."/>
<person name="Armstrong J."/>
<person name="Belter E.A."/>
<person name="Caruso L."/>
<person name="Cedroni M."/>
<person name="Cotton M."/>
<person name="Davidson T."/>
<person name="Desai A."/>
<person name="Elliott G."/>
<person name="Erb T."/>
<person name="Fronick C."/>
<person name="Gaige T."/>
<person name="Haakenson W."/>
<person name="Haglund K."/>
<person name="Holmes A."/>
<person name="Harkins R."/>
<person name="Kim K."/>
<person name="Kruchowski S.S."/>
<person name="Strong C.M."/>
<person name="Grewal N."/>
<person name="Goyea E."/>
<person name="Hou S."/>
<person name="Levy A."/>
<person name="Martinka S."/>
<person name="Mead K."/>
<person name="McLellan M.D."/>
<person name="Meyer R."/>
<person name="Randall-Maher J."/>
<person name="Tomlinson C."/>
<person name="Dauphin-Kohlberg S."/>
<person name="Kozlowicz-Reilly A."/>
<person name="Shah N."/>
<person name="Swearengen-Shahid S."/>
<person name="Snider J."/>
<person name="Strong J.T."/>
<person name="Thompson J."/>
<person name="Yoakum M."/>
<person name="Leonard S."/>
<person name="Pearman C."/>
<person name="Trani L."/>
<person name="Radionenko M."/>
<person name="Waligorski J.E."/>
<person name="Wang C."/>
<person name="Rock S.M."/>
<person name="Tin-Wollam A.-M."/>
<person name="Maupin R."/>
<person name="Latreille P."/>
<person name="Wendl M.C."/>
<person name="Yang S.-P."/>
<person name="Pohl C."/>
<person name="Wallis J.W."/>
<person name="Spieth J."/>
<person name="Bieri T.A."/>
<person name="Berkowicz N."/>
<person name="Nelson J.O."/>
<person name="Osborne J."/>
<person name="Ding L."/>
<person name="Meyer R."/>
<person name="Sabo A."/>
<person name="Shotland Y."/>
<person name="Sinha P."/>
<person name="Wohldmann P.E."/>
<person name="Cook L.L."/>
<person name="Hickenbotham M.T."/>
<person name="Eldred J."/>
<person name="Williams D."/>
<person name="Jones T.A."/>
<person name="She X."/>
<person name="Ciccarelli F.D."/>
<person name="Izaurralde E."/>
<person name="Taylor J."/>
<person name="Schmutz J."/>
<person name="Myers R.M."/>
<person name="Cox D.R."/>
<person name="Huang X."/>
<person name="McPherson J.D."/>
<person name="Mardis E.R."/>
<person name="Clifton S.W."/>
<person name="Warren W.C."/>
<person name="Chinwalla A.T."/>
<person name="Eddy S.R."/>
<person name="Marra M.A."/>
<person name="Ovcharenko I."/>
<person name="Furey T.S."/>
<person name="Miller W."/>
<person name="Eichler E.E."/>
<person name="Bork P."/>
<person name="Suyama M."/>
<person name="Torrents D."/>
<person name="Waterston R.H."/>
<person name="Wilson R.K."/>
</authorList>
<dbReference type="PubMed" id="15815621"/>
<dbReference type="DOI" id="10.1038/nature03466"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
</reference>
<reference key="5">
<citation type="journal article" date="1997" name="J. Biol. Chem." volume="272" first="25737" last="25742">
<title>Purification and characterization of the human interleukin-18 receptor.</title>
<authorList>
<person name="Torigoe K."/>
<person name="Ushio S."/>
<person name="Okura T."/>
<person name="Kobayashi S."/>
<person name="Taniai M."/>
<person name="Kunikata T."/>
<person name="Murakami T."/>
<person name="Sanou O."/>
<person name="Kojima H."/>
<person name="Fujii M."/>
<person name="Ohta T."/>
<person name="Ikeda M."/>
<person name="Ikegami H."/>
<person name="Kurimoto M."/>
</authorList>
<dbReference type="PubMed" id="9325300"/>
<dbReference type="DOI" id="10.1074/jbc.272.41.25737"/>
</citation>
<scope>PROTEIN SEQUENCE OF 19-29; 55-58; 59-71; 211-221; 222-231; 269-275; 276-280; 319-315 AND 524-535</scope>
<scope>CHARACTERIZATION</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2000" name="Int. Immunol." volume="12" first="151" last="160">
<title>IL-12 synergizes with IL-18 or IL-1beta for IFN-gamma production from human T cells.</title>
<authorList>
<person name="Tominaga K."/>
<person name="Yoshimoto T."/>
<person name="Torigoe K."/>
<person name="Kurimoto M."/>
<person name="Matsui K."/>
<person name="Hada T."/>
<person name="Okamura H."/>
<person name="Nakanishi K."/>
</authorList>
<dbReference type="PubMed" id="10653850"/>
<dbReference type="DOI" id="10.1093/intimm/12.2.151"/>
</citation>
<scope>FUNCTION</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>INDUCTION BY IL12/INTERLEUKIN-12</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2000" name="J. Immunol." volume="165" first="1933" last="1938">
<title>IFN-alpha and IL-12 induce IL-18 receptor gene expression in human NK and T cells.</title>
<authorList>
<person name="Sareneva T."/>
<person name="Julkunen I."/>
<person name="Matikainen S."/>
</authorList>
<dbReference type="PubMed" id="10925275"/>
<dbReference type="DOI" id="10.4049/jimmunol.165.4.1933"/>
</citation>
<scope>TISSUE SPECIFICITY</scope>
<scope>INDUCTION BY IL12/INTERLEUKIN-12</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2000" name="J. Immunol." volume="165" first="4950" last="4956">
<title>IL-18 receptors, their role in ligand binding and function: anti-IL-1RAcPL antibody, a potent antagonist of IL-18.</title>
<authorList>
<person name="Debets R."/>
<person name="Timans J.C."/>
<person name="Churakowa T."/>
<person name="Zurawski S."/>
<person name="de Waal Malefyt R."/>
<person name="Moore K.W."/>
<person name="Abrams J.S."/>
<person name="O'Garra A."/>
<person name="Bazan J.F."/>
<person name="Kastelein R.A."/>
</authorList>
<dbReference type="PubMed" id="11046021"/>
<dbReference type="DOI" id="10.4049/jimmunol.165.9.4950"/>
</citation>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2003" name="Nat. Struct. Biol." volume="10" first="966" last="971">
<title>The structure and binding mode of interleukin-18.</title>
<authorList>
<person name="Kato Z."/>
<person name="Jee J."/>
<person name="Shikano H."/>
<person name="Mishima M."/>
<person name="Ohki I."/>
<person name="Ohnishi H."/>
<person name="Li A."/>
<person name="Hashimoto K."/>
<person name="Matsukuma E."/>
<person name="Omoya K."/>
<person name="Yamamoto Y."/>
<person name="Yoneda T."/>
<person name="Hara T."/>
<person name="Kondo N."/>
<person name="Shirakawa M."/>
</authorList>
<dbReference type="PubMed" id="14528293"/>
<dbReference type="DOI" id="10.1038/nsb993"/>
</citation>
<scope>SUBUNIT</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2014" name="FEBS Lett." volume="588" first="3838" last="3843">
<title>Structural basis for the specific recognition of IL-18 by its alpha receptor.</title>
<authorList>
<person name="Wei H."/>
<person name="Wang D."/>
<person name="Qian Y."/>
<person name="Liu X."/>
<person name="Fan S."/>
<person name="Yin H.S."/>
<person name="Wang X."/>
</authorList>
<dbReference type="PubMed" id="25261253"/>
<dbReference type="DOI" id="10.1016/j.febslet.2014.09.019"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.80 ANGSTROMS) OF 19-329</scope>
<scope>GLYCOSYLATION AT ASN-197; ASN-203; ASN-236 AND ASN-297</scope>
<scope>DISULFIDE BONDS</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2014" name="Nat. Commun." volume="5" first="5340" last="5340">
<title>The structural basis for receptor recognition of human interleukin-18.</title>
<authorList>
<person name="Tsutsumi N."/>
<person name="Kimura T."/>
<person name="Arita K."/>
<person name="Ariyoshi M."/>
<person name="Ohnishi H."/>
<person name="Yamamoto T."/>
<person name="Zuo X."/>
<person name="Maenaka K."/>
<person name="Park E.Y."/>
<person name="Kondo N."/>
<person name="Shirakawa M."/>
<person name="Tochio H."/>
<person name="Kato Z."/>
</authorList>
<dbReference type="PubMed" id="25500532"/>
<dbReference type="DOI" id="10.1038/ncomms6340"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (3.10 ANGSTROMS) OF 20-329</scope>
<scope>GLYCOSYLATION AT ASN-91; ASN-102; ASN-150; ASN-197; ASN-203; ASN-236 AND ASN-297</scope>
<scope>DISULFIDE BONDS</scope>
<scope>MUTAGENESIS OF ASN-297</scope>
<scope>SUBUNIT</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>FUNCTION</scope>
</reference>
<comment type="function">
<text evidence="4 8 11 12 13 14">Within the IL18 receptor complex, responsible for the binding of the proinflammatory cytokine IL18, but not IL1A nor IL1B (PubMed:8626725, PubMed:14528293, PubMed:25261253, PubMed:25500532). Involved in IL18-mediated IFNG synthesis from T-helper 1 (Th1) cells (PubMed:10653850). Contributes to IL18-induced cytokine production, either independently of SLC12A3, or as a complex with SLC12A3 (By similarity).</text>
</comment>
<comment type="catalytic activity">
<reaction evidence="7">
<text>H2O + NAD(+) = ADP-D-ribose + H(+) + nicotinamide</text>
<dbReference type="Rhea" id="RHEA:16301"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:17154"/>
<dbReference type="ChEBI" id="CHEBI:57540"/>
<dbReference type="ChEBI" id="CHEBI:57967"/>
<dbReference type="EC" id="3.2.2.6"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="7">
<dbReference type="Rhea" id="RHEA:16302"/>
</physiologicalReaction>
</comment>
<comment type="subunit">
<text evidence="4 11 13 20">Forms a ternary complex with IL18 and IL18RAP (PubMed:14528293, PubMed:25500532). Within this complex, IL18R1 is involved in ligand-binding and IL18RAP in signaling leading to NF-kappa-B and JNK activation (Probable). Interacts with SLC12A3 in peritoneal macrophages; this interaction is increased by IL18 treatment (By similarity).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-9817499">
<id>Q13478</id>
</interactant>
<interactant intactId="EBI-3910835">
<id>Q14116</id>
<label>IL18</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="11">Membrane</location>
<topology evidence="20">Single-pass type I membrane protein</topology>
</subcellularLocation>
</comment>
<comment type="tissue specificity">
<text evidence="8 9 10 14">Highly expressed in leukocytes, spleen, lung. Also expressed, but at lower levels, in liver, small intestine, colon, prostate, thymus, placenta, and heart. Specifically coexpressed with IL18R1 in Th1 cells (PubMed:10925275, PubMed:11046021, PubMed:10653850).</text>
</comment>
<comment type="induction">
<text evidence="8 9">Induced by IL12/interleukin-12 in T-cells. Proposed to be a phenotypic marker for T-helper 1 (Th1) cells.</text>
</comment>
<comment type="domain">
<text evidence="7">The TIR domain mediates NAD(+) hydrolase (NADase) activity. Self-association of TIR domains is required for NADase activity.</text>
</comment>
<comment type="PTM">
<text evidence="12 13">N-glycosylated. N-linked glycosyl chains contribute to ligand recognition and intra-receptor interactions required for formation of an active ternary receptor complex.</text>
</comment>
<comment type="similarity">
<text evidence="20">Belongs to the interleukin-1 receptor family.</text>
</comment>
<dbReference type="EC" id="3.2.2.6" evidence="7"/>
<dbReference type="EMBL" id="U43672">
<property type="protein sequence ID" value="AAC50390.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK313967">
<property type="protein sequence ID" value="BAG36682.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AC007248">
<property type="protein sequence ID" value="AAY15048.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC069575">
<property type="protein sequence ID" value="AAH69575.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC093975">
<property type="protein sequence ID" value="AAH93975.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC093977">
<property type="protein sequence ID" value="AAH93977.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS2060.1"/>
<dbReference type="RefSeq" id="NP_001269328.1">
<property type="nucleotide sequence ID" value="NM_001282399.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_003846.1">
<property type="nucleotide sequence ID" value="NM_003855.3"/>
</dbReference>
<dbReference type="PDB" id="3WO3">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.10"/>
<property type="chains" value="B/D/F/H/J/L=20-329"/>
</dbReference>
<dbReference type="PDB" id="3WO4">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.10"/>
<property type="chains" value="B=20-329"/>
</dbReference>
<dbReference type="PDB" id="4R6U">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A/C=19-329"/>
</dbReference>
<dbReference type="PDBsum" id="3WO3"/>
<dbReference type="PDBsum" id="3WO4"/>
<dbReference type="PDBsum" id="4R6U"/>
<dbReference type="SASBDB" id="Q13478"/>
<dbReference type="SMR" id="Q13478"/>
<dbReference type="BioGRID" id="114337">
<property type="interactions" value="4"/>
</dbReference>
<dbReference type="IntAct" id="Q13478">
<property type="interactions" value="3"/>
</dbReference>
<dbReference type="MINT" id="Q13478"/>
<dbReference type="STRING" id="9606.ENSP00000387211"/>
<dbReference type="GlyGen" id="Q13478">
<property type="glycosylation" value="8 sites"/>
</dbReference>
<dbReference type="iPTMnet" id="Q13478"/>
<dbReference type="PhosphoSitePlus" id="Q13478"/>
<dbReference type="BioMuta" id="IL18R1"/>
<dbReference type="EPD" id="Q13478"/>
<dbReference type="jPOST" id="Q13478"/>
<dbReference type="MassIVE" id="Q13478"/>
<dbReference type="MaxQB" id="Q13478"/>
<dbReference type="PaxDb" id="Q13478"/>
<dbReference type="PeptideAtlas" id="Q13478"/>
<dbReference type="PRIDE" id="Q13478"/>
<dbReference type="ProteomicsDB" id="59476"/>
<dbReference type="ABCD" id="Q13478">
<property type="antibodies" value="1 sequenced antibody"/>
</dbReference>
<dbReference type="Antibodypedia" id="2363">
<property type="antibodies" value="819 antibodies"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000233957">
<property type="protein sequence ID" value="ENSP00000233957"/>
<property type="gene ID" value="ENSG00000115604"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000409599">
<property type="protein sequence ID" value="ENSP00000387211"/>
<property type="gene ID" value="ENSG00000115604"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000410040">
<property type="protein sequence ID" value="ENSP00000386663"/>
<property type="gene ID" value="ENSG00000115604"/>
</dbReference>
<dbReference type="GeneID" id="8809"/>
<dbReference type="KEGG" id="hsa:8809"/>
<dbReference type="UCSC" id="uc002tbw.6">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="8809"/>
<dbReference type="DisGeNET" id="8809"/>
<dbReference type="GeneCards" id="IL18R1"/>
<dbReference type="HGNC" id="HGNC:5988">
<property type="gene designation" value="IL18R1"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000115604">
<property type="expression patterns" value="Tissue enhanced (lung)"/>
</dbReference>
<dbReference type="MIM" id="604494">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q13478"/>
<dbReference type="OpenTargets" id="ENSG00000115604"/>
<dbReference type="PharmGKB" id="PA29804"/>
<dbReference type="VEuPathDB" id="HostDB:ENSG00000115604.10"/>
<dbReference type="eggNOG" id="ENOG502QUAC">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT01000000214361"/>
<dbReference type="HOGENOM" id="CLU_025552_3_1_1"/>
<dbReference type="InParanoid" id="Q13478"/>
<dbReference type="OMA" id="NFLEFWP"/>
<dbReference type="OrthoDB" id="985064at2759"/>
<dbReference type="PhylomeDB" id="Q13478"/>
<dbReference type="TreeFam" id="TF325519"/>
<dbReference type="PathwayCommons" id="Q13478"/>
<dbReference type="Reactome" id="R-HSA-9008059">
<property type="pathway name" value="Interleukin-37 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9012546">
<property type="pathway name" value="Interleukin-18 signaling"/>
</dbReference>
<dbReference type="SIGNOR" id="Q13478"/>
<dbReference type="BioGRID-ORCS" id="8809">
<property type="hits" value="7 hits in 874 CRISPR screens"/>
</dbReference>
<dbReference type="GeneWiki" id="IL18R1"/>
<dbReference type="GenomeRNAi" id="8809"/>
<dbReference type="Pharos" id="Q13478">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:Q13478"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 2"/>
</dbReference>
<dbReference type="RNAct" id="Q13478">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000115604">
<property type="expression patterns" value="Expressed in right lung and 146 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="Q13478">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q13478">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0045092">
<property type="term" value="C:interleukin-18 receptor complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0004908">
<property type="term" value="F:interleukin-1 receptor activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0042007">
<property type="term" value="F:interleukin-18 binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042008">
<property type="term" value="F:interleukin-18 receptor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050135">
<property type="term" value="F:NAD(P)+ nucleosidase activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0061809">
<property type="term" value="F:NAD+ nucleotidase, cyclic ADP-ribose generating"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0038023">
<property type="term" value="F:signaling receptor activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0071345">
<property type="term" value="P:cellular response to cytokine stimulus"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0006955">
<property type="term" value="P:immune response"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0006954">
<property type="term" value="P:inflammatory response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0035655">
<property type="term" value="P:interleukin-18-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030101">
<property type="term" value="P:natural killer cell activation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0120163">
<property type="term" value="P:negative regulation of cold-induced thermogenesis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="YuBioLab"/>
</dbReference>
<dbReference type="GO" id="GO:0032729">
<property type="term" value="P:positive regulation of interferon-gamma production"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051092">
<property type="term" value="P:positive regulation of NF-kappaB transcription factor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1901224">
<property type="term" value="P:positive regulation of NIK/NF-kappaB signaling"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:2000556">
<property type="term" value="P:positive regulation of T-helper 1 cell cytokine production"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007165">
<property type="term" value="P:signal transduction"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0045063">
<property type="term" value="P:T-helper 1 cell differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="Gene3D" id="2.60.40.10">
<property type="match status" value="3"/>
</dbReference>
<dbReference type="Gene3D" id="3.40.50.10140">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR007110">
<property type="entry name" value="Ig-like_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR036179">
<property type="entry name" value="Ig-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR013783">
<property type="entry name" value="Ig-like_fold"/>
</dbReference>
<dbReference type="InterPro" id="IPR003599">
<property type="entry name" value="Ig_sub"/>
</dbReference>
<dbReference type="InterPro" id="IPR015621">
<property type="entry name" value="IL-1_rcpt_fam"/>
</dbReference>
<dbReference type="InterPro" id="IPR004074">
<property type="entry name" value="IL-1_rcpt_I/II-typ"/>
</dbReference>
<dbReference type="InterPro" id="IPR000157">
<property type="entry name" value="TIR_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR035897">
<property type="entry name" value="Toll_tir_struct_dom_sf"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR11890">
<property type="entry name" value="PTHR11890"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF01582">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR01536">
<property type="entry name" value="INTRLKN1R12F"/>
</dbReference>
<dbReference type="SMART" id="SM00409">
<property type="entry name" value="IG"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="SMART" id="SM00255">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF48726">
<property type="entry name" value="SSF48726"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF52200">
<property type="entry name" value="SSF52200"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50835">
<property type="entry name" value="IG_LIKE"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50104">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0378">Hydrolase</keyword>
<keyword id="KW-0393">Immunoglobulin domain</keyword>
<keyword id="KW-0395">Inflammatory response</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0520">NAD</keyword>
<keyword id="KW-0675">Receptor</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0732">Signal</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<feature type="signal peptide" evidence="15">
<location>
<begin position="1"/>
<end position="18"/>
</location>
</feature>
<feature type="chain" description="Interleukin-18 receptor 1" id="PRO_0000015448">
<location>
<begin position="19"/>
<end position="541"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="5">
<location>
<begin position="22"/>
<end position="329"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="5">
<location>
<begin position="330"/>
<end position="350"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="5">
<location>
<begin position="351"/>
<end position="541"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 1">
<location>
<begin position="33"/>
<end position="121"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 2">
<location>
<begin position="133"/>
<end position="212"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 3">
<location>
<begin position="220"/>
<end position="312"/>
</location>
</feature>
<feature type="domain" description="TIR" evidence="7">
<location>
<begin position="373"/>
<end position="520"/>
</location>
</feature>
<feature type="active site" evidence="7">
<location>
<position position="455"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="1 2 13">
<location>
<position position="91"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="1 2 13">
<location>
<position position="102"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="1 2 13">
<location>
<position position="150"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="1 2 3 12 13">
<location>
<position position="197"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="1 2 3 12 13">
<location>
<position position="203"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="1 2 3 12 13">
<location>
<position position="236"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="5">
<location>
<position position="255"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="1 2 3 12 13">
<location>
<position position="297"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1 2 3 12 13">
<location>
<begin position="22"/>
<end position="41"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1 2 3 12 13">
<location>
<begin position="43"/>
<end position="81"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1 2 3 12 13">
<location>
<begin position="119"/>
<end position="158"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1 2 3 6 12 13">
<location>
<begin position="140"/>
<end position="185"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1 2 3 6 12 13">
<location>
<begin position="237"/>
<end position="298"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs11465635." id="VAR_053379">
<original>R</original>
<variation>H</variation>
<location>
<position position="210"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs11465644." id="VAR_053380">
<original>N</original>
<variation>K</variation>
<location>
<position position="232"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs11465648." id="VAR_053381">
<original>S</original>
<variation>N</variation>
<location>
<position position="310"/>
</location>
</feature>
<feature type="sequence variant" id="VAR_014955" evidence="14">
<location>
<position position="317"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs12619169." id="VAR_053382">
<original>G</original>
<variation>R</variation>
<location>
<position position="423"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreases the affinity for IL18 suggesting that the N-linked glycosylation contributes to ligand recognition." evidence="13">
<original>N</original>
<variation>Q</variation>
<location>
<position position="297"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="26"/>
<end position="31"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="36"/>
<end position="39"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="43"/>
<end position="47"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="55"/>
<end position="59"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="76"/>
<end position="79"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="82"/>
<end position="87"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="90"/>
<end position="92"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="94"/>
<end position="100"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="103"/>
<end position="112"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="116"/>
<end position="120"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="122"/>
<end position="124"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="125"/>
<end position="131"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="134"/>
<end position="139"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="143"/>
<end position="145"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="146"/>
<end position="148"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="149"/>
<end position="156"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="166"/>
<end position="168"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="170"/>
<end position="174"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="177"/>
<end position="179"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="181"/>
<end position="191"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="194"/>
<end position="207"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="216"/>
<end position="219"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="221"/>
<end position="226"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="233"/>
<end position="241"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="246"/>
<end position="250"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="261"/>
<end position="263"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="266"/>
<end position="270"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="272"/>
<end position="274"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="276"/>
<end position="284"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="290"/>
<end position="292"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="296"/>
<end position="302"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="305"/>
<end position="314"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3WO3"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3WO4"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4R6U"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q61098"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000255"/>
<evidence key="6" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00114"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00204"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10653850"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10925275"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11046021"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14528293"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25261253"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25500532"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8626725"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9325300"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="10653850"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="14528293"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="25261253"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="25500532"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000305"/>
<evidence key="21" type="ECO:0000312">
<source>
<dbReference type="HGNC" id="HGNC:5988"/>
</source>
</evidence>
<sequence length="541" mass="62304" checksum="7173DB9C7EA71D32" modified="1996-11-01" version="1" precursor="true">MNCRELPLTLWVLISVSTAESCTSRPHITVVEGEPFYLKHCSCSLAHEIETTTKSWYKSSGSQEHVELNPRSSSRIALHDCVLEFWPVELNDTGSYFFQMKNYTQKWKLNVIRRNKHSCFTERQVTSKIVEVKKFFQITCENSYYQTLVNSTSLYKNCKKLLLENNKNPTIKKNAEFEDQGYYSCVHFLHHNGKLFNITKTFNITIVEDRSNIVPVLLGPKLNHVAVELGKNVRLNCSALLNEEDVIYWMFGEENGSDPNIHEEKEMRIMTPEGKWHASKVLRIENIGESNLNVLYNCTVASTGGTDTKSFILVRKADMADIPGHVFTRGMIIAVLILVAVVCLVTVCVIYRVDLVLFYRHLTRRDETLTDGKTYDAFVSYLKECRPENGEEHTFAVEILPRVLEKHFGYKLCIFERDVVPGGAVVDEIHSLIEKSRRLIIVLSKSYMSNEVRYELESGLHEALVERKIKIILIEFTPVTDFTFLPQSLKLLKSHRVLKWKADKSLSYNSRFWKNLLYLMPAKTVKPGRDEPEVLPVLSES</sequence>
</entry>
<entry dataset="Swiss-Prot" created="2002-01-31" modified="2021-02-10" version="160">
<accession>Q9EPQ1</accession>
<accession>Q9EPW5</accession>
<name>TLR1_MOUSE</name>
<protein>
<recommendedName>
<fullName>Toll-like receptor 1</fullName>
<ecNumber evidence="4">3.2.2.6</ecNumber>
</recommendedName>
<alternativeName>
<fullName>Toll/interleukin-1 receptor-like protein</fullName>
<shortName>TIL</shortName>
</alternativeName>
<cdAntigenName>CD281</cdAntigenName>
</protein>
<gene>
<name type="primary">Tlr1</name>
</gene>
<organism>
<name type="scientific">Mus musculus</name>
<name type="common">Mouse</name>
<dbReference type="NCBI Taxonomy" id="10090"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Glires</taxon>
<taxon>Rodentia</taxon>
<taxon>Myomorpha</taxon>
<taxon>Muroidea</taxon>
<taxon>Muridae</taxon>
<taxon>Murinae</taxon>
<taxon>Mus</taxon>
<taxon>Mus</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="2000" name="Proc. Natl. Acad. Sci. U.S.A." volume="97" first="13766" last="13771">
<title>The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between Toll-like receptors.</title>
<authorList>
<person name="Ozinsky A."/>
<person name="Underhill D.M."/>
<person name="Fontenot J.D."/>
<person name="Hajjar A.M."/>
<person name="Smith K.D."/>
<person name="Wilson C.B."/>
<person name="Schroeder L."/>
<person name="Aderem A."/>
</authorList>
<dbReference type="PubMed" id="11095740"/>
<dbReference type="DOI" id="10.1073/pnas.250476497"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>SUBCELLULAR LOCATION</scope>
<source>
<strain>BALB/cJ</strain>
<tissue>Macrophage</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="2001" name="J. Immunol." volume="166" first="15" last="19">
<title>Functional interactions between Toll-like receptor (TLR) 2 and TLR1 or TLR6 in response to phenol-soluble modulin.</title>
<authorList>
<person name="Hajjar A.M."/>
<person name="O'Mahony D.S."/>
<person name="Ozinsky A."/>
<person name="Underhill D.M."/>
<person name="Aderem A."/>
<person name="Klebanoff S.J."/>
<person name="Wilson C.B."/>
</authorList>
<dbReference type="PubMed" id="11123271"/>
<dbReference type="DOI" id="10.4049/jimmunol.166.1.15"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<source>
<tissue>Macrophage</tissue>
</source>
</reference>
<reference key="3">
<citation type="submission" date="2000-10" db="EMBL/GenBank/DDBJ databases">
<title>Cloning of Mus musculus Toll-like receptor 1.</title>
<authorList>
<person name="Thomson D.P."/>
<person name="Campbell C.C."/>
<person name="Liew F.Y."/>
<person name="Xu D."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<source>
<strain>BALB/cJ</strain>
<tissue>Spleen</tissue>
</source>
</reference>
<reference key="4">
<citation type="submission" date="2009-01" db="UniProtKB">
<authorList>
<person name="Lubec G."/>
<person name="Sunyer B."/>
<person name="Chen W.-Q."/>
</authorList>
</citation>
<scope>PROTEIN SEQUENCE OF 681-692</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<source>
<strain>OF1</strain>
<tissue>Hippocampus</tissue>
</source>
</reference>
<reference key="5">
<citation type="journal article" date="2007" name="J. Exp. Med." volume="204" first="2963" last="2976">
<title>A protein associated with Toll-like receptor (TLR) 4 (PRAT4A) is required for TLR-dependent immune responses.</title>
<authorList>
<person name="Takahashi K."/>
<person name="Shibata T."/>
<person name="Akashi-Takamura S."/>
<person name="Kiyokawa T."/>
<person name="Wakabayashi Y."/>
<person name="Tanimura N."/>
<person name="Kobayashi T."/>
<person name="Matsumoto F."/>
<person name="Fukui R."/>
<person name="Kouro T."/>
<person name="Nagai Y."/>
<person name="Takatsu K."/>
<person name="Saitoh S."/>
<person name="Miyake K."/>
</authorList>
<dbReference type="PubMed" id="17998391"/>
<dbReference type="DOI" id="10.1084/jem.20071132"/>
</citation>
<scope>INTERACTION WITH CNPY3</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2009" name="Cell. Immunol." volume="258" first="29" last="37">
<title>TLR2 and its co-receptors determine responses of macrophages and dendritic cells to lipoproteins of Mycobacterium tuberculosis.</title>
<authorList>
<person name="Drage M.G."/>
<person name="Pecora N.D."/>
<person name="Hise A.G."/>
<person name="Febbraio M."/>
<person name="Silverstein R.L."/>
<person name="Golenbock D.T."/>
<person name="Boom W.H."/>
<person name="Harding C.V."/>
</authorList>
<dbReference type="PubMed" id="19362712"/>
<dbReference type="DOI" id="10.1016/j.cellimm.2009.03.008"/>
</citation>
<scope>FUNCTION</scope>
<source>
<tissue>Macrophage</tissue>
</source>
</reference>
<comment type="function">
<text evidence="2 7">Participates in the innate immune response to microbial agents. Specifically recognizes diacylated and triacylated lipopeptides. Cooperates with TLR2 to mediate the innate immune response to bacterial lipoproteins or lipopeptides. Forms the activation cluster TLR2:TLR1:CD14 in response to triacylated lipopeptides, this cluster triggers signaling from the cell surface and subsequently is targeted to the Golgi in a lipid-raft dependent pathway. Acts via MYD88 and TRAF6, leading to NF-kappa-B activation, cytokine secretion and the inflammatory response (By similarity). Acts as a coreceptor for M.tuberculosis lipoproteins LprG, LpqH and PhoS1 (pstS1), in conjunction with TLR2 and for some but not all lipoproteins CD14 and/or CD36. The lipoproteins act as agonists to modulate antigen presenting cell functions in response to the pathogen (PubMed:19362712).</text>
</comment>
<comment type="catalytic activity">
<reaction evidence="4">
<text>H2O + NAD(+) = ADP-D-ribose + H(+) + nicotinamide</text>
<dbReference type="Rhea" id="RHEA:16301"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:17154"/>
<dbReference type="ChEBI" id="CHEBI:57540"/>
<dbReference type="ChEBI" id="CHEBI:57967"/>
<dbReference type="EC" id="3.2.2.6"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="4">
<dbReference type="Rhea" id="RHEA:16302"/>
</physiologicalReaction>
</comment>
<comment type="subunit">
<text evidence="2 6">Interacts (via extracellular domain) with TLR2. TLR2 seems to exist in heterodimers with either TLR1 or TLR6 before stimulation by the ligand. The heterodimers form bigger oligomers in response to their corresponding ligands as well as further heterotypic associations with other receptors such as CD14 and/or CD36 (By similarity). Binds MYD88 (via TIR domain). Interacts with CNPY3 (PubMed:17998391).</text>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="5 6">Cell membrane</location>
<topology evidence="3">Single-pass type I membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="5">Cytoplasmic vesicle</location>
<location evidence="5">Phagosome membrane</location>
<topology evidence="3">Single-pass type I membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="2">Membrane raft</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="2">Golgi apparatus</location>
</subcellularLocation>
<text evidence="2">Does not reside in lipid rafts before stimulation but accumulates increasingly in the raft upon the presence of the microbial ligand. In response to triacylated lipoproteins, TLR2:TLR1 heterodimers are recruited in lipid rafts, this recruitment determine the intracellular targeting to the Golgi apparatus.</text>
</comment>
<comment type="domain">
<text evidence="4">The TIR domain mediates NAD(+) hydrolase (NADase) activity. Self-association of TIR domains is required for NADase activity.</text>
</comment>
<comment type="similarity">
<text evidence="8">Belongs to the Toll-like receptor family.</text>
</comment>
<dbReference type="EC" id="3.2.2.6" evidence="4"/>
<dbReference type="EMBL" id="AY009154">
<property type="protein sequence ID" value="AAG37302.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF316985">
<property type="protein sequence ID" value="AAG35062.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS19302.1"/>
<dbReference type="RefSeq" id="NP_001263374.1">
<property type="nucleotide sequence ID" value="NM_001276445.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_109607.1">
<property type="nucleotide sequence ID" value="NM_030682.2"/>
</dbReference>
<dbReference type="RefSeq" id="XP_006503914.1">
<property type="nucleotide sequence ID" value="XM_006503851.2"/>
</dbReference>
<dbReference type="RefSeq" id="XP_006503915.1">
<property type="nucleotide sequence ID" value="XM_006503852.3"/>
</dbReference>
<dbReference type="RefSeq" id="XP_006503916.1">
<property type="nucleotide sequence ID" value="XM_006503853.1"/>
</dbReference>
<dbReference type="RefSeq" id="XP_006503917.1">
<property type="nucleotide sequence ID" value="XM_006503854.1"/>
</dbReference>
<dbReference type="RefSeq" id="XP_006503919.1">
<property type="nucleotide sequence ID" value="XM_006503856.1"/>
</dbReference>
<dbReference type="RefSeq" id="XP_011239022.1">
<property type="nucleotide sequence ID" value="XM_011240720.2"/>
</dbReference>
<dbReference type="BioGRID" id="204223">
<property type="interactions" value="2"/>
</dbReference>
<dbReference type="IntAct" id="Q9EPQ1">
<property type="interactions" value="6"/>
</dbReference>
<dbReference type="STRING" id="10090.ENSMUSP00000060793"/>
<dbReference type="ChEMBL" id="CHEMBL2146338"/>
<dbReference type="GlyGen" id="Q9EPQ1">
<property type="glycosylation" value="9 sites"/>
</dbReference>
<dbReference type="iPTMnet" id="Q9EPQ1"/>
<dbReference type="PhosphoSitePlus" id="Q9EPQ1"/>
<dbReference type="MaxQB" id="Q9EPQ1"/>
<dbReference type="PaxDb" id="Q9EPQ1"/>
<dbReference type="PRIDE" id="Q9EPQ1"/>
<dbReference type="Antibodypedia" id="10459">
<property type="antibodies" value="647 antibodies"/>
</dbReference>
<dbReference type="Ensembl" id="ENSMUST00000059349">
<property type="protein sequence ID" value="ENSMUSP00000060793"/>
<property type="gene ID" value="ENSMUSG00000044827"/>
</dbReference>
<dbReference type="Ensembl" id="ENSMUST00000197315">
<property type="protein sequence ID" value="ENSMUSP00000142500"/>
<property type="gene ID" value="ENSMUSG00000044827"/>
</dbReference>
<dbReference type="GeneID" id="21897"/>
<dbReference type="KEGG" id="mmu:21897"/>
<dbReference type="UCSC" id="uc008xmw.2">
<property type="organism name" value="mouse"/>
</dbReference>
<dbReference type="CTD" id="7096"/>
<dbReference type="MGI" id="MGI:1341295">
<property type="gene designation" value="Tlr1"/>
</dbReference>
<dbReference type="eggNOG" id="KOG4641">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000162884"/>
<dbReference type="InParanoid" id="Q9EPQ1"/>
<dbReference type="OMA" id="NNIETTW"/>
<dbReference type="OrthoDB" id="282372at2759"/>
<dbReference type="PhylomeDB" id="Q9EPQ1"/>
<dbReference type="TreeFam" id="TF351113"/>
<dbReference type="Reactome" id="R-MMU-1461957">
<property type="pathway name" value="Beta defensins"/>
</dbReference>
<dbReference type="Reactome" id="R-MMU-5686938">
<property type="pathway name" value="Regulation of TLR by endogenous ligand"/>
</dbReference>
<dbReference type="BioGRID-ORCS" id="21897">
<property type="hits" value="2 hits in 17 CRISPR screens"/>
</dbReference>
<dbReference type="PRO" id="PR:Q9EPQ1"/>
<dbReference type="Proteomes" id="UP000000589">
<property type="component" value="Chromosome 5"/>
</dbReference>
<dbReference type="RNAct" id="Q9EPQ1">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSMUSG00000044827">
<property type="expression patterns" value="Expressed in lymph node and 135 other tissues"/>
</dbReference>
<dbReference type="Genevisible" id="Q9EPQ1">
<property type="organism ID" value="MM"/>
</dbReference>
<dbReference type="GO" id="GO:0005794">
<property type="term" value="C:Golgi apparatus"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005887">
<property type="term" value="C:integral component of plasma membrane"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0016020">
<property type="term" value="C:membrane"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045121">
<property type="term" value="C:membrane raft"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045335">
<property type="term" value="C:phagocytic vesicle"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030670">
<property type="term" value="C:phagocytic vesicle membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0035354">
<property type="term" value="C:Toll-like receptor 1-Toll-like receptor 2 protein complex"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0042802">
<property type="term" value="F:identical protein binding"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0071723">
<property type="term" value="F:lipopeptide binding"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0050135">
<property type="term" value="F:NAD(P)+ nucleosidase activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0061809">
<property type="term" value="F:NAD+ nucleotidase, cyclic ADP-ribose generating"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0038023">
<property type="term" value="F:signaling receptor activity"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0035663">
<property type="term" value="F:Toll-like receptor 2 binding"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0004888">
<property type="term" value="F:transmembrane signaling receptor activity"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042497">
<property type="term" value="F:triacyl lipopeptide binding"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007250">
<property type="term" value="P:activation of NF-kappaB-inducing kinase activity"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001775">
<property type="term" value="P:cell activation"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0071221">
<property type="term" value="P:cellular response to bacterial lipopeptide"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0071727">
<property type="term" value="P:cellular response to triacyl bacterial lipopeptide"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006952">
<property type="term" value="P:defense response"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0042495">
<property type="term" value="P:detection of triacyl bacterial lipopeptide"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0006954">
<property type="term" value="P:inflammatory response"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0045087">
<property type="term" value="P:innate immune response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0042116">
<property type="term" value="P:macrophage activation"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001774">
<property type="term" value="P:microglial cell activation"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0002755">
<property type="term" value="P:MyD88-dependent toll-like receptor signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0032755">
<property type="term" value="P:positive regulation of interleukin-6 production"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032757">
<property type="term" value="P:positive regulation of interleukin-8 production"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0034137">
<property type="term" value="P:positive regulation of toll-like receptor 2 signaling pathway"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0032760">
<property type="term" value="P:positive regulation of tumor necrosis factor production"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032493">
<property type="term" value="P:response to bacterial lipoprotein"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0034130">
<property type="term" value="P:toll-like receptor 1 signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0002224">
<property type="term" value="P:toll-like receptor signaling pathway"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="Gene3D" id="3.40.50.10140">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="3.80.10.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR000483">
<property type="entry name" value="Cys-rich_flank_reg_C"/>
</dbReference>
<dbReference type="InterPro" id="IPR001611">
<property type="entry name" value="Leu-rich_rpt"/>
</dbReference>
<dbReference type="InterPro" id="IPR003591">
<property type="entry name" value="Leu-rich_rpt_typical-subtyp"/>
</dbReference>
<dbReference type="InterPro" id="IPR032675">
<property type="entry name" value="LRR_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR000157">
<property type="entry name" value="TIR_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR027190">
<property type="entry name" value="TLR1"/>
</dbReference>
<dbReference type="InterPro" id="IPR017241">
<property type="entry name" value="Toll-like_receptor"/>
</dbReference>
<dbReference type="InterPro" id="IPR035897">
<property type="entry name" value="Toll_tir_struct_dom_sf"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR24365">
<property type="entry name" value="PTHR24365"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR24365:SF261">
<property type="entry name" value="PTHR24365:SF261"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF13855">
<property type="entry name" value="LRR_8"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF01582">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PIRSF" id="PIRSF037595">
<property type="entry name" value="Toll-like_receptor"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00369">
<property type="entry name" value="LRR_TYP"/>
<property type="match status" value="6"/>
</dbReference>
<dbReference type="SMART" id="SM00082">
<property type="entry name" value="LRRCT"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00255">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF52200">
<property type="entry name" value="SSF52200"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51450">
<property type="entry name" value="LRR"/>
<property type="match status" value="10"/>
</dbReference>
<dbReference type="PROSITE" id="PS50104">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-0968">Cytoplasmic vesicle</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0333">Golgi apparatus</keyword>
<keyword id="KW-0378">Hydrolase</keyword>
<keyword id="KW-0391">Immunity</keyword>
<keyword id="KW-0395">Inflammatory response</keyword>
<keyword id="KW-0399">Innate immunity</keyword>
<keyword id="KW-0433">Leucine-rich repeat</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0520">NAD</keyword>
<keyword id="KW-0675">Receptor</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0732">Signal</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<feature type="signal peptide" evidence="3">
<location>
<begin position="1"/>
<end position="25"/>
</location>
</feature>
<feature type="chain" description="Toll-like receptor 1" id="PRO_0000034706">
<location>
<begin position="26"/>
<end position="795"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="3">
<location>
<begin position="26"/>
<end position="582"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="3">
<location>
<begin position="583"/>
<end position="603"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="3">
<location>
<begin position="604"/>
<end position="795"/>
</location>
</feature>
<feature type="repeat" description="LRR 1">
<location>
<begin position="54"/>
<end position="77"/>
</location>
</feature>
<feature type="repeat" description="LRR 2">
<location>
<begin position="78"/>
<end position="101"/>
</location>
</feature>
<feature type="repeat" description="LRR 3">
<location>
<begin position="102"/>
<end position="125"/>
</location>
</feature>
<feature type="repeat" description="LRR 4">
<location>
<begin position="126"/>
<end position="150"/>
</location>
</feature>
<feature type="repeat" description="LRR 5">
<location>
<begin position="151"/>
<end position="175"/>
</location>
</feature>
<feature type="repeat" description="LRR 6">
<location>
<begin position="176"/>
<end position="199"/>
</location>
</feature>
<feature type="repeat" description="LRR 7">
<location>
<begin position="200"/>
<end position="223"/>
</location>
</feature>
<feature type="repeat" description="LRR 8">
<location>
<begin position="224"/>
<end position="250"/>
</location>
</feature>
<feature type="repeat" description="LRR 9">
<location>
<begin position="251"/>
<end position="278"/>
</location>
</feature>
<feature type="repeat" description="LRR 10">
<location>
<begin position="279"/>
<end position="308"/>
</location>
</feature>
<feature type="repeat" description="LRR 11">
<location>
<begin position="309"/>
<end position="337"/>
</location>
</feature>
<feature type="repeat" description="LRR 12">
<location>
<begin position="338"/>
<end position="361"/>
</location>
</feature>
<feature type="repeat" description="LRR 13">
<location>
<begin position="362"/>
<end position="388"/>
</location>
</feature>
<feature type="repeat" description="LRR 14">
<location>
<begin position="389"/>
<end position="414"/>
</location>
</feature>
<feature type="repeat" description="LRR 15">
<location>
<begin position="415"/>
<end position="437"/>
</location>
</feature>
<feature type="repeat" description="LRR 16">
<location>
<begin position="438"/>
<end position="457"/>
</location>
</feature>
<feature type="repeat" description="LRR 17">
<location>
<begin position="458"/>
<end position="478"/>
</location>
</feature>
<feature type="repeat" description="LRR 18">
<location>
<begin position="479"/>
<end position="500"/>
</location>
</feature>
<feature type="repeat" description="LRR 19">
<location>
<begin position="501"/>
<end position="524"/>
</location>
</feature>
<feature type="domain" description="LRRCT">
<location>
<begin position="524"/>
<end position="579"/>
</location>
</feature>
<feature type="domain" description="TIR" evidence="4">
<location>
<begin position="638"/>
<end position="779"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with bacterial lipopeptide" evidence="1">
<location>
<begin position="316"/>
<end position="319"/>
</location>
</feature>
<feature type="active site" evidence="4">
<location>
<position position="713"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="3">
<location>
<position position="38"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="3">
<location>
<position position="59"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="3">
<location>
<position position="88"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="3">
<location>
<position position="140"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="3">
<location>
<position position="166"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="3">
<location>
<position position="251"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="3">
<location>
<position position="296"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="3">
<location>
<position position="333"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="3">
<location>
<position position="432"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1">
<location>
<begin position="113"/>
<end position="135"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1">
<location>
<begin position="226"/>
<end position="233"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1">
<location>
<begin position="346"/>
<end position="371"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1">
<location>
<begin position="422"/>
<end position="445"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; AAG35062." ref="3" evidence="8">
<original>N</original>
<variation>D</variation>
<location>
<position position="88"/>
</location>
</feature>
<evidence key="1" type="ECO:0000250"/>
<evidence key="2" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q15399"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000255"/>
<evidence key="4" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00204"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11095740"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17998391"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19362712"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000305"/>
<sequence length="795" mass="90673" checksum="855356429872D232" modified="2001-03-01" version="1" precursor="true">MTKPNSLIFYCIIVLGLTLMKIQLSEECELIIKRPNANLTRVPKDLPLQTTTLDLSQNNISELQTSDILSLSKLRVLIMSYNRLQYLNISVFKFNTELEYLDLSHNELKVILCHPTVSLKHLDLSFNAFDALPICKEFGNMSQLQFLGLSGSRVQSSSVQLIAHLNISKVLLVLGDAYGEKEDPESLRHVSTETLHIVFPSKREFRFLLDVSVSTTIGLELSNIKCVLEDQGCSYFLRALSKLGKNLKLSNLTLNNVETTWNSFINILQIVWHTPVKYFSISNVKLQGQLAFRMFNYSDTSLKALSIHQVVTDVFSFPQSYIYSIFANMNIQNFTMSGTHMVHMLCPSQVSPFLHVDFTDNLLTDMVFKDCRNLVRLKTLSLQKNQLKNLENIILTSAKMTSLQKLDISQNSLRYSDGGIPCAWTQSLLVLNLSSNMLTGSVFRCLPPKVKVLDLHNNRIMSIPKDVTHLQALQELNVASNSLTDLPGCGAFSSLSVLVIDHNSVSHPSEDFFQSCQNIRSLTAGNNPFQCTCELRDFVKNIGWVAREVVEGWPDSYRCDYPESSRGTALRDFHMSPLSCDTVLLTVTIGATMLVLAVTGAFLCLYFDLPWYVRMLCQWTQTRHRARHIPLEELQRNLQFHAFVSYSGHDSAWVKNELLPNLEKDDIQICLHERNFVPGKSIVENIINFIEKSYKSIFVLSPHFIQSEWCHYELYFAHHNLFHEGSDNLILILLAPIPQYSIPTNYHKLKTLMSRRTYLEWPTEKNKHGLFWANLRASINVKLVNQAEGTCYTQQ</sequence>
</entry>
<entry dataset="Swiss-Prot" created="2002-01-31" modified="2021-02-10" version="205">
<accession>Q15399</accession>
<accession>D1CS39</accession>
<accession>D1CS41</accession>
<accession>O15452</accession>
<accession>Q32MK3</accession>
<accession>Q32MK4</accession>
<accession>Q9UG90</accession>
<name>TLR1_HUMAN</name>
<protein>
<recommendedName>
<fullName>Toll-like receptor 1</fullName>
<ecNumber evidence="6">3.2.2.6</ecNumber>
</recommendedName>
<alternativeName>
<fullName>Toll/interleukin-1 receptor-like protein</fullName>
<shortName>TIL</shortName>
</alternativeName>
<cdAntigenName>CD281</cdAntigenName>
</protein>
<gene>
<name type="primary">TLR1</name>
<name type="synonym">KIAA0012</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1998" name="Proc. Natl. Acad. Sci. U.S.A." volume="95" first="588" last="593">
<title>A family of human receptors structurally related to Drosophila Toll.</title>
<authorList>
<person name="Rock F.L."/>
<person name="Hardiman G."/>
<person name="Timans J.C."/>
<person name="Kastelein R.A."/>
<person name="Bazan J.F."/>
</authorList>
<dbReference type="PubMed" id="9435236"/>
<dbReference type="DOI" id="10.1073/pnas.95.2.588"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>VARIANTS SER-248 AND ILE-602</scope>
<source>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="2008" name="Immunogenetics" volume="60" first="727" last="735">
<title>Natural selection in the TLR-related genes in the course of primate evolution.</title>
<authorList>
<person name="Nakajima T."/>
<person name="Ohtani H."/>
<person name="Satta Y."/>
<person name="Uno Y."/>
<person name="Akari H."/>
<person name="Ishida T."/>
<person name="Kimura A."/>
</authorList>
<dbReference type="PubMed" id="18810425"/>
<dbReference type="DOI" id="10.1007/s00251-008-0332-0"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
</reference>
<reference key="3">
<citation type="journal article" date="2009" name="PLoS ONE" volume="4" first="E7803" last="E7803">
<title>The heterogeneous allelic repertoire of human Toll-Like receptor (TLR) genes.</title>
<authorList>
<person name="Georgel P."/>
<person name="Macquin C."/>
<person name="Bahram S."/>
</authorList>
<dbReference type="PubMed" id="19924287"/>
<dbReference type="DOI" id="10.1371/journal.pone.0007803"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>VARIANTS THR-80 AND ILE-602</scope>
</reference>
<reference key="4">
<citation type="journal article" date="1994" name="DNA Res." volume="1" first="27" last="35">
<title>Prediction of the coding sequences of unidentified human genes. I. The coding sequences of 40 new genes (KIAA0001-KIAA0040) deduced by analysis of randomly sampled cDNA clones from human immature myeloid cell line KG-1.</title>
<authorList>
<person name="Nomura N."/>
<person name="Miyajima N."/>
<person name="Sazuka T."/>
<person name="Tanaka A."/>
<person name="Kawarabayasi Y."/>
<person name="Sato S."/>
<person name="Nagase T."/>
<person name="Seki N."/>
<person name="Ishikawa K."/>
<person name="Tabata S."/>
</authorList>
<dbReference type="PubMed" id="7584026"/>
<dbReference type="DOI" id="10.1093/dnares/1.1.27"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<scope>VARIANT THR-80</scope>
<source>
<tissue>Bone marrow</tissue>
</source>
</reference>
<reference key="5">
<citation type="journal article" date="2001" name="Genome Res." volume="11" first="422" last="435">
<title>Towards a catalog of human genes and proteins: sequencing and analysis of 500 novel complete protein coding human cDNAs.</title>
<authorList>
<person name="Wiemann S."/>
<person name="Weil B."/>
<person name="Wellenreuther R."/>
<person name="Gassenhuber J."/>
<person name="Glassl S."/>
<person name="Ansorge W."/>
<person name="Boecher M."/>
<person name="Bloecker H."/>
<person name="Bauersachs S."/>
<person name="Blum H."/>
<person name="Lauber J."/>
<person name="Duesterhoeft A."/>
<person name="Beyer A."/>
<person name="Koehrer K."/>
<person name="Strack N."/>
<person name="Mewes H.-W."/>
<person name="Ottenwaelder B."/>
<person name="Obermaier B."/>
<person name="Tampe J."/>
<person name="Heubner D."/>
<person name="Wambutt R."/>
<person name="Korn B."/>
<person name="Klein M."/>
<person name="Poustka A."/>
</authorList>
<dbReference type="PubMed" id="11230166"/>
<dbReference type="DOI" id="10.1101/gr.gr1547r"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<scope>VARIANTS SER-248 AND ILE-602</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="6">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<scope>VARIANTS SER-248 AND ILE-602</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2004" name="Protein Sci." volume="13" first="2819" last="2824">
<title>Signal peptide prediction based on analysis of experimentally verified cleavage sites.</title>
<authorList>
<person name="Zhang Z."/>
<person name="Henzel W.J."/>
</authorList>
<dbReference type="PubMed" id="15340161"/>
<dbReference type="DOI" id="10.1110/ps.04682504"/>
</citation>
<scope>PROTEIN SEQUENCE OF 25-39</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2006" name="J. Biol. Chem." volume="281" first="31002" last="31011">
<title>Membrane sorting of toll-like receptor (TLR)-2/6 and TLR2/1 heterodimers at the cell surface determines heterotypic associations with CD36 and intracellular targeting.</title>
<authorList>
<person name="Triantafilou M."/>
<person name="Gamper F.G."/>
<person name="Haston R.M."/>
<person name="Mouratis M.A."/>
<person name="Morath S."/>
<person name="Hartung T."/>
<person name="Triantafilou K."/>
</authorList>
<dbReference type="PubMed" id="16880211"/>
<dbReference type="DOI" id="10.1074/jbc.m602794200"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH TLR2 AND CD14</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2007" name="J. Immunol." volume="178" first="7520" last="7524">
<title>Cutting edge: A common polymorphism impairs cell surface trafficking and functional responses of TLR1 but protects against leprosy.</title>
<authorList>
<person name="Johnson C.M."/>
<person name="Lyle E.A."/>
<person name="Omueti K.O."/>
<person name="Stepensky V.A."/>
<person name="Yegin O."/>
<person name="Alpsoy E."/>
<person name="Hamann L."/>
<person name="Schumann R.R."/>
<person name="Tapping R.I."/>
</authorList>
<dbReference type="PubMed" id="17548585"/>
<dbReference type="DOI" id="10.4049/jimmunol.178.12.7520"/>
</citation>
<scope>INVOLVEMENT IN PROTECTION AGAINST LEPROSY</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2009" name="J. Proteome Res." volume="8" first="651" last="661">
<title>Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry.</title>
<authorList>
<person name="Chen R."/>
<person name="Jiang X."/>
<person name="Sun D."/>
<person name="Han G."/>
<person name="Wang F."/>
<person name="Ye M."/>
<person name="Wang L."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="19159218"/>
<dbReference type="DOI" id="10.1021/pr8008012"/>
</citation>
<scope>GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-163</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="11">
<citation type="journal article" date="2011" name="Infect. Immun." volume="79" first="663" last="673">
<title>Mycobacterium tuberculosis lipoproteins directly regulate human memory CD4(+) T cell activation via Toll-like receptors 1 and 2.</title>
<authorList>
<person name="Lancioni C.L."/>
<person name="Li Q."/>
<person name="Thomas J.J."/>
<person name="Ding X."/>
<person name="Thiel B."/>
<person name="Drage M.G."/>
<person name="Pecora N.D."/>
<person name="Ziady A.G."/>
<person name="Shank S."/>
<person name="Harding C.V."/>
<person name="Boom W.H."/>
<person name="Rojas R.E."/>
</authorList>
<dbReference type="PubMed" id="21078852"/>
<dbReference type="DOI" id="10.1128/iai.00806-10"/>
</citation>
<scope>FUNCTION</scope>
<source>
<tissue>T-cell</tissue>
</source>
</reference>
<reference key="12">
<citation type="journal article" date="2000" name="Nature" volume="408" first="111" last="115">
<title>Structural basis for signal transduction by the Toll/interleukin-1 receptor domains.</title>
<authorList>
<person name="Xu Y."/>
<person name="Tao X."/>
<person name="Shen B."/>
<person name="Horng T."/>
<person name="Medzhitov R."/>
<person name="Manley J.L."/>
<person name="Tong L."/>
</authorList>
<dbReference type="PubMed" id="11081518"/>
<dbReference type="DOI" id="10.1038/35040600"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.9 ANGSTROMS) OF 625-785</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2007" name="Cell" volume="130" first="1071" last="1082">
<title>Crystal structure of the TLR1-TLR2 heterodimer induced by binding of a tri-acylated lipopeptide.</title>
<authorList>
<person name="Jin M.S."/>
<person name="Kim S.E."/>
<person name="Heo J.Y."/>
<person name="Lee M.E."/>
<person name="Kim H.M."/>
<person name="Paik S.-G."/>
<person name="Lee H."/>
<person name="Lee J.-O."/>
</authorList>
<dbReference type="PubMed" id="17889651"/>
<dbReference type="DOI" id="10.1016/j.cell.2007.09.008"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF 25-476 IN COMPLEX WITH TLR2 AND BACTERIAL LIPOPEPTIDE ANALOG</scope>
<scope>DISULFIDE BONDS</scope>
<scope>GLYCOSYLATION AT ASN-51; ASN-163; ASN-330 AND ASN-429</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2009" name="J. Infect. Dis." volume="199" first="1816" last="1819">
<title>Polymorphism N248S in the human Toll-like receptor 1 gene is related to leprosy and leprosy reactions.</title>
<authorList>
<person name="Schuring R.P."/>
<person name="Hamann L."/>
<person name="Faber W.R."/>
<person name="Pahan D."/>
<person name="Richardus J.H."/>
<person name="Schumann R.R."/>
<person name="Oskam L."/>
</authorList>
<dbReference type="PubMed" id="19456232"/>
<dbReference type="DOI" id="10.1086/599121"/>
</citation>
<scope>ASSOCIATION OF VARIANT SER-248 WITH SUSCEPTIBILITY TO LEPROSY</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2011" name="Hum. Mutat." volume="32" first="643" last="652">
<title>Functional characterization of naturally occurring genetic variants in the human TLR1-2-6 gene family.</title>
<authorList>
<person name="Ben-Ali M."/>
<person name="Corre B."/>
<person name="Manry J."/>
<person name="Barreiro L.B."/>
<person name="Quach H."/>
<person name="Boniotto M."/>
<person name="Pellegrini S."/>
<person name="Quintana-Murci L."/>
</authorList>
<dbReference type="PubMed" id="21618349"/>
<dbReference type="DOI" id="10.1002/humu.21486"/>
</citation>
<scope>VARIANTS PRO-44; THR-75; THR-80; TYR-118; SER-248; LEU-305; LEU-315; ASN-352; VAL-460; ALA-542; CYS-554; GLY-587; ILE-602; ALA-651; ALA-674; PRO-720 AND LEU-733</scope>
<scope>CHARACTERIZATION OF VARIANTS LEU-315; CYS-554; ILE-602; ALA-651 AND PRO-720</scope>
</reference>
<comment type="function">
<text evidence="10 14">Participates in the innate immune response to microbial agents. Specifically recognizes diacylated and triacylated lipopeptides. Cooperates with TLR2 to mediate the innate immune response to bacterial lipoproteins or lipopeptides (PubMed:21078852). Forms the activation cluster TLR2:TLR1:CD14 in response to triacylated lipopeptides, this cluster triggers signaling from the cell surface and subsequently is targeted to the Golgi in a lipid-raft dependent pathway (PubMed:16880211). Acts via MYD88 and TRAF6, leading to NF-kappa-B activation, cytokine secretion and the inflammatory response.</text>
</comment>
<comment type="catalytic activity">
<reaction evidence="6">
<text>H2O + NAD(+) = ADP-D-ribose + H(+) + nicotinamide</text>
<dbReference type="Rhea" id="RHEA:16301"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:17154"/>
<dbReference type="ChEBI" id="CHEBI:57540"/>
<dbReference type="ChEBI" id="CHEBI:57967"/>
<dbReference type="EC" id="3.2.2.6"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="6">
<dbReference type="Rhea" id="RHEA:16302"/>
</physiologicalReaction>
</comment>
<comment type="subunit">
<text evidence="4 10 11">Interacts (via extracellular domain) with TLR2. TLR2 seems to exist in heterodimers with either TLR1 or TLR6 before stimulation by the ligand. The heterodimers form bigger oligomers in response to their corresponding ligands as well as further heterotypic associations with other receptors such as CD14 and/or CD36 (PubMed:16880211, PubMed:17889651). The activation cluster TLR2:TLR1:CD14 forms in response to triacylated lipopeptides (PubMed:16880211). Binds MYD88 (via TIR domain). Interacts with CNPY3 (By similarity).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-9009517">
<id>Q15399</id>
</interactant>
<interactant intactId="EBI-9009517">
<id>Q15399</id>
<label>TLR1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-9009517">
<id>Q15399</id>
</interactant>
<interactant intactId="EBI-16825459">
<id>Q9BXR5</id>
<label>TLR10</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-9009517">
<id>Q15399</id>
</interactant>
<interactant intactId="EBI-973722">
<id>O60603</id>
<label>TLR2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="10">Cell membrane</location>
<topology evidence="5">Single-pass type I membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="4">Cytoplasmic vesicle</location>
<location evidence="4">Phagosome membrane</location>
<topology evidence="5">Single-pass type I membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="10">Membrane raft</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="10">Golgi apparatus</location>
</subcellularLocation>
<text evidence="10">Does not reside in lipid rafts before stimulation but accumulates increasingly in the raft upon the presence of the microbial ligand. In response to triacylated lipoproteins, TLR2:TLR1 heterodimers are recruited in lipid rafts, this recruitment determine the intracellular targeting to the Golgi apparatus.</text>
</comment>
<comment type="tissue specificity">
<text>Ubiquitous. Highly expressed in spleen, ovary, peripheral blood leukocytes, thymus and small intestine.</text>
</comment>
<comment type="domain">
<text evidence="6">The TIR domain mediates NAD(+) hydrolase (NADase) activity. Self-association of TIR domains is required for NADase activity.</text>
</comment>
<comment type="polymorphism">
<text>Genetic variations in TLR1 may influence susceptibility to or protection against contracting leprosy and define the leprosy susceptibility locus 5 [MIM:613223]. Ser-602 is a common allele in Caucasians. It is associated with impaired cell surface expression and receptor function resulting in protection against leprosy.</text>
</comment>
<comment type="similarity">
<text evidence="18">Belongs to the Toll-like receptor family.</text>
</comment>
<comment type="sequence caution" evidence="18">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="BAA02801" version="2"/>
</conflict>
<text>Extended N-terminus.</text>
</comment>
<dbReference type="EC" id="3.2.2.6" evidence="6"/>
<dbReference type="EMBL" id="U88540">
<property type="protein sequence ID" value="AAC34137.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB445617">
<property type="protein sequence ID" value="BAG55014.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="DQ012259">
<property type="protein sequence ID" value="AAY85638.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="DQ012260">
<property type="protein sequence ID" value="AAY85639.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="DQ012261">
<property type="protein sequence ID" value="AAY85640.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="D13637">
<property type="protein sequence ID" value="BAA02801.2"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AL050262">
<property type="protein sequence ID" value="CAB43364.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC109093">
<property type="protein sequence ID" value="AAI09094.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC109094">
<property type="protein sequence ID" value="AAI09095.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS33973.1"/>
<dbReference type="PIR" id="T08664">
<property type="entry name" value="T08664"/>
</dbReference>
<dbReference type="RefSeq" id="NP_003254.2">
<property type="nucleotide sequence ID" value="NM_003263.3"/>
</dbReference>
<dbReference type="RefSeq" id="XP_005262719.1">
<property type="nucleotide sequence ID" value="XM_005262662.4"/>
</dbReference>
<dbReference type="RefSeq" id="XP_011512044.1">
<property type="nucleotide sequence ID" value="XM_011513742.2"/>
</dbReference>
<dbReference type="RefSeq" id="XP_011512045.1">
<property type="nucleotide sequence ID" value="XM_011513743.2"/>
</dbReference>
<dbReference type="RefSeq" id="XP_011512046.1">
<property type="nucleotide sequence ID" value="XM_011513744.2"/>
</dbReference>
<dbReference type="RefSeq" id="XP_011512047.1">
<property type="nucleotide sequence ID" value="XM_011513745.2"/>
</dbReference>
<dbReference type="RefSeq" id="XP_016864060.1">
<property type="nucleotide sequence ID" value="XM_017008571.1"/>
</dbReference>
<dbReference type="RefSeq" id="XP_016864061.1">
<property type="nucleotide sequence ID" value="XM_017008572.1"/>
</dbReference>
<dbReference type="PDB" id="1FYV">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.90"/>
<property type="chains" value="A=625-785"/>
</dbReference>
<dbReference type="PDB" id="2Z7X">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="B=25-475"/>
</dbReference>
<dbReference type="PDB" id="6NIH">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="A/B=1-475"/>
</dbReference>
<dbReference type="PDBsum" id="1FYV"/>
<dbReference type="PDBsum" id="2Z7X"/>
<dbReference type="PDBsum" id="6NIH"/>
<dbReference type="SMR" id="Q15399"/>
<dbReference type="BioGRID" id="112951">
<property type="interactions" value="13"/>
</dbReference>
<dbReference type="CORUM" id="Q15399"/>
<dbReference type="IntAct" id="Q15399">
<property type="interactions" value="6"/>
</dbReference>
<dbReference type="STRING" id="9606.ENSP00000354932"/>
<dbReference type="BindingDB" id="Q15399"/>
<dbReference type="ChEMBL" id="CHEMBL3885643"/>
<dbReference type="GlyGen" id="Q15399">
<property type="glycosylation" value="6 sites"/>
</dbReference>
<dbReference type="iPTMnet" id="Q15399"/>
<dbReference type="PhosphoSitePlus" id="Q15399"/>
<dbReference type="BioMuta" id="TLR1"/>
<dbReference type="DMDM" id="146291086"/>
<dbReference type="EPD" id="Q15399"/>
<dbReference type="jPOST" id="Q15399"/>
<dbReference type="MassIVE" id="Q15399"/>
<dbReference type="PaxDb" id="Q15399"/>
<dbReference type="PeptideAtlas" id="Q15399"/>
<dbReference type="PRIDE" id="Q15399"/>
<dbReference type="ProteomicsDB" id="60569"/>
<dbReference type="Antibodypedia" id="10459">
<property type="antibodies" value="647 antibodies"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000308979">
<property type="protein sequence ID" value="ENSP00000354932"/>
<property type="gene ID" value="ENSG00000174125"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000502213">
<property type="protein sequence ID" value="ENSP00000421259"/>
<property type="gene ID" value="ENSG00000174125"/>
</dbReference>
<dbReference type="GeneID" id="7096"/>
<dbReference type="KEGG" id="hsa:7096"/>
<dbReference type="UCSC" id="uc003gtl.4">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="7096"/>
<dbReference type="DisGeNET" id="7096"/>
<dbReference type="GeneCards" id="TLR1"/>
<dbReference type="HGNC" id="HGNC:11847">
<property type="gene designation" value="TLR1"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000174125">
<property type="expression patterns" value="Tissue enhanced (blood, lymphoid tissue)"/>
</dbReference>
<dbReference type="MalaCards" id="TLR1"/>
<dbReference type="MIM" id="601194">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="613223">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q15399"/>
<dbReference type="OpenTargets" id="ENSG00000174125"/>
<dbReference type="PharmGKB" id="PA36549"/>
<dbReference type="VEuPathDB" id="HostDB:ENSG00000174125.7"/>
<dbReference type="eggNOG" id="KOG4641">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000162884"/>
<dbReference type="HOGENOM" id="CLU_006000_3_0_1"/>
<dbReference type="InParanoid" id="Q15399"/>
<dbReference type="OMA" id="NNIETTW"/>
<dbReference type="OrthoDB" id="282372at2759"/>
<dbReference type="PhylomeDB" id="Q15399"/>
<dbReference type="TreeFam" id="TF351113"/>
<dbReference type="PathwayCommons" id="Q15399"/>
<dbReference type="Reactome" id="R-HSA-1236974">
<property type="pathway name" value="ER-Phagosome pathway"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1461957">
<property type="pathway name" value="Beta defensins"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-166058">
<property type="pathway name" value="MyD88:MAL(TIRAP) cascade initiated on plasma membrane"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-168179">
<property type="pathway name" value="Toll Like Receptor TLR1:TLR2 Cascade"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5602498">
<property type="pathway name" value="MyD88 deficiency (TLR2/4)"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5603041">
<property type="pathway name" value="IRAK4 deficiency (TLR2/4)"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5686938">
<property type="pathway name" value="Regulation of TLR by endogenous ligand"/>
</dbReference>
<dbReference type="BioGRID-ORCS" id="7096">
<property type="hits" value="4 hits in 876 CRISPR screens"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="Q15399"/>
<dbReference type="GeneWiki" id="TLR_1"/>
<dbReference type="GenomeRNAi" id="7096"/>
<dbReference type="Pharos" id="Q15399">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:Q15399"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 4"/>
</dbReference>
<dbReference type="RNAct" id="Q15399">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000174125">
<property type="expression patterns" value="Expressed in blood and 175 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="Q15399">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q15399">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005794">
<property type="term" value="C:Golgi apparatus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005887">
<property type="term" value="C:integral component of plasma membrane"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0016020">
<property type="term" value="C:membrane"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045121">
<property type="term" value="C:membrane raft"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030670">
<property type="term" value="C:phagocytic vesicle membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0035354">
<property type="term" value="C:Toll-like receptor 1-Toll-like receptor 2 protein complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0042802">
<property type="term" value="F:identical protein binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="IntAct"/>
</dbReference>
<dbReference type="GO" id="GO:0071723">
<property type="term" value="F:lipopeptide binding"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0050135">
<property type="term" value="F:NAD(P)+ nucleosidase activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0061809">
<property type="term" value="F:NAD+ nucleotidase, cyclic ADP-ribose generating"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0038023">
<property type="term" value="F:signaling receptor activity"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0035663">
<property type="term" value="F:Toll-like receptor 2 binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004888">
<property type="term" value="F:transmembrane signaling receptor activity"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001775">
<property type="term" value="P:cell activation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="AgBase"/>
</dbReference>
<dbReference type="GO" id="GO:0071221">
<property type="term" value="P:cellular response to bacterial lipopeptide"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0071727">
<property type="term" value="P:cellular response to triacyl bacterial lipopeptide"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042495">
<property type="term" value="P:detection of triacyl bacterial lipopeptide"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0006955">
<property type="term" value="P:immune response"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0006954">
<property type="term" value="P:inflammatory response"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0045087">
<property type="term" value="P:innate immune response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0042116">
<property type="term" value="P:macrophage activation"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001774">
<property type="term" value="P:microglial cell activation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0002755">
<property type="term" value="P:MyD88-dependent toll-like receptor signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0032755">
<property type="term" value="P:positive regulation of interleukin-6 production"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032757">
<property type="term" value="P:positive regulation of interleukin-8 production"/>
<property type="evidence" value="ECO:0000316"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0034137">
<property type="term" value="P:positive regulation of toll-like receptor 2 signaling pathway"/>
<property type="evidence" value="ECO:0000316"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032760">
<property type="term" value="P:positive regulation of tumor necrosis factor production"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007165">
<property type="term" value="P:signal transduction"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0034130">
<property type="term" value="P:toll-like receptor 1 signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0002224">
<property type="term" value="P:toll-like receptor signaling pathway"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0038123">
<property type="term" value="P:toll-like receptor TLR1:TLR2 signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="Gene3D" id="3.40.50.10140">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="3.80.10.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR000483">
<property type="entry name" value="Cys-rich_flank_reg_C"/>
</dbReference>
<dbReference type="InterPro" id="IPR001611">
<property type="entry name" value="Leu-rich_rpt"/>
</dbReference>
<dbReference type="InterPro" id="IPR003591">
<property type="entry name" value="Leu-rich_rpt_typical-subtyp"/>
</dbReference>
<dbReference type="InterPro" id="IPR032675">
<property type="entry name" value="LRR_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR000157">
<property type="entry name" value="TIR_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR027190">
<property type="entry name" value="TLR1"/>
</dbReference>
<dbReference type="InterPro" id="IPR017241">
<property type="entry name" value="Toll-like_receptor"/>
</dbReference>
<dbReference type="InterPro" id="IPR035897">
<property type="entry name" value="Toll_tir_struct_dom_sf"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR24365">
<property type="entry name" value="PTHR24365"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR24365:SF261">
<property type="entry name" value="PTHR24365:SF261"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF13855">
<property type="entry name" value="LRR_8"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="Pfam" id="PF01463">
<property type="entry name" value="LRRCT"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF01582">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PIRSF" id="PIRSF037595">
<property type="entry name" value="Toll-like_receptor"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00369">
<property type="entry name" value="LRR_TYP"/>
<property type="match status" value="4"/>
</dbReference>
<dbReference type="SMART" id="SM00082">
<property type="entry name" value="LRRCT"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00255">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF52200">
<property type="entry name" value="SSF52200"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51450">
<property type="entry name" value="LRR"/>
<property type="match status" value="10"/>
</dbReference>
<dbReference type="PROSITE" id="PS50104">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-0968">Cytoplasmic vesicle</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0333">Golgi apparatus</keyword>
<keyword id="KW-0378">Hydrolase</keyword>
<keyword id="KW-0391">Immunity</keyword>
<keyword id="KW-0395">Inflammatory response</keyword>
<keyword id="KW-0399">Innate immunity</keyword>
<keyword id="KW-0433">Leucine-rich repeat</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0520">NAD</keyword>
<keyword id="KW-0675">Receptor</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0732">Signal</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<feature type="signal peptide" evidence="8">
<location>
<begin position="1"/>
<end position="24"/>
</location>
</feature>
<feature type="chain" description="Toll-like receptor 1" id="PRO_0000034705">
<location>
<begin position="25"/>
<end position="786"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="5">
<location>
<begin position="25"/>
<end position="580"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="5">
<location>
<begin position="581"/>
<end position="601"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="5">
<location>
<begin position="602"/>
<end position="786"/>
</location>
</feature>
<feature type="repeat" description="LRR 1">
<location>
<begin position="54"/>
<end position="77"/>
</location>
</feature>
<feature type="repeat" description="LRR 2">
<location>
<begin position="78"/>
<end position="101"/>
</location>
</feature>
<feature type="repeat" description="LRR 3">
<location>
<begin position="102"/>
<end position="125"/>
</location>
</feature>
<feature type="repeat" description="LRR 4">
<location>
<begin position="126"/>
<end position="150"/>
</location>
</feature>
<feature type="repeat" description="LRR 5">
<location>
<begin position="151"/>
<end position="175"/>
</location>
</feature>
<feature type="repeat" description="LRR 6">
<location>
<begin position="176"/>
<end position="199"/>
</location>
</feature>
<feature type="repeat" description="LRR 7">
<location>
<begin position="200"/>
<end position="223"/>
</location>
</feature>
<feature type="repeat" description="LRR 8">
<location>
<begin position="224"/>
<end position="250"/>
</location>
</feature>
<feature type="repeat" description="LRR 9">
<location>
<begin position="251"/>
<end position="278"/>
</location>
</feature>
<feature type="repeat" description="LRR 10">
<location>
<begin position="279"/>
<end position="308"/>
</location>
</feature>
<feature type="repeat" description="LRR 11">
<location>
<begin position="309"/>
<end position="337"/>
</location>
</feature>
<feature type="repeat" description="LRR 12">
<location>
<begin position="338"/>
<end position="361"/>
</location>
</feature>
<feature type="repeat" description="LRR 13">
<location>
<begin position="362"/>
<end position="388"/>
</location>
</feature>
<feature type="repeat" description="LRR 14">
<location>
<begin position="389"/>
<end position="414"/>
</location>
</feature>
<feature type="repeat" description="LRR 15">
<location>
<begin position="415"/>
<end position="437"/>
</location>
</feature>
<feature type="repeat" description="LRR 16">
<location>
<begin position="438"/>
<end position="457"/>
</location>
</feature>
<feature type="repeat" description="LRR 17">
<location>
<begin position="458"/>
<end position="478"/>
</location>
</feature>
<feature type="repeat" description="LRR 18">
<location>
<begin position="479"/>
<end position="500"/>
</location>
</feature>
<feature type="repeat" description="LRR 19">
<location>
<begin position="501"/>
<end position="524"/>
</location>
</feature>
<feature type="domain" description="LRRCT">
<location>
<begin position="525"/>
<end position="579"/>
</location>
</feature>
<feature type="domain" description="TIR" evidence="6">
<location>
<begin position="635"/>
<end position="776"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with bacterial lipopeptide">
<location>
<begin position="313"/>
<end position="316"/>
</location>
</feature>
<feature type="active site" evidence="6">
<location>
<position position="710"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="11">
<location>
<position position="51"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="5">
<location>
<position position="137"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="11 12">
<location>
<position position="163"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="11">
<location>
<position position="330"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="11">
<location>
<position position="429"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="5">
<location>
<position position="578"/>
</location>
</feature>
<feature type="disulfide bond" evidence="11">
<location>
<begin position="110"/>
<end position="132"/>
</location>
</feature>
<feature type="disulfide bond" evidence="11">
<location>
<begin position="223"/>
<end position="230"/>
</location>
</feature>
<feature type="disulfide bond" evidence="11">
<location>
<begin position="343"/>
<end position="368"/>
</location>
</feature>
<feature type="disulfide bond" evidence="11">
<location>
<begin position="419"/>
<end position="442"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs76600635." id="VAR_066340" evidence="15">
<original>S</original>
<variation>P</variation>
<location>
<position position="44"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs137853170." id="VAR_066341" evidence="15">
<original>I</original>
<variation>T</variation>
<location>
<position position="75"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs5743611." id="VAR_031916" evidence="13 15 16">
<original>R</original>
<variation>T</variation>
<location>
<position position="80"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs5743612." id="VAR_018474" evidence="15">
<original>H</original>
<variation>Y</variation>
<location>
<position position="118"/>
</location>
</feature>
<feature type="sequence variant" description="May confer susceptibility to leprosy; dbSNP:rs4833095." id="VAR_031917" evidence="7 9 15 17">
<original>N</original>
<variation>S</variation>
<location>
<position position="248"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs3923647." id="VAR_031918" evidence="15">
<original>H</original>
<variation>L</variation>
<location>
<position position="305"/>
</location>
</feature>
<feature type="sequence variant" description="Severe impairment of activity; dbSNP:rs5743613." id="VAR_031919" evidence="15">
<original>P</original>
<variation>L</variation>
<location>
<position position="315"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs76796448." id="VAR_066342" evidence="15">
<original>H</original>
<variation>N</variation>
<location>
<position position="352"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs137853171." id="VAR_066343" evidence="15">
<original>I</original>
<variation>V</variation>
<location>
<position position="460"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs137853172." id="VAR_066344" evidence="15">
<original>V</original>
<variation>A</variation>
<location>
<position position="542"/>
</location>
</feature>
<feature type="sequence variant" description="Severe impairment of activity; dbSNP:rs137853173." id="VAR_066345" evidence="15">
<original>Y</original>
<variation>C</variation>
<location>
<position position="554"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs5743617." id="VAR_031920" evidence="15">
<original>V</original>
<variation>G</variation>
<location>
<position position="587"/>
</location>
</feature>
<feature type="sequence variant" description="Severe impairment of activity; dbSNP:rs5743618." id="VAR_031921" evidence="7 9 13 15 17">
<original>S</original>
<variation>I</variation>
<location>
<position position="602"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs5743619." id="VAR_052358">
<original>L</original>
<variation>R</variation>
<location>
<position position="631"/>
</location>
</feature>
<feature type="sequence variant" description="Severe impairment of activity; dbSNP:rs137853174." id="VAR_066346" evidence="15">
<original>V</original>
<variation>A</variation>
<location>
<position position="651"/>
</location>
</feature>
<feature type="sequence variant" id="VAR_066347" evidence="15">
<original>V</original>
<variation>A</variation>
<location>
<position position="674"/>
</location>
</feature>
<feature type="sequence variant" description="Severe impairment of activity; dbSNP:rs113706342." id="VAR_066348" evidence="15">
<original>H</original>
<variation>P</variation>
<location>
<position position="720"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs5743621." id="VAR_052359" evidence="15">
<original>P</original>
<variation>L</variation>
<location>
<position position="733"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 5; CAB43364." ref="5" evidence="18">
<original>E</original>
<variation>G</variation>
<location>
<position position="182"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 5; CAB43364." ref="5" evidence="18">
<original>N</original>
<variation>S</variation>
<location>
<position position="228"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 5; CAB43364." ref="5" evidence="18">
<original>F</original>
<variation>S</variation>
<location>
<position position="276"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="28"/>
<end position="30"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="48"/>
<end position="51"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="62"/>
<end position="65"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="73"/>
<end position="75"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="83"/>
<end position="85"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="86"/>
<end position="89"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="97"/>
<end position="99"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="107"/>
<end position="109"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="117"/>
<end position="120"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="133"/>
<end position="137"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="143"/>
<end position="150"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="153"/>
<end position="159"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="164"/>
<end position="171"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="173"/>
<end position="178"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="181"/>
<end position="184"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="189"/>
<end position="195"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="198"/>
<end position="200"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="214"/>
<end position="218"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="221"/>
<end position="223"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="227"/>
<end position="230"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="231"/>
<end position="238"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="239"/>
<end position="242"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="248"/>
<end position="257"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="258"/>
<end position="269"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="274"/>
<end position="285"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="301"/>
<end position="309"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="317"/>
<end position="324"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="329"/>
<end position="336"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="352"/>
<end position="354"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="362"/>
<end position="367"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="376"/>
<end position="378"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="387"/>
<end position="394"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="402"/>
<end position="404"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="414"/>
<end position="416"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="427"/>
<end position="429"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="437"/>
<end position="441"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="449"/>
<end position="451"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="462"/>
<end position="466"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="472"/>
<end position="474"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="487"/>
<end position="491"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="504"/>
<end position="516"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="517"/>
<end position="520"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="521"/>
<end position="523"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="529"/>
<end position="531"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="536"/>
<end position="538"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="631"/>
<end position="633"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="637"/>
<end position="642"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="645"/>
<end position="647"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="648"/>
<end position="653"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="655"/>
<end position="660"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="661"/>
<end position="663"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="669"/>
<end position="672"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="679"/>
<end position="689"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="690"/>
<end position="698"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="699"/>
<end position="704"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="707"/>
<end position="712"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="724"/>
<end position="732"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="736"/>
<end position="738"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="744"/>
<end position="751"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="762"/>
<end position="764"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="767"/>
<end position="777"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1FYV"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2Z7X"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="6NIH"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q9EPQ1"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000255"/>
<evidence key="6" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00204"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11230166"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15340161"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16880211"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17889651"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19159218"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19924287"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21078852"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21618349"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7584026"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9435236"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000305"/>
<sequence length="786" mass="90291" checksum="1BFCCC5E42EA5242" modified="2007-05-01" version="3" precursor="true">MTSIFHFAIIFMLILQIRIQLSEESEFLVDRSKNGLIHVPKDLSQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLVKISCHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPPRIKVLDLHSNKIKSIPKQVVKLEALQELNVAFNSLTDLPGCGSFSSLSVLIIDHNSVSHPSADFFQSCQKMRSIKAGDNPFQCTCELGEFVKNIDQVSSEVLEGWPDSYKCDYPESYRGTLLKDFHMSELSCNITLLIVTIVATMLVLAVTVTSLCSYLDLPWYLRMVCQWTQTRRRARNIPLEELQRNLQFHAFISYSGHDSFWVKNELLPNLEKEGMQICLHERNFVPGKSIVENIITCIEKSYKSIFVLSPNFVQSEWCHYELYFAHHNLFHEGSNSLILILLEPIPQYSIPSSYHKLKSLMARRTYLEWPKEKSKRGLFWANLRAAINIKLTEQAKK</sequence>
</entry>
<entry dataset="Swiss-Prot" created="2016-07-06" modified="2021-02-10" version="167">
<accession>Q9VUN0</accession>
<accession>Q6NN49</accession>
<accession>Q9NBK9</accession>
<name>TOLL6_DROME</name>
<protein>
<recommendedName>
<fullName evidence="11">Toll-like receptor 6</fullName>
<ecNumber evidence="3">3.2.2.6</ecNumber>
</recommendedName>
</protein>
<gene>
<name type="primary" evidence="15">Toll-6</name>
<name type="synonym" evidence="15">Tl-6</name>
<name type="ORF" evidence="15">CG7250</name>
</gene>
<organism evidence="16">
<name type="scientific">Drosophila melanogaster</name>
<name type="common">Fruit fly</name>
<dbReference type="NCBI Taxonomy" id="7227"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Ecdysozoa</taxon>
<taxon>Arthropoda</taxon>
<taxon>Hexapoda</taxon>
<taxon>Insecta</taxon>
<taxon>Pterygota</taxon>
<taxon>Neoptera</taxon>
<taxon>Holometabola</taxon>
<taxon>Diptera</taxon>
<taxon>Brachycera</taxon>
<taxon>Muscomorpha</taxon>
<taxon>Ephydroidea</taxon>
<taxon>Drosophilidae</taxon>
<taxon>Drosophila</taxon>
<taxon>Sophophora</taxon>
</lineage>
</organism>
<reference key="1" evidence="12">
<citation type="journal article" date="2000" name="Proc. Natl. Acad. Sci. U.S.A." volume="97" first="10520" last="10525">
<title>Toll-related receptors and the control of antimicrobial peptide expression in Drosophila.</title>
<authorList>
<person name="Tauszig S."/>
<person name="Jouanguy E."/>
<person name="Hoffmann J.A."/>
<person name="Imler J.L."/>
</authorList>
<dbReference type="PubMed" id="10973475"/>
<dbReference type="DOI" id="10.1073/pnas.180130797"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>FUNCTION</scope>
<scope>DEVELOPMENTAL STAGE</scope>
</reference>
<reference key="2" evidence="16">
<citation type="journal article" date="2000" name="Science" volume="287" first="2185" last="2195">
<title>The genome sequence of Drosophila melanogaster.</title>
<authorList>
<person name="Adams M.D."/>
<person name="Celniker S.E."/>
<person name="Holt R.A."/>
<person name="Evans C.A."/>
<person name="Gocayne J.D."/>
<person name="Amanatides P.G."/>
<person name="Scherer S.E."/>
<person name="Li P.W."/>
<person name="Hoskins R.A."/>
<person name="Galle R.F."/>
<person name="George R.A."/>
<person name="Lewis S.E."/>
<person name="Richards S."/>
<person name="Ashburner M."/>
<person name="Henderson S.N."/>
<person name="Sutton G.G."/>
<person name="Wortman J.R."/>
<person name="Yandell M.D."/>
<person name="Zhang Q."/>
<person name="Chen L.X."/>
<person name="Brandon R.C."/>
<person name="Rogers Y.-H.C."/>
<person name="Blazej R.G."/>
<person name="Champe M."/>
<person name="Pfeiffer B.D."/>
<person name="Wan K.H."/>
<person name="Doyle C."/>
<person name="Baxter E.G."/>
<person name="Helt G."/>
<person name="Nelson C.R."/>
<person name="Miklos G.L.G."/>
<person name="Abril J.F."/>
<person name="Agbayani A."/>
<person name="An H.-J."/>
<person name="Andrews-Pfannkoch C."/>
<person name="Baldwin D."/>
<person name="Ballew R.M."/>
<person name="Basu A."/>
<person name="Baxendale J."/>
<person name="Bayraktaroglu L."/>
<person name="Beasley E.M."/>
<person name="Beeson K.Y."/>
<person name="Benos P.V."/>
<person name="Berman B.P."/>
<person name="Bhandari D."/>
<person name="Bolshakov S."/>
<person name="Borkova D."/>
<person name="Botchan M.R."/>
<person name="Bouck J."/>
<person name="Brokstein P."/>
<person name="Brottier P."/>
<person name="Burtis K.C."/>
<person name="Busam D.A."/>
<person name="Butler H."/>
<person name="Cadieu E."/>
<person name="Center A."/>
<person name="Chandra I."/>
<person name="Cherry J.M."/>
<person name="Cawley S."/>
<person name="Dahlke C."/>
<person name="Davenport L.B."/>
<person name="Davies P."/>
<person name="de Pablos B."/>
<person name="Delcher A."/>
<person name="Deng Z."/>
<person name="Mays A.D."/>
<person name="Dew I."/>
<person name="Dietz S.M."/>
<person name="Dodson K."/>
<person name="Doup L.E."/>
<person name="Downes M."/>
<person name="Dugan-Rocha S."/>
<person name="Dunkov B.C."/>
<person name="Dunn P."/>
<person name="Durbin K.J."/>
<person name="Evangelista C.C."/>
<person name="Ferraz C."/>
<person name="Ferriera S."/>
<person name="Fleischmann W."/>
<person name="Fosler C."/>
<person name="Gabrielian A.E."/>
<person name="Garg N.S."/>
<person name="Gelbart W.M."/>
<person name="Glasser K."/>
<person name="Glodek A."/>
<person name="Gong F."/>
<person name="Gorrell J.H."/>
<person name="Gu Z."/>
<person name="Guan P."/>
<person name="Harris M."/>
<person name="Harris N.L."/>
<person name="Harvey D.A."/>
<person name="Heiman T.J."/>
<person name="Hernandez J.R."/>
<person name="Houck J."/>
<person name="Hostin D."/>
<person name="Houston K.A."/>
<person name="Howland T.J."/>
<person name="Wei M.-H."/>
<person name="Ibegwam C."/>
<person name="Jalali M."/>
<person name="Kalush F."/>
<person name="Karpen G.H."/>
<person name="Ke Z."/>
<person name="Kennison J.A."/>
<person name="Ketchum K.A."/>
<person name="Kimmel B.E."/>
<person name="Kodira C.D."/>
<person name="Kraft C.L."/>
<person name="Kravitz S."/>
<person name="Kulp D."/>
<person name="Lai Z."/>
<person name="Lasko P."/>
<person name="Lei Y."/>
<person name="Levitsky A.A."/>
<person name="Li J.H."/>
<person name="Li Z."/>
<person name="Liang Y."/>
<person name="Lin X."/>
<person name="Liu X."/>
<person name="Mattei B."/>
<person name="McIntosh T.C."/>
<person name="McLeod M.P."/>
<person name="McPherson D."/>
<person name="Merkulov G."/>
<person name="Milshina N.V."/>
<person name="Mobarry C."/>
<person name="Morris J."/>
<person name="Moshrefi A."/>
<person name="Mount S.M."/>
<person name="Moy M."/>
<person name="Murphy B."/>
<person name="Murphy L."/>
<person name="Muzny D.M."/>
<person name="Nelson D.L."/>
<person name="Nelson D.R."/>
<person name="Nelson K.A."/>
<person name="Nixon K."/>
<person name="Nusskern D.R."/>
<person name="Pacleb J.M."/>
<person name="Palazzolo M."/>
<person name="Pittman G.S."/>
<person name="Pan S."/>
<person name="Pollard J."/>
<person name="Puri V."/>
<person name="Reese M.G."/>
<person name="Reinert K."/>
<person name="Remington K."/>
<person name="Saunders R.D.C."/>
<person name="Scheeler F."/>
<person name="Shen H."/>
<person name="Shue B.C."/>
<person name="Siden-Kiamos I."/>
<person name="Simpson M."/>
<person name="Skupski M.P."/>
<person name="Smith T.J."/>
<person name="Spier E."/>
<person name="Spradling A.C."/>
<person name="Stapleton M."/>
<person name="Strong R."/>
<person name="Sun E."/>
<person name="Svirskas R."/>
<person name="Tector C."/>
<person name="Turner R."/>
<person name="Venter E."/>
<person name="Wang A.H."/>
<person name="Wang X."/>
<person name="Wang Z.-Y."/>
<person name="Wassarman D.A."/>
<person name="Weinstock G.M."/>
<person name="Weissenbach J."/>
<person name="Williams S.M."/>
<person name="Woodage T."/>
<person name="Worley K.C."/>
<person name="Wu D."/>
<person name="Yang S."/>
<person name="Yao Q.A."/>
<person name="Ye J."/>
<person name="Yeh R.-F."/>
<person name="Zaveri J.S."/>
<person name="Zhan M."/>
<person name="Zhang G."/>
<person name="Zhao Q."/>
<person name="Zheng L."/>
<person name="Zheng X.H."/>
<person name="Zhong F.N."/>
<person name="Zhong W."/>
<person name="Zhou X."/>
<person name="Zhu S.C."/>
<person name="Zhu X."/>
<person name="Smith H.O."/>
<person name="Gibbs R.A."/>
<person name="Myers E.W."/>
<person name="Rubin G.M."/>
<person name="Venter J.C."/>
</authorList>
<dbReference type="PubMed" id="10731132"/>
<dbReference type="DOI" id="10.1126/science.287.5461.2185"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
<source>
<strain evidence="16">Berkeley</strain>
</source>
</reference>
<reference key="3" evidence="16">
<citation type="journal article" date="2002" name="Genome Biol." volume="3" first="RESEARCH0083.1" last="RESEARCH0083.22">
<title>Annotation of the Drosophila melanogaster euchromatic genome: a systematic review.</title>
<authorList>
<person name="Misra S."/>
<person name="Crosby M.A."/>
<person name="Mungall C.J."/>
<person name="Matthews B.B."/>
<person name="Campbell K.S."/>
<person name="Hradecky P."/>
<person name="Huang Y."/>
<person name="Kaminker J.S."/>
<person name="Millburn G.H."/>
<person name="Prochnik S.E."/>
<person name="Smith C.D."/>
<person name="Tupy J.L."/>
<person name="Whitfield E.J."/>
<person name="Bayraktaroglu L."/>
<person name="Berman B.P."/>
<person name="Bettencourt B.R."/>
<person name="Celniker S.E."/>
<person name="de Grey A.D.N.J."/>
<person name="Drysdale R.A."/>
<person name="Harris N.L."/>
<person name="Richter J."/>
<person name="Russo S."/>
<person name="Schroeder A.J."/>
<person name="Shu S.Q."/>
<person name="Stapleton M."/>
<person name="Yamada C."/>
<person name="Ashburner M."/>
<person name="Gelbart W.M."/>
<person name="Rubin G.M."/>
<person name="Lewis S.E."/>
</authorList>
<dbReference type="PubMed" id="12537572"/>
<dbReference type="DOI" id="10.1186/gb-2002-3-12-research0083"/>
</citation>
<scope>GENOME REANNOTATION</scope>
<source>
<strain evidence="16">Berkeley</strain>
</source>
</reference>
<reference key="4" evidence="13 14">
<citation type="submission" date="2009-01" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Carlson J."/>
<person name="Booth B."/>
<person name="Chavez C."/>
<person name="Frise E."/>
<person name="George R."/>
<person name="Pacleb J."/>
<person name="Park S."/>
<person name="Rubin G.M."/>
<person name="Stapleton M."/>
<person name="Wan K."/>
<person name="Yu C."/>
<person name="Celniker S."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<strain evidence="13 14">Berkeley</strain>
<tissue evidence="13">Embryo</tissue>
</source>
</reference>
<reference key="5" evidence="11">
<citation type="journal article" date="2002" name="Gene Expr. Patterns" volume="2" first="311" last="317">
<title>Tissue and stage-specific expression of the Tolls in Drosophila embryos.</title>
<authorList>
<person name="Kambris Z."/>
<person name="Hoffmann J.A."/>
<person name="Imler J.L."/>
<person name="Capovilla M."/>
</authorList>
<dbReference type="PubMed" id="12617819"/>
<dbReference type="DOI" id="10.1016/s1567-133x(02)00020-0"/>
</citation>
<scope>DEVELOPMENTAL STAGE</scope>
</reference>
<reference key="6" evidence="11">
<citation type="journal article" date="2010" name="Dev. Growth Differ." volume="52" first="771" last="783">
<title>Functional analysis of Toll-related genes in Drosophila.</title>
<authorList>
<person name="Yagi Y."/>
<person name="Nishida Y."/>
<person name="Ip Y.T."/>
</authorList>
<dbReference type="PubMed" id="21158756"/>
<dbReference type="DOI" id="10.1111/j.1440-169x.2010.01213.x"/>
</citation>
<scope>DISRUPTION PHENOTYPE</scope>
</reference>
<reference key="7" evidence="11">
<citation type="journal article" date="2013" name="Nat. Neurosci." volume="16" first="1248" last="1256">
<title>Toll-6 and Toll-7 function as neurotrophin receptors in the Drosophila melanogaster CNS.</title>
<authorList>
<person name="McIlroy G."/>
<person name="Foldi I."/>
<person name="Aurikko J."/>
<person name="Wentzell J.S."/>
<person name="Lim M.A."/>
<person name="Fenton J.C."/>
<person name="Gay N.J."/>
<person name="Hidalgo A."/>
</authorList>
<dbReference type="PubMed" id="23892553"/>
<dbReference type="DOI" id="10.1038/nn.3474"/>
</citation>
<scope>FUNCTION</scope>
<scope>DEVELOPMENTAL STAGE</scope>
</reference>
<reference key="8" evidence="11">
<citation type="journal article" date="2014" name="Nature" volume="515" first="523" last="527">
<title>A positional Toll receptor code directs convergent extension in Drosophila.</title>
<authorList>
<person name="Pare A.C."/>
<person name="Vichas A."/>
<person name="Fincher C.T."/>
<person name="Mirman Z."/>
<person name="Farrell D.L."/>
<person name="Mainieri A."/>
<person name="Zallen J.A."/>
</authorList>
<dbReference type="PubMed" id="25363762"/>
<dbReference type="DOI" id="10.1038/nature13953"/>
</citation>
<scope>FUNCTION</scope>
<scope>DEVELOPMENTAL STAGE</scope>
</reference>
<reference key="9" evidence="11">
<citation type="journal article" date="2015" name="Neuron" volume="85" first="1013" last="1028">
<title>Toll receptors instruct axon and dendrite targeting and participate in synaptic partner matching in a Drosophila olfactory circuit.</title>
<authorList>
<person name="Ward A."/>
<person name="Hong W."/>
<person name="Favaloro V."/>
<person name="Luo L."/>
</authorList>
<dbReference type="PubMed" id="25741726"/>
<dbReference type="DOI" id="10.1016/j.neuron.2015.02.003"/>
</citation>
<scope>FUNCTION</scope>
<scope>DEVELOPMENTAL STAGE</scope>
<scope>DISRUPTION PHENOTYPE</scope>
</reference>
<comment type="function">
<text evidence="5 8 9 10">Toll-related receptor which binds to the neurotrophin spz5 (PubMed:10973475, PubMed:23892553). Functions in olfactory circuit assembly by promoting synaptic partner matching between olfactory receptor neurons (ORN) axons and projection neurons (PN) dendrites partners in the antennal lobe (PubMed:25741726). Involved in the targeting of specific classes of PN dendrites (Va1d, Va1v, DC3 and DA1) (PubMed:25741726). Functions with Toll-7 to regulate motor axon targeting and neuronal survival in the central nervous system (CNS) (PubMed:23892553). Possibly functions with 18w and Toll-8 during convergent extension, to help direct proper planar cell polarity, cell intercalation and axis elongation (PubMed:25363762). Promotes heterophilic cell adhesion with 18w in vitro (PubMed:25363762). May be an upstream component of the NF-kappa-B (rel) regulatory cascade (PubMed:23892553).</text>
</comment>
<comment type="catalytic activity">
<reaction evidence="3">
<text>H2O + NAD(+) = ADP-D-ribose + H(+) + nicotinamide</text>
<dbReference type="Rhea" id="RHEA:16301"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:17154"/>
<dbReference type="ChEBI" id="CHEBI:57540"/>
<dbReference type="ChEBI" id="CHEBI:57967"/>
<dbReference type="EC" id="3.2.2.6"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="3">
<dbReference type="Rhea" id="RHEA:16302"/>
</physiologicalReaction>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="11">Cell membrane</location>
<topology evidence="11">Single-pass type I membrane protein</topology>
</subcellularLocation>
</comment>
<comment type="developmental stage">
<text evidence="5 6 8 9 10">Expressed 48 hours after puparium formation in lateral glomeruli in the anterior and central regions of the antennal lobe, including the DA1, VA1d, VA1v, DC3. DC1, DA4l and DA4m glomeruli (at protein level) (PubMed:25741726). Expressed zygotically (PubMed:12617819). High levels of expression in embryos and pupae, and relatively low levels of expression in larvae and adults (PubMed:10973475). At cellular blastoderm stage, expressed as several segmentally separated stripes, with the anterior stripes appearing first (PubMed:12617819). At germ band extension, strongly expressed in the delaminating neuroblasts (PubMed:12617819). Expression decreases at germ band extension, remaining in a specific subset of neurons in the central nervous system (PubMed:12617819). Expressed in 6 segmentally repeated stripes in the germband (PubMed:25363762). In larvae, detected in the fat body (PubMed:12617819). In larvae, expressed in the optic lobes and the ventral nerve cord of the CNS (PubMed:23892553). Expressed 48 hours after puparium formation in ORN axons and PN dendrites that target to largely overlaping glomeruli (PubMed:25741726).</text>
</comment>
<comment type="domain">
<text evidence="3">The TIR domain mediates NAD(+) hydrolase (NADase) activity. Self-association of TIR domains is required for NADase activity.</text>
</comment>
<comment type="disruption phenotype">
<text evidence="7 10">Viable (PubMed:25741726). Dorsomedial or dorsolateral mistargeting of VA1d ORN axons (PubMed:25741726). No effect on the immune response to septic injury using a mixture of Gram-positive and Gram-negative bacteria; adult flies are able induce expression of antibacterial peptide genes (Drs, AttA, DptA and Mtk) and mount a proper innate immune response (PubMed:21158756).</text>
</comment>
<comment type="similarity">
<text evidence="11">Belongs to the Toll-like receptor family.</text>
</comment>
<dbReference type="EC" id="3.2.2.6" evidence="3"/>
<dbReference type="EMBL" id="AF247766">
<property type="protein sequence ID" value="AAF86226.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AE014296">
<property type="protein sequence ID" value="AAF49645.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AE014296">
<property type="protein sequence ID" value="AFH04436.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AE014296">
<property type="protein sequence ID" value="AFH04437.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BT011445">
<property type="protein sequence ID" value="AAR99103.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BT057976">
<property type="protein sequence ID" value="ACM16686.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001246765.1">
<property type="nucleotide sequence ID" value="NM_001259836.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001246766.1">
<property type="nucleotide sequence ID" value="NM_001259837.3"/>
</dbReference>
<dbReference type="RefSeq" id="NP_524081.1">
<property type="nucleotide sequence ID" value="NM_079357.4"/>
</dbReference>
<dbReference type="IntAct" id="Q9VUN0">
<property type="interactions" value="4"/>
</dbReference>
<dbReference type="STRING" id="7227.FBpp0297411"/>
<dbReference type="PaxDb" id="Q9VUN0"/>
<dbReference type="PRIDE" id="Q9VUN0"/>
<dbReference type="EnsemblMetazoa" id="FBtr0075614">
<property type="protein sequence ID" value="FBpp0075367"/>
<property type="gene ID" value="FBgn0036494"/>
</dbReference>
<dbReference type="EnsemblMetazoa" id="FBtr0306307">
<property type="protein sequence ID" value="FBpp0297410"/>
<property type="gene ID" value="FBgn0036494"/>
</dbReference>
<dbReference type="EnsemblMetazoa" id="FBtr0306308">
<property type="protein sequence ID" value="FBpp0297411"/>
<property type="gene ID" value="FBgn0036494"/>
</dbReference>
<dbReference type="GeneID" id="39663"/>
<dbReference type="KEGG" id="dme:Dmel_CG7250"/>
<dbReference type="UCSC" id="CG7250-RA">
<property type="organism name" value="d. melanogaster"/>
</dbReference>
<dbReference type="CTD" id="39663"/>
<dbReference type="FlyBase" id="FBgn0036494">
<property type="gene designation" value="Toll-6"/>
</dbReference>
<dbReference type="eggNOG" id="KOG4641">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000168338"/>
<dbReference type="HOGENOM" id="CLU_004280_0_0_1"/>
<dbReference type="InParanoid" id="Q9VUN0"/>
<dbReference type="OMA" id="NFLYNEW"/>
<dbReference type="OrthoDB" id="737804at2759"/>
<dbReference type="PhylomeDB" id="Q9VUN0"/>
<dbReference type="Reactome" id="R-DME-376176">
<property type="pathway name" value="Signaling by ROBO receptors"/>
</dbReference>
<dbReference type="Reactome" id="R-DME-428890">
<property type="pathway name" value="Role of ABL in ROBO-SLIT signaling"/>
</dbReference>
<dbReference type="BioGRID-ORCS" id="39663">
<property type="hits" value="0 hits in 1 CRISPR screen"/>
</dbReference>
<dbReference type="GenomeRNAi" id="39663"/>
<dbReference type="PRO" id="PR:Q9VUN0"/>
<dbReference type="Proteomes" id="UP000000803">
<property type="component" value="Chromosome 3L"/>
</dbReference>
<dbReference type="Bgee" id="FBgn0036494">
<property type="expression patterns" value="Expressed in embryo and 46 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="Q9VUN0">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="GO" id="GO:0016021">
<property type="term" value="C:integral component of membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0008201">
<property type="term" value="F:heparin binding"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0050135">
<property type="term" value="F:NAD(P)+ nucleosidase activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0061809">
<property type="term" value="F:NAD+ nucleotidase, cyclic ADP-ribose generating"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0005030">
<property type="term" value="F:neurotrophin receptor activity"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="FlyBase"/>
</dbReference>
<dbReference type="GO" id="GO:0048495">
<property type="term" value="F:Roundabout binding"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0003401">
<property type="term" value="P:axis elongation"/>
<property type="evidence" value="ECO:0000316"/>
<property type="project" value="FlyBase"/>
</dbReference>
<dbReference type="GO" id="GO:0007411">
<property type="term" value="P:axon guidance"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0060026">
<property type="term" value="P:convergent extension"/>
<property type="evidence" value="ECO:0000316"/>
<property type="project" value="FlyBase"/>
</dbReference>
<dbReference type="GO" id="GO:0070983">
<property type="term" value="P:dendrite guidance"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="FlyBase"/>
</dbReference>
<dbReference type="GO" id="GO:0007165">
<property type="term" value="P:signal transduction"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="FlyBase"/>
</dbReference>
<dbReference type="Gene3D" id="3.40.50.10140">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="3.80.10.10">
<property type="match status" value="6"/>
</dbReference>
<dbReference type="InterPro" id="IPR001611">
<property type="entry name" value="Leu-rich_rpt"/>
</dbReference>
<dbReference type="InterPro" id="IPR003591">
<property type="entry name" value="Leu-rich_rpt_typical-subtyp"/>
</dbReference>
<dbReference type="InterPro" id="IPR032675">
<property type="entry name" value="LRR_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR000157">
<property type="entry name" value="TIR_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR035897">
<property type="entry name" value="Toll_tir_struct_dom_sf"/>
</dbReference>
<dbReference type="Pfam" id="PF13855">
<property type="entry name" value="LRR_8"/>
<property type="match status" value="6"/>
</dbReference>
<dbReference type="Pfam" id="PF01582">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00369">
<property type="entry name" value="LRR_TYP"/>
<property type="match status" value="23"/>
</dbReference>
<dbReference type="SMART" id="SM00255">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF52200">
<property type="entry name" value="SSF52200"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51450">
<property type="entry name" value="LRR"/>
<property type="match status" value="24"/>
</dbReference>
<dbReference type="PROSITE" id="PS50104">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-0217">Developmental protein</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0378">Hydrolase</keyword>
<keyword id="KW-0433">Leucine-rich repeat</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0520">NAD</keyword>
<keyword id="KW-0675">Receptor</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0732">Signal</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<feature type="signal peptide" evidence="2">
<location>
<begin position="1"/>
<end position="14"/>
</location>
</feature>
<feature type="chain" description="Toll-like receptor 6" id="PRO_0000436858">
<location>
<begin position="15"/>
<end position="1514"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="11">
<location>
<begin position="15"/>
<end position="1057"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="2">
<location>
<begin position="1058"/>
<end position="1078"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="11">
<location>
<begin position="1079"/>
<end position="1514"/>
</location>
</feature>
<feature type="repeat" description="LRR 1" evidence="2">
<location>
<begin position="145"/>
<end position="168"/>
</location>
</feature>
<feature type="repeat" description="LRR 2" evidence="2">
<location>
<begin position="170"/>
<end position="191"/>
</location>
</feature>
<feature type="repeat" description="LRR 3" evidence="2">
<location>
<begin position="199"/>
<end position="222"/>
</location>
</feature>
<feature type="repeat" description="LRR 4" evidence="2">
<location>
<begin position="224"/>
<end position="246"/>
</location>
</feature>
<feature type="repeat" description="LRR 5" evidence="2">
<location>
<begin position="276"/>
<end position="299"/>
</location>
</feature>
<feature type="repeat" description="LRR 6" evidence="2">
<location>
<begin position="300"/>
<end position="323"/>
</location>
</feature>
<feature type="repeat" description="LRR 7" evidence="2">
<location>
<begin position="324"/>
<end position="347"/>
</location>
</feature>
<feature type="repeat" description="LRR 8" evidence="2">
<location>
<begin position="349"/>
<end position="372"/>
</location>
</feature>
<feature type="repeat" description="LRR 9" evidence="2">
<location>
<begin position="374"/>
<end position="398"/>
</location>
</feature>
<feature type="repeat" description="LRR 10" evidence="2">
<location>
<begin position="399"/>
<end position="422"/>
</location>
</feature>
<feature type="repeat" description="LRR 11" evidence="2">
<location>
<begin position="424"/>
<end position="446"/>
</location>
</feature>
<feature type="repeat" description="LRR 12" evidence="2">
<location>
<begin position="448"/>
<end position="470"/>
</location>
</feature>
<feature type="repeat" description="LRR 13" evidence="2">
<location>
<begin position="471"/>
<end position="494"/>
</location>
</feature>
<feature type="repeat" description="LRR 14" evidence="2">
<location>
<begin position="495"/>
<end position="518"/>
</location>
</feature>
<feature type="repeat" description="LRR 15" evidence="2">
<location>
<begin position="519"/>
<end position="541"/>
</location>
</feature>
<feature type="repeat" description="LRR 16" evidence="2">
<location>
<begin position="543"/>
<end position="565"/>
</location>
</feature>
<feature type="repeat" description="LRR 17" evidence="2">
<location>
<begin position="566"/>
<end position="589"/>
</location>
</feature>
<feature type="repeat" description="LRR 18" evidence="2">
<location>
<begin position="591"/>
<end position="612"/>
</location>
</feature>
<feature type="repeat" description="LRR 19" evidence="2">
<location>
<begin position="614"/>
<end position="635"/>
</location>
</feature>
<feature type="repeat" description="LRR 20" evidence="2">
<location>
<begin position="636"/>
<end position="658"/>
</location>
</feature>
<feature type="repeat" description="LRR 21" evidence="2">
<location>
<begin position="660"/>
<end position="682"/>
</location>
</feature>
<feature type="repeat" description="LRR 22" evidence="2">
<location>
<begin position="683"/>
<end position="705"/>
</location>
</feature>
<feature type="repeat" description="LRR 23" evidence="2">
<location>
<begin position="707"/>
<end position="729"/>
</location>
</feature>
<feature type="repeat" description="LRR 24" evidence="2">
<location>
<begin position="858"/>
<end position="881"/>
</location>
</feature>
<feature type="repeat" description="LRR 25" evidence="2">
<location>
<begin position="883"/>
<end position="905"/>
</location>
</feature>
<feature type="repeat" description="LRR 26" evidence="2">
<location>
<begin position="906"/>
<end position="929"/>
</location>
</feature>
<feature type="repeat" description="LRR 27" evidence="2">
<location>
<begin position="930"/>
<end position="953"/>
</location>
</feature>
<feature type="repeat" description="LRR 28" evidence="2">
<location>
<begin position="955"/>
<end position="977"/>
</location>
</feature>
<feature type="domain" description="TIR" evidence="3">
<location>
<begin position="1111"/>
<end position="1244"/>
</location>
</feature>
<feature type="active site" evidence="3">
<location>
<position position="1187"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="111"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="174"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="230"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="253"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="331"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="359"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="406"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="494"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="557"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="620"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="708"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="829"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="891"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="900"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="948"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="1024"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="1033"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1">
<location>
<begin position="752"/>
<end position="802"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1">
<location>
<begin position="826"/>
<end position="832"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1">
<location>
<begin position="830"/>
<end position="845"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1">
<location>
<begin position="993"/>
<end position="1020"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAF86226." ref="1" evidence="11">
<original>K</original>
<variation>Q</variation>
<location>
<position position="249"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 4; AAR99103." ref="4" evidence="11">
<original>Y</original>
<variation>C</variation>
<location>
<position position="889"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAF86226." ref="1" evidence="11">
<original>V</original>
<variation>A</variation>
<location>
<position position="1475"/>
</location>
</feature>
<evidence key="1" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P08953"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000255"/>
<evidence key="3" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00204"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00498"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10973475"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12617819"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21158756"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23892553"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25363762"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25741726"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000305"/>
<evidence key="12" type="ECO:0000312">
<source>
<dbReference type="EMBL" id="AAF86226.1"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000312">
<source>
<dbReference type="EMBL" id="AAR99103.1"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000312">
<source>
<dbReference type="EMBL" id="ACM16686.1"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000312">
<source>
<dbReference type="FlyBase" id="FBgn0036494"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000312">
<source>
<dbReference type="Proteomes" id="UP000000803"/>
</source>
</evidence>
<sequence length="1514" mass="170158" checksum="5BC45E5EE9A1E28F" modified="2000-05-01" version="1" precursor="true">MIYYMLLILPVVLAQDQQHTTESLSTKHHQQQQLSHSNAIMGEAGVSNSQLMQPSTPARTLRPLTAGAGGDPSLYDAPDDCHFMPAAGLDQPEIALTCNLRTVNSEFDTTNFSVIPAEHTIALHILCNDEIMAKSRLEAQSFAHLVRLQQLSIQYCKLGRLGRQVLDGLEQLRNLTLRTHNILWPALNFEIEADAFSVTRRLERLDLSSNNIWSLPDNIFCTLSELSALNMSENRLQDVNELGFRDRSKEPTNGSTESTSTTESAKKSSSSSTSCSLDLEYLDVSHNDFVVLPANGFGTLRRLRVLSVNNNGISMIADKALSGLKNLQILNLSSNKIVALPTELFAEQAKIIQEVYLQNNSISVLNPQLFSNLDQLQALDLSMNQITSTWIDKNTFVGLIRLVLLNLSHNKLTKLEPEIFSDLYTLQILNLRHNQLENIAADTFAPMNNLHTLLLSHNKLKYLDAYALNGLYVLSLLSLDNNALIGVHPDAFRNCSALQDLNLNGNQLKTVPLALRNMRHLRTVDLGENMITVMEDSAFKGLGNLYGLRLIGNYLENITMHTFRDLPNLQILNLARNRIAVVEPGAFEMTSSIQAVRLDGNELNDINGLFSNMPSLLWLNISDNRLESFDYGHVPSTLQWLDLHKNRLSSLSNRFGLDSELKLQTLDVSFNQLQRIGPSSIPNSIELLFLNDNLITTVDPDTFMHKTNLTRVDLYANQITTLDIKSLRILPVWEHRALPEFYIGGNPFTCDCNIDWLQKINHITSRQYPRIMDLETIYCKLLNNRERAYIPLIEAEPKHFLCTYKTHCFAVCHCCEFDACDCEMTCPTNCTCFHDQTWSTNIVECSGAAYSEMPRRVPMDTSELYIDGNNFVELAGHSFLGRKNLAVLYANNSNVAHIYNTTFSGLKRLLILHLEDNHIISLEGNEFHNLENLRELYLQSNKIASIANGSFQMLRKLEVLRLDGNRLMHFEVWQLSANPYLVEISLADNQWSCECGYLARFRNYLGQSSEKIIDASRVSCIYNNATSVLREKNGTKCTLRDGVAHYMHTNEIEGLLPLLLVATCAFVAFFGLIFGLFCYRHELKIWAHSTNCLMNFCYKSPRFVDQLDKERPNDAYFAYSLQDEHFVNQILAQTLENDIGYRLCLHYRDVNINAYITDALIEAAESAKQFVLVLSKNFLYNEWSRFEYKSALHELVKRRKRVVFILYGDLPQRDIDMDMRHYLRTSTCIEWDDKKFWQKLRLALPLPNGRGNNNKRVVSGCLSGRTPSVNMYATSHEYQAGNGGVIPPPSARYADCGSNNYATINECAAAGGGRGYKPIPTSASAAAAACKFNTMNQLSKKQQRDLSVAGMAKTLEHQHHHNHQANRRSQHEYAVPSYLPSAAPAYDSVDYAKQQIRNNANCECVNLGTAKRAAGKNPASGLPSSFSSNFVPPGGASYNCKKSCSCIGDDELLCSCGGGGGIGVNLLESGTQSSVTMSSSSNNSRQPELTHYESNLSLNDDEDEDHDQQKNLWA</sequence>
</entry>
<entry dataset="Swiss-Prot" created="2005-04-26" modified="2021-02-10" version="113">
<accession>Q689D1</accession>
<name>TLR2_CANLF</name>
<protein>
<recommendedName>
<fullName>Toll-like receptor 2</fullName>
<ecNumber evidence="5">3.2.2.6</ecNumber>
</recommendedName>
<cdAntigenName>CD282</cdAntigenName>
</protein>
<gene>
<name type="primary">TLR2</name>
</gene>
<organism>
<name type="scientific">Canis lupus familiaris</name>
<name type="common">Dog</name>
<name type="synonym">Canis familiaris</name>
<dbReference type="NCBI Taxonomy" id="9615"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Laurasiatheria</taxon>
<taxon>Carnivora</taxon>
<taxon>Caniformia</taxon>
<taxon>Canidae</taxon>
<taxon>Canis</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="submission" date="2004-09" db="EMBL/GenBank/DDBJ databases">
<title>Molecular cloning of canine Toll-like receptor 2 (TLR2) gene.</title>
<authorList>
<person name="Ishii M."/>
<person name="Kano R."/>
<person name="Hasegawa A."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
</reference>
<comment type="function">
<text evidence="2 3">Cooperates with LY96 to mediate the innate immune response to bacterial lipoproteins and other microbial cell wall components. Cooperates with TLR1 or TLR6 to mediate the innate immune response to bacterial lipoproteins or lipopeptides. Acts via MYD88 and TRAF6, leading to NF-kappa-B activation, cytokine secretion and the inflammatory response (By similarity). May also promote apoptosis in response to lipoproteins. Forms activation clusters composed of several receptors depending on the ligand, these clusters trigger signaling from the cell surface and subsequently are targeted to the Golgi in a lipid-raft dependent pathway. Forms the cluster TLR2:TLR6:CD14:CD36 in response to diacylated lipopeptides and TLR2:TLR1:CD14 in response to triacylated lipopeptides (By similarity).</text>
</comment>
<comment type="catalytic activity">
<reaction evidence="5">
<text>H2O + NAD(+) = ADP-D-ribose + H(+) + nicotinamide</text>
<dbReference type="Rhea" id="RHEA:16301"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:17154"/>
<dbReference type="ChEBI" id="CHEBI:57540"/>
<dbReference type="ChEBI" id="CHEBI:57967"/>
<dbReference type="EC" id="3.2.2.6"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="5">
<dbReference type="Rhea" id="RHEA:16302"/>
</physiologicalReaction>
</comment>
<comment type="subunit">
<text evidence="2 3">Interacts with LY96, TLR1 and TLR6 (via extracellular domain). TLR2 seems to exist in heterodimers with either TLR1 or TLR6 before stimulation by the ligand. The heterodimers form bigger oligomers in response to their corresponding ligands as well as further heterotypic associations with other receptors such as CD14 and/or CD36. Binds MYD88 (via TIR domain). Interacts with TICAM1. Interacts with CNPY3. Interacts with ATG16L1. Interacts with PPP1R11. Interacts with TICAM2.</text>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="3">Membrane</location>
<topology evidence="4">Single-pass type I membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="3">Cytoplasmic vesicle</location>
<location evidence="3">Phagosome membrane</location>
<topology evidence="4">Single-pass type I membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="2">Membrane raft</location>
</subcellularLocation>
<text evidence="2">Does not reside in lipid rafts before stimulation but accumulates increasingly in the raft upon the presence of the microbial ligand. In response to diacylated lipoproteins, TLR2:TLR6 heterodimers are recruited in lipid rafts, this recruitment determine the intracellular targeting to the Golgi apparatus. Triacylated lipoproteins induce the same mechanism for TLR2:TLR1 heterodimers.</text>
</comment>
<comment type="domain">
<text evidence="1">Ester-bound lipid substrates are bound through a crevice formed between the LRR 11 and LRR 12.</text>
</comment>
<comment type="domain">
<text evidence="1">The ATG16L1-binding motif mediates interaction with ATG16L1.</text>
</comment>
<comment type="domain">
<text evidence="5">The TIR domain mediates NAD(+) hydrolase (NADase) activity. Self-association of TIR domains is required for NADase activity.</text>
</comment>
<comment type="PTM">
<text evidence="3">Ubiquitinated at Lys-755 by PPP1R11, leading to its degradation. Deubiquitinated by USP2.</text>
</comment>
<comment type="PTM">
<text evidence="2">Glycosylation of Asn-443 is critical for secretion of the N-terminal ectodomain of TLR2.</text>
</comment>
<comment type="similarity">
<text evidence="6">Belongs to the Toll-like receptor family.</text>
</comment>
<dbReference type="EC" id="3.2.2.6" evidence="5"/>
<dbReference type="EMBL" id="AB189639">
<property type="protein sequence ID" value="BAD42423.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="STRING" id="9612.ENSCAFP00000012269"/>
<dbReference type="eggNOG" id="KOG4641">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="InParanoid" id="Q689D1"/>
<dbReference type="Proteomes" id="UP000002254">
<property type="component" value="Unplaced"/>
</dbReference>
<dbReference type="GO" id="GO:0005794">
<property type="term" value="C:Golgi apparatus"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005887">
<property type="term" value="C:integral component of plasma membrane"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0045121">
<property type="term" value="C:membrane raft"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030670">
<property type="term" value="C:phagocytic vesicle membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0050135">
<property type="term" value="F:NAD(P)+ nucleosidase activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0061809">
<property type="term" value="F:NAD+ nucleotidase, cyclic ADP-ribose generating"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0038023">
<property type="term" value="F:signaling receptor activity"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0004888">
<property type="term" value="F:transmembrane signaling receptor activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0042497">
<property type="term" value="F:triacyl lipopeptide binding"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0071726">
<property type="term" value="P:cellular response to diacyl bacterial lipopeptide"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071727">
<property type="term" value="P:cellular response to triacyl bacterial lipopeptide"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006954">
<property type="term" value="P:inflammatory response"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0045087">
<property type="term" value="P:innate immune response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0002755">
<property type="term" value="P:MyD88-dependent toll-like receptor signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0050729">
<property type="term" value="P:positive regulation of inflammatory response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0034134">
<property type="term" value="P:toll-like receptor 2 signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0002224">
<property type="term" value="P:toll-like receptor signaling pathway"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="Gene3D" id="3.40.50.10140">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="3.80.10.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR000483">
<property type="entry name" value="Cys-rich_flank_reg_C"/>
</dbReference>
<dbReference type="InterPro" id="IPR001611">
<property type="entry name" value="Leu-rich_rpt"/>
</dbReference>
<dbReference type="InterPro" id="IPR003591">
<property type="entry name" value="Leu-rich_rpt_typical-subtyp"/>
</dbReference>
<dbReference type="InterPro" id="IPR032675">
<property type="entry name" value="LRR_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR000157">
<property type="entry name" value="TIR_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR027185">
<property type="entry name" value="TLR2"/>
</dbReference>
<dbReference type="InterPro" id="IPR017241">
<property type="entry name" value="Toll-like_receptor"/>
</dbReference>
<dbReference type="InterPro" id="IPR035897">
<property type="entry name" value="Toll_tir_struct_dom_sf"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR24365">
<property type="entry name" value="PTHR24365"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR24365:SF17">
<property type="entry name" value="PTHR24365:SF17"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF13855">
<property type="entry name" value="LRR_8"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="Pfam" id="PF01463">
<property type="entry name" value="LRRCT"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF01582">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PIRSF" id="PIRSF037595">
<property type="entry name" value="Toll-like_receptor"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00369">
<property type="entry name" value="LRR_TYP"/>
<property type="match status" value="7"/>
</dbReference>
<dbReference type="SMART" id="SM00082">
<property type="entry name" value="LRRCT"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00255">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF52200">
<property type="entry name" value="SSF52200"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51450">
<property type="entry name" value="LRR"/>
<property type="match status" value="11"/>
</dbReference>
<dbReference type="PROSITE" id="PS50104">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at transcript level"/>
<keyword id="KW-0968">Cytoplasmic vesicle</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0378">Hydrolase</keyword>
<keyword id="KW-0391">Immunity</keyword>
<keyword id="KW-0395">Inflammatory response</keyword>
<keyword id="KW-0399">Innate immunity</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0433">Leucine-rich repeat</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0520">NAD</keyword>
<keyword id="KW-0675">Receptor</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0732">Signal</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="signal peptide" evidence="4">
<location>
<begin position="1"/>
<end position="17"/>
</location>
</feature>
<feature type="chain" description="Toll-like receptor 2" id="PRO_0000034708">
<location>
<begin position="18"/>
<end position="785"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="4">
<location>
<begin position="18"/>
<end position="589"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="4">
<location>
<begin position="590"/>
<end position="610"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="4">
<location>
<begin position="611"/>
<end position="785"/>
</location>
</feature>
<feature type="repeat" description="LRR 1">
<location>
<begin position="54"/>
<end position="77"/>
</location>
</feature>
<feature type="repeat" description="LRR 2">
<location>
<begin position="78"/>
<end position="101"/>
</location>
</feature>
<feature type="repeat" description="LRR 3">
<location>
<begin position="102"/>
<end position="125"/>
</location>
</feature>
<feature type="repeat" description="LRR 4">
<location>
<begin position="126"/>
<end position="150"/>
</location>
</feature>
<feature type="repeat" description="LRR 5">
<location>
<begin position="151"/>
<end position="175"/>
</location>
</feature>
<feature type="repeat" description="LRR 6">
<location>
<begin position="176"/>
<end position="199"/>
</location>
</feature>
<feature type="repeat" description="LRR 7">
<location>
<begin position="200"/>
<end position="223"/>
</location>
</feature>
<feature type="repeat" description="LRR 8">
<location>
<begin position="224"/>
<end position="250"/>
</location>
</feature>
<feature type="repeat" description="LRR 9">
<location>
<begin position="251"/>
<end position="278"/>
</location>
</feature>
<feature type="repeat" description="LRR 10">
<location>
<begin position="279"/>
<end position="308"/>
</location>
</feature>
<feature type="repeat" description="LRR 11">
<location>
<begin position="309"/>
<end position="337"/>
</location>
</feature>
<feature type="repeat" description="LRR 12">
<location>
<begin position="338"/>
<end position="361"/>
</location>
</feature>
<feature type="repeat" description="LRR 13">
<location>
<begin position="362"/>
<end position="388"/>
</location>
</feature>
<feature type="repeat" description="LRR 14">
<location>
<begin position="389"/>
<end position="414"/>
</location>
</feature>
<feature type="repeat" description="LRR 15">
<location>
<begin position="415"/>
<end position="437"/>
</location>
</feature>
<feature type="repeat" description="LRR 16">
<location>
<begin position="438"/>
<end position="457"/>
</location>
</feature>
<feature type="repeat" description="LRR 17">
<location>
<begin position="458"/>
<end position="478"/>
</location>
</feature>
<feature type="repeat" description="LRR 18">
<location>
<begin position="479"/>
<end position="500"/>
</location>
</feature>
<feature type="repeat" description="LRR 19">
<location>
<begin position="501"/>
<end position="524"/>
</location>
</feature>
<feature type="domain" description="LRRCT">
<location>
<begin position="525"/>
<end position="579"/>
</location>
</feature>
<feature type="domain" description="TIR" evidence="5">
<location>
<begin position="640"/>
<end position="783"/>
</location>
</feature>
<feature type="short sequence motif" description="ATG16L1-binding motif">
<location>
<begin position="762"/>
<end position="779"/>
</location>
</feature>
<feature type="active site" evidence="5">
<location>
<position position="717"/>
</location>
</feature>
<feature type="site" description="Interaction with bacterial lipopeptide" evidence="1">
<location>
<position position="350"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="115"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="200"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="246"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="415"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="443"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1">
<location>
<begin position="31"/>
<end position="37"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1">
<location>
<begin position="354"/>
<end position="383"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1">
<location>
<begin position="433"/>
<end position="455"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="2">
<location>
<position position="755"/>
</location>
</feature>
<evidence key="1" type="ECO:0000250"/>
<evidence key="2" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="O60603"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q9QUN7"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000255"/>
<evidence key="5" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00204"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000305"/>
<sequence length="785" mass="90277" checksum="717606848DD91881" modified="2004-10-11" version="1" precursor="true">MSRVLWTLWVLGAVTNLSKEEAPDQSSSLSCDPTGVCDGRSRSLNSMPSGLTAAVRSLDLSNNEITYIGNSDLRDCVNLKALRLESNGINTIEEESFLSLWSLEHLDLSYNLLSNLSSSWFRPLSSLKFLNLLGNPYKSLGETPLFSQLTNLRILKVGNIYSFTEIQDKDFAGLTFLEELEIDASNLQRYEPKSLKSIQNISYLALRMKQPVLLVEIFVDLSSSLKHLELRDTHLDTFHFSEASINETHTLVKKWTFRNVKVTDRSFTGVVRLLNYVSGVLEVEFEDCTLYGLGDFDIPDVDKIKNIGQIETLTVRRLHIPHFYSFYDMSSIYSLTEDVKRITVENSKVFLVPCLLSQHLKSLEYLDLSENLMVEEYLKNSACEDAWPSLQTLVLRQNHLASLERTGETLLTLKNLTNIDISKNSFHSMPETCQWPEKMKYLNLSSTRIHSVTGCIPKTLEILDVSNNNLNLFSLNLPQLKELYISRNKLMTLPDASLLPMLLVLKISRNAITTFSKEQLDSFHTLKTLEAGGNNFICSCEFLSFTQEQQALAKVLIDWPANYLCDSPSHVRGQQVQDVRLSVSECHRTALVSGMCCALFLLILLTEVLCHRFHGLWYMRMMWAWLQAKRKPRKAPSRDVCYDAFVSYSEHDSYWVENLLVQKLEHFNPPFKLCLHKRDFIPGKWIIDNIIDSIEKSRKTIFVLSENFVKSEWCKYELDFSHFRLFDENSDAAILILLEPIEKKAIPQRFCKLRKIMNTKTYLEWPTDDAQQEGFWLNLRTAIKS</sequence>
</entry>
<entry dataset="Swiss-Prot" created="2010-06-15" modified="2021-02-10" version="108">
<accession>Q704V6</accession>
<accession>B5T272</accession>
<accession>B5T275</accession>
<accession>B5T276</accession>
<accession>Q3BK20</accession>
<accession>Q706D2</accession>
<name>TLR6_BOVIN</name>
<protein>
<recommendedName>
<fullName evidence="15">Toll-like receptor 6</fullName>
<ecNumber evidence="5">3.2.2.6</ecNumber>
</recommendedName>
<cdAntigenName evidence="3">CD286</cdAntigenName>
</protein>
<gene>
<name type="primary" evidence="15">TLR6</name>
</gene>
<organism>
<name type="scientific">Bos taurus</name>
<name type="common">Bovine</name>
<dbReference type="NCBI Taxonomy" id="9913"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Laurasiatheria</taxon>
<taxon>Artiodactyla</taxon>
<taxon>Ruminantia</taxon>
<taxon>Pecora</taxon>
<taxon>Bovidae</taxon>
<taxon>Bovinae</taxon>
<taxon>Bos</taxon>
</lineage>
</organism>
<reference key="1" evidence="9">
<citation type="journal article" date="2006" name="Vet. Immunol. Immunopathol." volume="112" first="2" last="11">
<title>Expression of TOLL-like receptors (TLR) by bovine antigen-presenting cells-potential role in pathogen discrimination?</title>
<authorList>
<person name="Werling D."/>
<person name="Piercy J."/>
<person name="Coffey T.J."/>
</authorList>
<dbReference type="PubMed" id="16701904"/>
<dbReference type="DOI" id="10.1016/j.vetimm.2006.03.007"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
</reference>
<reference key="2" evidence="8 10">
<citation type="journal article" date="2008" name="Genomics" volume="92" first="235" last="245">
<title>Analysis of sequence variability and protein domain architectures for bovine peptidoglycan recognition protein 1 and Toll-like receptors 2 and 6.</title>
<authorList>
<person name="Seabury C.M."/>
<person name="Womack J.E."/>
</authorList>
<dbReference type="PubMed" id="18639626"/>
<dbReference type="DOI" id="10.1016/j.ygeno.2008.06.005"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>VARIANT ASN-214</scope>
<source>
<strain evidence="10">Angus</strain>
<strain evidence="11">Charolais</strain>
<strain evidence="12">Holstein</strain>
<strain evidence="13">Limousin</strain>
</source>
</reference>
<reference key="3" evidence="15">
<citation type="submission" date="2004-01" db="EMBL/GenBank/DDBJ databases">
<title>Structure and tissue-specific expression the bovine TLR6-encoding gene.</title>
<authorList>
<person name="Yang W."/>
<person name="Weikard R."/>
<person name="Zerbe H."/>
<person name="Seyfert H.M."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA]</scope>
<source>
<tissue evidence="14">Mammary gland</tissue>
</source>
</reference>
<reference key="4" evidence="8 16">
<citation type="journal article" date="2006" name="Gene" volume="384" first="45" last="50">
<title>Genomic organization and transcript profiling of the bovine toll-like receptor gene cluster TLR6-TLR1-TLR10.</title>
<authorList>
<person name="Opsal M.A."/>
<person name="Vage D.I."/>
<person name="Hayes B."/>
<person name="Berget I."/>
<person name="Lien S."/>
</authorList>
<dbReference type="PubMed" id="16950576"/>
<dbReference type="DOI" id="10.1016/j.gene.2006.06.027"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 165-422</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>VARIANT ASN-214</scope>
<source>
<tissue evidence="6">Semen</tissue>
</source>
</reference>
<comment type="function">
<text evidence="2 3">Participates in the innate immune response to Gram-positive bacteria and fungi. Specifically recognizes diacylated and, to a lesser extent, triacylated lipopeptides. In response to diacylated lipopeptides, forms the activation cluster TLR2:TLR6:CD14:CD36, this cluster triggers signaling from the cell surface and subsequently is targeted to the Golgi in a lipid-raft dependent pathway. Acts via MYD88 and TRAF6, leading to NF-kappa-B activation, cytokine secretion and the inflammatory response. Recognizes mycoplasmal macrophage-activating lipopeptide-2kD (MALP-2), soluble tuberculosis factor (STF), phenol-soluble modulin (PSM) and B.burgdorferi outer surface protein A lipoprotein (OspA-L) cooperatively with TLR2. In complex with TLR4, promotes sterile inflammation in monocytes/macrophages in response to oxidized low-density lipoprotein (oxLDL) or amyloid-beta 42. In this context, the initial signal is provided by oxLDL- or amyloid-beta 42-binding to CD36. This event induces the formation of a heterodimer of TLR4 and TLR6, which is rapidly internalized and triggers inflammatory response, leading to the NF-kappa-B-dependent production of CXCL1, CXCL2 and CCL9 cytokines, via MYD88 signaling pathway, and CCL5 cytokine, via TICAM1 signaling pathway, as well as IL1B secretion.</text>
</comment>
<comment type="catalytic activity">
<reaction evidence="5">
<text>H2O + NAD(+) = ADP-D-ribose + H(+) + nicotinamide</text>
<dbReference type="Rhea" id="RHEA:16301"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:17154"/>
<dbReference type="ChEBI" id="CHEBI:57540"/>
<dbReference type="ChEBI" id="CHEBI:57967"/>
<dbReference type="EC" id="3.2.2.6"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="5">
<dbReference type="Rhea" id="RHEA:16302"/>
</physiologicalReaction>
</comment>
<comment type="subunit">
<text evidence="2 3">Homodimer (via cytoplasmic TIR domain) (By similarity). Heterodimer with TLR2 via their respective extracellular domains. Binds MYD88 via their respective TIR domains (By similarity). Interacts with CD36, following CD36 stimulation by oxLDL or amyloid-beta 42, and forms a heterodimer with TLR4. The trimeric complex is internalized and triggers inflammatory response. LYN kinase activity facilitates TLR4-TLR6 heterodimerization and signal initiation (By similarity). The heterodimer TLR2:TLR6 interacts with CD14 and CD36 in response to triacylated lipopeptides.</text>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="3">Cell membrane</location>
<topology evidence="4">Single-pass type I membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="2">Cytoplasmic vesicle</location>
<location evidence="2">Phagosome membrane</location>
<topology evidence="4">Single-pass type I membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="3">Membrane raft</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="3">Golgi apparatus</location>
</subcellularLocation>
<text evidence="3">Upon complex formation with CD36 and TLR4, internalized through dynamin-dependent endocytosis. Does not reside in lipid rafts before stimulation but accumulates increasingly in the raft upon the presence of the microbial ligand. In response to diacylated lipoproteins, TLR2:TLR6 heterodimers are recruited in lipid rafts, this recruitment determine the intracellular targeting to the Golgi apparatus.</text>
</comment>
<comment type="tissue specificity">
<text evidence="6">Highest expression levels seen in blood and lymph node, intermediate expression seen in spleen and lowest expression seen in the liver, lung and udder cistern.</text>
</comment>
<comment type="domain">
<text evidence="5">The TIR domain mediates NAD(+) hydrolase (NADase) activity. Self-association of TIR domains is required for NADase activity.</text>
</comment>
<comment type="similarity">
<text evidence="4">Belongs to the Toll-like receptor family.</text>
</comment>
<comment type="sequence caution" evidence="8">
<conflict type="frameshift">
<sequence resource="EMBL-CDS" id="CAJ35083" version="1"/>
</conflict>
</comment>
<dbReference type="EC" id="3.2.2.6" evidence="5"/>
<dbReference type="EMBL" id="AY487803">
<property type="protein sequence ID" value="AAY40896.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="EU746466">
<property type="protein sequence ID" value="ACH92795.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="EU746469">
<property type="protein sequence ID" value="ACH92798.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="EU746470">
<property type="protein sequence ID" value="ACH92799.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="EU746471">
<property type="protein sequence ID" value="ACH92800.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AJ618974">
<property type="protein sequence ID" value="CAF02015.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AJ620670">
<property type="protein sequence ID" value="CAF06197.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AM113851">
<property type="protein sequence ID" value="CAJ35083.1"/>
<property type="status" value="ALT_FRAME"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001001159.1">
<property type="nucleotide sequence ID" value="NM_001001159.1"/>
</dbReference>
<dbReference type="STRING" id="9913.ENSBTAP00000035880"/>
<dbReference type="PaxDb" id="Q704V6"/>
<dbReference type="GeneID" id="407237"/>
<dbReference type="KEGG" id="bta:407237"/>
<dbReference type="CTD" id="10333"/>
<dbReference type="eggNOG" id="KOG4641">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="InParanoid" id="Q704V6"/>
<dbReference type="OrthoDB" id="282372at2759"/>
<dbReference type="Proteomes" id="UP000009136">
<property type="component" value="Unplaced"/>
</dbReference>
<dbReference type="GO" id="GO:0005794">
<property type="term" value="C:Golgi apparatus"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005887">
<property type="term" value="C:integral component of plasma membrane"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0045121">
<property type="term" value="C:membrane raft"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030670">
<property type="term" value="C:phagocytic vesicle membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0035355">
<property type="term" value="C:Toll-like receptor 2-Toll-like receptor 6 protein complex"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0042802">
<property type="term" value="F:identical protein binding"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071723">
<property type="term" value="F:lipopeptide binding"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0050135">
<property type="term" value="F:NAD(P)+ nucleosidase activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0061809">
<property type="term" value="F:NAD+ nucleotidase, cyclic ADP-ribose generating"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0038023">
<property type="term" value="F:signaling receptor activity"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0035663">
<property type="term" value="F:Toll-like receptor 2 binding"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0004888">
<property type="term" value="F:transmembrane signaling receptor activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0071221">
<property type="term" value="P:cellular response to bacterial lipopeptide"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0071726">
<property type="term" value="P:cellular response to diacyl bacterial lipopeptide"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042496">
<property type="term" value="P:detection of diacyl bacterial lipopeptide"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0006954">
<property type="term" value="P:inflammatory response"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0045087">
<property type="term" value="P:innate immune response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0032611">
<property type="term" value="P:interleukin-1 beta production"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0002755">
<property type="term" value="P:MyD88-dependent toll-like receptor signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:1900227">
<property type="term" value="P:positive regulation of NLRP3 inflammasome complex assembly"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0034150">
<property type="term" value="P:toll-like receptor 6 signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0002224">
<property type="term" value="P:toll-like receptor signaling pathway"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="Gene3D" id="3.40.50.10140">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="3.80.10.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR000483">
<property type="entry name" value="Cys-rich_flank_reg_C"/>
</dbReference>
<dbReference type="InterPro" id="IPR001611">
<property type="entry name" value="Leu-rich_rpt"/>
</dbReference>
<dbReference type="InterPro" id="IPR003591">
<property type="entry name" value="Leu-rich_rpt_typical-subtyp"/>
</dbReference>
<dbReference type="InterPro" id="IPR032675">
<property type="entry name" value="LRR_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR000157">
<property type="entry name" value="TIR_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR027187">
<property type="entry name" value="TLR6"/>
</dbReference>
<dbReference type="InterPro" id="IPR017241">
<property type="entry name" value="Toll-like_receptor"/>
</dbReference>
<dbReference type="InterPro" id="IPR035897">
<property type="entry name" value="Toll_tir_struct_dom_sf"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR24365">
<property type="entry name" value="PTHR24365"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR24365:SF422">
<property type="entry name" value="PTHR24365:SF422"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF13855">
<property type="entry name" value="LRR_8"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF01463">
<property type="entry name" value="LRRCT"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF01582">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PIRSF" id="PIRSF037595">
<property type="entry name" value="Toll-like_receptor"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00369">
<property type="entry name" value="LRR_TYP"/>
<property type="match status" value="5"/>
</dbReference>
<dbReference type="SMART" id="SM00082">
<property type="entry name" value="LRRCT"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00255">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF52200">
<property type="entry name" value="SSF52200"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51450">
<property type="entry name" value="LRR"/>
<property type="match status" value="10"/>
</dbReference>
<dbReference type="PROSITE" id="PS50104">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at transcript level"/>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-0968">Cytoplasmic vesicle</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0333">Golgi apparatus</keyword>
<keyword id="KW-0378">Hydrolase</keyword>
<keyword id="KW-0391">Immunity</keyword>
<keyword id="KW-0395">Inflammatory response</keyword>
<keyword id="KW-0399">Innate immunity</keyword>
<keyword id="KW-0433">Leucine-rich repeat</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0520">NAD</keyword>
<keyword id="KW-0675">Receptor</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0732">Signal</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<feature type="signal peptide" evidence="4">
<location>
<begin position="1"/>
<end position="23"/>
</location>
</feature>
<feature type="chain" description="Toll-like receptor 6" id="PRO_0000394670" evidence="4">
<location>
<begin position="24"/>
<end position="793"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="4">
<location>
<begin position="24"/>
<end position="584"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="4">
<location>
<begin position="585"/>
<end position="605"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="4">
<location>
<begin position="606"/>
<end position="793"/>
</location>
</feature>
<feature type="repeat" description="LRR 1">
<location>
<begin position="54"/>
<end position="77"/>
</location>
</feature>
<feature type="repeat" description="LRR 2">
<location>
<begin position="78"/>
<end position="101"/>
</location>
</feature>
<feature type="repeat" description="LRR 3">
<location>
<begin position="102"/>
<end position="122"/>
</location>
</feature>
<feature type="repeat" description="LRR 4">
<location>
<begin position="123"/>
<end position="147"/>
</location>
</feature>
<feature type="repeat" description="LRR 5">
<location>
<begin position="148"/>
<end position="168"/>
</location>
</feature>
<feature type="repeat" description="LRR 6">
<location>
<begin position="169"/>
<end position="196"/>
</location>
</feature>
<feature type="repeat" description="LRR 7">
<location>
<begin position="197"/>
<end position="219"/>
</location>
</feature>
<feature type="repeat" description="LRR 8">
<location>
<begin position="220"/>
<end position="250"/>
</location>
</feature>
<feature type="repeat" description="LRR 9">
<location>
<begin position="251"/>
<end position="277"/>
</location>
</feature>
<feature type="repeat" description="LRR 10">
<location>
<begin position="278"/>
<end position="303"/>
</location>
</feature>
<feature type="repeat" description="LRR 11">
<location>
<begin position="304"/>
<end position="330"/>
</location>
</feature>
<feature type="repeat" description="LRR 12">
<location>
<begin position="331"/>
<end position="354"/>
</location>
</feature>
<feature type="repeat" description="LRR 13">
<location>
<begin position="355"/>
<end position="378"/>
</location>
</feature>
<feature type="repeat" description="LRR 14">
<location>
<begin position="379"/>
<end position="404"/>
</location>
</feature>
<feature type="repeat" description="LRR 15">
<location>
<begin position="405"/>
<end position="428"/>
</location>
</feature>
<feature type="repeat" description="LRR 16">
<location>
<begin position="429"/>
<end position="449"/>
</location>
</feature>
<feature type="repeat" description="LRR 17">
<location>
<begin position="450"/>
<end position="473"/>
</location>
</feature>
<feature type="repeat" description="LRR 18">
<location>
<begin position="474"/>
<end position="495"/>
</location>
</feature>
<feature type="repeat" description="LRR 19">
<location>
<begin position="496"/>
<end position="519"/>
</location>
</feature>
<feature type="domain" description="LRRCT">
<location>
<begin position="520"/>
<end position="575"/>
</location>
</feature>
<feature type="domain" description="TIR" evidence="5">
<location>
<begin position="640"/>
<end position="781"/>
</location>
</feature>
<feature type="active site" evidence="5">
<location>
<position position="715"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="63"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="145"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="253"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="285"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="359"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="423"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="434"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1">
<location>
<begin position="117"/>
<end position="140"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1">
<location>
<begin position="235"/>
<end position="265"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1">
<location>
<begin position="348"/>
<end position="373"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1">
<location>
<begin position="424"/>
<end position="447"/>
</location>
</feature>
<feature type="sequence variant" description="In strain: Angus, Charolais, Holstein and Limousin." evidence="6 7">
<original>D</original>
<variation>N</variation>
<location>
<position position="214"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; CAF02015/AAY40896." ref="1" evidence="8">
<original>G</original>
<variation>A</variation>
<location>
<position position="221"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; ACH92795/ACH92799/ACH92800/ACH92798 and 4; CAJ35083." ref="2 4" evidence="8">
<original>V</original>
<variation>M</variation>
<location>
<position position="259"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; ACH92795/ACH92799/ACH92800/ACH92798." ref="2" evidence="8">
<original>EH</original>
<variation>DY</variation>
<location>
<begin position="503"/>
<end position="504"/>
</location>
</feature>
<evidence key="1" type="ECO:0000250"/>
<evidence key="2" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q9EPW9"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q9Y2C9"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000255"/>
<evidence key="5" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00204"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16950576"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18639626"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000305"/>
<evidence key="9" type="ECO:0000312">
<source>
<dbReference type="EMBL" id="AAY40896.1"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000312">
<source>
<dbReference type="EMBL" id="ACH92795.1"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000312">
<source>
<dbReference type="EMBL" id="ACH92798.1"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000312">
<source>
<dbReference type="EMBL" id="ACH92799.1"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000312">
<source>
<dbReference type="EMBL" id="ACH92800.1"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000312">
<source>
<dbReference type="EMBL" id="CAF02015.1"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000312">
<source>
<dbReference type="EMBL" id="CAF06197.1"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000312">
<source>
<dbReference type="EMBL" id="CAJ35083.1"/>
</source>
</evidence>
<sequence length="793" mass="90927" checksum="C11C26009F8E3668" modified="2004-07-05" version="1" precursor="true">MIKDKESPIRSCHFVYIVALVFGTIIQFSDESEFVVDMSKTSLIHVPKDLPPKTKVLDLSQNNISELHLSDISFLSGLRVLRLSHNRIQGLDISIFKFNHDLEYLDLSHNQLQKISCHPITTTLKHLDLSFNDFDALPICKEFGNLTQLNFLGLSATKLQQLDLLPIAHLHLSCILLDLEDYMKENKKESLQILNTKKLHLVFHPNSFFSVQVDISANSLGCLQLTNIKLNDYNCQVLLKFLSGLTGGPTLLNFTLNHVETTWKCLVKVFQFLWPKPIEYLNIYNLTIVESIDEEVFTYYKTTLKALKIEHITNKVFIFSQTALYTVFSEMNILMLTISDTRFIHMLCPQEPSTFKFLNFTQNSFTDSVFQNCDTLARLETLILQKNELKDLFKTSLMTKDMLSLETLDVSWNSLEYDRSNGNCSWVGSIVVLNLSSNALTDSVFRCLPPRIKVLDLHNNRIRSIPKDVTGLETLQELNLASNSLAHLPGCGIFSSLSILIIEHNSISNPSADFFQSCQKIRSLKAGNNPFQCSCELRDFIQSVGQVSSDVVEGWPESYKCDYPESYKGTPLKDFQVSELSCNTALLIITIVVPGLVLAVAVTVLCIYLDLPWYLRMVCQWTQTRRRARNVPLEELQRTLQFHAFISYSEHDSAWVKNELIPNLEKEDIRICLHERNFVAGKSIVENIINCIEKSYKSIFVLSPNFVQSEWCHYELYFAHHNLFHEGSDNLILILLDPIPQYSIPSSYHKLRALMAQRTYLEWPKEKSKHGLFWANLRASINIKLMEKAAEIH</sequence>
</entry>
<entry dataset="Swiss-Prot" created="2009-02-10" modified="2021-02-10" version="102">
<accession>Q6T752</accession>
<name>TLR2_HORSE</name>
<protein>
<recommendedName>
<fullName>Toll-like receptor 2</fullName>
<ecNumber evidence="5">3.2.2.6</ecNumber>
</recommendedName>
<cdAntigenName>CD282</cdAntigenName>
</protein>
<gene>
<name type="primary">TLR2</name>
</gene>
<organism>
<name type="scientific">Equus caballus</name>
<name type="common">Horse</name>
<dbReference type="NCBI Taxonomy" id="9796"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Laurasiatheria</taxon>
<taxon>Perissodactyla</taxon>
<taxon>Equidae</taxon>
<taxon>Equus</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="submission" date="2003-10" db="EMBL/GenBank/DDBJ databases">
<title>Cloning and sequencing of equine toll-like receptor 2 (TLR2).</title>
<authorList>
<person name="Vandenplas M.L."/>
<person name="McNeill B.W."/>
<person name="Cordonnier-Pratt M.-M."/>
<person name="Pratt L.H."/>
<person name="Moore J.N."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
</reference>
<comment type="function">
<text evidence="2 3">Cooperates with LY96 to mediate the innate immune response to bacterial lipoproteins and other microbial cell wall components. Cooperates with TLR1 or TLR6 to mediate the innate immune response to bacterial lipoproteins or lipopeptides. Acts via MYD88 and TRAF6, leading to NF-kappa-B activation, cytokine secretion and the inflammatory response (By similarity). May also promote apoptosis in response to lipoproteins. Forms activation clusters composed of several receptors depending on the ligand, these clusters trigger signaling from the cell surface and subsequently are targeted to the Golgi in a lipid-raft dependent pathway. Forms the cluster TLR2:TLR6:CD14:CD36 in response to diacylated lipopeptides and TLR2:TLR1:CD14 in response to triacylated lipopeptides (By similarity).</text>
</comment>
<comment type="catalytic activity">
<reaction evidence="5">
<text>H2O + NAD(+) = ADP-D-ribose + H(+) + nicotinamide</text>
<dbReference type="Rhea" id="RHEA:16301"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:17154"/>
<dbReference type="ChEBI" id="CHEBI:57540"/>
<dbReference type="ChEBI" id="CHEBI:57967"/>
<dbReference type="EC" id="3.2.2.6"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="5">
<dbReference type="Rhea" id="RHEA:16302"/>
</physiologicalReaction>
</comment>
<comment type="subunit">
<text evidence="2 3">Interacts with LY96, TLR1 and TLR6 (via extracellular domain). TLR2 seems to exist in heterodimers with either TLR1 or TLR6 before stimulation by the ligand. The heterodimers form bigger oligomers in response to their corresponding ligands as well as further heterotypic associations with other receptors such as CD14 and/or CD36. Binds MYD88 (via TIR domain). Interacts with TICAM1. Interacts with CNPY3. Interacts with ATG16L1. Interacts with PPP1R11. Interacts with TICAM2.</text>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="3">Membrane</location>
<topology evidence="4">Single-pass type I membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="3">Cytoplasmic vesicle</location>
<location evidence="3">Phagosome membrane</location>
<topology evidence="4">Single-pass type I membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="2">Membrane raft</location>
</subcellularLocation>
<text evidence="2">Does not reside in lipid rafts before stimulation but accumulates increasingly in the raft upon the presence of the microbial ligand. In response to diacylated lipoproteins, TLR2:TLR6 heterodimers are recruited in lipid rafts, this recruitment determine the intracellular targeting to the Golgi apparatus. Triacylated lipoproteins induce the same mechanism for TLR2:TLR1 heterodimers.</text>
</comment>
<comment type="domain">
<text evidence="1">Ester-bound lipid substrates are bound through a crevice formed between the LRR 11 and LRR 12.</text>
</comment>
<comment type="domain">
<text evidence="1">The ATG16L1-binding motif mediates interaction with ATG16L1.</text>
</comment>
<comment type="domain">
<text evidence="5">The TIR domain mediates NAD(+) hydrolase (NADase) activity. Self-association of TIR domains is required for NADase activity.</text>
</comment>
<comment type="PTM">
<text evidence="3">Ubiquitinated at Lys-754 by PPP1R11, leading to its degradation. Deubiquitinated by USP2.</text>
</comment>
<comment type="PTM">
<text evidence="2">Glycosylation of Asn-442 is critical for secretion of the N-terminal ectodomain of TLR2.</text>
</comment>
<comment type="similarity">
<text evidence="6">Belongs to the Toll-like receptor family.</text>
</comment>
<dbReference type="EC" id="3.2.2.6" evidence="5"/>
<dbReference type="EMBL" id="AY429602">
<property type="protein sequence ID" value="AAR08196.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001075265.1">
<property type="nucleotide sequence ID" value="NM_001081796.1"/>
</dbReference>
<dbReference type="SMR" id="Q6T752"/>
<dbReference type="PaxDb" id="Q6T752"/>
<dbReference type="GeneID" id="100009701"/>
<dbReference type="KEGG" id="ecb:100009701"/>
<dbReference type="CTD" id="7097"/>
<dbReference type="InParanoid" id="Q6T752"/>
<dbReference type="OrthoDB" id="282372at2759"/>
<dbReference type="Proteomes" id="UP000002281">
<property type="component" value="Unplaced"/>
</dbReference>
<dbReference type="GO" id="GO:0005794">
<property type="term" value="C:Golgi apparatus"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016021">
<property type="term" value="C:integral component of membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0045121">
<property type="term" value="C:membrane raft"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030670">
<property type="term" value="C:phagocytic vesicle membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0050135">
<property type="term" value="F:NAD(P)+ nucleosidase activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0061809">
<property type="term" value="F:NAD+ nucleotidase, cyclic ADP-ribose generating"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0004888">
<property type="term" value="F:transmembrane signaling receptor activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0071726">
<property type="term" value="P:cellular response to diacyl bacterial lipopeptide"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071727">
<property type="term" value="P:cellular response to triacyl bacterial lipopeptide"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006954">
<property type="term" value="P:inflammatory response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0045087">
<property type="term" value="P:innate immune response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0002755">
<property type="term" value="P:MyD88-dependent toll-like receptor signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0050729">
<property type="term" value="P:positive regulation of inflammatory response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0034134">
<property type="term" value="P:toll-like receptor 2 signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="Gene3D" id="3.40.50.10140">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="3.80.10.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR000483">
<property type="entry name" value="Cys-rich_flank_reg_C"/>
</dbReference>
<dbReference type="InterPro" id="IPR001611">
<property type="entry name" value="Leu-rich_rpt"/>
</dbReference>
<dbReference type="InterPro" id="IPR003591">
<property type="entry name" value="Leu-rich_rpt_typical-subtyp"/>
</dbReference>
<dbReference type="InterPro" id="IPR026906">
<property type="entry name" value="LRR_5"/>
</dbReference>
<dbReference type="InterPro" id="IPR032675">
<property type="entry name" value="LRR_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR000157">
<property type="entry name" value="TIR_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR027185">
<property type="entry name" value="TLR2"/>
</dbReference>
<dbReference type="InterPro" id="IPR017241">
<property type="entry name" value="Toll-like_receptor"/>
</dbReference>
<dbReference type="InterPro" id="IPR035897">
<property type="entry name" value="Toll_tir_struct_dom_sf"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR24365">
<property type="entry name" value="PTHR24365"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR24365:SF17">
<property type="entry name" value="PTHR24365:SF17"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF13306">
<property type="entry name" value="LRR_5"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF13855">
<property type="entry name" value="LRR_8"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="Pfam" id="PF01463">
<property type="entry name" value="LRRCT"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF01582">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PIRSF" id="PIRSF037595">
<property type="entry name" value="Toll-like_receptor"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00369">
<property type="entry name" value="LRR_TYP"/>
<property type="match status" value="8"/>
</dbReference>
<dbReference type="SMART" id="SM00082">
<property type="entry name" value="LRRCT"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00255">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF52200">
<property type="entry name" value="SSF52200"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51450">
<property type="entry name" value="LRR"/>
<property type="match status" value="9"/>
</dbReference>
<dbReference type="PROSITE" id="PS50104">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at transcript level"/>
<keyword id="KW-0968">Cytoplasmic vesicle</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0378">Hydrolase</keyword>
<keyword id="KW-0391">Immunity</keyword>
<keyword id="KW-0395">Inflammatory response</keyword>
<keyword id="KW-0399">Innate immunity</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0433">Leucine-rich repeat</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0520">NAD</keyword>
<keyword id="KW-0675">Receptor</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0732">Signal</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="signal peptide" evidence="4">
<location>
<begin position="1"/>
<end position="20"/>
</location>
</feature>
<feature type="chain" description="Toll-like receptor 2" id="PRO_0000363773">
<location>
<begin position="21"/>
<end position="784"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="4">
<location>
<begin position="21"/>
<end position="587"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="4">
<location>
<begin position="588"/>
<end position="608"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="4">
<location>
<begin position="609"/>
<end position="784"/>
</location>
</feature>
<feature type="repeat" description="LRR 1">
<location>
<begin position="54"/>
<end position="77"/>
</location>
</feature>
<feature type="repeat" description="LRR 2">
<location>
<begin position="78"/>
<end position="101"/>
</location>
</feature>
<feature type="repeat" description="LRR 3">
<location>
<begin position="102"/>
<end position="125"/>
</location>
</feature>
<feature type="repeat" description="LRR 4">
<location>
<begin position="126"/>
<end position="150"/>
</location>
</feature>
<feature type="repeat" description="LRR 5">
<location>
<begin position="151"/>
<end position="175"/>
</location>
</feature>
<feature type="repeat" description="LRR 6">
<location>
<begin position="176"/>
<end position="199"/>
</location>
</feature>
<feature type="repeat" description="LRR 7">
<location>
<begin position="200"/>
<end position="223"/>
</location>
</feature>
<feature type="repeat" description="LRR 8">
<location>
<begin position="224"/>
<end position="250"/>
</location>
</feature>
<feature type="repeat" description="LRR 9">
<location>
<begin position="251"/>
<end position="278"/>
</location>
</feature>
<feature type="repeat" description="LRR 10">
<location>
<begin position="279"/>
<end position="308"/>
</location>
</feature>
<feature type="repeat" description="LRR 11">
<location>
<begin position="309"/>
<end position="337"/>
</location>
</feature>
<feature type="repeat" description="LRR 12">
<location>
<begin position="338"/>
<end position="361"/>
</location>
</feature>
<feature type="repeat" description="LRR 13">
<location>
<begin position="362"/>
<end position="388"/>
</location>
</feature>
<feature type="repeat" description="LRR 14">
<location>
<begin position="389"/>
<end position="414"/>
</location>
</feature>
<feature type="repeat" description="LRR 15">
<location>
<begin position="415"/>
<end position="437"/>
</location>
</feature>
<feature type="repeat" description="LRR 16">
<location>
<begin position="438"/>
<end position="457"/>
</location>
</feature>
<feature type="repeat" description="LRR 17">
<location>
<begin position="458"/>
<end position="478"/>
</location>
</feature>
<feature type="repeat" description="LRR 18">
<location>
<begin position="479"/>
<end position="500"/>
</location>
</feature>
<feature type="repeat" description="LRR 19">
<location>
<begin position="501"/>
<end position="524"/>
</location>
</feature>
<feature type="domain" description="LRRCT">
<location>
<begin position="525"/>
<end position="579"/>
</location>
</feature>
<feature type="domain" description="TIR" evidence="5">
<location>
<begin position="639"/>
<end position="782"/>
</location>
</feature>
<feature type="short sequence motif" description="ATG16L1-binding motif">
<location>
<begin position="761"/>
<end position="778"/>
</location>
</feature>
<feature type="active site" evidence="5">
<location>
<position position="716"/>
</location>
</feature>
<feature type="site" description="Interaction with bacterial lipopeptide" evidence="1">
<location>
<position position="349"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="115"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="199"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="414"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="442"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1">
<location>
<begin position="31"/>
<end position="37"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1">
<location>
<begin position="353"/>
<end position="382"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1">
<location>
<begin position="432"/>
<end position="454"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="2">
<location>
<position position="754"/>
</location>
</feature>
<evidence key="1" type="ECO:0000250"/>
<evidence key="2" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="O60603"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q9QUN7"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000255"/>
<evidence key="5" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00204"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000305"/>
<sequence length="784" mass="90164" checksum="6E170C4DF7FDE5D1" modified="2004-07-05" version="1" precursor="true">MPHALWTVWVLGAVISLSKEGVPDQPSSLSCDPTGVCDGRSRSLNSIPSGLTAAVKSLDLSNNKIASVGNSDLWKCVNLKALRLGSNDINTIEEDSFSSLRSLEHLDLSNNHLSNLSSSWFRPLSSLKFLNLLGSTYKTLGETSLFSHLTNLRILKVGNIHFTEIQGKDFAGLTFLEELEIDATNLQRYEPKSFKSIQNISHLILRMKQPVLLPEIILDTLSSLEYLELRDTYLNTFHFAEVSDPETNTLIKKFTFRNVKITDESFDEIVKLLNYISGVSEAEFDECTLDGLGEFRTPDIDKIKVIGKLETLTIRRLRIPQFYLFRDLSSIYSLTERVKRITIENSKVFLVPCSLSRHLKSLEYLDLSDNLMVEEYLKNSACERAWPSLQTLILRQNHLTSLGKTGETLLTLKNLTKLDISKNSFHSMPETCQWPEKMKYLNLSSIRIDRLTQCIPQTLEVLDISNNNLNSFSLILPQVKELYISRNKLKTLPDASFLPMLLVMRISRKTINTFSKEQLDSFQKLKTLEAGGNNFICSCEFLSFTQEEQALDQILIDWPENYLCDSPSHVRGQRVQDTHLSVSECHRTALVSAVCCALFLSILLTGVLCHHFHGLWYMKMMWAWLQAKRKPRTAPQRDICYDAFVSYSERDSYWVENLMVQELEHFNPPFKLCLHKRDFIPGKWIIDNIIDSIEKSHKTIFVLSENFVKSEWCKYELDFSHFRLFDENNDAAILILLEPIDKKAIPQRFCKLRKIMNTKTYLEWPTDEAQQEGFWLNLRAAIKS</sequence>
</entry>
<entry dataset="Swiss-Prot" created="2002-01-31" modified="2021-02-10" version="161">
<accession>Q9EPW9</accession>
<accession>Q9WTQ4</accession>
<name>TLR6_MOUSE</name>
<protein>
<recommendedName>
<fullName>Toll-like receptor 6</fullName>
<ecNumber evidence="4">3.2.2.6</ecNumber>
</recommendedName>
<cdAntigenName>CD286</cdAntigenName>
</protein>
<gene>
<name type="primary">Tlr6</name>
</gene>
<organism>
<name type="scientific">Mus musculus</name>
<name type="common">Mouse</name>
<dbReference type="NCBI Taxonomy" id="10090"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Glires</taxon>
<taxon>Rodentia</taxon>
<taxon>Myomorpha</taxon>
<taxon>Muroidea</taxon>
<taxon>Muridae</taxon>
<taxon>Murinae</taxon>
<taxon>Mus</taxon>
<taxon>Mus</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1999" name="Gene" volume="231" first="59" last="65">
<title>TLR6: a novel member of an expanding Toll-like receptor family.</title>
<authorList>
<person name="Takeuchi O."/>
<person name="Kawai T."/>
<person name="Sanjo H."/>
<person name="Copeland N.G."/>
<person name="Gilbert D.J."/>
<person name="Jenkins N.A."/>
<person name="Takeda K."/>
<person name="Akira S."/>
</authorList>
<dbReference type="PubMed" id="10231569"/>
<dbReference type="DOI" id="10.1016/s0378-1119(99)00098-0"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<source>
<tissue>Embryo</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="2000" name="Proc. Natl. Acad. Sci. U.S.A." volume="97" first="13766" last="13771">
<title>The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between Toll-like receptors.</title>
<authorList>
<person name="Ozinsky A."/>
<person name="Underhill D.M."/>
<person name="Fontenot J.D."/>
<person name="Hajjar A.M."/>
<person name="Smith K.D."/>
<person name="Wilson C.B."/>
<person name="Schroeder L."/>
<person name="Aderem A."/>
</authorList>
<dbReference type="PubMed" id="11095740"/>
<dbReference type="DOI" id="10.1073/pnas.250476497"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>MUTAGENESIS OF PRO-680</scope>
<scope>SUBCELLULAR LOCATION</scope>
<source>
<strain>BALB/cJ</strain>
<tissue>Macrophage</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="2010" name="Nat. Immunol." volume="11" first="155" last="161">
<title>CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer.</title>
<authorList>
<person name="Stewart C.R."/>
<person name="Stuart L.M."/>
<person name="Wilkinson K."/>
<person name="van Gils J.M."/>
<person name="Deng J."/>
<person name="Halle A."/>
<person name="Rayner K.J."/>
<person name="Boyer L."/>
<person name="Zhong R."/>
<person name="Frazier W.A."/>
<person name="Lacy-Hulbert A."/>
<person name="El Khoury J."/>
<person name="Golenbock D.T."/>
<person name="Moore K.J."/>
</authorList>
<dbReference type="PubMed" id="20037584"/>
<dbReference type="DOI" id="10.1038/ni.1836"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2013" name="Nat. Immunol." volume="14" first="812" last="820">
<title>CD36 coordinates NLRP3 inflammasome activation by facilitating intracellular nucleation of soluble ligands into particulate ligands in sterile inflammation.</title>
<authorList>
<person name="Sheedy F.J."/>
<person name="Grebe A."/>
<person name="Rayner K.J."/>
<person name="Kalantari P."/>
<person name="Ramkhelawon B."/>
<person name="Carpenter S.B."/>
<person name="Becker C.E."/>
<person name="Ediriweera H.N."/>
<person name="Mullick A.E."/>
<person name="Golenbock D.T."/>
<person name="Stuart L.M."/>
<person name="Latz E."/>
<person name="Fitzgerald K.A."/>
<person name="Moore K.J."/>
</authorList>
<dbReference type="PubMed" id="23812099"/>
<dbReference type="DOI" id="10.1038/ni.2639"/>
</citation>
<scope>FUNCTION</scope>
<scope>DISRUPTION PHENOTYPE</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2009" name="Immunity" volume="31" first="873" last="884">
<title>Recognition of lipopeptide patterns by Toll-like receptor 2-Toll-like receptor 6 heterodimer.</title>
<authorList>
<person name="Kang J.Y."/>
<person name="Nan X."/>
<person name="Jin M.S."/>
<person name="Youn S.J."/>
<person name="Ryu Y.H."/>
<person name="Mah S."/>
<person name="Han S.H."/>
<person name="Lee H."/>
<person name="Paik S.G."/>
<person name="Lee J.O."/>
</authorList>
<dbReference type="PubMed" id="19931471"/>
<dbReference type="DOI" id="10.1016/j.immuni.2009.09.018"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.9 ANGSTROMS) OF 1-483 IN COMPLEX WITH TLR2 AND LIPOPEPTIDE</scope>
<scope>DISULFIDE BONDS</scope>
<scope>GLYCOSYLATION AT ASN-144; ASN-195; ASN-214; ASN-253; ASN-359; ASN-401 AND ASN-434</scope>
<scope>FUNCTION</scope>
<scope>LRR REPEATS</scope>
<scope>SUBUNIT</scope>
</reference>
<comment type="function">
<text evidence="6 7 8">Participates in the innate immune response to Gram-positive bacteria and fungi. Specifically recognizes diacylated and, to a lesser extent, triacylated lipopeptides (PubMed:19931471). In response to diacylated lipopeptides, forms the activation cluster TLR2:TLR6:CD14:CD36, this cluster triggers signaling from the cell surface and subsequently is targeted to the Golgi in a lipid-raft dependent pathway. Acts via MYD88 and TRAF6, leading to NF-kappa-B activation, cytokine secretion and the inflammatory response. Recognizes mycoplasmal macrophage-activating lipopeptide-2kD (MALP-2), soluble tuberculosis factor (STF), phenol-soluble modulin (PSM) and B.burgdorferi outer surface protein A lipoprotein (OspA-L) cooperatively with TLR2. In complex with TLR4, promotes sterile inflammation in monocytes/macrophages in response to oxidized low-density lipoprotein (oxLDL) or amyloid-beta 42. In this context, the initial signal is provided by oxLDL- or amyloid-beta 42-binding to CD36. This event induces the formation of a heterodimer of TLR4 and TLR6, which is rapidly internalized and triggers inflammatory response, leading to the NF-kappa-B-dependent production of CXCL1, CXCL2 and CCL9 cytokines, via MYD88 signaling pathway, and CCL5 cytokine, via TICAM1 signaling pathway, as well as IL1B secretion (PubMed:20037584, PubMed:23812099).</text>
</comment>
<comment type="catalytic activity">
<reaction evidence="4">
<text>H2O + NAD(+) = ADP-D-ribose + H(+) + nicotinamide</text>
<dbReference type="Rhea" id="RHEA:16301"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:17154"/>
<dbReference type="ChEBI" id="CHEBI:57540"/>
<dbReference type="ChEBI" id="CHEBI:57967"/>
<dbReference type="EC" id="3.2.2.6"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="4">
<dbReference type="Rhea" id="RHEA:16302"/>
</physiologicalReaction>
</comment>
<comment type="subunit">
<text evidence="2 6 9">Homodimer (via cytoplasmic TIR domain) (By similarity). Heterodimer with TLR2 via their respective extracellular domains (PubMed:19931471). Binds MYD88 via their respective TIR domains (Probable). Interacts with CD36, following CD36 stimulation by oxLDL or amyloid-beta 42, and forms a heterodimer with TLR4. The trimeric complex is internalized and triggers inflammatory response. LYN kinase activity facilitates TLR4:TLR6 heterodimerization and signal initiation (By similarity). The heterodimer TLR2:TLR6 interacts with CD14 and CD36 in response to triacylated lipopeptides (By similarity).</text>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="5">Cell membrane</location>
<topology evidence="3">Single-pass type I membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="5">Cytoplasmic vesicle</location>
<location evidence="5">Phagosome membrane</location>
<topology evidence="3">Single-pass type I membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="2">Membrane raft</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="2">Golgi apparatus</location>
</subcellularLocation>
<text evidence="2">Upon complex formation with CD36 and TLR4, internalized through dynamin-dependent endocytosis. Does not reside in lipid rafts before stimulation but accumulates increasingly in the raft upon the presence of the microbial ligand. In response to diacylated lipoproteins, TLR2:TLR6 heterodimers are recruited in lipid rafts, this recruitment determine the intracellular targeting to the Golgi apparatus.</text>
</comment>
<comment type="tissue specificity">
<text evidence="8">Detected in thymus, spleen, ovary and lung. Expressed in macrohpages.</text>
</comment>
<comment type="domain">
<text evidence="4">The TIR domain mediates NAD(+) hydrolase (NADase) activity. Self-association of TIR domains is required for NADase activity.</text>
</comment>
<comment type="disruption phenotype">
<text evidence="8">Animals with a double knockout of APOE and TLR6, fed a Western diet for 12 weeks, have less aortic plaque formation than single APOE knockout mice. They also show lower serum concentrations of IL1A, ILB and IL18.</text>
</comment>
<comment type="similarity">
<text evidence="9">Belongs to the Toll-like receptor family.</text>
</comment>
<comment type="sequence caution" evidence="9">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="AAG38563" version="1"/>
</conflict>
<text>Extended N-terminus.</text>
</comment>
<comment type="sequence caution" evidence="9">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="BAA78632" version="1"/>
</conflict>
<text>Extended N-terminus.</text>
</comment>
<dbReference type="EC" id="3.2.2.6" evidence="4"/>
<dbReference type="EMBL" id="AB020808">
<property type="protein sequence ID" value="BAA78632.1"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF314636">
<property type="protein sequence ID" value="AAG38563.1"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="RefSeq" id="NP_035734.3">
<property type="nucleotide sequence ID" value="NM_011604.3"/>
</dbReference>
<dbReference type="RefSeq" id="XP_006503920.1">
<property type="nucleotide sequence ID" value="XM_006503857.2"/>
</dbReference>
<dbReference type="RefSeq" id="XP_006503921.1">
<property type="nucleotide sequence ID" value="XM_006503858.3"/>
</dbReference>
<dbReference type="RefSeq" id="XP_006503922.1">
<property type="nucleotide sequence ID" value="XM_006503859.3"/>
</dbReference>
<dbReference type="RefSeq" id="XP_006503923.1">
<property type="nucleotide sequence ID" value="XM_006503860.1"/>
</dbReference>
<dbReference type="PDB" id="3A79">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.90"/>
<property type="chains" value="B=1-482"/>
</dbReference>
<dbReference type="PDBsum" id="3A79"/>
<dbReference type="SMR" id="Q9EPW9"/>
<dbReference type="IntAct" id="Q9EPW9">
<property type="interactions" value="4"/>
</dbReference>
<dbReference type="STRING" id="10090.ENSMUSP00000062096"/>
<dbReference type="ChEMBL" id="CHEMBL2146341"/>
<dbReference type="GlyGen" id="Q9EPW9">
<property type="glycosylation" value="10 sites"/>
</dbReference>
<dbReference type="iPTMnet" id="Q9EPW9"/>
<dbReference type="PhosphoSitePlus" id="Q9EPW9"/>
<dbReference type="MaxQB" id="Q9EPW9"/>
<dbReference type="PaxDb" id="Q9EPW9"/>
<dbReference type="PRIDE" id="Q9EPW9"/>
<dbReference type="Ensembl" id="ENSMUST00000062315">
<property type="protein sequence ID" value="ENSMUSP00000062096"/>
<property type="gene ID" value="ENSMUSG00000051498"/>
</dbReference>
<dbReference type="GeneID" id="21899"/>
<dbReference type="KEGG" id="mmu:21899"/>
<dbReference type="CTD" id="10333"/>
<dbReference type="MGI" id="MGI:1341296">
<property type="gene designation" value="Tlr6"/>
</dbReference>
<dbReference type="eggNOG" id="KOG4641">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000162201"/>
<dbReference type="InParanoid" id="Q9EPW9"/>
<dbReference type="OrthoDB" id="282372at2759"/>
<dbReference type="PhylomeDB" id="Q9EPW9"/>
<dbReference type="Reactome" id="R-MMU-5686938">
<property type="pathway name" value="Regulation of TLR by endogenous ligand"/>
</dbReference>
<dbReference type="BioGRID-ORCS" id="21899">
<property type="hits" value="0 hits in 17 CRISPR screens"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="Q9EPW9"/>
<dbReference type="PRO" id="PR:Q9EPW9"/>
<dbReference type="Proteomes" id="UP000000589">
<property type="component" value="Chromosome 5"/>
</dbReference>
<dbReference type="RNAct" id="Q9EPW9">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="GO" id="GO:0005794">
<property type="term" value="C:Golgi apparatus"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005887">
<property type="term" value="C:integral component of plasma membrane"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0045121">
<property type="term" value="C:membrane raft"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030670">
<property type="term" value="C:phagocytic vesicle membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0043235">
<property type="term" value="C:receptor complex"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0035355">
<property type="term" value="C:Toll-like receptor 2-Toll-like receptor 6 protein complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0042498">
<property type="term" value="F:diacyl lipopeptide binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0042802">
<property type="term" value="F:identical protein binding"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071723">
<property type="term" value="F:lipopeptide binding"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050135">
<property type="term" value="F:NAD(P)+ nucleosidase activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0061809">
<property type="term" value="F:NAD+ nucleotidase, cyclic ADP-ribose generating"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0046982">
<property type="term" value="F:protein heterodimerization activity"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0038023">
<property type="term" value="F:signaling receptor activity"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0005102">
<property type="term" value="F:signaling receptor binding"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0035663">
<property type="term" value="F:Toll-like receptor 2 binding"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0004888">
<property type="term" value="F:transmembrane signaling receptor activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0001775">
<property type="term" value="P:cell activation"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:1904646">
<property type="term" value="P:cellular response to amyloid-beta"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0071221">
<property type="term" value="P:cellular response to bacterial lipopeptide"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0071726">
<property type="term" value="P:cellular response to diacyl bacterial lipopeptide"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0140052">
<property type="term" value="P:cellular response to oxidised low-density lipoprotein particle stimulus"/>
<property type="evidence" value="ECO:0000316"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0042496">
<property type="term" value="P:detection of diacyl bacterial lipopeptide"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0006954">
<property type="term" value="P:inflammatory response"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0045087">
<property type="term" value="P:innate immune response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0032611">
<property type="term" value="P:interleukin-1 beta production"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001774">
<property type="term" value="P:microglial cell activation"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0002755">
<property type="term" value="P:MyD88-dependent toll-like receptor signaling pathway"/>
<property type="evidence" value="ECO:0000316"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032717">
<property type="term" value="P:negative regulation of interleukin-8 production"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0034136">
<property type="term" value="P:negative regulation of toll-like receptor 2 signaling pathway"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0032720">
<property type="term" value="P:negative regulation of tumor necrosis factor production"/>
<property type="evidence" value="ECO:0000316"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0046209">
<property type="term" value="P:nitric oxide metabolic process"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:1900017">
<property type="term" value="P:positive regulation of cytokine production involved in inflammatory response"/>
<property type="evidence" value="ECO:0000316"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0010628">
<property type="term" value="P:positive regulation of gene expression"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0043123">
<property type="term" value="P:positive regulation of I-kappaB kinase/NF-kappaB signaling"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0050729">
<property type="term" value="P:positive regulation of inflammatory response"/>
<property type="evidence" value="ECO:0000316"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032735">
<property type="term" value="P:positive regulation of interleukin-12 production"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032755">
<property type="term" value="P:positive regulation of interleukin-6 production"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043507">
<property type="term" value="P:positive regulation of JUN kinase activity"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0043032">
<property type="term" value="P:positive regulation of macrophage activation"/>
<property type="evidence" value="ECO:0000316"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0051092">
<property type="term" value="P:positive regulation of NF-kappaB transcription factor activity"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0045429">
<property type="term" value="P:positive regulation of nitric oxide biosynthetic process"/>
<property type="evidence" value="ECO:0000316"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1900227">
<property type="term" value="P:positive regulation of NLRP3 inflammasome complex assembly"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1903223">
<property type="term" value="P:positive regulation of oxidative stress-induced neuron death"/>
<property type="evidence" value="ECO:0000316"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1903428">
<property type="term" value="P:positive regulation of reactive oxygen species biosynthetic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032493">
<property type="term" value="P:response to bacterial lipoprotein"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0034150">
<property type="term" value="P:toll-like receptor 6 signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0002224">
<property type="term" value="P:toll-like receptor signaling pathway"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0035666">
<property type="term" value="P:TRIF-dependent toll-like receptor signaling pathway"/>
<property type="evidence" value="ECO:0000316"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="Gene3D" id="3.40.50.10140">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="3.80.10.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR000483">
<property type="entry name" value="Cys-rich_flank_reg_C"/>
</dbReference>
<dbReference type="InterPro" id="IPR001611">
<property type="entry name" value="Leu-rich_rpt"/>
</dbReference>
<dbReference type="InterPro" id="IPR003591">
<property type="entry name" value="Leu-rich_rpt_typical-subtyp"/>
</dbReference>
<dbReference type="InterPro" id="IPR032675">
<property type="entry name" value="LRR_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR000157">
<property type="entry name" value="TIR_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR027187">
<property type="entry name" value="TLR6"/>
</dbReference>
<dbReference type="InterPro" id="IPR017241">
<property type="entry name" value="Toll-like_receptor"/>
</dbReference>
<dbReference type="InterPro" id="IPR035897">
<property type="entry name" value="Toll_tir_struct_dom_sf"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR24365">
<property type="entry name" value="PTHR24365"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR24365:SF422">
<property type="entry name" value="PTHR24365:SF422"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF13855">
<property type="entry name" value="LRR_8"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF01582">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PIRSF" id="PIRSF037595">
<property type="entry name" value="Toll-like_receptor"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00369">
<property type="entry name" value="LRR_TYP"/>
<property type="match status" value="4"/>
</dbReference>
<dbReference type="SMART" id="SM00082">
<property type="entry name" value="LRRCT"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00255">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF52200">
<property type="entry name" value="SSF52200"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51450">
<property type="entry name" value="LRR"/>
<property type="match status" value="10"/>
</dbReference>
<dbReference type="PROSITE" id="PS50104">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-0968">Cytoplasmic vesicle</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0333">Golgi apparatus</keyword>
<keyword id="KW-0378">Hydrolase</keyword>
<keyword id="KW-0391">Immunity</keyword>
<keyword id="KW-0395">Inflammatory response</keyword>
<keyword id="KW-0399">Innate immunity</keyword>
<keyword id="KW-0433">Leucine-rich repeat</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0520">NAD</keyword>
<keyword id="KW-0675">Receptor</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0732">Signal</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<feature type="signal peptide" evidence="3">
<location>
<begin position="1"/>
<end position="27"/>
</location>
</feature>
<feature type="chain" description="Toll-like receptor 6" id="PRO_0000034732">
<location>
<begin position="28"/>
<end position="795"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="3">
<location>
<begin position="28"/>
<end position="584"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="3">
<location>
<begin position="585"/>
<end position="605"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="3">
<location>
<begin position="606"/>
<end position="795"/>
</location>
</feature>
<feature type="repeat" description="LRR 1" evidence="6">
<location>
<begin position="54"/>
<end position="77"/>
</location>
</feature>
<feature type="repeat" description="LRR 2" evidence="6">
<location>
<begin position="78"/>
<end position="101"/>
</location>
</feature>
<feature type="repeat" description="LRR 3" evidence="6">
<location>
<begin position="102"/>
<end position="125"/>
</location>
</feature>
<feature type="repeat" description="LRR 4" evidence="6">
<location>
<begin position="126"/>
<end position="150"/>
</location>
</feature>
<feature type="repeat" description="LRR 5" evidence="6">
<location>
<begin position="151"/>
<end position="175"/>
</location>
</feature>
<feature type="repeat" description="LRR 6" evidence="6">
<location>
<begin position="176"/>
<end position="199"/>
</location>
</feature>
<feature type="repeat" description="LRR 7" evidence="6">
<location>
<begin position="200"/>
<end position="223"/>
</location>
</feature>
<feature type="repeat" description="LRR 8" evidence="6">
<location>
<begin position="224"/>
<end position="250"/>
</location>
</feature>
<feature type="repeat" description="LRR 9" evidence="6">
<location>
<begin position="251"/>
<end position="278"/>
</location>
</feature>
<feature type="repeat" description="LRR 10" evidence="6">
<location>
<begin position="279"/>
<end position="308"/>
</location>
</feature>
<feature type="repeat" description="LRR 11" evidence="6">
<location>
<begin position="309"/>
<end position="337"/>
</location>
</feature>
<feature type="repeat" description="LRR 12" evidence="6">
<location>
<begin position="338"/>
<end position="361"/>
</location>
</feature>
<feature type="repeat" description="LRR 13" evidence="6">
<location>
<begin position="362"/>
<end position="388"/>
</location>
</feature>
<feature type="repeat" description="LRR 14" evidence="6">
<location>
<begin position="389"/>
<end position="414"/>
</location>
</feature>
<feature type="repeat" description="LRR 15" evidence="6">
<location>
<begin position="415"/>
<end position="437"/>
</location>
</feature>
<feature type="repeat" description="LRR 16" evidence="6">
<location>
<begin position="438"/>
<end position="457"/>
</location>
</feature>
<feature type="repeat" description="LRR 17" evidence="6">
<location>
<begin position="458"/>
<end position="478"/>
</location>
</feature>
<feature type="repeat" description="LRR 18" evidence="6">
<location>
<begin position="479"/>
<end position="500"/>
</location>
</feature>
<feature type="repeat" description="LRR 19" evidence="6">
<location>
<begin position="501"/>
<end position="524"/>
</location>
</feature>
<feature type="domain" description="LRRCT">
<location>
<begin position="525"/>
<end position="576"/>
</location>
</feature>
<feature type="domain" description="TIR" evidence="4">
<location>
<begin position="640"/>
<end position="781"/>
</location>
</feature>
<feature type="active site" evidence="4">
<location>
<position position="715"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="3">
<location>
<position position="42"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="3">
<location>
<position position="114"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="6">
<location>
<position position="144"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="6">
<location>
<position position="195"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="6">
<location>
<position position="214"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="6">
<location>
<position position="253"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine">
<location>
<position position="285"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="6">
<location>
<position position="359"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="6">
<location>
<position position="401"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="6">
<location>
<position position="434"/>
</location>
</feature>
<feature type="disulfide bond" evidence="6">
<location>
<begin position="117"/>
<end position="139"/>
</location>
</feature>
<feature type="disulfide bond" evidence="6">
<location>
<begin position="235"/>
<end position="265"/>
</location>
</feature>
<feature type="disulfide bond" evidence="6">
<location>
<begin position="348"/>
<end position="373"/>
</location>
</feature>
<feature type="disulfide bond" evidence="6">
<location>
<begin position="424"/>
<end position="447"/>
</location>
</feature>
<feature type="mutagenesis site" description="Dominant negative mutant, blocks response to Gram-positive pathogens." evidence="5">
<original>P</original>
<variation>H</variation>
<location>
<position position="680"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; BAA78632." ref="1" evidence="9">
<original>Y</original>
<variation>H</variation>
<location>
<position position="181"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="35"/>
<end position="37"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="56"/>
<end position="58"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="69"/>
<end position="71"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="72"/>
<end position="74"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="80"/>
<end position="82"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="93"/>
<end position="98"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="104"/>
<end position="106"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="124"/>
<end position="127"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="140"/>
<end position="144"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="150"/>
<end position="154"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="160"/>
<end position="163"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="164"/>
<end position="166"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="171"/>
<end position="180"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="185"/>
<end position="187"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="190"/>
<end position="193"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="196"/>
<end position="203"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="205"/>
<end position="207"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="214"/>
<end position="229"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="235"/>
<end position="246"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="252"/>
<end position="261"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="263"/>
<end position="273"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="276"/>
<end position="288"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="306"/>
<end position="314"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="321"/>
<end position="329"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="334"/>
<end position="341"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="357"/>
<end position="359"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="367"/>
<end position="372"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="381"/>
<end position="383"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="394"/>
<end position="397"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="398"/>
<end position="401"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="407"/>
<end position="409"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="432"/>
<end position="434"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="442"/>
<end position="445"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="453"/>
<end position="456"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="467"/>
<end position="470"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="476"/>
<end position="479"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3A79"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q9Y2C9"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000255"/>
<evidence key="4" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00204"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11095740"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19931471"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20037584"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23812099"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000305"/>
<sequence length="795" mass="91116" checksum="34D8BD175A26C233" modified="2002-01-31" version="2" precursor="true">MSQDRKPIVGSFHFVCALALIVGSMTPFSNELESMVDYSNRNLTHVPKDLPPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQNISCCPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPPKVKVLDLHNNRIMSIPKDVTHLQALQELNVASNSLTDLPGCGAFSSLSVLVIDHNSVSHPSEDFFQSCQNIRSLTAGNNPFQCTCELRDFVKNIGWVAREVVEGWPDSYRCDYPESSKGTALRDFHMSPLSCDTVLLTVTIGATMLVLAVTGAFLCLYFDLPWYVRMLCQWTQTRHRARHIPLEELQRNLQFHAFVSYSEHDSAWVKNELLPNLEKDDIRVCLHERNFVPGKSIVENIINFIEKSYKAIFVLSPHFIQSEWCHYELYFAHHNLFHEGSDNLILILLEPILQNNIPSRYHKLRALMAQRTYLEWPTEKGKRGLFWANLRASFIMKLALVNEDDVKT</sequence>
</entry>
<entry dataset="Swiss-Prot" created="2002-01-31" modified="2021-02-10" version="221">
<accession>O60603</accession>
<accession>B3Y612</accession>
<accession>D1CS45</accession>
<accession>D1CS48</accession>
<accession>D1CS49</accession>
<accession>O15454</accession>
<accession>Q8NI00</accession>
<name>TLR2_HUMAN</name>
<protein>
<recommendedName>
<fullName>Toll-like receptor 2</fullName>
<ecNumber evidence="10">3.2.2.6</ecNumber>
</recommendedName>
<alternativeName>
<fullName>Toll/interleukin-1 receptor-like protein 4</fullName>
</alternativeName>
<cdAntigenName>CD282</cdAntigenName>
</protein>
<gene>
<name type="primary">TLR2</name>
<name type="synonym">TIL4</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1998" name="Blood" volume="91" first="4020" last="4027">
<title>Cloning and characterization of two Toll/Interleukin-1 receptor-like genes TIL3 and TIL4: evidence for a multi-gene receptor family in humans.</title>
<authorList>
<person name="Chaudhary P.M."/>
<person name="Ferguson C."/>
<person name="Nguyen V."/>
<person name="Nguyen O."/>
<person name="Massa H.F."/>
<person name="Eby M."/>
<person name="Jasmin A."/>
<person name="Trask B.J."/>
<person name="Hood L."/>
<person name="Nelson P.S."/>
</authorList>
<dbReference type="PubMed" id="9596645"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<source>
<tissue>Leukocyte</tissue>
<tissue>Prostate</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="1998" name="Proc. Natl. Acad. Sci. U.S.A." volume="95" first="588" last="593">
<title>A family of human receptors structurally related to Drosophila Toll.</title>
<authorList>
<person name="Rock F.L."/>
<person name="Hardiman G."/>
<person name="Timans J.C."/>
<person name="Kastelein R.A."/>
<person name="Bazan J.F."/>
</authorList>
<dbReference type="PubMed" id="9435236"/>
<dbReference type="DOI" id="10.1073/pnas.95.2.588"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
</reference>
<reference key="3">
<citation type="journal article" date="1998" name="Nature" volume="395" first="284" last="288">
<title>Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling.</title>
<authorList>
<person name="Yang R.-B."/>
<person name="Mark M.R."/>
<person name="Gray A.M."/>
<person name="Huang A."/>
<person name="Xie M.-H."/>
<person name="Zhang M."/>
<person name="Goddard A.D."/>
<person name="Wood W.I."/>
<person name="Gurney A.L."/>
<person name="Godowski P.J."/>
</authorList>
<dbReference type="PubMed" id="9751057"/>
<dbReference type="DOI" id="10.1038/26239"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>RESPONSE TO LIPOPOLYSACCHARIDE</scope>
<source>
<tissue>Fetal lung</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="2008" name="Immunogenetics" volume="60" first="727" last="735">
<title>Natural selection in the TLR-related genes in the course of primate evolution.</title>
<authorList>
<person name="Nakajima T."/>
<person name="Ohtani H."/>
<person name="Satta Y."/>
<person name="Uno Y."/>
<person name="Akari H."/>
<person name="Ishida T."/>
<person name="Kimura A."/>
</authorList>
<dbReference type="PubMed" id="18810425"/>
<dbReference type="DOI" id="10.1007/s00251-008-0332-0"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2009" name="PLoS ONE" volume="4" first="E7803" last="E7803">
<title>The heterogeneous allelic repertoire of human Toll-Like receptor (TLR) genes.</title>
<authorList>
<person name="Georgel P."/>
<person name="Macquin C."/>
<person name="Bahram S."/>
</authorList>
<dbReference type="PubMed" id="19924287"/>
<dbReference type="DOI" id="10.1371/journal.pone.0007803"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>VARIANTS HIS-631 AND GLN-753</scope>
</reference>
<reference key="6">
<citation type="submission" date="2005-09" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Blood</tissue>
</source>
</reference>
<reference key="8">
<citation type="journal article" date="2002" name="Di 4 Jun Yi Da Xue Xue Bao" volume="23" first="1085" last="1089">
<title>Cloning and sequencing of extracellular domain and its N-terminal and C-terminal fragments of Toll-like receptor 2.</title>
<authorList>
<person name="Zhang L."/>
<person name="Yu W.B."/>
<person name="Ma Y.Y."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 1-586</scope>
</reference>
<reference key="9">
<citation type="journal article" date="1999" name="Science" volume="285" first="732" last="736">
<title>Host defense mechanisms triggered by microbial lipoproteins through Toll-like receptors.</title>
<authorList>
<person name="Brightbill H.D."/>
<person name="Libraty D.H."/>
<person name="Krutzik S.R."/>
<person name="Yang R.B."/>
<person name="Belisle J.T."/>
<person name="Bleharski J.R."/>
<person name="Maitland M."/>
<person name="Norgard M.V."/>
<person name="Plevy S.E."/>
<person name="Smale S.T."/>
<person name="Brennan P.J."/>
<person name="Bloom B.R."/>
<person name="Godowski P.J."/>
<person name="Modlin R.L."/>
</authorList>
<dbReference type="PubMed" id="10426995"/>
<dbReference type="DOI" id="10.1126/science.285.5428.732"/>
</citation>
<scope>FUNCTION</scope>
<source>
<tissue>T-cell</tissue>
</source>
</reference>
<reference key="10">
<citation type="journal article" date="1999" name="Science" volume="285" first="736" last="739">
<title>Cell activation and apoptosis by bacterial lipoproteins through Toll-like receptor-2.</title>
<authorList>
<person name="Aliprantis A.O."/>
<person name="Yang R.-B."/>
<person name="Mark M.R."/>
<person name="Suggett S."/>
<person name="Devaux B."/>
<person name="Radolf J.D."/>
<person name="Klimpel G.R."/>
<person name="Godowski P.J."/>
<person name="Zychlinsky A."/>
</authorList>
<dbReference type="PubMed" id="10426996"/>
<dbReference type="DOI" id="10.1126/science.285.5428.736"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2001" name="J. Immunol." volume="167" first="987" last="994">
<title>Cooperation of Toll-like receptor 2 and 6 for cellular activation by soluble tuberculosis factor and Borrelia burgdorferi outer surface protein A lipoprotein: role of Toll-interacting protein and IL-1 receptor signaling molecules in Toll-like receptor 2 signaling.</title>
<authorList>
<person name="Bulut Y."/>
<person name="Faure E."/>
<person name="Thomas L."/>
<person name="Equils O."/>
<person name="Arditi M."/>
</authorList>
<dbReference type="PubMed" id="11441107"/>
<dbReference type="DOI" id="10.4049/jimmunol.167.2.987"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2002" name="J. Immunol." volume="169" first="6668" last="6672">
<title>A novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling.</title>
<authorList>
<person name="Yamamoto M."/>
<person name="Sato S."/>
<person name="Mori K."/>
<person name="Hoshino K."/>
<person name="Takeuchi O."/>
<person name="Takeda K."/>
<person name="Akira S."/>
</authorList>
<dbReference type="PubMed" id="12471095"/>
<dbReference type="DOI" id="10.4049/jimmunol.169.12.6668"/>
</citation>
<scope>INTERACTION WITH TICAM1</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2006" name="J. Biol. Chem." volume="281" first="31002" last="31011">
<title>Membrane sorting of toll-like receptor (TLR)-2/6 and TLR2/1 heterodimers at the cell surface determines heterotypic associations with CD36 and intracellular targeting.</title>
<authorList>
<person name="Triantafilou M."/>
<person name="Gamper F.G."/>
<person name="Haston R.M."/>
<person name="Mouratis M.A."/>
<person name="Morath S."/>
<person name="Hartung T."/>
<person name="Triantafilou K."/>
</authorList>
<dbReference type="PubMed" id="16880211"/>
<dbReference type="DOI" id="10.1074/jbc.m602794200"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH CD14; CD36; TLR1 AND TLR6</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="34589" last="34594">
<title>Four N-linked glycosylation sites in human toll-like receptor 2 cooperate to direct efficient biosynthesis and secretion.</title>
<authorList>
<person name="Weber A.N."/>
<person name="Morse M.A."/>
<person name="Gay N.J."/>
</authorList>
<dbReference type="PubMed" id="15173186"/>
<dbReference type="DOI" id="10.1074/jbc.m403830200"/>
</citation>
<scope>GLYCOSYLATION AT ASN-114; ASN-199 AND ASN-442</scope>
<scope>MUTAGENESIS OF ASN-114; ASN-199; THR-416 AND ASN-442</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2005" name="J. Biol. Chem." volume="280" first="20961" last="20967">
<title>Mycobacterium tuberculosis heat shock proteins use diverse Toll-like receptor pathways to activate pro-inflammatory signals.</title>
<authorList>
<person name="Bulut Y."/>
<person name="Michelsen K.S."/>
<person name="Hayrapetian L."/>
<person name="Naiki Y."/>
<person name="Spallek R."/>
<person name="Singh M."/>
<person name="Arditi M."/>
</authorList>
<dbReference type="PubMed" id="15809303"/>
<dbReference type="DOI" id="10.1074/jbc.m411379200"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2006" name="Infect. Immun." volume="74" first="2686" last="2696">
<title>The mycobacterial 38-kilodalton glycolipoprotein antigen activates the mitogen-activated protein kinase pathway and release of proinflammatory cytokines through Toll-like receptors 2 and 4 in human monocytes.</title>
<authorList>
<person name="Jung S.B."/>
<person name="Yang C.S."/>
<person name="Lee J.S."/>
<person name="Shin A.R."/>
<person name="Jung S.S."/>
<person name="Son J.W."/>
<person name="Harding C.V."/>
<person name="Kim H.J."/>
<person name="Park J.K."/>
<person name="Paik T.H."/>
<person name="Song C.H."/>
<person name="Jo E.K."/>
</authorList>
<dbReference type="PubMed" id="16622205"/>
<dbReference type="DOI" id="10.1128/iai.74.5.2686-2696.2006"/>
</citation>
<scope>FUNCTION</scope>
<source>
<tissue>Monocyte</tissue>
</source>
</reference>
<reference key="17">
<citation type="journal article" date="2009" name="Cell. Immunol." volume="258" first="29" last="37">
<title>TLR2 and its co-receptors determine responses of macrophages and dendritic cells to lipoproteins of Mycobacterium tuberculosis.</title>
<authorList>
<person name="Drage M.G."/>
<person name="Pecora N.D."/>
<person name="Hise A.G."/>
<person name="Febbraio M."/>
<person name="Silverstein R.L."/>
<person name="Golenbock D.T."/>
<person name="Boom W.H."/>
<person name="Harding C.V."/>
</authorList>
<dbReference type="PubMed" id="19362712"/>
<dbReference type="DOI" id="10.1016/j.cellimm.2009.03.008"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2010" name="Biochem. Biophys. Res. Commun." volume="400" first="403" last="408">
<title>Non-acylated Mycobacterium bovis glycoprotein MPB83 binds to TLR1/2 and stimulates production of matrix metalloproteinase 9.</title>
<authorList>
<person name="Chambers M.A."/>
<person name="Whelan A.O."/>
<person name="Spallek R."/>
<person name="Singh M."/>
<person name="Coddeville B."/>
<person name="Guerardel Y."/>
<person name="Elass E."/>
</authorList>
<dbReference type="PubMed" id="20800577"/>
<dbReference type="DOI" id="10.1016/j.bbrc.2010.08.085"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH M.BOVIS MPB83 AND M.TUBERCULOSIS ESXA (MICROBIAL INFECTION)</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2011" name="Infect. Immun." volume="79" first="663" last="673">
<title>Mycobacterium tuberculosis lipoproteins directly regulate human memory CD4(+) T cell activation via Toll-like receptors 1 and 2.</title>
<authorList>
<person name="Lancioni C.L."/>
<person name="Li Q."/>
<person name="Thomas J.J."/>
<person name="Ding X."/>
<person name="Thiel B."/>
<person name="Drage M.G."/>
<person name="Pecora N.D."/>
<person name="Ziady A.G."/>
<person name="Shank S."/>
<person name="Harding C.V."/>
<person name="Boom W.H."/>
<person name="Rojas R.E."/>
</authorList>
<dbReference type="PubMed" id="21078852"/>
<dbReference type="DOI" id="10.1128/iai.00806-10"/>
</citation>
<scope>FUNCTION</scope>
<source>
<tissue>T-cell</tissue>
</source>
</reference>
<reference key="20">
<citation type="journal article" date="2012" name="Infect. Immun." volume="80" first="2816" last="2825">
<title>Staphylococcal superantigen-like protein 3 binds to the Toll-like receptor 2 extracellular domain and inhibits cytokine production induced by Staphylococcus aureus, cell wall component, or lipopeptides in murine macrophages.</title>
<authorList>
<person name="Yokoyama R."/>
<person name="Itoh S."/>
<person name="Kamoshida G."/>
<person name="Takii T."/>
<person name="Fujii S."/>
<person name="Tsuji T."/>
<person name="Onozaki K."/>
</authorList>
<dbReference type="PubMed" id="22665377"/>
<dbReference type="DOI" id="10.1128/iai.00399-12"/>
</citation>
<scope>INTERACTION WITH STAPHYLOCOCCUS AUREUS SUPERANTIGEN-LIKE PROTEIN 3 (MICROBIAL INFECTION)</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2013" name="EMBO J." volume="32" first="566" last="582">
<title>TMEM59 defines a novel ATG16L1-binding motif that promotes local activation of LC3.</title>
<authorList>
<person name="Boada-Romero E."/>
<person name="Letek M."/>
<person name="Fleischer A."/>
<person name="Pallauf K."/>
<person name="Ramon-Barros C."/>
<person name="Pimentel-Muinos F.X."/>
</authorList>
<dbReference type="PubMed" id="23376921"/>
<dbReference type="DOI" id="10.1038/emboj.2013.8"/>
</citation>
<scope>INTERACTION WITH ATG16L1</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2014" name="J. Immunol." volume="193" first="6090" last="6102">
<title>TRAM is required for TLR2 endosomal signaling to type I IFN induction.</title>
<authorList>
<person name="Stack J."/>
<person name="Doyle S.L."/>
<person name="Connolly D.J."/>
<person name="Reinert L.S."/>
<person name="O'Keeffe K.M."/>
<person name="McLoughlin R.M."/>
<person name="Paludan S.R."/>
<person name="Bowie A.G."/>
</authorList>
<dbReference type="PubMed" id="25385819"/>
<dbReference type="DOI" id="10.4049/jimmunol.1401605"/>
</citation>
<scope>INTERACTION WITH TICAM2</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2016" name="Elife" volume="5">
<title>RING finger E3 ligase PPP1R11 regulates TLR2 signaling and innate immunity.</title>
<authorList>
<person name="McKelvey A.C."/>
<person name="Lear T.B."/>
<person name="Dunn S.R."/>
<person name="Evankovich J."/>
<person name="Londino J.D."/>
<person name="Bednash J.S."/>
<person name="Zhang Y."/>
<person name="McVerry B.J."/>
<person name="Liu Y."/>
<person name="Chen B.B."/>
</authorList>
<dbReference type="PubMed" id="27805901"/>
<dbReference type="DOI" id="10.7554/elife.18496"/>
</citation>
<scope>UBIQUITINATION AT LYS-754</scope>
<scope>MUTAGENESIS OF LYS-709; LYS-714; 742-LYS--LYS-743; LYS-751 AND LYS-754</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2000" name="Nature" volume="408" first="111" last="115">
<title>Structural basis for signal transduction by the Toll/interleukin-1 receptor domains.</title>
<authorList>
<person name="Xu Y."/>
<person name="Tao X."/>
<person name="Shen B."/>
<person name="Horng T."/>
<person name="Medzhitov R."/>
<person name="Manley J.L."/>
<person name="Tong L."/>
</authorList>
<dbReference type="PubMed" id="11081518"/>
<dbReference type="DOI" id="10.1038/35040600"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF 639-784</scope>
<scope>MUTAGENESIS</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2007" name="Cell" volume="130" first="1071" last="1082">
<title>Crystal structure of the TLR1-TLR2 heterodimer induced by binding of a tri-acylated lipopeptide.</title>
<authorList>
<person name="Jin M.S."/>
<person name="Kim S.E."/>
<person name="Heo J.Y."/>
<person name="Lee M.E."/>
<person name="Kim H.M."/>
<person name="Paik S.-G."/>
<person name="Lee H."/>
<person name="Lee J.-O."/>
</authorList>
<dbReference type="PubMed" id="17889651"/>
<dbReference type="DOI" id="10.1016/j.cell.2007.09.008"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) OF 1-509 IN COMPLEX WITH TLR1 AND BACTERIAL LIPOPEPTIDE ANALOG</scope>
<scope>DISULFIDE BONDS</scope>
<scope>GLYCOSYLATION AT ASN-114; ASN-199; ASN-414 AND ASN-442</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2001" name="FEMS Immunol. Med. Microbiol." volume="31" first="53" last="58">
<title>Detection of Toll-like receptor 2 (TLR2) mutation in the lepromatous leprosy patients.</title>
<authorList>
<person name="Kang T.-J."/>
<person name="Chae G.-T."/>
</authorList>
<dbReference type="PubMed" id="11476982"/>
<dbReference type="DOI" id="10.1111/j.1574-695x.2001.tb01586.x"/>
</citation>
<scope>VARIANT TRP-677</scope>
<scope>ASSOCIATION WITH LEPROSIS</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2003" name="J. Immunol." volume="170" first="3451" last="3454">
<title>A Toll-like receptor 2 polymorphism that is associated with lepromatous leprosy is unable to mediate mycobacterial signaling.</title>
<authorList>
<person name="Bochud P.-Y."/>
<person name="Hawn T.R."/>
<person name="Aderem A."/>
</authorList>
<dbReference type="PubMed" id="12646604"/>
<dbReference type="DOI" id="10.4049/jimmunol.170.7.3451"/>
</citation>
<scope>VARIANT TRP-677</scope>
<scope>ASSOCIATION WITH LEPROSIS</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2011" name="Hum. Mutat." volume="32" first="643" last="652">
<title>Functional characterization of naturally occurring genetic variants in the human TLR1-2-6 gene family.</title>
<authorList>
<person name="Ben-Ali M."/>
<person name="Corre B."/>
<person name="Manry J."/>
<person name="Barreiro L.B."/>
<person name="Quach H."/>
<person name="Boniotto M."/>
<person name="Pellegrini S."/>
<person name="Quintana-Murci L."/>
</authorList>
<dbReference type="PubMed" id="21618349"/>
<dbReference type="DOI" id="10.1002/humu.21486"/>
</citation>
<scope>VARIANTS ASP-89; ILE-411; HIS-571; HIS-631; ARG-636 AND GLN-753</scope>
<scope>CHARACTERIZATION OF VARIANTS ILE-411; HIS-631 AND GLN-753</scope>
</reference>
<comment type="function">
<text evidence="8 11 12 14 19 20 21 22 23 26">Cooperates with LY96 to mediate the innate immune response to bacterial lipoproteins and other microbial cell wall components. Cooperates with TLR1 or TLR6 to mediate the innate immune response to bacterial lipoproteins or lipopeptides (PubMed:21078852, PubMed:17889651). Acts via MYD88 and TRAF6, leading to NF-kappa-B activation, cytokine secretion and the inflammatory response. May also activate immune cells and promote apoptosis in response to the lipid moiety of lipoproteins (PubMed:10426995, PubMed:10426996). Recognizes mycoplasmal macrophage-activating lipopeptide-2kD (MALP-2), soluble tuberculosis factor (STF), phenol-soluble modulin (PSM) and B.burgdorferi outer surface protein A lipoprotein (OspA-L) cooperatively with TLR6 (PubMed:11441107). Stimulation of monocytes in vitro with M.tuberculosis PstS1 induces p38 MAPK and ERK1/2 activation primarily via this receptor, but also partially via TLR4 (PubMed:16622205). MAPK activation in response to bacterial peptidoglycan also occurs via this receptor (PubMed:16622205). Acts as a receptor for M.tuberculosis lipoproteins LprA, LprG, LpqH and PstS1, some lipoproteins are dependent on other coreceptors (TLR1, CD14 and/or CD36); the lipoproteins act as agonists to modulate antigen presenting cell functions in response to the pathogen (PubMed:19362712). M.tuberculosis HSP70 (dnaK) but not HSP65 (groEL-2) acts via this protein to stimulate NF-kappa-B expression (PubMed:15809303). Recognizes M.tuberculosis major T-antigen EsxA (ESAT-6) which inhibits downstream MYD88-dependent signaling (shown in mouse) (By similarity). Forms activation clusters composed of several receptors depending on the ligand, these clusters trigger signaling from the cell surface and subsequently are targeted to the Golgi in a lipid-raft dependent pathway. Forms the cluster TLR2:TLR6:CD14:CD36 in response to diacylated lipopeptides and TLR2:TLR1:CD14 in response to triacylated lipopeptides (PubMed:16880211). Required for normal uptake of M.tuberculosis, a process that is inhibited by M.tuberculosis LppM (By similarity).</text>
</comment>
<comment type="catalytic activity">
<reaction evidence="10">
<text>H2O + NAD(+) = ADP-D-ribose + H(+) + nicotinamide</text>
<dbReference type="Rhea" id="RHEA:16301"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:17154"/>
<dbReference type="ChEBI" id="CHEBI:57540"/>
<dbReference type="ChEBI" id="CHEBI:57967"/>
<dbReference type="EC" id="3.2.2.6"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="10">
<dbReference type="Rhea" id="RHEA:16302"/>
</physiologicalReaction>
</comment>
<comment type="subunit">
<text evidence="8 16 21 22 29 30">Interacts with LY96, TLR1 and TLR6 (via extracellular domain) (PubMed:17889651). TLR2 seems to exist in heterodimers with either TLR1 or TLR6 before stimulation by the ligand. The heterodimers form bigger oligomers in response to their corresponding ligands as well as further heterotypic associations with other receptors such as CD14 and/or CD36 (PubMed:16880211). Binds MYD88 (via TIR domain). Interacts with TICAM1 (PubMed:12471095). Interacts with CNPY3 (By similarity). Interacts with ATG16L1 (PubMed:23376921). Interacts with PPP1R11 (By similarity). Interacts with TICAM2 (PubMed:25385819).</text>
</comment>
<comment type="subunit">
<text evidence="25">(Microbial infection) Interacts with M.tuberculosis EsxA.</text>
</comment>
<comment type="subunit">
<text evidence="25">(Microbial infection) Interacts with M.bovis MPB83.</text>
</comment>
<comment type="subunit">
<text evidence="28">(Microbial infection) Interacts with Staphylococcus aureus protein SSL5.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-973722">
<id>O60603</id>
</interactant>
<interactant intactId="EBI-489411">
<id>P61073</id>
<label>CXCR4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-973722">
<id>O60603</id>
</interactant>
<interactant intactId="EBI-297353">
<id>P00533</id>
<label>EGFR</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-973722">
<id>O60603</id>
</interactant>
<interactant intactId="EBI-447677">
<id>Q99836</id>
<label>MYD88</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-973722">
<id>O60603</id>
</interactant>
<interactant intactId="EBI-3505892">
<id>C3PTT6</id>
<label>PAUF</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-973722">
<id>O60603</id>
</interactant>
<interactant intactId="EBI-9009517">
<id>Q15399</id>
<label>TLR1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-973722">
<id>O60603</id>
</interactant>
<interactant intactId="EBI-16825459">
<id>Q9BXR5</id>
<label>TLR10</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-973722">
<id>O60603</id>
</interactant>
<interactant intactId="EBI-973722">
<id>O60603</id>
<label>TLR2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-973722">
<id>O60603</id>
</interactant>
<interactant intactId="EBI-13940779">
<id>Q9Y2C9</id>
<label>TLR6</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="8">Membrane</location>
<topology evidence="9">Single-pass type I membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="8">Cytoplasmic vesicle</location>
<location evidence="8">Phagosome membrane</location>
<topology evidence="9">Single-pass type I membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="21">Membrane raft</location>
</subcellularLocation>
<text evidence="21">Does not reside in lipid rafts before stimulation but accumulates increasingly in the raft upon the presence of the microbial ligand. In response to diacylated lipoproteins, TLR2:TLR6 heterodimers are recruited in lipid rafts, this recruitment determines the intracellular targeting to the Golgi apparatus. Triacylated lipoproteins induce the same mechanism for TLR2:TLR1 heterodimers.</text>
</comment>
<comment type="tissue specificity">
<text>Highly expressed in peripheral blood leukocytes, in particular in monocytes, in bone marrow, lymph node and in spleen. Also detected in lung and in fetal liver. Levels are low in other tissues.</text>
</comment>
<comment type="domain">
<text evidence="7">Ester-bound lipid substrates are bound through a crevice formed between the LRR 11 and LRR 12.</text>
</comment>
<comment type="domain">
<text evidence="29">The ATG16L1-binding motif mediates interaction with ATG16L1.</text>
</comment>
<comment type="domain">
<text evidence="10">The TIR domain mediates NAD(+) hydrolase (NADase) activity. Self-association of TIR domains is required for NADase activity.</text>
</comment>
<comment type="PTM">
<text evidence="18 22">Glycosylation of Asn-442 is critical for secretion of the N-terminal ectodomain of TLR2.</text>
</comment>
<comment type="PTM">
<text evidence="8 31">Ubiquitinated at Lys-754 by PPP1R11, leading to its degradation (PubMed:27805901). Deubiquitinated by USP2 (By similarity).</text>
</comment>
<comment type="polymorphism">
<text evidence="15 17">Genetic variations in TLR2 are associated with susceptibility to leprosy [MIM:246300]. Leprosy is a chronic disease associated with depressed cellular (but not humoral) immunity, the bacterium requires a lower temperature than 37 degrees Celsius and thrives particularly in peripheral Schwann cells and macrophages. The Trp-677 polymorphism in the intracellular domain of TLR2 has a role in susceptibility to lepromatous leprosy. Wild-type TLR2 mediates CD14-enhanced Mycobacterium leprae-dependent activation of NFKB1, but TLR2 containing the Trp-677 polymorphism did not. The impaired function of the Trp-677 polymorphism provides a molecular mechanism for the poor cellular immune response associated with lepromatous leprosy.</text>
</comment>
<comment type="similarity">
<text evidence="32">Belongs to the Toll-like receptor family.</text>
</comment>
<dbReference type="EC" id="3.2.2.6" evidence="10"/>
<dbReference type="EMBL" id="AF051152">
<property type="protein sequence ID" value="AAC34377.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U88878">
<property type="protein sequence ID" value="AAC34133.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB445624">
<property type="protein sequence ID" value="BAG55021.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="DQ012265">
<property type="protein sequence ID" value="AAY85644.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="DQ012266">
<property type="protein sequence ID" value="AAY85645.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="DQ012267">
<property type="protein sequence ID" value="AAY85646.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="DQ012268">
<property type="protein sequence ID" value="AAY85647.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="DQ012269">
<property type="protein sequence ID" value="AAY85648.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="DQ012270">
<property type="protein sequence ID" value="AAY85649.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="DQ012271">
<property type="protein sequence ID" value="AAY85650.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471056">
<property type="protein sequence ID" value="EAX04952.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471056">
<property type="protein sequence ID" value="EAX04953.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC033756">
<property type="protein sequence ID" value="AAH33756.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF502291">
<property type="protein sequence ID" value="AAM23001.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS3784.1"/>
<dbReference type="RefSeq" id="NP_001305716.1">
<property type="nucleotide sequence ID" value="NM_001318787.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001305718.1">
<property type="nucleotide sequence ID" value="NM_001318789.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001305719.1">
<property type="nucleotide sequence ID" value="NM_001318790.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001305720.1">
<property type="nucleotide sequence ID" value="NM_001318791.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001305722.1">
<property type="nucleotide sequence ID" value="NM_001318793.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001305724.1">
<property type="nucleotide sequence ID" value="NM_001318795.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001305725.1">
<property type="nucleotide sequence ID" value="NM_001318796.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_003255.2">
<property type="nucleotide sequence ID" value="NM_003264.4"/>
</dbReference>
<dbReference type="RefSeq" id="XP_011530517.1">
<property type="nucleotide sequence ID" value="XM_011532215.2"/>
</dbReference>
<dbReference type="RefSeq" id="XP_011530518.1">
<property type="nucleotide sequence ID" value="XM_011532216.2"/>
</dbReference>
<dbReference type="RefSeq" id="XP_016864062.1">
<property type="nucleotide sequence ID" value="XM_017008573.1"/>
</dbReference>
<dbReference type="RefSeq" id="XP_016864063.1">
<property type="nucleotide sequence ID" value="XM_017008574.1"/>
</dbReference>
<dbReference type="RefSeq" id="XP_016864064.1">
<property type="nucleotide sequence ID" value="XM_017008575.1"/>
</dbReference>
<dbReference type="RefSeq" id="XP_016864065.1">
<property type="nucleotide sequence ID" value="XM_017008576.1"/>
</dbReference>
<dbReference type="PDB" id="1FYW">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.00"/>
<property type="chains" value="A=636-784"/>
</dbReference>
<dbReference type="PDB" id="1FYX">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A=636-784"/>
</dbReference>
<dbReference type="PDB" id="1O77">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.20"/>
<property type="chains" value="A/B/C/D/E=639-784"/>
</dbReference>
<dbReference type="PDB" id="2Z7X">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="A=27-506"/>
</dbReference>
<dbReference type="PDB" id="2Z80">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80"/>
<property type="chains" value="A/B=1-284"/>
</dbReference>
<dbReference type="PDB" id="6NIG">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.35"/>
<property type="chains" value="A/B/C/D=1-507"/>
</dbReference>
<dbReference type="PDBsum" id="1FYW"/>
<dbReference type="PDBsum" id="1FYX"/>
<dbReference type="PDBsum" id="1O77"/>
<dbReference type="PDBsum" id="2Z7X"/>
<dbReference type="PDBsum" id="2Z80"/>
<dbReference type="PDBsum" id="6NIG"/>
<dbReference type="SMR" id="O60603"/>
<dbReference type="BioGRID" id="112952">
<property type="interactions" value="29"/>
</dbReference>
<dbReference type="CORUM" id="O60603"/>
<dbReference type="DIP" id="DIP-35138N"/>
<dbReference type="IntAct" id="O60603">
<property type="interactions" value="40"/>
</dbReference>
<dbReference type="MINT" id="O60603"/>
<dbReference type="STRING" id="9606.ENSP00000260010"/>
<dbReference type="BindingDB" id="O60603"/>
<dbReference type="ChEMBL" id="CHEMBL4163"/>
<dbReference type="DrugBank" id="DB00210">
<property type="generic name" value="Adapalene"/>
</dbReference>
<dbReference type="DrugBank" id="DB05475">
<property type="generic name" value="Golotimod"/>
</dbReference>
<dbReference type="DrugBank" id="DB00045">
<property type="generic name" value="Lyme disease vaccine (recombinant OspA)"/>
</dbReference>
<dbReference type="DrugBank" id="DB03963">
<property type="generic name" value="S-(Dimethylarsenic)Cysteine"/>
</dbReference>
<dbReference type="DrugBank" id="DB11601">
<property type="generic name" value="Tuberculin purified protein derivative"/>
</dbReference>
<dbReference type="GuidetoPHARMACOLOGY" id="1752"/>
<dbReference type="TCDB" id="8.A.43.1.16">
<property type="family name" value="the neat-domain containing methaemoglobin heme sequestration (n-mhs) family"/>
</dbReference>
<dbReference type="GlyConnect" id="1816">
<property type="glycosylation" value="3 N-Linked glycans (1 site)"/>
</dbReference>
<dbReference type="GlyGen" id="O60603">
<property type="glycosylation" value="4 sites"/>
</dbReference>
<dbReference type="iPTMnet" id="O60603"/>
<dbReference type="PhosphoSitePlus" id="O60603"/>
<dbReference type="SwissPalm" id="O60603"/>
<dbReference type="BioMuta" id="TLR2"/>
<dbReference type="EPD" id="O60603"/>
<dbReference type="jPOST" id="O60603"/>
<dbReference type="MassIVE" id="O60603"/>
<dbReference type="PaxDb" id="O60603"/>
<dbReference type="PeptideAtlas" id="O60603"/>
<dbReference type="PRIDE" id="O60603"/>
<dbReference type="ProteomicsDB" id="49481"/>
<dbReference type="ABCD" id="O60603">
<property type="antibodies" value="3 sequenced antibodies"/>
</dbReference>
<dbReference type="Antibodypedia" id="16689">
<property type="antibodies" value="1363 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="7097"/>
<dbReference type="Ensembl" id="ENST00000260010">
<property type="protein sequence ID" value="ENSP00000260010"/>
<property type="gene ID" value="ENSG00000137462"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000642580">
<property type="protein sequence ID" value="ENSP00000495339"/>
<property type="gene ID" value="ENSG00000137462"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000642700">
<property type="protein sequence ID" value="ENSP00000494425"/>
<property type="gene ID" value="ENSG00000137462"/>
</dbReference>
<dbReference type="GeneID" id="7097"/>
<dbReference type="KEGG" id="hsa:7097"/>
<dbReference type="UCSC" id="uc063aif.1">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="7097"/>
<dbReference type="DisGeNET" id="7097"/>
<dbReference type="GeneCards" id="TLR2"/>
<dbReference type="HGNC" id="HGNC:11848">
<property type="gene designation" value="TLR2"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000137462">
<property type="expression patterns" value="Tissue enhanced (blood)"/>
</dbReference>
<dbReference type="MalaCards" id="TLR2"/>
<dbReference type="MIM" id="246300">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="603028">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_O60603"/>
<dbReference type="OpenTargets" id="ENSG00000137462"/>
<dbReference type="PharmGKB" id="PA36550"/>
<dbReference type="VEuPathDB" id="HostDB:ENSG00000137462.6"/>
<dbReference type="eggNOG" id="KOG4641">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000156323"/>
<dbReference type="HOGENOM" id="CLU_006000_3_0_1"/>
<dbReference type="InParanoid" id="O60603"/>
<dbReference type="OMA" id="CTLNGVG"/>
<dbReference type="OrthoDB" id="282372at2759"/>
<dbReference type="PhylomeDB" id="O60603"/>
<dbReference type="TreeFam" id="TF351113"/>
<dbReference type="PathwayCommons" id="O60603"/>
<dbReference type="Reactome" id="R-HSA-1236974">
<property type="pathway name" value="ER-Phagosome pathway"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1461957">
<property type="pathway name" value="Beta defensins"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-166058">
<property type="pathway name" value="MyD88:MAL(TIRAP) cascade initiated on plasma membrane"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-168179">
<property type="pathway name" value="Toll Like Receptor TLR1:TLR2 Cascade"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-168188">
<property type="pathway name" value="Toll Like Receptor TLR6:TLR2 Cascade"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5602498">
<property type="pathway name" value="MyD88 deficiency (TLR2/4)"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5603041">
<property type="pathway name" value="IRAK4 deficiency (TLR2/4)"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5686938">
<property type="pathway name" value="Regulation of TLR by endogenous ligand"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6798695">
<property type="pathway name" value="Neutrophil degranulation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9637628">
<property type="pathway name" value="Modulation by Mtb of host immune system"/>
</dbReference>
<dbReference type="SignaLink" id="O60603"/>
<dbReference type="SIGNOR" id="O60603"/>
<dbReference type="BioGRID-ORCS" id="7097">
<property type="hits" value="2 hits in 879 CRISPR screens"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="O60603"/>
<dbReference type="GeneWiki" id="TLR_2"/>
<dbReference type="GenomeRNAi" id="7097"/>
<dbReference type="Pharos" id="O60603">
<property type="development level" value="Tchem"/>
</dbReference>
<dbReference type="PRO" id="PR:O60603"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 4"/>
</dbReference>
<dbReference type="RNAct" id="O60603">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000137462">
<property type="expression patterns" value="Expressed in blood and 173 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="O60603">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="O60603">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0044297">
<property type="term" value="C:cell body"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0042995">
<property type="term" value="C:cell projection"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0009986">
<property type="term" value="C:cell surface"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005794">
<property type="term" value="C:Golgi apparatus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005887">
<property type="term" value="C:integral component of plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0031226">
<property type="term" value="C:intrinsic component of plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045121">
<property type="term" value="C:membrane raft"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030670">
<property type="term" value="C:phagocytic vesicle membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0030667">
<property type="term" value="C:secretory granule membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0035354">
<property type="term" value="C:Toll-like receptor 1-Toll-like receptor 2 protein complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0001540">
<property type="term" value="F:amyloid-beta binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0042802">
<property type="term" value="F:identical protein binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="IntAct"/>
</dbReference>
<dbReference type="GO" id="GO:0001530">
<property type="term" value="F:lipopolysaccharide binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001875">
<property type="term" value="F:lipopolysaccharide immune receptor activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050135">
<property type="term" value="F:NAD(P)+ nucleosidase activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0061809">
<property type="term" value="F:NAD+ nucleotidase, cyclic ADP-ribose generating"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0038187">
<property type="term" value="F:pattern recognition receptor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042834">
<property type="term" value="F:peptidoglycan binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0044877">
<property type="term" value="F:protein-containing complex binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0038023">
<property type="term" value="F:signaling receptor activity"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0035325">
<property type="term" value="F:Toll-like receptor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004888">
<property type="term" value="F:transmembrane signaling receptor activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0042497">
<property type="term" value="F:triacyl lipopeptide binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0006915">
<property type="term" value="P:apoptotic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0001775">
<property type="term" value="P:cell activation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="AgBase"/>
</dbReference>
<dbReference type="GO" id="GO:0071221">
<property type="term" value="P:cellular response to bacterial lipopeptide"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0071726">
<property type="term" value="P:cellular response to diacyl bacterial lipopeptide"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071346">
<property type="term" value="P:cellular response to interferon-gamma"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071223">
<property type="term" value="P:cellular response to lipoteichoic acid"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0071727">
<property type="term" value="P:cellular response to triacyl bacterial lipopeptide"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032289">
<property type="term" value="P:central nervous system myelin formation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0002374">
<property type="term" value="P:cytokine secretion involved in immune response"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CACAO"/>
</dbReference>
<dbReference type="GO" id="GO:0050830">
<property type="term" value="P:defense response to Gram-positive bacterium"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042496">
<property type="term" value="P:detection of diacyl bacterial lipopeptide"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0042495">
<property type="term" value="P:detection of triacyl bacterial lipopeptide"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0007252">
<property type="term" value="P:I-kappaB phosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0006955">
<property type="term" value="P:immune response"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0006954">
<property type="term" value="P:inflammatory response"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0045087">
<property type="term" value="P:innate immune response"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032613">
<property type="term" value="P:interleukin-10 production"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="CACAO"/>
</dbReference>
<dbReference type="GO" id="GO:0007612">
<property type="term" value="P:learning"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0006691">
<property type="term" value="P:leukotriene metabolic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0014005">
<property type="term" value="P:microglia development"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0001774">
<property type="term" value="P:microglial cell activation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0002755">
<property type="term" value="P:MyD88-dependent toll-like receptor signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0008285">
<property type="term" value="P:negative regulation of cell population proliferation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0050765">
<property type="term" value="P:negative regulation of phagocytosis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0051964">
<property type="term" value="P:negative regulation of synapse assembly"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0043312">
<property type="term" value="P:neutrophil degranulation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0046209">
<property type="term" value="P:nitric oxide metabolic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:1903974">
<property type="term" value="P:positive regulation of cellular response to macrophage colony-stimulating factor stimulus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032722">
<property type="term" value="P:positive regulation of chemokine production"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0010628">
<property type="term" value="P:positive regulation of gene expression"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050729">
<property type="term" value="P:positive regulation of inflammatory response"/>
<property type="evidence" value="ECO:0000316"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032728">
<property type="term" value="P:positive regulation of interferon-beta production"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032733">
<property type="term" value="P:positive regulation of interleukin-10 production"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0032735">
<property type="term" value="P:positive regulation of interleukin-12 production"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032741">
<property type="term" value="P:positive regulation of interleukin-18 production"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032755">
<property type="term" value="P:positive regulation of interleukin-6 production"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032757">
<property type="term" value="P:positive regulation of interleukin-8 production"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1904466">
<property type="term" value="P:positive regulation of matrix metallopeptidase secretion"/>
<property type="evidence" value="ECO:0000316"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0051092">
<property type="term" value="P:positive regulation of NF-kappaB transcription factor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1901224">
<property type="term" value="P:positive regulation of NIK/NF-kappaB signaling"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0051770">
<property type="term" value="P:positive regulation of nitric-oxide synthase biosynthetic process"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0048714">
<property type="term" value="P:positive regulation of oligodendrocyte differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0034123">
<property type="term" value="P:positive regulation of toll-like receptor signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045944">
<property type="term" value="P:positive regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032760">
<property type="term" value="P:positive regulation of tumor necrosis factor production"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0030177">
<property type="term" value="P:positive regulation of Wnt signaling pathway"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0070542">
<property type="term" value="P:response to fatty acid"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0001666">
<property type="term" value="P:response to hypoxia"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0032868">
<property type="term" value="P:response to insulin"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0032570">
<property type="term" value="P:response to progesterone"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0009636">
<property type="term" value="P:response to toxic substance"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007165">
<property type="term" value="P:signal transduction"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0034134">
<property type="term" value="P:toll-like receptor 2 signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0002224">
<property type="term" value="P:toll-like receptor signaling pathway"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0038123">
<property type="term" value="P:toll-like receptor TLR1:TLR2 signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0038124">
<property type="term" value="P:toll-like receptor TLR6:TLR2 signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0032640">
<property type="term" value="P:tumor necrosis factor production"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="Gene3D" id="3.40.50.10140">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="3.80.10.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR000483">
<property type="entry name" value="Cys-rich_flank_reg_C"/>
</dbReference>
<dbReference type="InterPro" id="IPR001611">
<property type="entry name" value="Leu-rich_rpt"/>
</dbReference>
<dbReference type="InterPro" id="IPR003591">
<property type="entry name" value="Leu-rich_rpt_typical-subtyp"/>
</dbReference>
<dbReference type="InterPro" id="IPR032675">
<property type="entry name" value="LRR_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR000157">
<property type="entry name" value="TIR_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR027185">
<property type="entry name" value="TLR2"/>
</dbReference>
<dbReference type="InterPro" id="IPR017241">
<property type="entry name" value="Toll-like_receptor"/>
</dbReference>
<dbReference type="InterPro" id="IPR035897">
<property type="entry name" value="Toll_tir_struct_dom_sf"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR24365">
<property type="entry name" value="PTHR24365"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR24365:SF17">
<property type="entry name" value="PTHR24365:SF17"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF13855">
<property type="entry name" value="LRR_8"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="Pfam" id="PF01463">
<property type="entry name" value="LRRCT"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF01582">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PIRSF" id="PIRSF037595">
<property type="entry name" value="Toll-like_receptor"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00369">
<property type="entry name" value="LRR_TYP"/>
<property type="match status" value="7"/>
</dbReference>
<dbReference type="SMART" id="SM00082">
<property type="entry name" value="LRRCT"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00255">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF52200">
<property type="entry name" value="SSF52200"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51450">
<property type="entry name" value="LRR"/>
<property type="match status" value="11"/>
</dbReference>
<dbReference type="PROSITE" id="PS50104">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0968">Cytoplasmic vesicle</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0378">Hydrolase</keyword>
<keyword id="KW-0391">Immunity</keyword>
<keyword id="KW-0395">Inflammatory response</keyword>
<keyword id="KW-0399">Innate immunity</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0433">Leucine-rich repeat</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0520">NAD</keyword>
<keyword id="KW-0675">Receptor</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0732">Signal</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="signal peptide" evidence="9">
<location>
<begin position="1"/>
<end position="20"/>
</location>
</feature>
<feature type="chain" description="Toll-like receptor 2" id="PRO_0000034710">
<location>
<begin position="21"/>
<end position="784"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="9">
<location>
<begin position="21"/>
<end position="588"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="9">
<location>
<begin position="589"/>
<end position="609"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="9">
<location>
<begin position="610"/>
<end position="784"/>
</location>
</feature>
<feature type="repeat" description="LRR 1">
<location>
<begin position="54"/>
<end position="77"/>
</location>
</feature>
<feature type="repeat" description="LRR 2">
<location>
<begin position="78"/>
<end position="101"/>
</location>
</feature>
<feature type="repeat" description="LRR 3">
<location>
<begin position="102"/>
<end position="125"/>
</location>
</feature>
<feature type="repeat" description="LRR 4">
<location>
<begin position="126"/>
<end position="150"/>
</location>
</feature>
<feature type="repeat" description="LRR 5">
<location>
<begin position="151"/>
<end position="175"/>
</location>
</feature>
<feature type="repeat" description="LRR 6">
<location>
<begin position="176"/>
<end position="199"/>
</location>
</feature>
<feature type="repeat" description="LRR 7">
<location>
<begin position="200"/>
<end position="223"/>
</location>
</feature>
<feature type="repeat" description="LRR 8">
<location>
<begin position="224"/>
<end position="250"/>
</location>
</feature>
<feature type="repeat" description="LRR 9">
<location>
<begin position="251"/>
<end position="278"/>
</location>
</feature>
<feature type="repeat" description="LRR 10">
<location>
<begin position="279"/>
<end position="308"/>
</location>
</feature>
<feature type="repeat" description="LRR 11">
<location>
<begin position="309"/>
<end position="337"/>
</location>
</feature>
<feature type="repeat" description="LRR 12">
<location>
<begin position="338"/>
<end position="361"/>
</location>
</feature>
<feature type="repeat" description="LRR 13">
<location>
<begin position="362"/>
<end position="388"/>
</location>
</feature>
<feature type="repeat" description="LRR 14">
<location>
<begin position="389"/>
<end position="414"/>
</location>
</feature>
<feature type="repeat" description="LRR 15">
<location>
<begin position="415"/>
<end position="437"/>
</location>
</feature>
<feature type="repeat" description="LRR 16">
<location>
<begin position="438"/>
<end position="457"/>
</location>
</feature>
<feature type="repeat" description="LRR 17">
<location>
<begin position="458"/>
<end position="478"/>
</location>
</feature>
<feature type="repeat" description="LRR 18">
<location>
<begin position="479"/>
<end position="500"/>
</location>
</feature>
<feature type="repeat" description="LRR 19">
<location>
<begin position="501"/>
<end position="524"/>
</location>
</feature>
<feature type="domain" description="LRRCT">
<location>
<begin position="525"/>
<end position="579"/>
</location>
</feature>
<feature type="domain" description="TIR" evidence="10">
<location>
<begin position="639"/>
<end position="782"/>
</location>
</feature>
<feature type="short sequence motif" description="ATG16L1-binding motif">
<location>
<begin position="761"/>
<end position="778"/>
</location>
</feature>
<feature type="active site" evidence="10">
<location>
<position position="716"/>
</location>
</feature>
<feature type="site" description="Interaction with bacterial lipopeptide">
<location>
<position position="349"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="18 22">
<location>
<position position="114"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="18 22">
<location>
<position position="199"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="22">
<location>
<position position="414"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="18 22">
<location>
<position position="442"/>
</location>
</feature>
<feature type="disulfide bond" evidence="22">
<location>
<begin position="30"/>
<end position="36"/>
</location>
</feature>
<feature type="disulfide bond" evidence="22">
<location>
<begin position="353"/>
<end position="382"/>
</location>
</feature>
<feature type="disulfide bond" evidence="22">
<location>
<begin position="432"/>
<end position="454"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="31">
<location>
<position position="754"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs137853176." id="VAR_066349" evidence="27">
<original>N</original>
<variation>D</variation>
<location>
<position position="89"/>
</location>
</feature>
<feature type="sequence variant" description="Reduces TLR2-mediated NF-kappa-B activation; dbSNP:rs5743699." id="VAR_026765" evidence="27">
<original>T</original>
<variation>I</variation>
<location>
<position position="411"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs61735277." id="VAR_066350" evidence="27">
<original>R</original>
<variation>H</variation>
<location>
<position position="571"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs5743703." id="VAR_026766">
<original>R</original>
<variation>H</variation>
<location>
<position position="579"/>
</location>
</feature>
<feature type="sequence variant" description="Reduces TLR2-mediated NF-kappa-B activation; dbSNP:rs5743704." id="VAR_024663" evidence="24 27">
<original>P</original>
<variation>H</variation>
<location>
<position position="631"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs137853177." id="VAR_066351" evidence="27">
<original>S</original>
<variation>R</variation>
<location>
<position position="636"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs121917864." id="VAR_031236" evidence="15 17">
<original>R</original>
<variation>W</variation>
<location>
<position position="677"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs5743706." id="VAR_052360">
<original>Y</original>
<variation>N</variation>
<location>
<position position="715"/>
</location>
</feature>
<feature type="sequence variant" description="Reduces TLR2-mediated NF-kappa-B activation; dbSNP:rs5743708." id="VAR_031237" evidence="24 27">
<original>R</original>
<variation>Q</variation>
<location>
<position position="753"/>
</location>
</feature>
<feature type="mutagenesis site" description="Prevents addition of N-glycans. Reduces secretion of the N-terminal ectodomain." evidence="18">
<original>N</original>
<variation>S</variation>
<location>
<position position="114"/>
</location>
</feature>
<feature type="mutagenesis site" description="Prevents addition of N-glycans. Reduces secretion of the N-terminal ectodomain." evidence="18">
<original>N</original>
<variation>D</variation>
<location>
<position position="199"/>
</location>
</feature>
<feature type="mutagenesis site" description="Prevents addition of N-glycans. Reduces secretion of the N-terminal ectodomain." evidence="18">
<original>T</original>
<variation>A</variation>
<location>
<position position="416"/>
</location>
</feature>
<feature type="mutagenesis site" description="Prevents addition of N-glycans. Prevents secretion of the N-terminal ectodomain." evidence="18">
<original>N</original>
<variation>D</variation>
<location>
<position position="442"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes the interaction with MYD88. No effect on oligomerization or on the structure of the TIR domain." evidence="13">
<original>P</original>
<variation>F</variation>
<location>
<position position="681"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced protein stability." evidence="31">
<original>K</original>
<variation>R</variation>
<location>
<position position="709"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced protein stability." evidence="31">
<original>K</original>
<variation>R</variation>
<location>
<position position="714"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced protein stability." evidence="31">
<original>KK</original>
<variation>RR</variation>
<location>
<begin position="742"/>
<end position="743"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced protein stability." evidence="31">
<original>K</original>
<variation>R</variation>
<location>
<position position="751"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of PPP1R11-mediated ubiquitination and degradation." evidence="31">
<original>K</original>
<variation>R</variation>
<location>
<position position="754"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 8; AAM23001." ref="8" evidence="32">
<original>L</original>
<variation>Q</variation>
<location>
<position position="59"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 8; AAM23001." ref="8" evidence="32">
<original>S</original>
<variation>C</variation>
<location>
<position position="68"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; AAC34133." ref="2" evidence="32">
<original>D</original>
<variation>E</variation>
<location>
<position position="726"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="34"/>
<end position="37"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="56"/>
<end position="58"/>
</location>
</feature>
<feature type="turn" evidence="5">
<location>
<begin position="69"/>
<end position="74"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="80"/>
<end position="82"/>
</location>
</feature>
<feature type="turn" evidence="5">
<location>
<begin position="93"/>
<end position="98"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="104"/>
<end position="106"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="117"/>
<end position="120"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="127"/>
<end position="130"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="137"/>
<end position="139"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="153"/>
<end position="161"/>
</location>
</feature>
<feature type="turn" evidence="5">
<location>
<begin position="167"/>
<end position="172"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="175"/>
<end position="183"/>
</location>
</feature>
<feature type="turn" evidence="5">
<location>
<begin position="191"/>
<end position="196"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="198"/>
<end position="206"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="208"/>
<end position="210"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="213"/>
<end position="220"/>
</location>
</feature>
<feature type="turn" evidence="5">
<location>
<begin position="221"/>
<end position="223"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="224"/>
<end position="231"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="253"/>
<end position="258"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="260"/>
<end position="262"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="263"/>
<end position="274"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="281"/>
<end position="283"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="288"/>
<end position="291"/>
</location>
</feature>
<feature type="turn" evidence="6">
<location>
<begin position="300"/>
<end position="302"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="311"/>
<end position="316"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="322"/>
<end position="324"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="329"/>
<end position="334"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="340"/>
<end position="346"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="353"/>
<end position="358"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="364"/>
<end position="366"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="374"/>
<end position="380"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="391"/>
<end position="393"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="402"/>
<end position="408"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="409"/>
<end position="411"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="417"/>
<end position="419"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="440"/>
<end position="442"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="460"/>
<end position="463"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="481"/>
<end position="483"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="495"/>
<end position="497"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="503"/>
<end position="505"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="518"/>
<end position="520"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="527"/>
<end position="529"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="539"/>
<end position="544"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="545"/>
<end position="547"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="548"/>
<end position="550"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="641"/>
<end position="646"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="649"/>
<end position="651"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="652"/>
<end position="656"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="658"/>
<end position="663"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="666"/>
<end position="668"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="672"/>
<end position="674"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="675"/>
<end position="678"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="681"/>
<end position="683"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="685"/>
<end position="695"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="696"/>
<end position="703"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="705"/>
<end position="711"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="713"/>
<end position="716"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="717"/>
<end position="719"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="720"/>
<end position="722"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="723"/>
<end position="725"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="726"/>
<end position="728"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="733"/>
<end position="738"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="742"/>
<end position="744"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="750"/>
<end position="758"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="761"/>
<end position="763"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="768"/>
<end position="770"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="771"/>
<end position="783"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1FYW"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1FYX"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1O77"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2Z7X"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2Z80"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PDB" id="6NIG"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000250"/>
<evidence key="8" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q9QUN7"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000255"/>
<evidence key="10" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00204"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10426995"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10426996"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11081518"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11441107"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11476982"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12471095"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12646604"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15173186"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15809303"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16622205"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16880211"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17889651"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19362712"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19924287"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20800577"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21078852"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21618349"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22665377"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23376921"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25385819"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="27805901"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000305"/>
<sequence length="784" mass="89838" checksum="7DBE6B24CF1FAF8B" modified="1998-08-01" version="1" precursor="true">MPHTLWMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFDDCTLNGVGNFRASDNDRVIDPGKVETLTIRRLHIPRFYLFYDLSTLYSLTERVKRITVENSKVFLVPCLLSQHLKSLEYLDLSENLMVEEYLKNSACEDAWPSLQTLILRQNHLASLEKTGETLLTLKNLTNIDISKNSFHSMPETCQWPEKMKYLNLSSTRIHSVTGCIPKTLEILDVSNNNLNLFSLNLPQLKELYISRNKLMTLPDASLLPMLLVLKISRNAITTFSKEQLDSFHTLKTLEAGGNNFICSCEFLSFTQEQQALAKVLIDWPANYLCDSPSHVRGQQVQDVRLSVSECHRTALVSGMCCALFLLILLTGVLCHRFHGLWYMKMMWAWLQAKRKPRKAPSRNICYDAFVSYSERDAYWVENLMVQELENFNPPFKLCLHKRDFIPGKWIIDNIIDSIEKSHKTVFVLSENFVKSEWCKYELDFSHFRLFDENNDAAILILLEPIEKKAIPQRFCKLRKIMNTKTYLEWPMDEAQREGFWVNLRAAIKS</sequence>
</entry>
<entry dataset="Swiss-Prot" created="2009-02-10" modified="2021-02-10" version="74">
<accession>B3Y615</accession>
<name>TLR2_GORGO</name>
<protein>
<recommendedName>
<fullName>Toll-like receptor 2</fullName>
<ecNumber evidence="5">3.2.2.6</ecNumber>
</recommendedName>
<cdAntigenName>CD282</cdAntigenName>
</protein>
<gene>
<name type="primary">TLR2</name>
</gene>
<organism>
<name type="scientific">Gorilla gorilla gorilla</name>
<name type="common">Western lowland gorilla</name>
<dbReference type="NCBI Taxonomy" id="9595"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Gorilla</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="submission" date="2008-07" db="EMBL/GenBank/DDBJ databases">
<title>Molecular evolution of the Toll-like receptor-related genes in primates.</title>
<authorList>
<person name="Nakajima T."/>
<person name="Ohtani H."/>
<person name="Satta Y."/>
<person name="Uno Y."/>
<person name="Akari H."/>
<person name="Ishida T."/>
<person name="Kimura A."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
</reference>
<comment type="function">
<text evidence="2 3">Cooperates with LY96 to mediate the innate immune response to bacterial lipoproteins and other microbial cell wall components. Cooperates with TLR1 or TLR6 to mediate the innate immune response to bacterial lipoproteins or lipopeptides. Acts via MYD88 and TRAF6, leading to NF-kappa-B activation, cytokine secretion and the inflammatory response (By similarity). May also promote apoptosis in response to lipoproteins. Forms activation clusters composed of several receptors depending on the ligand, these clusters trigger signaling from the cell surface and subsequently are targeted to the Golgi in a lipid-raft dependent pathway. Forms the cluster TLR2:TLR6:CD14:CD36 in response to diacylated lipopeptides and TLR2:TLR1:CD14 in response to triacylated lipopeptides (By similarity).</text>
</comment>
<comment type="catalytic activity">
<reaction evidence="5">
<text>H2O + NAD(+) = ADP-D-ribose + H(+) + nicotinamide</text>
<dbReference type="Rhea" id="RHEA:16301"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:17154"/>
<dbReference type="ChEBI" id="CHEBI:57540"/>
<dbReference type="ChEBI" id="CHEBI:57967"/>
<dbReference type="EC" id="3.2.2.6"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="5">
<dbReference type="Rhea" id="RHEA:16302"/>
</physiologicalReaction>
</comment>
<comment type="subunit">
<text evidence="2 3">Interacts with LY96, TLR1 and TLR6 (via extracellular domain). TLR2 seems to exist in heterodimers with either TLR1 or TLR6 before stimulation by the ligand. The heterodimers form bigger oligomers in response to their corresponding ligands as well as further heterotypic associations with other receptors such as CD14 and/or CD36. Binds MYD88 (via TIR domain). Interacts with TICAM1. Interacts with CNPY3. Interacts with ATG16L1. Interacts with PPP1R11. Interacts with TICAM2.</text>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="3">Membrane</location>
<topology evidence="4">Single-pass type I membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="3">Cytoplasmic vesicle</location>
<location evidence="3">Phagosome membrane</location>
<topology evidence="4">Single-pass type I membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="2">Membrane raft</location>
</subcellularLocation>
<text evidence="2">Does not reside in lipid rafts before stimulation but accumulates increasingly in the raft upon the presence of the microbial ligand. In response to diacylated lipoproteins, TLR2:TLR6 heterodimers are recruited in lipid rafts, this recruitment determine the intracellular targeting to the Golgi apparatus. Triacylated lipoproteins induce the same mechanism for TLR2:TLR1 heterodimers.</text>
</comment>
<comment type="domain">
<text evidence="1">Ester-bound lipid substrates are bound through a crevice formed between the LRR 11 and LRR 12.</text>
</comment>
<comment type="domain">
<text evidence="1">The ATG16L1-binding motif mediates interaction with ATG16L1.</text>
</comment>
<comment type="domain">
<text evidence="5">The TIR domain mediates NAD(+) hydrolase (NADase) activity. Self-association of TIR domains is required for NADase activity.</text>
</comment>
<comment type="PTM">
<text evidence="3">Ubiquitinated at Lys-754 by PPP1R11, leading to its degradation. Deubiquitinated by USP2.</text>
</comment>
<comment type="PTM">
<text evidence="2">Glycosylation of Asn-442 is critical for secretion of the N-terminal ectodomain of TLR2.</text>
</comment>
<comment type="similarity">
<text evidence="6">Belongs to the Toll-like receptor family.</text>
</comment>
<dbReference type="EC" id="3.2.2.6" evidence="5"/>
<dbReference type="EMBL" id="AB445627">
<property type="protein sequence ID" value="BAG55024.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001266693.1">
<property type="nucleotide sequence ID" value="NM_001279764.1"/>
</dbReference>
<dbReference type="RefSeq" id="XP_018880449.1">
<property type="nucleotide sequence ID" value="XM_019024904.1"/>
</dbReference>
<dbReference type="RefSeq" id="XP_018880450.1">
<property type="nucleotide sequence ID" value="XM_019024905.1"/>
</dbReference>
<dbReference type="RefSeq" id="XP_018880451.1">
<property type="nucleotide sequence ID" value="XM_019024906.1"/>
</dbReference>
<dbReference type="RefSeq" id="XP_018880452.1">
<property type="nucleotide sequence ID" value="XM_019024907.1"/>
</dbReference>
<dbReference type="RefSeq" id="XP_018880453.1">
<property type="nucleotide sequence ID" value="XM_019024908.1"/>
</dbReference>
<dbReference type="RefSeq" id="XP_018880454.1">
<property type="nucleotide sequence ID" value="XM_019024909.1"/>
</dbReference>
<dbReference type="RefSeq" id="XP_018880455.1">
<property type="nucleotide sequence ID" value="XM_019024910.1"/>
</dbReference>
<dbReference type="RefSeq" id="XP_018880456.1">
<property type="nucleotide sequence ID" value="XM_019024911.1"/>
</dbReference>
<dbReference type="RefSeq" id="XP_018880457.1">
<property type="nucleotide sequence ID" value="XM_019024912.1"/>
</dbReference>
<dbReference type="SMR" id="B3Y615"/>
<dbReference type="STRING" id="9593.ENSGGOP00000003012"/>
<dbReference type="Ensembl" id="ENSGGOT00000003080">
<property type="protein sequence ID" value="ENSGGOP00000003012"/>
<property type="gene ID" value="ENSGGOG00000003066"/>
</dbReference>
<dbReference type="GeneID" id="101128447"/>
<dbReference type="KEGG" id="ggo:101128447"/>
<dbReference type="CTD" id="7097"/>
<dbReference type="eggNOG" id="KOG4641">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000156323"/>
<dbReference type="InParanoid" id="B3Y615"/>
<dbReference type="OrthoDB" id="282372at2759"/>
<dbReference type="Proteomes" id="UP000001519">
<property type="component" value="Chromosome 4"/>
</dbReference>
<dbReference type="GO" id="GO:0009986">
<property type="term" value="C:cell surface"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005794">
<property type="term" value="C:Golgi apparatus"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005887">
<property type="term" value="C:integral component of plasma membrane"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0045121">
<property type="term" value="C:membrane raft"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030670">
<property type="term" value="C:phagocytic vesicle membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0035354">
<property type="term" value="C:Toll-like receptor 1-Toll-like receptor 2 protein complex"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0001540">
<property type="term" value="F:amyloid-beta binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0042802">
<property type="term" value="F:identical protein binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0001530">
<property type="term" value="F:lipopolysaccharide binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0050135">
<property type="term" value="F:NAD(P)+ nucleosidase activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0061809">
<property type="term" value="F:NAD+ nucleotidase, cyclic ADP-ribose generating"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0038187">
<property type="term" value="F:pattern recognition receptor activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0042834">
<property type="term" value="F:peptidoglycan binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0044877">
<property type="term" value="F:protein-containing complex binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0038023">
<property type="term" value="F:signaling receptor activity"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0035325">
<property type="term" value="F:Toll-like receptor binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0004888">
<property type="term" value="F:transmembrane signaling receptor activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0042497">
<property type="term" value="F:triacyl lipopeptide binding"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0001775">
<property type="term" value="P:cell activation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0071726">
<property type="term" value="P:cellular response to diacyl bacterial lipopeptide"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071346">
<property type="term" value="P:cellular response to interferon-gamma"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0071223">
<property type="term" value="P:cellular response to lipoteichoic acid"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0071727">
<property type="term" value="P:cellular response to triacyl bacterial lipopeptide"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0002374">
<property type="term" value="P:cytokine secretion involved in immune response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0050830">
<property type="term" value="P:defense response to Gram-positive bacterium"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0042496">
<property type="term" value="P:detection of diacyl bacterial lipopeptide"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0042495">
<property type="term" value="P:detection of triacyl bacterial lipopeptide"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007252">
<property type="term" value="P:I-kappaB phosphorylation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0006954">
<property type="term" value="P:inflammatory response"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0032613">
<property type="term" value="P:interleukin-10 production"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0002755">
<property type="term" value="P:MyD88-dependent toll-like receptor signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:1903974">
<property type="term" value="P:positive regulation of cellular response to macrophage colony-stimulating factor stimulus"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0032722">
<property type="term" value="P:positive regulation of chemokine production"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0050729">
<property type="term" value="P:positive regulation of inflammatory response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0032755">
<property type="term" value="P:positive regulation of interleukin-6 production"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0032757">
<property type="term" value="P:positive regulation of interleukin-8 production"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:1904466">
<property type="term" value="P:positive regulation of matrix metallopeptidase secretion"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0051092">
<property type="term" value="P:positive regulation of NF-kappaB transcription factor activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:1901224">
<property type="term" value="P:positive regulation of NIK/NF-kappaB signaling"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0034123">
<property type="term" value="P:positive regulation of toll-like receptor signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0030177">
<property type="term" value="P:positive regulation of Wnt signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0034134">
<property type="term" value="P:toll-like receptor 2 signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0002224">
<property type="term" value="P:toll-like receptor signaling pathway"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="Gene3D" id="3.40.50.10140">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="3.80.10.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR000483">
<property type="entry name" value="Cys-rich_flank_reg_C"/>
</dbReference>
<dbReference type="InterPro" id="IPR001611">
<property type="entry name" value="Leu-rich_rpt"/>
</dbReference>
<dbReference type="InterPro" id="IPR003591">
<property type="entry name" value="Leu-rich_rpt_typical-subtyp"/>
</dbReference>
<dbReference type="InterPro" id="IPR032675">
<property type="entry name" value="LRR_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR000157">
<property type="entry name" value="TIR_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR027185">
<property type="entry name" value="TLR2"/>
</dbReference>
<dbReference type="InterPro" id="IPR017241">
<property type="entry name" value="Toll-like_receptor"/>
</dbReference>
<dbReference type="InterPro" id="IPR035897">
<property type="entry name" value="Toll_tir_struct_dom_sf"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR24365">
<property type="entry name" value="PTHR24365"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR24365:SF17">
<property type="entry name" value="PTHR24365:SF17"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF13855">
<property type="entry name" value="LRR_8"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="Pfam" id="PF01463">
<property type="entry name" value="LRRCT"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF01582">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PIRSF" id="PIRSF037595">
<property type="entry name" value="Toll-like_receptor"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00369">
<property type="entry name" value="LRR_TYP"/>
<property type="match status" value="7"/>
</dbReference>
<dbReference type="SMART" id="SM00082">
<property type="entry name" value="LRRCT"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00255">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF52200">
<property type="entry name" value="SSF52200"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51450">
<property type="entry name" value="LRR"/>
<property type="match status" value="11"/>
</dbReference>
<dbReference type="PROSITE" id="PS50104">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at transcript level"/>
<keyword id="KW-0968">Cytoplasmic vesicle</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0378">Hydrolase</keyword>
<keyword id="KW-0391">Immunity</keyword>
<keyword id="KW-0395">Inflammatory response</keyword>
<keyword id="KW-0399">Innate immunity</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0433">Leucine-rich repeat</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0520">NAD</keyword>
<keyword id="KW-0675">Receptor</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0732">Signal</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="signal peptide" evidence="4">
<location>
<begin position="1"/>
<end position="20"/>
</location>
</feature>
<feature type="chain" description="Toll-like receptor 2" id="PRO_0000363774">
<location>
<begin position="21"/>
<end position="784"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="4">
<location>
<begin position="21"/>
<end position="587"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="4">
<location>
<begin position="588"/>
<end position="608"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="4">
<location>
<begin position="609"/>
<end position="784"/>
</location>
</feature>
<feature type="repeat" description="LRR 1">
<location>
<begin position="54"/>
<end position="77"/>
</location>
</feature>
<feature type="repeat" description="LRR 2">
<location>
<begin position="78"/>
<end position="101"/>
</location>
</feature>
<feature type="repeat" description="LRR 3">
<location>
<begin position="102"/>
<end position="125"/>
</location>
</feature>
<feature type="repeat" description="LRR 4">
<location>
<begin position="126"/>
<end position="150"/>
</location>
</feature>
<feature type="repeat" description="LRR 5">
<location>
<begin position="151"/>
<end position="175"/>
</location>
</feature>
<feature type="repeat" description="LRR 6">
<location>
<begin position="176"/>
<end position="199"/>
</location>
</feature>
<feature type="repeat" description="LRR 7">
<location>
<begin position="200"/>
<end position="223"/>
</location>
</feature>
<feature type="repeat" description="LRR 8">
<location>
<begin position="224"/>
<end position="250"/>
</location>
</feature>
<feature type="repeat" description="LRR 9">
<location>
<begin position="251"/>
<end position="278"/>
</location>
</feature>
<feature type="repeat" description="LRR 10">
<location>
<begin position="279"/>
<end position="308"/>
</location>
</feature>
<feature type="repeat" description="LRR 11">
<location>
<begin position="309"/>
<end position="337"/>
</location>
</feature>
<feature type="repeat" description="LRR 12">
<location>
<begin position="338"/>
<end position="361"/>
</location>
</feature>
<feature type="repeat" description="LRR 13">
<location>
<begin position="362"/>
<end position="388"/>
</location>
</feature>
<feature type="repeat" description="LRR 14">
<location>
<begin position="389"/>
<end position="414"/>
</location>
</feature>
<feature type="repeat" description="LRR 15">
<location>
<begin position="415"/>
<end position="437"/>
</location>
</feature>
<feature type="repeat" description="LRR 16">
<location>
<begin position="438"/>
<end position="457"/>
</location>
</feature>
<feature type="repeat" description="LRR 17">
<location>
<begin position="458"/>
<end position="478"/>
</location>
</feature>
<feature type="repeat" description="LRR 18">
<location>
<begin position="479"/>
<end position="500"/>
</location>
</feature>
<feature type="repeat" description="LRR 19">
<location>
<begin position="501"/>
<end position="524"/>
</location>
</feature>
<feature type="domain" description="LRRCT">
<location>
<begin position="525"/>
<end position="579"/>
</location>
</feature>
<feature type="domain" description="TIR" evidence="5">
<location>
<begin position="639"/>
<end position="782"/>
</location>
</feature>
<feature type="short sequence motif" description="ATG16L1-binding motif">
<location>
<begin position="761"/>
<end position="778"/>
</location>
</feature>
<feature type="active site" evidence="5">
<location>
<position position="716"/>
</location>
</feature>
<feature type="site" description="Interaction with bacterial lipopeptide" evidence="1">
<location>
<position position="349"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="114"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="199"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="414"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="442"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1">
<location>
<begin position="30"/>
<end position="36"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1">
<location>
<begin position="353"/>
<end position="382"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1">
<location>
<begin position="432"/>
<end position="454"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="2">
<location>
<position position="754"/>
</location>
</feature>
<evidence key="1" type="ECO:0000250"/>
<evidence key="2" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="O60603"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q9QUN7"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000255"/>
<evidence key="5" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00204"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000305"/>
<sequence length="784" mass="89824" checksum="1465031E6825069C" modified="2008-09-23" version="1" precursor="true">MPHTLWMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFDDCTLNGVGNFRASDNDRVIDPGKVETLTIRRLHIPRFYLFYDLSTLYSLTERVKRITVENSKVFLVPCLLSQHLKSLEYLDLSENLMVEEYLKNSACEDAWPSLQTLILRQNHLASLEKTGETLLTLKNLTNVDISKNSFHSMPETCQWPEKMKYLNLSSTRIHSVTGCIPKTLEILDVSNNNLNLFSLNLPQLKELYISRNKLMTLPDASLLPMLLVLKISRNAITTFSKEQLDSFHTLKTLEAGGNNFICSCEFLSFTQEQQALAKVLIDWPANYLCDSPSHVRGQQVQDVRLSVSECHRTALVSGMCCALFLLILLTGVLCHRFHGLWYMKMMWAWLQAKRKPRKAPSRNICYDAFVSYSERDAYWVENLMVQELENFNPPFKLCLHKRDFIPGKWIIDNIIDSIEKSHKTVFVLSENFVKSEWCKYELDFSHFRLFDENNDAAILILLEPIEKKAIPQRFCKLRKIMNTKTYLEWPMDEAQREGFWVNLRAAIKS</sequence>
</entry>
<entry dataset="Swiss-Prot" created="2009-02-10" modified="2021-02-10" version="73">
<accession>B3Y613</accession>
<name>TLR2_PANTR</name>
<protein>
<recommendedName>
<fullName>Toll-like receptor 2</fullName>
<ecNumber evidence="5">3.2.2.6</ecNumber>
</recommendedName>
<cdAntigenName>CD282</cdAntigenName>
</protein>
<gene>
<name type="primary">TLR2</name>
</gene>
<organism>
<name type="scientific">Pan troglodytes</name>
<name type="common">Chimpanzee</name>
<dbReference type="NCBI Taxonomy" id="9598"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Pan</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="submission" date="2008-07" db="EMBL/GenBank/DDBJ databases">
<title>Molecular evolution of the Toll-like receptor-related genes in primates.</title>
<authorList>
<person name="Nakajima T."/>
<person name="Ohtani H."/>
<person name="Satta Y."/>
<person name="Uno Y."/>
<person name="Akari H."/>
<person name="Ishida T."/>
<person name="Kimura A."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
</reference>
<comment type="function">
<text evidence="2 3">Cooperates with LY96 to mediate the innate immune response to bacterial lipoproteins and other microbial cell wall components. Cooperates with TLR1 or TLR6 to mediate the innate immune response to bacterial lipoproteins or lipopeptides. Acts via MYD88 and TRAF6, leading to NF-kappa-B activation, cytokine secretion and the inflammatory response (By similarity). May also promote apoptosis in response to lipoproteins. Forms activation clusters composed of several receptors depending on the ligand, these clusters trigger signaling from the cell surface and subsequently are targeted to the Golgi in a lipid-raft dependent pathway. Forms the cluster TLR2:TLR6:CD14:CD36 in response to diacylated lipopeptides and TLR2:TLR1:CD14 in response to triacylated lipopeptides (By similarity).</text>
</comment>
<comment type="catalytic activity">
<reaction evidence="5">
<text>H2O + NAD(+) = ADP-D-ribose + H(+) + nicotinamide</text>
<dbReference type="Rhea" id="RHEA:16301"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:17154"/>
<dbReference type="ChEBI" id="CHEBI:57540"/>
<dbReference type="ChEBI" id="CHEBI:57967"/>
<dbReference type="EC" id="3.2.2.6"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="5">
<dbReference type="Rhea" id="RHEA:16302"/>
</physiologicalReaction>
</comment>
<comment type="subunit">
<text evidence="2 3">Interacts with LY96, TLR1 and TLR6 (via extracellular domain). TLR2 seems to exist in heterodimers with either TLR1 or TLR6 before stimulation by the ligand. The heterodimers form bigger oligomers in response to their corresponding ligands as well as further heterotypic associations with other receptors such as CD14 and/or CD36. Binds MYD88 (via TIR domain). Interacts with TICAM1. Interacts with CNPY3. Interacts with ATG16L1. Interacts with PPP1R11. Interacts with TICAM2.</text>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="3">Membrane</location>
<topology evidence="4">Single-pass type I membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="3">Cytoplasmic vesicle</location>
<location evidence="3">Phagosome membrane</location>
<topology evidence="4">Single-pass type I membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="2">Membrane raft</location>
</subcellularLocation>
<text evidence="2">Does not reside in lipid rafts before stimulation but accumulates increasingly in the raft upon the presence of the microbial ligand. In response to diacylated lipoproteins, TLR2:TLR6 heterodimers are recruited in lipid rafts, this recruitment determine the intracellular targeting to the Golgi apparatus. Triacylated lipoproteins induce the same mechanism for TLR2:TLR1 heterodimers.</text>
</comment>
<comment type="domain">
<text evidence="1">Ester-bound lipid substrates are bound through a crevice formed between the LRR 11 and LRR 12.</text>
</comment>
<comment type="domain">
<text evidence="1">The ATG16L1-binding motif mediates interaction with ATG16L1.</text>
</comment>
<comment type="domain">
<text evidence="5">The TIR domain mediates NAD(+) hydrolase (NADase) activity. Self-association of TIR domains is required for NADase activity.</text>
</comment>
<comment type="PTM">
<text evidence="3">Ubiquitinated at Lys-754 by PPP1R11, leading to its degradation. Deubiquitinated by USP2.</text>
</comment>
<comment type="PTM">
<text evidence="2">Glycosylation of Asn-442 is critical for secretion of the N-terminal ectodomain of TLR2.</text>
</comment>
<comment type="similarity">
<text evidence="6">Belongs to the Toll-like receptor family.</text>
</comment>
<dbReference type="EC" id="3.2.2.6" evidence="5"/>
<dbReference type="EMBL" id="AB445625">
<property type="protein sequence ID" value="BAG55022.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001123941.1">
<property type="nucleotide sequence ID" value="NM_001130469.1"/>
</dbReference>
<dbReference type="SMR" id="B3Y613"/>
<dbReference type="STRING" id="9598.ENSPTRP00000028379"/>
<dbReference type="PaxDb" id="B3Y613"/>
<dbReference type="GeneID" id="471325"/>
<dbReference type="KEGG" id="ptr:471325"/>
<dbReference type="CTD" id="7097"/>
<dbReference type="eggNOG" id="KOG4641">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="InParanoid" id="B3Y613"/>
<dbReference type="Proteomes" id="UP000002277">
<property type="component" value="Unplaced"/>
</dbReference>
<dbReference type="GO" id="GO:0005794">
<property type="term" value="C:Golgi apparatus"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005887">
<property type="term" value="C:integral component of plasma membrane"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0045121">
<property type="term" value="C:membrane raft"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030670">
<property type="term" value="C:phagocytic vesicle membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0050135">
<property type="term" value="F:NAD(P)+ nucleosidase activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0061809">
<property type="term" value="F:NAD+ nucleotidase, cyclic ADP-ribose generating"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0038023">
<property type="term" value="F:signaling receptor activity"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0004888">
<property type="term" value="F:transmembrane signaling receptor activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0042497">
<property type="term" value="F:triacyl lipopeptide binding"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0071726">
<property type="term" value="P:cellular response to diacyl bacterial lipopeptide"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071727">
<property type="term" value="P:cellular response to triacyl bacterial lipopeptide"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006954">
<property type="term" value="P:inflammatory response"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0045087">
<property type="term" value="P:innate immune response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0002755">
<property type="term" value="P:MyD88-dependent toll-like receptor signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0050729">
<property type="term" value="P:positive regulation of inflammatory response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0034134">
<property type="term" value="P:toll-like receptor 2 signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0002224">
<property type="term" value="P:toll-like receptor signaling pathway"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="Gene3D" id="3.40.50.10140">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="3.80.10.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR000483">
<property type="entry name" value="Cys-rich_flank_reg_C"/>
</dbReference>
<dbReference type="InterPro" id="IPR001611">
<property type="entry name" value="Leu-rich_rpt"/>
</dbReference>
<dbReference type="InterPro" id="IPR003591">
<property type="entry name" value="Leu-rich_rpt_typical-subtyp"/>
</dbReference>
<dbReference type="InterPro" id="IPR032675">
<property type="entry name" value="LRR_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR000157">
<property type="entry name" value="TIR_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR027185">
<property type="entry name" value="TLR2"/>
</dbReference>
<dbReference type="InterPro" id="IPR017241">
<property type="entry name" value="Toll-like_receptor"/>
</dbReference>
<dbReference type="InterPro" id="IPR035897">
<property type="entry name" value="Toll_tir_struct_dom_sf"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR24365">
<property type="entry name" value="PTHR24365"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR24365:SF17">
<property type="entry name" value="PTHR24365:SF17"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF13855">
<property type="entry name" value="LRR_8"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="Pfam" id="PF01463">
<property type="entry name" value="LRRCT"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF01582">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PIRSF" id="PIRSF037595">
<property type="entry name" value="Toll-like_receptor"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00369">
<property type="entry name" value="LRR_TYP"/>
<property type="match status" value="7"/>
</dbReference>
<dbReference type="SMART" id="SM00082">
<property type="entry name" value="LRRCT"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00255">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF52200">
<property type="entry name" value="SSF52200"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51450">
<property type="entry name" value="LRR"/>
<property type="match status" value="11"/>
</dbReference>
<dbReference type="PROSITE" id="PS50104">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at transcript level"/>
<keyword id="KW-0968">Cytoplasmic vesicle</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0378">Hydrolase</keyword>
<keyword id="KW-0391">Immunity</keyword>
<keyword id="KW-0395">Inflammatory response</keyword>
<keyword id="KW-0399">Innate immunity</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0433">Leucine-rich repeat</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0520">NAD</keyword>
<keyword id="KW-0675">Receptor</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0732">Signal</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="signal peptide" evidence="4">
<location>
<begin position="1"/>
<end position="20"/>
</location>
</feature>
<feature type="chain" description="Toll-like receptor 2" id="PRO_0000363777">
<location>
<begin position="21"/>
<end position="784"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="4">
<location>
<begin position="21"/>
<end position="587"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="4">
<location>
<begin position="588"/>
<end position="608"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="4">
<location>
<begin position="609"/>
<end position="784"/>
</location>
</feature>
<feature type="repeat" description="LRR 1">
<location>
<begin position="54"/>
<end position="77"/>
</location>
</feature>
<feature type="repeat" description="LRR 2">
<location>
<begin position="78"/>
<end position="101"/>
</location>
</feature>
<feature type="repeat" description="LRR 3">
<location>
<begin position="102"/>
<end position="125"/>
</location>
</feature>
<feature type="repeat" description="LRR 4">
<location>
<begin position="126"/>
<end position="150"/>
</location>
</feature>
<feature type="repeat" description="LRR 5">
<location>
<begin position="151"/>
<end position="175"/>
</location>
</feature>
<feature type="repeat" description="LRR 6">
<location>
<begin position="176"/>
<end position="199"/>
</location>
</feature>
<feature type="repeat" description="LRR 7">
<location>
<begin position="200"/>
<end position="223"/>
</location>
</feature>
<feature type="repeat" description="LRR 8">
<location>
<begin position="224"/>
<end position="250"/>
</location>
</feature>
<feature type="repeat" description="LRR 9">
<location>
<begin position="251"/>
<end position="278"/>
</location>
</feature>
<feature type="repeat" description="LRR 10">
<location>
<begin position="279"/>
<end position="308"/>
</location>
</feature>
<feature type="repeat" description="LRR 11">
<location>
<begin position="309"/>
<end position="337"/>
</location>
</feature>
<feature type="repeat" description="LRR 12">
<location>
<begin position="338"/>
<end position="361"/>
</location>
</feature>
<feature type="repeat" description="LRR 13">
<location>
<begin position="362"/>
<end position="388"/>
</location>
</feature>
<feature type="repeat" description="LRR 14">
<location>
<begin position="389"/>
<end position="414"/>
</location>
</feature>
<feature type="repeat" description="LRR 15">
<location>
<begin position="415"/>
<end position="437"/>
</location>
</feature>
<feature type="repeat" description="LRR 16">
<location>
<begin position="438"/>
<end position="457"/>
</location>
</feature>
<feature type="repeat" description="LRR 17">
<location>
<begin position="458"/>
<end position="478"/>
</location>
</feature>
<feature type="repeat" description="LRR 18">
<location>
<begin position="479"/>
<end position="500"/>
</location>
</feature>
<feature type="repeat" description="LRR 19">
<location>
<begin position="501"/>
<end position="524"/>
</location>
</feature>
<feature type="domain" description="LRRCT">
<location>
<begin position="525"/>
<end position="579"/>
</location>
</feature>
<feature type="domain" description="TIR" evidence="5">
<location>
<begin position="639"/>
<end position="782"/>
</location>
</feature>
<feature type="short sequence motif" description="ATG16L1-binding motif">
<location>
<begin position="761"/>
<end position="778"/>
</location>
</feature>
<feature type="active site" evidence="5">
<location>
<position position="716"/>
</location>
</feature>
<feature type="site" description="Interaction with bacterial lipopeptide" evidence="1">
<location>
<position position="349"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="114"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="199"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="414"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="442"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1">
<location>
<begin position="30"/>
<end position="36"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1">
<location>
<begin position="353"/>
<end position="382"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1">
<location>
<begin position="432"/>
<end position="454"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="2">
<location>
<position position="754"/>
</location>
</feature>
<evidence key="1" type="ECO:0000250"/>
<evidence key="2" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="O60603"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q9QUN7"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000255"/>
<evidence key="5" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00204"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000305"/>
<sequence length="784" mass="89825" checksum="9F46005D894F7CB5" modified="2008-09-23" version="1" precursor="true">MPHTLWMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFRFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFDDCTLNGVGNFRASDNDRVIDPGKVETLTIRRLHIPRFYLFYDLSTLYSLTERVKRITVENSKVFLVPCLLSQHLKSLEYLDLSENLIVEEYLKNSACEDAWPSLQTLILRQNHLASLEKTGETLLTLKNLTNVDISKNSFHSMPETCQWPEKMKYLNLSSTRIHSVTGCIPKTLEILDVSNNNLNLFSLNLPQLKELYISRNKLMTLPDASLLPMLLVLKISRNAITTFSKEQLDSFHTLKTLEAGGNNFICSCEFLSFTQEQQALAKVLIDWPANYLCDSPSHVRGQQVQDVRLSVSECHRTALVSGMCCALFLLILLTGVLCHRFHGLWYMKMMWAWLQAKRKPRKAPSRNICYDAFVSYSERDAYWVENLMVQELENFNPPFKLCLHKRDFIPGKWIIDNIIDSIEKSHKTVFVLSENFVKSEWCKYELDFSHFRLFDENNDAAILILLEPIEKKAIPQRFCKLRKIMNTKTYLEWPMDEAQREGFWVNLRAAIKS</sequence>
</entry>
<entry dataset="Swiss-Prot" created="2009-02-10" modified="2021-02-10" version="72">
<accession>B3Y614</accession>
<name>TLR2_PANPA</name>
<protein>
<recommendedName>
<fullName>Toll-like receptor 2</fullName>
<ecNumber evidence="5">3.2.2.6</ecNumber>
</recommendedName>
<cdAntigenName>CD282</cdAntigenName>
</protein>
<gene>
<name type="primary">TLR2</name>
</gene>
<organism>
<name type="scientific">Pan paniscus</name>
<name type="common">Pygmy chimpanzee</name>
<name type="synonym">Bonobo</name>
<dbReference type="NCBI Taxonomy" id="9597"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Pan</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="submission" date="2008-07" db="EMBL/GenBank/DDBJ databases">
<title>Molecular evolution of the Toll-like receptor-related genes in primates.</title>
<authorList>
<person name="Nakajima T."/>
<person name="Ohtani H."/>
<person name="Satta Y."/>
<person name="Uno Y."/>
<person name="Akari H."/>
<person name="Ishida T."/>
<person name="Kimura A."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
</reference>
<comment type="function">
<text evidence="2 3">Cooperates with LY96 to mediate the innate immune response to bacterial lipoproteins and other microbial cell wall components. Cooperates with TLR1 or TLR6 to mediate the innate immune response to bacterial lipoproteins or lipopeptides. Acts via MYD88 and TRAF6, leading to NF-kappa-B activation, cytokine secretion and the inflammatory response (By similarity). May also promote apoptosis in response to lipoproteins. Forms activation clusters composed of several receptors depending on the ligand, these clusters trigger signaling from the cell surface and subsequently are targeted to the Golgi in a lipid-raft dependent pathway. Forms the cluster TLR2:TLR6:CD14:CD36 in response to diacylated lipopeptides and TLR2:TLR1:CD14 in response to triacylated lipopeptides (By similarity).</text>
</comment>
<comment type="catalytic activity">
<reaction evidence="5">
<text>H2O + NAD(+) = ADP-D-ribose + H(+) + nicotinamide</text>
<dbReference type="Rhea" id="RHEA:16301"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:17154"/>
<dbReference type="ChEBI" id="CHEBI:57540"/>
<dbReference type="ChEBI" id="CHEBI:57967"/>
<dbReference type="EC" id="3.2.2.6"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="5">
<dbReference type="Rhea" id="RHEA:16302"/>
</physiologicalReaction>
</comment>
<comment type="subunit">
<text evidence="2 3">Interacts with LY96, TLR1 and TLR6 (via extracellular domain). TLR2 seems to exist in heterodimers with either TLR1 or TLR6 before stimulation by the ligand. The heterodimers form bigger oligomers in response to their corresponding ligands as well as further heterotypic associations with other receptors such as CD14 and/or CD36. Binds MYD88 (via TIR domain). Interacts with TICAM1. Interacts with CNPY3. Interacts with ATG16L1. Interacts with PPP1R11. Interacts with TICAM2.</text>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="3">Membrane</location>
<topology evidence="4">Single-pass type I membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="3">Cytoplasmic vesicle</location>
<location evidence="3">Phagosome membrane</location>
<topology evidence="4">Single-pass type I membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="2">Membrane raft</location>
</subcellularLocation>
<text evidence="2">Does not reside in lipid rafts before stimulation but accumulates increasingly in the raft upon the presence of the microbial ligand. In response to diacylated lipoproteins, TLR2:TLR6 heterodimers are recruited in lipid rafts, this recruitment determine the intracellular targeting to the Golgi apparatus. Triacylated lipoproteins induce the same mechanism for TLR2:TLR1 heterodimers.</text>
</comment>
<comment type="domain">
<text evidence="1">Ester-bound lipid substrates are bound through a crevice formed between the LRR 11 and LRR 12.</text>
</comment>
<comment type="domain">
<text evidence="1">The ATG16L1-binding motif mediates interaction with ATG16L1.</text>
</comment>
<comment type="domain">
<text evidence="5">The TIR domain mediates NAD(+) hydrolase (NADase) activity. Self-association of TIR domains is required for NADase activity.</text>
</comment>
<comment type="PTM">
<text evidence="3">Ubiquitinated at Lys-754 by PPP1R11, leading to its degradation. Deubiquitinated by USP2.</text>
</comment>
<comment type="PTM">
<text evidence="2">Glycosylation of Asn-442 is critical for secretion of the N-terminal ectodomain of TLR2.</text>
</comment>
<comment type="similarity">
<text evidence="6">Belongs to the Toll-like receptor family.</text>
</comment>
<dbReference type="EC" id="3.2.2.6" evidence="5"/>
<dbReference type="EMBL" id="AB445626">
<property type="protein sequence ID" value="BAG55023.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001266165.1">
<property type="nucleotide sequence ID" value="NM_001279236.1"/>
</dbReference>
<dbReference type="RefSeq" id="XP_008974366.1">
<property type="nucleotide sequence ID" value="XM_008976118.1"/>
</dbReference>
<dbReference type="RefSeq" id="XP_008974367.1">
<property type="nucleotide sequence ID" value="XM_008976119.2"/>
</dbReference>
<dbReference type="RefSeq" id="XP_008974370.1">
<property type="nucleotide sequence ID" value="XM_008976122.1"/>
</dbReference>
<dbReference type="STRING" id="9597.NP_001266165.1"/>
<dbReference type="Ensembl" id="ENSPPAT00000029196">
<property type="protein sequence ID" value="ENSPPAP00000007123"/>
<property type="gene ID" value="ENSPPAG00000026253"/>
</dbReference>
<dbReference type="GeneID" id="100994768"/>
<dbReference type="KEGG" id="pps:100994768"/>
<dbReference type="CTD" id="7097"/>
<dbReference type="eggNOG" id="KOG4641">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000156323"/>
<dbReference type="OMA" id="CTLNGVG"/>
<dbReference type="OrthoDB" id="282372at2759"/>
<dbReference type="Proteomes" id="UP000240080">
<property type="component" value="Chromosome 4"/>
</dbReference>
<dbReference type="GO" id="GO:0009986">
<property type="term" value="C:cell surface"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005794">
<property type="term" value="C:Golgi apparatus"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005887">
<property type="term" value="C:integral component of plasma membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045121">
<property type="term" value="C:membrane raft"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030670">
<property type="term" value="C:phagocytic vesicle membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0035354">
<property type="term" value="C:Toll-like receptor 1-Toll-like receptor 2 protein complex"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0001540">
<property type="term" value="F:amyloid-beta binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0042802">
<property type="term" value="F:identical protein binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0001530">
<property type="term" value="F:lipopolysaccharide binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0050135">
<property type="term" value="F:NAD(P)+ nucleosidase activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0061809">
<property type="term" value="F:NAD+ nucleotidase, cyclic ADP-ribose generating"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0038187">
<property type="term" value="F:pattern recognition receptor activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0042834">
<property type="term" value="F:peptidoglycan binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0044877">
<property type="term" value="F:protein-containing complex binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0035325">
<property type="term" value="F:Toll-like receptor binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0004888">
<property type="term" value="F:transmembrane signaling receptor activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0042497">
<property type="term" value="F:triacyl lipopeptide binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0001775">
<property type="term" value="P:cell activation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0071726">
<property type="term" value="P:cellular response to diacyl bacterial lipopeptide"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071346">
<property type="term" value="P:cellular response to interferon-gamma"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0071223">
<property type="term" value="P:cellular response to lipoteichoic acid"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0071727">
<property type="term" value="P:cellular response to triacyl bacterial lipopeptide"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0002374">
<property type="term" value="P:cytokine secretion involved in immune response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0050830">
<property type="term" value="P:defense response to Gram-positive bacterium"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0042496">
<property type="term" value="P:detection of diacyl bacterial lipopeptide"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0042495">
<property type="term" value="P:detection of triacyl bacterial lipopeptide"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007252">
<property type="term" value="P:I-kappaB phosphorylation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0006954">
<property type="term" value="P:inflammatory response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0032613">
<property type="term" value="P:interleukin-10 production"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0002755">
<property type="term" value="P:MyD88-dependent toll-like receptor signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:1903974">
<property type="term" value="P:positive regulation of cellular response to macrophage colony-stimulating factor stimulus"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0032722">
<property type="term" value="P:positive regulation of chemokine production"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0050729">
<property type="term" value="P:positive regulation of inflammatory response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0032755">
<property type="term" value="P:positive regulation of interleukin-6 production"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0032757">
<property type="term" value="P:positive regulation of interleukin-8 production"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:1904466">
<property type="term" value="P:positive regulation of matrix metallopeptidase secretion"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0051092">
<property type="term" value="P:positive regulation of NF-kappaB transcription factor activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:1901224">
<property type="term" value="P:positive regulation of NIK/NF-kappaB signaling"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0034123">
<property type="term" value="P:positive regulation of toll-like receptor signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0030177">
<property type="term" value="P:positive regulation of Wnt signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0034134">
<property type="term" value="P:toll-like receptor 2 signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="Gene3D" id="3.40.50.10140">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="3.80.10.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR000483">
<property type="entry name" value="Cys-rich_flank_reg_C"/>
</dbReference>
<dbReference type="InterPro" id="IPR001611">
<property type="entry name" value="Leu-rich_rpt"/>
</dbReference>
<dbReference type="InterPro" id="IPR003591">
<property type="entry name" value="Leu-rich_rpt_typical-subtyp"/>
</dbReference>
<dbReference type="InterPro" id="IPR032675">
<property type="entry name" value="LRR_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR000157">
<property type="entry name" value="TIR_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR027185">
<property type="entry name" value="TLR2"/>
</dbReference>
<dbReference type="InterPro" id="IPR017241">
<property type="entry name" value="Toll-like_receptor"/>
</dbReference>
<dbReference type="InterPro" id="IPR035897">
<property type="entry name" value="Toll_tir_struct_dom_sf"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR24365">
<property type="entry name" value="PTHR24365"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR24365:SF17">
<property type="entry name" value="PTHR24365:SF17"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF13855">
<property type="entry name" value="LRR_8"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="Pfam" id="PF01463">
<property type="entry name" value="LRRCT"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF01582">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PIRSF" id="PIRSF037595">
<property type="entry name" value="Toll-like_receptor"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00369">
<property type="entry name" value="LRR_TYP"/>
<property type="match status" value="7"/>
</dbReference>
<dbReference type="SMART" id="SM00082">
<property type="entry name" value="LRRCT"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00255">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF52200">
<property type="entry name" value="SSF52200"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51450">
<property type="entry name" value="LRR"/>
<property type="match status" value="11"/>
</dbReference>
<dbReference type="PROSITE" id="PS50104">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at transcript level"/>
<keyword id="KW-0968">Cytoplasmic vesicle</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0378">Hydrolase</keyword>
<keyword id="KW-0391">Immunity</keyword>
<keyword id="KW-0395">Inflammatory response</keyword>
<keyword id="KW-0399">Innate immunity</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0433">Leucine-rich repeat</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0520">NAD</keyword>
<keyword id="KW-0675">Receptor</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0732">Signal</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="signal peptide" evidence="4">
<location>
<begin position="1"/>
<end position="20"/>
</location>
</feature>
<feature type="chain" description="Toll-like receptor 2" id="PRO_0000363776">
<location>
<begin position="21"/>
<end position="784"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="4">
<location>
<begin position="21"/>
<end position="587"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="4">
<location>
<begin position="588"/>
<end position="608"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="4">
<location>
<begin position="609"/>
<end position="784"/>
</location>
</feature>
<feature type="repeat" description="LRR 1">
<location>
<begin position="54"/>
<end position="77"/>
</location>
</feature>
<feature type="repeat" description="LRR 2">
<location>
<begin position="78"/>
<end position="101"/>
</location>
</feature>
<feature type="repeat" description="LRR 3">
<location>
<begin position="102"/>
<end position="125"/>
</location>
</feature>
<feature type="repeat" description="LRR 4">
<location>
<begin position="126"/>
<end position="150"/>
</location>
</feature>
<feature type="repeat" description="LRR 5">
<location>
<begin position="151"/>
<end position="175"/>
</location>
</feature>
<feature type="repeat" description="LRR 6">
<location>
<begin position="176"/>
<end position="199"/>
</location>
</feature>
<feature type="repeat" description="LRR 7">
<location>
<begin position="200"/>
<end position="223"/>
</location>
</feature>
<feature type="repeat" description="LRR 8">
<location>
<begin position="224"/>
<end position="250"/>
</location>
</feature>
<feature type="repeat" description="LRR 9">
<location>
<begin position="251"/>
<end position="278"/>
</location>
</feature>
<feature type="repeat" description="LRR 10">
<location>
<begin position="279"/>
<end position="308"/>
</location>
</feature>
<feature type="repeat" description="LRR 11">
<location>
<begin position="309"/>
<end position="337"/>
</location>
</feature>
<feature type="repeat" description="LRR 12">
<location>
<begin position="338"/>
<end position="361"/>
</location>
</feature>
<feature type="repeat" description="LRR 13">
<location>
<begin position="362"/>
<end position="388"/>
</location>
</feature>
<feature type="repeat" description="LRR 14">
<location>
<begin position="389"/>
<end position="414"/>
</location>
</feature>
<feature type="repeat" description="LRR 15">
<location>
<begin position="415"/>
<end position="437"/>
</location>
</feature>
<feature type="repeat" description="LRR 16">
<location>
<begin position="438"/>
<end position="457"/>
</location>
</feature>
<feature type="repeat" description="LRR 17">
<location>
<begin position="458"/>
<end position="478"/>
</location>
</feature>
<feature type="repeat" description="LRR 18">
<location>
<begin position="479"/>
<end position="500"/>
</location>
</feature>
<feature type="repeat" description="LRR 19">
<location>
<begin position="501"/>
<end position="524"/>
</location>
</feature>
<feature type="domain" description="LRRCT">
<location>
<begin position="525"/>
<end position="579"/>
</location>
</feature>
<feature type="domain" description="TIR" evidence="5">
<location>
<begin position="639"/>
<end position="782"/>
</location>
</feature>
<feature type="short sequence motif" description="ATG16L1-binding motif">
<location>
<begin position="761"/>
<end position="778"/>
</location>
</feature>
<feature type="active site" evidence="5">
<location>
<position position="716"/>
</location>
</feature>
<feature type="site" description="Interaction with bacterial lipopeptide" evidence="1">
<location>
<position position="349"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="114"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="199"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="414"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="442"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1">
<location>
<begin position="30"/>
<end position="36"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1">
<location>
<begin position="353"/>
<end position="382"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1">
<location>
<begin position="432"/>
<end position="454"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="2">
<location>
<position position="754"/>
</location>
</feature>
<evidence key="1" type="ECO:0000250"/>
<evidence key="2" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="O60603"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q9QUN7"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000255"/>
<evidence key="5" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00204"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000305"/>
<sequence length="784" mass="89801" checksum="5CF2E5B88C3A59B0" modified="2008-09-23" version="1" precursor="true">MPHTLWMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYESKSLKSIQNVSHLILHMKQHILLLEIFVDVSSSVECLELRDTDLDTFRFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFDDCTLNGVGNFRASDNDRVIDPGKVETLTIRRLHIPRFYLFYDLSTLYSLTERVKRITVENSKVFLVPCLLSQHLKSLEYLDLSENLIVEEYLKNSACEDAWPSLQTLILRQNHLASLEKTGETLLTLKNLTNVDISKNSFHSMPETCQWPEKMKYLNLSSTRIHSVTGCIPKTLEILDVSNNNLNLFSLNLPQLKELYISRNKLMTLPDASLLPMLLVLKISRNAITTFSKEQLDSFHTLKTLEAGGNNFICSCEFLSFTQEQQALAKVLIDWPANYLCDSPSHVRGQQVQDVRLSVSECHRTALVSGMCCALFLLILLTGVLCHRFHGLWYMKMMWAWLQAKRKPRKAPSRNICYDAFVSYSERDAYWVENLMVQELENFNPPFKLCLHKRDFIPGKWIIDNIIDSIEKSHKTVFVLSENFVKSEWCKYELDFSHFRLFDENNDAAILILLEPIEKKAIPQRFCKLRKIMNTKTYLEWPMDEAQREGFWVNLRAAIKS</sequence>
</entry>
<entry dataset="Swiss-Prot" created="2002-01-31" modified="2021-02-10" version="110">
<accession>Q95M53</accession>
<accession>B3Y617</accession>
<name>TLR2_MACFA</name>
<protein>
<recommendedName>
<fullName>Toll-like receptor 2</fullName>
<ecNumber evidence="5">3.2.2.6</ecNumber>
</recommendedName>
<cdAntigenName>CD282</cdAntigenName>
</protein>
<gene>
<name type="primary">TLR2</name>
</gene>
<organism>
<name type="scientific">Macaca fascicularis</name>
<name type="common">Crab-eating macaque</name>
<name type="synonym">Cynomolgus monkey</name>
<dbReference type="NCBI Taxonomy" id="9541"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Cercopithecidae</taxon>
<taxon>Cercopithecinae</taxon>
<taxon>Macaca</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="submission" date="2001-07" db="EMBL/GenBank/DDBJ databases">
<title>Macaca fascicularis Toll-like receptor 2.</title>
<authorList>
<person name="Roberts F.A."/>
<person name="Tang S."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<source>
<tissue>Monocyte</tissue>
</source>
</reference>
<reference key="2">
<citation type="submission" date="2008-07" db="EMBL/GenBank/DDBJ databases">
<title>Molecular evolution of the Toll-like receptor-related genes in primates.</title>
<authorList>
<person name="Nakajima T."/>
<person name="Ohtani H."/>
<person name="Satta Y."/>
<person name="Uno Y."/>
<person name="Akari H."/>
<person name="Ishida T."/>
<person name="Kimura A."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
</reference>
<comment type="function">
<text evidence="2 3">Cooperates with LY96 to mediate the innate immune response to bacterial lipoproteins and other microbial cell wall components. Cooperates with TLR1 or TLR6 to mediate the innate immune response to bacterial lipoproteins or lipopeptides. Acts via MYD88 and TRAF6, leading to NF-kappa-B activation, cytokine secretion and the inflammatory response (By similarity). May also promote apoptosis in response to lipoproteins. Forms activation clusters composed of several receptors depending on the ligand, these clusters trigger signaling from the cell surface and subsequently are targeted to the Golgi in a lipid-raft dependent pathway. Forms the cluster TLR2:TLR6:CD14:CD36 in response to diacylated lipopeptides and TLR2:TLR1:CD14 in response to triacylated lipopeptides (By similarity).</text>
</comment>
<comment type="catalytic activity">
<reaction evidence="5">
<text>H2O + NAD(+) = ADP-D-ribose + H(+) + nicotinamide</text>
<dbReference type="Rhea" id="RHEA:16301"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:17154"/>
<dbReference type="ChEBI" id="CHEBI:57540"/>
<dbReference type="ChEBI" id="CHEBI:57967"/>
<dbReference type="EC" id="3.2.2.6"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="5">
<dbReference type="Rhea" id="RHEA:16302"/>
</physiologicalReaction>
</comment>
<comment type="subunit">
<text evidence="2 3">Interacts with LY96, TLR1 and TLR6 (via extracellular domain). TLR2 seems to exist in heterodimers with either TLR1 or TLR6 before stimulation by the ligand. The heterodimers form bigger oligomers in response to their corresponding ligands as well as further heterotypic associations with other receptors such as CD14 and/or CD36. Binds MYD88 (via TIR domain). Interacts with TICAM1. Interacts with CNPY3. Interacts with ATG16L1. Interacts with PPP1R11. Interacts with TICAM2.</text>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="3">Membrane</location>
<topology evidence="4">Single-pass type I membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="3">Cytoplasmic vesicle</location>
<location evidence="3">Phagosome membrane</location>
<topology evidence="4">Single-pass type I membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="2">Membrane raft</location>
</subcellularLocation>
<text evidence="2">Does not reside in lipid rafts before stimulation but accumulates increasingly in the raft upon the presence of the microbial ligand. In response to diacylated lipoproteins, TLR2:TLR6 heterodimers are recruited in lipid rafts, this recruitment determine the intracellular targeting to the Golgi apparatus. Triacylated lipoproteins induce the same mechanism for TLR2:TLR1 heterodimers.</text>
</comment>
<comment type="domain">
<text evidence="1">Ester-bound lipid substrates are bound through a crevice formed between the LRR 11 and LRR 12.</text>
</comment>
<comment type="domain">
<text evidence="1">The ATG16L1-binding motif mediates interaction with ATG16L1.</text>
</comment>
<comment type="domain">
<text evidence="5">The TIR domain mediates NAD(+) hydrolase (NADase) activity. Self-association of TIR domains is required for NADase activity.</text>
</comment>
<comment type="PTM">
<text evidence="3">Ubiquitinated at Lys-754 by PPP1R11, leading to its degradation. Deubiquitinated by USP2.</text>
</comment>
<comment type="PTM">
<text evidence="2">Glycosylation of Asn-442 is critical for secretion of the N-terminal ectodomain of TLR2.</text>
</comment>
<comment type="similarity">
<text evidence="6">Belongs to the Toll-like receptor family.</text>
</comment>
<dbReference type="EC" id="3.2.2.6" evidence="5"/>
<dbReference type="EMBL" id="AY045573">
<property type="protein sequence ID" value="AAK91868.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB445629">
<property type="protein sequence ID" value="BAG55026.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001306542.1">
<property type="nucleotide sequence ID" value="NM_001319613.1"/>
</dbReference>
<dbReference type="SMR" id="Q95M53"/>
<dbReference type="STRING" id="9541.XP_005556164.1"/>
<dbReference type="GeneID" id="102146068"/>
<dbReference type="KEGG" id="mcf:102146068"/>
<dbReference type="CTD" id="7097"/>
<dbReference type="eggNOG" id="KOG4641">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="Proteomes" id="UP000233100">
<property type="component" value="Unplaced"/>
</dbReference>
<dbReference type="GO" id="GO:0005794">
<property type="term" value="C:Golgi apparatus"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016021">
<property type="term" value="C:integral component of membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0045121">
<property type="term" value="C:membrane raft"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030670">
<property type="term" value="C:phagocytic vesicle membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0050135">
<property type="term" value="F:NAD(P)+ nucleosidase activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0061809">
<property type="term" value="F:NAD+ nucleotidase, cyclic ADP-ribose generating"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0004888">
<property type="term" value="F:transmembrane signaling receptor activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0071726">
<property type="term" value="P:cellular response to diacyl bacterial lipopeptide"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071727">
<property type="term" value="P:cellular response to triacyl bacterial lipopeptide"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006954">
<property type="term" value="P:inflammatory response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0045087">
<property type="term" value="P:innate immune response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0002755">
<property type="term" value="P:MyD88-dependent toll-like receptor signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0050729">
<property type="term" value="P:positive regulation of inflammatory response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0034134">
<property type="term" value="P:toll-like receptor 2 signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="Gene3D" id="3.40.50.10140">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="3.80.10.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR000483">
<property type="entry name" value="Cys-rich_flank_reg_C"/>
</dbReference>
<dbReference type="InterPro" id="IPR001611">
<property type="entry name" value="Leu-rich_rpt"/>
</dbReference>
<dbReference type="InterPro" id="IPR003591">
<property type="entry name" value="Leu-rich_rpt_typical-subtyp"/>
</dbReference>
<dbReference type="InterPro" id="IPR032675">
<property type="entry name" value="LRR_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR000157">
<property type="entry name" value="TIR_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR027185">
<property type="entry name" value="TLR2"/>
</dbReference>
<dbReference type="InterPro" id="IPR017241">
<property type="entry name" value="Toll-like_receptor"/>
</dbReference>
<dbReference type="InterPro" id="IPR035897">
<property type="entry name" value="Toll_tir_struct_dom_sf"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR24365">
<property type="entry name" value="PTHR24365"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR24365:SF17">
<property type="entry name" value="PTHR24365:SF17"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF13855">
<property type="entry name" value="LRR_8"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="Pfam" id="PF01463">
<property type="entry name" value="LRRCT"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF01582">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PIRSF" id="PIRSF037595">
<property type="entry name" value="Toll-like_receptor"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00369">
<property type="entry name" value="LRR_TYP"/>
<property type="match status" value="7"/>
</dbReference>
<dbReference type="SMART" id="SM00082">
<property type="entry name" value="LRRCT"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00255">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF52200">
<property type="entry name" value="SSF52200"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51450">
<property type="entry name" value="LRR"/>
<property type="match status" value="11"/>
</dbReference>
<dbReference type="PROSITE" id="PS50104">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at transcript level"/>
<keyword id="KW-0968">Cytoplasmic vesicle</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0378">Hydrolase</keyword>
<keyword id="KW-0391">Immunity</keyword>
<keyword id="KW-0395">Inflammatory response</keyword>
<keyword id="KW-0399">Innate immunity</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0433">Leucine-rich repeat</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0520">NAD</keyword>
<keyword id="KW-0675">Receptor</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0732">Signal</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="signal peptide" evidence="4">
<location>
<begin position="1"/>
<end position="18"/>
</location>
</feature>
<feature type="chain" description="Toll-like receptor 2" id="PRO_0000034711">
<location>
<begin position="19"/>
<end position="784"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="4">
<location>
<begin position="19"/>
<end position="587"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="4">
<location>
<begin position="588"/>
<end position="608"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="4">
<location>
<begin position="609"/>
<end position="784"/>
</location>
</feature>
<feature type="repeat" description="LRR 1">
<location>
<begin position="54"/>
<end position="77"/>
</location>
</feature>
<feature type="repeat" description="LRR 2">
<location>
<begin position="78"/>
<end position="101"/>
</location>
</feature>
<feature type="repeat" description="LRR 3">
<location>
<begin position="102"/>
<end position="125"/>
</location>
</feature>
<feature type="repeat" description="LRR 4">
<location>
<begin position="126"/>
<end position="150"/>
</location>
</feature>
<feature type="repeat" description="LRR 5">
<location>
<begin position="151"/>
<end position="175"/>
</location>
</feature>
<feature type="repeat" description="LRR 6">
<location>
<begin position="176"/>
<end position="199"/>
</location>
</feature>
<feature type="repeat" description="LRR 7">
<location>
<begin position="200"/>
<end position="223"/>
</location>
</feature>
<feature type="repeat" description="LRR 8">
<location>
<begin position="224"/>
<end position="250"/>
</location>
</feature>
<feature type="repeat" description="LRR 9">
<location>
<begin position="251"/>
<end position="278"/>
</location>
</feature>
<feature type="repeat" description="LRR 10">
<location>
<begin position="279"/>
<end position="308"/>
</location>
</feature>
<feature type="repeat" description="LRR 11">
<location>
<begin position="309"/>
<end position="337"/>
</location>
</feature>
<feature type="repeat" description="LRR 12">
<location>
<begin position="338"/>
<end position="361"/>
</location>
</feature>
<feature type="repeat" description="LRR 13">
<location>
<begin position="362"/>
<end position="388"/>
</location>
</feature>
<feature type="repeat" description="LRR 14">
<location>
<begin position="389"/>
<end position="414"/>
</location>
</feature>
<feature type="repeat" description="LRR 15">
<location>
<begin position="415"/>
<end position="437"/>
</location>
</feature>
<feature type="repeat" description="LRR 16">
<location>
<begin position="438"/>
<end position="457"/>
</location>
</feature>
<feature type="repeat" description="LRR 17">
<location>
<begin position="458"/>
<end position="478"/>
</location>
</feature>
<feature type="repeat" description="LRR 18">
<location>
<begin position="479"/>
<end position="500"/>
</location>
</feature>
<feature type="repeat" description="LRR 19">
<location>
<begin position="501"/>
<end position="524"/>
</location>
</feature>
<feature type="domain" description="LRRCT">
<location>
<begin position="525"/>
<end position="579"/>
</location>
</feature>
<feature type="domain" description="TIR" evidence="5">
<location>
<begin position="639"/>
<end position="782"/>
</location>
</feature>
<feature type="short sequence motif" description="ATG16L1-binding motif">
<location>
<begin position="761"/>
<end position="778"/>
</location>
</feature>
<feature type="active site" evidence="5">
<location>
<position position="716"/>
</location>
</feature>
<feature type="site" description="Interaction with bacterial lipopeptide" evidence="1">
<location>
<position position="349"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="114"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="199"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="414"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="442"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1">
<location>
<begin position="30"/>
<end position="36"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1">
<location>
<begin position="353"/>
<end position="382"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1">
<location>
<begin position="432"/>
<end position="454"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="2">
<location>
<position position="754"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; BAG55026." ref="2" evidence="6">
<original>G</original>
<variation>V</variation>
<location>
<position position="49"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; BAG55026." ref="2" evidence="6">
<original>S</original>
<variation>C</variation>
<location>
<position position="56"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; BAG55026." ref="2" evidence="6">
<original>D</original>
<variation>N</variation>
<location>
<position position="235"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; BAG55026." ref="2" evidence="6">
<original>V</original>
<variation>L</variation>
<location>
<position position="312"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; BAG55026." ref="2" evidence="6">
<original>T</original>
<variation>I</variation>
<location>
<position position="405"/>
</location>
</feature>
<evidence key="1" type="ECO:0000250"/>
<evidence key="2" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="O60603"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q9QUN7"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000255"/>
<evidence key="5" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00204"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000305"/>
<sequence length="784" mass="89988" checksum="3386E36DB32CAB3E" modified="2001-12-01" version="1" precursor="true">MPHTLWMVWVLGVIISLSKEESSNQASLSCDHNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRYVNLQALVLTSNGINTIEEDSFSSLGRLEHLDLSYNYLSNLSSSWFKPLSSLKFLNLLGNPYKTLGETSLFSHLTKLRILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDLTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLSQISGLLELEFDDCTLNGVGDFRGSDNDRVIDPGKVETVTIRRLHIPQFYSFNDLSTLYPLTERVKRITVENSKVFLVPCLLSRHLKSLEYLDLSENLMVEEYLKNSACEDAWPSLQTLILRQNHLASLGKTGETLLTLKNLTNLDISKNTFHYMPETCQWPEKMKYLNLSSTRIHSVTGCIPKTLEILDISNNNLNLFSLNLPQLKELYISRNKLMTLPDASLLPMLLVLKISRNTITTFSKEQLDSFHTLKTLEAGGNNFICSCEFLSFTQEQQALAKVLVDWPANYLCDSPSHVRGQRVQDVRLSVSECHRAALVSGMCCALFLLILLMGVLCHRFHGLWYMKMMWAWLQAKRKPRKAPNRDICYDAFVSYSERDAYWVENLMVQELENFNPPFKLCLHKRDFIPGKWIIDNIIDSIEKSHKTVFVLSENFVKSEWCKYELDFSHFRLFDENNDAAILVLLEPIEKKAIPQRFCKLRKIMNTKTYLEWPMDEARQEGFWVNLRAAIKS</sequence>
</entry>
<entry dataset="Swiss-Prot" created="2009-02-10" modified="2021-02-10" version="75">
<accession>B3Y618</accession>
<name>TLR2_MACMU</name>
<protein>
<recommendedName>
<fullName>Toll-like receptor 2</fullName>
<ecNumber evidence="5">3.2.2.6</ecNumber>
</recommendedName>
<cdAntigenName>CD282</cdAntigenName>
</protein>
<gene>
<name type="primary">TLR2</name>
</gene>
<organism>
<name type="scientific">Macaca mulatta</name>
<name type="common">Rhesus macaque</name>
<dbReference type="NCBI Taxonomy" id="9544"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Cercopithecidae</taxon>
<taxon>Cercopithecinae</taxon>
<taxon>Macaca</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="submission" date="2008-07" db="EMBL/GenBank/DDBJ databases">
<title>Molecular evolution of the Toll-like receptor-related genes in primates.</title>
<authorList>
<person name="Nakajima T."/>
<person name="Ohtani H."/>
<person name="Satta Y."/>
<person name="Uno Y."/>
<person name="Akari H."/>
<person name="Ishida T."/>
<person name="Kimura A."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
</reference>
<comment type="function">
<text evidence="2 3">Cooperates with LY96 to mediate the innate immune response to bacterial lipoproteins and other microbial cell wall components. Cooperates with TLR1 or TLR6 to mediate the innate immune response to bacterial lipoproteins or lipopeptides. Acts via MYD88 and TRAF6, leading to NF-kappa-B activation, cytokine secretion and the inflammatory response (By similarity). May also promote apoptosis in response to lipoproteins. Forms activation clusters composed of several receptors depending on the ligand, these clusters trigger signaling from the cell surface and subsequently are targeted to the Golgi in a lipid-raft dependent pathway. Forms the cluster TLR2:TLR6:CD14:CD36 in response to diacylated lipopeptides and TLR2:TLR1:CD14 in response to triacylated lipopeptides (By similarity).</text>
</comment>
<comment type="catalytic activity">
<reaction evidence="5">
<text>H2O + NAD(+) = ADP-D-ribose + H(+) + nicotinamide</text>
<dbReference type="Rhea" id="RHEA:16301"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:17154"/>
<dbReference type="ChEBI" id="CHEBI:57540"/>
<dbReference type="ChEBI" id="CHEBI:57967"/>
<dbReference type="EC" id="3.2.2.6"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="5">
<dbReference type="Rhea" id="RHEA:16302"/>
</physiologicalReaction>
</comment>
<comment type="subunit">
<text evidence="2 3">Interacts with LY96, TLR1 and TLR6 (via extracellular domain). TLR2 seems to exist in heterodimers with either TLR1 or TLR6 before stimulation by the ligand. The heterodimers form bigger oligomers in response to their corresponding ligands as well as further heterotypic associations with other receptors such as CD14 and/or CD36. Binds MYD88 (via TIR domain). Interacts with TICAM1. Interacts with CNPY3. Interacts with ATG16L1. Interacts with PPP1R11. Interacts with TICAM2.</text>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="3">Membrane</location>
<topology evidence="4">Single-pass type I membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="3">Cytoplasmic vesicle</location>
<location evidence="3">Phagosome membrane</location>
<topology evidence="4">Single-pass type I membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="2">Membrane raft</location>
</subcellularLocation>
<text evidence="2">Does not reside in lipid rafts before stimulation but accumulates increasingly in the raft upon the presence of the microbial ligand. In response to diacylated lipoproteins, TLR2:TLR6 heterodimers are recruited in lipid rafts, this recruitment determine the intracellular targeting to the Golgi apparatus. Triacylated lipoproteins induce the same mechanism for TLR2:TLR1 heterodimers.</text>
</comment>
<comment type="domain">
<text evidence="1">Ester-bound lipid substrates are bound through a crevice formed between the LRR 11 and LRR 12.</text>
</comment>
<comment type="domain">
<text evidence="1">The ATG16L1-binding motif mediates interaction with ATG16L1.</text>
</comment>
<comment type="domain">
<text evidence="5">The TIR domain mediates NAD(+) hydrolase (NADase) activity. Self-association of TIR domains is required for NADase activity.</text>
</comment>
<comment type="PTM">
<text evidence="3">Ubiquitinated at Lys-754 by PPP1R11, leading to its degradation. Deubiquitinated by USP2.</text>
</comment>
<comment type="PTM">
<text evidence="2">Glycosylation of Asn-442 is critical for secretion of the N-terminal ectodomain of TLR2.</text>
</comment>
<comment type="similarity">
<text evidence="6">Belongs to the Toll-like receptor family.</text>
</comment>
<dbReference type="EC" id="3.2.2.6" evidence="5"/>
<dbReference type="EMBL" id="AB445630">
<property type="protein sequence ID" value="BAG55027.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001123897.1">
<property type="nucleotide sequence ID" value="NM_001130425.1"/>
</dbReference>
<dbReference type="SMR" id="B3Y618"/>
<dbReference type="STRING" id="9544.ENSMMUP00000020834"/>
<dbReference type="GeneID" id="574290"/>
<dbReference type="KEGG" id="mcc:574290"/>
<dbReference type="CTD" id="7097"/>
<dbReference type="eggNOG" id="KOG4641">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="InParanoid" id="B3Y618"/>
<dbReference type="OrthoDB" id="282372at2759"/>
<dbReference type="Proteomes" id="UP000006718">
<property type="component" value="Unplaced"/>
</dbReference>
<dbReference type="GO" id="GO:0005794">
<property type="term" value="C:Golgi apparatus"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005887">
<property type="term" value="C:integral component of plasma membrane"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0045121">
<property type="term" value="C:membrane raft"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030670">
<property type="term" value="C:phagocytic vesicle membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0050135">
<property type="term" value="F:NAD(P)+ nucleosidase activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0061809">
<property type="term" value="F:NAD+ nucleotidase, cyclic ADP-ribose generating"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0038023">
<property type="term" value="F:signaling receptor activity"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0004888">
<property type="term" value="F:transmembrane signaling receptor activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0042497">
<property type="term" value="F:triacyl lipopeptide binding"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0071726">
<property type="term" value="P:cellular response to diacyl bacterial lipopeptide"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071727">
<property type="term" value="P:cellular response to triacyl bacterial lipopeptide"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006954">
<property type="term" value="P:inflammatory response"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0045087">
<property type="term" value="P:innate immune response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0002755">
<property type="term" value="P:MyD88-dependent toll-like receptor signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0050729">
<property type="term" value="P:positive regulation of inflammatory response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0034134">
<property type="term" value="P:toll-like receptor 2 signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0002224">
<property type="term" value="P:toll-like receptor signaling pathway"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="Gene3D" id="3.40.50.10140">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="3.80.10.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR000483">
<property type="entry name" value="Cys-rich_flank_reg_C"/>
</dbReference>
<dbReference type="InterPro" id="IPR001611">
<property type="entry name" value="Leu-rich_rpt"/>
</dbReference>
<dbReference type="InterPro" id="IPR003591">
<property type="entry name" value="Leu-rich_rpt_typical-subtyp"/>
</dbReference>
<dbReference type="InterPro" id="IPR032675">
<property type="entry name" value="LRR_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR000157">
<property type="entry name" value="TIR_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR027185">
<property type="entry name" value="TLR2"/>
</dbReference>
<dbReference type="InterPro" id="IPR017241">
<property type="entry name" value="Toll-like_receptor"/>
</dbReference>
<dbReference type="InterPro" id="IPR035897">
<property type="entry name" value="Toll_tir_struct_dom_sf"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR24365">
<property type="entry name" value="PTHR24365"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR24365:SF17">
<property type="entry name" value="PTHR24365:SF17"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF13855">
<property type="entry name" value="LRR_8"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="Pfam" id="PF01463">
<property type="entry name" value="LRRCT"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF01582">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PIRSF" id="PIRSF037595">
<property type="entry name" value="Toll-like_receptor"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00369">
<property type="entry name" value="LRR_TYP"/>
<property type="match status" value="7"/>
</dbReference>
<dbReference type="SMART" id="SM00082">
<property type="entry name" value="LRRCT"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00255">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF52200">
<property type="entry name" value="SSF52200"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51450">
<property type="entry name" value="LRR"/>
<property type="match status" value="11"/>
</dbReference>
<dbReference type="PROSITE" id="PS50104">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at transcript level"/>
<keyword id="KW-0968">Cytoplasmic vesicle</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0378">Hydrolase</keyword>
<keyword id="KW-0391">Immunity</keyword>
<keyword id="KW-0395">Inflammatory response</keyword>
<keyword id="KW-0399">Innate immunity</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0433">Leucine-rich repeat</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0520">NAD</keyword>
<keyword id="KW-0675">Receptor</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0732">Signal</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="signal peptide" evidence="4">
<location>
<begin position="1"/>
<end position="20"/>
</location>
</feature>
<feature type="chain" description="Toll-like receptor 2" id="PRO_0000363778">
<location>
<begin position="21"/>
<end position="784"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="4">
<location>
<begin position="21"/>
<end position="587"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="4">
<location>
<begin position="588"/>
<end position="608"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="4">
<location>
<begin position="609"/>
<end position="784"/>
</location>
</feature>
<feature type="repeat" description="LRR 1">
<location>
<begin position="54"/>
<end position="77"/>
</location>
</feature>
<feature type="repeat" description="LRR 2">
<location>
<begin position="78"/>
<end position="101"/>
</location>
</feature>
<feature type="repeat" description="LRR 3">
<location>
<begin position="102"/>
<end position="125"/>
</location>
</feature>
<feature type="repeat" description="LRR 4">
<location>
<begin position="126"/>
<end position="150"/>
</location>
</feature>
<feature type="repeat" description="LRR 5">
<location>
<begin position="151"/>
<end position="175"/>
</location>
</feature>
<feature type="repeat" description="LRR 6">
<location>
<begin position="176"/>
<end position="199"/>
</location>
</feature>
<feature type="repeat" description="LRR 7">
<location>
<begin position="200"/>
<end position="223"/>
</location>
</feature>
<feature type="repeat" description="LRR 8">
<location>
<begin position="224"/>
<end position="250"/>
</location>
</feature>
<feature type="repeat" description="LRR 9">
<location>
<begin position="251"/>
<end position="278"/>
</location>
</feature>
<feature type="repeat" description="LRR 10">
<location>
<begin position="279"/>
<end position="308"/>
</location>
</feature>
<feature type="repeat" description="LRR 11">
<location>
<begin position="309"/>
<end position="337"/>
</location>
</feature>
<feature type="repeat" description="LRR 12">
<location>
<begin position="338"/>
<end position="361"/>
</location>
</feature>
<feature type="repeat" description="LRR 13">
<location>
<begin position="362"/>
<end position="388"/>
</location>
</feature>
<feature type="repeat" description="LRR 14">
<location>
<begin position="389"/>
<end position="414"/>
</location>
</feature>
<feature type="repeat" description="LRR 15">
<location>
<begin position="415"/>
<end position="437"/>
</location>
</feature>
<feature type="repeat" description="LRR 16">
<location>
<begin position="438"/>
<end position="457"/>
</location>
</feature>
<feature type="repeat" description="LRR 17">
<location>
<begin position="458"/>
<end position="478"/>
</location>
</feature>
<feature type="repeat" description="LRR 18">
<location>
<begin position="479"/>
<end position="500"/>
</location>
</feature>
<feature type="repeat" description="LRR 19">
<location>
<begin position="501"/>
<end position="524"/>
</location>
</feature>
<feature type="domain" description="LRRCT">
<location>
<begin position="525"/>
<end position="579"/>
</location>
</feature>
<feature type="domain" description="TIR" evidence="5">
<location>
<begin position="639"/>
<end position="782"/>
</location>
</feature>
<feature type="short sequence motif" description="ATG16L1-binding motif">
<location>
<begin position="761"/>
<end position="778"/>
</location>
</feature>
<feature type="active site" evidence="5">
<location>
<position position="716"/>
</location>
</feature>
<feature type="site" description="Interaction with bacterial lipopeptide" evidence="1">
<location>
<position position="349"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="114"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="199"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="414"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="442"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1">
<location>
<begin position="30"/>
<end position="36"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1">
<location>
<begin position="353"/>
<end position="382"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1">
<location>
<begin position="432"/>
<end position="454"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="2">
<location>
<position position="754"/>
</location>
</feature>
<evidence key="1" type="ECO:0000250"/>
<evidence key="2" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="O60603"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q9QUN7"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000255"/>
<evidence key="5" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00204"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000305"/>
<sequence length="784" mass="90071" checksum="DB9540DD390BF91D" modified="2008-09-23" version="1" precursor="true">MPHTLWMVWVLGVIISLSKEESSNQASLSCDHNGICKGSSGSLNSIPSVLTEAVKCLDLSNNRITYISNSDLQRYVNLQALVLTSNGINTIEEDSFSSLGRLEHLDLSYNYLSNLSSSWFKPLSSLKFLNLLGNPYKTLGETSLFSHLTKLRILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDLTSSVECLELRDTDLNTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLSQISGLLELEFDDCTLNGVGDFRGSDNDRVIDPGKVETLTIRRLHIPQFYSFNDLSTLYPLTERVKRITVENSKVFLVPCLLSRHLKSLEYLDLSENLMVEEYLKNSACEDAWPSLQTLILRQNHLASLGKIGETLLTLKNLTNLDISKNTFHYMPETCQWPEKMKYLNLSSTRIHSVTGCIPKTLEILDISNNNLNLFSLNLPQLKELYISRNKLMTLPDASLLPMLLVLKISRNTITTFSKEQLDSFHTLKTLEAGGNNFICSCEFLSFTQEQQALAKVLVDWPANYLCDSPSHVRGQRVQDVRLSVSECHRAALVSGMCCALFLLILLMGVLCHRFHGLWYMKMMWAWLQAKRKPRKAPNRDICYDAFVSYSERDAYWVENLMVQELENFNPPFKLCLHKRDFIPGKWIIDNIIDSIEKSHKTVFVLSENFVKSEWCKYELDFSHFRLFDENNDAAILVLLEPIEKKAIPQRFCKLRKIMNTKTYLEWPMDEARQEGFWVNLRAAIKS</sequence>
</entry>
<entry dataset="Swiss-Prot" created="2002-01-31" modified="2021-02-10" version="181">
<accession>Q9QUN7</accession>
<accession>Q3U400</accession>
<accession>Q9DBC4</accession>
<name>TLR2_MOUSE</name>
<protein>
<recommendedName>
<fullName>Toll-like receptor 2</fullName>
<ecNumber evidence="8">3.2.2.6</ecNumber>
</recommendedName>
<cdAntigenName>CD282</cdAntigenName>
</protein>
<gene>
<name type="primary">Tlr2</name>
</gene>
<organism>
<name type="scientific">Mus musculus</name>
<name type="common">Mouse</name>
<dbReference type="NCBI Taxonomy" id="10090"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Glires</taxon>
<taxon>Rodentia</taxon>
<taxon>Myomorpha</taxon>
<taxon>Muroidea</taxon>
<taxon>Muridae</taxon>
<taxon>Murinae</taxon>
<taxon>Mus</taxon>
<taxon>Mus</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1999" name="Nature" volume="401" first="811" last="815">
<title>The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens.</title>
<authorList>
<person name="Underhill D.M."/>
<person name="Ozinsky A."/>
<person name="Hajjar A.M."/>
<person name="Stevens A."/>
<person name="Wilson C.B."/>
<person name="Bassetti M."/>
<person name="Aderem A."/>
</authorList>
<dbReference type="PubMed" id="10548109"/>
<dbReference type="DOI" id="10.1038/44605"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>MUTAGENESIS OF PRO-681</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1999" name="J. Immunol." volume="162" first="6971" last="6975">
<title>Cells that carry a null allele for Toll-like receptor 2 are capable of responding to endotoxin.</title>
<authorList>
<person name="Heine H."/>
<person name="Kirschning C.J."/>
<person name="Lien E."/>
<person name="Monks B.G."/>
<person name="Rothe M."/>
<person name="Golenbock D.T."/>
</authorList>
<dbReference type="PubMed" id="10358136"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<source>
<tissue>Macrophage</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="2000" name="Blood" volume="95" first="1378" last="1385">
<title>Gene expressions of lipopolysaccharide receptors, Toll-like receptors 2 and 4, are differently regulated in mouse T lymphocytes.</title>
<authorList>
<person name="Matsuguchi T."/>
<person name="Takagi K."/>
<person name="Musikacharoen T."/>
<person name="Yoshikai Y."/>
</authorList>
<dbReference type="PubMed" id="10666214"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<source>
<tissue>Macrophage</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="2000" name="J. Biol. Chem." volume="275" first="24255" last="24263">
<title>The lipopolysaccharide-activated Toll-like receptor (TLR)-4 induces synthesis of the closely related receptor TLR-2 in adipocytes.</title>
<authorList>
<person name="Lin Y."/>
<person name="Lee H."/>
<person name="Berg A.H."/>
<person name="Lisanti M.P."/>
<person name="Shapiro L."/>
<person name="Scherer P.E."/>
</authorList>
<dbReference type="PubMed" id="10823826"/>
<dbReference type="DOI" id="10.1074/jbc.m002137200"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<source>
<tissue>Adipocyte</tissue>
</source>
</reference>
<reference key="5">
<citation type="journal article" date="2005" name="Science" volume="309" first="1559" last="1563">
<title>The transcriptional landscape of the mammalian genome.</title>
<authorList>
<person name="Carninci P."/>
<person name="Kasukawa T."/>
<person name="Katayama S."/>
<person name="Gough J."/>
<person name="Frith M.C."/>
<person name="Maeda N."/>
<person name="Oyama R."/>
<person name="Ravasi T."/>
<person name="Lenhard B."/>
<person name="Wells C."/>
<person name="Kodzius R."/>
<person name="Shimokawa K."/>
<person name="Bajic V.B."/>
<person name="Brenner S.E."/>
<person name="Batalov S."/>
<person name="Forrest A.R."/>
<person name="Zavolan M."/>
<person name="Davis M.J."/>
<person name="Wilming L.G."/>
<person name="Aidinis V."/>
<person name="Allen J.E."/>
<person name="Ambesi-Impiombato A."/>
<person name="Apweiler R."/>
<person name="Aturaliya R.N."/>
<person name="Bailey T.L."/>
<person name="Bansal M."/>
<person name="Baxter L."/>
<person name="Beisel K.W."/>
<person name="Bersano T."/>
<person name="Bono H."/>
<person name="Chalk A.M."/>
<person name="Chiu K.P."/>
<person name="Choudhary V."/>
<person name="Christoffels A."/>
<person name="Clutterbuck D.R."/>
<person name="Crowe M.L."/>
<person name="Dalla E."/>
<person name="Dalrymple B.P."/>
<person name="de Bono B."/>
<person name="Della Gatta G."/>
<person name="di Bernardo D."/>
<person name="Down T."/>
<person name="Engstrom P."/>
<person name="Fagiolini M."/>
<person name="Faulkner G."/>
<person name="Fletcher C.F."/>
<person name="Fukushima T."/>
<person name="Furuno M."/>
<person name="Futaki S."/>
<person name="Gariboldi M."/>
<person name="Georgii-Hemming P."/>
<person name="Gingeras T.R."/>
<person name="Gojobori T."/>
<person name="Green R.E."/>
<person name="Gustincich S."/>
<person name="Harbers M."/>
<person name="Hayashi Y."/>
<person name="Hensch T.K."/>
<person name="Hirokawa N."/>
<person name="Hill D."/>
<person name="Huminiecki L."/>
<person name="Iacono M."/>
<person name="Ikeo K."/>
<person name="Iwama A."/>
<person name="Ishikawa T."/>
<person name="Jakt M."/>
<person name="Kanapin A."/>
<person name="Katoh M."/>
<person name="Kawasawa Y."/>
<person name="Kelso J."/>
<person name="Kitamura H."/>
<person name="Kitano H."/>
<person name="Kollias G."/>
<person name="Krishnan S.P."/>
<person name="Kruger A."/>
<person name="Kummerfeld S.K."/>
<person name="Kurochkin I.V."/>
<person name="Lareau L.F."/>
<person name="Lazarevic D."/>
<person name="Lipovich L."/>
<person name="Liu J."/>
<person name="Liuni S."/>
<person name="McWilliam S."/>
<person name="Madan Babu M."/>
<person name="Madera M."/>
<person name="Marchionni L."/>
<person name="Matsuda H."/>
<person name="Matsuzawa S."/>
<person name="Miki H."/>
<person name="Mignone F."/>
<person name="Miyake S."/>
<person name="Morris K."/>
<person name="Mottagui-Tabar S."/>
<person name="Mulder N."/>
<person name="Nakano N."/>
<person name="Nakauchi H."/>
<person name="Ng P."/>
<person name="Nilsson R."/>
<person name="Nishiguchi S."/>
<person name="Nishikawa S."/>
<person name="Nori F."/>
<person name="Ohara O."/>
<person name="Okazaki Y."/>
<person name="Orlando V."/>
<person name="Pang K.C."/>
<person name="Pavan W.J."/>
<person name="Pavesi G."/>
<person name="Pesole G."/>
<person name="Petrovsky N."/>
<person name="Piazza S."/>
<person name="Reed J."/>
<person name="Reid J.F."/>
<person name="Ring B.Z."/>
<person name="Ringwald M."/>
<person name="Rost B."/>
<person name="Ruan Y."/>
<person name="Salzberg S.L."/>
<person name="Sandelin A."/>
<person name="Schneider C."/>
<person name="Schoenbach C."/>
<person name="Sekiguchi K."/>
<person name="Semple C.A."/>
<person name="Seno S."/>
<person name="Sessa L."/>
<person name="Sheng Y."/>
<person name="Shibata Y."/>
<person name="Shimada H."/>
<person name="Shimada K."/>
<person name="Silva D."/>
<person name="Sinclair B."/>
<person name="Sperling S."/>
<person name="Stupka E."/>
<person name="Sugiura K."/>
<person name="Sultana R."/>
<person name="Takenaka Y."/>
<person name="Taki K."/>
<person name="Tammoja K."/>
<person name="Tan S.L."/>
<person name="Tang S."/>
<person name="Taylor M.S."/>
<person name="Tegner J."/>
<person name="Teichmann S.A."/>
<person name="Ueda H.R."/>
<person name="van Nimwegen E."/>
<person name="Verardo R."/>
<person name="Wei C.L."/>
<person name="Yagi K."/>
<person name="Yamanishi H."/>
<person name="Zabarovsky E."/>
<person name="Zhu S."/>
<person name="Zimmer A."/>
<person name="Hide W."/>
<person name="Bult C."/>
<person name="Grimmond S.M."/>
<person name="Teasdale R.D."/>
<person name="Liu E.T."/>
<person name="Brusic V."/>
<person name="Quackenbush J."/>
<person name="Wahlestedt C."/>
<person name="Mattick J.S."/>
<person name="Hume D.A."/>
<person name="Kai C."/>
<person name="Sasaki D."/>
<person name="Tomaru Y."/>
<person name="Fukuda S."/>
<person name="Kanamori-Katayama M."/>
<person name="Suzuki M."/>
<person name="Aoki J."/>
<person name="Arakawa T."/>
<person name="Iida J."/>
<person name="Imamura K."/>
<person name="Itoh M."/>
<person name="Kato T."/>
<person name="Kawaji H."/>
<person name="Kawagashira N."/>
<person name="Kawashima T."/>
<person name="Kojima M."/>
<person name="Kondo S."/>
<person name="Konno H."/>
<person name="Nakano K."/>
<person name="Ninomiya N."/>
<person name="Nishio T."/>
<person name="Okada M."/>
<person name="Plessy C."/>
<person name="Shibata K."/>
<person name="Shiraki T."/>
<person name="Suzuki S."/>
<person name="Tagami M."/>
<person name="Waki K."/>
<person name="Watahiki A."/>
<person name="Okamura-Oho Y."/>
<person name="Suzuki H."/>
<person name="Kawai J."/>
<person name="Hayashizaki Y."/>
</authorList>
<dbReference type="PubMed" id="16141072"/>
<dbReference type="DOI" id="10.1126/science.1112014"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<strain>C57BL/6J</strain>
<strain>NOD</strain>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="6">
<citation type="submission" date="2007-04" db="UniProtKB">
<authorList>
<person name="Lubec G."/>
<person name="Kang S.U."/>
</authorList>
</citation>
<scope>PROTEIN SEQUENCE OF 405-413 AND 754-759</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<source>
<strain>C57BL/6J</strain>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="7">
<citation type="journal article" date="2000" name="Proc. Natl. Acad. Sci. U.S.A." volume="97" first="13766" last="13771">
<title>The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between Toll-like receptors.</title>
<authorList>
<person name="Ozinsky A."/>
<person name="Underhill D.M."/>
<person name="Fontenot J.D."/>
<person name="Hajjar A.M."/>
<person name="Smith K.D."/>
<person name="Wilson C.B."/>
<person name="Schroeder L."/>
<person name="Aderem A."/>
</authorList>
<dbReference type="PubMed" id="11095740"/>
<dbReference type="DOI" id="10.1073/pnas.250476497"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<source>
<strain>BALB/cJ</strain>
<tissue>Macrophage</tissue>
</source>
</reference>
<reference key="8">
<citation type="journal article" date="2005" name="Nature" volume="433" first="523" last="527">
<title>CD36 is a sensor of diacylglycerides.</title>
<authorList>
<person name="Hoebe K."/>
<person name="Georgel P."/>
<person name="Rutschmann S."/>
<person name="Du X."/>
<person name="Mudd S."/>
<person name="Crozat K."/>
<person name="Sovath S."/>
<person name="Shamel L."/>
<person name="Hartung T."/>
<person name="Zaehringer U."/>
<person name="Beutler B."/>
</authorList>
<dbReference type="PubMed" id="15690042"/>
<dbReference type="DOI" id="10.1038/nature03253"/>
</citation>
<scope>FUNCTION</scope>
<scope>DISRUPTION PHENOTYPE</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2007" name="Nat. Immunol." volume="8" first="610" last="618">
<title>Direct extracellular interaction between the early secreted antigen ESAT-6 of Mycobacterium tuberculosis and TLR2 inhibits TLR signaling in macrophages.</title>
<authorList>
<person name="Pathak S.K."/>
<person name="Basu S."/>
<person name="Basu K.K."/>
<person name="Banerjee A."/>
<person name="Pathak S."/>
<person name="Bhattacharyya A."/>
<person name="Kaisho T."/>
<person name="Kundu M."/>
<person name="Basu J."/>
</authorList>
<dbReference type="PubMed" id="17486091"/>
<dbReference type="DOI" id="10.1038/ni1468"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH M.TUBERCULOSIS ESXA</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2015" name="Nat. Immunol." volume="16" first="326" last="326">
<title>Corrigendum: Direct extracellular interaction between the early secreted antigen ESAT-6 of Mycobacterium tuberculosis and TLR2 inhibits TLR signaling in macrophages.</title>
<authorList>
<person name="Pathak S.K."/>
<person name="Basu S."/>
<person name="Basu K.K."/>
<person name="Banerjee A."/>
<person name="Pathak S."/>
<person name="Bhattacharyya A."/>
<person name="Kaisho T."/>
<person name="Kundu M."/>
<person name="Basu J."/>
</authorList>
<dbReference type="PubMed" id="25689444"/>
<dbReference type="DOI" id="10.1038/ni0315-326b"/>
</citation>
<scope>ERRATUM OF PUBMED:17486091</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2008" name="Int. Immunol." volume="20" first="1407" last="1415">
<title>A single base mutation in the PRAT4A gene reveals differential interaction of PRAT4A with Toll-like receptors.</title>
<authorList>
<person name="Kiyokawa T."/>
<person name="Akashi-Takamura S."/>
<person name="Shibata T."/>
<person name="Matsumoto F."/>
<person name="Nishitani C."/>
<person name="Kuroki Y."/>
<person name="Seto Y."/>
<person name="Miyake K."/>
</authorList>
<dbReference type="PubMed" id="18780723"/>
<dbReference type="DOI" id="10.1093/intimm/dxn098"/>
</citation>
<scope>INTERACTION WITH CNPY3</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2009" name="Cell. Immunol." volume="258" first="29" last="37">
<title>TLR2 and its co-receptors determine responses of macrophages and dendritic cells to lipoproteins of Mycobacterium tuberculosis.</title>
<authorList>
<person name="Drage M.G."/>
<person name="Pecora N.D."/>
<person name="Hise A.G."/>
<person name="Febbraio M."/>
<person name="Silverstein R.L."/>
<person name="Golenbock D.T."/>
<person name="Boom W.H."/>
<person name="Harding C.V."/>
</authorList>
<dbReference type="PubMed" id="19362712"/>
<dbReference type="DOI" id="10.1016/j.cellimm.2009.03.008"/>
</citation>
<scope>FUNCTION</scope>
<scope>TISSUE SPECIFICITY</scope>
<source>
<tissue>Macrophage</tissue>
</source>
</reference>
<reference key="13">
<citation type="journal article" date="2012" name="Infect. Immun." volume="80" first="2816" last="2825">
<title>Staphylococcal superantigen-like protein 3 binds to the Toll-like receptor 2 extracellular domain and inhibits cytokine production induced by Staphylococcus aureus, cell wall component, or lipopeptides in murine macrophages.</title>
<authorList>
<person name="Yokoyama R."/>
<person name="Itoh S."/>
<person name="Kamoshida G."/>
<person name="Takii T."/>
<person name="Fujii S."/>
<person name="Tsuji T."/>
<person name="Onozaki K."/>
</authorList>
<dbReference type="PubMed" id="22665377"/>
<dbReference type="DOI" id="10.1128/iai.00399-12"/>
</citation>
<scope>INTERACTION WITH STAPHYLOCOCCUS AUREUS SUPERANTIGEN-LIKE PROTEIN 3 (MICROBIAL INFECTION)</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2012" name="J. Immunol." volume="188" first="668" last="677">
<title>Recombinant MPT83 derived from Mycobacterium tuberculosis induces cytokine production and upregulates the function of mouse macrophages through TLR2.</title>
<authorList>
<person name="Chen S.T."/>
<person name="Li J.Y."/>
<person name="Zhang Y."/>
<person name="Gao X."/>
<person name="Cai H."/>
</authorList>
<dbReference type="PubMed" id="22174456"/>
<dbReference type="DOI" id="10.4049/jimmunol.1102177"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH M.TUBERCULOSIS MPT83 (MICROBIAL INFECTION)</scope>
<source>
<tissue>Macrophage</tissue>
</source>
</reference>
<reference key="15">
<citation type="journal article" date="2016" name="Cell. Microbiol.">
<title>LppM impact on the colonization of macrophages by Mycobacterium tuberculosis.</title>
<authorList>
<person name="Deboosere N."/>
<person name="Iantomasi R."/>
<person name="Queval C.J."/>
<person name="Song O.R."/>
<person name="Deloison G."/>
<person name="Jouny S."/>
<person name="Debrie A.S."/>
<person name="Chamaillard M."/>
<person name="Nigou J."/>
<person name="Cohen-Gonsaud M."/>
<person name="Locht C."/>
<person name="Brodin P."/>
<person name="Veyron-Churlet R."/>
</authorList>
<dbReference type="PubMed" id="27220037"/>
<dbReference type="DOI" id="10.1111/cmi.12619"/>
</citation>
<scope>FUNCTION</scope>
<source>
<tissue>Macrophage</tissue>
</source>
</reference>
<reference key="16">
<citation type="journal article" date="2016" name="Elife" volume="5">
<title>RING finger E3 ligase PPP1R11 regulates TLR2 signaling and innate immunity.</title>
<authorList>
<person name="McKelvey A.C."/>
<person name="Lear T.B."/>
<person name="Dunn S.R."/>
<person name="Evankovich J."/>
<person name="Londino J.D."/>
<person name="Bednash J.S."/>
<person name="Zhang Y."/>
<person name="McVerry B.J."/>
<person name="Liu Y."/>
<person name="Chen B.B."/>
</authorList>
<dbReference type="PubMed" id="27805901"/>
<dbReference type="DOI" id="10.7554/elife.18496"/>
</citation>
<scope>UBIQUITINATION AT LYS-754</scope>
<scope>DEUBIQUITINATION</scope>
<scope>INTERACTION WITH PPP1R11</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2007" name="Cell" volume="130" first="1071" last="1082">
<title>Crystal structure of the TLR1-TLR2 heterodimer induced by binding of a tri-acylated lipopeptide.</title>
<authorList>
<person name="Jin M.S."/>
<person name="Kim S.E."/>
<person name="Heo J.Y."/>
<person name="Lee M.E."/>
<person name="Kim H.M."/>
<person name="Paik S.-G."/>
<person name="Lee H."/>
<person name="Lee J.-O."/>
</authorList>
<dbReference type="PubMed" id="17889651"/>
<dbReference type="DOI" id="10.1016/j.cell.2007.09.008"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) OF 27-506</scope>
<scope>DISULFIDE BONDS</scope>
<scope>GLYCOSYLATION AT ASN-147; ASN-414 AND ASN-442</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2009" name="Immunity" volume="31" first="873" last="884">
<title>Recognition of lipopeptide patterns by Toll-like receptor 2-Toll-like receptor 6 heterodimer.</title>
<authorList>
<person name="Kang J.Y."/>
<person name="Nan X."/>
<person name="Jin M.S."/>
<person name="Youn S.J."/>
<person name="Ryu Y.H."/>
<person name="Mah S."/>
<person name="Han S.H."/>
<person name="Lee H."/>
<person name="Paik S.G."/>
<person name="Lee J.O."/>
</authorList>
<dbReference type="PubMed" id="19931471"/>
<dbReference type="DOI" id="10.1016/j.immuni.2009.09.018"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.9 ANGSTROMS) OF 1-506 IN COMPLEX WITH TLR6 AND LIPOPEPTIDE</scope>
<scope>DISULFIDE BONDS</scope>
<scope>GLYCOSYLATION AT ASN-147; ASN-414 AND ASN-442</scope>
<scope>FUNCTION</scope>
<scope>LRR REPEATS</scope>
<scope>SUBUNIT</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2015" name="Proc. Natl. Acad. Sci. U.S.A." volume="112" first="11018" last="11023">
<title>Structural basis for inhibition of TLR2 by staphylococcal superantigen-like protein 3 (SSL3).</title>
<authorList>
<person name="Koymans K.J."/>
<person name="Feitsma L.J."/>
<person name="Brondijk T.H."/>
<person name="Aerts P.C."/>
<person name="Lukkien E."/>
<person name="Loessl P."/>
<person name="van Kessel K.P."/>
<person name="de Haas C.J."/>
<person name="van Strijp J.A."/>
<person name="Huizinga E.G."/>
</authorList>
<dbReference type="PubMed" id="26283364"/>
<dbReference type="DOI" id="10.1073/pnas.1502026112"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (3.20 ANGSTROMS) OF 25-589</scope>
<scope>GLYCOSYLATION AT ASN-414 AND ASN-442</scope>
<scope>INTERACTION WITH STAPHYLOCOCCAL SUPERANTIGEN-LIKE PROTEIN 3</scope>
</reference>
<comment type="function">
<text evidence="6 11 12 15 17 20">Cooperates with LY96 to mediate the innate immune response to bacterial lipoproteins and other microbial cell wall components. Cooperates with TLR1 or TLR6 to mediate the innate immune response to bacterial lipoproteins or lipopeptides. Acts via MYD88 and TRAF6, leading to NF-kappa-B activation, cytokine secretion and the inflammatory response (By similarity) (PubMed:15690042). May also promote apoptosis in response to lipoproteins (By similarity). Forms activation clusters composed of several receptors depending on the ligand, these clusters trigger signaling from the cell surface and subsequently are targeted to the Golgi in a lipid-raft dependent pathway. Forms the cluster TLR2:TLR6:CD14:CD36 in response to diacylated lipopeptides and TLR2:TLR1:CD14 in response to triacylated lipopeptides (By similarity). Recognizes M.tuberculosis major T-antigen EsxA (ESAT-6) which inhibits downstream MYD88-dependent signaling (PubMed:17486091). Acts as the major receptor for M.tuberculosis lipoproteins LprA, LprG, LpqH and PhoS1 (pstS1), in conjunction with TLR1 and for some but not all lipoproteins CD14 and/or CD36. The lipoproteins act as agonists to modulate antigen presenting cell functions in response to the pathogen (PubMed:19362712). Recombinant MPT83 from M.tuberculosis stimulates secretion of cytokines (TNF-alpha, IL-6 and IL-12p40) by mouse macrophage cell lines in a TLR2-dependent fashion, which leads to increased host innate immunity responses against the bacterium (PubMed:22174456). Lung macrophages which express low levels of TLR2 respond poorly to stimulation by M.tuberculosis LpqH (PubMed:19362712). Required for normal uptake of M.tuberculosis, a process that is inhibited by M.tuberculosis LppM (PubMed:27220037). Interacts with TICAM2 (By similarity).</text>
</comment>
<comment type="catalytic activity">
<reaction evidence="8">
<text>H2O + NAD(+) = ADP-D-ribose + H(+) + nicotinamide</text>
<dbReference type="Rhea" id="RHEA:16301"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:17154"/>
<dbReference type="ChEBI" id="CHEBI:57540"/>
<dbReference type="ChEBI" id="CHEBI:57967"/>
<dbReference type="EC" id="3.2.2.6"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="8">
<dbReference type="Rhea" id="RHEA:16302"/>
</physiologicalReaction>
</comment>
<comment type="subunit">
<text evidence="6 14 16 17 21">Interacts with LY96, TLR1 and TLR6 (via extracellular domain). TLR2 seems to exist in heterodimers with either TLR1 or TLR6 before stimulation by the ligand (PubMed:19931471). The heterodimers form bigger oligomers in response to their corresponding ligands as well as further heterotypic associations with other receptors such as CD14 and/or CD36 (By similarity). Binds MYD88 (via TIR domain). Interacts with TICAM1 (By similarity). Interacts with CNPY3 (PubMed:18780723). Interacts with ATG16L1 (By similarity). Interacts with non-modified M.tuberculosis protein MPT83 (PubMed:22174456). Interacts with PPP1R11 (PubMed:27805901).</text>
</comment>
<comment type="subunit">
<text evidence="18 19">(Microbial infection) Interacts with Staphylococcus aureus protein SSL3; this interaction inhibits TLR2-mediated cytokine production.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-3505834">
<id>Q9QUN7</id>
</interactant>
<interactant intactId="EBI-525108">
<id>P22366</id>
<label>Myd88</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="10">Cell membrane</location>
<topology evidence="7">Single-pass type I membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="10">Cytoplasmic vesicle</location>
<location evidence="10">Phagosome membrane</location>
<topology evidence="7">Single-pass type I membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="6">Membrane raft</location>
</subcellularLocation>
<text evidence="6">Does not reside in lipid rafts before stimulation but accumulates increasingly in the raft upon the presence of the microbial ligand. In response to diacylated lipoproteins, TLR2:TLR6 heterodimers are recruited in lipid rafts, this recruitment determine the intracellular targeting to the Golgi apparatus. Triacylated lipoproteins induce the same mechanism for TLR2:TLR1 heterodimers.</text>
</comment>
<comment type="tissue specificity">
<text evidence="15">Detected in a macrophage cell line, smooth muscle, lung, spleen, thymus, brain and adipose tissue. Cell surface expression detected in lung alveolar macrophages, dendritic macrophages and at lower levels in lung macrophages (at protein level) (PubMed:19362712).</text>
</comment>
<comment type="domain">
<text>Ester-bound lipid substrates are bound through a crevice formed between the LRR 11 and LRR 12.</text>
</comment>
<comment type="domain">
<text evidence="5">The ATG16L1-binding motif mediates interaction with ATG16L1.</text>
</comment>
<comment type="domain">
<text evidence="8">The TIR domain mediates NAD(+) hydrolase (NADase) activity. Self-association of TIR domains is required for NADase activity.</text>
</comment>
<comment type="PTM">
<text evidence="21">Ubiquitinated at Lys-754 by PPP1R11, leading to its degradation. Deubiquitinated by USP2.</text>
</comment>
<comment type="PTM">
<text evidence="6">Glycosylation of Asn-442 is critical for secretion of the N-terminal ectodomain of TLR2.</text>
</comment>
<comment type="disruption phenotype">
<text evidence="11">Mutants succumb to Staphylococcus aureus infection within 5 days.</text>
</comment>
<comment type="similarity">
<text evidence="22">Belongs to the Toll-like receptor family.</text>
</comment>
<dbReference type="EC" id="3.2.2.6" evidence="8"/>
<dbReference type="EMBL" id="AF185284">
<property type="protein sequence ID" value="AAF04277.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF124741">
<property type="protein sequence ID" value="AAD46481.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF216289">
<property type="protein sequence ID" value="AAF28345.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF165189">
<property type="protein sequence ID" value="AAD49335.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK005043">
<property type="protein sequence ID" value="BAB23770.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK154504">
<property type="protein sequence ID" value="BAE32635.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS17435.1"/>
<dbReference type="RefSeq" id="NP_036035.3">
<property type="nucleotide sequence ID" value="NM_011905.3"/>
</dbReference>
<dbReference type="PDB" id="2Z81">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80"/>
<property type="chains" value="A=27-506"/>
</dbReference>
<dbReference type="PDB" id="2Z82">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="A=27-506"/>
</dbReference>
<dbReference type="PDB" id="3A79">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.90"/>
<property type="chains" value="A=1-506"/>
</dbReference>
<dbReference type="PDB" id="3A7B">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.53"/>
<property type="chains" value="A=1-506"/>
</dbReference>
<dbReference type="PDB" id="3A7C">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="A=1-506"/>
</dbReference>
<dbReference type="PDB" id="5D3I">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.20"/>
<property type="chains" value="A=25-589"/>
</dbReference>
<dbReference type="PDBsum" id="2Z81"/>
<dbReference type="PDBsum" id="2Z82"/>
<dbReference type="PDBsum" id="3A79"/>
<dbReference type="PDBsum" id="3A7B"/>
<dbReference type="PDBsum" id="3A7C"/>
<dbReference type="PDBsum" id="5D3I"/>
<dbReference type="SMR" id="Q9QUN7"/>
<dbReference type="DIP" id="DIP-61222N"/>
<dbReference type="IntAct" id="Q9QUN7">
<property type="interactions" value="10"/>
</dbReference>
<dbReference type="STRING" id="10090.ENSMUSP00000029623"/>
<dbReference type="BindingDB" id="Q9QUN7"/>
<dbReference type="ChEMBL" id="CHEMBL1075106"/>
<dbReference type="GuidetoPHARMACOLOGY" id="1752"/>
<dbReference type="GlyGen" id="Q9QUN7">
<property type="glycosylation" value="3 sites"/>
</dbReference>
<dbReference type="iPTMnet" id="Q9QUN7"/>
<dbReference type="PhosphoSitePlus" id="Q9QUN7"/>
<dbReference type="SwissPalm" id="Q9QUN7"/>
<dbReference type="MaxQB" id="Q9QUN7"/>
<dbReference type="PaxDb" id="Q9QUN7"/>
<dbReference type="PeptideAtlas" id="Q9QUN7"/>
<dbReference type="PRIDE" id="Q9QUN7"/>
<dbReference type="ABCD" id="Q9QUN7">
<property type="antibodies" value="22 sequenced antibodies"/>
</dbReference>
<dbReference type="GeneID" id="24088"/>
<dbReference type="KEGG" id="mmu:24088"/>
<dbReference type="CTD" id="7097"/>
<dbReference type="MGI" id="MGI:1346060">
<property type="gene designation" value="Tlr2"/>
</dbReference>
<dbReference type="eggNOG" id="KOG4641">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="InParanoid" id="Q9QUN7"/>
<dbReference type="OrthoDB" id="282372at2759"/>
<dbReference type="PhylomeDB" id="Q9QUN7"/>
<dbReference type="Reactome" id="R-MMU-1461957">
<property type="pathway name" value="Beta defensins"/>
</dbReference>
<dbReference type="Reactome" id="R-MMU-5686938">
<property type="pathway name" value="Regulation of TLR by endogenous ligand"/>
</dbReference>
<dbReference type="Reactome" id="R-MMU-6798695">
<property type="pathway name" value="Neutrophil degranulation"/>
</dbReference>
<dbReference type="BioGRID-ORCS" id="24088">
<property type="hits" value="1 hit in 17 CRISPR screens"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="Q9QUN7"/>
<dbReference type="PRO" id="PR:Q9QUN7"/>
<dbReference type="Proteomes" id="UP000000589">
<property type="component" value="Unplaced"/>
</dbReference>
<dbReference type="RNAct" id="Q9QUN7">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="GO" id="GO:0044297">
<property type="term" value="C:cell body"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0042995">
<property type="term" value="C:cell projection"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0009986">
<property type="term" value="C:cell surface"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0009897">
<property type="term" value="C:external side of plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0005794">
<property type="term" value="C:Golgi apparatus"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005887">
<property type="term" value="C:integral component of plasma membrane"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0031226">
<property type="term" value="C:intrinsic component of plasma membrane"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0045121">
<property type="term" value="C:membrane raft"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030670">
<property type="term" value="C:phagocytic vesicle membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0035354">
<property type="term" value="C:Toll-like receptor 1-Toll-like receptor 2 protein complex"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0035355">
<property type="term" value="C:Toll-like receptor 2-Toll-like receptor 6 protein complex"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0001540">
<property type="term" value="F:amyloid-beta binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0042498">
<property type="term" value="F:diacyl lipopeptide binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0042802">
<property type="term" value="F:identical protein binding"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0071723">
<property type="term" value="F:lipopeptide binding"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0001530">
<property type="term" value="F:lipopolysaccharide binding"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0070891">
<property type="term" value="F:lipoteichoic acid binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0050135">
<property type="term" value="F:NAD(P)+ nucleosidase activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0061809">
<property type="term" value="F:NAD+ nucleotidase, cyclic ADP-ribose generating"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0038187">
<property type="term" value="F:pattern recognition receptor activity"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0042834">
<property type="term" value="F:peptidoglycan binding"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0044877">
<property type="term" value="F:protein-containing complex binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0038023">
<property type="term" value="F:signaling receptor activity"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0035325">
<property type="term" value="F:Toll-like receptor binding"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0004888">
<property type="term" value="F:transmembrane signaling receptor activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0042497">
<property type="term" value="F:triacyl lipopeptide binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0001775">
<property type="term" value="P:cell activation"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0002752">
<property type="term" value="P:cell surface pattern recognition receptor signaling pathway"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0071221">
<property type="term" value="P:cellular response to bacterial lipopeptide"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0071726">
<property type="term" value="P:cellular response to diacyl bacterial lipopeptide"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071346">
<property type="term" value="P:cellular response to interferon-gamma"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0071223">
<property type="term" value="P:cellular response to lipoteichoic acid"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0071224">
<property type="term" value="P:cellular response to peptidoglycan"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0071727">
<property type="term" value="P:cellular response to triacyl bacterial lipopeptide"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032289">
<property type="term" value="P:central nervous system myelin formation"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0002374">
<property type="term" value="P:cytokine secretion involved in immune response"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0006952">
<property type="term" value="P:defense response"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0050830">
<property type="term" value="P:defense response to Gram-positive bacterium"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0042496">
<property type="term" value="P:detection of diacyl bacterial lipopeptide"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0042495">
<property type="term" value="P:detection of triacyl bacterial lipopeptide"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0007252">
<property type="term" value="P:I-kappaB phosphorylation"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0006954">
<property type="term" value="P:inflammatory response"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0045087">
<property type="term" value="P:innate immune response"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032613">
<property type="term" value="P:interleukin-10 production"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0007612">
<property type="term" value="P:learning"/>
<property type="evidence" value="ECO:0000316"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0006691">
<property type="term" value="P:leukotriene metabolic process"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0014005">
<property type="term" value="P:microglia development"/>
<property type="evidence" value="ECO:0000316"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0001774">
<property type="term" value="P:microglial cell activation"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0002755">
<property type="term" value="P:MyD88-dependent toll-like receptor signaling pathway"/>
<property type="evidence" value="ECO:0000316"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0030837">
<property type="term" value="P:negative regulation of actin filament polymerization"/>
<property type="evidence" value="ECO:0000316"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0008285">
<property type="term" value="P:negative regulation of cell population proliferation"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0032695">
<property type="term" value="P:negative regulation of interleukin-12 production"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0032700">
<property type="term" value="P:negative regulation of interleukin-17 production"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0050765">
<property type="term" value="P:negative regulation of phagocytosis"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0051964">
<property type="term" value="P:negative regulation of synapse assembly"/>
<property type="evidence" value="ECO:0000316"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0046209">
<property type="term" value="P:nitric oxide metabolic process"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:1903974">
<property type="term" value="P:positive regulation of cellular response to macrophage colony-stimulating factor stimulus"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0032722">
<property type="term" value="P:positive regulation of chemokine production"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0001819">
<property type="term" value="P:positive regulation of cytokine production"/>
<property type="evidence" value="ECO:0000316"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0070374">
<property type="term" value="P:positive regulation of ERK1 and ERK2 cascade"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0010628">
<property type="term" value="P:positive regulation of gene expression"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0050729">
<property type="term" value="P:positive regulation of inflammatory response"/>
<property type="evidence" value="ECO:0000316"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032728">
<property type="term" value="P:positive regulation of interferon-beta production"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032731">
<property type="term" value="P:positive regulation of interleukin-1 beta production"/>
<property type="evidence" value="ECO:0000316"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032733">
<property type="term" value="P:positive regulation of interleukin-10 production"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0032735">
<property type="term" value="P:positive regulation of interleukin-12 production"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032741">
<property type="term" value="P:positive regulation of interleukin-18 production"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032755">
<property type="term" value="P:positive regulation of interleukin-6 production"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032757">
<property type="term" value="P:positive regulation of interleukin-8 production"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0002687">
<property type="term" value="P:positive regulation of leukocyte migration"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0060907">
<property type="term" value="P:positive regulation of macrophage cytokine production"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:1904466">
<property type="term" value="P:positive regulation of matrix metallopeptidase secretion"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0051092">
<property type="term" value="P:positive regulation of NF-kappaB transcription factor activity"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:1901224">
<property type="term" value="P:positive regulation of NIK/NF-kappaB signaling"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0045429">
<property type="term" value="P:positive regulation of nitric oxide biosynthetic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0051770">
<property type="term" value="P:positive regulation of nitric-oxide synthase biosynthetic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0048714">
<property type="term" value="P:positive regulation of oligodendrocyte differentiation"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0034123">
<property type="term" value="P:positive regulation of toll-like receptor signaling pathway"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0045944">
<property type="term" value="P:positive regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032760">
<property type="term" value="P:positive regulation of tumor necrosis factor production"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0030177">
<property type="term" value="P:positive regulation of Wnt signaling pathway"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:1904417">
<property type="term" value="P:positive regulation of xenophagy"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0002730">
<property type="term" value="P:regulation of dendritic cell cytokine production"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0032493">
<property type="term" value="P:response to bacterial lipoprotein"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0009617">
<property type="term" value="P:response to bacterium"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0070542">
<property type="term" value="P:response to fatty acid"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0002238">
<property type="term" value="P:response to molecule of fungal origin"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0032494">
<property type="term" value="P:response to peptidoglycan"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0034134">
<property type="term" value="P:toll-like receptor 2 signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0002224">
<property type="term" value="P:toll-like receptor signaling pathway"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0032640">
<property type="term" value="P:tumor necrosis factor production"/>
<property type="evidence" value="ECO:0000316"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="Gene3D" id="3.40.50.10140">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="3.80.10.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR000483">
<property type="entry name" value="Cys-rich_flank_reg_C"/>
</dbReference>
<dbReference type="InterPro" id="IPR001611">
<property type="entry name" value="Leu-rich_rpt"/>
</dbReference>
<dbReference type="InterPro" id="IPR003591">
<property type="entry name" value="Leu-rich_rpt_typical-subtyp"/>
</dbReference>
<dbReference type="InterPro" id="IPR032675">
<property type="entry name" value="LRR_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR000157">
<property type="entry name" value="TIR_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR027185">
<property type="entry name" value="TLR2"/>
</dbReference>
<dbReference type="InterPro" id="IPR017241">
<property type="entry name" value="Toll-like_receptor"/>
</dbReference>
<dbReference type="InterPro" id="IPR035897">
<property type="entry name" value="Toll_tir_struct_dom_sf"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR24365">
<property type="entry name" value="PTHR24365"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR24365:SF17">
<property type="entry name" value="PTHR24365:SF17"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF13516">
<property type="entry name" value="LRR_6"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF13855">
<property type="entry name" value="LRR_8"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="Pfam" id="PF01582">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PIRSF" id="PIRSF037595">
<property type="entry name" value="Toll-like_receptor"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00369">
<property type="entry name" value="LRR_TYP"/>
<property type="match status" value="7"/>
</dbReference>
<dbReference type="SMART" id="SM00082">
<property type="entry name" value="LRRCT"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00255">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF52200">
<property type="entry name" value="SSF52200"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51450">
<property type="entry name" value="LRR"/>
<property type="match status" value="9"/>
</dbReference>
<dbReference type="PROSITE" id="PS50104">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-0968">Cytoplasmic vesicle</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0378">Hydrolase</keyword>
<keyword id="KW-0391">Immunity</keyword>
<keyword id="KW-0395">Inflammatory response</keyword>
<keyword id="KW-0399">Innate immunity</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0433">Leucine-rich repeat</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0520">NAD</keyword>
<keyword id="KW-0675">Receptor</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0732">Signal</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="signal peptide" evidence="7">
<location>
<begin position="1"/>
<end position="24"/>
</location>
</feature>
<feature type="chain" description="Toll-like receptor 2" id="PRO_0000034712">
<location>
<begin position="25"/>
<end position="784"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="7">
<location>
<begin position="25"/>
<end position="587"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="7">
<location>
<begin position="588"/>
<end position="608"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="7">
<location>
<begin position="609"/>
<end position="784"/>
</location>
</feature>
<feature type="repeat" description="LRR 1" evidence="16">
<location>
<begin position="54"/>
<end position="77"/>
</location>
</feature>
<feature type="repeat" description="LRR 2" evidence="16">
<location>
<begin position="78"/>
<end position="101"/>
</location>
</feature>
<feature type="repeat" description="LRR 3" evidence="16">
<location>
<begin position="102"/>
<end position="125"/>
</location>
</feature>
<feature type="repeat" description="LRR 4" evidence="16">
<location>
<begin position="126"/>
<end position="150"/>
</location>
</feature>
<feature type="repeat" description="LRR 5" evidence="16">
<location>
<begin position="151"/>
<end position="175"/>
</location>
</feature>
<feature type="repeat" description="LRR 6" evidence="16">
<location>
<begin position="176"/>
<end position="199"/>
</location>
</feature>
<feature type="repeat" description="LRR 7" evidence="16">
<location>
<begin position="200"/>
<end position="223"/>
</location>
</feature>
<feature type="repeat" description="LRR 8" evidence="16">
<location>
<begin position="224"/>
<end position="250"/>
</location>
</feature>
<feature type="repeat" description="LRR 9" evidence="16">
<location>
<begin position="251"/>
<end position="278"/>
</location>
</feature>
<feature type="repeat" description="LRR 10" evidence="16">
<location>
<begin position="279"/>
<end position="308"/>
</location>
</feature>
<feature type="repeat" description="LRR 11" evidence="16">
<location>
<begin position="309"/>
<end position="337"/>
</location>
</feature>
<feature type="repeat" description="LRR 12" evidence="16">
<location>
<begin position="338"/>
<end position="361"/>
</location>
</feature>
<feature type="repeat" description="LRR 13" evidence="16">
<location>
<begin position="362"/>
<end position="388"/>
</location>
</feature>
<feature type="repeat" description="LRR 14" evidence="16">
<location>
<begin position="389"/>
<end position="414"/>
</location>
</feature>
<feature type="repeat" description="LRR 15" evidence="16">
<location>
<begin position="415"/>
<end position="437"/>
</location>
</feature>
<feature type="repeat" description="LRR 16" evidence="16">
<location>
<begin position="438"/>
<end position="457"/>
</location>
</feature>
<feature type="repeat" description="LRR 17" evidence="16">
<location>
<begin position="458"/>
<end position="478"/>
</location>
</feature>
<feature type="repeat" description="LRR 18" evidence="16">
<location>
<begin position="479"/>
<end position="500"/>
</location>
</feature>
<feature type="repeat" description="LRR 19" evidence="16">
<location>
<begin position="501"/>
<end position="524"/>
</location>
</feature>
<feature type="domain" description="LRRCT">
<location>
<begin position="525"/>
<end position="576"/>
</location>
</feature>
<feature type="domain" description="TIR" evidence="8">
<location>
<begin position="639"/>
<end position="782"/>
</location>
</feature>
<feature type="short sequence motif" description="ATG16L1-binding motif">
<location>
<begin position="761"/>
<end position="778"/>
</location>
</feature>
<feature type="active site" evidence="8">
<location>
<position position="716"/>
</location>
</feature>
<feature type="site" description="Interaction with bacterial lipopeptide" evidence="5">
<location>
<position position="349"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="13 16 19">
<location>
<position position="147"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="13 16 19">
<location>
<position position="414"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="13 16 19">
<location>
<position position="442"/>
</location>
</feature>
<feature type="disulfide bond">
<location>
<begin position="30"/>
<end position="36"/>
</location>
</feature>
<feature type="disulfide bond">
<location>
<begin position="353"/>
<end position="382"/>
</location>
</feature>
<feature type="disulfide bond">
<location>
<begin position="432"/>
<end position="454"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="21">
<location>
<position position="754"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes MYD88-binding and response to microbial cell wall components." evidence="9">
<original>P</original>
<variation>H</variation>
<location>
<position position="681"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 5; BAB23770." ref="5" evidence="22">
<original>L</original>
<variation>P</variation>
<location>
<position position="59"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 5; BAB23770." ref="5" evidence="22">
<original>I</original>
<variation>M</variation>
<location>
<position position="82"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="34"/>
<end position="37"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="44"/>
<end position="46"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="56"/>
<end position="58"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="71"/>
<end position="74"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="80"/>
<end position="82"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="93"/>
<end position="98"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="104"/>
<end position="106"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="117"/>
<end position="120"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="128"/>
<end position="130"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="137"/>
<end position="139"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="153"/>
<end position="161"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="167"/>
<end position="172"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="175"/>
<end position="183"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="191"/>
<end position="196"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="198"/>
<end position="206"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="208"/>
<end position="210"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="213"/>
<end position="219"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="221"/>
<end position="223"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="224"/>
<end position="231"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="245"/>
<end position="247"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="253"/>
<end position="258"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="260"/>
<end position="262"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="263"/>
<end position="270"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="271"/>
<end position="275"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="281"/>
<end position="286"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="288"/>
<end position="290"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="299"/>
<end position="301"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="304"/>
<end position="306"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="311"/>
<end position="316"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="322"/>
<end position="324"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="330"/>
<end position="334"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="340"/>
<end position="346"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="353"/>
<end position="358"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="364"/>
<end position="366"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="374"/>
<end position="380"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="391"/>
<end position="393"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="402"/>
<end position="408"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="409"/>
<end position="411"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="417"/>
<end position="419"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="440"/>
<end position="442"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="460"/>
<end position="463"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="481"/>
<end position="483"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="495"/>
<end position="497"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="503"/>
<end position="505"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="518"/>
<end position="521"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="527"/>
<end position="529"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="539"/>
<end position="544"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="549"/>
<end position="553"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="556"/>
<end position="561"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="564"/>
<end position="567"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="568"/>
<end position="572"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2Z81"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3A79"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3A7C"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5D3I"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000250"/>
<evidence key="6" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="O60603"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000255"/>
<evidence key="8" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00204"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10548109"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11095740"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15690042"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17486091"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17889651"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18780723"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19362712"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19931471"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22174456"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22665377"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26283364"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="27220037"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="27805901"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000305"/>
<sequence length="784" mass="89449" checksum="606D56BF85F320A2" modified="2000-05-01" version="1" precursor="true">MLRALWLFWILVAITVLFSKRCSAQESLSCDASGVCDGRSRSFTSIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFHPMPDSCQWPEKMRFLNLSSTGIRVVKTCIPQTLEVLDVSNNNLDSFSLFLPRLQELYISRNKLKTLPDASLFPVLLVMKIRENAVSTFSKDQLGSFPKLETLEAGDNHFVCSCELLSFTMETPALAQILVDWPDSYLCDSPPRLHGHRLQDARPSVLECHQAALVSGVCCALLLLILLVGALCHHFHGLWYLRMMWAWLQAKRKPKKAPCRDVCYDAFVSYSEQDSHWVENLMVQQLENSDPPFKLCLHKRDFVPGKWIIDNIIDSIEKSHKTVFVLSENFVRSEWCKYELDFSHFRLFDENNDAAILVLLEPIERKAIPQRFCKLRKIMNTKTYLEWPLDEGQQEVFWVNLRTAIKS</sequence>
</entry>
<entry dataset="Swiss-Prot" created="2002-01-31" modified="2021-02-10" version="114">
<accession>Q9R1F8</accession>
<name>TLR2_CRIGR</name>
<protein>
<recommendedName>
<fullName>Toll-like receptor 2</fullName>
<ecNumber evidence="5">3.2.2.6</ecNumber>
</recommendedName>
<cdAntigenName>CD282</cdAntigenName>
</protein>
<gene>
<name type="primary">TLR2</name>
</gene>
<organism>
<name type="scientific">Cricetulus griseus</name>
<name type="common">Chinese hamster</name>
<name type="synonym">Cricetulus barabensis griseus</name>
<dbReference type="NCBI Taxonomy" id="10029"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Glires</taxon>
<taxon>Rodentia</taxon>
<taxon>Myomorpha</taxon>
<taxon>Muroidea</taxon>
<taxon>Cricetidae</taxon>
<taxon>Cricetinae</taxon>
<taxon>Cricetulus</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1999" name="J. Immunol." volume="162" first="6971" last="6975">
<title>Cells that carry a null allele for Toll-like receptor 2 are capable of responding to endotoxin.</title>
<authorList>
<person name="Heine H."/>
<person name="Kirschning C.J."/>
<person name="Lien E."/>
<person name="Monks B.G."/>
<person name="Rothe M."/>
<person name="Golenbock D.T."/>
</authorList>
<dbReference type="PubMed" id="10358136"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<source>
<tissue>Ovarian carcinoma</tissue>
</source>
</reference>
<comment type="function">
<text evidence="2 3">Cooperates with LY96 to mediate the innate immune response to bacterial lipoproteins and other microbial cell wall components. Cooperates with TLR1 or TLR6 to mediate the innate immune response to bacterial lipoproteins or lipopeptides. Acts via MYD88 and TRAF6, leading to NF-kappa-B activation, cytokine secretion and the inflammatory response (By similarity). May also promote apoptosis in response to lipoproteins. Forms activation clusters composed of several receptors depending on the ligand, these clusters trigger signaling from the cell surface and subsequently are targeted to the Golgi in a lipid-raft dependent pathway. Forms the cluster TLR2:TLR6:CD14:CD36 in response to diacylated lipopeptides and TLR2:TLR1:CD14 in response to triacylated lipopeptides (By similarity).</text>
</comment>
<comment type="catalytic activity">
<reaction evidence="5">
<text>H2O + NAD(+) = ADP-D-ribose + H(+) + nicotinamide</text>
<dbReference type="Rhea" id="RHEA:16301"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:17154"/>
<dbReference type="ChEBI" id="CHEBI:57540"/>
<dbReference type="ChEBI" id="CHEBI:57967"/>
<dbReference type="EC" id="3.2.2.6"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="5">
<dbReference type="Rhea" id="RHEA:16302"/>
</physiologicalReaction>
</comment>
<comment type="subunit">
<text evidence="2 3">Interacts with LY96, TLR1 and TLR6 (via extracellular domain). TLR2 seems to exist in heterodimers with either TLR1 or TLR6 before stimulation by the ligand. The heterodimers form bigger oligomers in response to their corresponding ligands as well as further heterotypic associations with other receptors such as CD14 and/or CD36. Binds MYD88 (via TIR domain). Interacts with TICAM1. Interacts with CNPY3. Interacts with ATG16L1. Interacts with PPP1R11. Interacts with TICAM2.</text>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="3">Membrane</location>
<topology evidence="4">Single-pass type I membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="3">Cytoplasmic vesicle</location>
<location evidence="3">Phagosome membrane</location>
<topology evidence="4">Single-pass type I membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="2">Membrane raft</location>
</subcellularLocation>
<text evidence="2">Does not reside in lipid rafts before stimulation but accumulates increasingly in the raft upon the presence of the microbial ligand. In response to diacylated lipoproteins, TLR2:TLR6 heterodimers are recruited in lipid rafts, this recruitment determine the intracellular targeting to the Golgi apparatus. Triacylated lipoproteins induce the same mechanism for TLR2:TLR1 heterodimers.</text>
</comment>
<comment type="domain">
<text evidence="1">Ester-bound lipid substrates are bound through a crevice formed between the LRR 11 and LRR 12.</text>
</comment>
<comment type="domain">
<text evidence="1">The ATG16L1-binding motif mediates interaction with ATG16L1.</text>
</comment>
<comment type="domain">
<text evidence="5">The TIR domain mediates NAD(+) hydrolase (NADase) activity. Self-association of TIR domains is required for NADase activity.</text>
</comment>
<comment type="PTM">
<text evidence="3">Ubiquitinated at Lys-754 by PPP1R11, leading to its degradation. Deubiquitinated by USP2.</text>
</comment>
<comment type="PTM">
<text evidence="2">Glycosylation of Asn-442 is critical for secretion of the N-terminal ectodomain of TLR2.</text>
</comment>
<comment type="similarity">
<text evidence="6">Belongs to the Toll-like receptor family.</text>
</comment>
<comment type="sequence caution" evidence="6">
<conflict type="frameshift">
<sequence resource="EMBL-CDS" id="AAD46477" version="1"/>
</conflict>
<text>A natural deletion may however lead to truncated protein which lacks transmembrane or intracellular domain.</text>
</comment>
<dbReference type="EC" id="3.2.2.6" evidence="5"/>
<dbReference type="EMBL" id="AF113614">
<property type="protein sequence ID" value="AAD46477.1"/>
<property type="status" value="ALT_FRAME"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="SMR" id="Q9R1F8"/>
<dbReference type="STRING" id="10029.XP_007635375.1"/>
<dbReference type="eggNOG" id="KOG4641">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GO" id="GO:0005794">
<property type="term" value="C:Golgi apparatus"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016021">
<property type="term" value="C:integral component of membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0045121">
<property type="term" value="C:membrane raft"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030670">
<property type="term" value="C:phagocytic vesicle membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0050135">
<property type="term" value="F:NAD(P)+ nucleosidase activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0061809">
<property type="term" value="F:NAD+ nucleotidase, cyclic ADP-ribose generating"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0004888">
<property type="term" value="F:transmembrane signaling receptor activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0071726">
<property type="term" value="P:cellular response to diacyl bacterial lipopeptide"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071727">
<property type="term" value="P:cellular response to triacyl bacterial lipopeptide"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006954">
<property type="term" value="P:inflammatory response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0045087">
<property type="term" value="P:innate immune response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0002755">
<property type="term" value="P:MyD88-dependent toll-like receptor signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0050729">
<property type="term" value="P:positive regulation of inflammatory response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0034134">
<property type="term" value="P:toll-like receptor 2 signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="Gene3D" id="3.40.50.10140">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="3.80.10.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR000483">
<property type="entry name" value="Cys-rich_flank_reg_C"/>
</dbReference>
<dbReference type="InterPro" id="IPR001611">
<property type="entry name" value="Leu-rich_rpt"/>
</dbReference>
<dbReference type="InterPro" id="IPR003591">
<property type="entry name" value="Leu-rich_rpt_typical-subtyp"/>
</dbReference>
<dbReference type="InterPro" id="IPR032675">
<property type="entry name" value="LRR_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR000157">
<property type="entry name" value="TIR_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR027185">
<property type="entry name" value="TLR2"/>
</dbReference>
<dbReference type="InterPro" id="IPR017241">
<property type="entry name" value="Toll-like_receptor"/>
</dbReference>
<dbReference type="InterPro" id="IPR035897">
<property type="entry name" value="Toll_tir_struct_dom_sf"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR24365">
<property type="entry name" value="PTHR24365"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR24365:SF17">
<property type="entry name" value="PTHR24365:SF17"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF13855">
<property type="entry name" value="LRR_8"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="Pfam" id="PF01463">
<property type="entry name" value="LRRCT"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF01582">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PIRSF" id="PIRSF037595">
<property type="entry name" value="Toll-like_receptor"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00369">
<property type="entry name" value="LRR_TYP"/>
<property type="match status" value="6"/>
</dbReference>
<dbReference type="SMART" id="SM00082">
<property type="entry name" value="LRRCT"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00255">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF52200">
<property type="entry name" value="SSF52200"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51450">
<property type="entry name" value="LRR"/>
<property type="match status" value="9"/>
</dbReference>
<dbReference type="PROSITE" id="PS50104">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at transcript level"/>
<keyword id="KW-0968">Cytoplasmic vesicle</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0378">Hydrolase</keyword>
<keyword id="KW-0391">Immunity</keyword>
<keyword id="KW-0395">Inflammatory response</keyword>
<keyword id="KW-0399">Innate immunity</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0433">Leucine-rich repeat</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0520">NAD</keyword>
<keyword id="KW-0675">Receptor</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0732">Signal</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="signal peptide" evidence="4">
<location>
<begin position="1"/>
<end position="24"/>
</location>
</feature>
<feature type="chain" description="Toll-like receptor 2" id="PRO_0000034709">
<location>
<begin position="25"/>
<end position="784"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="4">
<location>
<begin position="25"/>
<end position="588"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="4">
<location>
<begin position="589"/>
<end position="609"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="4">
<location>
<begin position="610"/>
<end position="784"/>
</location>
</feature>
<feature type="repeat" description="LRR 1">
<location>
<begin position="54"/>
<end position="77"/>
</location>
</feature>
<feature type="repeat" description="LRR 2">
<location>
<begin position="78"/>
<end position="101"/>
</location>
</feature>
<feature type="repeat" description="LRR 3">
<location>
<begin position="102"/>
<end position="125"/>
</location>
</feature>
<feature type="repeat" description="LRR 4">
<location>
<begin position="126"/>
<end position="150"/>
</location>
</feature>
<feature type="repeat" description="LRR 5">
<location>
<begin position="151"/>
<end position="175"/>
</location>
</feature>
<feature type="repeat" description="LRR 6">
<location>
<begin position="176"/>
<end position="199"/>
</location>
</feature>
<feature type="repeat" description="LRR 7">
<location>
<begin position="200"/>
<end position="223"/>
</location>
</feature>
<feature type="repeat" description="LRR 8">
<location>
<begin position="224"/>
<end position="250"/>
</location>
</feature>
<feature type="repeat" description="LRR 9">
<location>
<begin position="251"/>
<end position="278"/>
</location>
</feature>
<feature type="repeat" description="LRR 10">
<location>
<begin position="279"/>
<end position="308"/>
</location>
</feature>
<feature type="repeat" description="LRR 11">
<location>
<begin position="309"/>
<end position="337"/>
</location>
</feature>
<feature type="repeat" description="LRR 12">
<location>
<begin position="338"/>
<end position="361"/>
</location>
</feature>
<feature type="repeat" description="LRR 13">
<location>
<begin position="362"/>
<end position="388"/>
</location>
</feature>
<feature type="repeat" description="LRR 14">
<location>
<begin position="389"/>
<end position="414"/>
</location>
</feature>
<feature type="repeat" description="LRR 15">
<location>
<begin position="415"/>
<end position="437"/>
</location>
</feature>
<feature type="repeat" description="LRR 16">
<location>
<begin position="438"/>
<end position="457"/>
</location>
</feature>
<feature type="repeat" description="LRR 17">
<location>
<begin position="458"/>
<end position="478"/>
</location>
</feature>
<feature type="repeat" description="LRR 18">
<location>
<begin position="479"/>
<end position="500"/>
</location>
</feature>
<feature type="repeat" description="LRR 19">
<location>
<begin position="501"/>
<end position="524"/>
</location>
</feature>
<feature type="domain" description="LRRCT">
<location>
<begin position="525"/>
<end position="579"/>
</location>
</feature>
<feature type="domain" description="TIR" evidence="5">
<location>
<begin position="639"/>
<end position="782"/>
</location>
</feature>
<feature type="short sequence motif" description="ATG16L1-binding motif">
<location>
<begin position="761"/>
<end position="778"/>
</location>
</feature>
<feature type="active site" evidence="5">
<location>
<position position="716"/>
</location>
</feature>
<feature type="site" description="Interaction with bacterial lipopeptide" evidence="1">
<location>
<position position="349"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="114"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="147"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="414"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="442"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1">
<location>
<begin position="30"/>
<end position="36"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1">
<location>
<begin position="353"/>
<end position="382"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1">
<location>
<begin position="432"/>
<end position="454"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="2">
<location>
<position position="754"/>
</location>
</feature>
<evidence key="1" type="ECO:0000250"/>
<evidence key="2" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="O60603"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q9QUN7"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000255"/>
<evidence key="5" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00204"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000305"/>
<sequence length="784" mass="89210" checksum="715D8592B4230092" modified="2002-01-31" version="2" precursor="true">MLHVLWTFWILVAMTDLSRKGCSAQASLSCDAAGVCDGRSRSFTSIPSGLTAAMKSLDLSNNKITSIGHGDLRGCVNLRALILQSSGINTIEEDAFSSLSKLEYLDLSDNHLSNLSSSWFRPLSSLKYLNLLGNPYRILGETPLFLNLTHLQTLRVGNVATFSGIRRTDFAGLTSLDELEIKALSLQNYEPGSLQSIQSIHHLTFHLSQSDFLLGVFEDTLSSVGYLELRDANLDSFYFSELSTDEMNSPMKKLAFQNADLTDESFNELLKLLRYTPELLEVEFDDCTLNGVGDFQPSESDVVRELGKVETLIIRRLHIPRFYSFYDLSTVYTLLEKVKRITVENSKVFLVPCLFSQHLKSLEFLDLSENLMVEEYLKNAACEGSWPSLQTLILRQNRLKSIERTGKILLTLKNLTALDISRNSFQSMPDSCQWPGKMRFLNLSSTGIQAVKMCIPQTLEVLDVSNNNLISFSLFLPLLRELYISRNKLHTLPDASLFPVLLVMKIRENAISTFSKDQLSSFPKLVSLEAGGNHFICSCELLSFTLEHPALVQVLAGWPDSYLCDSPSRLRGQRVQDARPSVLECHQTLLVSGVCCALVLLILLIGGLCHHFHGLWYLRMMWAWLQAKRKPKKAPCRDICYDAFVSYSEQDSYWVENLMVQQLENSEPPFKLCLHKRDFVPGKWIIDNIIDSIEKSHKTLFVLSENFVRSEWCKYELDFSHFRLFDENNDAGILVLLEPIEKKAIPQRFCKLRKIMNTKTYLEWPLDEGQQEVFWVNLRTAIKS</sequence>
</entry>
<entry dataset="Swiss-Prot" created="2002-01-31" modified="2021-02-10" version="126">
<accession>Q9DGB6</accession>
<name>TLR22_CHICK</name>
<protein>
<recommendedName>
<fullName>Toll-like receptor 2 type-2</fullName>
<ecNumber evidence="3">3.2.2.6</ecNumber>
</recommendedName>
</protein>
<gene>
<name type="primary">TLR2-2</name>
</gene>
<organism>
<name type="scientific">Gallus gallus</name>
<name type="common">Chicken</name>
<dbReference type="NCBI Taxonomy" id="9031"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Archelosauria</taxon>
<taxon>Archosauria</taxon>
<taxon>Dinosauria</taxon>
<taxon>Saurischia</taxon>
<taxon>Theropoda</taxon>
<taxon>Coelurosauria</taxon>
<taxon>Aves</taxon>
<taxon>Neognathae</taxon>
<taxon>Galloanserae</taxon>
<taxon>Galliformes</taxon>
<taxon>Phasianidae</taxon>
<taxon>Phasianinae</taxon>
<taxon>Gallus</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="2001" name="J. Biol. Chem." volume="276" first="47143" last="47149">
<title>Molecular cloning and functional characterization of chicken Toll-like receptors. A single chicken Toll covers multiple molecular patterns.</title>
<authorList>
<person name="Fukui A."/>
<person name="Inoue N."/>
<person name="Matsumoto M."/>
<person name="Nomura M."/>
<person name="Yamada K."/>
<person name="Matsuda Y."/>
<person name="Toyoshima K."/>
<person name="Seya T."/>
</authorList>
<dbReference type="PubMed" id="11590137"/>
<dbReference type="DOI" id="10.1074/jbc.m103902200"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<comment type="function">
<text>Participates in the innate immune response to microbial agents. Acts via MYD88 and TRAF6, leading to NF-kappa-B activation, cytokine secretion and the inflammatory response. Mediates the response to mycoplasmal macrophage-activating lipopeptide-2kD (MALP-2).</text>
</comment>
<comment type="catalytic activity">
<reaction evidence="3">
<text>H2O + NAD(+) = ADP-D-ribose + H(+) + nicotinamide</text>
<dbReference type="Rhea" id="RHEA:16301"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:17154"/>
<dbReference type="ChEBI" id="CHEBI:57540"/>
<dbReference type="ChEBI" id="CHEBI:57967"/>
<dbReference type="EC" id="3.2.2.6"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="3">
<dbReference type="Rhea" id="RHEA:16302"/>
</physiologicalReaction>
</comment>
<comment type="subunit">
<text evidence="1">Binds MYD88 (via TIR domain).</text>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="1">Membrane</location>
<topology evidence="1">Single-pass type I membrane protein</topology>
</subcellularLocation>
</comment>
<comment type="tissue specificity">
<text>Highly expressed in ovary. Also detected in brain, heart, lung, liver, spleen and kidney, and at low levels in gizzard, muscle, testis and proventriculus.</text>
</comment>
<comment type="domain">
<text evidence="3">The TIR domain mediates NAD(+) hydrolase (NADase) activity. Self-association of TIR domains is required for NADase activity.</text>
</comment>
<comment type="PTM">
<text>N-glycosylated.</text>
</comment>
<comment type="similarity">
<text evidence="4">Belongs to the Toll-like receptor family.</text>
</comment>
<dbReference type="EC" id="3.2.2.6" evidence="3"/>
<dbReference type="EMBL" id="AB046533">
<property type="protein sequence ID" value="BAB16842.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="SMR" id="Q9DGB6"/>
<dbReference type="STRING" id="9031.ENSGALP00000038134"/>
<dbReference type="eggNOG" id="KOG4641">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="InParanoid" id="Q9DGB6"/>
<dbReference type="PhylomeDB" id="Q9DGB6"/>
<dbReference type="PRO" id="PR:Q9DGB6"/>
<dbReference type="Proteomes" id="UP000000539">
<property type="component" value="Unplaced"/>
</dbReference>
<dbReference type="GO" id="GO:0005887">
<property type="term" value="C:integral component of plasma membrane"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0050135">
<property type="term" value="F:NAD(P)+ nucleosidase activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0061809">
<property type="term" value="F:NAD+ nucleotidase, cyclic ADP-ribose generating"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0038023">
<property type="term" value="F:signaling receptor activity"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0004888">
<property type="term" value="F:transmembrane signaling receptor activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0042497">
<property type="term" value="F:triacyl lipopeptide binding"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0042494">
<property type="term" value="P:detection of bacterial lipoprotein"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="Roslin"/>
</dbReference>
<dbReference type="GO" id="GO:0006954">
<property type="term" value="P:inflammatory response"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0045087">
<property type="term" value="P:innate immune response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0002755">
<property type="term" value="P:MyD88-dependent toll-like receptor signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0050729">
<property type="term" value="P:positive regulation of inflammatory response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0034134">
<property type="term" value="P:toll-like receptor 2 signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0002224">
<property type="term" value="P:toll-like receptor signaling pathway"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="Gene3D" id="3.40.50.10140">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="3.80.10.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR000483">
<property type="entry name" value="Cys-rich_flank_reg_C"/>
</dbReference>
<dbReference type="InterPro" id="IPR018247">
<property type="entry name" value="EF_Hand_1_Ca_BS"/>
</dbReference>
<dbReference type="InterPro" id="IPR001611">
<property type="entry name" value="Leu-rich_rpt"/>
</dbReference>
<dbReference type="InterPro" id="IPR003591">
<property type="entry name" value="Leu-rich_rpt_typical-subtyp"/>
</dbReference>
<dbReference type="InterPro" id="IPR032675">
<property type="entry name" value="LRR_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR000157">
<property type="entry name" value="TIR_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR027185">
<property type="entry name" value="TLR2"/>
</dbReference>
<dbReference type="InterPro" id="IPR017241">
<property type="entry name" value="Toll-like_receptor"/>
</dbReference>
<dbReference type="InterPro" id="IPR035897">
<property type="entry name" value="Toll_tir_struct_dom_sf"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR24365">
<property type="entry name" value="PTHR24365"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR24365:SF17">
<property type="entry name" value="PTHR24365:SF17"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF13855">
<property type="entry name" value="LRR_8"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="Pfam" id="PF01582">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PIRSF" id="PIRSF037595">
<property type="entry name" value="Toll-like_receptor"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00369">
<property type="entry name" value="LRR_TYP"/>
<property type="match status" value="7"/>
</dbReference>
<dbReference type="SMART" id="SM00082">
<property type="entry name" value="LRRCT"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00255">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF52200">
<property type="entry name" value="SSF52200"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51450">
<property type="entry name" value="LRR"/>
<property type="match status" value="11"/>
</dbReference>
<dbReference type="PROSITE" id="PS50104">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at transcript level"/>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0378">Hydrolase</keyword>
<keyword id="KW-0391">Immunity</keyword>
<keyword id="KW-0395">Inflammatory response</keyword>
<keyword id="KW-0399">Innate immunity</keyword>
<keyword id="KW-0433">Leucine-rich repeat</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0520">NAD</keyword>
<keyword id="KW-0675">Receptor</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0732">Signal</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<feature type="signal peptide" evidence="2">
<location>
<begin position="1"/>
<end position="24"/>
</location>
</feature>
<feature type="chain" description="Toll-like receptor 2 type-2" id="PRO_0000034714">
<location>
<begin position="25"/>
<end position="781"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="2">
<location>
<begin position="25"/>
<end position="585"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="2">
<location>
<begin position="586"/>
<end position="606"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="2">
<location>
<begin position="607"/>
<end position="781"/>
</location>
</feature>
<feature type="repeat" description="LRR 1">
<location>
<begin position="53"/>
<end position="74"/>
</location>
</feature>
<feature type="repeat" description="LRR 2">
<location>
<begin position="77"/>
<end position="98"/>
</location>
</feature>
<feature type="repeat" description="LRR 3">
<location>
<begin position="101"/>
<end position="122"/>
</location>
</feature>
<feature type="repeat" description="LRR 4">
<location>
<begin position="125"/>
<end position="146"/>
</location>
</feature>
<feature type="repeat" description="LRR 5">
<location>
<begin position="150"/>
<end position="171"/>
</location>
</feature>
<feature type="repeat" description="LRR 6">
<location>
<begin position="174"/>
<end position="195"/>
</location>
</feature>
<feature type="repeat" description="LRR 7">
<location>
<begin position="358"/>
<end position="378"/>
</location>
</feature>
<feature type="repeat" description="LRR 8">
<location>
<begin position="385"/>
<end position="406"/>
</location>
</feature>
<feature type="repeat" description="LRR 9">
<location>
<begin position="411"/>
<end position="432"/>
</location>
</feature>
<feature type="repeat" description="LRR 10">
<location>
<begin position="434"/>
<end position="455"/>
</location>
</feature>
<feature type="repeat" description="LRR 11">
<location>
<begin position="456"/>
<end position="474"/>
</location>
</feature>
<feature type="repeat" description="LRR 12">
<location>
<begin position="475"/>
<end position="496"/>
</location>
</feature>
<feature type="repeat" description="LRR 13">
<location>
<begin position="497"/>
<end position="518"/>
</location>
</feature>
<feature type="domain" description="LRRCT">
<location>
<begin position="530"/>
<end position="584"/>
</location>
</feature>
<feature type="domain" description="TIR" evidence="3">
<location>
<begin position="636"/>
<end position="779"/>
</location>
</feature>
<feature type="active site" evidence="3">
<location>
<position position="713"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="2">
<location>
<position position="37"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="2">
<location>
<position position="109"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="2">
<location>
<position position="150"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="2">
<location>
<position position="184"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="2">
<location>
<position position="301"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="2">
<location>
<position position="313"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="2">
<location>
<position position="390"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="2">
<location>
<position position="439"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1">
<location>
<begin position="30"/>
<end position="36"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1">
<location>
<begin position="350"/>
<end position="379"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1">
<location>
<begin position="429"/>
<end position="451"/>
</location>
</feature>
<evidence key="1" type="ECO:0000250"/>
<evidence key="2" type="ECO:0000255"/>
<evidence key="3" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00204"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000305"/>
<sequence length="781" mass="89095" checksum="7211B399C6320454" modified="2001-03-01" version="1" precursor="true">MHTWKMWAICTALAAHLPEEQALRQACLSCDATQSCNCSFMGLDFIPPGLTGKITVLNLAHNRIKVIRTHDLQKAVNLRTLLLQSNQISSIDEDSFGSQGKLELLDLSNNSLAHLSPVWFGPLFSLQHLRIQGNSYSDLGESSPFSSLRNLSSLHLGNPQFSIIRQGNFEGIVFLNTLRIDGDNLSQYEPGSLKSIRKINHMIISIRRIDVFSAVIRDLLHSAIWLDVRKLAFSVPEKIQLLRIMSSSFAKKISLKQCLFTDATVPEIVSILEGMPKLMEVEMKDCTLLGTGKWYKQIHANQSQSLRILTIENLSIEEFYLFTDLQSVLDLLSLFRKVTVENTKVFLVPCKLSQHLLSLEYLDLSANLLGDQSLEHSACQGAWPSLQTLNLSQNSLSDLKMTGKSLFHLRNLNLLDISENNFGEIPDMCEWPENLKYLNLSSTQIPKLTTCIPSTLEVLDVSANNLQDFGLQLPFLKELYLTKNHLKTLPEATDIPNLVAMSISRNKLNSFSKEEFESFKQMELLDASANNFICSCEFLSFIHHEAGIAQVLVGWPESYICDSPLTVRGAQVGSVQLSLMECHRSLLVSLICTLVFLFILILVVVGYKYHAVWYMRMTWAWLQAKRKPKRAPTKDICYDAFVSYSENDSNWVENIMVQQLEQACPPFRLCLHKRDFVPGKWIVDNIIDSIEKSHKTLFVLSEHFVQSEWCKYELDFSHFRLFDENNDVAILILLEPIQSQAIPKRFCKLRKIMNTKTYLEWPPDEEQQQMFWENLKAALKS</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>